Clustering O 0 1.1000312269970891e-06
of O 0 1.1868988991636797e-07
missense O 0 3.8482039599330164e-07
mutations O 0 8.294749775927812e-09
in O 0 9.680283241664256e-09
the O 0 1.7929925206772168e-06
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
gene O 0 1.1019212251994759e-05
in O 0 1.0682451545562799e-07
a O 0 2.5469828912605408e-08
sporadic B-Disease 0 6.046196176612284e-06
T I-Disease 0 0.00012000056449323893
- I-Disease 0 4.325282498029992e-05
cell I-Disease 0 5.153835809323937e-05
leukaemia I-Disease 1 0.9999949932098389
. O 0 2.4230548660852946e-06

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 3.3451422496000305e-05
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.1709474501131467e-09
is O 0 6.468001828574543e-11
a O 0 1.213951439371641e-10
recessive B-Disease 0 6.1366369763504736e-09
multi I-Disease 0 1.7042611943907104e-06
- I-Disease 0 0.0019921266939491034
system I-Disease 0 5.1208447985118255e-05
disorder I-Disease 1 0.9785485863685608
caused O 0 2.3721505315599245e-10
by O 0 6.931539760571259e-13
mutations O 0 6.557448160859902e-12
in O 0 3.322837491270825e-11
the O 0 5.731417007659445e-10
ATM O 0 8.415803876005157e-08
gene O 0 2.783591357413684e-09
at O 0 3.302944406868846e-08
11q22 O 0 1.487010649725562e-06
- O 0 1.1274952385065262e-06
q23 O 0 2.973357595692505e-06
( O 0 5.853763029861625e-10
ref O 0 6.463472601581088e-08
. O 0 4.3837061758367213e-10
3 O 0 6.5761076584180955e-09
) O 0 1.5525972729690807e-09
. O 0 3.554176331022063e-08

The O 0 1.4079645893616544e-07
risk O 0 1.2447753761080094e-07
of O 0 7.3091519503520885e-09
cancer B-Disease 0 2.3861801423663564e-07
, O 0 5.389983459558323e-10
especially O 0 1.5138800213421177e-09
lymphoid B-Disease 0 6.198290066095069e-06
neoplasias I-Disease 0 0.01844942755997181
, O 0 7.406373292440094e-10
is O 0 6.71075131228327e-12
substantially O 0 2.620722527879593e-10
elevated O 0 1.3817306188101952e-09
in O 0 3.7007861219962024e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 1.2982214911971823e-06
and O 0 2.7993496409806085e-10
has O 0 3.771967460597381e-11
long O 0 1.4727856087470848e-11
been O 0 2.4564612496891236e-11
associated O 0 2.593888437374403e-10
with O 0 3.1955676993433713e-10
chromosomal O 1 1.0
instability O 1 1.0
. O 0 5.126707947056275e-06

By O 0 2.0079507834225296e-08
analysing O 0 2.125031414834666e-06
tumour B-Disease 1 1.0
DNA O 0 2.8882466196478163e-08
from O 0 2.8738900148539415e-10
patients O 0 6.159920490356185e-11
with O 0 3.7901805175280523e-13
sporadic B-Disease 0 3.742018250818546e-09
T I-Disease 0 6.266488412620674e-07
- I-Disease 0 3.807591383520048e-06
cell I-Disease 0 0.00179068255238235
prolymphocytic I-Disease 1 0.9999632835388184
leukaemia I-Disease 1 1.0
( O 0 2.101605778292992e-09
T B-Disease 0 7.825443049114256e-08
- I-Disease 0 5.818104753529951e-08
PLL I-Disease 0 7.868455327297852e-07
) O 0 2.0435839132026956e-10
, O 0 6.971508786923764e-11
a O 0 3.2037761332759374e-10
rare O 0 3.816325033767498e-09
clonal B-Disease 0 2.4463429326715413e-07
malignancy I-Disease 0 2.2266537769155548e-07
with O 0 6.474972034237192e-12
similarities O 0 1.7660464757263128e-10
to O 0 9.412292056865112e-10
a O 0 2.725246250889768e-09
mature B-Disease 0 8.457997324740063e-08
T I-Disease 0 1.4890795796418388e-07
- I-Disease 0 6.707283972673395e-08
cell I-Disease 0 5.491696342119212e-08
leukaemia I-Disease 0 9.276363925891928e-07
seen O 0 1.6739170050072971e-09
in O 0 9.03348174041696e-10
A B-Disease 1 1.0
- I-Disease 1 0.9996894598007202
T I-Disease 1 1.0
, O 0 3.4794508940727553e-10
we O 0 1.2977675878378392e-10
demonstrate O 0 1.958036927041107e-10
a O 0 9.672337930588526e-11
high O 0 4.580050505520461e-10
frequency O 0 1.0613922185598312e-08
of O 0 3.5885467930540926e-09
ATM O 0 2.0378622593852924e-06
mutations O 0 1.2547143057872745e-07
in O 0 7.762632776575629e-07
T B-Disease 0 0.00010883317008847371
- I-Disease 0 3.691305755637586e-05
PLL I-Disease 0 0.00019432022236287594
. O 0 2.0125230548728723e-06

In O 0 1.9205002033118035e-08
marked O 0 9.93679716287943e-09
contrast O 0 6.282807607504992e-10
to O 0 8.105502935507047e-10
the O 0 2.824422640212987e-10
ATM O 0 5.7298269240391164e-08
mutation O 0 2.60417937214541e-10
pattern O 0 9.843036802292815e-11
in O 0 2.392220643798737e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
, O 0 2.2966828439052733e-09
the O 0 7.030292459297982e-10
most O 0 1.2895035733651028e-11
frequent O 0 7.276702677916358e-12
nucleotide O 0 1.0829287466762594e-09
changes O 0 1.0314041842818256e-09
in O 0 6.242492633923291e-10
this O 0 1.5740659886631647e-09
leukaemia B-Disease 0 5.285225597617682e-06
were O 0 4.175464596301026e-08
missense O 0 1.1767871228585136e-06
mutations O 0 1.9098835934983072e-07
. O 0 3.5536723430595885e-07

These O 0 6.585622269739133e-09
clustered O 0 9.98036542299019e-10
in O 0 7.945969437983535e-10
the O 0 2.2099457819280133e-09
region O 0 9.613451146250895e-10
corresponding O 0 9.515492394029934e-09
to O 0 7.094634213444806e-08
the O 0 4.162550837349954e-08
kinase O 0 3.888206734359301e-08
domain O 0 7.0677539376617915e-09
, O 0 5.442438860692178e-11
which O 0 8.827967003244286e-12
is O 0 2.493492608571235e-12
highly O 0 2.1323387500160607e-11
conserved O 0 5.632696045698715e-11
in O 0 6.320427514694416e-10
ATM O 0 1.908219502411157e-07
- O 0 8.879231572223034e-09
related O 0 8.946887675165272e-10
proteins O 0 7.302623783456141e-11
in O 0 1.2023199102983995e-09
mouse O 0 3.5362504036129394e-08
, O 0 2.6927399199294655e-10
yeast O 0 1.4624802480156518e-09
and O 0 1.628567170008921e-09
Drosophila O 0 4.4382022679201327e-07
. O 0 1.8364386278335587e-07

The O 0 2.3833325712985243e-07
resulting O 0 8.748377133827034e-09
amino O 0 1.4404336390327899e-08
- O 0 1.91006694905127e-08
acid O 0 1.17794387577419e-08
substitutions O 0 2.133644017021652e-08
are O 0 6.487659021114922e-11
predicted O 0 1.0511898018705779e-08
to O 0 2.235101526082417e-08
interfere O 0 7.972435582814796e-07
with O 0 6.3032992159151036e-09
ATP O 0 1.5156976587604731e-05
binding O 0 5.4811273741961486e-08
or O 0 4.696291355799076e-09
substrate O 0 2.5934555836215623e-08
recognition O 0 8.666057027539864e-08
. O 0 1.4283334337505948e-07

Two O 0 6.228297877441946e-08
of O 0 3.527371816858249e-08
seventeen O 0 1.246917662456326e-07
mutated O 0 5.936162139619228e-08
T B-Disease 0 3.792049199091707e-07
- I-Disease 0 1.9216312807657232e-07
PLL I-Disease 0 3.712938905664487e-06
samples O 0 2.8333337454000684e-08
had O 0 6.637637661732754e-10
a O 0 6.070090263765593e-11
previously O 0 4.844367129663851e-10
reported O 0 3.965830330798781e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
allele O 0 2.296155571457348e-06
. O 0 4.321513245031383e-07

In O 0 2.585222880213678e-08
contrast O 0 4.053362534506277e-09
, O 0 4.5774745105475745e-10
no O 0 8.384248850745735e-10
mutations O 0 2.3082448452615978e-10
were O 0 9.346083906791591e-10
detected O 0 4.708390566321441e-09
in O 0 2.3119297587470555e-09
the O 0 2.3777742441666305e-08
p53 O 0 1.5171991663009976e-08
gene O 0 1.1184949855191917e-08
, O 0 1.0077654266638092e-09
suggesting O 0 1.1934259802615088e-08
that O 0 1.1404518995838941e-10
this O 0 6.823969167513155e-10
tumour B-Disease 1 1.0
suppressor O 0 8.333984737873834e-07
is O 0 1.333651383772505e-10
not O 0 1.0276746120752023e-10
frequently O 0 7.305939880852819e-11
altered O 0 1.107122060695076e-09
in O 0 1.1507681474398623e-09
this O 0 7.309751914874596e-09
leukaemia B-Disease 0 3.417629704927094e-05
. O 0 3.5276551102469966e-07

Occasional O 0 3.8176231100806035e-06
missense O 0 2.0805143776669865e-06
mutations O 0 3.912010981821368e-08
in O 0 5.070023956221803e-09
ATM O 0 1.3713246289626113e-06
were O 0 1.4163582306991884e-08
also O 0 9.209297213708112e-10
found O 0 4.280685528268435e-11
in O 0 1.9504366177702792e-10
tumour B-Disease 1 1.0
DNA O 0 7.009141711478151e-09
from O 0 9.271260148491223e-11
patients O 0 4.69702991778842e-11
with O 0 4.168658148707982e-13
B B-Disease 0 8.79968720113311e-09
- I-Disease 0 5.9300937493844685e-09
cell I-Disease 0 4.5112545876691e-07
non I-Disease 1 1.0
- I-Disease 1 1.0
Hodgkins I-Disease 1 1.0
lymphomas I-Disease 1 0.9999711513519287
( O 0 8.632835418742602e-11
B B-Disease 0 9.39267685851064e-09
- I-Disease 0 6.698865351317806e-10
NHL I-Disease 0 1.1386429576987211e-07
) O 0 6.106576355691118e-11
and O 0 1.2635141544148354e-10
a O 0 4.49757031617537e-09
B B-Disease 0 6.608462399526616e-07
- I-Disease 0 7.740825935798057e-08
NHL I-Disease 0 2.8097838367102668e-06
cell O 0 7.46098123727279e-07
line O 0 1.1363316616552765e-06
. O 0 4.3062257759629574e-07

The O 0 1.592840845887622e-07
evidence O 0 5.4958775308477925e-08
of O 0 1.3306284962766313e-09
a O 0 9.352087854130886e-11
significant O 0 7.433656468158745e-11
proportion O 0 1.0998937871598002e-10
of O 0 9.643238430001588e-10
loss O 0 1.4027108363734442e-09
- O 0 7.14257408773733e-09
of O 0 2.7538296976103993e-08
- O 0 4.379587803526874e-09
function O 0 9.63812585297319e-10
mutations O 0 1.7036104471568336e-10
and O 0 1.1651294512526889e-11
a O 0 9.015833912773275e-11
complete O 0 1.2795754678052162e-08
absence O 0 2.4725559910621087e-07
of O 0 7.414236335989699e-09
the O 0 1.2334759880161528e-09
normal O 0 3.028096440260697e-09
copy O 0 4.005736542467275e-08
of O 0 2.071424143323952e-09
ATM O 0 1.622739489448577e-07
in O 0 4.5557539962715055e-09
the O 0 1.1539909472446652e-08
majority O 0 3.021160543958956e-10
of O 0 3.7171916655864834e-09
mutated O 0 4.6999949177006783e-07
tumours B-Disease 1 1.0
establishes O 0 1.4030247186269662e-08
somatic O 0 4.8828233900621854e-08
inactivation O 0 1.344245390555443e-07
of O 0 1.04236903553101e-08
this O 0 1.948726180422966e-10
gene O 0 1.893589313128885e-10
in O 0 2.909186780364337e-10
the O 0 1.1305698599528569e-09
pathogenesis O 0 2.6470476655049424e-07
of O 0 3.267708104104372e-09
sporadic B-Disease 0 1.1276715667918324e-06
T I-Disease 0 8.251352846855298e-05
- I-Disease 0 5.2421361033339053e-05
PLL I-Disease 0 0.13576443493366241
and O 0 6.368644278609281e-08
suggests O 0 4.9142538927071655e-08
that O 0 4.64749939921294e-11
ATM O 0 5.2350088708408293e-08
acts O 0 8.085897285070587e-09
as O 0 1.0887386103775043e-08
a O 0 8.244185067951548e-08
tumour B-Disease 1 1.0
suppressor O 0 0.00015341691323556006
. O 0 1.859023200267984e-06

As O 0 2.12590393289247e-07
constitutional O 0 2.0613086348930665e-07
DNA O 0 1.3766594975095359e-08
was O 0 5.097513522400732e-09
not O 0 5.013800485897946e-11
available O 0 4.3943795824397114e-10
, O 0 2.606707731611646e-11
a O 0 2.506723162376545e-10
putative O 0 5.685995461135462e-07
hereditary O 1 0.9999566078186035
predisposition O 1 0.9999998807907104
to O 1 0.9228274822235107
T B-Disease 0 0.018379736691713333
- I-Disease 0 2.1352179828681983e-05
PLL I-Disease 0 2.4173668862204067e-05
will O 0 4.7407957559642e-09
require O 0 3.498671796720032e-09
further O 0 1.8251198330432317e-09
investigation O 0 9.391454280915923e-10
. O 0 1.7191521539672294e-09
. O 0 5.57068275952588e-08

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 0 3.16826998414399e-07
kinase O 0 3.114819335792163e-08
is O 0 2.960967582232854e-11
involved O 0 6.353999357916473e-12
in O 0 3.574893506219645e-11
the O 0 7.242191846223989e-10
modulation O 0 3.895562983302625e-08
of O 0 2.165036594448111e-09
the O 0 6.643265049177671e-09
Ca2 O 0 4.0908091136770963e-07
+ O 0 5.130279987497488e-07
homeostasis O 0 1.0699463928176556e-06
in O 0 3.0605622924895215e-08
skeletal O 0 7.296713647519937e-06
muscle O 0 4.107987479073927e-07
cells O 0 6.966652676965168e-07
. O 0 2.3007535787655797e-07

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 3.1109652809391264e-06
DM B-Disease 1 1.0
) O 0 6.120786100183295e-09
, O 0 2.0280752077717068e-10
the O 0 6.913790651097429e-10
most O 0 2.030385859441708e-10
prevalent O 0 1.8602507623199926e-07
muscular B-Disease 0 2.3923161052152864e-07
disorder I-Disease 0 3.6506122569335275e-08
in O 0 5.617043288830281e-11
adults O 0 4.0924569288947055e-11
, O 0 2.292906533044037e-12
is O 0 1.8284202277230044e-12
caused O 0 1.597864549007788e-11
by O 0 1.85886948195213e-11
( O 0 7.607849766833041e-11
CTG O 0 1.0065019928617858e-08
) O 0 1.2435640191210684e-11
n O 0 1.3272465071434425e-10
- O 0 3.2898511692636134e-10
repeat O 0 3.227973721653399e-10
expansion O 0 7.506352206476663e-10
in O 0 1.0986755255570912e-10
a O 0 3.6676287007431085e-11
gene O 0 5.56910940974209e-12
encoding O 0 3.499377454474484e-10
a O 0 1.5315673174143285e-09
protein O 0 3.43662720503346e-09
kinase O 0 7.594754691808703e-08
( O 0 2.3150932282334225e-09
DM B-Disease 1 0.9999501705169678
protein O 0 3.311921759063807e-08
kinase O 0 3.569925155488818e-08
; O 0 3.408431314966265e-10
DMPK O 0 4.634211734355631e-07
) O 0 4.225507443944565e-11
and O 0 1.193988744679908e-11
involves O 0 3.215473373674449e-11
changes O 0 2.874805671293501e-10
in O 0 2.0418082780082614e-09
cytoarchitecture O 0 1.510116476310941e-06
and O 0 2.885383487694071e-08
ion O 0 2.1720379663747735e-05
homeostasis O 0 0.039649203419685364
. O 0 2.27510608965531e-05

To O 0 3.5685225441284274e-08
obtain O 0 8.240664328695857e-08
clues O 0 1.7235697669093497e-07
to O 0 3.606517751109095e-09
the O 0 9.391293298577352e-10
normal O 0 5.418042903215792e-09
biological O 0 7.217277442350678e-09
role O 0 1.6728263219079054e-08
of O 0 4.51015758073936e-08
DMPK O 0 0.00010937478509731591
in O 0 2.494892328286369e-07
cellular O 0 1.852234731813951e-06
ion O 0 3.7265467653924134e-06
homeostasis O 0 1.893215267045889e-05
, O 0 4.5715435881277244e-09
we O 0 3.228523670628647e-09
have O 0 1.3979106761041749e-10
compared O 0 4.2401951394488435e-10
the O 0 2.2201784855013784e-09
resting O 0 5.5272256105354245e-08
[ O 0 2.5342481890788804e-08
Ca2 O 0 4.79763251348686e-08
+ O 0 1.6872462538231048e-08
] O 0 1.0581176823620808e-08
i O 0 3.7177445566527467e-09
, O 0 6.262715346316838e-11
the O 0 1.1140312283774989e-10
amplitude O 0 6.716085465541255e-10
and O 0 1.591748260976189e-10
shape O 0 9.118518384809704e-09
of O 0 2.4889979854947342e-08
depolarization O 0 1.066199430965753e-07
- O 0 3.599736331239001e-08
induced O 0 3.658433200826039e-08
Ca2 O 0 1.4457155472769045e-08
+ O 0 6.816336384218857e-09
transients O 0 3.3612146399519816e-09
, O 0 2.4960731398460112e-11
and O 0 1.6913807160401362e-11
the O 0 3.0581318033462424e-10
content O 0 2.0445558579496037e-09
of O 0 6.398993557255039e-10
ATP O 0 3.1798116140180355e-08
- O 0 7.589624928527883e-09
driven O 0 2.3698598639043666e-08
ion O 0 6.528195939381476e-08
pumps O 0 5.453711793279581e-08
in O 0 7.59777929459915e-09
cultured O 0 2.4111279344651848e-05
skeletal O 0 0.00020449969451874495
muscle O 0 1.0046036180710871e-07
cells O 0 1.1456397608355928e-08
of O 0 2.356695394389874e-10
wild O 0 2.6672788977499806e-10
- O 0 3.0439847864549563e-10
type O 0 1.6821489756679853e-09
and O 0 3.70644959168942e-10
DMPK O 0 1.6075673556770198e-06
[ O 0 5.2340102030257185e-08
- O 0 2.199665374291726e-07
/ O 0 2.2421181711251847e-06
- O 0 2.0687382402684307e-06
] O 0 1.0976419844155316e-06
knockout O 0 1.7880536688608117e-05
mice O 0 1.5011742107162718e-05
. O 0 7.842280069780827e-07

In O 0 1.7508087069018075e-07
vitro O 0 3.355957574058266e-07
- O 0 4.70185952394786e-08
differentiated O 0 4.432246569763265e-08
DMPK O 0 3.3059088764275657e-06
[ O 0 4.8389697582251756e-08
- O 0 7.866356810382058e-08
/ O 0 1.7663724349858967e-07
- O 0 1.9924564753637242e-07
] O 0 5.0066216061850355e-08
myotubes O 0 7.494170972677239e-08
exhibit O 0 2.927166287136629e-09
a O 0 5.178752982004653e-10
higher O 0 1.8967396542279857e-08
resting O 0 5.784345944448432e-07
[ O 0 1.4546975535267848e-07
Ca2 O 0 7.881973829171329e-07
+ O 0 3.1426401392309344e-07
] O 0 6.125167573145518e-08
i O 0 1.1550567613483054e-08
than O 0 2.0060156313839173e-10
do O 0 6.521146400650935e-10
wild O 0 4.483121873732898e-09
- O 0 4.633086359007166e-09
type O 0 2.059547377086801e-08
myotubes O 0 4.33103593877604e-07
because O 0 1.0985524712125994e-09
of O 0 4.3066564203719793e-10
an O 0 3.1450276410938116e-11
altered O 0 1.4476353449310864e-09
open O 0 2.0241344156346486e-09
probability O 0 3.175056884074934e-10
of O 0 5.745620992869682e-11
voltage O 0 6.835106369784683e-10
- O 0 5.962326188324596e-09
dependent O 0 2.0913381248988117e-08
l O 0 1.2395921622498918e-08
- O 0 7.310728022957846e-09
type O 0 7.10756653532485e-09
Ca2 O 0 4.090301430892396e-08
+ O 0 1.2672805915769914e-08
and O 0 2.354161587891923e-10
Na O 0 2.983808542467159e-07
+ O 0 2.454201251111954e-07
channels O 0 8.047620525530874e-08
. O 0 9.454853255874696e-08

The O 0 4.116001036891248e-06
mutant O 0 1.3453050087264273e-06
myotubes O 0 1.2571712204589858e-06
exhibit O 0 2.8413920105663237e-08
smaller O 0 1.0298119024199082e-09
and O 0 7.550319258697868e-10
slower O 0 7.478763563995017e-08
Ca2 O 0 2.2216352135728812e-07
+ O 0 1.0394826688298053e-07
responses O 0 1.928306403442548e-09
upon O 0 6.069655889007208e-09
triggering O 0 7.324783446449601e-09
by O 0 1.6969720073589656e-10
acetylcholine O 0 2.8352905800943518e-08
or O 0 1.343833311295839e-08
high O 0 5.675377678926452e-08
external O 0 2.714577362894488e-07
K O 0 1.6093664498839644e-06
+ O 0 1.8787852695822949e-06
. O 0 2.0993937255298079e-07

In O 0 9.520832833231907e-08
addition O 0 2.9225821762679516e-08
, O 0 1.087648304753941e-09
we O 0 9.457081784347565e-10
observed O 0 1.1310681280463086e-09
that O 0 2.9336193196893845e-11
these O 0 9.174299514524975e-11
Ca2 O 0 3.7330877944441454e-07
+ O 0 5.698307177226525e-07
transients O 0 1.8629457088081836e-07
partially O 0 1.4943724480076526e-08
result O 0 3.47692319380144e-10
from O 0 1.265088866997388e-10
an O 0 3.6009396853220466e-11
influx O 0 4.1708120290806505e-10
of O 0 1.8364117171376648e-10
extracellular O 0 3.2264102500789704e-10
Ca2 O 0 5.542530434610171e-09
+ O 0 1.845661845578661e-09
through O 0 9.278194185169397e-11
the O 0 6.449046296985728e-10
l O 0 3.147875293763036e-09
- O 0 3.6789475910126157e-09
type O 0 5.320032414601883e-09
Ca2 O 0 2.049787752866905e-07
+ O 0 3.1722245807941363e-07
channel O 0 2.933115297309996e-07
. O 0 1.1564460322688319e-07

Neither O 0 4.0200757212005556e-06
the O 0 2.2717374648095756e-08
content O 0 3.5304328349639036e-09
nor O 0 1.0697168484341546e-08
the O 0 1.968657181716793e-10
activity O 0 5.218892540348463e-10
of O 0 3.9313499677895436e-10
Na O 0 1.1793741094834331e-07
+ O 0 8.212514757133249e-08
/ O 0 1.4402472459096316e-07
K O 0 9.384282151359002e-08
+ O 0 8.586539479438215e-08
ATPase O 0 8.675167464389233e-07
and O 0 8.525468331299635e-09
sarcoplasmic O 0 1.1770468518079724e-05
reticulum O 0 7.150441092562687e-07
Ca2 O 0 3.965878363487718e-07
+ O 0 1.3168290990961395e-07
- O 0 2.8897565229613065e-08
ATPase O 0 1.6889856624402455e-07
are O 0 8.60477383790581e-11
affected O 0 3.36508737541763e-10
by O 0 5.049908824439342e-10
DMPK O 0 3.0495481041725725e-05
absence O 0 2.342278094147332e-06
. O 0 3.7251288631523494e-07

In O 0 6.18527664641988e-08
conclusion O 0 3.199217957217115e-08
, O 0 1.648179148716622e-09
our O 0 3.978915419367013e-09
data O 0 9.413391843793306e-09
suggest O 0 3.1290905422309834e-09
that O 0 5.916473561073943e-11
DMPK O 0 4.7278763304348104e-07
is O 0 7.978252086759952e-11
involved O 0 4.78612739718276e-11
in O 0 2.3098391255249595e-10
modulating O 0 8.715537802572726e-08
the O 0 2.3727727338496152e-08
initial O 0 3.875676668485539e-09
events O 0 4.741507741989892e-10
of O 0 4.2706485570143116e-10
excitation O 0 1.8950370872516942e-07
- O 0 5.517524073184177e-07
contraction O 0 1.539035388020693e-08
coupling O 0 2.028060830383538e-09
in O 0 3.2154949813900657e-09
skeletal O 0 2.451420414217864e-06
muscle O 0 7.813898150743626e-08
. O 0 2.1211462808423676e-08
. O 0 5.723338958318891e-08

Constitutional O 0 7.23265839042142e-05
RB1 O 0 0.0004928396083414555
- O 0 4.528156750893686e-06
gene O 0 2.5097445899291415e-08
mutations O 0 7.67996866102294e-09
in O 0 1.4911345491697148e-09
patients O 0 2.1877639699852125e-09
with O 0 2.4734997036701678e-11
isolated O 0 1.7110597383407367e-08
unilateral B-Disease 0 5.634108219965128e-06
retinoblastoma I-Disease 1 0.9999618530273438
. O 0 0.0146148931235075

In O 0 8.638415494033325e-08
most O 0 2.276359989394905e-09
patients O 0 5.50371859198151e-10
with O 0 8.590929183316387e-12
isolated O 0 2.7701805294100268e-09
unilateral B-Disease 0 3.243578248657286e-06
retinoblastoma I-Disease 1 0.9999707937240601
, O 0 2.3925323944240517e-08
tumor B-Disease 0 4.986892690794775e-06
development O 0 3.2445072406517284e-08
is O 0 3.644498591803824e-11
initiated O 0 2.5754803845146057e-10
by O 0 2.135008489445589e-11
somatic O 0 1.1265751886924136e-08
inactivation O 0 8.731610989798355e-08
of O 0 1.5767591676763004e-08
both O 0 1.3989890357279933e-09
alleles O 0 1.7384284012322837e-09
of O 0 4.612146664584316e-09
the O 0 3.289854433319306e-08
RB1 O 0 1.3482331269187853e-05
gene O 0 1.6220401732880418e-07
. O 0 5.558709403885587e-07

However O 0 8.597984333391651e-07
, O 0 6.224364579310304e-09
some O 0 4.170820078197579e-10
of O 0 5.070533992679316e-10
these O 0 1.0443639703039409e-10
patients O 0 1.5422574328738392e-10
can O 0 2.455296244097127e-10
transmit O 0 4.103421247236838e-08
retinoblastoma B-Disease 0 2.7684870929078897e-06
predisposition O 0 2.134578608092852e-05
to O 0 4.859020918956958e-06
their O 0 1.7959395108846365e-06
offspring O 0 5.400811915023951e-06
. O 0 7.348771191573178e-07

To O 0 2.429560197469982e-08
determine O 0 9.977801695981725e-09
the O 0 3.6777760836770312e-09
frequency O 0 7.673411772657346e-08
and O 0 5.227520083472825e-10
nature O 0 3.835100237381539e-09
of O 0 7.0348034064693366e-09
constitutional O 0 8.469982049064129e-07
RB1 O 0 1.389681528962683e-05
- O 0 3.02516895089866e-07
gene O 0 4.69630911936747e-09
mutations O 0 1.4996397457167632e-09
in O 0 4.2597961269486007e-10
patients O 0 1.2754397538117246e-09
with O 0 1.4717746119052855e-11
isolated O 0 6.2678964241058566e-09
unilateral B-Disease 0 8.897203542801435e-07
retinoblastoma I-Disease 0 0.0012391925556585193
, O 0 1.6503694411085235e-08
we O 0 9.76115810402689e-09
analyzed O 0 9.28581567194442e-09
DNA O 0 8.779803550851284e-09
from O 0 4.57940618758812e-09
peripheral O 0 1.1927452305826591e-06
blood O 0 1.2826230033624597e-07
and O 0 5.971795058457019e-09
from O 0 3.3189284209811376e-08
tumor B-Disease 0 6.046196176612284e-06
tissue O 0 1.4136478512227768e-06
. O 0 6.538601269312494e-07

The O 0 1.2421523365446774e-07
analysis O 0 3.4380651214860336e-08
of O 0 3.5871732251280264e-08
tumors B-Disease 1 1.0
from O 0 1.490677448146016e-08
54 O 0 4.644289930411105e-08
( O 0 1.25417412566442e-10
71 O 0 5.5039102164755604e-09
% O 0 9.318346094744356e-11
) O 0 2.0459189897792385e-11
of O 0 1.8745041630019443e-10
76 O 0 6.651581951899743e-09
informative O 0 6.533363183791607e-09
patients O 0 2.8923243799994225e-09
showed O 0 1.6553939330421485e-09
loss O 0 1.4494671018994154e-09
of O 0 5.262978497455606e-09
constitutional O 0 5.836638592882082e-06
heterozygosity O 0 0.0015278077917173505
( O 0 8.434298024440068e-07
LOH O 1 0.9999295473098755
) O 0 6.247081518750974e-09
at O 0 1.6084214848888223e-07
intragenic O 0 3.6115559396421304e-06
loci O 0 5.477165814227192e-07
. O 0 5.117125851938908e-07

Three O 0 1.1016673084895956e-07
of O 0 2.0078319451499738e-08
13 O 0 4.2955122125931666e-07
uninformative O 0 0.00011715102300513536
patients O 0 4.5450499897015106e-07
had O 0 8.746496149569793e-08
constitutional O 0 9.540331120660994e-06
deletions O 0 2.445905738568399e-05
. O 0 4.72516239824472e-06

For O 0 5.980129458293959e-08
39 O 0 7.022151038427182e-08
randomly O 0 1.5021942800785837e-08
selected O 0 1.2723190820906893e-06
tumors B-Disease 1 1.0
, O 0 9.643503773304474e-08
SSCP O 0 4.5975968532729894e-05
, O 0 6.5092327083959844e-09
hetero O 0 1.5173330325524148e-07
- O 0 5.9763989312955346e-09
duplex O 0 2.254110142985155e-08
analysis O 0 3.2191707077799947e-09
, O 0 1.3765707324031595e-11
sequencing O 0 1.5323058100147335e-10
, O 0 5.050608889445307e-11
and O 0 1.4393884695262926e-10
Southern O 0 3.18350110717347e-08
blot O 0 2.0004587497624016e-07
analysis O 0 1.1560656876241637e-09
were O 0 5.074587416942222e-10
used O 0 2.771734397555292e-09
to O 0 9.893149410800106e-09
identify O 0 8.057511280412655e-08
mutations O 0 2.2579985170523287e-07
. O 0 1.6025205695768818e-06

Mutations O 0 5.160551381777623e-07
were O 0 2.2726476700540843e-08
detected O 0 2.5320739283074545e-08
in O 0 1.6123531398903879e-09
21 O 0 5.805168612482703e-08
( O 0 3.7966910171327584e-10
91 O 0 3.073385101970416e-08
% O 0 1.6330330143699e-10
) O 0 9.208941248450841e-11
of O 0 1.3501708640006882e-09
23 O 0 1.492675323788717e-06
tumors B-Disease 1 1.0
with O 0 3.169386900481186e-06
LOH O 1 1.0
. O 0 4.072652882314287e-05

In O 0 7.680161928647067e-08
6 O 0 1.0699151431481368e-07
( O 0 3.163378448078902e-10
38 O 0 3.3869953508514072e-09
% O 0 1.1570357172363543e-10
) O 0 8.161268882922457e-11
of O 0 7.450835504130282e-10
16 O 0 3.5162150879841647e-07
tumors B-Disease 1 1.0
without O 0 0.00024857159587554634
LOH O 1 1.0
, O 0 1.5619833204638667e-09
one O 0 1.7702214694104157e-10
mutation O 0 3.8245059896802047e-10
was O 0 7.024917869635772e-10
detected O 0 9.468686945623972e-10
, O 0 1.581735784017546e-11
and O 0 2.5705319817159733e-11
in O 0 5.446086359661706e-10
9 O 0 7.606337959487064e-08
( O 0 4.32211877399169e-10
56 O 0 5.836285232874161e-09
% O 0 1.5386523999350032e-10
) O 0 1.6009372993952553e-10
of O 0 1.5290572141779535e-09
the O 0 8.310556864898899e-08
tumors B-Disease 1 1.0
without O 0 0.0007440416957251728
LOH O 1 1.0
, O 0 4.908995876462541e-09
both O 0 1.1069277716657666e-09
mutations O 0 1.7332933976987874e-09
were O 0 2.8970066345834766e-09
found O 0 5.343880893349251e-09
. O 0 1.1250511278149133e-07

Thus O 0 5.8021250026740745e-08
, O 0 3.4245792313036816e-10
a O 0 1.8360475639855878e-10
total O 0 1.7214479841598518e-10
of O 0 2.426844003533546e-10
45 O 0 3.1407145772988088e-09
mutations O 0 6.438525268492867e-10
were O 0 3.188920461028033e-09
identified O 0 2.3597158005372876e-08
in O 0 1.1609633787657003e-07
tumors B-Disease 1 1.0
of O 0 6.781280603718187e-07
36 O 0 1.2293855888856342e-07
patients O 0 5.692959881287152e-09
. O 0 6.636707183815815e-08

Thirty O 0 2.584316405318532e-07
- O 0 8.182025368341783e-08
nine O 0 4.798426100904862e-09
of O 0 1.1236561681116086e-09
the O 0 1.3512476693122721e-09
mutations O 0 5.958775695091845e-10
- O 0 4.2385153165014344e-09
including O 0 1.092899215571208e-09
34 O 0 7.154861947356039e-08
small O 0 1.2019919504169252e-09
mutations O 0 2.072191662705336e-08
, O 0 1.569323559991176e-09
2 O 0 1.623346292944916e-07
large O 0 3.435881978930411e-08
structural O 0 0.0005462082917802036
alterations O 1 0.9998700618743896
, O 0 2.1678516759493505e-08
and O 0 2.611671989782849e-09
hypermethylation O 0 4.624517259799177e-06
in O 0 5.443921935466278e-08
3 O 0 3.6071087379241362e-06
tumors O 1 1.0
- O 0 6.065747015782108e-08
were O 0 1.3899750239687592e-09
not O 0 6.604902735851681e-10
detected O 0 1.7775644289841352e-09
in O 0 3.9330599888032225e-10
the O 0 2.7725857165705747e-09
corresponding O 0 9.89624560077118e-09
peripheral O 0 2.136882244485605e-07
blood O 0 3.2751852785395386e-08
DNA O 0 6.008576036720115e-08
. O 0 1.4767633160772675e-07

In O 0 6.13138624316889e-08
6 O 0 1.207008182291247e-07
( O 0 1.8883596075713882e-10
17 O 0 1.6872389041466818e-09
% O 0 2.4246077368061947e-11
) O 0 6.965564409988634e-12
of O 0 5.998581492638877e-11
the O 0 2.5300486705681635e-10
36 O 0 1.108043101716305e-09
patients O 0 3.80711157044189e-10
, O 0 2.716006933245474e-11
a O 0 1.551175715652775e-10
mutation O 0 3.941546256047701e-10
was O 0 2.199046944539873e-09
detected O 0 2.5063324748941795e-09
in O 0 2.796755882439328e-10
constitutional O 0 1.0936775929337728e-08
DNA O 0 2.205515770015154e-09
, O 0 6.084347609069951e-11
and O 0 6.499846494367745e-11
1 O 0 1.3905830265059649e-08
of O 0 1.3023356837393862e-09
these O 0 7.608488838961591e-11
mutations O 0 2.664980180977494e-10
is O 0 1.6630381100002367e-11
known O 0 1.4886643306954994e-10
to O 0 4.922147134323041e-10
be O 0 3.9168973620107295e-10
associated O 0 1.5541111730854595e-09
with O 0 6.634900268087662e-11
reduced O 0 4.526186714315372e-08
expressivity O 0 1.4948792568247882e-06
. O 0 4.370044450752175e-07

The O 0 2.3570714802190196e-07
presence O 0 2.925560238509206e-08
of O 0 1.0312906084664064e-08
a O 0 3.3827731726887578e-09
constitutional O 0 1.5422170918100164e-07
mutation O 0 2.0509574039095924e-09
was O 0 6.783830164280857e-10
not O 0 1.1198087596087092e-10
associated O 0 1.2275935823424788e-10
with O 0 3.3355863644085604e-12
an O 0 1.054177925507993e-11
early O 0 1.2249489200755193e-09
age O 0 5.907444533548301e-10
at O 0 1.1973515512408994e-09
treatment O 0 7.870615270633152e-09
. O 0 3.595797082311947e-08

In O 0 6.58026380051524e-08
1 O 0 2.3579910646276403e-07
patient O 0 2.1633788094277406e-07
, O 0 3.410032700656984e-09
somatic O 0 3.27648081110965e-06
mosaicism O 0 5.246297223493457e-05
was O 0 1.8241416910314e-07
demonstrated O 0 1.4440372453350392e-08
by O 0 5.919125606324016e-11
molecular O 0 2.879201321803748e-10
analysis O 0 1.5566291311497338e-10
of O 0 8.543692142648496e-11
DNA O 0 2.6377278139477767e-10
and O 0 2.349734018469718e-10
RNA O 0 9.85860371116587e-09
from O 0 7.292498160893501e-09
peripheral O 0 2.150175077986205e-06
blood O 0 9.958637292584172e-07
. O 0 9.007541734717961e-07

In O 0 1.5970906019902031e-07
2 O 0 1.2817217509564216e-07
patients O 0 9.447404636375722e-09
without O 0 3.1290250390725305e-09
a O 0 2.50123699530036e-09
detectable O 0 4.79154721233499e-07
mutation O 0 3.9054484091138875e-09
in O 0 1.7149305309160923e-09
peripheral O 0 4.8590577534923796e-06
blood O 0 6.754520995855273e-07
, O 0 1.8462006368125117e-09
mosaicism O 0 7.533868711107061e-07
was O 0 8.094569459160539e-09
suggested O 0 1.9779509141670815e-09
because O 0 4.725227500945728e-11
1 O 0 1.935772431238547e-09
of O 0 3.206894194640597e-10
the O 0 8.918316085626543e-10
patients O 0 4.156677668731845e-09
showed O 0 3.278409721474418e-08
multifocal O 1 0.9999996423721313
tumors B-Disease 1 1.0
and O 0 1.8805748425165802e-07
the O 0 2.59986023820602e-07
other O 0 7.602399820783035e-10
later O 0 1.1133949762154316e-08
developed O 0 1.0717999820997193e-08
bilateral B-Disease 0 6.80969287714106e-06
retinoblastoma I-Disease 0 0.016285603865981102
. O 0 3.899112016370054e-06

In O 0 1.670846216939026e-08
conclusion O 0 2.319735692424274e-08
, O 0 8.544592255965711e-10
our O 0 2.814352084712368e-09
results O 0 8.519612237911645e-10
emphasize O 0 1.5679122000733514e-08
that O 0 1.4855158769755406e-10
the O 0 1.018493955839972e-09
manifestation O 0 4.502619432855681e-08
and O 0 3.322440100816948e-10
transmissibility O 0 4.5038953544462856e-07
of O 0 3.6995442265208567e-09
retinoblastoma B-Disease 0 5.6827840211326475e-09
depend O 0 2.3821400407797455e-09
on O 0 1.1787844478305942e-08
the O 0 8.955937658150503e-10
nature O 0 2.636636187158814e-10
of O 0 1.553757678074419e-10
the O 0 1.751871703259411e-10
first O 0 7.737689933229319e-10
mutation O 0 4.570579678619957e-11
, O 0 3.4460936708391454e-12
its O 0 1.1404273358994743e-11
time O 0 7.890327974324762e-11
in O 0 3.0853798682617395e-11
development O 0 5.906746203265811e-10
, O 0 3.52877310705324e-11
and O 0 5.4036199126361595e-11
the O 0 1.1472900407483166e-09
number O 0 4.649328422257071e-10
and O 0 1.108678843175781e-10
types O 0 1.044936848160205e-08
of O 0 1.6489337673064597e-09
cells O 0 8.133782536390299e-10
that O 0 3.349288901777214e-11
are O 0 6.5212267010006375e-12
affected O 0 1.0077456924495465e-10
. O 0 1.6457855078755301e-09
. O 0 1.5641641937236272e-07

Hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.6215659379959106
the I-Disease 0 0.0017331814160570502
fifth I-Disease 0 7.305556209757924e-06
component I-Disease 0 1.7656969930612831e-07
of I-Disease 0 4.759023841671706e-09
complement I-Disease 0 4.847635182159138e-08
in O 0 5.564575644712022e-07
man O 0 3.5878230846719816e-05
. O 0 1.8943819668493234e-05

I O 0 0.0014792749425396323
. O 0 1.7524238501209766e-05

Clinical O 0 1.875992165878415e-05
, O 0 8.8132257047846e-09
immunochemical O 0 9.74242880147358e-07
, O 0 1.458872245230225e-09
and O 0 5.458107854572347e-10
family O 0 2.828909773100463e-09
studies O 0 4.946622667034717e-08
. O 0 2.2089865581165213e-07

The O 0 8.198442174034426e-07
first O 0 5.1195176098417505e-08
recognized O 0 7.991632244852553e-09
human O 0 5.540670144910109e-09
kindred O 0 7.4176150519633666e-06
with O 0 6.524919715644728e-09
hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 1.0
the I-Disease 1 0.9999985694885254
fifth I-Disease 0 0.0013163608964532614
component I-Disease 0 1.6530052562302444e-06
of I-Disease 0 1.0424215588500374e-06
complement I-Disease 0 2.82667824649252e-05
( O 0 3.581970275945423e-08
C5 O 0 0.0002313420845894143
) O 0 3.94746946241753e-09
is O 0 1.7531898155453973e-09
described O 0 4.900419980913284e-08
. O 0 2.3124340486901929e-07

The O 0 9.228073167832918e-07
proband O 0 7.71864415582968e-06
, O 0 2.645342167539866e-09
a O 0 7.403958002250022e-10
20 O 0 5.124690116709019e-10
- O 0 8.004106821779544e-10
year O 0 7.958376735395234e-10
- O 0 8.607310419961323e-09
old O 0 8.76521344395087e-09
black O 0 1.9053383870648588e-10
female O 0 1.7061989321387472e-10
with O 0 1.2208664634805189e-10
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 1 1.0
age O 1 0.9999784231185913
11 O 0 2.6089930997841293e-06
, O 0 2.2592094861551004e-09
lacked O 0 2.0968965941392526e-07
serum O 0 3.963427630537808e-08
hemolytic O 0 9.318231519728215e-09
complement O 0 2.945772292761717e-09
activity O 0 1.0253320859021642e-08
, O 0 2.2843356373147827e-10
even O 0 2.32839497682491e-10
during O 0 5.204242814471627e-09
remission O 0 3.2670371297172096e-07
. O 0 4.374597750711473e-08

C5 O 0 0.0005344696692191064
was O 0 4.0570612327428535e-06
undetectable O 0 7.321542852878338e-06
in O 0 1.1035469427156386e-08
her O 0 3.1700722047389718e-09
serum O 0 1.3159347389546383e-08
by O 0 4.248752460966898e-10
both O 0 5.775214972914e-09
immunodiffusion O 0 1.8546882074588211e-06
and O 0 2.5167434358763785e-08
hemolytic O 0 7.336701855820138e-06
assays O 0 1.727779454085976e-05
. O 0 1.2414645425451454e-05

Other O 0 1.5163081457103544e-08
complement O 0 3.154077665712407e-09
components O 0 1.6939047497999127e-08
were O 0 1.5485218662902867e-09
normal O 0 1.862396459273441e-08
during O 0 3.098754319807995e-08
remission O 0 6.098775315876992e-07
of O 0 5.401028513318806e-09
lupus O 0 3.6617916521208826e-07
, O 0 8.634915005245603e-10
but O 0 4.892422911240146e-09
C1 O 0 7.583219849038869e-05
, O 0 1.9152656349774588e-08
C4 O 0 9.859324927674606e-05
, O 0 2.138892085667976e-08
C2 O 0 5.704359864466824e-06
, O 0 2.101822271782794e-09
and O 0 3.5731522185500353e-09
C3 O 0 0.00010853986896108836
levels O 0 0.00023538997629657388
fell O 0 1.2583583156811073e-05
during O 0 2.0081095044588437e-06
exacerbations O 0 0.382639080286026
. O 0 2.829564436979126e-06

A O 0 1.4130346244201064e-06
younger O 0 3.693454431186183e-08
half O 0 3.3981575331409886e-09
- O 0 3.319877706076113e-08
sister O 0 1.6082688958363178e-08
, O 0 6.7770017375679e-10
who O 0 9.283580015839732e-10
had O 0 8.872392598391343e-09
no O 0 4.68806895526086e-08
underlying O 1 0.9500935673713684
disease O 0 0.00020655970729421824
, O 0 1.2388701176035966e-10
was O 0 2.7570989047376315e-08
also O 0 9.660179323134344e-09
found O 0 2.5028166206197966e-09
to O 0 1.459075491538897e-07
lack O 0 7.942793672555126e-06
immunochemically O 0 0.00037727842573076487
detectable O 0 7.726302283117548e-05
C5 O 0 2.768646299955435e-05
. O 0 2.5230597202607896e-06

By O 0 1.7809648511502019e-07
hemolytic O 0 5.493746812135214e-06
assay O 0 1.2038760814903071e-06
, O 0 3.681334348470955e-09
she O 0 4.69760619292714e-10
exhibited O 0 2.620054173618769e-09
1 O 0 6.559258913796384e-09
- O 0 1.0082946033662665e-08
2 O 0 1.1411297684560395e-08
% O 0 3.544863846904889e-10
of O 0 4.872185432880372e-10
the O 0 7.165863458169497e-10
normal O 0 2.428253864650287e-08
serum O 0 1.4223239475086302e-07
C5 O 0 1.857389690940181e-07
level O 0 2.6330958746711985e-08
and O 0 3.991386943180686e-10
normal O 0 2.644556573727641e-08
concentrations O 0 4.294864908160889e-08
of O 0 1.6781240841368117e-09
other O 0 3.746458421272081e-10
complement O 0 6.608195324275812e-09
components O 0 1.0888574308864918e-07
. O 0 3.242416823923122e-07

C5 O 0 2.226364813395776e-05
levels O 0 8.369012789444241e-07
of O 0 8.809393214903594e-09
other O 0 4.1763045799392273e-10
family O 0 1.821700151838357e-10
members O 0 2.189702932864357e-11
were O 0 9.322559391122809e-11
either O 0 6.295810539569402e-10
normal O 0 3.944303017533457e-08
or O 0 5.902241473343395e-10
approximately O 0 2.6963003010860298e-11
half O 0 3.7219696075174724e-11
- O 0 1.0823092422285185e-09
normal O 0 1.0158229812873287e-08
, O 0 6.638524174817917e-10
consistent O 0 4.557606914090684e-08
with O 0 4.2003664435519283e-10
autosomal O 0 5.301620262798679e-07
codominant O 0 3.8147118175402284e-07
inheritance O 0 2.0649153498197848e-09
of O 0 1.5462375824171204e-09
the O 0 1.3915109065010256e-09
gene O 0 7.72996422426786e-09
determining O 0 4.770504801854258e-06
C5 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 1.4789191482122988e-05

Normal O 0 3.860882134176791e-05
hemolytic O 0 1.148829596786527e-05
titers O 0 2.8651527372858254e-06
were O 0 1.3168311774336416e-08
restored O 0 1.102975062394762e-07
to O 0 1.0971521469116396e-08
both O 0 4.43190639742852e-09
homozygous O 1 0.9134896397590637
C5 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
( O 0 6.645940970884112e-07
C5D B-Disease 1 1.0
) O 0 8.305513610196158e-09
sera O 0 9.252300259277035e-08
by O 0 7.75112682371848e-11
addition O 0 8.728455180850858e-10
of O 0 2.946986210616842e-09
highly O 0 4.1238209291805106e-08
purified O 0 4.146007199778978e-07
human O 0 1.3038194879300136e-07
C5 O 0 4.395890573505312e-05
. O 0 1.2684554349107202e-06

In O 0 5.288914053380722e-07
specific O 0 5.942262077951455e-07
C5 O 0 2.275496444781311e-05
titrations O 0 7.445461505994899e-06
, O 0 1.5413524900864672e-09
however O 0 8.697976228155824e-10
, O 0 6.291917681311432e-11
it O 0 2.1023734836367325e-11
was O 0 8.29213475661561e-10
noted O 0 8.835303599852296e-10
that O 0 2.6865875843440357e-11
when O 0 7.985072325578102e-11
limited O 0 8.501918058456681e-10
amounts O 0 5.925205881496254e-10
of O 0 8.56163973050883e-10
C5 O 0 7.62366525464131e-08
were O 0 2.9141975499413775e-09
assayed O 0 9.676115553247655e-08
in O 0 2.0194761418679263e-09
the O 0 3.577148133260266e-09
presence O 0 3.174943197237212e-09
of O 0 1.36950650819756e-09
low O 0 2.8166411425445403e-08
dilutions O 0 5.05660295857524e-07
of O 0 1.1986157844035006e-08
either O 0 1.877306488040631e-07
C5D B-Disease 1 1.0
serum O 0 4.7229548272298416e-07
, O 0 4.2492467877686124e-10
curving O 0 2.0311536896855387e-09
rather O 0 2.9715774285676844e-10
than O 0 3.0852095184163986e-11
linear O 0 1.3458353875783757e-10
dose O 0 4.521889351849495e-08
- O 0 1.1245615105792695e-08
response O 0 4.9921440314903975e-09
plots O 0 2.3883455213535854e-09
were O 0 1.1471089855774608e-08
consistently O 0 9.148481971976707e-09
obtained O 0 6.723496870364443e-09
, O 0 3.34706151683406e-10
suggesting O 0 1.244210623418951e-09
some O 0 4.896768407425256e-11
inhibitory O 0 1.3312465796389006e-07
effect O 0 3.048883741030295e-07
. O 0 5.688826831828919e-07

Further O 0 2.0959848257007252e-07
studies O 0 2.7683070058515113e-08
suggested O 0 9.076646989569781e-09
that O 0 1.229918528133922e-10
low O 0 2.537483823061848e-08
dilutions O 0 3.546806055965135e-06
of O 0 1.4109390633620933e-07
C5D B-Disease 1 1.0
serum O 0 4.476766832794965e-07
contain O 0 1.4465892927972845e-09
a O 0 1.4551672367080215e-10
factor O 0 2.463087234172434e-10
( O 0 9.348338075865215e-12
or O 0 3.439771384394774e-11
factors O 0 1.5599074809635738e-10
) O 0 1.3181937312534142e-11
interfering O 0 3.5797622643940485e-09
at O 0 9.316436511142001e-09
some O 0 3.753295729769235e-10
step O 0 1.0715384135551176e-08
in O 0 1.9408039619861484e-09
the O 0 6.516040151893776e-09
hemolytic O 0 3.5829819466925983e-07
assay O 0 5.903440296606277e-07
of O 0 1.0896588946707197e-06
C5 O 0 8.338822226505727e-06
, O 0 1.2767225054943765e-09
rather O 0 5.837172967204651e-10
than O 0 1.6616565068350297e-10
a O 0 1.873740274049851e-09
true O 0 4.235252504258824e-08
C5 O 0 3.465639338173787e-06
inhibitor O 0 5.823234232593677e-07
or O 0 4.9526832412993826e-08
inactivator O 0 1.29982981889043e-05
. O 0 7.310089245038398e-07

Of O 0 8.124353030325437e-07
clinical O 0 3.134766757284524e-06
interest O 0 4.0636916764924536e-07
are O 0 6.192318324771406e-10
( O 0 1.7038802313518175e-10
a O 0 1.9900943115658265e-09
) O 0 1.509868063909181e-10
the O 0 1.5745194037464216e-09
documentation O 0 6.33559238849557e-07
of O 0 7.006016744526278e-08
membranous O 1 0.999962329864502
glomerulonephritis B-Disease 1 1.0
, O 0 2.7169960503670154e-06
vasculitis B-Disease 1 1.0
, O 0 9.792691990639923e-09
and O 0 7.623051523353297e-09
arthritis B-Disease 1 1.0
in O 0 2.517790065326153e-08
an O 0 5.19125353815042e-10
individual O 0 2.872903581696562e-10
lacking O 0 1.2370622926027863e-06
C5 O 0 7.817393452569377e-06
( O 0 1.941128785487578e-10
and O 0 7.227850262747637e-11
its O 0 5.4997072868046004e-11
biologic O 0 1.3339573889936673e-09
functions O 0 1.6855686291172844e-10
) O 0 6.2972092818025516e-12
, O 0 1.0013457077406862e-11
and O 0 1.3091533933307087e-11
( O 0 9.186007857153733e-12
b O 0 2.1547539308386376e-09
) O 0 5.119214514098802e-12
a O 0 4.931259914298103e-11
remarkable O 0 2.7598318075305883e-10
propensity O 0 1.4841523565678472e-08
to O 0 4.614909787648003e-09
bacterial B-Disease 1 1.0
infections I-Disease 1 1.0
in O 0 2.5040139406407036e-10
the O 0 5.904470801176842e-10
proband O 0 1.6567245353371618e-08
, O 0 1.8879011201566875e-11
even O 0 6.741621844108536e-11
during O 0 6.287998455256627e-10
periods O 0 1.6079590992035264e-08
of O 0 5.606641817479385e-10
low O 0 3.914233381863141e-09
- O 0 5.790543600170395e-10
dose O 0 4.443010848120821e-09
or O 0 1.7313397937535058e-10
alternate O 0 1.6901772426081152e-08
- O 0 1.0269647532368253e-07
day O 0 6.758045856258832e-08
corticosteroid O 0 4.803649426321499e-05
therapy O 0 3.9812966861063614e-05
. O 0 1.3201008641772205e-07

Other O 0 2.8684333130968298e-08
observations O 0 1.925080894693565e-08
indicate O 0 5.2626276669798244e-09
that O 0 1.3126896791781917e-10
the O 0 7.948095515075693e-09
C5D B-Disease 1 1.0
state O 0 1.876909294651341e-09
is O 0 6.857511086755252e-11
compatible O 0 7.285018366331997e-09
with O 0 1.2336747075292198e-11
normal O 0 6.585081813170746e-09
coagulation O 0 2.0408270628990977e-09
function O 0 7.53009876675037e-10
and O 0 2.1925752879958793e-10
the O 0 1.3288227185270785e-09
capacity O 0 2.5412267845581482e-09
to O 0 9.21274523335569e-09
mount O 0 2.379054876655573e-06
a O 0 3.2528328119951766e-07
neutrophilic O 0 0.0006937362486496568
leukocytosis O 0 5.800303188152611e-05
during O 0 5.418884938990232e-06
pyogenic B-Disease 0 0.0005660758470185101
infection I-Disease 0 3.244625474962959e-07
. O 0 3.111427115953802e-09
. O 0 4.31190478877852e-08

Susceptibility O 0 3.3398384402971715e-05
to O 0 2.386845153523609e-05
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 0 3.7251361391099636e-06
twins O 0 1.2805757876321877e-07
: O 0 9.168037162776699e-11
the O 0 1.8812880420160383e-10
role O 0 1.0050894561075552e-09
of O 0 1.8797898793110335e-09
genes O 0 1.6967787175303783e-09
, O 0 1.3844556612241377e-09
HLA O 0 1.491808689024765e-06
, O 0 4.084249827229769e-09
and O 0 3.5105500728604966e-09
the O 0 7.405722612929821e-07
environment O 0 1.2071928949808353e-06
. O 0 4.5044063767818443e-07

OBJECTIVE O 0 1.0674028999346774e-05
To O 0 3.627049238730251e-08
determine O 0 9.904553621709056e-09
the O 0 1.9064883005626143e-09
relative O 0 1.1706080016438136e-07
effects O 0 2.5981105409300653e-06
of O 0 2.7088560727861477e-08
genetic O 0 3.867096420862026e-09
and O 0 1.1402931376913727e-10
environmental O 0 1.0994134075348327e-10
factors O 0 1.0125585786502356e-10
in O 0 4.289896909925872e-11
susceptibility O 0 1.1528089771672967e-07
to O 0 4.7522639761155006e-06
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 0 1.326413183733166e-07
AS B-Disease 1 1.0
) O 0 2.0460577676573166e-09
. O 0 1.7722165068789764e-08

METHODS O 0 6.069212304282701e-06
Twins O 0 4.799179578185431e-07
with O 0 1.8747545182939973e-10
AS B-Disease 1 0.9999998807907104
were O 0 3.2255917381540655e-10
identified O 0 1.4347671661862904e-10
from O 0 8.185589012166261e-11
the O 0 2.8357436399062408e-09
Royal O 0 1.6264364603557624e-05
National O 0 4.795409950020257e-06
Hospital O 0 8.662198524689302e-06
for O 0 2.212025762560188e-08
Rheumatic B-Disease 0 0.0009978266898542643
Diseases I-Disease 0 0.24114768207073212
database O 0 2.180126017492512e-07
. O 0 2.2316942249744898e-07

Clinical O 0 6.276288786466466e-06
and O 0 8.113767435702357e-09
radiographic O 0 1.126272195506317e-06
examinations O 0 6.036236186446331e-07
were O 0 3.4841276530528376e-09
performed O 0 6.55556986473016e-09
to O 0 8.175938148724526e-09
establish O 0 5.0527077632978035e-08
diagnoses O 0 3.264606675656978e-06
, O 0 3.3945410371494233e-10
and O 0 3.0595262434651715e-10
disease O 0 3.431598827319249e-08
severity O 0 9.345197327093047e-07
was O 0 1.8342220187150815e-08
assessed O 0 1.5179953294364168e-08
using O 0 6.807436392364252e-09
a O 0 2.620683892118336e-09
combination O 0 7.895244458211437e-09
of O 0 3.281874327853984e-09
validated O 0 5.1523141308962295e-08
scoring O 0 1.6563959093218728e-08
systems O 0 8.439980092589394e-08
. O 0 1.441057975171134e-07

HLA O 0 3.1887284421827644e-05
typing O 0 4.630042440112447e-06
for O 0 1.1944644384698222e-08
HLA O 0 1.1562386958985371e-07
- O 0 8.318708211163539e-08
B27 O 0 5.830725058331154e-07
, O 0 1.8353715769414691e-10
HLA O 0 6.162817367538764e-09
- O 0 8.1964550702196e-09
B60 O 0 1.1400804567074374e-07
, O 0 1.1741943528598142e-10
and O 0 1.2554569883693745e-10
HLA O 0 2.6020529730885755e-06
- O 0 0.0002721102209761739
DR1 O 1 0.9999998807907104
was O 0 1.512304152129218e-06
performed O 0 2.8710825716871113e-08
by O 0 3.9174427590715766e-10
polymerase O 0 1.097847146525055e-08
chain O 0 2.2018171730309177e-09
reaction O 0 1.8673172730299115e-10
with O 0 3.742754803998105e-12
sequence O 0 2.0472814415972707e-11
- O 0 3.563669359607502e-10
specific O 0 2.3832430473547106e-10
primers O 0 2.0776134590505535e-08
, O 0 3.122900271712581e-10
and O 0 1.4635370693127925e-10
zygosity O 0 1.2255763692792243e-07
was O 0 1.0039978626252832e-08
assessed O 0 1.67682916440981e-08
using O 0 1.2835696061586077e-08
microsatellite O 0 3.820172764790186e-07
markers O 0 2.1388068205396848e-07
. O 0 2.743199161159282e-07

Genetic O 0 7.130459835025249e-06
and O 0 7.244198130251789e-09
environmental O 0 2.7260627089020772e-09
variance O 0 1.1752950834775788e-09
components O 0 9.020814317750592e-09
were O 0 1.62437918671543e-09
assessed O 0 7.449617367427663e-09
with O 0 5.337314964992679e-11
the O 0 5.461849639232241e-09
program O 0 2.3750852395920674e-09
Mx O 0 2.952907074416089e-08
, O 0 8.184195508798009e-12
using O 0 3.138340282093921e-11
data O 0 1.0794821980741887e-10
from O 0 8.972033185838946e-12
this O 0 7.26527562069923e-12
and O 0 1.7435206056681807e-11
previous O 0 4.5457695940775977e-10
studies O 0 4.798835773200949e-10
of O 0 1.9193520384153118e-10
twins O 0 1.2623279310730595e-08
with O 0 2.3090418466154006e-10
AS B-Disease 1 1.0
. O 0 6.979267936912947e-07

RESULTS O 0 9.274311310036865e-07
Six O 0 6.064716728815256e-08
of O 0 8.617938362931454e-09
8 O 0 5.492931904882425e-07
monozygotic O 0 2.5443732738494873e-05
( O 0 3.53540734465696e-08
MZ O 0 0.00014044342970009893
) O 0 9.184883076329697e-09
twin O 0 2.901349773765105e-07
pairs O 0 1.7062527390976356e-08
were O 0 1.3098097717545443e-08
disease O 0 6.433584331944076e-08
concordant O 0 7.630644560663313e-09
, O 0 4.898561764554721e-11
compared O 0 6.132020585747355e-11
with O 0 2.5614664469347792e-12
4 O 0 5.6153348637622e-09
of O 0 1.4595430419817035e-09
15 O 0 5.192206220527851e-09
B27 O 0 1.604540784683195e-07
- O 0 8.728014933012673e-08
positive O 0 7.389952649816678e-09
dizygotic O 0 1.7995503185375128e-06
( O 0 2.9216220553962557e-09
DZ O 0 7.629860192537308e-05
) O 0 1.7272374641663646e-09
twin O 0 7.561813220036129e-08
pairs O 0 2.0673744938193295e-09
( O 0 5.600418739870605e-11
27 O 0 3.809154769385259e-09
% O 0 6.051201206780377e-11
) O 0 6.162890076738536e-12
and O 0 1.7383969264095356e-11
4 O 0 5.344115372452052e-09
of O 0 9.73180469543422e-09
32 O 0 1.811944230212248e-07
DZ O 0 8.813072054181248e-05
twin O 0 3.301313995507371e-07
pairs O 0 4.937946940231086e-09
overall O 0 4.152970944915069e-08
( O 0 2.2347412809153866e-10
12 O 0 2.281758781919052e-09
. O 0 1.1242387576437807e-10
5 O 0 2.1277661854668395e-09
% O 0 1.5702510125503721e-10
) O 0 4.5099296519524046e-10
. O 0 1.646765923624116e-08

Nonsignificant O 0 1.303248336625984e-05
increases O 0 1.0992111221241885e-08
in O 0 8.283045915824516e-10
similarity O 0 3.0175151266575995e-10
with O 0 4.868343575492595e-12
regard O 0 1.879664424109251e-09
to O 0 2.115327468743544e-09
age O 0 2.1735351296570116e-09
at O 0 2.2963675405662798e-09
disease O 0 9.85359793759244e-10
onset O 0 1.5541861131396217e-08
and O 0 5.1726890132330894e-11
all O 0 1.9081096425122013e-10
of O 0 8.531775841369438e-10
the O 0 1.0929179783403242e-09
disease O 0 9.377868481763585e-10
severity O 0 5.666793700953576e-10
scores O 0 6.340479530297927e-11
assessed O 0 6.816866515713116e-10
were O 0 6.783635875251548e-10
noted O 0 2.3280632976963034e-09
in O 0 5.605062192159949e-09
disease O 0 7.661638790068537e-08
- O 0 1.231504711540765e-07
concordant O 0 5.610091307062248e-07
MZ O 0 5.4073338105808944e-05
twins O 0 2.1387212711942993e-07
compared O 0 4.846245182932307e-09
with O 0 5.866751529026715e-10
concordant O 0 1.4637203094025608e-05
DZ O 1 0.9995415210723877
twins O 0 0.0002048419846687466
. O 0 4.8008046178438235e-06

HLA O 0 1.3436993867799174e-05
- O 0 1.78263303496351e-06
B27 O 0 1.4219716604202404e-06
and O 0 4.3019274253985884e-10
B60 O 0 2.5218175991881253e-08
were O 0 9.674551437743872e-11
associated O 0 5.280592074718982e-10
with O 0 1.6188998058774828e-11
the O 0 8.689142738660394e-09
disease O 0 5.249113588234877e-09
in O 0 1.7289933373909605e-10
probands O 0 5.929305046947775e-08
, O 0 3.026770847847082e-11
and O 0 2.7886739792370996e-11
the O 0 1.0349711088153413e-09
rate O 0 6.996015144977719e-08
of O 0 5.06823305546078e-10
disease O 0 2.5239468848248237e-10
concordance O 0 2.071108173851144e-09
was O 0 7.612833141656949e-10
significantly O 0 1.5727096291939802e-09
increased O 0 4.728252012142775e-09
among O 0 1.0491661983635936e-09
DZ O 0 1.1759136214095633e-05
twin O 0 3.981278240416941e-08
pairs O 0 4.0329245498682553e-10
in O 0 4.415753873665551e-10
which O 0 1.0521114535144704e-10
the O 0 8.58554782823262e-10
co O 0 2.7131774604782777e-09
- O 0 2.3385984704304974e-08
twin O 0 3.239671642063513e-08
was O 0 6.2814082824047546e-09
positive O 0 2.1726140331246313e-10
for O 0 1.1901762908550495e-10
both O 0 1.0198157873730906e-09
B27 O 0 2.95060385724355e-06
and O 0 4.4724909997739815e-08
DR1 O 0 0.21728530526161194
. O 0 4.58189970231615e-06

Additive O 0 1.458993665437447e-06
genetic O 0 3.409722282299299e-08
effects O 0 1.2748542665974583e-08
were O 0 8.05180422336349e-10
estimated O 0 1.373149233208082e-10
to O 0 3.512544144435026e-10
contribute O 0 1.79139669764794e-09
97 O 0 1.1617098749638899e-07
% O 0 2.8776639404703985e-10
of O 0 6.147666403721885e-11
the O 0 6.816135156295644e-11
population O 0 2.0756725331583237e-12
variance O 0 5.325339058614986e-10
. O 0 2.7365979704541132e-08

CONCLUSION O 0 7.71169084146095e-07
Susceptibility O 0 1.5020960972833564e-06
to O 0 9.543833812131197e-08
AS B-Disease 1 1.0
is O 0 2.6715760159667923e-10
largely O 0 1.432470253526219e-10
genetically O 0 1.5525195018462057e-10
determined O 0 3.368233747469418e-10
, O 0 1.733897608824364e-10
and O 0 2.2949872557909146e-10
the O 0 3.345608012850221e-09
environmental O 0 2.506911123134614e-09
trigger O 0 2.1823263196552034e-08
for O 0 9.358712693696702e-10
the O 0 4.781424145505753e-09
disease O 0 9.66377289302045e-09
is O 0 3.9038730581530956e-11
probably O 0 2.1879476008734855e-09
ubiquitous O 0 1.7777627192572254e-07
. O 0 1.40783157576152e-07

HLA O 0 9.699480870040134e-06
- O 0 7.187524602159101e-07
B27 O 0 8.73574776960595e-07
accounts O 0 9.608629447654948e-10
for O 0 1.8871029738853906e-10
a O 0 2.7418509129795154e-10
minority O 0 3.488227068304539e-11
of O 0 5.033301553325487e-10
the O 0 1.0924406934620379e-09
overall O 0 2.2060049786887248e-08
genetic O 0 1.994328258092537e-08
susceptibility O 0 1.8308305982372985e-07
to O 0 6.184711196510762e-07
AS B-Disease 1 1.0
. O 0 2.433776535326615e-05

Cell O 0 9.546618429112641e-08
cycle O 0 8.986501320862317e-09
- O 0 1.4062637276879286e-08
dependent O 0 1.2370224844460154e-08
colocalization O 0 4.968597977494937e-07
of O 0 1.604962562851142e-08
BARD1 O 0 5.953469553787727e-06
and O 0 6.551931885923068e-09
BRCA1 O 0 1.9319215116553323e-09
proteins O 0 4.435402739533245e-11
in O 0 4.975686529462564e-10
discrete O 0 1.0607284828267893e-08
nuclear O 0 2.2444365299634228e-07
domains O 0 3.57738230150062e-07
. O 0 6.546850386257574e-07

Germ O 0 8.562073162465822e-06
- O 0 1.931039008695734e-07
line O 0 1.585855713415185e-08
mutations O 0 2.899460893601713e-09
of O 0 2.1801991323400216e-09
the O 0 1.1081324302608664e-08
BRCA1 O 0 1.7711554889388026e-08
gene O 0 5.250806456302826e-09
predispose O 0 3.574973916897761e-08
women O 0 1.1734779814531748e-10
to O 0 5.383774676070985e-11
early O 0 5.2615963141988686e-08
- O 0 1.3018666322750505e-06
onset O 1 0.9999985694885254
breast B-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 0 4.711105816568306e-08
compromising O 0 3.3301904522886616e-07
the O 0 2.8731204082532713e-08
genes O 0 2.4626278793959955e-09
presumptive O 0 1.2247070912962954e-07
function O 0 4.905766459728511e-09
as O 0 2.431450374373867e-09
a O 0 5.5700741796727016e-09
tumor B-Disease 0 1.4257790326155373e-07
suppressor O 0 8.41747532831505e-06
. O 0 1.2020610711260815e-06

Although O 0 6.021482477081008e-07
the O 0 4.8355193627003246e-08
biochemical O 0 5.05042407894507e-07
properties O 0 1.0727243306973833e-06
of O 0 1.5211900006306678e-07
BRCA1 O 0 1.1461555260439127e-08
polypeptides O 0 1.1593027648970633e-09
are O 0 5.524063411560531e-12
not O 0 3.682833552010045e-11
understood O 0 8.368416515303068e-10
, O 0 3.1998660665610856e-11
their O 0 2.695180745249104e-10
expression O 0 1.1585451709095196e-08
pattern O 0 1.0993866927933027e-09
and O 0 1.1092816942781525e-10
subcellular O 0 9.980127657627236e-08
localization O 0 5.908892717343406e-07
suggest O 0 1.329373500169595e-08
a O 0 9.34968436006045e-10
role O 0 3.903183998232862e-09
in O 0 3.4383973446239224e-09
cell O 0 5.6758324262773385e-08
- O 0 5.25452570343532e-08
cycle O 0 2.7761059229192142e-08
regulation O 0 1.5410731748488615e-06
. O 0 2.114786354923126e-07

When O 0 6.536999421768996e-07
resting O 0 8.513997613590618e-07
cells O 0 1.9631508862971714e-08
are O 0 1.1151686518662274e-10
induced O 0 1.4386756230777564e-09
to O 0 1.7140436292528705e-10
proliferate O 0 1.3547936106306224e-09
, O 0 5.955398674206691e-11
the O 0 3.137874959868725e-10
steady O 0 6.908811744921195e-09
- O 0 4.2095976704459304e-10
state O 0 1.9370595405465707e-11
levels O 0 6.24686358197124e-10
of O 0 1.243175701270971e-10
BRCA1 O 0 9.289775892984409e-11
increase O 0 3.133770326568808e-11
in O 0 1.937230376114485e-10
late O 0 2.3340984967035183e-07
G1 O 0 2.258529896437267e-08
and O 0 5.627852697753788e-11
reach O 0 7.64187102486602e-10
a O 0 6.389489631830614e-11
maximum O 0 2.5166222439310104e-09
during O 0 7.471388840940563e-09
S O 0 1.7664261520167202e-07
phase O 0 1.3117028174747247e-07
. O 0 1.2370929880489712e-06

Moreover O 0 7.776577604090562e-07
, O 0 1.6518865164627528e-09
in O 0 1.0837551966957903e-09
S O 0 6.039851285777331e-08
phase O 0 2.444662960954247e-08
cells O 0 3.541994786360192e-08
, O 0 6.4079617168033565e-09
BRCA1 O 0 1.0485485368860736e-08
polypeptides O 0 8.083614666531957e-09
are O 0 2.603568749481866e-10
hyperphosphorylated O 0 6.941518648773126e-08
and O 0 3.8701197802026854e-10
accumulate O 0 6.518078965456198e-09
into O 0 1.9212136326274276e-09
discrete O 0 2.1288919072048884e-08
subnuclear O 0 1.2831554840886383e-06
foci O 0 5.227884685155004e-07
termed O 0 2.1267496208565717e-07
" O 0 1.9617252178250055e-07
BRCA1 O 0 9.745479445655292e-08
nuclear O 0 3.9708245935798914e-07
dots O 0 1.4134618595562642e-06
. O 0 1.0569345931799035e-06

" O 0 1.078808509191731e-05
BRCA1 O 0 4.723801794170868e-06
associates O 0 2.710497994939942e-07
in O 0 1.8124966416621646e-08
vivo O 0 2.9420170903904364e-06
with O 0 6.668969820822213e-10
a O 0 4.347835425022595e-09
structurally O 0 5.1480906648748714e-08
related O 0 4.5502503098759917e-08
protein O 0 1.1802494981338896e-07
termed O 0 1.3295581311467686e-06
BARD1 O 0 0.00019436115690041333
. O 0 1.2398839999150368e-06

Here O 0 5.0353037295280956e-08
we O 0 2.719861447175731e-09
show O 0 1.5022105781525852e-09
that O 0 1.5916714127262033e-11
the O 0 1.5151416232761505e-10
steady O 0 1.1001339395022569e-08
- O 0 2.4452353475368227e-09
state O 0 1.0032177172325518e-10
levels O 0 8.640619775235336e-09
of O 0 5.685556470069741e-10
BARD1 O 0 1.976690953142679e-07
, O 0 1.182988290659992e-10
unlike O 0 5.673229108715816e-10
those O 0 2.480431970930397e-10
of O 0 7.862733797381338e-10
BRCA1 O 0 6.346596581607855e-09
, O 0 3.1117697307792014e-10
remain O 0 6.404418328997963e-09
relatively O 0 1.5980154977057737e-09
constant O 0 3.4121407921361424e-09
during O 0 3.444837304300563e-09
cell O 0 1.3527880149410976e-08
cycle O 0 2.1846835451810875e-08
progression O 0 1.473479755986773e-07
. O 0 1.9429593578479398e-07

However O 0 4.968811708749854e-07
, O 0 9.379697019085143e-09
immunostaining O 0 1.27644511849212e-06
revealed O 0 2.8375575666927944e-08
that O 0 8.573078913443055e-10
BARD1 O 0 1.178638171950297e-06
resides O 0 8.014590768823382e-09
within O 0 1.2359392398408886e-09
BRCA1 O 0 1.8780623722847167e-09
nuclear O 0 1.1253511900122248e-08
dots O 0 5.618891574243889e-09
during O 0 1.1615048123303495e-07
S O 0 5.4427484741381704e-08
phase O 0 1.832606599805331e-08
of O 0 4.197613368006614e-09
the O 0 1.5301395706046605e-09
cell O 0 5.850794293493777e-10
cycle O 0 1.1730348636884713e-10
, O 0 6.266273090693719e-12
but O 0 4.419456987869719e-12
not O 0 8.31888724572849e-11
during O 0 5.890345544656839e-09
the O 0 7.868063534033354e-09
G1 O 0 2.3060124476614874e-07
phase O 0 1.2528931847555214e-07
. O 0 3.777514052671904e-07

Nevertheless O 0 1.5751378668937832e-05
, O 0 3.4951785465864305e-08
BARD1 O 0 1.1625869547060574e-06
polypeptides O 0 7.112583855217736e-09
are O 0 5.76778971805858e-11
found O 0 1.6030355862173273e-11
exclusively O 0 8.251772182221728e-11
in O 0 1.6840293048936417e-10
the O 0 5.445224271483085e-10
nuclear O 0 6.090495663357842e-09
fractions O 0 8.208501434125992e-09
of O 0 3.699240691545924e-09
both O 0 3.81653431080764e-10
G1 O 0 2.5294577099543858e-08
- O 0 1.821754125330699e-08
and O 0 1.3667039722164986e-09
S O 0 5.543516579109564e-08
- O 0 4.625387628465205e-09
phase O 0 2.9925796951602024e-08
cells O 0 6.701976218437267e-08
. O 0 1.2318783149112278e-07

Therefore O 0 2.0890583130039886e-07
, O 0 6.834872112726487e-10
progression O 0 1.6859079465803006e-08
to O 0 6.178872080653264e-09
S O 0 3.302673690086522e-08
phase O 0 1.499729229692548e-08
is O 0 2.407475885313204e-10
accompanied O 0 7.192033635305961e-09
by O 0 2.6621554960470917e-10
the O 0 3.0240907555878493e-09
aggregation O 0 1.380571434950184e-09
of O 0 5.772327060782345e-10
nuclear O 0 5.5168619894629956e-08
BARD1 O 0 3.0575743039662484e-06
polypeptides O 0 1.0298285246790329e-07
into O 0 3.902650291820464e-08
BRCA1 O 0 1.2085828871022386e-07
nuclear O 0 4.307026415517612e-07
dots O 0 8.934189850151597e-07
. O 0 1.5444954897247953e-06

This O 0 2.9547605251423192e-08
cell O 0 1.294767404402819e-08
cycle O 0 3.9361389703174154e-09
- O 0 8.07732636332048e-09
dependent O 0 1.1057740501030366e-08
colocalization O 0 6.572993811460037e-07
of O 0 1.7520171979867882e-08
BARD1 O 0 4.919214461551746e-06
and O 0 6.009960085151533e-09
BRCA1 O 0 2.9010001512119743e-08
indicates O 0 4.590372970625367e-09
a O 0 2.377436303380165e-10
role O 0 1.0961037633094861e-09
for O 0 2.373794494303638e-09
BARD1 O 0 1.1171739060955588e-05
in O 0 1.0465089417266427e-07
BRCA1 O 0 9.964699074771488e-07
- O 0 6.60110572425765e-07
mediated O 0 8.921844596443407e-07
tumor B-Disease 0 2.7996522476314567e-05
suppression O 0 8.303906361106783e-05
. O 0 5.929146027483512e-07

Ethnic O 0 6.6039489432512255e-09
differences O 0 3.565452599829655e-09
in O 0 5.914008838203699e-09
the O 0 2.942247512294216e-08
HFE O 0 4.941915540257469e-05
codon O 0 2.402232212261879e-06
282 O 0 1.0690640692700981e-06
( O 0 6.500227556216487e-08
Cys O 0 0.011493153870105743
/ O 0 9.917542774928734e-05
Tyr O 0 7.886825915193185e-05
) O 0 7.1094508058422434e-09
polymorphism O 0 6.956826723580889e-07
. O 0 2.642298397859122e-07

Recent O 0 3.584662877642586e-08
studies O 0 1.4605900933162275e-09
have O 0 2.642172765299211e-11
shown O 0 5.522667878565812e-10
that O 0 1.4227833133872991e-08
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 0 2.556562321842648e-07
HH B-Disease 0 7.331053348025307e-05
) O 0 1.0108199693936726e-10
is O 0 2.37154610185919e-12
likely O 0 1.9544315818520452e-11
to O 0 7.488358544360807e-11
be O 0 2.6862559399098984e-10
caused O 0 2.3226466583370353e-10
by O 0 3.3607366889398804e-11
homozygosity O 0 2.254024167314128e-08
for O 0 6.202720559400632e-10
a O 0 2.1420591966858638e-09
Cys282Tyr O 0 2.0428227287538903e-07
mutation O 0 6.177030553722318e-10
in O 0 3.2661301441194723e-10
the O 0 5.054131335668899e-09
HFE O 0 5.724283710151212e-06
gene O 0 1.1129661636744004e-08
located O 0 4.547384691022671e-09
4 O 0 2.950627902009728e-07
. O 0 5.05396087646659e-07

5 O 0 7.179617114161374e-06
Mb O 0 0.00028238576487638056
telomeric O 0 2.4237913748947904e-05
to O 0 7.3419340651526e-07
HLA O 0 1.0930353710136842e-05
- O 0 9.347637387691066e-06
A O 0 4.913775683235144e-06
. O 0 6.703708663735597e-07

Population O 0 1.6259291690801092e-09
studies O 0 4.497132888303668e-09
of O 0 5.643377432029695e-10
this O 0 5.0201062057331214e-11
polymorphism O 0 2.2344397443418984e-09
are O 0 1.983468250754683e-11
facilitated O 0 8.921974270492683e-10
by O 0 5.539364800188906e-11
the O 0 1.2819395545093926e-09
fact O 0 4.909161965827025e-10
that O 0 5.6961799860255624e-11
the O 0 2.048470948423642e-09
Cys282Tyr O 0 1.1770587207138306e-06
mutation O 0 8.78028938444686e-09
creates O 0 1.7630283899450205e-09
a O 0 9.269925271837565e-09
Rsal O 0 5.71479222344351e-06
restriction O 0 6.7400941361484e-07
site O 0 1.3661357911587402e-07
. O 0 8.792745376240418e-08

We O 0 1.1176934577861175e-07
have O 0 1.2965558626731877e-09
studied O 0 5.297533078874039e-09
the O 0 3.946618587491457e-09
codon O 0 1.760387107196948e-07
282 O 0 1.725013447639867e-07
( O 0 2.8970687182550137e-08
Cys O 0 0.004210398532450199
/ O 0 3.838106931652874e-05
Tyr O 0 1.4206258128979243e-05
) O 0 2.1228278856977312e-10
polymorphism O 0 1.4388292779443645e-09
in O 0 5.136685174433886e-11
different O 0 6.1490469834002415e-12
ethnic O 0 1.3637340388894525e-11
groups O 0 6.532434315698055e-11
. O 0 8.45804137838968e-09

In O 0 1.500241353369347e-08
agreement O 0 1.495632950820891e-08
with O 0 2.3372184743131186e-10
previous O 0 6.038181510348295e-08
observations O 0 1.4529284442232893e-07
the O 0 2.0363644992471563e-08
Tyr O 0 4.833425919059664e-06
allele O 0 2.015582722947329e-08
appeared O 0 9.100934228456481e-09
to O 0 1.0008980311226878e-09
be O 0 3.208050491920744e-10
rare O 0 2.255197140144105e-09
or O 0 1.3952768940228566e-09
absent O 0 4.5590329733613544e-08
in O 0 3.741461362949394e-09
Asiatic O 0 1.6330679954990046e-06
( O 0 2.004218041529171e-10
Indian O 0 4.4390441322761376e-10
, O 0 2.490342827787817e-11
Chinese O 0 3.4861999398394516e-10
) O 0 5.0984418076271965e-11
populations O 0 2.407617993860356e-10
. O 0 7.408864188818143e-09

The O 0 1.5086756377513666e-07
highest O 0 5.0227576764427795e-08
allele O 0 2.0386496046853608e-08
frequency O 0 1.781641856268834e-08
( O 0 2.02066835486292e-11
7 O 0 7.877219432295135e-10
. O 0 8.06248054430192e-11
5 O 0 7.448562322487362e-10
% O 0 3.6876061232371526e-11
) O 0 1.968310583966293e-11
was O 0 9.026007163903671e-10
found O 0 2.2204399430236776e-10
in O 0 1.1236904740030695e-09
Swedes O 0 1.4385605027200654e-06
. O 0 3.659264109501237e-07

Saamis O 0 0.00016727509500924498
( O 0 1.124657478257518e-09
2 O 0 8.25853518904296e-09
% O 0 3.754606348049805e-10
) O 0 5.887453025099632e-11
and O 0 1.909540581213065e-10
Mordvinians O 0 6.324497121568129e-07
( O 0 2.5572354997449587e-11
1 O 0 5.964312932427163e-10
. O 0 7.390818512753583e-11
8 O 0 1.4964597339073293e-09
% O 0 5.947214248847033e-11
) O 0 1.8496600084905168e-11
had O 0 1.1357911833265177e-10
significantly O 0 4.75206429761954e-10
lower O 0 1.268948945920556e-09
frequencies O 0 8.428618691880274e-09
of O 0 6.66320065789705e-09
the O 0 8.823725039519559e-08
Tyr O 0 3.969896715716459e-05
allele O 0 1.2229627373017138e-06
. O 0 5.334570687409723e-07

Comparisons O 0 4.430683020473225e-07
with O 0 2.6477904313537692e-09
allele O 0 3.442592699798297e-08
frequencies O 0 8.462414768928284e-09
based O 0 8.547820229409808e-10
on O 0 6.300030275241397e-09
prevalence O 0 1.9459090339069007e-08
estimates O 0 6.134796559642552e-10
of O 0 1.69947667050252e-09
HH B-Disease 1 0.9897991418838501
showed O 0 2.130361963281757e-06
some O 0 6.468242386148404e-09
disagreements O 0 1.294352536262977e-08
with O 0 6.03453842451529e-10
the O 0 2.5998346586675325e-08
RFLP O 0 1.1533735460034222e-06
data O 0 3.971871276320371e-09
, O 0 6.360065252231095e-11
particularly O 0 3.339014620351577e-10
in O 0 3.326741104814346e-09
Finns O 0 2.1439952888613334e-06
. O 0 1.8383765620910708e-07

The O 0 1.8751087509372155e-06
newly O 0 2.7589298952079844e-06
described O 0 2.418653934910253e-07
HFE O 0 0.00024995667627081275
marker O 0 3.797709382524772e-07
provides O 0 2.7410578251618745e-09
a O 0 7.497891890695385e-11
new O 0 1.0146272017008684e-10
approach O 0 5.685903414764937e-10
to O 0 7.605807650357121e-10
the O 0 2.6413982112671874e-10
screening O 0 9.102461895338365e-09
of O 0 1.2844022734270766e-08
HH B-Disease 0 1.5246162547555286e-05
as O 0 3.214256416583794e-09
well O 0 2.463246828732224e-10
as O 0 5.5608434523790606e-11
studies O 0 2.6339924685814253e-10
of O 0 8.912071081113027e-11
the O 0 2.5218246935132527e-10
relationship O 0 1.3255918585031168e-10
between O 0 4.0902037312662287e-10
the O 0 3.658467662148723e-08
HFE O 0 0.001042115967720747
Tyr O 0 2.5287055905209854e-05
allele O 0 2.8122178363787498e-08
and O 0 2.2551485678867778e-10
different O 0 2.9963533876298243e-09
disorders O 0 0.0028136749751865864
including O 0 2.9646801635863085e-07
cancer B-Disease 0 0.10803711414337158

Autosomal B-Disease 1 1.0
dominant I-Disease 1 0.999505877494812
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9796645641326904
associated O 0 9.162525316241954e-08
with O 0 1.8313887906185045e-10
a O 0 5.728785446024176e-09
missense O 0 4.205364945164547e-08
mutation O 0 1.306909358511632e-09
encoding O 0 7.180123162697782e-09
Gly23 O 0 1.4169196447255672e-06
- O 0 1.1369213552825386e-06
- O 0 9.272720262742951e-07
> O 0 1.1349865189913544e-06
Val O 0 3.4765028544825327e-07
in O 0 2.0407036060987593e-08
neurophysin O 0 1.2544487617560662e-05
II O 0 0.3047929108142853
. O 0 3.552503358150716e-06

Autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 7.367996435192481e-09
ADNDI B-Disease 0 0.00014902366092428565
) O 0 8.090814129779744e-10
is O 0 1.573657038012044e-10
an O 0 7.358414433333849e-10
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 4.73506843263749e-05
by O 0 5.095994182191532e-10
progressive O 0 1.8727727365330793e-05
degeneration O 0 0.22128742933273315
of O 0 1.6672837332976087e-08
the O 0 5.384837908906093e-09
magnocellular O 0 6.501765881239407e-08
neurons O 0 1.0052549015426848e-08
of O 0 1.7756201842189512e-08
the O 0 8.359665315538223e-08
hypothalamus O 0 3.227872866773396e-07
leading O 0 1.0999828603530659e-08
to O 0 1.6153328674661793e-09
decreased O 0 2.4298696388314056e-09
ability O 0 4.459445035465137e-10
to O 0 2.081610883664098e-09
produce O 0 5.200750052836156e-09
the O 0 6.529951690481539e-08
hormone O 0 9.966940979211358e-07
arginine O 0 9.105710319090576e-07
vasopressin O 0 6.287347332545323e-06
( O 0 5.5332352033587995e-09
AVP O 0 2.590885924291797e-05
) O 0 7.495411402658192e-09
. O 0 1.0866146737953386e-07

Affected O 0 2.9064148066026974e-07
individuals O 0 1.0746196293931476e-10
are O 0 2.749794662804117e-11
not O 0 2.746755600746553e-10
symptomatic O 0 1.1690066692437995e-08
at O 0 1.0180977172424832e-09
birth O 0 1.1039658964762111e-08
, O 0 5.6239256307488716e-11
but O 0 1.79728489035913e-11
usually O 0 3.3330396775888005e-10
develop O 0 1.0556503227121539e-08
diabetes B-Disease 0 0.09249533712863922
insipidus I-Disease 0 7.285866104211891e-06
at O 0 2.2525028953168658e-08
1 O 0 1.204664670240163e-07
- O 0 2.1583969100902323e-06
6 O 0 3.0491880806948757e-06
yr O 0 3.2612570066703483e-05
of O 0 2.5576394335757868e-08
age O 0 8.940413920299761e-08
. O 0 1.1422451251519306e-07

The O 0 1.9957558095029526e-07
genetic O 0 1.3332051018721813e-08
locus O 0 2.05142391962454e-08
of O 0 2.2678658950781028e-09
the O 0 1.7524039996885676e-09
disease O 0 2.321664416271574e-09
is O 0 9.867279736341938e-12
the O 0 6.734813262632144e-10
AVP O 0 4.253227962180972e-05
- O 0 2.4110133836074965e-06
neurophysin O 0 5.3070776630192995e-05
II O 1 0.9999996423721313
( O 0 3.4836162843276952e-09
NPII O 0 1.5533524901911733e-06
) O 0 1.5386317220311696e-10
gene O 0 1.402221339041887e-09
, O 0 9.376718845821586e-11
and O 0 1.7436745103349693e-10
mutations O 0 5.959165605418093e-09
that O 0 2.9582028493457813e-10
cause O 0 1.2315137354335093e-08
ADNDI B-Disease 0 1.3054484497843077e-06
have O 0 3.065835085802604e-10
been O 0 1.239101737882109e-10
found O 0 1.5004881018243488e-11
in O 0 2.1664180865910154e-11
both O 0 1.2298950746725268e-10
the O 0 5.967328298162045e-10
signal O 0 8.894419423199906e-09
peptide O 0 1.5565883026980032e-09
of O 0 3.341526388922489e-09
the O 0 2.5079549104134458e-08
prepro O 0 1.9091976355412044e-05
- O 0 7.683922376600094e-06
AVP O 0 0.0002606828056741506
- O 0 5.721886395804177e-07
NPII O 0 2.8131971703260206e-06
precursor O 0 1.890666823101128e-07
and O 0 1.4149831306653482e-09
within O 0 3.264692960414095e-09
NPII O 0 5.300221801007865e-06
itself O 0 9.700744207918888e-09
. O 0 3.2563363561166625e-08

An O 0 4.1081413826304924e-09
affected O 0 3.773783230354155e-10
girl O 0 2.9354019215332983e-09
who O 0 2.0743172457482473e-10
presented O 0 1.7891499393130061e-09
at O 0 2.6893998139598807e-09
9 O 0 2.7204374308809065e-09
months O 0 2.0857193749890257e-10
of O 0 3.394792086330867e-11
age O 0 1.676191130339788e-10
and O 0 8.325078126869556e-11
her O 0 2.0886531393315977e-10
similarly O 0 2.3087995404402761e-10
affected O 0 1.020714346378071e-10
younger O 0 5.7248505935803e-10
brother O 0 5.357116972248832e-09
and O 0 1.182391184961773e-09
father O 0 2.219548633775048e-08
were O 0 3.915696655809597e-09
all O 0 1.9104476334241838e-10
found O 0 3.054352604170418e-11
to O 0 1.0612089679229442e-10
have O 0 3.508304063926104e-11
a O 0 5.4430099316604696e-11
novel O 0 8.510533389127772e-10
missense O 0 3.5604863057869807e-08
mutation O 0 7.700161619439427e-10
( O 0 8.448822370887843e-12
G1758 O 0 3.1181282000858346e-09
- O 0 1.4920819024766274e-09
- O 0 2.5209456744335057e-09
> O 0 1.0110563053444821e-08
T O 0 3.329445164013123e-09
) O 0 4.378328428977785e-12
encoding O 0 3.170651241557465e-10
the O 0 7.009539615410176e-10
amino O 0 5.103892863900228e-10
acid O 0 2.995860504118042e-10
substitution O 0 9.218036112201844e-09
Gly23 O 0 3.05889852825203e-06
- O 0 1.2538665714600938e-06
- O 0 1.410304321325384e-06
> O 0 3.5568798466556473e-06
Val O 0 2.562604322520201e-06
within O 0 1.7245528738385474e-07
NPII O 0 0.00015752830950077623
. O 0 3.8539334923370916e-07

The O 0 2.5007955173350638e-06
mutation O 0 6.908352645496052e-08
was O 0 6.85545487044692e-08
confirmed O 0 1.119382719849682e-08
by O 0 8.453311939327079e-10
restriction O 0 1.803906002351141e-07
endonuclease O 0 5.154633981874213e-07
analysis O 0 3.5718183966082506e-08
. O 0 1.3015880995226325e-07

A O 0 4.905562491330784e-06
T1 O 0 5.000331839255523e-06
- O 0 2.140580193099595e-07
weighted O 0 1.7442789612687193e-07
magnetic O 0 1.4614094823173218e-07
resonance O 0 2.927671118868602e-07
imaging O 0 0.00023525331926066428
of O 0 2.490302449587034e-06
the O 0 1.3915394447394647e-05
fathers O 0 0.0022944470401853323
pituitary O 0 0.001029020408168435
gland O 0 5.035096819483442e-06
demonstrates O 0 1.5873044389991264e-07
an O 0 9.534708578229356e-10
attenuated O 0 2.6929924956675677e-07
posterior O 0 1.8192424988683342e-07
pituitary O 0 0.021803880110383034
bright O 0 0.0002816396008711308
spot O 0 0.00014404159446712583
. O 0 1.2391617474349914e-06

This O 0 8.393857342525735e-08
mutation O 0 2.6272767073010073e-08
may O 0 2.701708190500085e-09
be O 0 9.25684640051827e-10
valuable O 0 1.0194390220874538e-08
for O 0 1.0869510153055373e-10
developing O 0 3.1146077383858994e-10
models O 0 5.4701483342967094e-09
of O 0 1.0538919958946735e-08
dominantly B-Disease 0 1.7030155504471622e-05
inherited I-Disease 0 0.10421374440193176
neurodegeneration I-Disease 1 1.0
, O 0 2.5692345473338207e-10
as O 0 1.3296174057597643e-11
the O 0 8.623845561273047e-12
early O 0 1.8394474832206242e-10
age O 0 1.155024756394063e-10
of O 0 8.793001049500759e-11
onset O 0 6.79324898555933e-07
of O 0 2.6948388409664403e-08
symptoms O 0 0.0003018167335540056
suggests O 0 2.5153227056762262e-08
that O 0 5.435561029054625e-11
this O 0 1.3381512564691889e-10
mutation O 0 2.733762383133609e-10
may O 0 2.7862348539464676e-10
be O 0 5.9542426544823e-10
particularly O 0 5.048126916484819e-10
deleterious O 0 7.759776821103515e-08
to O 0 1.3060208914339455e-07
the O 0 2.8133936780250224e-07
magnocellular O 0 3.856252533296356e-06
neuron O 0 2.8765535375896434e-07
. O 0 2.3715420738312787e-08
. O 0 1.4394440484011284e-07

Frequent O 0 1.2187335585167602e-07
inactivation O 0 1.0213851965090726e-05
of O 0 7.488856681447942e-06
PTEN O 0 0.005124395247548819
/ O 0 3.385628224350512e-05
MMAC1 O 0 4.046856702188961e-05
in O 0 9.90276305401494e-08
primary O 1 0.9953717589378357
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 4.690164132625796e-05

Sporadic B-Disease 1 1.0
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 1.117405076911382e-06
the O 0 1.0784934723062634e-08
most O 0 8.553475289163615e-11
common O 0 8.320887034951596e-11
male B-Disease 0 5.850501333393154e-11
cancer I-Disease 0 2.434078980040333e-11
in O 0 1.86734482043871e-11
the O 0 1.319341969008292e-09
Western O 0 3.320435126852317e-08
world O 0 1.605325983256023e-09
, O 0 1.511342613558231e-11
yet O 0 3.489444844184675e-11
many O 0 2.470283092664838e-12
of O 0 1.1602483730721591e-11
the O 0 6.955650638795774e-11
major O 0 5.752082143928305e-10
genetic O 0 1.6708603944870504e-10
events O 0 2.931029377539751e-11
involved O 0 1.2299484347666478e-11
in O 0 1.19304011114707e-10
the O 0 1.9594574851566904e-09
progression O 0 2.260714992985413e-08
of O 0 1.336350613501125e-10
this O 0 7.14616421593206e-11
often O 0 6.773331895360002e-10
fatal O 0 8.58332604991574e-09
cancer B-Disease 0 1.1683840739351581e-07
remain O 0 4.649829676850459e-08
to O 0 2.0045412441049848e-08
be O 0 4.109459794676695e-08
elucidated O 0 1.33006033138372e-05
. O 0 4.728823114419356e-06

Numerous O 0 1.8946519730889122e-07
cytogenetic O 0 1.7001353626255877e-05
and O 0 2.290253675596432e-08
allelotype O 0 7.417633582917915e-07
studies O 0 7.6733348564062e-09
have O 0 3.1800204136622767e-10
reported O 0 2.0258446309373568e-10
frequent O 0 5.602237562740697e-10
loss O 0 2.1372108527373257e-09
of O 0 1.017818629378553e-08
heterozygosity O 0 3.3373612495779525e-06
on O 0 1.7527478348711156e-06
chromosomal O 0 1.2753159808198689e-06
arm O 0 4.94185997013119e-07
10q O 0 1.590971919540607e-06
in O 0 2.340222948760129e-08
sporadic B-Disease 1 0.9998669624328613
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.00011196590639883652

Deletion O 0 6.162189038150245e-06
mapping O 0 1.9626104119652155e-07
studies O 0 1.5783900408905538e-08
have O 0 2.3078838840007165e-10
unambiguously O 0 7.000337198803663e-09
identified O 0 8.469321910453687e-10
a O 0 1.3219315642132301e-09
region O 0 4.424878685682643e-09
of O 0 1.79153420987177e-08
chromosome O 0 7.575931704195682e-08
10q23 O 0 5.869454184903589e-07
to O 0 1.7516054162669548e-09
be O 0 7.942908553104644e-10
the O 0 7.950093361408506e-10
minimal O 0 4.2259809873712584e-08
area O 0 3.237384582632785e-09
of O 0 5.319119367186431e-09
loss O 0 4.1622808311103654e-08
. O 0 1.9924848970731546e-07

A O 0 3.919166147170472e-07
new O 0 3.523800984339687e-08
tumor B-Disease 0 7.588788264456525e-08
suppressor O 0 5.288379725243431e-07
gene O 0 7.630823262161357e-08
, O 0 7.196177875812282e-09
PTEN O 0 1.1857661775138695e-05
/ O 0 1.214584699482657e-06
MMAC1 O 0 9.81254197540693e-06
, O 0 1.2290070072751291e-09
was O 0 1.0054696630845683e-08
isolated O 0 4.879338710850334e-09
recently O 0 8.482125557485176e-10
at O 0 2.9238839127643246e-10
this O 0 2.9914109384021614e-11
region O 0 3.703149731304478e-10
of O 0 9.580465309966257e-10
chromosome O 0 8.736771306416813e-09
10q23 O 0 1.2808408200726262e-07
and O 0 1.8525525558032996e-10
found O 0 2.2934948384900622e-10
to O 0 3.01101255040237e-10
be O 0 1.0815905115979518e-10
inactivated O 0 2.9213376162573468e-09
by O 0 6.933662671793073e-11
mutation O 0 1.3363206097238844e-09
in O 0 2.347141370151462e-09
three O 0 1.6057394702784222e-07
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 0 2.220040329348194e-07
lines O 0 2.7247905265426198e-08
. O 0 2.5994708607868233e-07

We O 0 5.925313644183916e-07
screened O 0 3.935112545150332e-06
80 O 0 8.508822247677017e-06
prostate B-Disease 1 0.9999973773956299
tumors I-Disease 1 1.0
by O 0 3.6575311668229915e-09
microsatellite O 0 2.7769109678388304e-08
analysis O 0 6.102574001687344e-10
and O 0 8.959862712876188e-11
found O 0 3.1523919585829674e-10
chromosome O 0 1.8144639124528794e-09
10q23 O 0 6.489450044000478e-08
to O 0 2.3661188564005897e-09
be O 0 8.798122230757599e-10
deleted O 0 1.3037630530732258e-08
in O 0 1.7484543812784636e-09
23 O 0 2.4807180309949217e-08
cases O 0 2.8137294716401584e-09
. O 0 3.3527708609426554e-08

We O 0 3.8410316705039804e-08
then O 0 5.240438083475851e-10
proceeded O 0 4.150164101268672e-10
with O 0 1.3984266218972086e-12
sequence O 0 3.813474275943252e-12
analysis O 0 1.978390194723456e-11
of O 0 3.622066188646578e-11
the O 0 3.090664391081077e-10
entire O 0 6.8893362126232205e-09
PTEN O 0 1.2240465366630815e-05
/ O 0 6.341369044093881e-06
MMAC1 O 0 1.1574512427614536e-05
coding O 0 1.0658797009455157e-06
region O 0 9.362681296920528e-09
and O 0 3.6271771697293786e-10
tested O 0 3.555951089140308e-09
for O 0 2.4517629593212575e-10
homozygous O 0 8.517601735036351e-09
deletion O 0 2.2155843826254795e-09
with O 0 1.774750832406191e-11
new O 0 3.4178337937618153e-09
intragenic O 0 1.6088955590021214e-07
markers O 0 2.9387015043624842e-09
in O 0 1.5967503708136377e-10
these O 0 2.88500473510922e-11
23 O 0 7.046186967230028e-10
cases O 0 1.9973632123249097e-11
with O 0 3.1749162326955016e-11
10q23 O 0 8.219037226808723e-06
loss O 0 3.869947136081464e-07
of O 0 1.7613741647437564e-06
heterozygosity O 0 0.01101585105061531
. O 0 4.264567542122677e-05

The O 0 2.0457621374703194e-08
identification O 0 3.1019006030419405e-08
of O 0 6.118685114131495e-09
the O 0 7.614434416325366e-09
second O 0 6.760340198752601e-08
mutational O 0 9.60614329414966e-07
event O 0 8.30545054952836e-09
in O 0 1.561786810988508e-09
10 O 0 7.263484924635577e-09
( O 0 2.0534066114130667e-10
43 O 0 7.831203241437379e-09
% O 0 1.5629311178599892e-09
) O 0 1.4626149180685388e-08
tumors B-Disease 1 1.0
establishes O 0 1.9031813280889764e-06
PTEN O 0 0.00016471765411552042
/ O 0 8.39813583297655e-06
MMAC1 O 0 5.194366622163216e-06
as O 0 4.827811928009851e-09
a O 0 6.217822923204608e-10
main O 0 3.4164240880762975e-10
inactivation O 0 1.7615704450690828e-08
target O 0 5.585734541568854e-09
of O 0 1.7462481460839285e-09
10q O 0 6.734896373927768e-07
loss O 0 7.636556276224837e-09
in O 0 1.1236203079079132e-08
sporadic B-Disease 1 0.9954577684402466
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.7574466798796493e-07
. O 0 1.6429579829946306e-07

Risk O 0 6.815390861447668e-06
reversals O 0 1.9409405638270982e-07
in O 0 4.585332558093569e-09
predictive O 0 7.626472608990298e-08
testing O 0 6.23284712730765e-09
for O 0 1.083929479506196e-08
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 9.531278237773222e-07

The O 0 1.9280818719380477e-07
first O 0 4.000710429608034e-09
predictive O 0 3.1083544627108495e-09
testing O 0 1.2705327900874863e-09
for O 0 1.9256087835373137e-09
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 9.967272146527151e-11
HD B-Disease 0 2.2911567043593095e-07
) O 0 2.996464881777072e-11
was O 0 3.5006658682945613e-10
based O 0 5.5861443942761824e-11
on O 0 1.087725132187245e-09
analysis O 0 1.1603690230899133e-09
of O 0 6.795148332905399e-10
linked O 0 1.015388551017793e-09
polymorphic O 0 2.4332784676062147e-09
DNA O 0 1.8340603480382356e-09
markers O 0 1.5739098913059024e-09
to O 0 1.1192626825362595e-09
estimate O 0 7.315731909152134e-10
the O 0 2.7526611545702906e-10
likelihood O 0 4.701220301939202e-09
of O 0 3.0966731401349534e-09
inheriting O 0 2.201839777171699e-07
the O 0 2.0669877187629027e-07
mutation O 0 2.5371985401534403e-08
for O 0 1.636308510910567e-08
HD B-Disease 0 5.803495878353715e-05
. O 0 9.100917850446422e-07

Limits O 0 4.221912774937664e-07
to O 0 1.0869375621780364e-08
accuracy O 0 3.868337472567873e-08
included O 0 2.5957800353637595e-09
recombination O 0 2.6614396797519646e-10
between O 0 7.747816277436925e-11
the O 0 6.239528338447542e-10
DNA O 0 4.686616095206375e-10
markers O 0 8.973446430360354e-10
and O 0 2.9095198472717243e-10
the O 0 7.605043705893877e-09
mutation O 0 4.042144841065465e-09
, O 0 1.7011848874037838e-10
pedigree O 0 5.030348138035379e-09
structure O 0 2.1308854680768263e-09
, O 0 2.760210948693498e-10
and O 0 1.008893871223826e-10
whether O 0 3.093306444323929e-10
DNA O 0 1.631194179729789e-09
samples O 0 4.603375458600567e-09
were O 0 3.522695468660686e-10
available O 0 2.2270375765742756e-08
from O 0 9.112671728317423e-10
family O 0 1.4286564153920267e-09
members O 0 1.4207270915278514e-09
. O 0 1.0778254022625333e-07

With O 0 8.614171043141994e-10
direct O 0 6.425316723124297e-09
tests O 0 1.66044711313873e-09
for O 0 6.430989629713224e-10
the O 0 7.195312790031494e-09
HD B-Disease 0 1.7606520486879162e-05
mutation O 0 5.160120331026974e-09
, O 0 8.291071301735897e-11
we O 0 2.10364600738977e-10
have O 0 3.977378842945356e-11
assessed O 0 3.213195931550672e-09
the O 0 8.283835839506537e-10
accuracy O 0 9.47117015925869e-08
of O 0 4.989259672072421e-09
results O 0 3.5037803769455422e-09
obtained O 0 1.0023619267940376e-08
by O 0 1.2128636983632646e-10
linkage O 0 1.6248564715937164e-09
approaches O 0 1.9204369205994e-09
when O 0 1.8205434382245755e-10
requested O 0 7.383330391519394e-09
to O 0 3.7382230644311676e-09
do O 0 2.6636806094160193e-09
so O 0 3.320362040870606e-10
by O 0 1.181216097156934e-10
the O 0 1.5221202076531881e-09
test O 0 1.2531609083765716e-09
individuals O 0 1.0867790001256594e-10
. O 0 5.468847064094007e-08

For O 0 4.92949027375289e-07
six O 0 5.735039110277285e-09
such O 0 1.1099589997121129e-10
individuals O 0 2.3776708032996474e-11
, O 0 1.5027449770665946e-11
there O 0 1.302602730540725e-11
was O 0 9.783800436480306e-10
significant O 0 2.065222659553001e-09
disparity O 0 1.5640075901046657e-09
between O 0 1.5762974259203588e-10
the O 0 7.793206968642608e-09
tests O 0 1.2242838742793083e-08
. O 0 4.927741414917364e-08

Three O 0 7.69707071412995e-08
went O 0 7.08406062699396e-08
from O 0 1.469173560586512e-09
a O 0 8.243139504315877e-10
decreased O 0 3.6797125346765824e-09
risk O 0 1.378989811229303e-09
to O 0 5.428031912835252e-10
an O 0 2.7902860577633248e-11
increased O 0 1.3524950603915897e-10
risk O 0 1.9752731394984124e-10
, O 0 6.703459402152001e-12
while O 0 2.1442765965606903e-11
in O 0 5.2845394726830364e-11
another O 0 2.726877612602152e-10
three O 0 8.672874224346927e-11
the O 0 4.952999677065861e-10
risk O 0 2.3434914009357044e-09
was O 0 6.687060238874665e-09
decreased O 0 4.1508329218231665e-08
. O 0 7.417181535629425e-08

Knowledge O 0 2.770887931546895e-06
of O 0 3.1544704626185194e-08
the O 0 3.3451743597368022e-09
potential O 0 7.187902495431331e-10
reasons O 0 1.6812636838281492e-09
for O 0 7.838472926291473e-11
these O 0 1.163612522309121e-11
changes O 0 1.681128153352418e-10
in O 0 1.003271354882429e-10
results O 0 3.173464546701865e-10
and O 0 5.992509266583568e-11
impact O 0 7.26276505602641e-09
of O 0 2.8389351980351307e-10
these O 0 3.2080244710686046e-11
risk O 0 1.4369554157678266e-10
reversals O 0 2.9211189023214956e-10
on O 0 6.785305650680584e-10
both O 0 3.8410552516410235e-11
patients O 0 1.203434296659367e-10
and O 0 1.2535541181468712e-11
the O 0 1.421209483432051e-09
counseling O 0 7.534469936842925e-09
team O 0 5.206630959708747e-11
can O 0 9.306192969016358e-12
assist O 0 1.0898599800412967e-09
in O 0 3.866570674748715e-10
the O 0 3.080061761195907e-09
development O 0 4.747528148385527e-09
of O 0 1.2597482779153069e-10
strategies O 0 9.81475234418383e-10
for O 0 3.4303827139980925e-11
the O 0 2.4456339731138144e-11
prevention O 0 4.6268056053122564e-10
and O 0 2.2448765936433634e-12
, O 0 1.868515975625429e-12
where O 0 6.827451364682657e-12
necessary O 0 2.0679502554799e-09
, O 0 8.298887271829258e-11
management O 0 2.29547847396816e-09
of O 0 9.352111307592281e-10
a O 0 1.0947831530216945e-09
risk O 0 2.1754389400996388e-09
reversal O 0 1.6826015025728225e-09
in O 0 6.034480692918009e-10
any O 0 5.916081513568372e-10
predictive O 0 3.151131133805052e-09
testing O 0 6.111753325654945e-10
program O 0 1.0767499114550105e-09
. O 0 1.4379951673859637e-09
. O 0 5.71238913948946e-08

A O 0 2.1388373738773225e-07
novel O 0 2.491981199170823e-08
common O 0 1.109632030704688e-08
missense O 0 2.9882397711844533e-07
mutation O 0 1.0580450293673493e-08
G301C O 0 1.0353333124157871e-07
in O 0 2.311770996854534e-09
the O 0 6.504169647314484e-09
N O 0 1.606858468505834e-08
- O 0 1.5432389588454498e-08
acetylgalactosamine O 0 2.796146247874276e-07
- O 0 5.7813565490505425e-08
6 O 0 1.8418319314150722e-07
- O 0 3.798912189267867e-07
sulfate O 0 3.705185349645035e-07
sulfatase O 0 2.311974185431609e-06
gene O 0 3.074475785069808e-08
in O 0 3.738752241133625e-08
mucopolysaccharidosis B-Disease 0 0.00011874674964929
IVA I-Disease 0 0.005222899839282036
. O 0 1.0958284292428289e-05

Mucopolysaccharidosis B-Disease 0 0.020069031044840813
IVA I-Disease 1 0.999982476234436
( O 0 6.150176886876579e-06
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 7.36649639065945e-08
is O 0 3.6793899038656264e-09
an O 0 8.777409910010192e-09
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 0 1.7254477313599637e-07
by O 0 1.0400840605440109e-10
a O 0 1.779567497806056e-07
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 8.634772257209988e-07
N O 0 6.816339492843326e-08
- O 0 2.5107022239012622e-08
acetylgalactosamine O 0 3.1149204460234614e-07
- O 0 1.2167289753506338e-07
6 O 0 8.170335377144511e-07
- O 0 7.418817858706461e-06
sulfate O 0 2.043303311438649e-06
sulfatase O 0 1.6740075807319954e-05
( O 0 1.154089490640331e-09
GALNS O 0 2.719176109167165e-06
) O 0 2.5929447478034717e-09
. O 0 5.2053483301506276e-08

In O 0 7.230838861005395e-08
previous O 0 2.784320152215969e-08
studies O 0 9.79788605803833e-09
, O 0 1.445692038304358e-10
we O 0 1.4143483606510188e-10
have O 0 3.905556086869488e-11
found O 0 4.999848104980664e-11
two O 0 6.771028876473295e-11
common O 0 6.528290130702885e-10
mutations O 0 5.460367158427459e-10
in O 0 5.941740433001996e-10
Caucasians O 0 1.6837098826272268e-08
and O 0 6.324720192019129e-10
Japanese O 0 1.7653495660852059e-06
, O 0 2.1739414712840244e-09
respectively O 0 3.089406419576335e-08
. O 0 8.259861772330623e-08

To O 0 2.8449937872210285e-07
characterize O 0 4.2966919977516227e-07
the O 0 6.65595010218567e-08
mutational O 0 7.809047019691207e-06
spectrum O 0 4.543052511962742e-08
in O 0 2.6183644141752893e-10
various O 0 1.720903003432639e-10
ethnic O 0 8.333541322291804e-12
groups O 0 3.4788632478216508e-12
, O 0 3.3251309691784137e-12
mutations O 0 1.5441523060211182e-11
in O 0 1.3927262121349315e-10
the O 0 1.7364799598240666e-09
GALNS O 0 6.374854422119824e-08
gene O 0 5.775487310621941e-10
in O 0 1.7124039963789528e-09
Colombian O 0 1.609247556189075e-05
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 5.325507572706556e-07
were O 0 5.225230026439931e-09
investigated O 0 6.837339583398716e-09
, O 0 3.5193239988906555e-10
and O 0 3.2438601804685163e-10
genetic O 0 1.4863953401444974e-09
backgrounds O 0 4.710741796642992e-10
were O 0 1.1138787670006423e-09
extensively O 0 7.644786470528686e-10
analyzed O 0 1.0141846251698894e-09
to O 0 1.543211558541202e-09
identify O 0 2.677974952902673e-09
racial O 0 3.26615484658177e-10
origin O 0 1.1919597253662317e-10
, O 0 2.0741776352029007e-11
based O 0 2.1050617846074537e-11
on O 0 3.6438951855899404e-10
mitochondrial O 0 5.469717456740852e-10
DNA O 0 3.6583893692210268e-09
( O 0 6.388907736187832e-10
mtDNA O 0 3.319497920983849e-08
) O 0 1.991947495838531e-09
lineages O 0 5.4013298722566105e-08
. O 0 1.1324506488108455e-07

Three O 0 6.640036787075587e-08
novel O 0 8.551840124937371e-08
missense O 0 2.097575588777545e-06
mutations O 0 1.4513510393499018e-07
never O 0 1.148739627865325e-07
identified O 0 2.0893605068295074e-08
previously O 0 1.2777682911746524e-08
in O 0 2.392475106915981e-10
other O 0 3.2171664637870023e-11
populations O 0 7.31167904000074e-12
and O 0 2.1997401730006194e-12
found O 0 1.4932903871778258e-11
in O 0 8.961981851074441e-11
16 O 0 2.323352177313609e-09
out O 0 1.7481967262700238e-10
of O 0 2.1481952328095133e-10
19 O 0 2.694777201384113e-08
Colombian O 0 2.916120592999505e-06
MPS B-Disease 1 0.9997984766960144
IVA I-Disease 1 0.9999923706054688
unrelated O 0 2.4083286120912817e-07
alleles O 0 3.578792595604341e-09
account O 0 1.4356110744628836e-09
for O 0 1.823741824225067e-09
84 O 0 2.9114946187291935e-07
. O 0 2.772429184005887e-07

2 O 0 1.0779672976468646e-07
% O 0 2.8254316664089174e-09
of O 0 1.995879905791753e-09
the O 0 1.1964040869116843e-09
alleles O 0 3.488069000301408e-10
in O 0 8.661917849650536e-10
this O 0 1.0806735506463383e-09
study O 0 4.3333883148477526e-09
. O 0 2.0504655751096834e-08

The O 0 1.9066292225033976e-06
G301C O 0 8.407783752772957e-06
and O 0 1.3779230201294013e-08
S162F O 0 8.556732495890174e-07
mutations O 0 4.601690140049186e-09
account O 0 2.0633641462097785e-09
for O 0 3.137577087031218e-09
68 O 0 9.362377682009537e-07
. O 0 9.885474128168426e-07

4 O 0 3.9905273752083303e-07
% O 0 3.8371927857383525e-09
and O 0 9.067004924645516e-10
10 O 0 3.0230829395350156e-08
. O 0 1.2205002519749542e-07

5 O 0 2.1120794713169744e-07
% O 0 4.0135965662102535e-09
of O 0 1.4387963043205332e-09
mutations O 0 1.8221075759328187e-09
, O 0 2.2012028311202414e-10
respectively O 0 4.6421710919730685e-09
, O 0 1.6719220452543482e-10
whereas O 0 3.6547207482584554e-09
the O 0 9.375046516879593e-09
remaining O 0 1.1571587066327993e-07
F69V O 0 2.823671593432664e-06
is O 0 1.393563320295499e-10
limited O 0 5.713211570501642e-10
to O 0 1.5863873548127572e-09
a O 0 2.633903317672548e-09
single O 0 1.9954164542923536e-08
allele O 0 1.9889859004251775e-07
. O 0 3.0852788768243045e-07

The O 0 4.972276883563609e-07
skewed O 0 1.8422184666633257e-07
prevalence O 0 3.2226870416707243e-07
of O 0 1.9938404260955167e-09
G301C O 0 9.138928191987361e-08
in O 0 1.4029597483755651e-09
only O 0 1.616429989859114e-09
Colombian O 0 4.414301457700276e-08
patients O 0 3.0424711638943336e-09
and O 0 1.522816317489628e-10
haplotype O 0 5.356636911812984e-09
analysis O 0 8.143903884594295e-10
by O 0 2.875533491875082e-11
restriction O 0 1.535454652312751e-09
fragment O 0 3.589393782199579e-10
length O 0 1.2743764377098898e-10
polymorphisms O 0 3.5503802120473438e-09
in O 0 1.3381927788103098e-09
the O 0 1.9727448119510882e-08
GALNS O 0 3.0739647627342492e-06
gene O 0 2.1497468694064992e-08
suggest O 0 1.727541487639428e-08
that O 0 1.32823668730353e-10
G301C O 0 2.464809689683989e-08
originated O 0 2.8936268936519127e-09
from O 0 2.2537381683118696e-10
a O 0 1.0240219783241855e-09
common O 0 2.626919570758446e-09
ancestor O 0 1.8283685676578898e-07
. O 0 9.984410809238398e-08

Investigation O 0 3.8320536077662837e-07
of O 0 6.896635795783368e-08
the O 0 2.9033360604557856e-08
genetic O 0 1.2904233237520657e-08
background O 0 3.36213790141926e-09
by O 0 1.3732120995868513e-10
means O 0 1.2901526069697411e-08
of O 0 6.3591980570265605e-09
mtDNA O 0 6.756666692808722e-08
lineages O 0 5.839637218230109e-09
indicate O 0 7.062983087280372e-09
that O 0 7.069742707921378e-11
all O 0 9.838230924374969e-11
our O 0 4.947089404794269e-10
patients O 0 7.884461139529009e-11
are O 0 2.5294523420260617e-12
probably O 0 3.135356418937363e-10
of O 0 5.029577865300894e-10
native O 0 8.674355456150806e-09
American O 0 1.0156601319977199e-06
descent O 0 2.5766928956727497e-05

Low O 0 5.657188353325182e-07
frequency O 0 1.1642075037343602e-07
of O 0 2.1632544644489826e-08
BRCA1 O 0 8.843505838740384e-08
germline O 0 1.9706958198639768e-07
mutations O 0 6.340107883140433e-10
in O 0 2.34052416336894e-10
45 O 0 9.505606080040252e-09
German O 0 0.06908489018678665
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 5.716476039197005e-07
. O 0 4.2052485582644294e-07

In O 0 1.7533109186729234e-08
this O 0 4.3973225061222365e-10
study O 0 1.0084705986956877e-10
we O 0 2.4545691867938757e-11
investigated O 0 3.0684486201915107e-11
45 O 0 1.0838049346872936e-09
German O 0 0.00016493610746692866
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.3854331015750176e-09
for O 0 6.300819865856511e-10
germline O 0 5.97059042206638e-08
mutations O 0 6.513973249688831e-10
in O 0 3.148319605017491e-09
the O 0 4.182837898270009e-08
BRCA1 O 0 4.8621821235883544e-08
gene O 0 7.449094852063354e-08
. O 0 9.853678193394444e-07

We O 0 3.698621853231998e-08
identified O 0 6.4544152245105124e-09
four O 0 8.516558014370901e-10
germline O 0 5.846142130394583e-07
mutations O 0 1.2447239683410771e-08
in O 0 5.0218544878077864e-09
three O 0 4.816520160488835e-08
breast B-Disease 0 0.1267799288034439
cancer I-Disease 0 4.168001908055885e-07
families O 0 1.9050504229678467e-11
and O 0 1.5687832977118177e-11
in O 0 4.76529082860111e-09
one O 0 0.006205304525792599
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 7.664321856282186e-06
. O 0 1.8084900244019764e-09
among O 0 4.864027583484365e-12
these O 0 4.854398133469218e-12
were O 0 1.699761026374702e-10
one O 0 3.866231501614692e-10
frameshift O 0 1.214834384200003e-07
mutation O 0 1.052465758988319e-08
, O 0 9.706014880705993e-10
one O 0 4.418586829757487e-09
nonsense O 0 3.664907808342832e-07
mutation O 0 2.4048668834097953e-08
, O 0 6.16195650060547e-10
one O 0 1.203191019039096e-10
novel O 0 9.443418269583503e-10
splice O 0 5.1403389988990966e-08
site O 0 2.4129901632363726e-08
mutation O 0 2.313627955885522e-09
, O 0 2.0826304569787624e-10
and O 0 3.8021624737538673e-10
one O 0 7.578544014563704e-09
missense O 0 5.624890036415309e-06
mutation O 0 1.0574498219284578e-06
. O 0 2.4192222554120235e-06

The O 0 2.64787558990065e-06
missense O 0 5.664423042617273e-06
mutation O 0 5.668800184821521e-08
was O 0 2.8451283995423182e-08
also O 0 7.51067708026909e-10
found O 0 1.123475618092229e-10
in O 0 5.468674402209217e-10
2 O 0 2.4050854108281783e-07
. O 0 3.499508522963879e-07

8 O 0 2.3327410758611222e-07
% O 0 3.6319141027973956e-09
of O 0 2.4133341991472435e-09
the O 0 1.0927094784562996e-09
general O 0 3.5378340257352647e-09
population O 0 3.222177732964404e-11
, O 0 5.033855970948409e-11
suggesting O 0 1.3929952746849494e-09
that O 0 1.8906399015805597e-11
it O 0 1.6354449045019592e-11
is O 0 1.3415085015067163e-11
not O 0 3.407489013174114e-10
disease O 0 8.072101320699687e-10
associated O 0 8.833739961744413e-09
. O 0 2.052363896609677e-07

The O 0 6.446715161700922e-08
average O 0 2.60703370003057e-09
age O 0 4.2012957002235396e-10
of O 0 4.277888043802136e-10
disease O 0 7.008473357217326e-09
onset O 0 1.0126408369615092e-06
in O 0 3.208119103703666e-09
those O 0 2.4458137737326524e-09
families O 0 1.8117173039566836e-10
harbouring O 0 2.81674843449764e-08
causative O 0 1.4531022607400246e-08
mutations O 0 2.442447799566594e-09
was O 0 6.070663527424358e-09
between O 0 3.473926979413733e-10
32 O 0 2.4748396754148416e-07
. O 0 2.0582480431130534e-07

3 O 0 1.5597445326420711e-06
and O 0 9.182556937048503e-08
37 O 0 2.4302057681779843e-06
. O 0 1.3551065194405965e-06

4 O 0 1.350451412918119e-07
years O 0 4.4093177997694966e-09
, O 0 1.784582065456064e-10
whereas O 0 1.0438845343685443e-09
the O 0 2.036868451682494e-09
family O 0 1.4403779280414142e-09
harbouring O 0 1.0526363212193246e-06
the O 0 5.1525304911592684e-08
missense O 0 1.2740346164719085e-06
mutation O 0 8.814402541190702e-09
had O 0 9.658681632274124e-10
an O 0 2.0708572009975335e-11
average O 0 4.592785179946546e-11
age O 0 1.1612806549710086e-10
of O 0 5.045335260689399e-10
onset O 0 1.8820851437340025e-06
of O 0 1.5476005899017764e-07
51 O 0 1.15939485567651e-06
. O 0 1.1346088513164432e-06

2 O 0 2.0662696442741435e-06
years O 0 3.20305588275005e-07
. O 0 7.989454502421722e-07

These O 0 3.870175291353917e-08
findings O 0 2.6059513658083233e-08
show O 0 2.985948910350089e-08
that O 0 1.2488421408107797e-09
BRCA1 O 0 6.8782966877734e-08
is O 0 5.156634563796558e-10
implicated O 0 2.4212505334020307e-09
in O 0 3.3108571440010337e-10
a O 0 3.827972938630353e-10
small O 0 1.8691551778582394e-11
fraction O 0 2.732985227016371e-10
of O 0 1.1993978255020465e-08
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.2789728387474497e-08
suggesting O 0 2.8778848193411477e-09
the O 0 2.2765324347862048e-10
involvement O 0 4.960487576255446e-10
of O 0 1.216236694689954e-10
another O 0 1.200740201712236e-10
susceptibility O 0 3.2007665407007835e-09
gene O 0 7.681902225442627e-09
( O 0 9.994620242537167e-09
s O 0 4.456773240235634e-06
) O 0 4.2135422972933156e-07

Paternal O 0 6.225231481948867e-05
transmission O 0 0.00020921057148370892
of O 0 0.00011994669330306351
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.9999997615814209

We O 0 6.819856253059697e-07
report O 0 1.6412283088129698e-08
a O 0 8.703303633339488e-10
rare O 0 1.068415356186847e-09
case O 0 5.405230707467013e-10
of O 0 3.761302824756285e-09
paternally O 1 0.9679277539253235
transmitted O 1 1.0
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 2.541936510169762e-07
DM B-Disease 1 1.0
) O 0 1.1961902579571415e-08
. O 0 9.034902603843875e-08

The O 0 1.2200201808809652e-06
proband O 0 6.069675237085903e-06
is O 0 4.506541528837005e-10
a O 0 3.663212511106906e-10
23 O 0 2.5859414609641362e-09
year O 0 4.503490913521091e-10
old O 0 3.721343233564767e-08
, O 0 2.3634443291342677e-09
mentally B-Disease 1 1.0
retarded I-Disease 1 1.0
male O 0 1.8574193063614075e-06
who O 0 8.065045165039919e-08
suffers O 0 2.3229872567753773e-06
severe O 0 0.30076876282691956
muscular B-Disease 1 1.0
weakness I-Disease 1 1.0
. O 1 0.9998601675033569

He O 0 1.8157913928007474e-07
presented O 0 1.0491771007536954e-07
with O 0 3.770043832673764e-09
respiratory O 0 0.0007132951868698001
and O 0 7.893075526510529e-09
feeding O 0 1.1787848563926673e-07
difficulties O 0 8.679386098719988e-09
at O 0 7.25342346186153e-08
birth O 0 2.313740878889803e-06
. O 0 1.8784878648148151e-06

His O 0 1.0696590834413655e-05
two O 0 3.2312547659785196e-07
sibs O 0 0.0006048612995073199
suffer O 0 2.694608269848686e-07
from O 0 2.5897385569351172e-08
childhood O 0 0.00044168822932988405
onset O 1 1.0
DM B-Disease 1 1.0
. O 0 0.07352902740240097

Their O 0 4.6742652415332486e-08
late O 0 7.090425697242608e-06
father O 0 1.5477688464216044e-07
had O 0 1.9361388936545154e-08
the O 0 9.363837483178372e-10
adult O 0 1.3686421995728892e-09
type O 0 3.50834783446885e-09
of O 0 1.5268780018118377e-08
DM B-Disease 1 1.0
, O 0 5.12411579833838e-09
with O 0 9.80900152769415e-11
onset O 0 0.00988400261849165
around O 0 2.261360876332219e-09
30 O 0 9.458745786616873e-09
years O 0 3.174434715091934e-09
. O 0 3.8637068655589246e-08

Only O 0 9.752917407013229e-08
six O 0 1.3636053397547698e-09
other O 0 5.633692731071838e-12
cases O 0 2.7906307906860883e-12
of O 0 1.6071012576279742e-11
paternal O 0 2.071752714982722e-05
transmission O 1 1.0
of O 1 0.9999991655349731
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 5.667367986461613e-06
been O 0 2.982750046953697e-08
reported O 0 1.1861520654576907e-09
recently O 0 7.808025337396884e-09
. O 0 4.032005662679694e-08

We O 0 1.7548089203955897e-07
review O 0 3.504884915628281e-08
the O 0 2.5890751764734432e-09
sex O 0 2.1785394321849338e-10
related O 0 4.669428732562153e-11
effects O 0 1.0269834982423731e-09
on O 0 6.501018834370598e-09
transmission O 0 3.89245883525291e-07
of O 0 1.2332958476690692e-07
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.014791195280849934

Decreased O 0 5.147391675563995e-06
fertility O 0 9.130895506359593e-08
of O 0 3.765485701023863e-10
males O 0 8.591375527666756e-11
with O 0 1.753504893370339e-12
adult O 0 1.3152321898246555e-08
onset O 0 0.0005853356560692191
DM B-Disease 1 1.0
and O 0 2.412428834475122e-08
contraction O 0 1.6726755802665139e-07
of O 0 2.8550044550712528e-09
the O 0 7.566755000354419e-10
repeat O 0 2.035210222572914e-09
upon O 0 1.5055752200510142e-09
male O 0 8.903954240579992e-10
transmission O 0 5.557485582841082e-10
contribute O 0 9.009455681496803e-11
to O 0 5.350446197205372e-10
the O 0 1.5970922362384954e-09
almost O 0 9.240369580609809e-10
absent O 0 1.4714121476799846e-08
occurrence O 0 3.5397238473677817e-09
of O 0 3.9389308481574403e-10
paternal O 0 5.033306820223515e-07
transmission O 0 1.3381087228481192e-05
of O 0 1.3887880641050288e-06
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.05646345764398575

Also O 0 2.7490122178619458e-08
the O 0 1.475233157854916e-09
fathers O 0 8.504015269750198e-09
of O 0 1.1843616087858777e-09
the O 0 2.587426495281875e-09
reported O 0 3.3086744455346206e-09
congenitally O 0 3.4787258300639223e-06
affected O 0 1.0040375197917228e-09
children O 0 5.384845347400358e-10
showed O 0 1.1128403754057103e-09
, O 0 5.0374000110098294e-11
on O 0 7.889553010897998e-09
average O 0 6.1366369763504736e-09
, O 0 2.798730414088624e-10
shorter O 0 2.3534238380307215e-07
CTG O 0 3.4388008316454943e-06
repeat O 0 4.1724874222381914e-07
lengths O 0 1.189944214274874e-07
and O 0 2.094802331598089e-09
hence O 0 6.555106679684286e-09
less O 0 8.389576255929398e-10
severe O 0 1.8247786615077644e-09
clinical O 0 1.0849554143987916e-08
symptoms O 0 7.1368950749217674e-09
than O 0 1.6385953358066807e-11
the O 0 8.15795417330456e-11
mothers O 0 8.304951865101273e-11
of O 0 2.222014759689639e-11
children O 0 2.012699590325795e-10
with O 0 1.2155182416151433e-09
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.9999579191207886

We O 0 8.341444868165127e-08
conclude O 0 7.18755259754289e-08
that O 0 5.721859652751959e-10
paternal O 0 2.273533254992799e-06
transmission O 0 0.00015585479559376836
of O 0 1.3739212590735406e-05
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 0 6.018359499648795e-07
rare O 0 8.895844061385105e-09
and O 0 3.9707237498021186e-11
preferentially O 0 6.933913165863004e-11
occurs O 0 6.837146734189892e-12
with O 0 2.45127296282302e-13
onset O 0 2.6411547082716424e-07
of O 0 4.344530069033681e-08
DM B-Disease 1 1.0
past O 0 6.9330736707229335e-09
30 O 0 1.4026814154632916e-09
years O 0 8.656050876076904e-11
in O 0 4.651756410622987e-11
the O 0 5.204469077924045e-10
father O 0 5.6988698204918364e-09
. O 0 4.414872023517091e-09
. O 0 5.1072678530772464e-08

The O 0 2.3841153051762376e-06
RB1 O 0 3.206352994311601e-05
gene O 0 4.80127582136447e-08
mutation O 0 1.0351966395205636e-08
in O 0 2.9244431321018283e-09
a O 0 2.5499968359099512e-08
child O 0 3.667372823201731e-07
with O 0 3.71759050210585e-08
ectopic B-Disease 1 0.9999996423721313
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 1.0
. O 0 0.02066538669168949

The O 0 5.581121968134539e-06
RB1 O 0 9.277468052459881e-05
gene O 0 1.9376838622520154e-07
mutation O 0 4.872032022262829e-08
was O 0 1.542868055537383e-08
investigated O 0 5.208045994464783e-09
in O 0 3.606882348350382e-09
a O 0 4.57820377164353e-08
child O 0 4.16852657281197e-07
with O 0 1.1346815931290166e-08
ectopic B-Disease 1 0.9962013363838196
intracranial I-Disease 1 0.9999995231628418
retinoblastoma I-Disease 0 8.733202412258834e-05
using O 0 4.960066490866666e-08
DNA O 0 9.066525308298878e-09
obtained O 0 2.6606354452951564e-08
from O 0 1.6365293564746253e-09
both O 0 1.7349636172170335e-09
the O 0 1.3180448732441619e-08
pineal B-Disease 0 1.2269063518033363e-05
and I-Disease 0 1.260606836694933e-07
retinal I-Disease 1 0.9999873638153076
tumours I-Disease 1 1.0
of O 0 8.822746622172417e-07
the O 0 8.92477345360021e-08
patient O 0 1.566219509641087e-07
. O 0 6.471046276601555e-08

A O 0 1.6732320773371612e-06
nonsense O 0 9.164322705146333e-07
mutation O 0 6.290340692771679e-09
in O 0 4.678839093941178e-09
exon O 0 1.1742967132022386e-07
17 O 0 2.0994016836084484e-07
( O 0 4.714310053444137e-10
codon O 0 3.190649877637952e-08
556 O 0 5.051750573414893e-09
) O 0 2.8561522591452615e-10
of O 0 2.448539593302712e-09
the O 0 2.137627674869691e-08
RB1 O 0 2.174661631215713e-06
gene O 0 1.165898133592691e-08
was O 0 1.4579301321759885e-08
found O 0 5.978641470782975e-10
to O 0 5.860644747279764e-10
be O 0 3.6940633885151897e-10
present O 0 3.5444783219595877e-10
homozygously O 0 2.675161567822215e-07
in O 0 2.5939785874840027e-09
both O 0 3.830078032507345e-09
the O 0 2.0413889245674e-08
retinal B-Disease 0 5.024674010201124e-07
and I-Disease 0 3.679061677530626e-08
the I-Disease 0 3.46218075719662e-06
pineal I-Disease 1 0.9999991655349731
tumours I-Disease 1 1.0
. O 0 2.693138640097459e-06

The O 0 7.753859421200104e-08
same O 0 2.9509856780407517e-09
mutation O 0 2.050351000093542e-09
was O 0 1.7836097043755217e-09
present O 0 1.7271806207475038e-10
heterozygously O 0 3.1854568760536495e-08
in O 0 8.001236895260888e-10
the O 0 8.880243762554585e-10
DNA O 0 1.5965104793735918e-09
from O 0 8.685128172203349e-10
the O 0 4.995715841005222e-09
constitutional O 0 2.286151179475837e-08
cells O 0 1.8943562274387205e-09
of O 0 5.368222533164158e-10
the O 0 5.59395196830792e-10
patient O 0 6.037511823819841e-09
, O 0 6.818293152299759e-11
proving O 0 2.608416371785438e-09
it O 0 1.513711031519982e-11
to O 0 3.975446360993118e-10
be O 0 9.756797592075372e-10
of O 0 4.9732031826010825e-09
germline O 0 1.2572791092679836e-06
origin O 0 6.078347780658078e-08
. O 0 2.3350135336386302e-07

The O 0 2.3032541207612667e-07
initial O 0 2.4954390553943995e-08
mutation O 0 3.1193538863050208e-09
was O 0 3.937070225390471e-09
shown O 0 1.3931334974515153e-09
to O 0 2.247416253098322e-09
have O 0 4.850605334061342e-11
occurred O 0 4.892700689040907e-10
in O 0 5.026949967401606e-10
the O 0 9.984445270561082e-09
paternally O 0 7.493126190638577e-07
derived O 0 3.4573233165247075e-07
RB1 O 0 0.0001415194128639996
allele O 0 7.72461589804152e-07
. O 0 2.634970712733775e-07

The O 0 3.746441166185832e-07
mutation O 0 3.369115653129029e-09
is O 0 1.904479872416598e-11
in O 0 1.289164174717028e-11
an O 0 1.2877069202610336e-11
area O 0 1.1274640249192558e-10
of O 0 4.4030376566972507e-10
the O 0 1.2403720273113095e-09
gene O 0 1.4111208868072822e-09
that O 0 3.663820358212888e-10
encodes O 0 6.944094743666085e-10
the O 0 8.150664032591237e-10
protein O 0 1.3111482732863777e-10
- O 0 2.0548406032272482e-10
binding O 0 5.119863422109461e-10
region O 0 6.322380396994731e-10
known O 0 8.892108160907242e-10
as O 0 4.6343306969731657e-10
the O 0 8.767817027965918e-10
pocket O 0 1.1017634733434534e-06
region O 0 3.991997843399986e-09
and O 0 5.360150101552108e-10
has O 0 1.3742235127622848e-10
been O 0 4.1071049339258536e-10
detected O 0 1.3776437768342475e-09
in O 0 1.5845873224673568e-10
other O 0 1.5237693051783907e-10
cases O 0 1.1220814555290559e-10
of O 0 6.26662610692108e-10
retinoblastoma B-Disease 0 1.6591316409630963e-07
. O 0 2.1744318345895408e-08
. O 0 2.233459355238665e-07

Low O 0 1.0436786396894604e-05
levels O 0 1.2675228333591804e-07
of O 0 3.9627154890808924e-09
beta O 0 8.328186140715843e-08
hexosaminidase O 0 6.199863946676487e-07
A O 0 3.050514862934506e-08
in O 0 2.2204535987668805e-09
healthy O 0 8.8809928300293e-09
individuals O 0 1.2795636945839295e-11
with O 0 3.945289928086737e-11
apparent O 0 1.3542770602725795e-06
deficiency O 0 3.5238335840404034e-05
of O 0 3.376810354893678e-06
this O 0 5.783849488238957e-08
enzyme O 0 1.0119537563468839e-07
. O 0 1.7846269884103094e-07

Appreciable O 0 8.199910553230438e-06
beta O 0 3.302760887891054e-06
hexosaminidase O 0 3.3077139960369095e-05
A O 0 2.577095301603549e-06
( O 0 3.836146511559946e-09
hex O 0 3.398367596219032e-07
A O 0 2.650268413617596e-07
) O 0 3.063151954307841e-10
activity O 0 1.919506775749369e-09
has O 0 3.44982410693806e-11
been O 0 5.2710905085184834e-11
detected O 0 2.0226293973024667e-09
in O 0 1.470102084510927e-08
cultured O 1 1.0
skin O 1 1.0
fibroblasts O 1 1.0
and O 0 2.2100705336924875e-06
melanoma B-Disease 1 1.0
tissue O 0 1.2054661056026816e-06
from O 0 9.67610769286864e-10
healthy O 0 2.5800785952156957e-09
individuals O 0 6.988359543824707e-12
previously O 0 1.1593817572652654e-10
reported O 0 3.6597256475312534e-11
as O 0 1.6199918073667163e-09
having O 0 2.4510973162250593e-07
deficiency B-Disease 0 9.681663868832402e-06
of I-Disease 0 2.2196041982169845e-07
hex I-Disease 0 4.0798533973429585e-07
A I-Disease 0 1.8656388434123983e-08
activity O 0 3.232287992815941e-09
indistinguishable O 0 2.3198141185787335e-09
from O 0 1.4579112223023216e-11
that O 0 5.82713022799497e-13
of O 0 3.2056798621865612e-12
patients O 0 1.6561627069755502e-11
with O 0 8.766579684404974e-10
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 7.416555369843536e-09
TSD B-Disease 0 9.644172678235918e-05
) O 0 3.506595014357572e-09
. O 0 8.352127167654544e-08

Identification O 0 1.1239009154451196e-06
and O 0 1.6559473792199242e-08
quantitation O 0 0.0006103313062340021
of O 0 5.937933565292042e-06
hex O 0 4.548472588794539e-06
A O 0 4.701223019765166e-07
, O 0 5.608138953228092e-10
amounting O 0 1.45114897875942e-09
to O 0 3.3240201702255945e-09
3 O 0 1.1897830631824036e-07
. O 0 2.519505812870193e-07

5 O 0 3.353862041421962e-07
% O 0 1.1059259286128054e-08
- O 0 1.515403766916279e-07
6 O 0 5.299648364598397e-07
. O 0 5.018544015911175e-07

9 O 0 5.522061883311835e-07
% O 0 1.111968916944761e-08
of O 0 5.744508868588127e-09
total O 0 5.186732376927239e-09
beta O 0 2.2361341223131603e-07
hexosaminidase O 0 8.710699717084935e-07
activity O 0 3.124154446254579e-08
, O 0 6.435726396247787e-10
has O 0 7.979698152249526e-11
been O 0 7.640219706894769e-11
obtained O 0 1.6912728995066573e-09
by O 0 4.2834807922886853e-10
cellulose O 0 2.4995316039166937e-07
acetate O 0 1.7263248537346954e-06
gel O 0 1.2175698884675512e-06
electrophoresis O 0 2.571511892313083e-08
, O 0 3.070218246303824e-10
DEAE O 0 1.7685569275727175e-07
- O 0 3.5605252080017635e-09
cellulose O 0 5.771198985371484e-08
ion O 0 1.0199995159609898e-07
- O 0 4.358540479643125e-07
exchange O 0 2.577631221356569e-06
chromatography O 0 3.7049485968054796e-07
, O 0 1.5994151558729186e-09
radial O 0 9.73847047447407e-09
immunodiffusion O 0 6.950010060791101e-07
, O 0 1.2952433570134758e-09
and O 0 2.494566775368412e-09
radioimmunoassay O 0 2.627753019623924e-05
. O 0 1.088800786419597e-06

Previous O 0 5.070367478765547e-05
family O 0 3.804400705575972e-08
studies O 0 4.7188851937107756e-08
suggested O 0 6.526015283725428e-09
that O 0 2.943623816920038e-11
these O 0 1.6021369994567713e-11
individuals O 0 2.7671135782031397e-12
may O 0 1.1334452820754848e-10
be O 0 5.314458942362599e-11
compound O 0 2.091002260229402e-09
heterozygotes O 0 6.6779977103692545e-09
for O 0 2.114269453956652e-10
the O 0 5.494446564391353e-10
common O 0 6.084652226512333e-10
mutant O 0 6.129068808036209e-09
TSD B-Disease 0 1.4693625871586846e-07
gene O 0 6.323296886101559e-10
and O 0 2.4678084575846526e-10
a O 0 5.969404082151186e-09
rare O 0 5.198214481083596e-08
( O 0 8.073933743801831e-10
allelic O 0 1.0921020532350667e-07
) O 0 5.120205370801045e-10
mutant O 0 3.798013281652857e-08
gene O 0 2.3650734704006027e-08
. O 0 2.1625578483508434e-07

Thus O 0 3.0361979952431284e-07
, O 0 4.3250154568852395e-09
the O 0 5.19819165489821e-09
postulated O 0 5.3734829918994365e-08
rate O 0 2.1155139862116812e-08
mutant O 0 3.493390687836495e-09
gene O 0 8.641752313742757e-10
appears O 0 1.0420821983103679e-09
to O 0 2.4848734181404097e-10
code O 0 5.3665818317005787e-11
for O 0 7.617912550772488e-11
the O 0 4.4348633099211554e-10
expression O 0 3.0295810304892257e-09
of O 0 2.2163988699919202e-10
low O 0 1.4672133508142338e-09
amounts O 0 1.8649609634380226e-10
of O 0 1.3280295751982862e-09
hex O 0 2.0065654382506182e-07
A O 0 7.417788765451405e-07
. O 0 1.2050430768795195e-06

Heterozygotes O 0 2.026581387326587e-05
for O 0 6.573539224064007e-08
the O 0 3.1160372060412556e-08
rare O 0 1.806770555390358e-08
mutant O 0 7.76145014924623e-08
may O 0 4.38804148572558e-09
be O 0 4.859294078229937e-10
indistinguishable O 0 5.478585141105441e-09
from O 0 2.457812287026684e-10
heterozygotes O 0 2.6065379188366933e-08
for O 0 3.9481546920683286e-09
the O 0 1.066501997826208e-08
common O 0 3.6077992149330385e-08
TSD B-Disease 0 2.1491585357580334e-05
mutant O 0 1.0416325721962494e-06
. O 0 4.1251593074775883e-07

However O 0 1.042699508957412e-07
, O 0 5.485985554720685e-10
direct O 0 1.4295695738297809e-09
visualization O 0 2.299216106393942e-07
and O 0 1.7532064688907667e-09
quantitation O 0 0.00012152786075603217
of O 0 9.16614112611569e-07
hex O 0 5.682558708031138e-07
A O 0 5.148974224766789e-08
by O 0 1.998023413385397e-10
the O 0 6.235887917149796e-10
methods O 0 8.496054526574426e-09
described O 0 7.591213768698424e-10
may O 0 8.935462370018854e-10
prevent O 0 1.838943330945142e-09
false O 0 4.994115343492922e-09
- O 0 6.697156607060606e-09
positive O 0 3.059660302895395e-10
prenatal O 0 1.2996159171052568e-07
diagnosis O 0 5.532867817237275e-07
of O 0 3.6202394415596473e-09
TSD B-Disease 0 7.2054217525874265e-06
in O 0 9.620682916988699e-09
fetuses O 0 2.1006253803079744e-07
having O 0 1.7298749099836641e-09
the O 0 2.416258748638711e-09
incomplete O 0 8.829617570427217e-08
hex B-Disease 0 5.011278517486062e-06
A I-Disease 0 1.1747748430934735e-05
deficiency I-Disease 0 0.020672354847192764
of O 0 1.6301565892717917e-06
the O 0 3.377707855634071e-07
type O 0 7.288370511560061e-07
described O 0 5.4037796459738274e-09
in O 0 2.351703276559647e-09
the O 0 3.130698473796656e-07
four O 0 4.518371454764747e-08
healthy O 0 2.0077158069398138e-07
individuals O 0 7.261171663941468e-09

The O 0 1.4068292557567474e-06
tumor B-Disease 0 1.7444466493543587e-06
suppressor O 0 1.4477884178631939e-05
gene O 0 8.292568054457661e-07
Smad4 O 0 0.0002369823050685227
/ O 0 1.2726947716146242e-05
Dpc4 O 0 1.2126439287385438e-05
is O 0 2.508909191512032e-10
required O 0 8.45218395273406e-10
for O 0 7.675000079920835e-10
gastrulation O 0 1.9285820940240228e-07
and O 0 4.045158374932356e-10
later O 0 2.112481922722509e-08
for O 0 1.4492762545614823e-09
anterior O 0 3.4916187718891933e-09
development O 0 5.948947645606495e-08
of O 0 2.4480552696104496e-08
the O 0 2.7532520263662263e-08
mouse O 0 1.1599551186236567e-07
embryo O 0 8.051826938526574e-08
. O 0 1.70839626889574e-07

Mutations O 0 1.0003816441894742e-07
in O 0 2.290896006229559e-08
the O 0 1.0374820647029992e-07
SMAD4 O 0 0.0011159323621541262
/ O 0 2.457912705722265e-05
DPC4 O 0 1.9550425349734724e-05
tumor B-Disease 0 2.21058186866685e-07
suppressor O 0 8.406338736222096e-08
gene O 0 2.804181997717592e-09
, O 0 1.6689175041939563e-10
a O 0 2.014048483545139e-09
key O 0 5.360370209928078e-07
signal O 0 1.4646587260358501e-05
transducer O 0 1.3786244608127163e-06
in O 0 1.845390613652853e-07
most O 0 3.2728120658021e-08
TGFbeta O 0 2.1628600279655075e-06
- O 0 4.3427238693993786e-08
related O 0 3.1392350940961933e-09
pathways O 0 1.486304523901083e-09
, O 0 1.236685580330299e-11
are O 0 4.1815192259285483e-13
involved O 0 2.2190066624461213e-12
in O 0 7.595323675557708e-11
50 O 0 4.398777875280757e-08
% O 0 7.953919300973666e-09
of O 0 1.0263694605328055e-07
pancreatic B-Disease 1 0.9999997615814209
cancers I-Disease 1 1.0
. O 1 0.999107301235199

Homozygous O 0 3.703262336784974e-05
Smad4 O 0 1.8563427147455513e-05
mutant O 0 3.880413146362116e-07
mice O 0 3.149234117927335e-08
die O 0 1.8636471921240627e-08
before O 0 1.4763879896406706e-08
day O 0 4.702245348653378e-08
7 O 0 8.212097100113169e-07
. O 0 7.562576342934335e-07

5 O 0 1.6125466117955511e-06
of O 0 2.960453571176913e-07
embryogenesis O 0 6.326194852590561e-05
. O 0 5.655209861288313e-06

Mutant O 0 1.295737888540316e-06
embryos O 0 4.33158930945865e-08
have O 0 2.291466183468316e-10
reduced O 0 5.910194000868785e-10
size O 0 5.398584912441606e-10
, O 0 5.687378346053151e-10
fail O 0 9.374657139460396e-08
to O 0 4.038978929088444e-08
gastrulate O 0 1.7067399085135548e-06
or O 0 1.3251888475451779e-08
express O 0 4.501071515505828e-09
a O 0 1.8170613902412924e-09
mesodermal O 0 3.1129903277360427e-07
marker O 0 5.523916257743622e-08
, O 0 1.281147521403625e-09
and O 0 1.0312468656792362e-09
show O 0 1.3352823202694708e-07
abnormal O 0 1.4034695539066888e-07
visceral O 0 6.539249852721696e-07
endoderm O 0 7.713434024481103e-05
development O 0 6.620397243750631e-07
. O 0 1.0233059128950117e-06

Growth B-Disease 1 1.0
retardation I-Disease 1 1.0
of O 0 7.356715627793164e-07
the O 0 1.3592998016065394e-07
Smad4 O 0 1.2061539564456325e-05
- O 0 2.7591801199378096e-07
deficient O 0 6.413601738586294e-08
embryos O 0 9.172243409238945e-09
results O 0 4.27039825723341e-09
from O 0 8.672778606388931e-10
reduced O 0 1.9329139178125843e-08
cell O 0 5.8945516911990126e-08
proliferation O 0 2.948169424143998e-07
rather O 0 1.589943510182934e-09
than O 0 1.879394417869662e-10
increased O 0 9.680907187004095e-10
apoptosis O 0 2.028834131806434e-07
. O 0 1.372582971725933e-07

Aggregation O 0 1.4143329281068873e-06
of O 0 3.848860785637953e-07
mutant O 0 1.5863419093875564e-06
Smad4 O 0 1.0246954843751155e-05
ES O 0 6.078283149690833e-06
cells O 0 1.7734134161173642e-08
with O 0 1.5138473807851938e-10
wild O 0 1.2363760681921576e-08
- O 0 1.4815163318360192e-08
type O 0 1.0309704379096729e-07
tetraploid O 0 1.1384641993572586e-06
morulae O 0 5.948685611656401e-06
rescues O 0 8.537935514141282e-07
the O 0 2.5183285856655857e-07
gastrulation B-Disease 0 0.00028283626306802034
defect I-Disease 0 2.0747738744830713e-05
. O 0 8.878081416696659e-07

These O 0 1.311122588276703e-07
results O 0 8.450385990954601e-08
indicate O 0 4.556807553512954e-08
that O 0 5.072429698493863e-10
Smad4 O 0 4.814959311261191e-07
is O 0 1.398326593404775e-10
initially O 0 3.590831798572225e-10
required O 0 5.785664169977167e-10
for O 0 5.94734150816123e-10
the O 0 1.2408121197182709e-09
differentiation O 0 5.016971726945485e-09
of O 0 3.797279823913868e-09
the O 0 4.848889734176964e-09
visceral O 0 2.0616106155557645e-08
endoderm O 0 3.2659096405041055e-07
and O 0 1.3457633618596532e-10
that O 0 4.8687082143672455e-11
the O 0 9.922209720514275e-10
gastrulation B-Disease 0 1.184642201224051e-06
defect I-Disease 0 5.378169021241774e-08
in O 0 2.691842526658661e-09
the O 0 2.621200145824787e-08
epiblast O 0 7.385181106656091e-06
is O 0 8.055870553969058e-11
secondary O 0 2.2950232825280636e-09
and O 0 1.548769168469022e-10
non O 0 2.4168969048332656e-07
- O 0 1.5800081598627003e-07
cell O 0 6.571457902282418e-07
autonomous O 0 3.937928738650953e-07
. O 0 1.0376714953963528e-06

Rescued O 0 1.4241039025364444e-05
embryos O 0 4.7651664658587833e-07
show O 0 4.4225691908650333e-07
severe O 0 2.8617014891096915e-07
anterior O 0 5.003266210223956e-07
truncations O 0 0.00035235341056250036
, O 0 3.781106983069549e-08
indicating O 0 9.409733081611193e-08
a O 0 4.015924037759078e-09
second O 0 5.821587656384963e-09
important O 0 1.7870420698784528e-09
role O 0 6.238437322281243e-09
for O 0 7.778371724498356e-09
Smad4 O 0 7.59585009291186e-06
in O 0 3.985396190842039e-08
anterior O 0 1.0371412599852192e-06
patterning O 0 0.0014881108654662967
during O 1 0.9999969005584717
embryogenesis O 0 0.3239800035953522
. O 0 1.6595320175838424e-06

Prevalence O 0 1.0050354831037112e-05
of O 0 3.03762526243645e-08
p16 O 0 4.3229644575148996e-07
and O 0 8.453300281985321e-09
CDK4 O 0 0.00022354292741511017
germline O 0 0.00015448618796654046
mutations O 0 1.2692876794062613e-07
in O 0 1.6287543758153333e-08
48 O 0 1.196429707306379e-06
melanoma B-Disease 0 0.001383565366268158
- O 0 3.261961182943196e-06
prone O 0 3.562334072171325e-08
families O 0 1.9417174812463855e-10
in O 0 4.96014918027754e-09
France O 0 5.856114171365334e-07
. O 0 7.437650992869749e-07

The O 0 3.378868132131174e-05
French O 0 0.0006763776182197034
Familial B-Disease 1 0.9992577433586121
Melanoma I-Disease 1 1.0
Study O 0 1.4970034101224883e-07
Group O 0 4.769028283391208e-09
. O 0 1.6555020465602865e-08

Germline O 0 8.57074701343663e-05
mutations O 0 1.194042340557644e-07
in O 0 1.544920458229626e-08
the O 0 4.291237587494834e-08
p16 O 0 5.693467528544716e-07
and O 0 6.203433322582441e-09
CDK4 O 0 8.855098485582857e-07
genes O 0 6.196713142614385e-10
have O 0 7.00394950370331e-11
been O 0 1.4986097085500916e-10
reported O 0 7.847597571775111e-11
in O 0 2.985171554392707e-10
a O 0 4.827351851588446e-09
subset O 0 1.1774849184575942e-07
of O 0 1.0432063213272613e-08
melanoma B-Disease 0 6.1758264564559795e-06
pedigrees O 0 1.1224298646084208e-07
, O 0 4.0582651128495684e-10
but O 0 1.2980325148070904e-10
their O 0 6.369513250170655e-10
prevalence O 0 4.006729881211868e-08
is O 0 1.1202952628075469e-11
not O 0 5.4434148161197626e-11
well O 0 1.1394044596713115e-09
known O 0 5.59134427646768e-08
. O 0 6.307529361038178e-07

We O 0 1.8403132173716585e-07
searched O 0 6.42745163759173e-08
for O 0 1.3010049704220705e-09
such O 0 1.646680347633378e-09
germline O 0 6.7513465182855725e-06
mutations O 0 1.3556679334669752e-08
in O 0 5.0932760231603424e-09
48 O 0 4.690005539487174e-07
French O 0 3.129605147478287e-06
melanoma B-Disease 1 0.9935438632965088
- O 0 1.3294845757627627e-06
prone O 0 7.091168097161926e-09
families O 0 8.42336703860136e-12
selected O 0 1.3973987245119446e-10
according O 0 3.150581184829804e-11
to O 0 2.64237576264037e-10
two O 0 1.7847274005888814e-11
major O 0 7.493831249982819e-11
criteria O 0 8.721516286946951e-10
families O 0 2.6444703631750555e-12
with O 0 4.782891747587281e-13
at O 0 1.9460703881701846e-10
least O 0 8.423082370478951e-11
three O 0 3.422422761856225e-11
affected O 0 1.302364882604934e-10
members O 0 1.8548931834949656e-10
( O 0 1.4843093421035292e-10
n O 0 7.421791625716878e-09
= O 0 1.96054266154988e-08
20 O 0 8.049792499242869e-10
) O 0 2.16156016696889e-11
or O 0 5.223829702138971e-11
families O 0 2.295672115945613e-12
with O 0 2.7283822987347883e-13
two O 0 4.68077790069521e-12
affected O 0 1.4201837622573876e-11
members O 0 1.7096674770344933e-11
, O 0 1.0334037445214328e-11
one O 0 1.4530696958170441e-11
of O 0 1.1809047663347005e-11
them O 0 2.6776389265570355e-12
affected O 0 4.9990636630248275e-12
before O 0 5.858831475524795e-11
the O 0 1.7987569767008438e-10
age O 0 4.6547588006262686e-10
of O 0 1.7459907131200936e-10
50 O 0 1.1720602266507285e-09
( O 0 2.888110063603566e-11
n O 0 2.0257102661958015e-09
= O 0 2.8355719550177128e-08
28 O 0 1.2802346738283177e-08
) O 0 3.4057084929983716e-10
, O 0 1.2698755935680595e-10
and O 0 7.151413489170366e-11
one O 0 4.18852383332613e-11
additional O 0 5.1014209523359e-10
minor O 0 1.0358167656931982e-08
criterion O 0 1.627801793802064e-05
. O 0 1.139554797191522e-06

Sixteen O 0 6.870101287859143e-07
different O 0 1.8987304173379016e-08
p16 O 0 1.912274456117302e-06
germline O 0 2.8001086320728064e-06
mutations O 0 3.5282849975004638e-09
were O 0 4.643603557230591e-10
found O 0 8.368093024069267e-11
in O 0 5.182109602541729e-11
21 O 0 3.5633720418815074e-09
families O 0 2.9195468959075654e-11
, O 0 3.379132737513224e-11
while O 0 8.913363103157934e-11
one O 0 4.0918421428948193e-10
germline O 0 3.7876720853091683e-06
mutation O 0 4.3756742229561496e-08
, O 0 2.6122100038605822e-09
Arg24His O 0 2.3534780666523147e-06
, O 0 1.4911942791684396e-09
was O 0 1.6232773347724105e-08
detected O 0 3.3695464196625835e-09
in O 0 1.2018063211272079e-09
the O 0 3.013423111042357e-08
CDK4 O 0 1.450010222470155e-05
gene O 0 9.02019792192732e-08
. O 0 9.53498727085389e-07

The O 0 2.951656874472519e-08
frequency O 0 7.775096122486502e-08
of O 0 4.796934849338186e-09
p16 O 0 5.2468141831241155e-08
gene O 0 4.403837738919947e-09
mutation O 0 1.0885740087118734e-09
in O 0 4.385579122079264e-10
our O 0 5.40054445608007e-09
sample O 0 2.0498194253093516e-09
( O 0 8.585249178238996e-11
44 O 0 6.306062338978791e-10
% O 0 7.817151786992937e-11
) O 0 2.232831280979397e-11
is O 0 5.15529242559043e-12
among O 0 9.38866389146864e-13
the O 0 2.5556898611278633e-11
highest O 0 4.201568259976085e-10
rates O 0 9.54711976142164e-10
yet O 0 1.0807470890439319e-10
reported O 0 2.3034685270317823e-10
and O 0 1.6929954660405144e-10
the O 0 4.902642292137216e-09
CDK4 O 0 1.3965736798127182e-06
mutation O 0 1.9445649535043685e-09
is O 0 1.8681570179701623e-11
the O 0 2.5273863557551124e-10
second O 0 3.6391951674374923e-09
mutation O 0 1.7794438145202207e-09
detected O 0 1.4005642201553314e-09
in O 0 3.066829290521156e-10
this O 0 8.597412226585277e-10
gene O 0 7.942079882639064e-09
worldwide O 0 2.7289148718523393e-08
. O 0 1.6171469496839563e-07

In O 0 1.3468330450905341e-08
summary O 0 3.1521733490080805e-07
, O 0 2.3266905069263544e-10
our O 0 8.819442398610988e-10
results O 0 6.885733094819102e-10
show O 0 3.3111873243285572e-09
frequent O 0 7.653437883448078e-10
involvement O 0 2.2711512670525735e-09
of O 0 4.5541899140744135e-09
the O 0 3.053379060702355e-08
p16 O 0 2.0481483886669594e-07
gene O 0 5.870876762514854e-08
in O 0 1.1099516861179382e-08
familial B-Disease 0 4.490766514209099e-07
melanoma I-Disease 0 2.2752927179681137e-05
and O 0 1.6967324767414027e-10
confirm O 0 1.558026774262089e-08
the O 0 5.927446977693762e-09
role O 0 5.97551235159699e-08
of O 0 3.4818648941836727e-07
the O 0 1.5917399309728353e-07
CDK4 O 0 1.9034470824408345e-05
gene O 0 1.529104665110026e-08
as O 0 1.3039918478341406e-08
a O 0 3.134001858029478e-08
melanoma B-Disease 0 6.630395091633545e-06
- O 0 1.9707728426965332e-07
predisposing O 0 6.777239605071372e-07
gene O 0 2.1210816214534134e-08
. O 0 1.2386232484118409e-08
. O 0 1.0470080979985141e-07

Progression O 0 1.0773784197226632e-05
of O 0 2.0344356244095252e-07
somatic O 0 4.826480108022224e-06
CTG O 0 5.239302481641062e-06
repeat O 0 6.793003137772757e-08
length O 0 3.6950096315990777e-09
heterogeneity O 0 9.88537873780615e-09
in O 0 2.0080224150120785e-09
the O 0 3.297561113058123e-09
blood O 0 5.227270838403797e-10
cells O 0 3.1958375945606576e-09
of O 0 1.2794705739338497e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 0.0001645013689994812
. O 0 1.4684312645840691e-06

The O 0 2.501209728222875e-08
genetic O 0 9.045015847419791e-10
basis O 0 8.542201612726785e-09
of O 0 1.8099098042512196e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.7324103964710957e-06
DM B-Disease 1 1.0
) O 0 1.069957122901144e-09
is O 0 5.503096589531964e-11
the O 0 9.76822581155723e-11
expansion O 0 7.035175775271796e-10
of O 0 5.284108706149482e-10
an O 0 8.123700323547922e-11
unstable O 0 2.810286003906981e-09
CTG O 0 5.496496058299272e-08
repeat O 0 5.501832323062672e-09
in O 0 8.442919141593563e-10
the O 0 1.7724826051335185e-09
34 O 0 3.792719471817918e-09
UTR O 0 1.8107297705682868e-07
of O 0 4.981215884214407e-09
the O 0 1.8810748514397346e-08
DM B-Disease 1 0.9999995231628418
protein O 0 1.4724256480747044e-08
kinase O 0 1.5726595137266486e-08
gene O 0 3.77710440702117e-09
on O 0 1.537140192908737e-08
chromosome O 0 3.43242980704872e-08
19 O 0 4.889995466328401e-07
. O 0 3.563592088084988e-07

One O 0 7.002797275390549e-08
of O 0 2.026194145798854e-08
the O 0 9.216857499438902e-09
principal O 0 4.569104916640754e-08
features O 0 2.755589889602561e-08
of O 0 8.650864202763842e-08
the O 0 6.193456556502497e-06
DM B-Disease 1 1.0
mutation O 0 6.76448678404995e-07
is O 0 3.5881686510919053e-10
an O 0 5.967872029888355e-11
extraordinarily O 0 1.301899299477327e-08
high O 0 4.938062758697015e-08
level O 0 6.817963935645821e-07
of O 0 2.982391222872138e-08
somatic O 0 4.724621703644516e-06
mosaicism O 0 5.013223926653154e-06
, O 0 2.1337964728473935e-10
due O 0 4.295813038623919e-09
to O 0 3.4327882758589112e-09
an O 0 1.0044527709585083e-10
extremely O 0 1.57013707591247e-10
high O 0 3.2172786657014285e-10
degree O 0 1.7592839185454068e-08
of O 0 1.855199194267243e-08
somatic O 0 5.51898392586736e-06
instability O 0 2.941777097476006e-07
both O 0 5.259965241144471e-10
within O 0 1.981873415379809e-10
and O 0 6.811702590869828e-11
between O 0 1.7499572971257926e-11
different O 0 4.082596483101497e-10
tissues O 0 9.748676887966212e-08
. O 0 1.160898079888284e-07

This O 0 1.4705260298342182e-07
instability O 0 3.817543188233685e-07
appears O 0 2.3354236322603583e-09
to O 0 2.4496829564846223e-10
be O 0 6.619983727862433e-11
biased O 0 8.58363213840363e-10
towards O 0 6.793243745306654e-10
further O 0 1.0594858323997869e-10
expansion O 0 8.045770716336165e-10
and O 0 6.328264995358879e-11
continuous O 0 1.6649377432287338e-09
throughout O 0 2.5740168330123936e-10
the O 0 2.3753468636478203e-10
life O 0 6.915069628021797e-10
of O 0 1.6941421876470741e-10
an O 0 4.1171187986632773e-11
individual O 0 4.920136173480749e-11
, O 0 5.450666654138736e-11
features O 0 7.3223488383789e-10
that O 0 2.924394016876053e-12
could O 0 1.2019196402035526e-11
be O 0 1.344236267436516e-11
associated O 0 1.648744196725005e-10
with O 0 1.941109425973586e-11
the O 0 4.178139167976269e-09
progressive O 0 1.1188581083843019e-07
nature O 0 6.536176044846798e-10
of O 0 2.6583954482184424e-10
the O 0 1.1413207046118146e-09
disease O 0 6.510673333792738e-09
. O 0 2.162008883033195e-08

Although O 0 2.2718420211731427e-07
increasing O 0 1.1686521972364972e-08
measured O 0 1.4861749164651883e-08
allele O 0 1.6076002751219676e-08
size O 0 8.821966490657474e-10
between O 0 7.221703790527556e-11
patients O 0 8.119805272599478e-09
clearly O 0 9.902357822610952e-10
correlates O 0 4.792697905209309e-10
with O 0 4.28011185521493e-12
an O 0 1.0699784808165802e-11
increased O 0 7.739161395070582e-11
severity O 0 4.3009946715244496e-09
of O 0 1.4576784224118455e-10
symptoms O 0 3.589108121815343e-09
and O 0 1.8364492218592154e-11
an O 0 2.50244651389675e-11
earlier O 0 1.5393450403244913e-10
age O 0 4.0744282947535737e-10
of O 0 3.415277505247616e-10
onset O 0 4.83162878595067e-08
, O 0 3.308191914852543e-11
this O 0 1.1710467665015933e-11
correlation O 0 1.483126399470791e-10
is O 0 7.0194462221950804e-12
not O 0 5.4262486864908865e-11
precise O 0 1.3294926937135187e-08
and O 0 1.1997587368028917e-09
measured O 0 1.7544250496825953e-08
allele O 0 2.9143157220801186e-08
length O 0 1.2174952157550933e-09
cannot O 0 3.7050944534655628e-09
be O 0 2.965377388086665e-10
used O 0 1.5760306393275414e-09
as O 0 3.032643580702654e-10
an O 0 2.239903575118607e-11
accurate O 0 3.096247924716522e-09
predictor O 0 3.7964415611213553e-08
of O 0 1.9209205337489266e-09
age O 0 1.8781994626237974e-08
of O 0 2.3914191515927996e-08
onset O 0 2.8845452106907032e-05
. O 0 4.0993850802806264e-07

In O 0 1.4816971649622701e-08
order O 0 4.32077751355564e-09
to O 0 1.6695678173306305e-09
further O 0 5.936008906637369e-10
characterize O 0 8.286288988301749e-09
the O 0 6.718599454558216e-09
dynamics O 0 4.615923998585458e-08
of O 0 1.4619865851273062e-07
DM B-Disease 1 1.0
CTG O 0 1.2575582331919577e-05
repeat O 0 2.592363443909562e-07
somatic O 0 1.7477722167313914e-06
instability O 0 6.58542376186233e-08
, O 0 3.470322640364287e-11
we O 0 4.035492426335274e-11
have O 0 4.4179061450821955e-12
studied O 0 9.005178547294435e-11
repeat O 0 2.5073257359231604e-10
length O 0 1.0208661693766885e-10
changes O 0 1.0770841163409983e-10
over O 0 4.739794060709679e-12
time O 0 7.177993616158673e-11
in O 0 1.7485302095110455e-10
111 O 0 7.856683055251779e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 1.3893767025763282e-08
with O 0 1.6875967854060314e-12
varying O 0 1.0641804798483534e-10
clinical O 0 7.46970751919207e-09
severity O 0 2.141537258637527e-08
and O 0 6.014510001151052e-10
CTG O 0 1.1217343143243852e-07
repeat O 0 3.750971977467543e-09
size O 0 4.361862260271465e-10
over O 0 4.090607366724619e-11
time O 0 1.1931493293371176e-10
intervals O 0 1.193135729105066e-10
of O 0 5.7709035466979586e-11
1 O 0 1.0294368690821898e-09
- O 0 9.746090157136678e-09
7 O 0 2.364000017962553e-08
years O 0 1.1061052518357428e-08
. O 0 1.1484470974210126e-07

We O 0 1.7508622818240838e-07
have O 0 9.56096979365384e-10
found O 0 1.273368216425652e-10
a O 0 6.225450016605905e-11
direct O 0 3.9842823484903533e-10
progression O 0 8.571594989348341e-09
of O 0 8.082377545015618e-10
the O 0 1.217948075726838e-09
size O 0 8.573209364648449e-10
heterogeneity O 0 3.1122222576840386e-09
over O 0 7.945723246027825e-11
time O 0 6.052197076833465e-10
related O 0 9.159965563831918e-10
to O 0 2.386797204323443e-09
initial O 0 9.512407750378316e-09
CTG O 0 2.272721815188561e-07
repeat O 0 8.138628437848183e-09
size O 0 2.5573405615375577e-09
and O 0 6.62440824417132e-10
the O 0 3.546623883465827e-09
time O 0 2.6617812398654905e-09
interval O 0 4.4489971706696e-09
and O 0 1.344452466023327e-10
always O 0 1.2299449236863325e-09
biased O 0 1.8752703834223894e-09
towards O 0 2.9488249619902263e-09
further O 0 6.275935326982562e-09
expansion O 0 1.4622334276737092e-07
. O 0 3.9062479118001647e-07

Attempts O 0 3.47349413232223e-07
to O 0 8.747877089376743e-09
mathematically O 0 1.031188379130299e-08
model O 0 3.597704534286095e-08
the O 0 3.3465095583551374e-08
dynamics O 0 5.828401228313851e-08
have O 0 3.2852565112762022e-09
proved O 0 3.705392970232424e-08
only O 0 8.063530398949581e-10
partially O 0 7.579729732754004e-09
successful O 0 1.0431406849420455e-08
suggesting O 0 4.910503559329982e-09
that O 0 4.173529577489177e-12
individual O 0 2.842074665887484e-12
specific O 0 4.931222444271022e-11
genetic O 0 1.2990907238830118e-09
and O 0 3.931500125453624e-10
/ O 0 6.088610007282114e-06
or O 0 8.513572957724591e-09
environmental O 0 1.5392694896476655e-09
factors O 0 2.1975878894409107e-09
also O 0 1.4662500380513421e-10
play O 0 1.9306176657352125e-09
a O 0 1.3872231141576208e-09
role O 0 5.9529057239160466e-09
in O 0 1.492108303580153e-08
somatic O 0 3.069008698730613e-06
mosaicism O 0 8.695338692632504e-06
. O 0 4.7122920676656577e-08
. O 0 1.6599197749656014e-07

Aspartylglucosaminuria B-Disease 1 1.0
among O 0 6.870429558603064e-08
Palestinian O 0 2.2563872335013002e-06
Arabs O 0 2.059800635834108e-06
. O 0 2.5110716705967207e-07

Aspartylglucosaminuria B-Disease 1 1.0
( O 0 3.6909714253852144e-05
AGU B-Disease 1 1.0
) O 0 1.3802852194544357e-08
is O 0 5.173530492896816e-10
a O 0 2.5225281863328064e-09
rare O 0 2.77527021808055e-07
disorder B-Disease 1 0.9999978542327881
of I-Disease 0 3.201079380232841e-05
glycoprotein I-Disease 0 6.509112608910073e-06
metabolism I-Disease 0 7.081314834067598e-05
caused O 0 7.501864729420049e-08
by O 0 7.310960725703808e-10
the O 0 2.5384650825799326e-07
deficiency B-Disease 0 4.629680461221142e-06
of I-Disease 0 1.1651272302515281e-07
the I-Disease 0 6.751900372137243e-08
lysosomal I-Disease 0 9.114745580518502e-07
enzyme I-Disease 0 9.179419002691702e-09
aspartylglucosaminidase I-Disease 0 7.789930691615155e-07
( O 0 7.38665073551914e-10
AGA O 0 1.5974000007190625e-06
) O 0 1.173823793720885e-08
. O 0 1.009024188647345e-07

AGU B-Disease 1 1.0
is O 0 1.9456163613540411e-07
inherited O 0 1.2741392083626124e-06
as O 0 1.7284781961279805e-07
an O 0 3.4192048303793854e-08
autosomal O 1 0.9999910593032837
recessive O 1 0.9832392334938049
trait O 0 3.133577138214605e-06
and O 0 4.0370112808219005e-10
occurs O 0 4.509548637288141e-11
with O 0 4.58325976997187e-13
a O 0 4.229789088427971e-11
high O 0 1.987954467708164e-09
frequency O 0 6.56063789961081e-08
in O 0 8.327261546980935e-09
Finland O 0 2.0421879298737622e-07
because O 0 1.4119366786857768e-09
of O 0 3.591395403290676e-09
a O 0 4.0690095737261345e-09
founder O 0 6.821711195925673e-08
effect O 0 3.7736789693099126e-08
. O 0 9.764811892409853e-08

While O 0 4.90661129504133e-08
very O 0 1.0048345489011012e-09
few O 0 1.5109778983557476e-09
patients O 0 1.5296931499264588e-09
with O 0 1.9960350039482933e-10
AGU B-Disease 1 1.0
have O 0 4.4921009134668566e-09
been O 0 8.223572933729884e-10
reported O 0 5.022845681046384e-11
from O 0 2.035344115469684e-11
non O 0 7.226864884302131e-09
- O 0 2.6800699437501407e-09
Finnish O 0 1.842750307901042e-08
origin O 0 5.011508430463607e-10
, O 0 1.3530568158948153e-11
we O 0 9.782582383044414e-11
diagnosed O 0 4.093876171396005e-08
the O 0 4.72663819195418e-09
disorder O 0 1.7759880392986815e-06
in O 0 4.2290088098084766e-10
8 O 0 4.5816608285065286e-09
patients O 0 7.297304427389406e-11
originating O 0 5.536396341376815e-11
from O 0 3.996869848976736e-11
3 O 0 1.041970842940998e-09
unrelated O 0 5.806458647228396e-10
families O 0 2.2182290726480147e-11
, O 0 3.755397468691024e-12
all O 0 4.475912262352777e-12
Palestinian O 0 4.243700946204854e-09
Arabs O 0 1.1442807812400702e-09
from O 0 6.525584933525508e-11
the O 0 8.878206503304398e-11
region O 0 1.506953589691662e-10
of O 0 4.274348375243875e-10
Jerusalem O 0 1.2825768180846353e-06
. O 0 1.8898717257798126e-07

The O 0 1.3822089783843694e-07
clinical O 0 7.132746304705506e-07
diagnosis O 1 0.9995794892311096
of O 0 2.6865953259402886e-05
AGU B-Disease 1 1.0
is O 0 4.821453458703218e-09
often O 0 4.715449905545732e-11
difficult O 0 6.715146494418178e-11
, O 0 3.2254964758143823e-12
in O 0 6.317094417007674e-12
particular O 0 3.4200343945745004e-11
early O 0 2.1597656996164005e-09
in O 0 1.0998434107900579e-10
the O 0 5.811920944509552e-10
course O 0 3.7165537314365338e-09
of O 0 2.167555857024439e-10
the O 0 2.857231118369441e-10
disease O 0 2.2686909295632773e-10
, O 0 1.5731632576482246e-12
and O 0 1.9194674062000816e-12
most O 0 1.9990630678590193e-11
of O 0 4.137468492815266e-11
the O 0 6.711586841845474e-11
patients O 0 8.850929537895791e-12
are O 0 8.11172418298256e-13
diagnosed O 0 2.338114701849747e-10
after O 0 2.249675445931132e-10
the O 0 7.542000357574352e-10
age O 0 1.5813664822061924e-09
of O 0 9.304675918642147e-10
5 O 0 8.352219360574509e-09
years O 0 5.968629590569208e-09
. O 0 1.2899636203655973e-07

However O 0 2.2072134697737056e-07
, O 0 2.025706491437518e-09
since O 0 6.773008820459836e-10
these O 0 1.020268661222623e-10
patients O 0 2.880541638550227e-10
excrete O 0 2.3827171347079457e-09
early O 0 2.7049824602443096e-09
large O 0 8.391684569453162e-11
amounts O 0 1.076177036374304e-09
of O 0 5.570509387098355e-09
aspartylglucosamine O 0 9.450901643504039e-07
in O 0 2.8507779248343468e-08
urine O 0 8.88170426094348e-09
, O 0 5.057038815481363e-11
biochemical O 0 3.931050207572895e-10
screening O 0 2.423089284775415e-09
is O 0 2.953050304288496e-10
easy O 0 1.1716272396711247e-08
by O 0 1.6271328728834078e-09
urine O 0 1.0703373298781571e-08
chromatography O 0 6.326485113561375e-09
. O 0 1.5741028036586613e-08
. O 0 1.6166472960321698e-07

Detection O 0 1.5871464711381122e-05
of O 0 6.014457909486737e-08
heterozygous O 0 3.984299556947235e-09
carriers O 0 7.897710263549129e-10
of O 0 2.8080571201627436e-09
the O 0 4.793032530869823e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 3.497712697253519e-08
ATM O 0 2.6079385406774236e-06
) O 0 6.266889229777917e-10
gene O 0 2.445737778966617e-10
by O 0 1.5005403863899147e-10
G2 O 0 8.835665710194007e-08
phase O 0 6.69648230200437e-08
chromosomal O 0 2.199304560690507e-07
radiosensitivity O 0 2.80684866993397e-06
of O 0 6.249693740301154e-08
peripheral O 0 1.0776095223263837e-05
blood O 0 1.186924237117637e-06
lymphocytes O 0 3.4748723010125104e-07
. O 0 1.1945877531616134e-07

In O 0 9.489620538261079e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 2.6433912353240885e-05
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 6.080730918789357e-10
patients O 0 2.964677614514244e-09
, O 0 9.598233666197054e-12
mutations O 0 4.0103247112011076e-11
in O 0 1.5492153393470431e-10
a O 0 5.190124441334376e-10
single O 0 1.1542810041120788e-09
gene O 0 7.616478003846794e-10
, O 0 1.4434740902569132e-10
ATM O 0 4.1761097691050963e-08
, O 0 1.8782754865331874e-11
result O 0 2.0279271317757974e-11
in O 0 1.4188876462650768e-10
an O 0 1.405898331086064e-07
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 3.8489009313025235e-08
embraces O 0 1.075063038591395e-09
a O 0 8.57081836058704e-11
variety O 0 1.306467573014558e-10
of O 0 3.4052408115492483e-10
clinical O 0 1.0310781561884141e-08
features O 0 5.034033634387924e-09
and O 0 3.7115005513399524e-10
manifests O 0 6.6675869270227395e-09
extreme O 0 1.6377541101064708e-08
radiosensitivity O 0 3.049851571290674e-08
and O 0 3.461241571134366e-10
a O 0 9.582608484492994e-09
strong O 0 2.494587114654223e-08
pre O 0 1.7983003999688663e-05
- O 0 2.6234667984681437e-06
disposition O 0 1.1046272447856609e-05
to O 0 1.3326950920600211e-06
malignancy B-Disease 0 0.00021072023082524538
. O 0 3.613357080212154e-07

Heterozygotes O 0 8.57053692016052e-06
for O 0 7.569576609967044e-08
the O 0 1.501257607117168e-08
ATM O 0 4.7443487005693896e-07
gene O 0 3.090353972723392e-09
have O 0 2.5257382296750563e-10
no O 0 6.277030284440599e-11
clinical O 0 2.7742294572696835e-10
expression O 0 7.315076322456093e-10
of O 0 4.078620996494919e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
but O 0 1.3763910011732605e-09
may O 0 1.1642709019099584e-09
be O 0 6.382063211241018e-10
cancer B-Disease 0 4.492280325507636e-09
prone O 0 1.2351257516751701e-10
with O 0 3.5099757302037293e-12
a O 0 5.305731409777081e-10
moderate O 0 4.020430655060636e-09
increase O 0 5.385760171172649e-10
in O 0 2.3215847022584057e-09
in O 0 4.910056006224295e-08
vitro O 0 7.885170816734899e-06
radiosensitivity O 0 8.910788892535493e-06
. O 0 7.432475399582472e-07

We O 0 8.868639866932426e-08
performed O 0 6.1684175989285e-08
a O 0 2.1355615942297845e-08
blind O 0 1.7286792797222006e-07
chromosomal O 0 3.893936195709102e-08
analysis O 0 8.339690715786219e-09
on O 0 1.1124440923993006e-08
G2 O 0 8.381039862115358e-09
- O 0 9.375024090374495e-10
phase O 0 4.184615320923513e-09
lymphocytes O 0 1.2046911246343939e-09
from O 0 1.7533851107143228e-11
7 O 0 4.369148098870568e-10
unrelated O 0 1.7214235370488495e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 7.141991176240481e-08
, O 0 1.1413020702122356e-11
13 O 0 9.133251793747021e-11
obligate O 0 4.204049375289287e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 5.697411779692629e-06
( O 0 2.023217531010868e-11
parents O 0 3.2407174166415587e-11
of O 0 1.7241154684488613e-11
the O 0 3.169627754706639e-11
patients O 0 2.4655017610841767e-11
) O 0 7.865407544022096e-13
, O 0 1.4964059722247236e-12
and O 0 4.785869183593361e-12
14 O 0 1.129985660597299e-09
normal O 0 8.657053740535048e-08
controls O 0 1.6201849462049722e-07
following O 0 6.121953610715991e-09
X O 0 4.455598201502653e-08
- O 0 6.064425850382804e-09
irradiation O 0 1.266514626507842e-08
with O 0 2.0843582068663657e-11
1 O 0 7.364174603452511e-09
Gy O 0 1.927323864947539e-06
in O 0 8.927757144672199e-11
order O 0 5.366911914883588e-10
to O 0 7.201666485379121e-10
evaluate O 0 6.497200999433517e-09
this O 0 6.916613393137538e-10
cytogenetic O 0 8.129151183311478e-07
method O 0 1.740264679028769e-07
as O 0 6.901357263444652e-09
a O 0 2.1496473490145718e-09
tool O 0 6.079159220462316e-08
for O 0 1.1155456558498145e-09
detection O 0 2.7377629407965287e-07
of O 0 4.187156221746591e-08
ATM O 0 2.2939644622965716e-05
carriers O 0 4.2200045413665066e-07
. O 0 1.3143742307875073e-06

Both O 0 5.278423031995771e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
homozygotes O 0 5.17023763677571e-05
and O 0 1.1438470615132701e-08
heterozygotes O 0 2.327555193915032e-06
showed O 0 8.713539223492717e-09
significantly O 0 1.1668674915199517e-09
increased O 0 3.7483738335453154e-10
levels O 0 1.7918615480283506e-09
of O 0 6.64506116798691e-10
radiation O 0 7.224369255709462e-06
- O 0 1.508291347818158e-06
induced O 0 1.4154975360725075e-06
chromatid O 0 2.350862047251212e-07
damage O 0 1.059369747480332e-08
relative O 0 1.3928286968223347e-08
to O 0 1.481213263154757e-09
that O 0 4.0103708548455685e-11
of O 0 2.355679540322342e-10
normal O 0 2.1237291036868555e-08
controls O 0 6.865889758955745e-07
. O 0 3.8755646869503835e-07

These O 0 5.6857545338573345e-09
results O 0 2.189655123885359e-09
show O 0 5.591981100394605e-09
that O 0 2.038254981462373e-10
the O 0 1.0524110471976655e-09
G2 O 0 1.0962467911213025e-07
- O 0 5.216350373871137e-08
phase O 0 1.6978194139483094e-07
chromosomal O 0 3.697271722558071e-06
radiosensitivity O 0 1.846554141593515e-06
assay O 0 6.4404823696406766e-09
can O 0 5.6814667553917175e-11
be O 0 1.8183145961137015e-11
used O 0 3.5789735758351426e-11
for O 0 9.993251018358684e-12
the O 0 1.4758029867611988e-11
detection O 0 2.2540143085336695e-09
of O 0 4.601426351058535e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 0.00015985261416062713
. O 0 1.5114189864107175e-06

In O 0 1.2330959009432263e-07
combination O 0 6.52472280648908e-08
with O 0 3.082205324300702e-10
molecular O 0 1.2550248840170752e-08
genetic O 0 2.529794151939768e-09
analyses O 0 2.3485386968502553e-09
, O 0 2.246861030563707e-11
this O 0 2.6261553695561268e-11
test O 0 1.612284750152071e-10
may O 0 4.5198476905650153e-11
be O 0 5.7327694674702556e-11
of O 0 2.8785957992272238e-11
value O 0 1.8516764510589923e-10
in O 0 5.5566239109960947e-11
studies O 0 1.4913507095926093e-09
of O 0 8.797366723989342e-10
familial B-Disease 0 1.0324301413788817e-08
and I-Disease 0 1.4976417883616477e-09
sporadic I-Disease 0 1.1161766622080904e-07
cancers I-Disease 0 2.3123745052089362e-07
aimed O 0 6.07521855044979e-08
at O 0 1.4346975163448406e-08
determination O 0 3.723487296269923e-08
of O 0 5.858840523842446e-08
the O 0 1.2923396575104107e-08
potential O 0 3.1505542619214566e-09
involvement O 0 1.0289466167989758e-08
of O 0 1.0306809627991242e-08
ATM O 0 3.1323401344707236e-05
mutations O 0 1.1922898579541652e-07
in O 0 1.20624141786152e-08
tumor B-Disease 0 1.1839187209261581e-05
risk O 0 4.6997076452726105e-08
or O 0 1.5586375246012807e-10
development O 0 1.293532392310226e-09
. O 0 1.738130084305567e-09
. O 0 3.842350793092919e-08

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
: O 0 1.0596509980587143e-07
identification O 0 2.1186883714108262e-07
and O 0 1.3640753804278205e-10
detection O 0 2.6705654931902245e-07
of O 0 1.98978789001103e-08
founder O 0 1.0328422206384857e-07
- O 0 2.5106446699396656e-08
effect O 0 4.5046384400393435e-08
mutations O 0 3.871982290348797e-09
in O 0 1.6717092155005275e-09
the O 0 7.111200517329053e-09
ATM O 0 1.5684408083416201e-07
gene O 0 1.0597127619860203e-09
in O 0 5.300168637312197e-10
ethnic O 0 1.8401283274904756e-10
populations O 0 1.1652083742319519e-09
. O 0 1.850477993059485e-08

To O 0 5.67455522570981e-08
facilitate O 0 6.165758748011285e-08
the O 0 7.661124179492163e-09
evaluation O 0 8.005305573988153e-08
of O 0 4.2599790361919077e-08
ATM O 0 2.1001114873797633e-05
heterozygotes O 0 4.563671609503217e-06
for O 0 3.662117276093113e-09
susceptibility O 0 6.965471044395599e-08
to O 0 6.271555719195021e-09
other O 0 7.448903160955922e-10
diseases O 0 3.767623368844397e-08
, O 0 5.5589851298554205e-12
such O 0 7.151632064328339e-11
as O 0 1.2641614866026885e-08
breast B-Disease 0 1.3500923159881495e-05
cancer I-Disease 0 6.502832405885783e-08
, O 0 1.3740794613248397e-10
we O 0 4.96559904306082e-10
have O 0 9.365994091403707e-11
attempted O 0 3.6608183151543017e-09
to O 0 1.43314882183887e-09
define O 0 1.415550698879997e-08
the O 0 2.265220011565816e-09
most O 0 1.0709263337238539e-10
common O 0 5.845727374387266e-11
mutations O 0 1.6734334404300277e-11
and O 0 1.8411550496005846e-12
their O 0 7.339162264030641e-12
frequencies O 0 6.465426527491047e-10
in O 0 3.3237539387442894e-09
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 1.8423693290969823e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.3758345573933184e-09
homozygotes O 0 2.456941388118139e-07
from O 0 6.912828087735079e-10
10 O 0 6.196501090016682e-10
ethnic O 0 5.439326072886885e-11
populations O 0 8.848828336738279e-10
. O 0 2.3607197974229166e-08

Both O 0 7.977092053579327e-08
genomic O 0 2.45932994857867e-07
mutations O 0 7.572807270150861e-09
and O 0 3.729418718290134e-10
their O 0 4.169960765576519e-10
effects O 0 2.2073855632243067e-08
on O 0 8.717699273574908e-08
cDNA O 0 1.010462895578712e-07
were O 0 1.5894380922532036e-08
characterized O 0 1.3791930264517305e-08
. O 0 1.775013203086928e-07

Protein O 0 2.499654883081348e-08
- O 0 1.5014121501621958e-08
truncation O 0 5.380272227739624e-08
testing O 0 1.131677240806539e-08
of O 0 1.436608054738997e-09
the O 0 8.797669259763552e-10
entire O 0 7.343006203086588e-10
ATM O 0 8.272096607697677e-08
cDNA O 0 7.332837981266493e-08
detected O 0 1.132713745022329e-08
92 O 0 3.9844994859095095e-08
( O 0 1.5603389413865187e-10
66 O 0 3.5820846289169594e-09
% O 0 1.8272261481655505e-10
) O 0 7.15262779560355e-11
truncating O 0 2.4484847926942166e-08
mutations O 0 1.271478256015257e-09
in O 0 6.825726650561137e-10
140 O 0 7.210975372373696e-09
mutant O 0 8.78271766424632e-09
alleles O 0 1.770850466265017e-09
screened O 0 7.295436432741553e-08
. O 0 4.939970494888257e-07

The O 0 2.344240328966407e-06
haplotyping O 0 3.1662257242714986e-05
of O 0 3.617287092083643e-08
patients O 0 8.390252936862908e-09
with O 0 4.068586439975874e-11
identical O 0 3.9181042410518785e-08
mutations O 0 4.8826745313590436e-08
indicates O 0 3.254225333648719e-08
that O 0 2.7350297027162185e-10
almost O 0 5.045989737162415e-10
all O 0 3.54665602442239e-10
of O 0 5.234204736304093e-10
these O 0 1.3666119624833328e-10
represent O 0 4.063167857726313e-10
common O 0 1.3063211623531856e-09
ancestry O 0 8.81288486631604e-10
and O 0 4.187838964497814e-10
that O 0 1.7209818292673873e-10
very O 0 3.864417952303967e-10
few O 0 2.291073997184867e-09
spontaneously O 0 2.175314373076276e-09
recurring O 0 2.080790117986453e-08
ATM O 0 3.60235776497575e-06
mutations O 0 8.823943886682173e-08
exist O 0 1.1617042616762774e-07
. O 0 4.888349280918192e-07

Assays O 0 6.756770289939595e-06
requiring O 0 2.2405549771065125e-07
minimal O 0 6.651862918261031e-07
amounts O 0 2.8201673885064338e-08
of O 0 9.433989589524572e-09
genomic O 0 1.0533895533626492e-08
DNA O 0 3.2930542737119595e-09
were O 0 1.803787785803479e-09
designed O 0 5.8438485162071174e-09
to O 0 3.815102456172781e-09
allow O 0 1.022363194103093e-09
rapid O 0 6.822615805646137e-10
screening O 0 6.390638573883223e-10
for O 0 2.1390367255236242e-10
common O 0 7.296500625919577e-10
ethnic O 0 1.7817590458601984e-10
mutations O 0 5.803516334168535e-09
. O 0 5.401999914056432e-08

These O 0 4.4280131561436065e-08
rapid O 0 1.3809454912916408e-07
assays O 0 2.3888759415058303e-07
detected O 0 2.6148834209038796e-08
mutations O 0 3.737508358359065e-10
in O 0 1.648800956877139e-10
76 O 0 1.789573822463808e-08
% O 0 1.5285840648804339e-10
of O 0 4.3567571772484825e-10
Costa O 0 1.7081804415397528e-08
Rican O 0 3.70687814665871e-07
patients O 0 2.1607226230457854e-08
( O 0 1.864775001081398e-11
3 O 0 3.6727271224279434e-10
) O 0 1.306586436267132e-11
, O 0 8.540525925360143e-12
50 O 0 1.9773123416388927e-10
% O 0 2.1909354538940384e-11
of O 0 5.496529620341306e-11
Norwegian O 0 3.245708057875163e-08
patients O 0 1.0782795101249576e-08
( O 0 1.158373223730802e-11
1 O 0 7.442114702271851e-10
) O 0 3.70618605249895e-11
, O 0 1.0285270898857668e-11
25 O 0 1.0852750642609266e-10
% O 0 2.0469769976272367e-11
of O 0 4.417335594530947e-11
Polish O 0 1.2422525230704196e-08
patients O 0 6.648221084759598e-09
( O 0 3.5098350007617407e-12
4 O 0 3.104927981389949e-10
) O 0 2.378260435809132e-11
, O 0 8.718247478112229e-12
and O 0 5.5130639636802314e-12
14 O 0 1.906734492518325e-10
% O 0 3.440355639261483e-11
of O 0 9.102243958558631e-11
Italian O 0 7.825379455539405e-09
patients O 0 1.0150675855413738e-08
( O 0 1.0573696432314428e-11
1 O 0 1.0924344762131e-09
) O 0 1.482572120625747e-10
, O 0 3.970897916039107e-11
as O 0 3.140322030192877e-11
well O 0 1.7462030085790836e-11
as O 0 2.1866021146510484e-11
in O 0 1.5732720681782553e-11
patients O 0 1.9255746996904577e-10
of O 0 1.9415731522531843e-10
Amish O 0 4.876136472375947e-07
/ O 0 8.925911743062898e-07
Mennonite O 0 1.8291863170816214e-06
and O 0 2.964553047490881e-09
Irish O 0 4.592100211198158e-08
English O 0 3.6319850238442086e-08
backgrounds O 0 3.578938034820567e-08
. O 0 1.397871187691635e-07

Additional O 0 9.696102551970398e-07
mutations O 0 2.6517492202060566e-08
were O 0 3.5730569614145224e-09
observed O 0 2.396458809172941e-09
in O 0 6.624863435611417e-10
Japanese O 0 5.077546347820316e-07
, O 0 6.14072015459044e-10
Utah O 0 8.430902198597323e-09
Mormon O 0 4.132535647016766e-09
, O 0 2.6934577831982942e-11
and O 0 2.0559569671729783e-11
African O 0 2.330351023260846e-09
American O 0 2.1541417538628593e-09
patients O 0 1.9187051947255895e-09
. O 0 1.2690947848170708e-08

These O 0 2.0459104632664094e-08
assays O 0 6.922119766272772e-09
should O 0 1.6110673906055695e-10
facilitate O 0 1.9170690035430482e-10
screening O 0 4.5545173188443755e-10
for O 0 9.410841883550347e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 5.604038051387761e-07
in O 0 1.3959982059219556e-09
the O 0 4.739165726519445e-10
populations O 0 5.202660177672236e-11
studied O 0 1.4864802722058812e-09
. O 0 3.534717629705142e-09
. O 0 9.856049842937864e-08

The O 0 3.8294059777399525e-05
von B-Disease 1 0.9999953508377075
Hippel I-Disease 1 0.9999864101409912
- I-Disease 0 0.005940396338701248
Lindau I-Disease 0 0.0012989214155822992
tumor I-Disease 0 2.2342708689393476e-05
suppressor O 0 1.893002604447247e-06
gene O 0 1.680344574594983e-08
is O 0 5.759314206099653e-11
required O 0 8.236110404791219e-11
for O 0 9.343369133940627e-11
cell O 0 4.480461002209779e-10
cycle O 0 4.406717768468127e-10
exit O 0 3.1733995431437734e-09
upon O 0 5.841185313215647e-09
serum O 0 4.922847196553448e-08
withdrawal O 0 4.769231054524425e-07
. O 0 6.582987452929956e-07

The O 0 3.9342953073173703e-07
inactivation O 0 4.8561300900473725e-06
of O 0 7.767571901240444e-07
the O 0 7.681845204388082e-07
von B-Disease 1 1.0
Hippel I-Disease 1 1.0
- I-Disease 1 1.0
Lindau I-Disease 1 1.0
( I-Disease 0 2.1654490467426513e-07
VHL I-Disease 0 0.00023688693181611598
) I-Disease 0 3.042623930582522e-08
tumor I-Disease 0 3.7699021504522534e-06
suppressor O 0 5.97522193857003e-05
gene O 0 1.900326537906949e-06
predisposes O 0 5.772981239715591e-07
affected O 0 2.804415866197729e-10
individuals O 0 2.7465959194505896e-12
to O 0 2.5634924738504594e-10
the O 0 1.877643374115223e-09
human O 0 2.2100401508851064e-07
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 1.8985086835954235e-09
is O 0 1.9358514791179005e-11
associated O 0 1.5267045960776215e-10
with O 0 1.7755125494844926e-11
sporadic B-Disease 0 1.1963428505623597e-06
renal I-Disease 1 1.0
cell I-Disease 1 1.0
carcinomas I-Disease 1 1.0
( O 0 1.6107746603211126e-07
RCC B-Disease 0 0.00019821520254481584
) O 0 9.7402166332472e-09
and O 0 2.1215591061718442e-08
brain B-Disease 0 0.0005556715768761933
hemangioblastomas I-Disease 0 0.00036216340959072113
. O 0 1.0384417237219168e-06

VHL O 0 0.00012833549408242106
- O 0 3.023235649379785e-06
negative O 0 8.101955728534449e-08
786 O 0 6.263322234190127e-07
- O 0 2.633760004755459e-06
0 O 0 3.450053895903693e-07
RCC B-Disease 0 9.74692011368461e-06
cells O 0 3.309042995169875e-07
are O 0 1.305387242744871e-09
tumorigenic O 0 2.720283646340249e-06
in O 0 1.937482494440701e-07
nude O 0 0.00016969640273600817
mice O 0 4.163869959938893e-07
which O 0 9.52732337466955e-11
is O 0 1.565220696109204e-11
suppressed O 0 3.231447887053207e-10
by O 0 4.349365312350528e-11
the O 0 2.0777553011441796e-09
reintroduction O 0 1.2077647681962844e-07
of O 0 2.5212019139075892e-08
VHL B-Disease 0 2.6868670829571784e-05
. O 0 2.2908013761480106e-06

Remarkably O 0 8.888197044143453e-06
, O 0 5.207567155274262e-10
this O 0 2.0162411670798797e-11
occurs O 0 1.587082028298159e-11
without O 0 1.7563249465890607e-10
affecting O 0 2.089900474899764e-10
the O 0 2.0140128453860484e-10
growth O 0 6.606062363800902e-10
rate O 0 3.6323020147221996e-09
and O 0 5.1503804693320276e-11
cell O 0 4.989507029762308e-09
cycle O 0 1.3589136482750064e-09
profile O 0 1.727385678940152e-09
of O 0 3.6199201969289163e-10
these O 0 3.946780055552601e-11
cells O 0 1.2845627339608257e-10
in O 0 4.73634631514841e-10
culture O 0 3.9982101185387364e-08
. O 0 9.531299127729653e-08

The O 0 3.540793329648295e-07
786 O 0 1.901456272435098e-07
- O 0 1.8215635577689682e-07
0 O 0 3.450020358286565e-08
cell O 0 5.429248872701464e-08
line O 0 1.6752402132169664e-08
, O 0 3.798777126196029e-10
like O 0 3.5256192409960363e-10
many O 0 1.7342151326094069e-10
cancer B-Disease 0 1.2402159299540472e-09
cells O 0 1.154170869988036e-09
, O 0 2.8118501971263754e-10
fails O 0 8.798142658861252e-09
to O 0 1.264272420087309e-08
exit O 0 2.0418158896973182e-07
the O 0 3.6399466551984005e-08
cell O 0 5.31056354446946e-09
cycle O 0 7.965362258666175e-10
upon O 0 4.8839661204169715e-09
serum O 0 4.514564366786544e-08
withdrawal O 0 2.437886337247619e-07
. O 0 4.4687905642604164e-07

Here O 0 4.855870656683692e-07
, O 0 1.1540916000640777e-09
it O 0 2.0171949180469717e-11
is O 0 2.9144989373286467e-12
shown O 0 2.2060185275729616e-11
that O 0 4.106489887717446e-12
reintroduction O 0 4.063263059350675e-09
of O 0 1.344868549857381e-09
the O 0 3.6184859553145543e-09
wild O 0 1.265821492069108e-08
- O 0 8.831415598820058e-09
type O 0 2.3786270730852266e-08
VHL B-Disease 0 2.6515651825320674e-06
gene O 0 3.4692359207610934e-08
restores O 0 1.100877057069738e-06
the O 0 2.230170181860558e-08
ability O 0 1.6036405980912605e-08
of O 0 3.3325534332107054e-08
VHL O 0 0.0003728130250237882
- O 0 7.688450568821281e-05
negative O 0 4.842866019316716e-07
RCC B-Disease 0 2.5251581973861903e-05
cancer I-Disease 0 1.2024139550703694e-07
cells O 0 9.248181109811071e-10
to O 0 2.0734083339135623e-09
exit O 0 1.3135976750788814e-08
the O 0 2.0371249132011826e-09
cell O 0 2.2000203880878644e-09
cycle O 0 9.052005811582831e-10
and O 0 6.604273239396719e-10
enter O 0 3.1036822178975854e-07
G0 O 0 2.9819997507729568e-05
/ O 0 2.4709941499168053e-05
quiescence O 0 7.643475328222848e-06
in O 0 1.3308886082086246e-07
low O 0 1.0614022585286875e-06
serum O 0 3.0225706382225326e-07
. O 0 9.311873583328634e-08

Both O 0 7.389546112790413e-07
VHL O 0 0.00020954295177944005
- O 0 5.651856099575525e-06
positive O 0 6.353720749530112e-08
and O 0 7.163393878073521e-09
VHL O 0 5.699056782759726e-05
- O 0 4.3818686208396684e-06
negative O 0 8.880793700427603e-08
RCC B-Disease 0 4.260395598976174e-06
cells O 0 7.927552019282302e-07
exit O 0 1.0317764917999739e-06
the O 0 2.6424135768365886e-08
cell O 0 8.789119654295519e-09
cycle O 0 2.110233765506564e-09
by O 0 5.063826580276043e-10
contact O 0 8.584083133200693e-08
inhibition O 0 4.906133881377173e-07
. O 0 3.6133465641796647e-07

The O 0 1.3118848073645495e-05
cyclin O 0 9.999587746278848e-06
- O 0 1.7740143221089966e-06
dependent O 0 8.492589813613449e-07
kinase O 0 1.1031534086214378e-06
inhibitor O 0 4.981266101822257e-07
, O 0 4.759432403744768e-09
p27 O 0 4.30000636697514e-06
, O 0 5.555036985960271e-10
accumulates O 0 4.003908760097374e-09
upon O 0 8.408960749939354e-10
serum O 0 4.324066882333e-09
withdrawal O 0 1.3574533497262564e-08
, O 0 5.2715828230409656e-11
only O 0 3.1281987417086654e-11
in O 0 4.8640022565216157e-11
the O 0 6.737627122888057e-10
presence O 0 1.908212476919857e-09
of O 0 1.8484379582517363e-09
VHL B-Disease 0 2.7217213300900767e-06
, O 0 5.712840756011417e-10
as O 0 4.98691699046816e-10
a O 0 1.3305923030060285e-10
result O 0 6.171657629394645e-11
of O 0 1.5134721254028705e-10
the O 0 3.045163565751352e-10
stabilization O 0 1.1503680070745759e-06
of O 0 1.1242488540119666e-07
the O 0 6.368887284224911e-08
protein O 0 2.284433797683505e-08
. O 0 5.036197237018314e-08

We O 0 3.076247168110058e-08
propose O 0 1.5234453698553807e-08
that O 0 1.1821899015274084e-10
the O 0 9.979376214275248e-10
loss O 0 3.063282294490932e-09
of O 0 3.3440961111352863e-09
wild O 0 1.0219932455868275e-08
- O 0 6.839687483051193e-09
type O 0 2.4664275954933146e-08
VHL B-Disease 0 7.607825864397455e-06
gene O 0 4.161280386938415e-08
results O 0 2.868657489329962e-08
in O 0 6.526288842678696e-09
a O 0 9.178753757055347e-09
specific O 0 2.097474691709067e-07
cellular O 0 1.580088110131328e-06
defect O 0 6.243176926545857e-07
in O 0 8.983279897734064e-09
serum O 0 1.7199474200424447e-07
- O 0 8.60060254126438e-08
dependent O 0 8.025378406273376e-08
growth O 0 1.5630957861390016e-08
control O 0 2.755242967111826e-08
, O 0 1.0561023583433027e-10
which O 0 1.6785737730340422e-11
may O 0 5.953867954211489e-10
initiate O 0 2.733030157742178e-08
tumor B-Disease 0 1.7459217360737966e-07
formation O 0 7.152405601118517e-08
. O 0 4.1841147435661696e-07

This O 0 1.4750763277504575e-08
is O 0 6.274280539564359e-10
corrected O 0 1.6622159648704837e-08
by O 0 8.152681307826981e-11
the O 0 8.361141223822699e-10
reintroduction O 0 4.2770274433223676e-08
of O 0 1.961716122877988e-09
wild O 0 1.2580661845618124e-08
- O 0 2.9614350083306817e-08
type O 0 2.095037672233957e-07
VHL B-Disease 0 0.005209098570048809
, O 0 7.801776291671558e-08
implicating O 0 7.712787009950262e-06
VHL B-Disease 0 0.0033161432947963476
as O 0 2.0355088281576172e-07
the O 0 1.884687605979707e-08
first O 0 5.986860784901182e-09
tumor B-Disease 0 3.1259945743045137e-09
suppressor O 0 3.006969606644816e-08
involved O 0 5.068522823670207e-10
in O 0 2.647583485781979e-09
the O 0 4.726920508346666e-07
regulation O 0 0.00011072197958128527
of O 0 2.5693694283290824e-08
cell O 0 2.923433717327839e-09
cycle O 0 1.2329137710764826e-09
exit O 0 7.9877615632995e-09
, O 0 9.232613978893411e-11
which O 0 1.355412483639018e-11
is O 0 6.5119546040215415e-12
consistent O 0 4.164460720712526e-10
with O 0 4.523484885277096e-12
its O 0 1.8813096913650185e-10
gatekeeper O 0 1.748375133558966e-08
function O 0 7.606663632309107e-10
in O 0 5.940709590923632e-10
the O 0 5.30496491180088e-09
kidney O 0 4.614832604943331e-08
. O 0 1.558020912284519e-08
. O 0 1.1480354089599132e-07

Piebaldism B-Disease 1 1.0
with O 0 0.00029195009847171605
deafness B-Disease 1 1.0
: O 0 5.57321158112245e-08
molecular O 0 2.4185471403370684e-08
evidence O 0 4.348208459958869e-09
for O 0 6.13295969564831e-10
an O 0 8.280597318943705e-10
expanded O 0 1.8812124835676514e-05
syndrome O 1 1.0
. O 0 2.0194280295982026e-05

In O 0 8.9835880956457e-09
a O 0 2.2940560562290102e-09
South O 0 1.326939003121197e-08
African O 0 9.806410794510612e-09
girl O 0 4.378568618790268e-09
of O 0 7.198878160252775e-10
Xhosa O 0 4.2129514099542575e-07
stock O 0 1.3357096761978937e-08
with O 0 1.2134183415002386e-11
severe O 0 3.515750135463236e-09
piebaldism B-Disease 0 1.756206842173924e-07
and O 0 1.5292846988756992e-09
profound O 0 0.00022007880033925176
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 0 8.491430776302877e-07
identified O 0 3.68742014700274e-09
a O 0 1.678821109907247e-10
novel O 0 6.014934106346459e-10
missense O 0 6.477773872859416e-09
substitution O 0 4.703489597801536e-09
at O 0 2.523015574240617e-08
a O 0 2.6624411564313277e-09
highly O 0 1.7160725063192217e-09
conserved O 0 1.0431162600355037e-09
residue O 0 2.7045350847743066e-08
in O 0 6.389301532294667e-09
the O 0 5.1535131717628246e-08
intracellular O 0 1.8646646537945344e-07
kinase O 0 8.001671858437476e-08
domain O 0 1.196363719202509e-08
of O 0 3.054705377536493e-09
the O 0 3.288957017844041e-08
KIT O 0 0.00016855596913956106
proto O 0 0.0007272265502251685
- O 0 3.371822685949155e-06
oncogene O 0 7.278697739820927e-05
, O 0 1.0349833878819936e-08
R796G O 0 3.705347808136139e-06
. O 0 1.3110773977587087e-07

Though O 0 8.897509360394906e-07
auditory B-Disease 0 1.4865943740005605e-05
anomalies I-Disease 0 3.303945277366438e-06
have O 0 1.7408540164964847e-09
been O 0 5.810635306247036e-10
observed O 0 5.549996018316961e-10
in O 0 5.894590926480703e-10
mice O 0 3.317219210430267e-08
with O 0 1.1183999559793989e-10
dominant O 0 6.232896510027786e-08
white O 0 3.131695436309201e-08
spotting O 0 7.447272309946129e-06
( O 0 3.8146947822781385e-09
W O 0 2.0699180822703056e-05
) O 0 6.356090653802937e-10
due O 0 3.344129595461709e-08
to O 0 2.590420145054395e-08
KIT O 0 0.0002652245166245848
mutations O 0 2.988250571434037e-06
, O 0 3.9098701165585226e-08
deafness B-Disease 1 1.0
is O 0 1.209703670568274e-09
not O 0 2.570925417000325e-10
typical O 0 1.0774688918857578e-09
in O 0 3.5839620160516006e-10
human O 0 2.366994600322414e-09
piebaldism B-Disease 0 9.337784945273597e-07
. O 0 1.5591214719279378e-07

Thus O 0 3.813787330386731e-08
, O 0 2.3799862081119727e-10
the O 0 8.217437841295805e-11
occurrence O 0 7.396339984921951e-09
of O 0 6.156053444783538e-08
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 1 0.8707725405693054
this O 0 5.6861697572685443e-08
patient O 0 7.512213962002079e-09
extends O 0 9.098668346529948e-11
considerably O 0 1.2304113283789775e-10
the O 0 1.2455776687847475e-10
phenotypic O 0 3.798938941201868e-09
range O 0 8.679502450092969e-09
of O 0 1.5303147637979464e-09
piebaldism B-Disease 0 1.0350272816594952e-07
due O 0 6.003867270010232e-08
to O 0 5.4617064648709857e-08
KIT O 0 4.363603238743963e-06
gene O 0 1.7011767994290494e-08
mutation O 0 6.674900077108248e-10
in O 0 2.46296982808758e-10
humans O 0 1.059793586222213e-09
and O 0 1.109188574321962e-10
tightens O 0 3.234633538795606e-08
the O 0 3.0106410697783303e-09
clinical O 0 2.2208656247357794e-08
similarity O 0 5.909258637970538e-10
between O 0 3.101044074305115e-11
piebaldism B-Disease 0 2.1616376244537605e-08
and O 0 1.0344376744075845e-10
the O 0 2.2102987495831172e-10
various O 0 7.524553202742368e-11
forms O 0 4.5052697683622966e-10
of O 0 1.0208866640937231e-08
Waardenburg B-Disease 1 1.0
syndrome I-Disease 0 0.0006782715208828449
. O 0 1.7124442308613652e-08
. O 0 1.2158544393514603e-07

Cycloheximide O 0 2.566960120020667e-06
facilitates O 0 2.0510757536840174e-08
the O 0 1.7693110310190718e-09
identification O 0 7.422261205647374e-08
of O 0 5.391479973582136e-08
aberrant O 0 2.1809391625993158e-07
transcripts O 0 1.6823655357711687e-07
resulting O 0 1.1102670782747737e-08
from O 0 1.3075875937573755e-09
a O 0 6.893972614996358e-10
novel O 0 1.0288891960641422e-09
splice O 0 2.0143069434652716e-08
- O 0 1.2044711894532156e-08
site O 0 5.0343027524490935e-09
mutation O 0 5.502039379656765e-10
in O 0 1.9786931815257702e-10
COL17A1 O 0 6.409474053725717e-07
in O 0 2.763172579633988e-09
a O 0 7.480615238364408e-09
patient O 0 2.722265968202464e-08
with O 0 9.854030924572044e-10
generalized O 1 0.6749062538146973
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9998536109924316
. O 0 4.998939402867109e-06

Patients O 0 1.1183838068973273e-05
with O 0 7.674111124345018e-09
generalized O 0 0.0001266178151126951
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9936760067939758
often O 0 4.4783701191875025e-09
show O 0 2.416175926001074e-09
decreased O 0 3.877443699451533e-09
expression O 0 2.145989164148432e-09
of O 0 2.335080795390354e-09
type O 0 1.0636015446152669e-07
XVII O 0 0.00011202014866285026
collagen O 0 9.65006051956152e-07
, O 0 1.1073527872440536e-08
a O 0 1.4904669498605472e-08
transmembrane O 0 7.496340437285198e-09
hemidesmosomal O 0 5.817095427573804e-08
protein O 0 3.554599947719339e-10
encoded O 0 8.51490156161816e-10
by O 0 1.2393646109387646e-09
COL17A1 O 0 3.4957818570546806e-05
. O 0 1.2717938489004155e-06

This O 0 7.532160140044653e-08
report O 0 2.527760045722971e-08
documents O 0 1.8476915997212018e-08
a O 0 2.569696233578611e-09
novel O 0 2.1537596150977834e-09
splice O 0 1.3747839489042235e-07
- O 0 4.509220019599525e-08
site O 0 9.971161674116047e-09
mutation O 0 1.1613454642400711e-09
in O 0 3.5965549982641676e-10
COL17A1 O 0 5.005389084544731e-06
in O 0 7.453312633742826e-09
a O 0 9.680283241664256e-09
patient O 0 2.7787123713096662e-08
with O 0 4.1122000249416146e-10
generalized O 1 0.8126314282417297
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999550580978394
, O 0 5.943681546938251e-09
and O 0 1.5139658970930725e-10
applies O 0 3.883639188018151e-09
a O 0 1.2233232482561363e-10
new O 0 2.5925728230902223e-10
methodology O 0 4.778379025793811e-09
to O 0 1.692883278003876e-09
define O 0 8.553777242070737e-09
and O 0 9.148825586002829e-10
characterize O 0 8.230516357343731e-08
the O 0 9.314979898533693e-09
resulting O 0 1.109447311797851e-09
mRNA O 0 3.4679705773754677e-09
splice O 0 1.3196401482673537e-07
variants O 0 1.2748900246606354e-07
. O 0 3.350540396240831e-07

Mutational O 0 1.9979961507488042e-05
analysis O 0 8.911047189030796e-08
of O 0 1.9931951200646836e-08
COL17A1 O 0 1.2119605344196316e-05
identified O 0 1.4453287633386935e-07
a O 0 3.532273140649522e-08
maternally O 0 9.051717029251449e-07
inherited O 0 1.2050178384015453e-06
G O 0 3.418869596316654e-07
- O 0 1.4374781187598273e-07
to O 0 1.3100013518396736e-07
- O 0 5.663169417857716e-07
T O 0 1.1040632585945787e-07
transversion O 0 3.042078233761458e-08
at O 0 9.879681517332983e-10
the O 0 2.7638880073510563e-10
- O 0 8.211832880355985e-10
1 O 0 4.479549176039654e-09
position O 0 4.280079579643825e-08
of O 0 1.138444893911128e-08
exon O 0 6.192926775838714e-07
32 O 0 6.529378993036516e-07
. O 0 3.92972765439481e-07

This O 0 1.6875647546044092e-08
acceptor O 0 7.871230778278004e-09
splice O 0 1.1124699739184507e-07
- O 0 6.485910830633657e-08
site O 0 2.8726985235039137e-08
mutation O 0 2.290855505293621e-09
led O 0 6.429198839974504e-10
to O 0 1.0315871490362838e-09
the O 0 3.153728611593465e-09
formation O 0 1.1434130087195626e-08
of O 0 4.4966892431830274e-08
aberrant O 0 2.6088264348800294e-07
transcripts O 0 5.106468847770884e-07
present O 0 2.6092438432101517e-08
at O 0 1.8928889176095254e-06
extremely O 0 6.422195042432577e-07
low O 0 2.632780706335325e-06
levels O 0 2.5610768261685735e-07
. O 0 1.1412477363137441e-07

Based O 0 2.6203252900813823e-08
on O 0 4.950426202299241e-08
our O 0 8.067964962776841e-09
recent O 0 6.968574051136045e-10
finding O 0 2.2896542439809764e-09
that O 0 7.908197013906104e-11
cycloheximide O 0 8.758733116565054e-08
stabilized O 0 6.153940717013029e-07
mutant O 0 2.2921226161543018e-07
COL17A1 O 0 8.84940845935489e-07
transcripts O 0 1.6541139302717056e-07
in O 0 6.364659022040087e-09
keratinocytes O 0 1.8970816881846986e-06
homozygous O 0 8.016704100555216e-08
for O 0 3.386291469453795e-09
a O 0 6.175690625553898e-09
frameshift O 0 4.027187117117137e-07
mutation O 0 2.206584692743263e-09
, O 0 6.275163028091058e-11
the O 0 9.795994015959764e-10
effects O 0 4.044071602038457e-07
of O 0 1.2797809745279665e-07
the O 0 5.2370459968642535e-08
splice O 0 9.04448924643475e-08
- O 0 1.3494557471460666e-08
site O 0 3.843162232897157e-09
mutation O 0 8.45595260479115e-11
on O 0 4.1029085684485267e-10
splicing O 0 1.2841989693868072e-08
of O 0 2.1817601947304865e-08
COL17A1 O 0 1.9914868971682154e-06
transcripts O 0 1.0287173779488512e-07
were O 0 5.205702535704404e-09
determined O 0 3.6579288487104122e-09
using O 0 2.2524415665969855e-09
reverse O 0 1.203667387983387e-08
transcriptase O 0 3.836131412526811e-09
polymerase O 0 1.0348170098595233e-09
chain O 0 7.792994582977997e-10
reaction O 0 3.977206342042905e-10
of O 0 3.420629890449334e-10
total O 0 1.8647583477360286e-10
RNA O 0 3.7053896062566594e-10
from O 0 3.5129393838317924e-10
keratinocytes O 0 1.2031509122323314e-08
incubated O 0 2.68518163260012e-09
for O 0 4.556672539290929e-10
2 O 0 1.1115108833337217e-08
. O 0 9.273961154576682e-08

5 O 0 2.9225273578958877e-07
h O 0 6.64447057374673e-08
in O 0 5.985864581781186e-10
the O 0 1.1062861737798357e-09
presence O 0 7.936821200260624e-10
or O 0 1.90579019232473e-09
absence O 0 1.403064118221664e-07
of O 0 5.901591215717872e-09
10 O 0 2.1757013968226602e-08
microg O 0 1.440037408428907e-06
cycloheximide O 0 1.7061768176063197e-06
per O 0 3.3016573297572904e-07
ml O 0 1.1544637345650699e-05
. O 0 6.748063015038497e-07

Using O 0 1.2347270228474372e-07
this O 0 1.4651662105791274e-09
approach O 0 3.1065894745552214e-08
, O 0 1.346292965997975e-09
an O 0 5.315657913840255e-10
abnormally O 0 2.4652704766481293e-08
spliced O 0 1.920119352405436e-08
transcript O 0 4.2712886738627276e-07
was O 0 9.604368500504279e-08
identified O 0 5.044587414460011e-09
that O 0 4.364955966118522e-11
contains O 0 3.438302420555317e-11
an O 0 3.7952319238698795e-12
extra O 0 3.04848757348708e-10
264 O 0 5.656243806662076e-10
bases O 0 1.3340337723377615e-09
upstream O 0 2.350384997740207e-09
from O 0 8.142832519375531e-10
exon O 0 1.726981402327965e-08
32 O 0 5.863342700251906e-09
, O 0 3.592898895066199e-11
resulting O 0 4.2208112005504006e-11
in O 0 1.1687179002350945e-10
a O 0 1.4808602122329262e-09
premature O 0 7.829682857618536e-08
termination O 0 1.017799604596803e-07
codon O 0 4.0630251874063106e-07
27 O 0 6.832792109889851e-07
bp O 0 1.2589920572736446e-07
downstream O 0 1.4125192571157186e-08
from O 0 1.3811147780984356e-08
the O 0 1.4117777880073845e-07
cryptic O 0 9.482718041908811e-07
splice O 0 1.3607217397293425e-06
site O 0 6.801903396080888e-07
. O 0 2.2047521497370326e-07

Three O 0 1.9461917588614597e-07
other O 0 9.42481204191381e-10
splice O 0 1.8700422543815876e-08
variants O 0 1.3029501033656743e-08
, O 0 1.4060022590633992e-10
including O 0 1.9840509443702636e-11
one O 0 9.300266286260683e-12
derived O 0 1.6287061976871797e-10
from O 0 2.457081205164968e-10
the O 0 1.3625550687734744e-09
skipping O 0 2.7530525414931617e-08
of O 0 1.0857545085229958e-08
exon O 0 8.389807959474638e-08
32 O 0 6.366968108295623e-08
, O 0 6.096629312501989e-10
were O 0 2.382730679428846e-09
also O 0 1.5905259331816524e-09
identified O 0 1.766876955855423e-08
. O 0 6.580752653917443e-08

These O 0 2.7339996933051225e-08
results O 0 7.0441217303596204e-09
indicate O 0 1.4939109505007764e-08
the O 0 1.7022243614661647e-09
usefulness O 0 1.2787562297944532e-07
of O 0 1.6797380153477093e-09
cycloheximide O 0 1.4978711604385353e-08
treatment O 0 8.288782993304267e-10
in O 0 6.500131682907195e-11
evaluating O 0 1.159377815973528e-09
the O 0 3.3854516967579684e-09
abnormal O 0 1.1831881252533094e-08
processing O 0 2.483255556740005e-08
of O 0 1.2784313163649585e-08
mRNA O 0 1.8093638587401983e-08
due O 0 4.781965117217624e-07
to O 0 1.894899170906683e-08
splice O 0 2.8822865871802605e-08
- O 0 1.0127875427201616e-08
site O 0 4.046904589216638e-09
mutations O 0 8.257396988398114e-10
, O 0 5.986294793203228e-11
because O 0 9.049445914843801e-11
( O 0 1.186049730650396e-10
i O 0 1.354324030700127e-08
) O 0 5.331193264623835e-10
aberrant O 0 1.2430204421320923e-08
splicing O 0 2.0234946163100176e-08
often O 0 2.1491747270729888e-10
generates O 0 2.6332578478838187e-11
a O 0 7.68227564895696e-11
premature O 0 3.403333836971001e-09
termination O 0 6.167991895011937e-09
codon O 0 2.0227769681469e-08
, O 0 6.391711049325011e-10
( O 0 3.1884061363340876e-11
ii O 0 6.350050085757175e-08
) O 0 8.596133804772421e-10
transcripts O 0 8.34916491498916e-08
with O 0 3.3187225190189906e-10
premature O 0 9.321004768025887e-07
termination O 0 9.109030685294783e-08
codons O 0 2.2506991825821387e-08
can O 0 3.7126759999672743e-10
occur O 0 4.4341783023149617e-10
at O 0 8.836285481095274e-09
low O 0 1.1966619695158442e-07
or O 0 1.335118127165913e-09
undetectable O 0 5.576518802286046e-08
levels O 0 1.2105485502900137e-09
due O 0 3.0744153889372683e-09
to O 0 6.660138662795134e-09
nonsense O 0 7.340013485901409e-09
- O 0 1.0201134381659926e-09
mediated O 0 7.812758773262374e-10
mRNA O 0 1.5928507124396418e-10
decay O 0 2.3509587609993332e-09
, O 0 3.556625827183524e-11
and O 0 3.9386133243723975e-11
( O 0 1.9725724526020727e-11
iii O 0 6.653703366055197e-08
) O 0 1.0667130512231893e-09
the O 0 7.991785011540742e-09
levels O 0 5.5706610879724394e-08
of O 0 8.802603645996498e-10
these O 0 3.1346686357736075e-10
transcripts O 0 1.2381081937462568e-08
can O 0 5.488665077990618e-10
be O 0 3.619491928397167e-10
increased O 0 4.351408677827351e-10
by O 0 5.029942573564483e-10
cycloheximide O 0 1.6686826711520553e-06
. O 0 3.224777742616425e-07

A O 0 2.076121973004774e-06
deletion O 0 1.0707149158406537e-06
mutation O 0 2.1662025062596513e-08
in O 0 5.144632275744243e-09
COL17A1 O 0 5.232520834397292e-06
in O 0 1.1540878475102545e-08
five O 0 3.5592964131581084e-09
Austrian O 0 3.214018917674366e-08
families O 0 4.0461770045574497e-10
with O 0 3.701447759407728e-10
generalized O 0 3.8796020817244425e-05
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9987286925315857
represents O 0 1.8875907059623387e-08
propagation O 0 2.023325436084633e-07
of O 0 2.531924359061577e-08
an O 0 4.378042817165806e-09
ancestral O 0 5.123452410771279e-06
allele O 0 2.698511707421858e-06
. O 0 4.807754976354772e-07

Patients O 0 6.583441518159816e-06
with O 0 7.427257475711713e-09
generalized O 0 0.00023275494459085166
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999932050704956
, O 0 1.4582388629946763e-08
a O 0 8.56431869866725e-10
usually O 0 2.8285684905426933e-10
nonlethal O 0 6.39738857444172e-07
form O 0 2.220662231877668e-08
of O 0 2.7050100470660254e-06
junctional B-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999250173568726
, O 0 2.5377790535685563e-08
have O 0 2.3532289450400867e-09
generalized O 0 1.783611338623814e-07
blistering B-Disease 0 6.403602696991584e-07
, O 0 1.2226830214956408e-08
nail B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 3.3362316571583506e-06
patchy B-Disease 1 1.0
alopecia I-Disease 1 1.0
, O 0 6.155418930120504e-08
and O 0 1.4717424789978395e-07
dental B-Disease 1 1.0
abnormalities I-Disease 1 1.0
. O 1 0.5238960385322571

Skin B-Disease 1 1.0
fragility I-Disease 1 0.7849385142326355
in O 0 1.4963919880983667e-08
most O 0 1.8263375534122162e-10
cases O 0 8.239893142802934e-12
is O 0 4.663139991332999e-13
due O 0 1.0411757567219126e-10
to O 0 7.372462640375943e-10
mutations O 0 7.185239209173133e-11
in O 0 5.771523259312517e-10
the O 0 2.7495614673966884e-09
gene O 0 6.965530929825547e-10
encoding O 0 2.0891771868036813e-08
type O 0 1.9733072349481517e-06
XVII O 0 0.004087648820132017
collagen O 0 4.338421149441274e-06
( O 0 5.068795605467358e-09
COL17A1 O 0 6.263241630222183e-06
) O 0 6.236973160156367e-09
. O 0 8.683761620886798e-08

Recently O 0 1.958556367753772e-06
, O 0 2.4615667282290588e-09
we O 0 1.3554914968239018e-09
reported O 0 4.3884995637455404e-10
five O 0 1.439767471911324e-10
Austrian O 0 1.0749651835340046e-08
families O 0 1.2934035786837939e-10
with O 0 9.760831726213226e-11
generalized O 0 3.834861854556948e-05
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999983310699463
who O 0 7.996941775445521e-08
share O 0 8.978603638354343e-09
the O 0 1.339005439859875e-08
same O 0 5.762784027751877e-08
COL17A1 O 0 0.0001401742483722046
mutation O 0 3.0003187134752807e-07
. O 0 2.127135019236448e-07

Affected O 0 4.545167087144364e-08
individuals O 0 6.770008859069421e-11
in O 0 1.736664423379608e-10
three O 0 6.731817880911706e-11
families O 0 5.6369171483328095e-12
are O 0 5.158744525307624e-12
homozygous O 0 5.95670790470848e-10
for O 0 3.019674232884739e-10
4003delTC O 0 1.2289302020462856e-08
, O 0 7.117448991289521e-11
whereas O 0 3.686567440208677e-10
those O 0 1.5643379647212186e-10
in O 0 1.6503330646511216e-10
two O 0 2.4583890478879766e-10
others O 0 4.296859812402687e-10
are O 0 7.923173922508298e-11
compound O 0 5.250508294807332e-08
heterozygotes O 0 3.3414410154364305e-06
. O 0 2.5400851200174657e-07

To O 0 4.490569338599926e-08
determine O 0 1.9509474036283336e-09
if O 0 8.038070209437365e-10
the O 0 1.934694626726241e-09
occurrence O 0 8.76882566558379e-09
of O 0 6.694445553456774e-10
4003delTC O 0 7.049551165039247e-09
in O 0 3.6624089871928334e-10
these O 0 1.066863125620543e-10
unrelated O 0 1.5359027383254897e-09
families O 0 2.3681528960040055e-11
signifies O 0 1.428176910067691e-09
propagation O 0 1.816293071499331e-08
of O 0 1.2322790565733044e-09
an O 0 1.8920116862108927e-10
ancestral O 0 2.5110452384069504e-07
allele O 0 1.7269837826461298e-07
or O 0 4.006429854541693e-09
a O 0 1.8674331414558765e-08
mutational O 0 6.185600796015933e-05
hot O 0 5.9772966778837144e-05
spot O 0 1.2505657878136844e-06
, O 0 2.0195416450263792e-09
haplotypes O 0 2.2031331425864664e-08
were O 0 4.352340265967314e-09
determined O 0 1.22852013006991e-08
for O 0 7.622877440383036e-09
polymorphisms O 0 1.8129466639038583e-07
both O 0 8.043167021298814e-09
within O 0 5.14816589358702e-09
and O 0 7.955148539906531e-09
flanking O 0 4.970644567947602e-06
COL17A1 O 0 0.00027806436992250383
. O 0 1.4855876315778005e-06

Five O 0 8.693197628417693e-07
intragenic O 0 8.566399287701643e-07
polymorphisms O 0 9.712263704386714e-08
were O 0 2.357721573531535e-09
chosen O 0 2.021769196502987e-09
based O 0 9.694358649170454e-10
on O 0 2.217555561401241e-08
their O 0 3.633100575939352e-08
informativeness O 0 2.1775422283099033e-05
. O 0 7.92106789049285e-07

One O 0 3.880604992900771e-08
of O 0 1.3100390772180504e-09
these O 0 2.950312563698709e-11
, O 0 7.274177354216205e-12
not O 0 2.584543343231438e-11
previously O 0 2.0620725960096564e-10
reported O 0 8.035445225873517e-11
, O 0 3.7635883992637176e-11
was O 0 4.898641492445677e-09
2988 O 0 2.134077874416107e-07
A O 0 1.2860181186624686e-07
or O 0 7.328332607414723e-09
C O 0 5.367080007090408e-07
that O 0 2.4334242954004992e-11
introduces O 0 4.4973966217831673e-10
a O 0 2.1827030460830343e-10
new O 0 4.684435617186011e-10
restriction O 0 3.6160987537670053e-09
site O 0 5.320354157234419e-10
for O 0 6.993296913782032e-11
Eco0109 O 0 2.891540873406484e-07
I O 0 8.006234679669433e-07
. O 0 3.1833076263865223e-07

All O 0 6.92640185206983e-08
the O 0 1.3945193444442339e-08
4003delTC O 0 1.8779832089421689e-07
alleles O 0 9.478340778912298e-09
showed O 0 5.492731158796005e-09
the O 0 7.135204094232961e-10
same O 0 9.935181566333995e-10
haplotype O 0 2.22878391298309e-08
for O 0 6.377962602499565e-10
these O 0 4.6016873644916245e-10
five O 0 1.7249328632118477e-09
polymorphic O 0 2.3918934388689195e-08
markers O 0 2.557079312737187e-07
. O 0 1.0506194030313054e-06

Fourteen O 0 6.514154051728838e-07
microsatellite O 0 3.1101771469366213e-07
polymorphisms O 0 3.1341397033202156e-08
were O 0 2.0757588981012987e-09
selected O 0 8.828531239402082e-10
based O 0 1.6049088447100957e-10
on O 0 4.85624784829497e-09
their O 0 1.8065318130311425e-09
high O 0 2.895648876233281e-08
heterozygosity O 0 2.0923101828884683e-07
and O 0 8.046661115201914e-10
their O 0 2.665052623029851e-09
location O 0 6.253187478932887e-08
within O 0 5.944497782905955e-09
10q23 O 0 7.452035220012476e-07
- O 0 1.9579572096972697e-07
q25 O 0 3.959978130296804e-06
near O 0 9.093387234315742e-07
COL17A1 O 0 0.00011902471305802464
. O 0 1.0095716334035387e-06

Three O 0 1.967645424372222e-08
families O 0 4.3866585364149557e-10
shared O 0 1.7084044179327407e-09
microsatellite O 0 1.2751344513617369e-07
polymorphisms O 0 3.4457991660019616e-07
covering O 0 8.212546021013623e-08
at O 0 2.9272236190536205e-08
most O 0 5.852713869103354e-10
19 O 0 1.452351483521852e-08
cM O 0 1.1574518232748687e-08
, O 0 1.5067005976199255e-10
whereas O 0 8.421833785909882e-10
the O 0 1.5197760827589946e-09
others O 0 1.948976091625809e-09
shared O 0 5.044084594452158e-10
smaller O 0 7.595511719582504e-11
regions O 0 1.0767862990146426e-10
consistent O 0 2.9957363256727376e-09
with O 0 6.547274875035036e-12
cross O 0 5.559764870710637e-10
- O 0 1.753033451734609e-08
over O 0 4.365715844389939e-10
events O 0 2.648087027434798e-10
during O 0 1.082571476906935e-09
passage O 0 3.311048324405874e-09
of O 0 5.23993556877933e-11
this O 0 1.5068493328107557e-11
mutation O 0 3.972927889450695e-11
through O 0 3.8136580698955314e-11
several O 0 7.424870440697617e-11
generations O 0 1.1617182771317403e-08
. O 0 1.0630053282056906e-07

These O 0 1.1663878751733137e-07
results O 0 3.004057447242303e-08
indicate O 0 2.188603964725644e-08
that O 0 1.6568586780341121e-10
4003delTC O 0 1.55882347030456e-08
occurs O 0 4.108123563550947e-10
on O 0 2.304185953150295e-09
a O 0 1.2863801135409858e-09
single O 0 9.479878215756798e-09
ancestral O 0 1.8839065774045594e-07
allele O 0 7.866537288236941e-08
. O 0 9.142533841099976e-09
. O 0 1.2545191907520348e-07

The O 0 2.7428693556430517e-06
haptoglobin O 0 2.5496459784335457e-05
- O 0 8.178583357221214e-07
gene O 0 1.7332114410351096e-08
deletion O 0 7.668934642879321e-08
responsible O 0 1.6525586232774003e-08
for O 0 3.258722358623345e-08
anhaptoglobinemia B-Disease 0 8.208846702473238e-05
. O 0 1.2315440471866168e-06

We O 0 1.9947513862916821e-07
have O 0 1.0197185318361335e-09
found O 0 2.4436766499214e-10
an O 0 6.72948155533426e-11
allelic O 0 3.999476305693861e-08
deletion O 0 8.621132252528696e-08
of O 0 6.558085487995413e-07
the O 0 3.5696164104592754e-06
haptoglobin O 0 0.004660813603550196
( O 0 1.647713965269304e-09
Hp O 0 2.1980500974905226e-08
) O 0 7.913537880543942e-11
gene O 0 4.371123463187132e-10
from O 0 3.3260477705354674e-10
an O 0 1.6051414364337546e-10
individual O 0 5.495491908757977e-11
with O 0 1.292737722424775e-10
anhaptoglobinemia B-Disease 0 4.896691280009691e-06
. O 0 4.577976824293728e-07

The O 0 7.610182137796073e-07
Hp O 0 1.5901301253506972e-07
gene O 0 1.5480670079170977e-09
cluster O 0 6.167600319351152e-10
consists O 0 1.288793516351916e-10
of O 0 2.5847765594555483e-10
coding O 0 7.117173339565852e-08
regions O 0 6.6401986131836566e-09
of O 0 1.520609771432646e-07
the O 0 5.4755268763528875e-08
alpha O 0 3.308038998284246e-08
chain O 0 3.7813049913459906e-10
and O 0 9.056002475693603e-12
beta O 0 5.552865389724104e-10
chain O 0 1.9089833880325813e-10
of O 0 1.356706413879749e-10
the O 0 9.32418253718481e-10
haptoglobin O 0 2.800522906909464e-07
gene O 0 4.308860823698524e-09
( O 0 5.916360457103309e-11
Hp O 0 2.3137247673332695e-09
) O 0 1.3070351224941934e-11
and O 0 8.526906958294944e-11
of O 0 9.880849471954889e-10
the O 0 3.5315641522259966e-09
alpha O 0 2.40432562748083e-08
chain O 0 6.634384708270602e-10
and O 0 3.677681423286394e-11
beta O 0 2.93801782902392e-09
chain O 0 1.0376830505975931e-09
of O 0 3.185411101558344e-10
the O 0 1.1417518042122765e-09
haptoglobin O 0 3.347014398968895e-07
- O 0 2.08344683727546e-08
related O 0 5.017929183281922e-09
gene O 0 6.101553484683109e-09
( O 0 1.0594212312975415e-10
Hpr O 0 4.404201092711446e-08
) O 0 5.785473489172688e-11
, O 0 2.7432464286269997e-11
in O 0 5.502057490169854e-11
tandem O 0 4.813753395893627e-09
from O 0 8.274644858197178e-10
the O 0 2.3461895537479904e-08
5 O 0 8.595699085844899e-08
side O 0 5.7281003051912194e-08
. O 0 4.714620729373564e-07

Southern O 0 1.1385095604055095e-05
blot O 0 1.3023338397033513e-05
and O 0 7.897668297118798e-09
PCR O 0 6.176210831654316e-08
analyses O 0 2.9244988652976645e-09
have O 0 1.8941563595387123e-10
indicated O 0 5.469801278579212e-10
that O 0 1.5153519064559084e-11
the O 0 1.1195824128895637e-10
individual O 0 3.7894617999079117e-11
with O 0 9.577532343596484e-12
anhaptoglobinemia B-Disease 0 3.193407849266805e-08
was O 0 6.4133787169851075e-09
homozygous O 0 2.9255475819667254e-09
for O 0 4.955947874307753e-10
the O 0 1.3846035429310177e-09
gene O 0 1.905310353933487e-09
deletion O 0 4.857971358518398e-09
and O 0 1.3296459766554136e-10
that O 0 2.4980783067118928e-11
the O 0 3.0803892769881713e-10
gene O 0 4.236702932924885e-10
deletion O 0 3.1126734523212463e-09
was O 0 2.226165696228577e-09
included O 0 4.950544418846903e-10
at O 0 8.945779117475183e-10
least O 0 2.6660056107186136e-11
from O 0 3.977553356127039e-11
the O 0 4.731073310892953e-10
promoter O 0 7.326644180238873e-08
region O 0 7.100617693822642e-08
of O 0 5.630469672723848e-07
Hp O 0 1.9299154701002408e-06
to O 0 1.818210364490369e-07
Hpr O 0 2.572287485236302e-07
alpha O 0 3.533088488438807e-08
but O 0 4.2214093332049174e-10
not O 0 1.996706355811284e-09
to O 0 1.5536468112031798e-08
Hpr O 0 2.630478945775394e-07
beta O 0 1.8820766456428828e-07
( O 0 1.4943261072986047e-09
Hpdel O 0 1.1762328995246207e-06
) O 0 5.439704686693858e-09
. O 0 8.288015607149646e-08

In O 0 3.415385307903307e-08
addition O 0 3.923831037866421e-09
, O 0 1.279047145974488e-10
we O 0 4.458084457148459e-10
found O 0 1.4385431734709186e-10
seven O 0 4.6338863302075595e-11
individuals O 0 2.7756239147358475e-12
with O 0 3.8976283138481005e-12
hypohaptoglobinemia B-Disease 0 1.7225048054569925e-07
in O 0 1.8603754092794134e-09
three O 0 1.2942696914208796e-10
families O 0 7.519671517408621e-12
, O 0 5.982707818735777e-12
and O 0 1.3423634599718515e-11
the O 0 7.15144499174869e-10
genotypes O 0 1.9855899147103173e-09
of O 0 2.0100034969772196e-09
six O 0 3.220626432209883e-09
of O 0 1.8188158756871076e-09
the O 0 1.4551928551043147e-09
seven O 0 1.1866471694155223e-10
individuals O 0 5.286550819501301e-13
were O 0 6.840907007532593e-11
found O 0 9.746618789829853e-11
to O 0 3.792567593308149e-09
be O 0 9.023381153383525e-08
Hp2 O 0 0.0018051897641271353
/ O 0 0.001432748162187636
Hpdel O 0 0.0031093175057321787
. O 0 3.832027687167283e-06

The O 0 1.401315103066736e-06
phenotypes O 0 3.067587499572255e-07
and O 0 1.0180821741201385e-09
genotypes O 0 6.951943909427882e-09
in O 0 5.081280951557687e-10
one O 0 1.3634199325096574e-10
of O 0 1.2400686033586794e-10
these O 0 6.213679310668185e-12
three O 0 3.1981314298212826e-12
families O 0 8.121709142890066e-13
showed O 0 9.056629751702516e-11
the O 0 3.622558641946938e-10
father O 0 1.3063143455838144e-08
to O 0 4.198960823487141e-08
be O 0 4.8996906087950265e-08
hypohaptoglobinemic B-Disease 0 5.426947154774098e-06
( O 0 1.2395111603780151e-09
Hp2 O 0 1.186529289043392e-06
) O 0 1.7722688594457026e-10
and O 0 3.1912916753640275e-10
Hp2 O 0 1.9655358300951775e-06
/ O 0 1.540824854373568e-07
Hpdel O 0 6.53224446978129e-07
, O 0 1.543013633531487e-10
the O 0 5.429605653972658e-10
mother O 0 7.146399583213281e-10
to O 0 7.86175957667723e-10
be O 0 2.3453147757201975e-10
Hp2 O 0 2.9483540942010222e-08
- O 0 6.584730538605754e-09
1 O 0 8.20915957433499e-09
and O 0 1.7264272234029931e-09
Hp1 O 0 1.683353843873192e-06
/ O 0 1.3623977679344534e-07
Hp2 O 0 2.9622665920214786e-07
, O 0 8.50661832640931e-11
one O 0 2.2029825880176546e-11
of O 0 4.05150323012915e-11
the O 0 6.276096309321133e-11
two O 0 5.7606293867029645e-12
children O 0 3.2011053530123235e-11
to O 0 1.1169993402448952e-10
be O 0 1.2608137867076152e-09
hypohaptoglobinemic B-Disease 0 2.534466830184101e-06
( O 0 9.942858758549278e-10
Hp2 O 0 2.6939660529023968e-06
) O 0 5.576321626676872e-10
and O 0 1.1634982977071218e-09
Hp2 O 0 9.241078259947244e-06
/ O 0 6.791137252548651e-07
Hpdel O 0 1.7140883983302047e-06
, O 0 3.0808475215415854e-10
and O 0 6.584446876622962e-11
the O 0 5.080301734849968e-10
other O 0 3.154893013501692e-11
child O 0 3.842830498257399e-10
to O 0 4.147615861871401e-10
be O 0 1.9430819175880742e-09
Hp1 O 0 9.882816129902494e-07
and O 0 6.192333312782239e-09
Hp1 O 0 3.987197851529345e-05
/ O 0 4.598472969519207e-06
Hpdel O 0 7.1976473918766715e-06
, O 0 2.85169554636866e-09
showing O 0 1.199070709390071e-08
an O 0 4.6382037099945705e-10
anomalous O 0 3.806121355864889e-07
inheritance O 0 2.837281726897345e-06
of O 0 2.4037028197199106e-05
Hp O 0 1.037647734847269e-06
phenotypes O 0 3.3477800087666765e-08
in O 0 1.4900514155868905e-09
the O 0 5.9007807529098955e-09
child O 0 6.8105929784678665e-09
with O 0 4.5588718911027115e-10
Hp1 O 0 5.8908193750539795e-05
. O 0 1.008723756967811e-06

The O 0 2.969476736325305e-05
Hp2 O 1 0.8728368282318115
/ O 0 0.00011486413131933659
Hpdel O 0 1.9119415810564533e-05
individuals O 0 8.187435729389847e-10
had O 0 2.780741414909471e-09
an O 0 7.986443451013514e-11
extremely O 0 2.151403055705714e-09
low O 0 1.1297485258410234e-07
level O 0 3.6692969729301694e-07
of O 0 4.5598767428600695e-08
Hp O 0 1.0869110411704241e-07
( O 0 5.415970796840419e-11
mean O 0 2.745844385199092e-10
+ O 0 3.323118447084994e-10
/ O 0 1.3343722793379698e-09
- O 0 2.832478473990818e-09
SD O 0 6.108134442683877e-08
= O 0 1.1295315793802274e-08
0 O 0 1.0286419493965582e-09
. O 0 9.476957413268039e-11
049 O 0 5.272817915624728e-08
+ O 0 2.915031327432871e-09
/ O 0 3.806590598287585e-09
- O 0 5.556332727252311e-09
0 O 0 2.117353625763485e-09
. O 0 3.24271609564164e-10
043 O 0 6.130790097813588e-07
mg O 0 5.026063831792271e-07
/ O 0 3.7303330202576035e-08
ml O 0 6.182411027566559e-08
; O 0 8.133514695085609e-11
n O 0 7.428089809913274e-10
= O 0 1.4904663059311929e-09
6 O 0 4.812741316584379e-10
) O 0 6.533627371768658e-12
, O 0 2.356252562854544e-12
compared O 0 5.148904740071014e-12
with O 0 9.506275974735523e-13
the O 0 2.0427734503947192e-10
level O 0 1.9815871166173338e-09
( O 0 2.5524491374662173e-12
1 O 0 1.4759164723709972e-10
. O 0 3.908656037721059e-11
64 O 0 1.3227076378630187e-10
+ O 0 1.2750475675282757e-10
/ O 0 5.25691656871885e-10
- O 0 1.1948420031160367e-09
1 O 0 1.2101099011729843e-09
. O 0 5.37222710761398e-10
07 O 0 2.593397141481546e-07
mg O 0 2.42427461216721e-07
/ O 0 5.481765086301493e-08
ml O 0 5.2064503819337915e-08
) O 0 3.5727396735518724e-11
obtained O 0 1.5553180965355295e-09
from O 0 3.4012617722289917e-10
52 O 0 2.0109517606670124e-08
healthy O 0 2.7312946571100838e-08
volunteers O 0 1.773372915181426e-08
having O 0 1.1148145517836383e-08
phenotype O 0 1.627738015486102e-07
Hp2 O 0 2.487739038770087e-06
, O 0 1.1784534459380325e-09
whereas O 0 8.411531027263663e-09
the O 0 4.894112226594416e-09
serum O 0 1.7162108179036295e-08
Hp O 0 2.7235435240413608e-08
level O 0 1.1120961929123041e-08
of O 0 6.237434457823099e-10
an O 0 7.84494899597199e-11
individual O 0 5.3658140430901113e-11
with O 0 4.718049909091526e-11
Hp1 O 0 6.976259555813158e-06
/ O 0 2.4127477900037775e-06
Hpdel O 0 7.093501608324004e-06
was O 0 9.540138989905245e-08
0 O 0 1.9164922093750647e-07
. O 0 8.103285153993056e-08

50 O 0 1.8698284520723973e-06
mg O 0 9.49755576584721e-06
/ O 0 9.612869007469271e-07
ml O 0 8.591925961809466e-07
, O 0 3.5458239122654334e-10
which O 0 1.1668751902227381e-11
was O 0 1.0861966187603045e-10
approximately O 0 8.598054993674831e-13
half O 0 8.574117110748958e-12
the O 0 8.126226774818335e-11
level O 0 3.296234174499091e-09
of O 0 3.250066049620415e-10
Hp O 0 4.173241308080833e-09
in O 0 4.775679851576342e-10
control O 0 3.550937321961101e-08
sera O 0 6.104116323513153e-08
from O 0 2.262110360140568e-10
the O 0 7.254454259530974e-10
Hp1 O 0 1.7521567485800915e-07
phenotype O 0 5.66544311464412e-10
( O 0 8.28655720430671e-13
1 O 0 3.838067363926001e-11
. O 0 1.2991339774781618e-11
26 O 0 2.1092548541101763e-10
+ O 0 2.2576879254998516e-10
/ O 0 6.336142721607985e-10
- O 0 1.6164332095058853e-09
0 O 0 3.681185078985294e-10
. O 0 8.044661464756686e-11
33 O 0 1.5109778983557476e-09
mg O 0 2.548557453962985e-08
/ O 0 1.1272157429687013e-08
ml O 0 1.7275809227612626e-08
; O 0 4.470181516613714e-11
n O 0 5.818898141107809e-10
= O 0 9.641362153089972e-10
9 O 0 7.25695947778604e-10
) O 0 3.827802658173951e-11
, O 0 4.492961558355546e-11
showing O 0 4.243287943239693e-09
a O 0 2.579384705825305e-09
gene O 0 5.8548601522545596e-09
- O 0 1.480364630879194e-07
dosage O 0 6.093431238696212e-06
effect O 0 4.7516792278656794e-07
. O 0 5.903552846575622e-07

The O 0 8.105663482638192e-07
other O 0 1.1464353910639602e-08
allele O 0 6.75308555742049e-08
( O 0 1.4060504149870923e-10
Hp2 O 0 2.788474375847727e-07
) O 0 1.2039577668154777e-10
of O 0 3.14043735460956e-10
individuals O 0 2.0648659865285524e-11
with O 0 7.265445189919006e-11
Hp2 O 0 0.006839393638074398
/ O 0 1.309403705818113e-05
Hpdel O 0 1.5291858289856464e-05
was O 0 3.026475425826902e-08
found O 0 1.6511265965579724e-10
to O 0 3.2771940716713743e-10
have O 0 3.246953747537695e-11
, O 0 1.592464007882377e-11
in O 0 1.7057791290575608e-10
all O 0 9.19886944394932e-10
exons O 0 1.1531789745333754e-08
, O 0 6.040595246226133e-10
no O 0 2.467273052531027e-09
mutation O 0 4.0979500348647946e-10
, O 0 2.349127663225925e-11
by O 0 2.0030591768582795e-11
DNA O 0 1.6631064303496146e-09
sequencing O 0 9.143391821453406e-08
. O 0 4.3877341227016586e-07

On O 0 8.878827202352113e-07
the O 0 4.247304286053577e-09
basis O 0 5.523639323712359e-09
of O 0 6.606515889906461e-10
the O 0 4.3369749458399554e-10
present O 0 1.12016541875537e-10
study O 0 4.677221943083509e-10
, O 0 7.122541445525599e-11
the O 0 1.1830318946692842e-09
mechanism O 0 2.297469023915255e-07
of O 0 1.0409026529600851e-08
anhaptoglobinemia B-Disease 0 8.127925639200839e-07
and O 0 2.732960968643283e-09
the O 0 1.305086616554263e-08
mechanism O 0 3.7360726423685264e-07
of O 0 6.186808398922494e-09
anomalous O 0 5.848166892974405e-07
inheritance O 0 6.23517962594633e-07
of O 0 6.677006467725732e-07
Hp O 0 4.1828937469290395e-07
phenotypes O 0 3.692348471417972e-08
were O 0 2.6656323814933103e-09
well O 0 6.796357254756913e-09
explained O 0 1.617734710634977e-07
. O 0 1.7202016522332997e-07

However O 0 8.538491158560646e-08
, O 0 1.2470829924282612e-09
the O 0 1.6485847131875175e-09
mechanism O 0 7.564437964902027e-08
of O 0 2.429092305078484e-08
hypohaptoglobinemia B-Disease 0 1.3888653484173119e-05
remains O 0 8.646308060633601e-07
unknown O 0 1.3501939974958077e-05

ATM O 0 5.1882798288716e-05
mutations O 0 2.15707473216753e-07
and O 0 1.6234376065682454e-09
phenotypes O 0 4.1899644998011354e-07
in O 0 8.232406116803759e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
families O 0 8.127912565214501e-08
in O 0 6.972845856267895e-09
the O 0 1.354910583728497e-08
British O 0 6.855402290284474e-08
Isles O 0 6.142342954262858e-07
: O 0 4.875717607433216e-10
expression O 0 1.1230562035891012e-09
of O 0 9.095926789548514e-11
mutant O 0 8.886614222269884e-10
ATM O 0 4.368019546063806e-08
and O 0 1.2182192754561783e-10
the O 0 8.835774889526249e-10
risk O 0 8.286969332971239e-09
of O 0 1.6117320811304126e-09
leukemia B-Disease 1 0.9987213015556335
, O 0 1.173241201968267e-07
lymphoma B-Disease 1 1.0
, O 0 1.4475692751148017e-06
and O 0 3.1629824661649764e-06
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
. O 1 0.9852331280708313

We O 0 3.4422182437765514e-08
report O 0 1.389415693608953e-09
the O 0 4.4676520816189225e-10
spectrum O 0 2.8916957717228797e-09
of O 0 8.951565044768017e-10
59 O 0 3.534812442751445e-09
ATM O 0 1.2149700978625333e-07
mutations O 0 1.0718975707035838e-09
observed O 0 1.1177010428298217e-09
in O 0 1.0350189150187816e-08
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.0011875118361786008
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 7.006942248644066e-11
patients O 0 1.9384907568031906e-10
in O 0 6.402763041979398e-11
the O 0 2.484623395915264e-09
British O 0 7.204997132248536e-07
Isles O 0 3.0137505746097304e-05
. O 0 8.869567977853876e-07

Of O 0 4.001386514573824e-06
51 O 0 1.0327511290597613e-06
ATM O 0 5.982587936159689e-06
mutations O 0 1.4804260040079953e-08
identified O 0 1.2859312503721299e-09
in O 0 1.0098930719459887e-10
families O 0 1.2111154093497056e-11
native O 0 9.847506143856322e-11
to O 0 7.553977998675521e-10
the O 0 2.185849501401549e-09
British O 0 9.759225605421307e-08
Isles O 0 5.344403462004266e-07
, O 0 3.7588551715650453e-10
11 O 0 1.647176728347688e-09
were O 0 1.1842012925811218e-09
founder O 0 1.230774060445583e-08
mutations O 0 8.849369015351272e-10
, O 0 6.302559862891854e-11
and O 0 4.301449474386487e-11
2 O 0 4.903119243948595e-09
of O 0 2.09120143424002e-09
these O 0 2.8337848734238946e-10
11 O 0 2.4999109449197476e-09
conferred O 0 8.711981536180247e-08
a O 0 5.782931022935145e-09
milder O 0 1.500845314694743e-08
clinical O 0 5.703850280980305e-09
phenotype O 0 6.693884335717826e-10
with O 0 7.588802850011511e-12
respect O 0 1.4415652005439483e-09
to O 0 9.312564053232109e-09
both O 0 1.5104340889138257e-08
cerebellar B-Disease 0 0.0023570882622152567
degeneration I-Disease 1 1.0
and O 0 4.544820342289313e-08
cellular O 0 5.119674142406438e-07
features O 0 1.5594737590163277e-07
. O 0 2.127731448808845e-07

We O 0 1.5658679686225696e-08
report O 0 5.677980863261212e-10
, O 0 3.067335231296542e-12
in O 0 5.041636379210512e-12
two O 0 5.179263962151737e-11
A B-Disease 1 0.9999998807907104
- I-Disease 1 0.8683521151542664
T I-Disease 1 1.0
families O 0 1.7940354757328691e-10
, O 0 1.2429758611265385e-11
an O 0 1.6247028028493204e-11
ATM O 0 1.603278860784485e-06
mutation O 0 1.7107463889942665e-08
( O 0 5.018708365556179e-11
7271T O 0 1.3632775619498716e-07
- O 0 2.479105774000345e-07
- O 0 4.600998977366544e-07
> O 0 2.932371216957108e-07
G O 0 6.851990264067354e-08
) O 0 3.322381258996643e-11
that O 0 2.5060945072624685e-12
may O 0 2.3423984973902634e-11
be O 0 3.4922946479110095e-11
associated O 0 1.4212603316465788e-10
with O 0 1.1667767446654764e-12
an O 0 4.3051083531420176e-12
increased O 0 1.0583972587241419e-10
risk O 0 1.1914488284858749e-09
of O 0 1.6159953375449732e-09
breast B-Disease 0 3.2564005323365564e-06
cancer I-Disease 0 2.873395317237737e-07
in O 0 1.2360484191731302e-08
both O 0 2.4997216740985095e-08
homozygotes O 0 1.5946358189466991e-06
and O 0 8.010158758509078e-09
heterozygotes O 0 4.481123880850646e-07
( O 0 4.742798515033897e-11
relative O 0 1.81448467362344e-09
risk O 0 3.6199063191411085e-10
12 O 0 1.14161839703808e-10
. O 0 1.7693362400206247e-11
7 O 0 7.611642427463039e-10
; O 0 1.2432704865616984e-10
P O 0 2.7049889439467734e-08
= O 0 1.4462781194879426e-08
. O 0 2.7933333424101647e-10
0025 O 0 3.588021968425892e-07
) O 0 1.4071503684487396e-10
, O 0 1.369058512390442e-11
although O 0 1.8784116623260516e-11
there O 0 5.4843373765989245e-12
is O 0 1.4347355768717929e-12
a O 0 4.880634958681629e-12
less O 0 9.789694055406528e-11
severe O 0 2.4989284952425805e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
phenotype O 0 9.233767528371573e-09
in O 0 5.468567265687341e-11
terms O 0 1.403135663213817e-10
of O 0 1.0287585887336359e-11
the O 0 1.2619336131614034e-11
degree O 0 1.3463802295277105e-09
of O 0 3.964061079386738e-09
cerebellar B-Disease 0 3.486453351797536e-05
degeneration I-Disease 1 0.9998868703842163
. O 0 6.323803631858027e-07

This O 0 4.935520792059833e-08
mutation O 0 7.2688206564919255e-09
( O 0 5.813792156028619e-11
7271T O 0 2.8301903043370658e-08
- O 0 1.5135977804447975e-08
- O 0 2.030062518088016e-08
> O 0 6.529005247557507e-08
G O 0 5.583596518476952e-08
) O 0 6.182025030776472e-11
also O 0 8.001599383078428e-11
allows O 0 4.97103573582347e-11
expression O 0 1.574587682462436e-10
of O 0 6.12366407581888e-11
full O 0 2.397417542265856e-10
- O 0 6.149311615466502e-10
length O 0 1.3679575527891785e-10
ATM O 0 1.2662592041579046e-07
protein O 0 1.1650839182308914e-09
at O 0 9.808202028338542e-10
a O 0 4.692707888942493e-10
level O 0 1.1223174611885156e-09
comparable O 0 3.1652269694149027e-09
with O 0 1.6538584737824102e-11
that O 0 4.9935389156985366e-11
in O 0 3.6727201835340395e-10
unaffected O 0 5.441990680310482e-08
individuals O 0 7.636377641340175e-10
. O 0 4.3800582716357894e-08

In O 0 6.3260876537185595e-09
addition O 0 8.464783873840531e-10
, O 0 3.0960973368410194e-11
we O 0 1.77307925286474e-11
have O 0 9.662777305727288e-13
studied O 0 1.0154287133357087e-10
18 O 0 1.6828430204895994e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 3.268170800652115e-08
, O 0 4.478696059850851e-12
in O 0 5.063869462640369e-12
15 O 0 7.214077252237772e-11
families O 0 2.8812583829224137e-12
, O 0 1.1359205243088866e-11
who O 0 4.134486503160062e-11
developed O 0 3.467758746822369e-09
leukemia B-Disease 1 1.0
, O 0 1.7562750826982665e-06
lymphoma B-Disease 1 1.0
, O 0 2.6997267923434265e-06
preleukemic O 1 0.9837161302566528
T O 0 1.7096957890316844e-05
- O 0 6.11792927429633e-07
cell O 0 8.759315051065641e-07
proliferation O 1 0.8952050805091858
, O 0 1.7289753628801918e-08
or O 0 4.4279895519139245e-06
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 4.613043724788213e-09
mostly O 0 2.582770664005807e-10
in O 0 4.582943191611122e-10
childhood O 0 3.7331804492168885e-07
. O 0 2.8625913728319574e-07

A O 0 1.084328778233612e-05
wide O 0 3.5407731502345996e-07
variety O 0 4.9023270776160643e-08
of O 0 5.490722898571221e-08
ATM O 0 1.2637628969969228e-05
mutation O 0 1.7889869141640702e-08
types O 0 5.476046283092728e-09
, O 0 4.0668196588100614e-10
including O 0 9.276182044715142e-10
missense O 0 2.768893807569839e-07
mutations O 0 1.1215412598630792e-08
and O 0 1.219726541989985e-09
in O 0 1.6099201971542243e-08
- O 0 3.249332110044634e-07
frame O 0 8.592336371293641e-07
deletions O 0 2.2065336224841303e-07
, O 0 5.464816377198645e-10
were O 0 9.55686751957785e-10
seen O 0 7.148826530745112e-10
in O 0 1.3862597181280023e-10
these O 0 6.015049014429508e-10
patients O 0 2.2002091260020507e-09
. O 0 1.6285556014850044e-08

We O 0 3.3377954622437755e-08
also O 0 6.236423044647665e-10
show O 0 1.189486426023123e-10
that O 0 1.2750170927736115e-12
25 O 0 3.8239498373338066e-11
% O 0 4.965802508777317e-12
of O 0 1.647825452477658e-11
all O 0 1.5061088487478003e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 3.168889151083931e-08
carried O 0 4.4425677026005417e-10
in O 0 3.5549999055639603e-10
- O 0 4.623210969612046e-08
frame O 0 7.854929435779923e-07
deletions O 0 2.2681733753415756e-06
or O 0 8.451675626020005e-08
missense O 0 4.185439763659815e-07
mutations O 0 9.714316462350325e-09
, O 0 5.882121179023869e-11
many O 0 2.0950840021183303e-11
of O 0 1.3159334733003902e-10
which O 0 1.2258334972092833e-11
were O 0 1.3684482713660628e-10
also O 0 6.144149772291385e-11
associated O 0 3.982246477018947e-10
with O 0 6.627375037648875e-11
expression O 0 8.427127795584965e-08
of O 0 1.3437077228672933e-08
mutant O 0 1.7782909367269895e-08
ATM O 0 6.448996714425448e-07
protein O 0 1.7621585968186082e-08
. O 0 1.151658466369554e-07

The O 0 1.1608320846789866e-06
DMPK O 0 2.001948087126948e-05
gene O 0 9.363684227992053e-08
of O 0 2.0932777289317528e-08
severely O 0 2.7495123504195362e-05
affected O 0 5.371021416067379e-06
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 0.0034614817705005407
is O 0 2.8422239561898266e-10
hypermethylated O 0 1.3723991720837603e-08
proximal O 0 7.717677164009729e-09
to O 0 9.88475612473394e-09
the O 0 6.556057474682575e-09
largely O 0 4.555467114641942e-09
expanded O 0 9.238947384915264e-09
CTG O 0 1.5388114888992277e-06
repeat O 0 1.7347171876735956e-07
. O 0 2.578585167611891e-07

Using O 0 8.473262482766586e-07
methylation O 0 3.550047722455929e-06
- O 0 7.970147635205649e-06
sensitive O 0 9.609289008949418e-06
restriction O 0 3.185961929830228e-07
enzymes O 0 8.704033604978179e-10
, O 0 2.2421177761633437e-11
we O 0 4.536689773848579e-11
characterized O 0 2.944516852565471e-11
the O 0 3.7071620079265344e-11
methylation O 0 1.6386595413919736e-09
pattern O 0 4.6013015619905673e-10
on O 0 2.4909010409857046e-09
the O 0 4.851385404514019e-10
5 O 0 1.5336311109948042e-09
side O 0 7.400302037829931e-10
of O 0 6.034169830471114e-10
the O 0 1.978973651617366e-09
CTG O 0 1.9144698626405443e-07
repeat O 0 2.4008611987369477e-08
in O 0 4.837564127058158e-09
the O 0 1.1950613831857027e-08
DMPK O 0 1.6444297443740652e-06
gene O 0 8.007287277678188e-09
of O 0 9.6432750673614e-10
normal O 0 1.7464687473989216e-08
individuals O 0 1.4476034954080674e-11
and O 0 3.3958023892832756e-11
of O 0 3.9772288240591536e-10
patients O 0 7.898824927465853e-10
affected O 0 5.683301051995215e-10
with O 0 1.832329510342845e-09
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 1.8239481036630423e-08
showing O 0 2.2648658504209607e-09
expansions O 0 6.581528655402735e-09
of O 0 5.596836327725896e-09
the O 0 4.13296863399637e-09
repetitive O 0 3.6094423006005627e-09
sequence O 0 4.083010818334287e-09
. O 0 1.0735148947560447e-07

The O 0 3.9677698282503115e-07
gene O 0 3.919163660270897e-09
segment O 0 3.0377860227304154e-09
analyzed O 0 5.704198891010037e-09
corresponds O 0 2.3919104474856567e-09
to O 0 4.1896628388826684e-09
the O 0 5.8018345683308326e-09
genomic O 0 8.435860365807457e-08
SacI O 0 1.6956945501078735e-06
- O 0 3.1217599172350674e-08
HindIII O 0 9.823956048649052e-08
fragment O 0 3.5703044964918718e-09
carrying O 0 2.558921297080019e-09
exons O 0 4.984865409340955e-09
11 O 0 5.168236505426194e-09
- O 0 5.848847095535348e-08
15 O 0 1.2842632202136883e-07
. O 0 3.186429751167452e-07

There O 0 2.817038691205198e-08
is O 0 3.851996221992948e-10
constitutive O 0 7.211225749870209e-08
methylation O 0 4.817255216948979e-07
in O 0 1.0150234430739147e-07
intron O 0 4.784109023603378e-06
12 O 0 1.4620577815094293e-07
at O 0 2.0274777412510048e-08
restriction O 0 1.5131705666249218e-08
sites O 0 9.03722152667541e-10
of O 0 4.68643734929941e-10
SacII O 0 3.001451887030271e-07
and O 0 1.1342785599666172e-09
HhaI O 0 1.5684453273934196e-06
, O 0 2.0620725960096564e-10
localized O 0 2.7643851652214835e-09
1 O 0 2.713534730247602e-09
, O 0 2.952390068533539e-11
159 O 0 2.364944629018595e-10
- O 0 2.1800037330876876e-09
1 O 0 2.3772120272269603e-08
, O 0 1.5695061916787267e-09
232 O 0 9.031969838702025e-09
bp O 0 1.0608559364300163e-08
upstream O 0 3.8812322245007636e-09
of O 0 5.690159454729837e-09
the O 0 7.912131394505195e-08
CTG O 0 1.325678840657929e-05
repeat O 0 2.1187025822655414e-07
, O 0 7.387144229653586e-10
whereas O 0 5.09788988800608e-10
most O 0 2.3627027417871815e-11
, O 0 1.4851630125364834e-12
if O 0 1.8156314125772344e-12
not O 0 1.7212566441604515e-11
all O 0 1.0616173738708934e-11
, O 0 2.2890710160705652e-11
of O 0 1.6224646626206152e-10
the O 0 3.0792904337495486e-10
other O 0 6.432041704806934e-11
sites O 0 8.666694029102473e-10
of O 0 4.1742817535883603e-10
SacII O 0 6.825719083281001e-07
, O 0 7.66711361066541e-10
HhaI O 0 1.2870873433712404e-06
, O 0 5.054341389865158e-10
and O 0 2.5674365411454403e-10
HpaII O 0 8.828386057757598e-07
in O 0 1.227648094292988e-09
this O 0 4.719690194221471e-10
region O 0 3.187898833800773e-09
are O 0 2.3388863068518617e-10
unmethylated O 0 2.2048762104986963e-07
, O 0 7.773958560219896e-11
in O 0 8.650587191016967e-11
normal O 0 3.84872222980448e-09
individuals O 0 1.369110640830895e-11
and O 0 1.7486460196503018e-11
most O 0 9.014235191617814e-11
of O 0 3.7366387761750275e-10
the O 0 1.3108863994304443e-09
patients O 0 2.50326537276635e-09
. O 0 2.0932018784947104e-08

In O 0 3.489609667894911e-08
a O 0 2.0779296061590458e-09
number O 0 4.747878756816704e-10
of O 0 3.137874959868725e-10
young O 0 9.528710043227306e-10
and O 0 3.2650523951183175e-10
severely O 0 1.0042357700967841e-07
affected O 0 1.3148954147723657e-09
patients O 0 4.0424299463381885e-09
, O 0 3.1587642224106816e-11
however O 0 2.7905217026003015e-10
, O 0 4.8576975775205256e-11
complete O 0 2.624040096321778e-09
methylation O 0 5.7909030459768474e-08
of O 0 5.78137626661146e-09
these O 0 3.387142233357565e-10
restriction O 0 4.5875103715786736e-09
sites O 0 2.252350111975332e-10
was O 0 6.814123154619267e-10
found O 0 5.6411465776395886e-11
in O 0 1.160970625191382e-10
the O 0 5.258673940744529e-09
mutated O 0 8.239312165869705e-08
allele O 0 6.059312340767065e-07
. O 0 2.8836731758019596e-07

In O 0 4.8112500650177026e-08
most O 0 1.3804239973325139e-09
of O 0 2.0906779085727578e-10
these O 0 4.7042903426885996e-12
patients O 0 2.5308196510698266e-11
, O 0 1.1925292567674384e-12
the O 0 1.5325593225035128e-11
onset O 0 1.3953020072676736e-07
of O 0 3.49875195482241e-09
the O 0 2.442924262879842e-08
disease O 0 5.158622684575676e-07
was O 0 1.6895121461857343e-06
congenital O 1 1.0
. O 0 6.492438114946708e-05

Preliminary O 0 1.2931133142046747e-06
in O 0 6.397742708941223e-07
vivo O 0 0.000515224935952574
footprinting O 0 0.0002731632557697594
data O 0 3.795794043526257e-07
gave O 0 1.011083217150599e-08
evidence O 0 3.041978002826795e-09
for O 0 1.5501966377229337e-10
protein O 0 1.6919624035161007e-10
- O 0 1.4106552592707544e-09
DNA O 0 9.039105464125896e-09
contact O 0 4.90843632405813e-08
in O 0 1.5886765236672318e-09
normal O 0 2.0143977508269018e-07
genes O 0 3.854055297125569e-09
at O 0 2.564717860309429e-08
an O 0 7.679495928059055e-10
Sp1 O 0 6.543292130345435e-08
consensus O 0 6.51996856504411e-09
binding O 0 4.883581872228149e-10
site O 0 1.4903214218264793e-09
upstream O 0 5.450814799523584e-10
of O 0 4.09504319343057e-10
the O 0 4.76256500903105e-09
CTG O 0 9.398268616678251e-07
repeat O 0 1.3459753311906297e-08
and O 0 2.2599755400420918e-10
for O 0 1.5533488384456007e-10
a O 0 3.502139897526568e-11
significant O 0 2.6636423969272904e-11
reduction O 0 1.8837593707132783e-09
of O 0 8.457021749563864e-10
this O 0 6.679302944068155e-11
interaction O 0 1.6979626038526874e-10
in O 0 7.241704458316178e-11
cells O 0 2.2025931079028283e-10
with O 0 2.0517261500874184e-11
a O 0 3.7084386672603387e-09
hypermethylated O 0 1.5815911069694266e-07
DMPK O 0 8.822224799587275e-07
gene O 0 4.435694922477751e-09
. O 0 9.002748768693891e-09
. O 0 2.2676901778595493e-07

The O 0 0.00012573349522426724
hemochromatosis B-Disease 1 1.0
gene O 0 1.6801978119929117e-07
product O 0 4.650563489860815e-09
complexes O 0 2.6544397790928542e-09
with O 0 1.7242116068239e-10
the O 0 7.219205233610637e-09
transferrin O 0 1.0193129895696984e-07
receptor O 0 7.235539722927342e-09
and O 0 1.3159943135221397e-09
lowers O 0 7.810024982290997e-08
its O 0 1.1545584488459326e-09
affinity O 0 1.20577614559636e-09
for O 0 2.0083738838660992e-10
ligand O 0 3.5983274138118304e-09
binding O 0 3.9369595583593764e-08
. O 0 2.612237040011678e-07

We O 0 4.290742197099462e-07
recently O 0 1.2597595855368127e-07
reported O 0 8.830455477948362e-09
the O 0 3.17751203127159e-09
positional O 0 3.9493923509326123e-07
cloning O 0 1.2484574085647182e-07
of O 0 1.7742989300018053e-09
a O 0 6.332929181063207e-10
candidate O 0 3.202097698107309e-09
gene O 0 2.9856014549523024e-08
for O 0 4.728074600279797e-06
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 1 0.9999815225601196
HFE O 0 0.012164817191660404
. O 0 7.576522875751834e-07

The O 0 1.1646761777228676e-07
gene O 0 4.012591647839514e-10
product O 0 1.329488741319551e-10
, O 0 1.573332089610524e-11
a O 0 9.90250381693869e-11
member O 0 8.509543070189807e-10
of O 0 1.504551327968784e-08
the O 0 2.796567741825129e-07
major O 0 1.489924841280299e-07
histocompatibility O 0 6.336438787002407e-07
complex O 0 4.151213062186798e-08
class O 0 2.9537616796915245e-09
I O 0 3.134743664645612e-08
- O 0 5.420027093805402e-09
like O 0 2.7178531647464865e-10
family O 0 1.2798548332249027e-10
, O 0 1.0265319844160459e-11
was O 0 1.7146550845836828e-10
found O 0 3.2833673280219244e-11
to O 0 9.048312099579903e-10
have O 0 6.391406293104751e-10
a O 0 2.0942949596758353e-09
mutation O 0 1.1450361769860251e-09
, O 0 1.4498256761807937e-10
Cys O 0 2.3769315760091558e-07
- O 0 6.054881396266865e-08
282 O 0 1.3377052709984127e-07
- O 0 5.57670546186273e-06
- O 0 3.3792457543313503e-06
> O 0 1.8210856751466054e-06
Tyr O 0 2.2267704480327666e-05
( O 0 4.025145494690463e-11
C282Y O 0 1.2040118235745467e-08
) O 0 3.845744903085979e-12
, O 0 1.4567151738337225e-12
in O 0 7.547519033368477e-12
85 O 0 3.3538369859087425e-09
% O 0 2.3777446678252545e-10
of O 0 1.97143878999384e-09
patient O 0 1.9840614484678554e-08
chromosomes O 0 1.0851192655536579e-07
. O 0 9.610981805963092e-07

This O 0 2.7911420730220016e-08
mutation O 0 9.834695724464382e-09
eliminates O 0 1.6896164467539165e-08
the O 0 2.711935787047537e-09
ability O 0 5.705156347346474e-09
of O 0 1.411196937084469e-08
HFE O 0 9.011197835206985e-05
to O 0 9.910642262411784e-08
associate O 0 1.709501304958394e-07
with O 0 1.811689687158946e-10
beta2 O 0 4.4550666643772274e-05
- O 0 1.121350760513451e-05
microglobulin O 0 0.00013045707601122558
( O 0 9.161293945680882e-10
beta2m O 0 5.74879720716126e-07
) O 0 2.698385126453928e-10
and O 0 2.4412635801773774e-10
prevents O 0 1.0621693524726084e-09
cell O 0 2.1538921757269236e-08
- O 0 9.376910270475491e-08
surface O 0 7.109887434353368e-08
expression O 0 3.525963848005631e-06
. O 0 9.150436994787015e-07

A O 0 8.24931703391485e-06
second O 0 6.924862532287079e-07
mutation O 0 1.788877845854131e-08
that O 0 1.650550390808192e-10
has O 0 1.7270875701802524e-11
no O 0 2.760888566377684e-11
effect O 0 1.1374025055133075e-09
on O 0 4.075932480418487e-08
beta2m O 0 1.6533159623577376e-06
association O 0 4.4486156980383385e-09
, O 0 1.325222848125307e-10
H63D O 0 1.9334935075221438e-07
, O 0 4.860273988827046e-11
was O 0 4.488475702224548e-10
found O 0 1.765129535591381e-11
in O 0 3.872591136655501e-11
eight O 0 2.1453208653987588e-10
out O 0 5.311155681919644e-11
of O 0 9.005006462725618e-11
nine O 0 4.46640807671983e-10
patients O 0 2.26553442672639e-10
heterozygous O 0 1.643382652183334e-09
for O 0 2.6741673320174186e-09
the O 0 5.775735800739312e-08
C282Y O 0 8.7900862126844e-06
mutant O 0 1.1368128980393521e-06
. O 0 1.2089037682017079e-06

In O 0 1.174043262608393e-08
this O 0 3.2652142101241566e-10
report O 0 2.2131461940855246e-10
, O 0 1.2049404009284448e-11
we O 0 4.203970851990313e-11
demonstrate O 0 2.4277340138212367e-09
in O 0 2.395709186586714e-09
cultured O 0 6.171607651594968e-07
293 O 0 7.641732224783482e-08
cells O 0 5.962396443237594e-08
overexpressing O 0 2.597582579255686e-06
wild O 0 9.110384979749142e-08
- O 0 4.2185316573295495e-08
type O 0 9.70078488649051e-08
or O 0 2.59198706942243e-08
mutant O 0 6.368510696574958e-08
HFE O 0 5.13726661210967e-07
proteins O 0 7.860195827547045e-11
that O 0 1.9852321175850562e-11
both O 0 7.775560056932918e-11
the O 0 2.501828744172485e-09
wild O 0 2.2180337566624075e-08
- O 0 3.062512732299183e-08
type O 0 3.7118372375744e-08
and O 0 2.7093934207300663e-08
H63D O 0 8.713013085070997e-05
HFE O 0 2.258435051771812e-05
proteins O 0 1.7336934110545599e-09
form O 0 3.8755859632644274e-10
stable O 0 1.6987774742460715e-08
complexes O 0 5.781494727408187e-10
with O 0 4.8602372126893556e-11
the O 0 3.6219454102592863e-09
transferrin O 0 1.0592691523925168e-07
receptor O 0 3.881076793277316e-09
( O 0 2.962370071468712e-10
TfR O 0 1.224115521836211e-06
) O 0 2.6439750389073424e-09
. O 0 7.034806515093806e-08

The O 0 4.213765805616276e-06
C282Y O 0 3.507406290736981e-05
mutation O 0 4.6983455348481584e-08
nearly O 0 6.424455412101793e-10
completely O 0 2.261369536071811e-09
prevents O 0 1.066894239620808e-09
the O 0 9.538164702505014e-10
association O 0 1.8321337780236036e-09
of O 0 2.1637649449957053e-09
the O 0 3.091680245148609e-09
mutant O 0 2.5267478775958807e-08
HFE O 0 9.497451287643344e-07
protein O 0 1.7079645475703842e-09
with O 0 4.72667877060573e-11
the O 0 1.5475070114234768e-08
TfR O 0 2.2060965420678258e-05
. O 0 5.637035087602271e-07

Studies O 0 2.448550731060095e-07
on O 0 3.2517124992637036e-08
cell O 0 1.8189487249742342e-08
- O 0 1.7637658444868975e-08
associated O 0 6.5960055195546374e-09
transferrin O 0 1.3702667445159022e-07
at O 0 1.2085559220054165e-08
37 O 0 6.1572720255753666e-09
degrees O 0 1.6761902088546776e-07
C O 0 2.952198485672852e-07
suggest O 0 1.201098220882102e-09
that O 0 5.777732112188794e-11
the O 0 1.7221319925653233e-09
overexpressed O 0 5.92358446738217e-07
wild O 0 1.1337214544937524e-07
- O 0 6.509632299867008e-08
type O 0 5.520061563402123e-08
HFE O 0 3.4447978123353096e-06
protein O 0 9.666329958690767e-10
decreases O 0 3.8930111911916754e-10
the O 0 1.1288196766212621e-10
affinity O 0 1.0990994780968322e-09
of O 0 4.9391153389422016e-09
the O 0 1.7224252246705873e-08
TfR O 0 2.6398706722829957e-06
for O 0 1.1773800601133644e-08
transferrin O 0 1.577352350068395e-06
. O 0 4.95204119488335e-07

The O 0 2.1876745449844748e-05
overexpressed O 0 0.0002997383417095989
H63D O 0 6.216664041858166e-05
protein O 0 7.111566446837969e-09
does O 0 2.0011658996565984e-10
not O 0 6.312689954102169e-11
have O 0 1.3761533579348395e-11
this O 0 6.70087726625801e-12
effect O 0 4.294508360036531e-10
, O 0 2.530167915459902e-11
providing O 0 4.382627594168298e-10
the O 0 1.3084576477861987e-10
first O 0 3.605614695700865e-10
direct O 0 8.066683987451029e-10
evidence O 0 5.104437983405319e-10
for O 0 9.894310371016957e-11
a O 0 2.209211286130497e-10
functional O 0 7.903892651484057e-09
consequence O 0 1.1174244640699271e-08
of O 0 2.4545061538816526e-09
the O 0 9.168937609160821e-09
H63D O 0 1.5687364793848246e-05
mutation O 0 6.607731251051518e-08
. O 0 9.404421774661387e-08

Addition O 0 9.683534472060273e-07
of O 0 1.1497391483317188e-07
soluble O 0 2.370457252709457e-07
wild O 0 6.066117208547439e-08
- O 0 4.403495523774836e-08
type O 0 4.793489551957464e-07
HFE O 1 1.0
/ O 1 0.9999955892562866
beta2m O 1 0.7913751006126404
heterodimers O 0 6.966565706534311e-05
to O 0 5.174932198315219e-07
cultured O 0 1.3236852964837453e-06
cells O 0 8.160144915336787e-08
also O 0 6.378229611136987e-10
decreased O 0 2.2574651037388094e-09
the O 0 4.179014079230825e-10
apparent O 0 1.7860676271297393e-09
affinity O 0 3.036447981941137e-09
of O 0 5.738496788865177e-09
the O 0 5.373613554127132e-09
TfR O 0 1.8714914062911703e-07
for O 0 3.76907838273155e-10
its O 0 1.9072828386090812e-11
ligand O 0 5.200033181829156e-10
under O 0 8.508342363988675e-10
steady O 0 6.378756634006777e-09
- O 0 5.705501626707132e-10
state O 0 2.614784604115794e-11
conditions O 0 5.826319426915916e-09
, O 0 7.702948695564871e-11
both O 0 2.923860112358234e-11
in O 0 1.3526524345053303e-10
293 O 0 6.186557377496626e-10
cells O 0 7.956570402534169e-10
and O 0 5.225416765952673e-10
in O 0 1.0588808940781291e-08
HeLa O 0 2.674727966223145e-06
cells O 0 1.4714730411924393e-07
. O 0 3.827896932762087e-07

Furthermore O 0 1.495913153348738e-07
, O 0 8.288909558729074e-10
at O 0 7.233232346415264e-10
4 O 0 2.9360907038977757e-09
degrees O 0 1.6886892240108864e-07
C O 0 1.5538711295448593e-06
, O 0 7.891927666925369e-10
the O 0 5.422405191524149e-09
added O 0 2.6873500758028968e-08
soluble O 0 2.2563986235013545e-08
complex O 0 8.119185324062528e-09
of O 0 1.756534295793699e-08
HFE O 0 0.0005000984529033303
/ O 0 1.1810329851869028e-05
beta2m O 0 3.4027170841000043e-06
inhibited O 0 8.778820159704992e-08
binding O 0 8.176406218751708e-09
of O 0 7.949338964863273e-09
transferrin O 0 6.696992613797192e-07
to O 0 2.629112145768886e-07
HeLa O 0 8.041963155847043e-06
cell O 0 1.868559564854877e-07
TfR O 0 9.812006283027586e-07
in O 0 1.6244225964356929e-09
a O 0 1.9634607273388838e-09
concentration O 0 5.324552532215421e-08
- O 0 2.3528082593315958e-08
dependent O 0 2.012993327582535e-08
manner O 0 1.998996168595113e-07
. O 0 7.259166636686132e-07

Scatchard O 0 0.0006066421046853065
plots O 0 3.9298552678701526e-07
of O 0 7.955683400950875e-08
these O 0 1.2830598805635418e-09
data O 0 1.369846813759068e-08
indicate O 0 1.7461688983644308e-08
that O 0 3.8947642333475585e-10
the O 0 1.26232073682786e-08
added O 0 2.328819270758231e-08
heterodimer O 0 7.1924319833271966e-09
substantially O 0 6.145023156989282e-09
reduced O 0 2.8165105803168444e-09
the O 0 7.29683480304999e-10
affinity O 0 1.725722675871566e-09
of O 0 3.5507865536743566e-09
TfR O 0 5.387921646615723e-07
for O 0 3.2599887234141534e-09
transferrin O 0 3.859524042582052e-07
. O 0 3.3675311783554207e-07

These O 0 5.065358266165276e-08
results O 0 2.4613237670223498e-08
establish O 0 5.823023130346883e-08
a O 0 3.856283736780597e-09
molecular O 0 1.1337967009694694e-08
link O 0 2.1411615591659938e-08
between O 0 5.022349758299072e-10
HFE O 0 0.003204178065061569
and O 0 4.077238813238182e-08
a O 0 5.96722031787067e-08
key O 0 1.6265215663224808e-07
protein O 0 8.153136499267077e-10
involved O 0 2.9090035935652736e-10
in O 0 9.665113154255778e-10
iron O 0 1.2110546094845631e-06
transport O 0 1.5847103895794135e-07
, O 0 8.307000087803829e-10
the O 0 2.351936645439423e-09
TfR O 0 5.047963895776775e-07
, O 0 7.190558565239868e-11
and O 0 2.3151883188354816e-11
raise O 0 1.755431688899023e-09
the O 0 1.3725504066641747e-09
possibility O 0 7.382021216528756e-09
that O 0 8.589048916540776e-11
alterations O 0 2.1730790500384956e-09
in O 0 9.685930946190524e-10
this O 0 1.1722116333157118e-10
regulatory O 0 3.583804919493616e-10
mechanism O 0 8.236323623123099e-09
may O 0 7.039443472578455e-10
play O 0 1.2046751374228393e-09
a O 0 1.5081209892020553e-10
role O 0 2.2939498911522804e-10
in O 0 2.1956177154169865e-10
the O 0 1.66180957883455e-09
pathogenesis O 0 0.00027300024521537125
of O 0 8.813983072286646e-07
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 3.4246408176841214e-05
. O 0 1.664802766754292e-07

Genomic O 0 1.1694363877268188e-07
organization O 0 4.5549541916045655e-09
of O 0 1.590268028373032e-09
the O 0 1.637860336245467e-08
UBE3A O 0 0.00022916340094525367
/ O 0 1.2947648428962566e-05
E6 O 0 1.2506302482506726e-06
- O 0 1.999407231778605e-06
AP O 0 2.283261164848227e-05
gene O 0 4.7914117118352806e-09
and O 0 4.833135558435231e-10
related O 0 7.956104219886129e-09
pseudogenes O 0 7.188161816884531e-07
. O 0 4.0989709759742254e-07

The O 0 6.63318814986269e-07
UBE3A O 0 8.231801075453404e-06
gene O 0 1.1524028842302414e-08
encodes O 0 1.376438185651807e-09
the O 0 2.3769477497381786e-09
E6 O 0 5.9374301031311916e-08
- O 0 1.9576472709559312e-07
AP O 0 3.3320470720354933e-06
ubiquitin O 0 5.4121556125608095e-09
- O 0 3.4185771990991043e-09
protein O 0 1.5392100094491212e-10
ligase O 0 6.769482752133626e-10
and O 0 2.7082538989198213e-10
has O 0 4.836489195247928e-11
recently O 0 1.336269012108815e-10
been O 0 8.248310368053069e-11
shown O 0 1.889353951067818e-10
to O 0 2.2076865335840523e-10
be O 0 1.581993147592442e-10
mutated O 0 1.0350820645044223e-08
in O 0 1.6798468038814462e-07
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 5.5225432333827484e-06
who O 0 8.305304777245226e-10
lack O 0 8.490838254715527e-09
15q11 O 0 1.3844756949765724e-06
- O 0 3.5006235066248337e-07
q13 O 0 5.0926119001815096e-06
deletions O 0 1.662194648588411e-07
or O 0 9.394468314383175e-09
chromosome O 0 8.306436427574226e-08
15 O 0 6.498009383903991e-07
paternal O 0 0.0029574499931186438
uniparental B-Disease 1 0.9999387264251709
disomy I-Disease 0 0.049346599727869034
. O 0 1.378826164000202e-05

Previous O 0 7.465774615411647e-06
UBE3A O 0 3.534438292263076e-05
cDNA O 0 2.8470998358898214e-07
analysis O 0 1.4540256110251448e-08
has O 0 8.504946746867859e-11
shown O 0 1.1240714609117575e-10
a O 0 2.5212379406447383e-10
coding O 0 2.2396164922611206e-08
region O 0 2.502783091884453e-09
of O 0 1.7688385200997914e-09
approximately O 0 2.3310789409869415e-10
2 O 0 3.5018778987705446e-08
. O 0 1.2672497007315542e-07

6 O 0 3.6040621580468724e-06
kb O 0 4.115639967494644e-06
and O 0 4.597794589500381e-09
a O 0 6.157999887790311e-09
3 O 0 4.461355374019149e-08
- O 0 3.267542183493788e-07
untranslated O 0 4.838484528590925e-05
region O 0 4.9707214344607564e-08
( O 0 2.0738662176444933e-10
UTR O 0 9.489502872384037e-07
) O 0 6.270093333426985e-10
of O 0 2.115997155271998e-09
< O 0 1.5661061070204596e-07
50 O 0 4.393847774508686e-08
bp O 0 1.2193689613582137e-08
, O 0 7.345117569723669e-11
whereas O 0 5.928054713777442e-10
Northern O 0 7.414401870242671e-10
analysis O 0 5.038949812963267e-10
has O 0 1.3564625984952006e-11
indicated O 0 3.972897705262213e-11
mRNA O 0 4.032968750622423e-11
sizes O 0 5.782100909179633e-10
of O 0 4.748358928274854e-10
5 O 0 1.1931779120288866e-08
- O 0 2.0726550076233252e-07
8 O 0 6.219786428118823e-07
kb O 0 5.585135659202933e-05
. O 0 2.083981371470145e-06

We O 0 1.870625737865339e-06
have O 0 6.710697775247354e-09
analyzed O 0 1.8251764544174875e-08
additional O 0 1.2267125093501363e-08
cDNA O 0 2.04935588499211e-07
clones O 0 3.861828190565575e-08
and O 0 9.281437840513718e-10
provide O 0 3.320458796807202e-09
evidence O 0 8.489602909556027e-10
for O 0 1.5179155155031765e-10
an O 0 7.159398074385592e-11
additional O 0 2.489243700054544e-09
0 O 0 9.274209133991462e-08
. O 0 1.7783612804578297e-07

5 O 0 9.61182422543061e-07
kb O 0 2.0684503851953195e-06
of O 0 6.751217540568177e-08
5 O 0 1.0910402181707468e-07
- O 0 1.5104160411283374e-07
UTR O 0 5.982639322610339e-06
and O 0 5.303832040226553e-09
> O 0 5.2713499343326475e-08
2 O 0 1.5540765119226307e-08
kb O 0 3.854819112802943e-07
of O 0 1.913505442985297e-08
3 O 0 5.0038727295032e-07
- O 0 1.9198264453734737e-06
UTR O 0 0.00034047753433696926
. O 0 5.403243449109141e-06

We O 0 1.1340760863731703e-07
have O 0 4.922851570832165e-10
established O 0 1.4256431590808916e-09
the O 0 8.428100439772379e-10
genomic O 0 8.32594260202768e-09
organization O 0 2.184598946186611e-09
of O 0 1.3276294508202113e-09
UBE3A O 0 7.029199196040281e-07
and O 0 9.504822484629472e-10
the O 0 9.454092619876064e-09
sequence O 0 3.1499234331988646e-09
of O 0 2.0693834201779282e-08
intron O 0 1.0958533493976574e-06
- O 0 4.347257345216349e-07
exon O 0 6.470021389759495e-07
borders O 0 1.4470154496848409e-07
. O 0 4.143390697208815e-07

We O 0 1.0095783409269643e-06
have O 0 1.12143219155314e-08
also O 0 3.698118922201843e-09
mapped O 0 1.5960820221039285e-08
two O 0 1.3919196906186926e-09
highly O 0 7.975688554040516e-09
homologous O 0 2.7287834214462237e-09
processed O 0 1.0373213399361703e-08
pseudogenes O 0 4.352342841684731e-08
, O 0 6.939672170247491e-10
UBE3AP1 O 0 6.668861374237167e-08
and O 0 3.7343728109817675e-10
UBE3AP2 O 0 5.515951215784298e-07
, O 0 1.8209948826619637e-10
to O 0 5.998481711344539e-10
chromosomes O 0 9.517679006032509e-11
2 O 0 3.5190489411363046e-10
and O 0 6.68059010888733e-11
21 O 0 5.047455342577223e-09
, O 0 1.9839535569943223e-10
respectively O 0 2.7921256418039775e-09
, O 0 1.2055179077208322e-10
and O 0 2.5901791128601914e-11
determined O 0 6.966288657039854e-10
their O 0 1.3624250616572908e-09
genomic O 0 1.47330126765155e-07
organization O 0 7.148532432665888e-08
. O 0 2.672351513410831e-07

These O 0 4.447201362722808e-08
results O 0 2.887584171773483e-09
will O 0 2.486205408214204e-10
form O 0 2.2777084038305695e-11
the O 0 9.654348848142646e-11
basis O 0 1.919846365217026e-10
for O 0 2.5563334435374507e-11
studies O 0 2.5501450950926596e-10
of O 0 2.4909713181031634e-10
mutation O 0 3.41827538496986e-10
and O 0 4.421400745524551e-10
imprinting O 0 1.408061507390812e-06
of O 0 1.242642156285001e-06
UBE3A O 0 0.0010936319595202804
. O 0 7.570003617729526e-06

Mutation O 0 2.6535863071330823e-06
spectrum O 0 4.5708307538916415e-07
and O 0 6.473994229594382e-09
genotype O 0 7.326413538066845e-07
- O 0 1.2394406212479225e-06
phenotype O 0 1.4701952011364483e-07
analyses O 0 2.3247718416996577e-08
in O 0 6.248582984369477e-09
Cowden B-Disease 0 0.00033703152439557016
disease I-Disease 0 2.5193182295879524e-07
and O 0 1.3344867433318086e-09
Bannayan B-Disease 1 0.9999997615814209
- I-Disease 1 1.0
Zonana I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 5.769104749475673e-09
two O 0 5.13243980648781e-09
hamartoma B-Disease 0 0.0005532991490326822
syndromes I-Disease 0 8.148282176989596e-06
with O 0 2.232106588451188e-08
germline O 1 0.9993163347244263
PTEN O 0 0.03936879336833954
mutation O 0 1.618299165784265e-06
. O 0 4.3557150775086484e-07

The O 0 1.1763139809772838e-05
tumour B-Disease 1 1.0
suppressor O 0 0.0002727037062868476
gene O 0 1.1498951835164917e-06
PTEN O 0 4.964599611412268e-06
, O 0 1.5258990737621048e-09
which O 0 3.0918070187402336e-11
maps O 0 4.602620506943822e-09
to O 0 1.8690295533474455e-08
10q23 O 0 1.0183477570535615e-05
. O 0 3.950130746943614e-07

3 O 0 1.5100228267783677e-07
and O 0 1.6407517566818797e-09
encodes O 0 8.839837195573352e-10
a O 0 9.32436017286875e-10
403 O 0 1.2333889465310222e-09
amino O 0 7.63731022868086e-10
acid O 0 1.883428746296545e-09
dual O 0 6.902057236857218e-08
specificity O 0 6.1092185887901e-07
phosphatase O 0 0.0003195689641870558
( O 0 8.763072933959393e-09
protein O 0 2.1951008122300664e-08
tyrosine O 0 3.30106182389045e-08
phosphatase O 0 8.72811440899568e-08
; O 0 8.998327777343107e-11
PTPase O 0 5.329622965177805e-08
) O 0 1.8904667761776572e-11
, O 0 1.0493252967924693e-11
was O 0 5.149754511712956e-10
shown O 0 4.54199067245753e-10
recently O 0 9.899620012632226e-10
to O 0 1.894233214727592e-09
play O 0 5.5234636420209426e-08
a O 0 8.654573058208825e-09
broad O 0 5.76582648292856e-09
role O 0 9.413893664600437e-09
in O 0 1.0799713123788024e-08
human O 0 4.324753888340638e-08
malignancy B-Disease 0 2.1111756723257713e-05
. O 0 2.6717603418546787e-07

Somatic O 0 0.0008537006797268987
PTEN O 0 0.0003050428058486432
deletions O 0 1.579500462867145e-06
and O 0 7.3549806245409854e-09
mutations O 0 2.5290849414716376e-09
were O 0 9.571989867396269e-10
observed O 0 5.344520381811435e-10
in O 0 3.344266530369566e-10
sporadic B-Disease 0 4.4904666651746084e-07
breast I-Disease 0 0.19701135158538818
, I-Disease 0 6.410250108501714e-08
brain I-Disease 1 0.9999996423721313
, I-Disease 0 4.485810052301531e-07
prostate I-Disease 1 1.0
and I-Disease 1 0.999724805355072
kidney I-Disease 1 1.0
cancer I-Disease 0 0.0827661007642746
cell O 0 5.424114419838588e-07
lines O 0 2.963128631350287e-09
and O 0 1.5408792020110695e-09
in O 0 8.938040529926639e-09
several O 0 3.05363356822852e-09
primary O 0 2.3687216810230893e-07
tumours B-Disease 1 1.0
such O 0 1.4346810850440761e-08
as O 0 2.105188968926086e-06
endometrial B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 0 0.0002512830833438784
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 0.9575838446617126
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 1 0.9955529570579529

In O 0 8.077761748381818e-08
addition O 0 3.3561679657623245e-08
, O 0 7.754358932743344e-09
PTEN O 0 4.333301603764994e-06
was O 0 7.343699337525322e-08
identified O 0 6.912910688328111e-09
as O 0 8.706075305120464e-10
the O 0 5.593375762558139e-10
susceptibility O 0 8.358812531028548e-10
gene O 0 1.8113474609116054e-10
for O 0 1.1747325334710013e-09
two O 0 3.707054219148631e-08
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
Cowden B-Disease 1 1.0
disease I-Disease 1 0.9998843669891357
( O 0 3.189829650418474e-11
CD B-Disease 0 3.9539298768431763e-07
; O 0 2.7535866919947694e-09
MIM O 0 5.94031826040009e-06
158350 O 0 4.590541493598721e-07
) O 0 2.48368409172528e-10
and O 0 5.017237181270673e-10
Bannayan B-Disease 0 1.5473997336812317e-05
- I-Disease 0 8.27143776405137e-06
Zonana I-Disease 0 0.022056153044104576
( I-Disease 0 3.9887706471120055e-09
BZS I-Disease 0 5.140317625773605e-06
) I-Disease 0 6.520263218234845e-10
or I-Disease 0 5.382894685546091e-10
Ruvalcaba I-Disease 0 1.9686531231855042e-06
- I-Disease 0 8.085335707619379e-07
Riley I-Disease 0 4.7631470806663856e-05
- I-Disease 1 0.9999997615814209
Smith I-Disease 1 0.9999380111694336
syndrome I-Disease 1 1.0
( O 0 2.4537209597497167e-08
MIM O 0 0.00018764118431136012
153480 O 0 6.85677514411509e-06
) O 0 4.795342789520873e-09
. O 0 4.523839081116421e-08

Constitutive O 0 1.386287067361991e-06
DNA O 0 1.658954573713345e-07
from O 0 6.157671261775022e-09
37 O 0 1.4149891924830627e-08
CD B-Disease 0 7.95577193457575e-07
families O 0 5.524669610679211e-10
and O 0 3.3731198390007933e-10
seven O 0 3.1137541434134164e-09
BZS B-Disease 0 1.6984232615868677e-06
families O 0 2.1697149632515789e-10
was O 0 3.3011480216060818e-09
screened O 0 3.465214959419427e-08
for O 0 1.1602925553688692e-07
germline O 0 0.00011362160148564726
PTEN O 0 0.00013529611169360578
mutations O 0 1.990446435229387e-06
. O 0 1.4683640756629757e-06

PTEN O 0 0.0001035577297443524
mutations O 0 4.555947086259948e-08
were O 0 2.3915911473437745e-09
identified O 0 1.1332210725356617e-09
in O 0 2.5759419597370936e-10
30 O 0 1.9030885312076862e-08
of O 0 6.237699246014472e-09
37 O 0 1.0341452139073226e-07
( O 0 1.0138384576308113e-09
81 O 0 5.563334681824017e-08
% O 0 2.445098845615945e-10
) O 0 3.845101320676392e-11
CD B-Disease 0 1.4372780299254373e-07
families O 0 2.9219271446834227e-10
, O 0 5.512340930935444e-11
including O 0 3.0215982493864146e-10
missense O 0 1.5122812158097076e-07
and O 0 8.596400036253726e-09
nonsense O 0 1.8668225720830378e-06
point O 0 4.2941687183883914e-07
mutations O 0 1.4585670449207555e-08
, O 0 9.94282101096644e-10
deletions O 0 2.2236291030708344e-08
, O 0 1.0224684432458275e-09
insertions O 0 1.933762128203398e-08
, O 0 8.438105214558789e-10
a O 0 9.050836524693295e-09
deletion O 0 8.059937499638181e-07
/ O 0 5.566854270000476e-06
insertion O 0 6.217491090865224e-07
and O 0 2.68302251527075e-08
splice O 0 2.5800954972510226e-06
site O 0 6.638947525061667e-07
mutations O 0 7.947841851319026e-08
. O 0 2.2881934569340956e-07

These O 0 1.7238878768921495e-08
mutations O 0 3.783066748752617e-09
were O 0 1.1950812561778434e-09
scattered O 0 6.987886935760912e-10
over O 0 2.07999062418196e-10
the O 0 1.9143990837022784e-09
entire O 0 2.789309894168923e-09
length O 0 6.042926603555543e-09
of O 0 5.705156347346474e-09
PTEN O 0 1.3175765900541592e-07
, O 0 7.959147230174324e-11
with O 0 2.9314081544107307e-12
the O 0 1.5301621081320604e-10
exception O 0 3.1672178768538117e-10
of O 0 4.794021082887845e-11
the O 0 7.205716578972954e-11
first O 0 6.118962003753836e-10
, O 0 6.3760739743568e-11
fourth O 0 4.588630808655125e-09
and O 0 6.01014071843764e-10
last O 0 3.317573771255411e-08
exons O 0 9.487656598139438e-07
. O 0 4.5281205984792905e-07

A O 0 8.082929525699e-06
hot O 0 1.4172779629006982e-05
spot O 0 9.683202506494126e-07
for O 0 1.609705257976657e-08
PTEN O 0 3.820933670795057e-06
mutation O 0 9.527369115858164e-09
in O 0 8.376624394124121e-10
CD B-Disease 0 2.77473031928821e-06
was O 0 5.2671087047428955e-08
identified O 0 9.255085586801215e-09
in O 0 1.7861562229271044e-09
exon O 0 6.057838675133098e-08
5 O 0 1.389673531804192e-08
that O 0 1.295927254396645e-10
contains O 0 2.6174007405899147e-10
the O 0 5.091593258121918e-10
PTPase O 0 1.8234267429306783e-07
core O 0 8.45549319450356e-09
motif O 0 2.8368943305601135e-10
, O 0 2.996463320525944e-12
with O 0 4.880511142793531e-13
13 O 0 5.298793626096199e-10
of O 0 1.4351948518509516e-09
30 O 0 3.9791828498891846e-08
( O 0 4.157897082190942e-10
43 O 0 1.0455349475080311e-08
% O 0 3.0336619327719916e-10
) O 0 9.074335727277116e-11
CD B-Disease 0 4.872733825322939e-07
mutations O 0 8.04598965231662e-09
identified O 0 5.574622985449196e-09
in O 0 2.11249684411996e-09
this O 0 9.717170179612822e-09
exon O 0 9.529097155791533e-07
. O 0 5.395552875597787e-07

Seven O 0 1.8661499723293673e-07
of O 0 6.826016196725959e-09
30 O 0 3.7106335781800226e-08
( O 0 2.698704315573508e-10
23 O 0 8.940154394565525e-09
% O 0 1.2825061845855856e-10
) O 0 2.3053572939524258e-11
were O 0 7.605790303122362e-11
within O 0 1.4965616246254143e-10
the O 0 3.1779651132879394e-10
core O 0 1.0176124387584196e-09
motif O 0 4.470789294330757e-10
, O 0 1.557483655934e-11
the O 0 4.7024172750154136e-11
majority O 0 7.130094691748523e-12
( O 0 7.69987545945483e-12
five O 0 5.652380299925319e-11
of O 0 5.035469263781067e-11
seven O 0 4.4987413100328055e-11
) O 0 2.4552060037819068e-11
of O 0 8.56836684937079e-11
which O 0 3.1674642075874004e-11
were O 0 1.842946240060428e-09
missense O 0 1.0246520787404734e-07
mutations O 0 5.4997544296497836e-09
, O 0 3.442589269209151e-10
possibly O 0 2.1397163152414578e-08
pointing O 0 1.92951432609334e-08
to O 0 9.132232747788294e-09
the O 0 4.6630965755412035e-09
functional O 0 2.246705932407167e-08
significance O 0 2.4885993710199728e-08
of O 0 1.2247830527556403e-09
this O 0 1.7754558934157672e-10
region O 0 6.4101501884294976e-09
. O 0 7.215077602040765e-08

Germline O 0 0.014182948507368565
PTEN O 0 2.732722532527987e-05
mutations O 0 9.817696877689741e-09
were O 0 6.725711654276267e-10
identified O 0 4.328570279987787e-10
in O 0 1.798242527106808e-10
four O 0 1.0350638124378975e-09
of O 0 3.0240216997157177e-09
seven O 0 5.9697113918844025e-09
( O 0 3.504961598732592e-10
57 O 0 6.743431413269718e-08
% O 0 3.0569902165211715e-09
) O 0 1.7524709461369525e-09
BZS B-Disease 0 1.1006010936398525e-05
families O 0 1.8420254210838038e-09
studied O 0 2.700890888718277e-07
. O 0 9.636449931349489e-07

Interestingly O 0 1.0942806056846166e-06
, O 0 4.754333371437269e-09
none O 0 7.004397062360113e-09
of O 0 1.0706103781288334e-09
these O 0 1.7795039053414285e-10
mutations O 0 9.580922721852403e-10
was O 0 9.383239962801326e-09
observed O 0 6.282834252857583e-09
in O 0 8.298926879035662e-09
the O 0 1.3223652217675408e-07
PTPase O 0 9.943956683855504e-06
core O 0 8.463069889330654e-07
motif O 0 4.351878146735544e-07
. O 0 2.748242309280613e-07

It O 0 3.273823523386454e-08
is O 0 3.1894054064451893e-10
also O 0 4.9705902588348394e-11
worthy O 0 2.9815765412166684e-09
of O 0 1.568883578606517e-09
note O 0 1.0367259939414453e-08
that O 0 5.965652971617885e-11
a O 0 5.462492125296592e-10
single O 0 3.836138962043378e-09
nonsense O 0 4.6120607777311307e-08
point O 0 6.447512301832603e-09
mutation O 0 1.3019729738772412e-09
, O 0 6.883076747454808e-11
R233X O 0 3.628785805176449e-08
, O 0 1.0711735665136501e-10
was O 0 7.536938295693574e-10
observed O 0 5.056944862857904e-10
in O 0 4.579072399035766e-10
the O 0 4.06007849562684e-09
germline O 0 2.6764732297124283e-07
DNA O 0 1.2997928067193243e-08
from O 0 1.999408194564012e-09
two O 0 1.2051155906522837e-10
unrelated O 0 3.6936900760231595e-10
CD B-Disease 0 1.9097251424682327e-07
families O 0 5.254207485760887e-11
and O 0 1.3356574180001246e-10
one O 0 2.8096536208721545e-09
BZS B-Disease 0 0.00012847028847318143
family O 0 1.1957766332670872e-07
. O 0 4.258882597696356e-07

Genotype O 0 4.999387783755083e-06
- O 0 1.4541054724759306e-06
phenotype O 0 2.3554665773417582e-08
studies O 0 2.1318855569774087e-09
were O 0 1.707667340866692e-10
not O 0 5.0345571461773986e-11
performed O 0 1.3171443935533489e-09
on O 0 1.1994207405052748e-08
this O 0 1.0235416958437327e-09
small O 0 1.2976295593603027e-09
group O 0 6.923014383986015e-10
of O 0 3.991472485864733e-09
BZS B-Disease 0 4.202091440674849e-05
families O 0 3.296059603030699e-08
. O 0 4.0694547465136566e-07

However O 0 8.87479956190873e-08
, O 0 1.79471404404552e-09
genotype O 0 3.148285188103728e-08
- O 0 9.438060999400477e-08
phenotype O 0 6.346672165591372e-08
analysis O 0 7.319448158682462e-09
inthe O 0 2.9248528221614833e-07
group O 0 2.1475807243653833e-10
of O 0 3.0880600854210627e-10
CD B-Disease 0 1.0127884706889745e-05
families O 0 3.1070368500252243e-10
revealed O 0 7.092165188460342e-10
two O 0 2.3580295702152476e-11
possible O 0 4.3089407042451455e-10
associations O 0 7.993316425425334e-11
worthy O 0 2.407841037666003e-08
of O 0 1.281857020529742e-08
follow O 0 2.000702359339357e-08
- O 0 2.6018984300435477e-08
up O 0 1.6056384000151525e-09
in O 0 9.299814807128826e-10
independent O 0 1.77627657027557e-09
analyses O 0 4.2001062183771865e-08
. O 0 2.2722579728906567e-07

The O 0 1.7710684119265352e-07
first O 0 4.2390187360297205e-08
was O 0 2.09688213459458e-08
an O 0 3.4123995296120313e-10
association O 0 2.217417915950648e-10
noted O 0 5.801122915372048e-10
in O 0 6.015749010046534e-10
the O 0 7.553463632348212e-09
group O 0 1.0107371190004599e-10
of O 0 1.5869132397039465e-10
CD B-Disease 0 1.7168744079754106e-06
families O 0 1.1095911967018424e-09
with O 0 2.9539306556358724e-09
breast B-Disease 1 0.9999985694885254
disease I-Disease 1 0.9400452971458435
. O 0 1.3059107004664838e-05

A O 0 3.0231583991735533e-07
correlation O 0 7.255994027843826e-09
was O 0 3.0913678283894797e-09
observed O 0 5.807034852978177e-10
between O 0 2.385192911236178e-11
the O 0 6.696769805358826e-10
presence O 0 5.529742885812539e-09
/ O 0 8.498304850945715e-06
absence O 0 1.8624054973770399e-06
of O 0 1.9808927831377332e-08
a O 0 2.123802111952955e-08
PTEN O 0 1.2615223567991052e-06
mutation O 0 1.2948233596432601e-09
and O 0 1.1176493064368742e-10
the O 0 9.240440079771872e-10
type O 0 5.74933487484941e-08
of O 0 3.998240671876374e-08
breast O 0 0.00013317876437213272
involvement O 0 2.3834144258216838e-07
( O 0 4.269298692349821e-09
unaffected O 0 1.4429805560212117e-05
versus O 1 0.9854884743690491
benign O 1 0.9999754428863525
versus O 0 3.77792093786411e-05
malignant O 0 1.8126353324987576e-06
) O 0 5.329365837525302e-09
. O 0 1.1930781340652175e-07

Specifically O 0 5.79489153551549e-07
and O 0 7.490562614620444e-10
more O 0 1.49785739367303e-11
directly O 0 5.118953178007146e-11
, O 0 1.7354881420850177e-11
an O 0 3.345936722132237e-11
association O 0 1.6237587663336939e-10
was O 0 3.350026922532834e-09
also O 0 7.558701581311666e-11
observed O 0 7.720820510703774e-11
between O 0 2.2021581606856966e-12
the O 0 1.2208734023744228e-10
presence O 0 2.830867762426692e-10
of O 0 4.633818051491545e-10
a O 0 6.721650347429886e-09
PTEN O 0 0.00011413631000323221
mutation O 0 2.0880752344965003e-06
and O 0 9.59783079679255e-08
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 1 0.985072672367096
. O 0 1.3885285170545103e-06

Secondly O 0 3.5040009151998674e-06
, O 0 9.593709826560826e-09
there O 0 2.1820285855955746e-10
appeared O 0 1.0749918288865956e-08
to O 0 2.9851956462323415e-09
be O 0 8.122158945411684e-09
an O 0 2.497089868214175e-09
interdependent O 0 4.2787493725882086e-07
association O 0 2.7174570149668398e-08
between O 0 1.0831517904819066e-09
mutations O 0 1.3535518483820397e-08
upstream O 0 1.5626091531828479e-09
and O 0 2.335244220219579e-10
within O 0 1.8246778532571284e-09
the O 0 9.256391209078174e-09
PTPase O 0 3.81298775664618e-07
core O 0 4.793187713403313e-08
motif O 0 2.7027816429381346e-08
, O 0 5.870623986936607e-10
the O 0 1.9716981380923926e-09
core O 0 1.2583686981315623e-08
motif O 0 1.175746344728168e-08
containing O 0 1.1567427016245801e-09
the O 0 3.4498720546949357e-10
majority O 0 1.428282492277333e-10
of O 0 5.088294674493454e-09
missense O 0 5.71589794162719e-07
mutations O 0 2.3226046863555894e-08
, O 0 4.775151385416621e-10
and O 0 2.1808718719817932e-10
the O 0 9.824331215213533e-08
involvement O 0 1.5673773305024952e-05
of O 0 0.00024967253557406366
all O 0 6.925503726051829e-08
major O 0 1.6661940094309102e-07
organ O 1 0.9634168148040771
systems O 1 0.9738785624504089
( O 0 2.2299236235312492e-08
central O 1 1.0
nervous O 1 0.9999996423721313
system O 1 0.9999963045120239
, O 0 5.3436185254440716e-08
thyroid O 0 1.6453459465992637e-05
, O 0 8.707027099319475e-09
breast O 0 0.00031964885420165956
, O 0 1.8847779870156955e-07
skin O 1 0.9999909400939941
and O 0 2.9023949537076987e-06
gastrointestinal O 1 0.9999468326568604
tract O 0 8.266658369393554e-06
) O 0 4.909080253412412e-09
. O 0 1.4851242724489566e-07

However O 0 1.9467003653517168e-07
, O 0 6.715444866856046e-10
these O 0 5.985016648946129e-11
observations O 0 1.5370954509208445e-09
would O 0 3.15703130304712e-10
need O 0 1.347194578116273e-09
to O 0 1.2961379747267188e-09
be O 0 1.8084900244019764e-09
confirmed O 0 2.8707414223561045e-09
by O 0 1.5303663891685915e-10
studying O 0 8.852936161929392e-09
a O 0 4.945164833181082e-10
larger O 0 6.644132466426811e-11
number O 0 2.2876842087349303e-10
of O 0 1.8483208019670627e-10
CD B-Disease 0 7.003237669778173e-07
families O 0 2.6522890550495504e-09
. O 0 7.202565655006765e-08

Molecular O 0 0.0001877075555967167
defects O 1 0.8442020416259766
leading O 0 3.545814877270459e-07
to O 0 4.580148704746989e-09
human O 0 9.774306919396736e-10
complement B-Disease 0 9.27443579712417e-07
component I-Disease 1 1.0
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 6.647358663514069e-09
an O 0 4.3957543160999535e-10
African O 0 1.4324416319766442e-08
- O 0 1.5744781478588266e-08
American O 0 2.6292818589013223e-08
family O 0 6.8494787619499675e-09
. O 0 2.491895578771164e-08

Complement B-Disease 0 1.036597382153559e-06
component I-Disease 1 0.999990701675415
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 2.556846678825053e-10
C6D B-Disease 0 1.6322522355949332e-07
) O 0 3.027273223765725e-11
was O 0 1.6763901378169521e-09
diagnosed O 0 4.8322647216991754e-08
in O 0 6.37347508103403e-10
a O 0 6.533060759039699e-10
16 O 0 2.349904160148242e-10
- O 0 1.360583173903862e-10
year O 0 1.9198866108016688e-10
- O 0 2.2035941960041328e-09
old O 0 1.4678690263281169e-08
African O 0 8.808569873508532e-09
- O 0 1.4979132378911686e-09
American O 0 3.5055233715830525e-10
male O 0 1.8605979257291239e-10
with O 0 4.519700932958948e-11
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 3.0742006629225216e-07

The O 0 5.061050600829731e-08
patients O 0 1.1363167295996845e-08
father O 0 5.495633725871585e-09
and O 0 1.2979365360266115e-09
two O 0 1.4626029276598729e-09
brothers O 0 2.443840969590383e-07
also O 0 7.754805864124137e-08
had O 0 4.6376602114150955e-08
C6D B-Disease 0 3.2741398172220215e-05
, O 0 5.467151731330944e-10
but O 0 2.3018742467684206e-10
gave O 0 5.634464006476492e-09
no O 0 2.0692285662704535e-09
history O 0 4.162898026294215e-09
of O 0 4.20843582205066e-09
meningitis B-Disease 1 1.0
or O 0 2.0552808344120876e-09
other O 0 1.901919066682467e-09
neisserial B-Disease 0 1.0549523722147569e-05
infection I-Disease 0 6.962919769648579e-07
. O 0 8.357035596873175e-08

By O 0 8.430773412726467e-09
using O 0 3.4961169514957646e-09
exon O 0 9.53940659798036e-09
- O 0 4.186115898363596e-09
specific O 0 9.095567632400048e-10
polymerase O 0 3.7300251776173354e-09
chain O 0 3.11175929468277e-09
reaction O 0 4.041217360750693e-10
( O 0 2.758262195035055e-11
PCR O 0 5.667132096931482e-09
) O 0 4.510580797756347e-11
/ O 0 2.7128825852429372e-09
single O 0 2.0722934479522337e-09
- O 0 9.273934953313301e-10
strand O 0 1.0761113111712461e-09
conformation O 0 6.165471466701433e-10
polymorphism O 0 1.8179002747586992e-09
as O 0 1.148452027921465e-10
a O 0 2.8512737310082414e-11
screening O 0 1.7184037526263296e-10
step O 0 8.371193738199167e-10
and O 0 2.100100995883203e-11
nucleotide O 0 3.6932815139500974e-10
sequencing O 0 1.4203207499008386e-09
of O 0 1.6261368918080166e-09
target O 0 8.486078506564354e-09
exons O 0 4.083579696612105e-09
, O 0 9.385307114806452e-11
we O 0 1.572855873321899e-10
determined O 0 5.845953165994899e-10
that O 0 6.903667221225263e-11
the O 0 1.12062337187524e-09
proband O 0 4.053365216805105e-07
was O 0 2.776074303767473e-08
a O 0 1.5925598617627656e-09
compound O 0 8.532333062305497e-09
heterozygote O 0 2.168848389771938e-08
for O 0 6.638093408284362e-10
two O 0 4.6441525625162683e-10
C6 O 0 6.680918886559084e-06
gene O 0 4.823534993647627e-08
mutations O 0 1.503243822753575e-07
. O 0 1.071710016731231e-06

The O 0 3.75442795075287e-07
first O 0 4.862330627020128e-08
, O 0 2.999451242935436e-10
1195delC O 0 9.850539939293412e-09
located O 0 2.3280398442349082e-10
in O 0 3.404948822893772e-10
exon O 0 3.2701411356583776e-08
7 O 0 7.886548303304153e-08
, O 0 7.49102002650659e-10
is O 0 3.2662032800612195e-11
a O 0 1.810997705964379e-11
novel O 0 5.190300272905901e-11
mutation O 0 3.7892591842059176e-11
, O 0 2.7620987094745253e-12
while O 0 8.588536999643015e-12
the O 0 1.459678766746464e-10
second O 0 1.147900774434163e-09
, O 0 4.7653769819078207e-11
1936delG O 0 3.279884586149251e-09
in O 0 2.7458862961182717e-10
exon O 0 1.8887252650756636e-08
12 O 0 1.0730436983408254e-08
, O 0 3.4073263655010066e-10
has O 0 2.7483265663263978e-11
been O 0 2.337275338548661e-11
described O 0 3.652250377128574e-11
before O 0 4.895369665192106e-10
to O 0 3.1770333031033715e-09
cause O 0 5.611437536856556e-09
C6D B-Disease 0 7.370304047071841e-07
in O 0 9.758770458390131e-10
an O 0 1.367581881073221e-10
unrelated O 0 3.2489024803794564e-09
African O 0 5.805002700753903e-08
- O 0 2.407299071194302e-08
American O 0 1.6843328509708044e-08
individual O 0 8.047965627255849e-10
. O 0 3.3760066742161143e-08

Both O 0 1.4487193311651936e-07
mutations O 0 1.3952882405021683e-08
result O 0 1.696497053949031e-09
in O 0 5.2229980340712245e-09
premature O 0 4.583079089570674e-07
termination O 0 3.831235062534688e-07
codons O 0 5.763838544226019e-07
and O 0 5.53685914894686e-08
C6 O 0 6.946636858629063e-05
null O 0 5.038868039264344e-06
alleles O 0 3.9678985785940313e-07
. O 0 6.199574045240297e-07

Allele O 0 4.5950531557537033e-07
- O 0 1.896471957252288e-08
specific O 0 2.0787858101556367e-09
PCR O 0 1.0243081760563655e-07
indicated O 0 4.93017404679108e-09
that O 0 2.5663041136603226e-11
the O 0 4.2252595866543174e-10
probands O 0 7.156882020353805e-08
two O 0 5.587180718080731e-10
brothers O 0 2.1127114280261594e-08
also O 0 1.1934663257662237e-09
inherited O 0 2.7501554811237838e-08
the O 0 3.874422205285555e-08
1195delC O 0 2.981043678573769e-08
mutation O 0 2.757343242620891e-10
from O 0 5.053808413424399e-11
their O 0 1.0157915619757318e-09
heterozygous O 0 1.006732386343856e-08
mother O 0 2.2721695636107597e-09
and O 0 6.787130302221556e-10
the O 0 3.578785934266193e-09
1936delG O 0 1.2773613278227458e-08
mutation O 0 2.1033771946399327e-10
from O 0 7.780811411839395e-11
their O 0 9.379389487307321e-10
homozygous O 0 4.848763168752157e-08
father O 0 6.698794408066533e-08
. O 0 2.389421993598262e-08
. O 0 1.7411628050467698e-07

PAX6 O 0 0.0009107578080147505
mutations O 0 2.25030566980422e-06
reviewed O 0 1.0197256415267475e-05
. O 0 5.0890871534647886e-06

Mutations O 0 7.927884553282638e-07
in O 0 3.500208478612876e-08
PAX6 O 0 8.404641448578332e-06
are O 0 4.5519296665297304e-10
responsible O 0 9.240757603556915e-10
for O 0 3.2699400964730785e-09
human O 0 1.4143206783501228e-07
aniridia B-Disease 1 1.0
and O 0 3.240036150486958e-08
have O 0 3.861789554804318e-09
also O 0 4.4325124126665116e-10
been O 0 1.2136203153545466e-10
found O 0 1.5108900242033485e-11
in O 0 4.960125365993662e-11
patients O 0 3.3092031892500984e-10
with O 0 4.2943832517794434e-11
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 1.0353979895683096e-08
with O 0 1.5217958448943136e-08
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 0 2.3711852747965168e-07
with O 0 5.452629991964386e-08
autosomal B-Disease 1 1.0
dominant I-Disease 1 0.9999990463256836
keratitis I-Disease 1 1.0
, O 0 2.897260653611511e-09
and O 0 6.341559499745131e-10
with O 0 1.13026432657648e-08
isolated B-Disease 1 1.0
foveal I-Disease 1 1.0
hypoplasia I-Disease 1 1.0
. O 1 0.9999995231628418

No O 0 2.750843350440846e-06
locus O 0 1.9390294880849979e-07
other O 0 1.0090464019896217e-09
than O 0 1.6585219309028787e-10
chromosome O 0 1.367338242630467e-08
11p13 O 0 6.834720807091799e-07
has O 0 3.7392763885257807e-10
been O 0 4.740413617199124e-10
implicated O 0 5.000883263051037e-09
in O 0 1.1915632036618717e-08
aniridia B-Disease 1 1.0
, O 0 1.1583264125647474e-08
and O 0 1.4533704240093925e-09
PAX6 O 0 5.028613668400794e-05
is O 0 1.2186638365108138e-09
clearly O 0 2.4551054522703453e-09
the O 0 9.53887413501775e-10
major O 0 3.1706950398557865e-09
, O 0 9.241175880081443e-11
if O 0 2.7755299794596233e-11
not O 0 7.129323520427278e-11
only O 0 1.2338353949647995e-10
, O 0 6.183840939311125e-11
gene O 0 9.023838343225066e-10
responsible O 0 6.338083125001504e-08
. O 0 1.4162873185341596e-06

Twenty O 0 2.1990737764099322e-07
- O 0 8.675368690092e-08
eight O 0 6.369504479408761e-09
percent O 0 1.434001917210992e-09
of O 0 2.921336506034322e-10
identified O 0 9.295810343701305e-09
PAX6 O 0 1.0421301340102218e-05
mutations O 0 9.972573167260634e-08
are O 0 1.0085096091572154e-09
C O 0 4.674507181334775e-06
- O 0 1.979568878596183e-06
T O 0 3.002235871463199e-06
changes O 0 6.304792776745671e-08
at O 0 9.042419435445481e-08
CpG O 0 2.865650685635046e-07
dinucleotides O 0 1.470984756224425e-07
, O 0 1.559960910446634e-10
20 O 0 1.0498647506906877e-09
% O 0 3.0637582748571646e-11
are O 0 1.4775908361436274e-12
splicing O 0 3.5244982488080723e-09
errors O 0 4.1303785280888405e-08
, O 0 2.5479909848691307e-10
and O 0 7.583597638749495e-11
more O 0 1.2109444523511481e-11
than O 0 1.12820352018983e-11
30 O 0 5.33361410592903e-10
% O 0 8.799090622790828e-11
are O 0 2.3457024517226088e-11
deletion O 0 8.968556564070695e-09
or O 0 2.930473641526987e-09
insertion O 0 2.2983844161217348e-08
events O 0 2.4869288850482008e-08
. O 0 1.580273334411686e-07

There O 0 4.572374123767986e-08
is O 0 9.494349750838182e-10
a O 0 1.2569958407482318e-09
noticeably O 0 1.1780903719227354e-07
elevated O 0 6.885148451374334e-08
level O 0 4.531438335675375e-08
of O 0 1.9792074645863522e-09
mutation O 0 3.6171801665041414e-10
in O 0 4.763126004725393e-10
the O 0 8.64371862974167e-09
paired O 0 2.2990760406571553e-09
domain O 0 6.833125731908751e-10
compared O 0 7.620862968460429e-11
with O 0 1.7267539394877351e-12
the O 0 2.7458127438428903e-10
rest O 0 1.1638533470303969e-09
of O 0 6.194586510410716e-10
the O 0 2.0407533440902625e-09
gene O 0 1.0340126088692614e-08
. O 0 4.270025897312735e-07

Increased O 0 2.778697307803668e-07
mutation O 0 8.814570406912026e-09
in O 0 1.4885059851366123e-09
the O 0 1.1469800220709203e-08
homeodomain O 0 2.2649821573850204e-07
is O 0 7.682172953327182e-11
accounted O 0 1.2191538056871565e-10
for O 0 6.0392559009248e-11
by O 0 6.239048860878782e-11
the O 0 4.254674390580249e-09
hypermutable O 0 3.201880076630914e-07
CpG O 0 4.771496264766029e-07
dinucleotide O 0 5.784598897662363e-07
in O 0 2.7465070218113397e-08
codon O 0 8.109838631753519e-07
240 O 0 2.290337306476431e-07
. O 0 2.7452560402707604e-07

Very O 0 1.7556158127263188e-07
nearly O 0 2.95589219767578e-09
all O 0 1.0137799627552013e-10
mutations O 0 5.2512414555616616e-11
appear O 0 9.128658384760513e-10
to O 0 2.7893418685920324e-09
cause O 0 1.52711390200011e-08
loss O 0 8.163596909582793e-09
of O 0 3.872292264617272e-09
function O 0 1.0365737601603087e-08
of O 0 3.867819398095662e-09
the O 0 4.91243357103599e-09
mutant O 0 6.899227855683421e-08
allele O 0 4.776310458254329e-09
, O 0 8.345459046044112e-11
and O 0 2.1550065551489972e-11
more O 0 5.465029904311303e-12
than O 0 9.778454955478022e-12
80 O 0 2.705048129936216e-10
% O 0 9.770387277008297e-11
of O 0 4.072113202191474e-10
exonic O 0 6.217378256678785e-08
substitutions O 0 1.0012287887661842e-08
result O 0 1.5206953474233842e-09
in O 0 1.4406039916536884e-08
nonsense O 0 6.206785201356979e-07
codons O 0 1.1676160056595108e-06
. O 0 5.809044978377642e-07

In O 0 2.0110807952278265e-07
a O 0 2.468262927379783e-08
gene O 0 5.358905763586108e-09
with O 0 1.3550204014389777e-10
such O 0 2.245068353445845e-09
extraordinarily O 0 6.364575710904319e-08
high O 0 1.333146659732165e-08
sequence O 0 3.732307796155965e-10
conservation O 0 2.3649231462030684e-09
throughout O 0 1.6557245852144575e-10
evolution O 0 4.934320174676543e-10
, O 0 3.086227454152102e-11
there O 0 1.8521063155363393e-11
are O 0 6.060164869925444e-11
presumed O 0 2.7676952640831587e-07
undiscovered O 0 1.8039894712273963e-05
missense O 0 1.1893187547684647e-05
mutations O 0 3.320578230159299e-07
, O 0 2.202917626092926e-09
these O 0 4.0799419398496184e-10
are O 0 9.799688838185716e-11
hypothesized O 0 3.3958897915908892e-09
to O 0 1.131178151148049e-09
exist O 0 1.2778187397088914e-09
in O 0 7.93399013154783e-10
as O 0 2.8187785439115487e-09
- O 0 3.073947851817138e-08
yet O 0 4.6766528427610865e-09
unidentified O 0 2.8219432124387822e-08
phenotypes O 0 4.300225597830831e-08
. O 0 3.259877034977876e-09
. O 0 4.073842063689881e-08

Genetic O 0 1.1219755151614663e-06
heterogeneity O 0 1.2289822848288168e-07
and O 0 1.193052101555736e-09
penetrance O 0 1.1827881252202133e-07
analysis O 0 6.8437326916637176e-09
of O 0 6.266748897587604e-09
the O 0 3.295751582754747e-08
BRCA1 O 0 3.822708549705567e-08
and O 0 2.545388788632863e-09
BRCA2 O 0 3.8753828590643025e-08
genes O 0 5.0843076415674204e-09
in O 0 3.176804597160299e-08
breast B-Disease 0 0.27189141511917114
cancer I-Disease 0 1.2567549674713518e-05
families O 0 1.586600006930894e-08
. O 0 6.682842013105983e-07

The O 0 0.17950430512428284
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 5.9192980188527144e-06
Consortium O 0 6.056774992657665e-08
. O 0 1.4775493184515653e-07

The O 0 3.5721591018500476e-08
contribution O 0 4.3455823828253415e-08
of O 0 7.670803547910054e-09
BRCA1 O 0 2.7057474483171973e-08
and O 0 3.377550683580921e-09
BRCA2 O 0 4.922382504446432e-05
to O 0 0.031976521015167236
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 1 0.9907447695732117
assessed O 0 2.0376161558033346e-07
by O 0 1.0169429742745706e-09
linkage O 0 2.8106253324722275e-08
and O 0 5.251985513154978e-10
mutation O 0 9.779523024722181e-11
analysis O 0 2.683442877626785e-11
in O 0 1.2697708336173452e-11
237 O 0 8.85404111139465e-11
families O 0 7.264942987472711e-12
, O 0 3.745482656664079e-12
each O 0 1.2876522764715403e-12
with O 0 2.527195466783816e-12
at O 0 1.0358597313242512e-09
least O 0 8.17851897316757e-11
four O 0 2.965794623777107e-11
cases O 0 5.944356118448013e-11
of O 0 4.556318433657225e-09
breast B-Disease 0 0.01827736385166645
cancer I-Disease 0 7.955453042995941e-07
, O 0 1.0438646613764035e-09
collected O 0 2.119349584717156e-09
by O 0 1.1265445243324734e-09
the O 0 0.00011940098193008453
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 1.7325161252301768e-06
Consortium O 0 3.6078404264117125e-08
. O 0 1.930749959910827e-07

Families O 0 3.7483114390113315e-09
were O 0 6.750413006351152e-10
included O 0 3.963983308263863e-10
without O 0 3.9121111905515704e-10
regard O 0 3.5684120103240957e-09
to O 0 5.472903463754619e-09
the O 0 7.655252431959525e-09
occurrence O 0 4.4540180965668696e-07
of O 0 5.11754592480429e-07
ovarian B-Disease 1 1.0
or I-Disease 0 6.513298103527632e-06
other I-Disease 0 1.4525642200169386e-06
cancers I-Disease 0 0.12964756786823273
. O 0 2.777372628770536e-06

Overall O 0 2.8899605695187347e-06
, O 0 8.025237363540327e-09
disease O 0 3.737354958843753e-08
was O 0 4.963291111437229e-09
linked O 0 1.0082850110393338e-08
to O 0 1.385547410137633e-08
BRCA1 O 0 8.472444079643537e-09
in O 0 5.747201603512053e-10
an O 0 2.530462471506123e-11
estimated O 0 1.114695922371789e-11
52 O 0 1.2836100238278192e-10
% O 0 7.944780250346284e-12
of O 0 9.811878740051405e-12
families O 0 2.799955579890767e-12
, O 0 1.5585682050511807e-11
to O 0 1.7890849912660656e-09
BRCA2 O 0 5.925096413506026e-09
in O 0 4.68653560403709e-10
32 O 0 1.6064592989195603e-09
% O 0 5.5057420428328285e-11
of O 0 2.60192423162664e-11
families O 0 1.6898804404419376e-12
, O 0 2.489377410805349e-12
and O 0 4.9880724550810385e-12
to O 0 3.323086528173036e-10
neither O 0 7.133108548273981e-10
gene O 0 1.0793359955796333e-10
in O 0 3.6767852651387045e-10
16 O 0 4.068792414102518e-09
% O 0 1.206978961221239e-10
( O 0 6.781326368499041e-12
95 O 0 3.4766132195329646e-09
% O 0 2.281940469917032e-10
confidence O 0 1.6696484195222183e-08
interval O 0 2.4457964542534683e-08
[ O 0 9.643393639180431e-08
CI O 0 3.6312831070972607e-06
] O 0 3.769010348264601e-08
6 O 0 9.33246102619023e-09
% O 0 4.180353285754279e-10
- O 0 5.126804314414812e-09
28 O 0 3.7204970215753974e-09
% O 0 3.2886401934995035e-10
) O 0 1.2613760036472854e-10
, O 0 1.4476760068493633e-10
suggesting O 0 2.590245795630608e-09
other O 0 1.5955903265307825e-10
predisposition O 0 8.284649055667614e-08
genes O 0 8.316884247960843e-08
. O 0 6.942113941477146e-07

The O 0 1.701797600617283e-07
majority O 0 6.971751509432522e-10
( O 0 3.680137097838987e-11
81 O 0 1.2269693039357321e-09
% O 0 1.75829489856838e-11
) O 0 2.0010494997113604e-12
of O 0 5.954853277145844e-11
the O 0 5.378815259859948e-08
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 6.632588367416759e-10
were O 0 1.6475182329500626e-10
due O 0 9.205328166395077e-10
to O 0 5.9622236037171206e-09
BRCA1 O 0 2.579660485224622e-09
, O 0 3.4663202863605136e-11
with O 0 4.191606697151462e-12
most O 0 1.635670210387019e-10
others O 0 1.2950698846658781e-10
( O 0 1.5311451759258965e-11
14 O 0 3.989955588146188e-10
% O 0 5.0221556080476404e-11
) O 0 3.797754125067776e-11
due O 0 4.332859404598821e-09
to O 0 2.738812838742888e-07
BRCA2 O 0 3.7046202123747207e-06
. O 0 5.148988861947146e-07

Conversely O 0 4.712687484698108e-07
, O 0 1.6961443360941075e-09
the O 0 1.112025582727938e-09
majority O 0 4.192312469397663e-11
of O 0 1.9157092578936386e-10
families O 0 1.6098624169846865e-11
with O 0 4.1579322450358e-12
male B-Disease 0 3.097003764551687e-09
and I-Disease 0 1.2398280180292431e-09
female I-Disease 0 4.473608896660153e-07
breast I-Disease 0 0.024566182866692543
cancer I-Disease 0 0.0004163708072155714
were O 0 6.743958920196746e-07
due O 1 0.9999785423278809
to O 1 0.9999591112136841
BRCA2 O 0 3.1211072837322718e-06
( O 0 7.364213683302978e-10
76 O 0 1.4489583577415033e-07
% O 0 1.3842523793883288e-09
) O 0 1.4983561058556916e-09
. O 0 3.959740269010581e-08

The O 0 2.440102946366096e-07
largest O 0 2.0980412962501305e-09
proportion O 0 3.229728984255331e-10
( O 0 2.9432307285803816e-11
67 O 0 4.987585011662077e-09
% O 0 7.247853706093821e-11
) O 0 1.7696264592581556e-11
of O 0 4.552760599074723e-11
families O 0 1.2015369602047521e-11
due O 0 1.7294988774452236e-09
to O 0 3.4476768107083444e-09
other O 0 1.0952943413355953e-10
genes O 0 8.642786486490195e-11
was O 0 6.632486782010005e-10
found O 0 4.7555345078498235e-11
in O 0 2.2659957243931217e-11
families O 0 4.303868459537563e-12
with O 0 1.589977607040216e-12
four O 0 5.099589500678903e-11
or O 0 6.400271979067895e-11
five O 0 2.059288850553287e-11
cases O 0 9.989916012476119e-12
of O 0 2.5994550956198736e-10
female O 0 1.4389814850801486e-07
breast B-Disease 0 8.445447747362778e-05
cancer I-Disease 0 2.9722916679020273e-06
only O 0 2.191415688912457e-07
. O 0 3.539656063367147e-06

These O 0 3.2807118799382806e-08
estimates O 0 5.488489662752727e-09
were O 0 8.483565516748115e-10
not O 0 1.923515374757656e-10
substantially O 0 3.765071365791073e-09
affected O 0 1.622600942496888e-10
either O 0 1.1477863104403241e-10
by O 0 5.0899888470734567e-11
changing O 0 1.7195793233781842e-08
the O 0 4.924272101192173e-09
assumed O 0 1.8142779723007152e-08
penetrance O 0 1.7578681621444048e-08
model O 0 1.1154866363938254e-08
for O 0 3.917713709000736e-09
BRCA1 O 0 6.158540344358698e-09
or O 0 1.9096023373688098e-10
by O 0 2.690012795847352e-11
including O 0 1.7701540233616697e-10
or O 0 6.866689439277707e-10
excluding O 0 4.6583515711517975e-08
BRCA1 O 0 9.580546844745186e-08
mutation O 0 5.6124225267240035e-09
data O 0 3.2053989684754924e-08
. O 0 1.0334807143408398e-07

Among O 0 9.798521105608415e-09
those O 0 2.434316914712298e-10
families O 0 9.207075206407733e-12
with O 0 3.867887347214216e-12
disease O 0 3.489967204117761e-09
due O 0 7.649838948964316e-07
to O 0 1.017071440401196e-06
BRCA1 O 0 2.931676768014313e-08
that O 0 2.528374731802785e-10
were O 0 1.9721597965816073e-10
tested O 0 1.845858188520566e-10
by O 0 2.1515031076169144e-11
one O 0 1.8847971794411222e-10
of O 0 1.2406388416597025e-10
the O 0 1.7853378497800776e-10
standard O 0 1.268506077956033e-09
screening O 0 2.466340465190342e-10
methods O 0 1.2814584948728225e-08
, O 0 1.5381682039183886e-10
mutations O 0 2.8032126619947917e-10
were O 0 4.568089517764662e-10
detected O 0 1.2360972245772928e-09
in O 0 7.612295793713031e-10
the O 0 6.999469448487616e-09
coding O 0 1.7031638321896025e-08
sequence O 0 4.6026354949546544e-10
or O 0 1.8075649310667075e-10
splice O 0 6.10276362777995e-09
sites O 0 2.918841002230721e-10
in O 0 2.849669979154701e-11
an O 0 4.7336956403298824e-12
estimated O 0 7.0679855197763874e-12
63 O 0 1.4624969013610212e-09
% O 0 1.4739498510607518e-10
( O 0 3.0726535898972784e-11
95 O 0 2.8556867093243454e-08
% O 0 9.410622281436076e-10
CI O 0 9.561513252265286e-07
51 O 0 2.4982060864431332e-08
% O 0 6.03854466429965e-10
- O 0 1.953674200194655e-08
77 O 0 1.7991842682363313e-08
% O 0 5.546038628345684e-10
) O 0 7.146208624853045e-10
. O 0 1.5292037858216645e-08

The O 0 1.931845758917916e-07
estimated O 0 3.964386152688348e-09
sensitivity O 0 4.474512849128587e-08
was O 0 5.365576782878634e-08
identical O 0 3.073987286938973e-09
for O 0 3.755357969037476e-10
direct O 0 5.176619688462836e-10
sequencing O 0 1.6990489015711319e-09
and O 0 3.235944290302939e-10
other O 0 1.2417685768539855e-09
techniques O 0 3.264033693994861e-06
. O 0 9.98324708234577e-07

The O 0 8.94805339157756e-07
penetrance O 0 1.147649254562566e-05
of O 0 1.8069001725962153e-06
BRCA2 O 0 1.7836567849371932e-06
was O 0 1.564148632837714e-08
estimated O 0 3.31406499465281e-11
by O 0 1.6505801716734658e-12
maximizing O 0 1.9810695306432535e-09
the O 0 4.238345674423272e-09
LOD O 0 1.4690750504087191e-05
score O 0 2.426985759029776e-07
in O 0 3.290494632324226e-08
BRCA2 O 0 1.07597634269041e-06
- O 0 1.8833711123988905e-07
mutation O 0 1.7529189211273888e-09
families O 0 7.890598591187015e-11
, O 0 6.687040504660402e-11
over O 0 6.312521338980304e-11
all O 0 4.0772657472487595e-10
possible O 0 1.2780778213539179e-08
penetrance O 0 7.091467750797165e-07
functions O 0 5.933082434239623e-07
. O 0 1.1524443834787235e-06

The O 0 2.650702413120598e-08
estimated O 0 9.561238606403677e-11
cumulative O 0 1.5376672157785265e-09
risk O 0 1.1502727659262746e-08
of O 0 2.03263930131925e-08
breast B-Disease 1 0.6472859382629395
cancer I-Disease 0 2.0608636987162754e-05
reached O 0 3.5400842079980066e-07
28 O 0 7.911527433179799e-08
% O 0 3.034321405248619e-10
( O 0 1.6833541505167915e-11
95 O 0 5.637774691535924e-09
% O 0 1.7803593321819022e-10
CI O 0 6.665262475280542e-08
9 O 0 3.951559968129459e-09
% O 0 1.7400862695193808e-10
- O 0 1.4733153586021785e-09
44 O 0 2.651701080935709e-10
% O 0 1.4247582280635385e-11
) O 0 1.064642297932128e-12
by O 0 5.174795596370185e-13
age O 0 2.3139521548865005e-11
50 O 0 9.029756803391464e-11
years O 0 9.461347504069462e-12
and O 0 2.1238110228805063e-11
84 O 0 4.81753792413997e-09
% O 0 1.5058589097893815e-10
( O 0 3.6050010199240035e-11
95 O 0 1.167633989496153e-08
% O 0 4.4261086462604737e-10
CI O 0 3.4200698451058997e-07
43 O 0 4.1413965590209045e-09
% O 0 8.4281769063832e-11
- O 0 9.249856991466743e-10
95 O 0 3.697709916039571e-09
% O 0 2.995939260563851e-11
) O 0 3.832944378556746e-12
by O 0 6.208963898579611e-12
age O 0 4.2774309094717466e-10
70 O 0 4.164470546186294e-09
years O 0 3.1750464479785023e-09
. O 0 5.734769104037696e-08

The O 0 2.3530787984782364e-06
corresponding O 1 0.9999994039535522
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 0 6.054281129763694e-07
were O 0 5.660779844873787e-09
0 O 0 1.4767294942430453e-07
. O 0 1.1583942693960125e-07

4 O 0 4.825816972697794e-07
% O 0 5.241980183257056e-09
( O 0 1.0530810945486024e-10
95 O 0 2.1357163149104963e-08
% O 0 6.346641545640352e-10
CI O 0 3.3930305676221906e-07
0 O 0 4.582910495543047e-09
% O 0 5.340675818255036e-11
- O 0 4.378541695881921e-10
1 O 0 5.108801715003608e-10
% O 0 2.4521593089410487e-11
) O 0 1.0807316413313783e-12
by O 0 7.180628704486769e-13
age O 0 2.036648800995966e-11
50 O 0 5.0582635302554024e-11
years O 0 4.7828308154251875e-12
and O 0 1.835066126831819e-11
27 O 0 1.4704603090720525e-09
% O 0 9.984054555323141e-11
( O 0 1.3548180806399746e-11
95 O 0 6.871605950919957e-09
% O 0 1.6412798897746939e-10
CI O 0 1.7702899413052364e-07
0 O 0 2.349407779433932e-09
% O 0 8.005629492657818e-11
- O 0 1.3194829673324193e-09
47 O 0 1.548338790513526e-09
% O 0 3.4532279813426214e-11
) O 0 3.956229874951811e-12
by O 0 4.0459410995119516e-12
age O 0 3.6759786881113143e-10
70 O 0 3.786972513353248e-09
years O 0 3.2386076043167122e-09
. O 0 6.44241353597863e-08

The O 0 6.868096846801564e-08
lifetime O 0 1.7133791629930784e-07
risk O 0 1.49188977616177e-07
of O 0 4.633734107528653e-08
breast B-Disease 1 0.5256179571151733
cancer I-Disease 0 2.717882352953893e-06
appears O 0 4.934520347887883e-09
similar O 0 2.414101973879923e-10
to O 0 5.877484277050371e-09
the O 0 2.0094029551387393e-08
risk O 0 4.898429395439052e-08
in O 0 7.932845491609442e-09
BRCA1 O 0 8.56291837436629e-09
carriers O 0 4.1813341677965354e-10
, O 0 6.023816861988607e-11
but O 0 3.318802871410398e-11
there O 0 3.945831855700632e-11
was O 0 1.355354495302663e-09
some O 0 7.329583467940992e-11
suggestion O 0 4.563224020870393e-09
of O 0 2.8827290554644946e-10
a O 0 5.749482556716146e-10
lower O 0 7.680481139971107e-09
risk O 0 5.2416604390259636e-09
in O 0 3.1103708497681737e-09
BRCA2 O 0 4.0445449656090204e-08
carriers O 0 1.4986362151248045e-09
< O 0 4.527818475708045e-08
50 O 0 6.562137055965422e-09
years O 0 7.193443063435723e-10
of O 0 5.476231690337841e-10
age O 0 1.1716316805632232e-08
. O 0 1.067689083811274e-07

Eye B-Disease 1 0.9978502988815308
movement I-Disease 0 2.422924808342941e-05
abnormalities I-Disease 0 2.970218520204071e-05
correlate O 0 1.381484224793894e-07
with O 0 2.7316410244893063e-10
genotype O 0 5.627292125609529e-07
in O 0 4.1638622860773467e-07
autosomal O 1 0.999958872795105
dominant O 0 0.0030564446933567524
cerebellar B-Disease 1 0.9976474642753601
ataxia I-Disease 1 0.9999998807907104
type I-Disease 1 1.0
I I-Disease 1 0.9999998807907104
. O 0 6.08084665145725e-05

We O 0 3.9468545764975715e-07
compared O 0 1.0610343537109657e-07
horizontal O 0 1.926067170643364e-06
eye O 1 0.730201005935669
movements O 0 1.0249867955280934e-05
( O 0 4.9979078653450415e-09
visually O 0 5.606883135556018e-08
guided O 0 5.819225634695613e-07
saccades O 0 5.248433353699511e-06
, O 0 1.4413947813096684e-09
antisaccades O 0 9.02859724760674e-08
, O 0 6.968026156073392e-11
and O 0 1.890917457336716e-11
smooth O 0 1.2983227826168786e-09
pursuit O 0 4.823799137909646e-09
) O 0 2.5953024451741413e-11
in O 0 2.186945069482249e-10
control O 0 1.090852990159874e-07
subjects O 0 1.6676964378348202e-06
( O 0 1.4482780252844663e-10
n O 0 4.715454693382526e-09
= O 0 1.6256972656947255e-08
14 O 0 1.7681841546490773e-09
) O 0 3.928507519290747e-11
and O 0 2.3514721420037077e-11
patients O 0 1.4768906930751058e-10
with O 0 8.880568806365896e-13
three O 0 1.837563608220183e-11
forms O 0 3.8667330448660664e-10
of O 0 7.050842132372281e-09
autosomal O 0 1.0825041499629151e-05
dominant O 0 2.4419614419457503e-06
cerebellar B-Disease 0 3.074520645895973e-05
ataxias I-Disease 0 3.867817940772511e-05
type I-Disease 0 4.263997197995195e-06
I I-Disease 0 8.38965115690371e-06
spinocerebellar B-Disease 0 0.0005082512507215142
ataxias I-Disease 0 7.356382866419153e-06
1 I-Disease 0 6.46738200771324e-08
and I-Disease 0 1.1104507313675072e-09
2 I-Disease 0 2.6167493061279856e-08
( O 0 2.9460575645678944e-10
SCA1 B-Disease 0 7.295143404917326e-07
, O 0 1.688757605977642e-10
n O 0 4.091951499862745e-10
= O 0 1.5477865655810774e-09
11 O 0 1.8947923785539444e-10
; O 0 2.27285221893192e-11
SCA2 B-Disease 0 8.639799631282585e-08
, O 0 6.020566684084017e-11
n O 0 3.666574821536983e-10
= O 0 2.575501145685166e-09
10 O 0 3.4434821660767057e-10
) O 0 3.781101126643094e-11
and O 0 6.139174724140162e-10
SCA3 B-Disease 1 1.0
/ O 0 6.048093382560182e-06
Machado B-Disease 0 3.641717967184377e-07
- I-Disease 0 3.5302127798786387e-07
Joseph I-Disease 0 1.303926751461404e-06
disease I-Disease 0 0.40973854064941406
( O 0 5.221242327380082e-10
MJD B-Disease 1 1.0
) O 0 5.436787131607446e-10
( O 0 3.388523489578077e-11
n O 0 1.5186982782466885e-09
= O 0 1.207367006372806e-08
16 O 0 6.8870762426342935e-09
) O 0 1.7487246095626574e-09
. O 0 4.383868912327671e-08

In O 0 5.308809249982005e-07
SCA1 B-Disease 0 3.0038485419936478e-05
, O 0 9.135368905788255e-09
saccade O 0 1.8496857592253946e-06
amplitude O 0 5.7862106217498877e-08
was O 0 7.966916015789138e-09
significantly O 0 4.747255921699889e-09
increased O 0 8.515420590882172e-10
, O 0 4.90523767437967e-11
resulting O 0 2.025917905656982e-10
in O 0 1.7077690372957477e-09
hypermetria B-Disease 0 1.6002771872081212e-06
. O 0 1.6915163314479287e-07

The O 0 1.7819548929765006e-06
smooth O 0 2.9612428988912143e-06
pursuit O 0 5.6600979405629914e-06
gain O 0 2.6412658371555153e-06
was O 0 1.0565228336645305e-07
decreased O 0 1.6193646956708108e-07
. O 0 8.855709410227064e-08

In O 0 9.833871672526584e-07
SCA2 B-Disease 0 7.955139153636992e-05
, O 0 1.650548853149303e-08
saccade O 0 1.7197749002662022e-06
velocity O 0 1.968759022474842e-07
was O 0 1.3573864521276846e-07
markedly O 0 1.0327846666768892e-06
decreased O 0 6.366440175042953e-07
. O 0 1.5568065236948314e-07

The O 0 7.314817906944882e-08
percentage O 0 4.0600497186460416e-08
of O 0 7.79166065001391e-09
errors O 0 4.738583072594338e-07
in O 0 5.7213085824514565e-08
antisaccades O 0 4.5242752094054595e-05
was O 0 7.86077762882087e-08
greatly O 0 2.3499559631545708e-08
increased O 0 2.1503772096309604e-09
and O 0 1.012079725581927e-10
was O 0 7.92021670470433e-10
significantly O 0 7.008577052047826e-10
correlated O 0 1.4951472282476175e-09
with O 0 6.277661550313507e-12
age O 0 3.1607263473176772e-09
at O 0 7.78597097905731e-09
disease O 0 6.74945122014492e-09
onset O 0 4.749042830098915e-07
. O 0 1.7377885797031922e-07

In O 0 1.945582539519819e-08
addition O 0 3.468532794315138e-09
, O 0 1.4421530636354873e-10
a O 0 1.0702504160686743e-10
correlation O 0 1.1450967257742306e-10
between O 0 4.2416816586898776e-11
smooth O 0 3.439206253119664e-08
pursuit O 0 1.1544349831638101e-07
gain O 0 4.7673118785951374e-08
and O 0 7.358944703605985e-11
the O 0 3.7515637818508196e-10
number O 0 2.098444334963645e-10
of O 0 8.719752697672334e-10
trinucleotide O 0 1.2082525699952384e-06
repeats O 0 3.07503853491653e-08
was O 0 8.84768951436854e-08
found O 0 1.6475135922178197e-08
. O 0 1.615716342939777e-07

In O 0 1.4834639614491607e-06
SCA3 B-Disease 1 1.0
, O 0 1.7803857588205574e-07
gaze B-Disease 0 3.2148185709957033e-05
- I-Disease 0 9.274664080294315e-06
evoked I-Disease 0 1.5702188420618768e-06
nystagmus I-Disease 0 2.0759021936100908e-05
was O 0 2.0275667367286587e-08
often O 0 8.19690010311902e-11
present O 0 7.421670916718526e-11
as O 0 3.9846320687431103e-10
was O 0 4.885680748856203e-09
saccade O 0 4.773831392412831e-07
hypometria O 0 2.800122160806495e-07
and O 0 2.188890846355207e-09
smooth O 0 5.484441771841375e-07
pursuit O 0 6.129098892415641e-06
gain O 0 2.258720769532374e-06
was O 0 5.692354676511968e-08
markedly O 0 6.741283442579515e-08
decreased O 0 5.958668225503061e-08
. O 0 2.629246864671586e-08

Three O 0 2.723798075976447e-08
major O 0 1.1735886928931905e-08
criteria O 0 8.414840380055466e-08
, O 0 1.7614889546990753e-09
saccade O 0 1.5433853377544438e-06
amplitude O 0 5.198303654196934e-08
, O 0 3.9992054112758524e-10
saccade O 0 1.907646378640493e-07
velocity O 0 9.887188845425499e-09
, O 0 1.1972048352681952e-10
and O 0 1.003738411831101e-10
presence O 0 8.943804807870492e-09
of O 0 7.025098369695115e-08
gaze B-Disease 0 3.114780702162534e-05
- I-Disease 0 5.577939646173036e-06
evoked I-Disease 0 3.8541682556569867e-07
nystagmus I-Disease 0 3.884671286868979e-07
, O 0 2.7073180502990013e-11
permitted O 0 6.865550350454441e-10
the O 0 7.706005278329542e-11
correct O 0 1.0760518032171262e-09
assignment O 0 2.39275910196568e-09
of O 0 1.8271564816707553e-10
90 O 0 8.224451120142362e-10
% O 0 8.797127609705413e-11
of O 0 2.1598797750321808e-10
the O 0 5.991644402847385e-10
SCA1 B-Disease 0 1.6115122036808316e-07
, O 0 3.898485700926102e-11
90 O 0 3.35493605119197e-10
% O 0 4.9065758400690385e-11
of O 0 2.812804988927553e-10
the O 0 6.661253215689555e-10
SCA2 B-Disease 0 2.1255127080621605e-07
, O 0 4.1824408519852696e-11
and O 0 1.309038554636599e-11
93 O 0 2.2708612767985414e-09
% O 0 1.878787923847991e-11
of O 0 4.309940945801394e-11
the O 0 5.740121919450836e-11
patients O 0 1.2760084655560888e-10
with O 0 1.2229353814341426e-11
SCA3 B-Disease 1 1.0
to O 0 1.4052790220375755e-07
their O 0 8.232836634647356e-09
genetically O 0 1.1038795655338163e-08
confirmed O 0 3.767700373913385e-09
patient O 0 5.0267825457694926e-08
group O 0 1.8034874982308935e-10
and O 0 1.3544362853501468e-10
, O 0 6.103129807089047e-11
therefore O 0 5.562691973715062e-10
, O 0 7.768577447997416e-11
may O 0 3.479014631935229e-09
help O 0 4.5536445725247177e-08
orient O 0 1.57807312461955e-06
diagnoses O 0 4.382513361633755e-05
of O 0 4.04142959098408e-08
SCA1 B-Disease 0 2.76664814009564e-05
, O 0 1.751896183677104e-09
SCA2 B-Disease 0 2.5583528895367635e-06
, O 0 4.790586816127984e-10
and O 0 6.6087718630925e-10
SCA3 B-Disease 1 1.0
at O 0 6.018255760409374e-08
early O 0 7.494485032566445e-08
clinical O 0 2.1774532399376767e-08
stages O 0 4.634474137787947e-09
of O 0 5.234586986091472e-09
the O 0 1.5029938182919977e-08
diseases O 0 1.064685477558669e-07
. O 0 4.479908000121213e-09
. O 0 4.1525119343077677e-08

Genetic O 0 2.816684911977063e-07
basis O 0 3.1542718659238744e-08
and O 0 2.46730968989084e-10
molecular O 0 1.3647580843212381e-09
mechanism O 0 2.6725885504674807e-07
for O 0 8.496259056300914e-07
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 1 0.9999932050704956

Ventricular B-Disease 1 1.0
fibrillation I-Disease 1 1.0
causes O 0 2.087698931063642e-06
more O 0 6.349386988402372e-11
than O 0 1.874946552182788e-11
300 O 0 2.348963246134872e-10
, O 0 2.2448048628276318e-11
000 O 0 1.275026928482248e-08
sudden O 0 3.5956997379571476e-09
deaths O 0 7.43805295133626e-11
each O 0 3.5515329826346642e-12
year O 0 4.702623707109055e-11
in O 0 9.410119350405921e-10
the O 0 2.0919046050948964e-08
USA O 0 6.994272894189635e-07
alone O 0 6.028606946983928e-08
. O 0 1.1179430003949165e-07

In O 0 2.685551692138688e-08
approximately O 0 1.3728979064708824e-10
5 O 0 1.8433681248097855e-09
- O 0 1.3236528317861485e-08
12 O 0 9.35769950416443e-09
% O 0 7.407192637032267e-10
of O 0 1.7322911161077315e-10
these O 0 1.549486580709747e-11
cases O 0 2.0095531141905987e-11
, O 0 8.736708405343574e-12
there O 0 6.555134039742949e-12
are O 0 1.3047163176238552e-11
no O 0 1.5755798887795436e-09
demonstrable O 0 1.1918154996237718e-05
cardiac O 1 1.0
or O 0 8.317246624756081e-07
non O 1 1.0
- O 1 0.9713271856307983
cardiac O 1 1.0
causes O 0 1.2762878043304227e-07
to O 0 5.954220450021808e-10
account O 0 1.7312340450104102e-10
for O 0 1.0335955008544673e-10
the O 0 4.713152534918663e-09
episode O 0 1.0601317157465928e-08
, O 0 1.830808976643894e-10
which O 0 6.091589906109807e-12
is O 0 2.5950522655228403e-13
therefore O 0 1.7031375225060041e-12
classified O 0 1.2772065349775374e-10
as O 0 9.693087221762653e-09
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 0 1.8196532280967403e-08
IVF B-Disease 1 1.0
) O 0 2.9183024885526265e-09
. O 0 2.2840591640260755e-08

A O 0 5.492073000823439e-07
distinct O 0 6.6326046876952205e-09
group O 0 1.422348461233014e-09
of O 0 3.1617151119434084e-09
IVF B-Disease 1 1.0
patients O 0 4.984982524547377e-07
has O 0 1.3527575760952093e-11
been O 0 1.3390262856849411e-11
found O 0 9.74020170074752e-12
to O 0 2.5240959322658796e-10
present O 0 2.4821450450573934e-10
with O 0 1.2421896844472258e-10
a O 0 1.3665717446542658e-08
characteristic O 0 2.349359817799268e-08
electrocardiographic O 0 8.007272640497831e-07
pattern O 0 2.7154827719755303e-08
. O 0 1.4762535727186332e-07

Because O 0 4.498730987734234e-08
of O 0 1.5073345238647562e-08
the O 0 7.661460799113229e-09
small O 0 3.780122603824765e-10
size O 0 1.2957548367609206e-09
of O 0 7.882119401614318e-10
most O 0 1.1526215398793838e-10
pedigrees O 0 1.9107329052303612e-09
and O 0 6.059470980535053e-11
the O 0 5.413824943900636e-10
high O 0 1.5303585065851166e-09
incidence O 0 2.151969269448273e-09
of O 0 3.0678942719575275e-10
sudden B-Disease 0 1.4095964395721694e-08
death I-Disease 0 1.4789245383894922e-08
, O 0 2.0952807544549756e-10
however O 0 3.21816240322903e-10
, O 0 3.7074874420506276e-11
molecular O 0 3.5280209309540567e-10
genetic O 0 2.3304966290105256e-10
studies O 0 1.199722099443079e-09
of O 0 3.1640075004446544e-09
IVF B-Disease 1 1.0
have O 0 2.580969438170655e-09
not O 0 8.748105573275211e-10
yet O 0 4.768452854797545e-10
been O 0 8.690165809177586e-10
done O 0 4.618055271521371e-08
. O 0 3.0899315106580616e-07

Because O 0 5.583585220847453e-07
IVF B-Disease 1 1.0
causes O 0 1.2739313888232573e-06
cardiac O 1 0.9999995231628418
rhythm O 1 0.9995600581169128
disturbance O 0 1.5944115148158744e-05
, O 0 3.278306792697805e-10
we O 0 1.5548643483853652e-09
investigated O 0 5.1977750992193705e-09
whether O 0 1.4791981861606018e-08
malfunction O 0 4.4799384340876713e-05
of O 0 4.857908919575493e-08
ion O 0 1.4973062434364692e-07
channels O 0 3.9425426479056114e-08
could O 0 6.595314072654901e-09
cause O 0 4.313350121520898e-09
the O 0 1.8171479876372132e-09
disorder O 0 5.745056874673082e-09
by O 0 7.539749206919577e-12
studying O 0 1.0168706848778797e-10
mutations O 0 1.749436706610652e-11
in O 0 5.546194059569132e-11
the O 0 9.664634648132164e-10
cardiac O 0 3.43411761605239e-06
sodium O 0 2.563158432167256e-07
channel O 0 3.559854988566258e-08
gene O 0 2.19084270725034e-08
SCN5A O 0 1.609671198821161e-05
. O 0 1.226525000674883e-06

We O 0 1.464913310655902e-07
have O 0 8.889411984291939e-10
now O 0 4.688431309851637e-10
identified O 0 6.288876974736013e-09
a O 0 6.5950369609879544e-09
missense O 0 9.684550832389505e-07
mutation O 0 5.988324858208216e-08
, O 0 1.3511910479380163e-09
a O 0 1.369974134135532e-09
splice O 0 3.2680588901712326e-08
- O 0 1.5261676367117616e-08
donor O 0 6.270216346138113e-09
mutation O 0 2.9189037853427635e-09
, O 0 6.614871844723424e-11
and O 0 8.107602089690857e-11
a O 0 1.061709609118111e-09
frameshift O 0 2.3077276978256123e-08
mutation O 0 1.609031380356285e-10
in O 0 2.2668959764882146e-10
the O 0 3.557932171105449e-09
coding O 0 2.690181055697849e-08
region O 0 1.7877307412206278e-09
of O 0 2.6917397200065807e-09
SCN5A O 0 2.7161362936567457e-07
in O 0 9.476366358285304e-10
three O 0 1.265367033376208e-09
IVF B-Disease 1 1.0
families O 0 4.4081658323591455e-09
. O 0 3.410854176877365e-08

We O 0 1.536551792469254e-07
show O 0 1.4009389204261424e-08
that O 0 6.541635982904026e-11
sodium O 0 2.374609620048318e-09
channels O 0 9.170157411197977e-10
with O 0 3.67524101430039e-11
the O 0 7.296894199981807e-09
missense O 0 1.0043992233477184e-06
mutation O 0 1.4232317369078373e-07
recover O 0 7.64119192808721e-07
from O 0 8.061043388352118e-09
inactivation O 0 1.6494638543917972e-07
more O 0 2.5441351803046075e-10
rapidly O 0 3.262680681181962e-10
than O 0 4.17981491432351e-12
normal O 0 5.695647772863133e-11
and O 0 1.1098293291322836e-11
that O 0 1.6932658400414802e-11
the O 0 1.0335585720611107e-09
frameshift O 0 3.0388454774765705e-07
mutation O 0 1.961218520918351e-09
causes O 0 2.6891575077847563e-10
the O 0 3.2782690451149676e-10
sodium O 0 1.5245062101598705e-08
channel O 0 4.0691339187048925e-09
to O 0 1.2419675288199983e-09
be O 0 1.0678327111435237e-09
non O 0 1.2631593904188776e-07
- O 0 1.1543722422402425e-07
functional O 0 3.7297570543159964e-07
. O 0 4.0997292671818286e-07

Our O 0 8.3203268275156e-08
results O 0 7.167302307209411e-09
indicate O 0 6.645811900796161e-09
that O 0 6.301622418325437e-11
mutations O 0 7.148499014952847e-10
in O 0 6.248532247177252e-10
cardiac O 0 9.994906804422499e-07
ion O 0 2.2525935605699487e-07
- O 0 1.3794240203424124e-06
channel O 0 4.379038642809974e-08
genes O 0 1.7295508081272004e-10
contribute O 0 2.688716471688224e-10
to O 0 8.617770386187829e-10
the O 0 1.7935642970812182e-09
risk O 0 4.011965870631684e-09
of O 0 4.3339151711840884e-10
developing O 0 1.6147360781815223e-08
IVF B-Disease 1 1.0
. O 0 1.1333798966006725e-07
. O 0 2.2708933045123558e-07

Molecular O 0 2.7777434752351837e-07
heterogeneity O 0 2.3001787496923498e-07
in O 0 1.930044213338533e-08
mucopolysaccharidosis B-Disease 0 1.1102618373115547e-05
IVA I-Disease 0 5.465387221192941e-05
in O 0 1.8389518174899422e-07
Australia O 0 7.127783163696222e-08
and O 0 1.28322075187981e-10
Northern O 0 3.394406755674595e-09
Ireland O 0 3.1700844171922427e-09
: O 0 3.626831335257208e-10
nine O 0 2.370228180392786e-10
novel O 0 2.7262017643359115e-10
mutations O 0 1.1118920228980755e-09
including O 0 1.9242640814098877e-10
T312S O 0 5.485854330800066e-07
, O 0 6.311862144059432e-10
a O 0 1.5183303503363277e-09
common O 0 3.0486055901945974e-09
allele O 0 9.255561650434174e-09
that O 0 4.241066525745296e-11
confers O 0 4.4910322571922734e-08
a O 0 1.971368313036237e-08
mild O 0 3.1322397830990667e-07
phenotype O 0 1.5824058152702491e-07
. O 0 2.660356983597012e-07

Mucopolysaccharidosis B-Disease 0 0.02035277523100376
IVA I-Disease 1 0.9999865293502808
( O 0 5.983238224871457e-06
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 5.572786676566466e-08
is O 0 8.254393613071898e-09
an O 0 9.413462898066882e-09
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 0 8.301526577270124e-08
by O 0 1.6692359994241457e-10
a O 0 1.5002162001565011e-07
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 1.8457443218267144e-07
N O 0 2.269766774531945e-08
- O 0 8.257810435452484e-09
acetylgalactosamine O 0 7.912809962817846e-08
- O 0 5.621081555773344e-08
6 O 0 8.165326903508685e-07
- O 0 8.327586328960024e-06
sulfate O 0 3.890813786711078e-06
sulfatase O 0 1.999086089199409e-05
( O 0 1.3626979544767437e-09
GALNS O 0 3.919258688256377e-06
) O 0 3.374704737879597e-09
. O 0 5.464332275550987e-08

Previous O 0 1.0320840715394297e-07
studies O 0 6.36577546231365e-09
of O 0 3.242790203028534e-10
patients O 0 1.4210516097179493e-10
from O 0 2.3322208747567075e-11
a O 0 2.9222335662382193e-10
British O 0 1.5647753315306545e-08
- O 0 2.426957479428893e-08
Irish O 0 2.1681856310351577e-09
population O 0 3.221913361106665e-11
showed O 0 1.8255191802651893e-10
that O 0 1.526025486531246e-11
the O 0 8.056966205316485e-10
I113F O 0 5.288429747452028e-07
mutation O 0 2.9798028489125272e-09
is O 0 5.244515238755909e-11
the O 0 1.3552840794073262e-10
most O 0 5.091221541575486e-11
common O 0 4.830229966001909e-11
single O 0 1.7389657491762023e-09
mutation O 0 8.370575343974451e-09
among O 0 7.614487929075153e-10
MPS B-Disease 1 0.9999998807907104
IVA I-Disease 1 1.0
patients O 0 7.606933650095016e-06
and O 0 1.7952481723426672e-09
produces O 0 3.8068936891733074e-10
a O 0 2.1084070045418457e-09
severe O 0 1.062935961471112e-08
clinical O 0 1.1592815951644297e-07
phenotype O 0 1.3245852414911496e-07
. O 0 1.972837679886652e-07

We O 0 1.0619616830354062e-07
studied O 0 8.552590458066334e-08
mutations O 0 8.266209938767588e-09
in O 0 3.5247942342664373e-09
the O 0 9.986845128651112e-09
GALNS O 0 4.969252245246025e-07
gene O 0 8.221408553943377e-10
from O 0 1.8826233627589062e-10
23 O 0 7.435010385137275e-09
additional O 0 2.0701678238310706e-07
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 2.671890115379938e-06
( O 0 3.050894259448711e-11
15 O 0 4.5543613325094157e-10
from O 0 1.4663452396757037e-10
Australia O 0 4.549698673361746e-10
, O 0 6.826878472254716e-12
8 O 0 2.547539124098108e-10
from O 0 4.946152862284059e-11
Northern O 0 1.0953972173766147e-09
Ireland O 0 1.1342417005621996e-09
) O 0 8.107307880589332e-11
, O 0 1.7549711683884084e-11
with O 0 6.325603560917992e-13
various O 0 1.1210974509845428e-10
clinical O 0 1.46377374221629e-07
phenotypes O 0 8.00516602339485e-07
( O 0 6.094478255391778e-10
severe O 0 1.3533174580970808e-07
, O 0 1.8845346116957984e-10
16 O 0 9.150431523607949e-10
cases O 0 2.771969459525181e-11
; O 0 5.8257105736703174e-12
intermediate O 0 7.984985450626425e-10
, O 0 7.56426518644382e-12
4 O 0 1.1213475981097787e-10
cases O 0 1.0651586383747524e-11
; O 0 1.0993400634262684e-10
mild O 0 1.3318962821529112e-08
, O 0 7.059905438033809e-11
3 O 0 9.770392273011907e-10
cases O 0 3.0482083523963865e-10
) O 0 7.813086289054638e-10
. O 0 5.032778460645204e-08

We O 0 5.443889676826075e-07
found O 0 1.5980315737351702e-08
two O 0 9.30653942798898e-10
common O 0 7.399977297595228e-10
mutations O 0 1.5029499866869855e-09
that O 0 2.6686004100939797e-11
together O 0 2.265104336734991e-12
accounted O 0 1.910389346715391e-10
for O 0 2.621562411597722e-10
32 O 0 9.04646935140363e-09
% O 0 5.351671328313046e-10
of O 0 1.914220115750709e-09
the O 0 6.4892993201226545e-09
44 O 0 1.02151771486092e-08
unrelated O 0 5.885437914798786e-09
alleles O 0 1.0832406083238766e-09
in O 0 1.139580541043017e-09
these O 0 8.372343929252679e-10
patients O 0 5.558728144450242e-09
. O 0 3.008507221125001e-08

One O 0 9.598837635849122e-08
is O 0 1.138023120184073e-09
the O 0 3.0099174264108797e-09
T312S O 0 1.255615984518954e-06
mutation O 0 1.810036920346647e-08
, O 0 2.1866990163044164e-10
a O 0 3.6697508920546795e-10
novel O 0 4.012325582891663e-09
mutation O 0 2.426858936033227e-09
found O 0 1.3250711639045676e-10
exclusively O 0 5.352936982561118e-10
in O 0 7.159387527266858e-10
milder O 0 6.902661766616802e-07
patients O 0 8.038661292175675e-08
. O 0 2.3905053581074753e-07

The O 0 2.2287633782980265e-07
other O 0 7.30597082831963e-10
is O 0 5.82481354816089e-11
the O 0 3.3641503471848466e-10
previously O 0 3.5625362659885695e-09
described O 0 2.3539605820133147e-09
I113F O 0 1.7202968649598915e-07
that O 0 5.498553695693076e-11
produces O 0 4.525575747482691e-11
a O 0 9.98567784016302e-10
severe O 0 2.0187568949836532e-08
phenotype O 0 3.6223764254827984e-07
. O 0 7.315096013371658e-07

The O 0 2.3837674234528095e-06
I113F O 0 1.673215774644632e-05
and O 0 1.6403145508547823e-08
T312S O 0 1.3740016129304422e-06
mutations O 0 4.7883967901896085e-09
accounted O 0 8.734334921989273e-10
for O 0 2.3691526518376804e-10
8 O 0 9.423056113178063e-09
( O 0 8.782558708064769e-11
18 O 0 7.797796852671013e-10
% O 0 1.7988933259660556e-11
) O 0 3.5647398661381446e-12
and O 0 1.2885741085266744e-11
6 O 0 1.4117857993767302e-09
( O 0 4.646196621882481e-11
14 O 0 9.499602215967684e-10
% O 0 3.7335946834193834e-11
) O 0 2.3867992651749326e-11
of O 0 1.6017649706601134e-10
44 O 0 8.557036190737222e-10
unrelated O 0 2.7547213399259363e-09
alleles O 0 2.9187088301796393e-09
, O 0 1.5931916896860798e-09
respectively O 0 1.5719253099177877e-07
. O 0 2.8769679261131387e-07

The O 0 1.2314054629314342e-06
relatively O 0 1.6630063726097433e-07
high O 0 8.952084584734621e-08
residual O 0 6.874656719446648e-07
GALNS O 0 1.0686482028177124e-06
activity O 0 1.4537565817818177e-08
seen O 0 2.046053770854428e-09
when O 0 2.953253197546246e-10
the O 0 9.41029920653591e-10
T312S O 0 2.281638167289657e-08
mutant O 0 2.9972739845618435e-09
cDNA O 0 5.2039681008864136e-08
is O 0 1.2653429415365736e-09
overexpressed O 0 1.5574421752262424e-07
in O 0 3.2506195513093417e-09
mutant O 0 7.811973290472451e-09
cells O 0 2.52549359203158e-09
provides O 0 1.8923689004690658e-10
an O 0 5.6904758682918555e-12
explanation O 0 3.0906527337393186e-10
for O 0 9.237088177682651e-11
the O 0 1.734116628071547e-09
mild O 0 2.403647059168179e-08
phenotype O 0 3.216329202970769e-09
in O 0 2.633439855070918e-10
patients O 0 1.177248576400558e-10
with O 0 6.836973478682729e-13
this O 0 1.548591949118716e-10
mutation O 0 4.656999230689962e-09
. O 0 2.930284992430643e-08

The O 0 1.7200942892259263e-08
distribution O 0 1.1125469295825141e-10
and O 0 8.94916606097862e-12
relative O 0 7.047598615805839e-10
frequencies O 0 7.59538487660194e-10
of O 0 4.9091247733557e-10
the O 0 1.5102143979817129e-09
I113F O 0 6.149269893285236e-08
and O 0 5.175099793142124e-10
T312S O 0 1.7908446636738518e-07
mutations O 0 1.3570849999311463e-09
in O 0 4.3152736939333636e-10
Australia O 0 4.993845892364845e-10
corresponded O 0 6.341483588245822e-11
to O 0 2.9754168573425943e-10
those O 0 4.587996302318764e-11
observed O 0 1.455722348220334e-10
in O 0 1.3832698875226868e-10
Northern O 0 5.540754521859981e-09
Ireland O 0 2.4851873892117737e-09
and O 0 1.5501108729942814e-10
are O 0 7.1910212159909115e-12
unique O 0 1.057049517361186e-10
to O 0 1.500045226920932e-10
these O 0 9.598710715152947e-12
two O 0 3.672877540300545e-12
populations O 0 7.870573984214424e-12
, O 0 1.3037759240275282e-11
suggesting O 0 7.502286569760486e-10
that O 0 2.475453696193508e-11
both O 0 5.020604418315422e-11
mutations O 0 1.5107234907496547e-10
were O 0 2.706100621363561e-10
probably O 0 6.727315926546851e-10
introduced O 0 8.307094456760922e-10
to O 0 2.3746731248053266e-09
Australia O 0 1.1711529523950048e-09
by O 0 1.495750572011456e-11
Irish O 0 1.125977422411495e-09
migrants O 0 1.4196760433904387e-09
during O 0 1.927342951901778e-09
the O 0 1.3352149386136603e-09
19th O 0 7.059242079776595e-08
century O 0 5.367167545955454e-07
. O 0 2.9153926561775734e-07

Haplotype O 0 8.54976042319322e-06
analysis O 0 7.995051021225663e-08
using O 0 5.222721810582698e-08
6 O 0 1.0877676714926565e-07
RFLPs O 0 1.0500845064598252e-06
provides O 0 1.6522552215292308e-09
additional O 0 4.6555581612039987e-10
data O 0 2.3852180230932163e-09
that O 0 1.9425473729572929e-10
the O 0 8.237108772846113e-09
I113F O 0 1.1067953664678498e-06
mutation O 0 2.219323169683207e-09
originated O 0 2.629385820185348e-09
from O 0 6.335151847558507e-10
a O 0 2.3923849568063815e-09
common O 0 3.39492500778249e-09
ancestor O 0 5.610626772067917e-07
. O 0 2.4126640596477955e-07

The O 0 3.7205913372417854e-07
other O 0 7.820779579503778e-10
9 O 0 3.96011623493564e-09
novel O 0 1.580606645568139e-09
mutations O 0 5.576502593029886e-10
identified O 0 4.0161829417684203e-10
in O 0 8.396647960262626e-11
these O 0 1.8351091479740234e-10
23 O 0 6.280761244426003e-09
patients O 0 3.7531600050044744e-10
were O 0 4.8315382944474905e-11
each O 0 4.953183696532193e-12
limited O 0 4.891114180338718e-10
to O 0 4.678535781010851e-09
a O 0 5.638506106464547e-09
single O 0 5.64067121899825e-08
family O 0 2.323348979871298e-08
. O 0 2.827434002483642e-07

These O 0 1.0308032472039486e-07
data O 0 1.8025916759256688e-08
provide O 0 6.164412869047453e-10
further O 0 2.361762174718507e-10
evidence O 0 1.9457697952862674e-10
for O 0 1.1591694965007449e-10
extensive O 0 3.525002734150462e-09
allelic O 0 2.2519529352393874e-08
heterogeneity O 0 1.789300974053276e-08
in O 0 4.849077583912731e-08
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
in O 0 4.721955093600627e-08
British O 0 3.8673422864121676e-07
- O 0 2.0403754774633853e-07
Irish O 0 2.41435160752701e-09
patients O 0 3.9610961732883254e-10
and O 0 5.850807577138795e-13
provide O 0 6.363083237398426e-12
evidence O 0 2.5511167831004933e-11
for O 0 3.915677851407118e-11
their O 0 7.242315636091234e-10
transmission O 0 6.507572152258945e-07
to O 0 6.006204245068147e-08
Australia O 0 1.4530552761016224e-08
by O 0 2.750834560139026e-10
British O 0 2.2768436735987052e-07
- O 0 1.271855296636204e-07
Irish O 0 6.6363248230061345e-09
migrants O 0 4.197805658634479e-09
. O 0 8.091493586270815e-10
. O 0 1.2486141010015217e-08

Identification O 0 5.19059312864556e-06
of O 0 6.790282327528985e-07
constitutional O 0 0.00015601121413055807
WT1 O 0 0.17414243519306183
mutations O 0 5.988108000565262e-07
, O 0 5.511113787548538e-10
in O 0 2.7820237780140644e-10
patients O 0 8.379532623337127e-10
with O 0 5.27035637354345e-11
isolated O 0 1.6673321567850508e-07
diffuse B-Disease 1 0.9997407793998718
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 2.787545483329268e-08
and O 0 3.060454112358002e-10
analysis O 0 4.266099473682061e-09
of O 0 1.999679888342598e-08
genotype O 0 8.888841307452822e-07
/ O 0 4.632524451153586e-06
phenotype O 0 2.497557893832436e-08
correlations O 0 1.0794828364524278e-09
by O 0 6.52795040245735e-11
use O 0 9.557765245915562e-09
of O 0 3.826434280540525e-09
a O 0 4.219205429478734e-09
computerized O 0 2.6327955993110663e-07
mutation O 0 5.5158491107931695e-09
database O 0 3.627236111469756e-08
. O 0 9.75373666278756e-08

Constitutional O 0 1.0878420653170906e-05
mutations O 0 6.821814935165094e-08
of O 0 4.591101543383047e-08
the O 0 2.0423197355512457e-08
WT1 O 0 2.7402495561545948e-06
gene O 0 1.9130602879613434e-08
, O 0 5.894152388385976e-10
encoding O 0 1.202402977185102e-08
a O 0 2.9245226684793124e-08
zinc O 0 2.4956639208539855e-06
- O 0 2.1408363863884006e-06
finger O 0 5.327153189682576e-07
transcription O 0 2.0502798179222737e-06
factor O 0 1.530570017393984e-07
involved O 0 1.1677780964447493e-09
in O 0 1.1590778115078137e-08
renal O 1 1.0
and O 0 0.0010577213251963258
gonadal O 1 1.0
development O 1 0.9999998807907104
, O 0 1.772695656931944e-09
are O 0 2.2497601004367596e-11
found O 0 6.893311615963071e-11
in O 0 5.7117813950791074e-11
most O 0 2.3349626052104888e-11
patients O 0 3.3684121464316874e-11
with O 0 1.486603548594978e-11
Denys B-Disease 1 0.9999998807907104
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 3.3018154876884864e-09
DDS B-Disease 1 1.0
) O 0 5.069190067708007e-10
, O 0 1.5302992206756016e-10
or O 0 2.3726447473393364e-09
diffuse B-Disease 1 0.9978263974189758
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 0 4.415421628323202e-08
DMS B-Disease 0 4.6424389438470826e-05
) O 0 5.3577552117101135e-11
associated O 0 1.3448762103962508e-09
with O 0 1.164685570209656e-10
pseudohermaphroditism B-Disease 1 1.0
and O 0 8.724319400243985e-08
/ O 0 0.0002013523189816624
or O 0 4.642651845188084e-07
Wilms B-Disease 1 0.9998579025268555
tumor I-Disease 0 0.0001635638764128089
( O 0 4.80530459867623e-09
WT B-Disease 1 0.9999706745147705
) O 0 9.77703340510061e-09
. O 0 7.920193922927865e-08

Most O 0 7.461836304401004e-08
mutations O 0 5.997389251888308e-08
in O 0 4.03771593937563e-08
DDS B-Disease 1 1.0
patients O 0 8.675075514474884e-05
lie O 0 2.187877790049697e-08
in O 0 1.1256102716572514e-09
exon O 0 4.700443057004122e-08
8 O 0 7.429513715351277e-08
or O 0 6.53089626823089e-09
exon O 0 3.556359828849054e-08
9 O 0 4.1012224727410285e-08
, O 0 1.583630226953403e-09
encoding O 0 2.0773528319750767e-07
zinc O 0 0.00022228894522413611
finger O 0 1.2830679224862251e-05
2 O 0 1.508337504674273e-06
or O 0 3.868825331210246e-07
zinc O 0 0.0013393046101555228
finger O 0 1.614785787751316e-06
3 O 0 2.9988939331815345e-08
, O 0 3.569131656888658e-10
respectively O 0 1.0102942926693004e-09
, O 0 3.0722844407415906e-11
with O 0 6.9616994460841575e-12
a O 0 3.879781385052183e-09
hot O 0 8.875575758793275e-07
spot O 0 1.0469722155903582e-07
( O 0 3.285680894027365e-10
R394W O 0 5.524295687564518e-08
) O 0 1.051471409940774e-10
in O 0 1.8753349984024226e-09
exon O 0 2.4456150526930287e-07
9 O 0 6.61918477362633e-07
. O 0 6.125022196101781e-07

We O 0 5.487571286266757e-08
analyzed O 0 9.840250392301186e-09
a O 0 1.4899376177268664e-09
series O 0 1.3445042856830014e-09
of O 0 4.979199275112478e-10
24 O 0 8.84115713972733e-09
patients O 0 8.790388972279572e-10
, O 0 3.370712736705528e-11
10 O 0 1.2595013920702058e-09
with O 0 4.873904613234004e-10
isolated B-Disease 0 6.046288490324514e-06
DMS I-Disease 1 0.999993085861206
( O 0 3.209155252648088e-08
IDMS B-Disease 0 0.0015241650398820639
) O 0 9.75676095471556e-10
, O 0 1.927919351940588e-10
10 O 0 9.766106812136854e-10
with O 0 7.757280234832464e-11
DDS B-Disease 1 1.0
, O 0 1.128480087153605e-09
and O 0 6.026782545243137e-11
4 O 0 1.3430390133351011e-08
with O 0 9.180955440335481e-10
urogenital B-Disease 0 0.0005196455749683082
abnormalities I-Disease 1 0.9959182143211365
and O 0 2.0907305042783264e-07
/ O 1 0.999911904335022
or O 0 4.8248090024571866e-05
WT B-Disease 1 1.0
. O 0 2.8141173515905393e-06

We O 0 6.224408366506395e-07
report O 0 1.510593250486636e-07
WT1 O 0 8.874414925230667e-05
heterozygous O 0 1.6753591580709326e-07
mutations O 0 3.255577141203503e-09
in O 0 3.830653294567554e-10
16 O 0 7.618400132969327e-09
patients O 0 9.857733518359169e-10
, O 0 3.154850686248878e-11
4 O 0 4.261447639208882e-09
of O 0 4.223875915698727e-09
whom O 0 1.809142879949377e-08
presented O 0 4.639274777673563e-07
with O 0 1.0272350436935085e-07
IDMS B-Disease 1 0.9999978542327881
. O 0 4.9788024625740945e-05

One O 0 2.583320792837185e-07
male O 0 3.796224135044213e-08
and O 0 7.966912685120064e-10
two O 0 1.6533113766925567e-09
female O 0 1.8673299351235073e-08
IDMS B-Disease 0 0.0001329670922132209
patients O 0 8.096270676105632e-08
with O 0 2.67617772387041e-09
WT1 O 1 0.9171100854873657
mutations O 0 1.1659773917926941e-05
underwent O 0 0.019782325252890587
normal O 0 1.4232214198273141e-05
puberty O 0 1.5028559573693201e-05
. O 0 3.5047119695263973e-07

Two O 0 9.71881149780529e-07
mutations O 0 3.5176506685274944e-07
associated O 0 4.7266678393498296e-07
with O 0 3.269740700417856e-09
IDMS B-Disease 0 0.008522920310497284
are O 0 2.63592231375398e-10
different O 0 7.13955700115676e-11
from O 0 4.0316941452012145e-10
those O 0 3.0773297798880606e-10
described O 0 2.0972972247790267e-09
in O 0 2.0097937536434074e-08
DDS B-Disease 1 1.0
patients O 0 3.4676397717703367e-06
. O 0 1.3699545320378093e-07

No O 0 7.952821761136875e-06
WT1 O 0 4.6570577978855e-05
mutations O 0 3.358364608629927e-08
were O 0 6.448176659290539e-09
detected O 0 1.9992604904928157e-08
in O 0 3.2300879748703437e-09
the O 0 5.149779624957773e-08
six O 0 1.860177611945346e-08
other O 0 1.872318522444516e-09
IDMS B-Disease 1 0.7924032807350159
patients O 0 1.2887241496173374e-07
, O 0 7.138498125947024e-10
suggesting O 0 1.1600310934056779e-08
genetic O 0 4.108752449383246e-09
heterogeneity O 0 1.7901202298276075e-08
of O 0 9.291981406533978e-09
this O 0 8.849339927508026e-09
disease O 0 2.2415017042476393e-07
. O 0 1.311600215103681e-07

We O 0 9.75583589024609e-07
analyzed O 0 1.1781165767388302e-06
genotype O 0 2.9070599794067675e-06
/ O 0 4.5096339817973785e-06
phenotype O 0 3.785768498687503e-08
correlations O 0 3.318205044067213e-09
, O 0 4.296431613259877e-11
on O 0 4.690998145484571e-10
the O 0 5.5070132481960243e-11
basis O 0 1.8130792700521425e-10
of O 0 3.3887431055701356e-11
the O 0 2.0986565263392265e-10
constitution O 0 7.102253896107413e-09
of O 0 2.3499278078986663e-09
a O 0 4.240205520034124e-09
WT1 O 0 1.5643596498193801e-06
mutation O 0 2.1495325519538255e-09
database O 0 7.567231286031983e-10
of O 0 7.728309103782749e-10
84 O 0 2.28645653521653e-08
germ O 0 5.872663223271957e-06
- O 0 3.0532560231222305e-06
line O 0 3.2796802429402305e-07
mutations O 0 4.1490739732807924e-09
, O 0 3.92018431605301e-11
to O 0 3.1366004238364553e-10
compare O 0 1.3105189156092933e-09
the O 0 7.787362976685586e-10
distribution O 0 2.981961899628516e-10
and O 0 1.3949116861589062e-10
type O 0 5.1803983325271474e-08
of O 0 8.486143343588992e-09
mutations O 0 7.649891275995913e-10
, O 0 3.801906706124569e-11
according O 0 1.0711408149344237e-10
to O 0 3.739868414953662e-10
the O 0 5.257327351237961e-10
different O 0 9.647560528236454e-10
symptoms O 0 1.4218548471944814e-07
. O 0 1.1790378096065979e-07

This O 0 2.090297357426607e-08
demonstrated O 0 3.2533687743807604e-08
( O 0 3.188625058436756e-11
1 O 0 1.4298096040477049e-09
) O 0 2.0291975044717248e-10
the O 0 1.1754587303514086e-09
association O 0 1.3243636742821252e-10
between O 0 1.7548072370199286e-11
mutations O 0 1.6377056655247912e-10
in O 0 2.5797919356307375e-10
exons O 0 7.964450765562958e-10
8 O 0 7.03192892803628e-10
and O 0 7.300283988431744e-11
9 O 0 1.1450454806549715e-08
and O 0 3.9044651956032794e-09
DMS B-Disease 0 2.71162230092159e-06
; O 0 9.175283310902671e-10
( O 0 4.3610531852422696e-11
2 O 0 9.190275762627209e-10
) O 0 6.435624949618912e-11
among O 0 1.345449619771788e-11
patients O 0 1.3080458938219408e-10
with O 0 5.311751039016599e-12
DMS B-Disease 0 4.752418476527964e-07
, O 0 1.9732057654486823e-10
a O 0 2.686988687106151e-10
higher O 0 2.0963610847246628e-09
frequency O 0 8.429744013938034e-09
of O 0 6.965716892182172e-10
exon O 0 9.277336232571542e-09
8 O 0 1.1963317447793997e-08
mutations O 0 2.4154662714437336e-09
among O 0 1.1461652460464933e-10
46 O 0 5.847873740805198e-09
, O 0 1.8068729845666098e-09
XY O 0 4.007271127193235e-05
patients O 0 1.027450302615307e-08
with O 0 7.650821642890548e-11
female O 0 5.228859123462826e-09
phenotype O 0 3.119972502574342e-09
than O 0 8.821726682484154e-11
among O 0 2.3385595543379267e-11
46 O 0 5.692612159435839e-09
, O 0 5.095083466244432e-09
XY O 0 0.0006944569759070873
patients O 0 2.9754426478234564e-08
with O 0 7.143601682413347e-11
sexual O 0 1.5970771372053605e-09
ambiguity O 0 3.6841369954743186e-09
or O 0 3.4857829955825537e-09
male O 0 3.670985071480004e-09
phenotype O 0 1.092926305013009e-09
; O 0 6.243620898072066e-11
and O 0 5.122051671690997e-10
( O 0 8.246753280261032e-11
3 O 0 5.997867535967316e-09
) O 0 1.205662930603424e-10
statistically O 0 2.1262327454252272e-09
significant O 0 2.244900376702219e-10
evidence O 0 7.114873690206025e-10
that O 0 2.6929800403530102e-11
mutations O 0 1.5214141058095265e-10
in O 0 5.366124211647616e-10
exons O 0 3.915330726300681e-09
8 O 0 6.897974635933224e-09
and O 0 4.995522884243542e-10
9 O 0 1.6310455208667918e-08
preferentially O 0 1.5888764748339668e-09
affect O 0 4.447529899920255e-09
amino O 0 4.888754401299877e-10
acids O 0 1.429898838223309e-10
with O 0 1.6309271641534728e-12
different O 0 2.986963801299147e-11
functions O 0 3.247843105569359e-09
. O 0 3.889020661063114e-09
. O 0 7.215917463554433e-08

The O 0 1.4505900480799028e-06
185delAG O 0 7.949666724016424e-06
BRCA1 O 0 1.8268313795033464e-07
mutation O 0 1.0912348802349925e-09
originated O 0 1.0089808988311688e-09
before O 0 9.266915568240108e-10
the O 0 1.626582618596828e-10
dispersion O 0 4.105603412796199e-09
of O 0 4.384834995097009e-10
Jews O 0 2.2577490987885085e-09
in O 0 2.80049261558446e-10
the O 0 4.751837812122517e-10
diaspora O 0 9.75720726437146e-10
and O 0 6.640559629955689e-11
is O 0 1.13603978654786e-11
not O 0 7.570331167494615e-11
limited O 0 5.080972975690656e-09
to O 0 9.944461254463022e-08
Ashkenazim O 0 4.536220876616426e-05
. O 0 1.4377102388607454e-06

The O 0 3.276560391896055e-07
185delAG O 0 5.937565674685175e-07
mutation O 0 2.0971139491621216e-08
in O 0 8.366951576022075e-09
BRCA1 O 0 1.0716450304926184e-07
is O 0 7.575766125533789e-10
detected O 0 4.61956828345933e-09
in O 0 6.770928817623201e-10
Ashkenazi O 0 8.40491196640869e-08
Jews O 0 4.08477918156791e-09
both O 0 3.474912371737027e-11
in O 0 2.3635196577664885e-10
familial B-Disease 0 0.00022055207227822393
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 1.3937814401288051e-05
in O 0 1.4037038909009425e-07
the O 0 7.476424457308894e-08
general O 0 2.1566298968878073e-08
population O 0 3.8365247090332844e-10
. O 0 1.983709729813654e-08

All O 0 1.069370000550407e-06
tested O 0 9.799531426324393e-07
Ashkenazi O 0 5.457966949506954e-07
mutation O 0 1.473950628216869e-09
carriers O 0 4.056423252851715e-10
share O 0 5.964620464204984e-10
the O 0 3.4265590365123444e-10
same O 0 9.80038605824518e-10
allelic O 0 7.499217957729343e-08
pattern O 0 7.491967046746595e-09
at O 0 4.424999033858512e-08
the O 0 7.781995492450733e-08
BRCA1 O 0 1.6284336368244112e-07
locus O 0 2.655854984823236e-07
. O 0 4.0755796248959086e-07

Our O 0 3.56767912990108e-07
previous O 0 2.259645981439462e-08
study O 0 1.1567913293930587e-09
showed O 0 3.626692834934886e-10
that O 0 9.244926005291809e-12
this O 0 1.226430484946306e-10
Ashkenazi O 0 4.0930490285973065e-07
mutation O 0 2.8390447770476612e-09
also O 0 7.713489569294296e-11
occurs O 0 1.4006509493902364e-11
in O 0 4.648519416616814e-11
Iraqi O 0 1.8258310419128065e-08
Jews O 0 3.4358802469824923e-09
with O 0 3.239098225749082e-11
a O 0 3.1197985861375344e-10
similar O 0 5.995736684916153e-10
allelic O 0 2.989844745115988e-07
pattern O 0 4.154880173246056e-08
. O 0 4.4063861537324556e-07

We O 0 1.49301996543727e-07
extended O 0 1.0070169054188227e-07
our O 0 4.140741083347166e-09
analysis O 0 9.767895381429526e-10
to O 0 1.0728548049954156e-09
other O 0 2.4367882711651134e-10
non O 0 1.2324376541528181e-07
- O 0 4.9031591231596394e-08
Ashkenazi O 0 2.6703924049797934e-07
subsets O 0 7.096824017338577e-09
354 O 0 7.538379698246445e-09
of O 0 5.2559540053565e-10
Moroccan O 0 1.1114240123788477e-06
origin O 0 1.4473902965050911e-08
, O 0 6.243290329166484e-10
200 O 0 6.095144389206553e-09
Yemenites O 0 4.408462643823441e-07
and O 0 3.9397124451667764e-10
150 O 0 7.3092083496817395e-09
Iranian O 0 5.4459050602417847e-08
Jews O 0 1.7067125668290828e-07
. O 0 2.0524382193798374e-07

Heteroduplex O 0 1.5129046914807986e-05
analysis O 0 5.084581999881266e-08
complemented O 0 2.0185066063049817e-08
by O 0 2.1096370483864035e-10
direct O 0 1.885114286892531e-09
DNA O 0 2.043811120344685e-09
sequencing O 0 1.762884771494555e-08
of O 0 2.0723735616456906e-08
abnormally O 0 1.1622406503875027e-07
migrating O 0 1.2329755882944937e-08
bands O 0 4.67945682203208e-08
were O 0 1.3909517093679824e-08
employed O 0 2.6522658913563646e-07
. O 0 4.814458520741027e-07

Four O 0 9.143862200744479e-08
of O 0 9.265028744209758e-09
Moroccan O 0 0.00012868779595009983
origin O 0 1.1170643965385807e-08
( O 0 2.235750473644771e-11
1 O 0 2.014450967147141e-10
. O 0 1.6416016115905485e-11
1 O 0 6.10525185962274e-10
% O 0 2.071358883026786e-11
) O 0 8.75958420382128e-12
and O 0 1.0873278839806932e-11
none O 0 1.4007565107831965e-09
of O 0 5.53836365657645e-10
the O 0 2.1866501942469085e-09
Yemenites O 0 8.818440164759522e-07
or O 0 2.250156949656912e-09
Iranians O 0 3.323374997421524e-08
was O 0 6.436933208675555e-09
a O 0 4.289097133014508e-10
carrier O 0 3.2418254192201346e-10
of O 0 3.8742703489802466e-10
the O 0 3.3386342579433403e-09
185delAG O 0 6.179110414450406e-07
mutation O 0 4.501683648072685e-08
. O 0 6.322242285250468e-08

BRCA1 O 0 2.6125759177375585e-05
allelic O 0 9.687478268460836e-07
patterns O 0 1.5586568480330243e-08
were O 0 1.4068801679201215e-09
determined O 0 9.262833278178562e-10
for O 0 1.410644601129718e-09
four O 0 5.942273340053816e-10
of O 0 1.604761878937211e-10
these O 0 6.201460352184274e-12
individuals O 0 1.7766455082286747e-13
and O 0 1.5352032796053794e-12
for O 0 7.323756184840491e-11
12 O 0 1.2106154967383986e-09
additional O 0 6.0171863047742136e-09
non O 0 7.559670507362171e-07
- O 0 3.4212015975754184e-07
Ashkenazi O 0 6.624104003094544e-07
185delAG O 0 3.203736653745182e-08
mutation O 0 2.6747268289106785e-10
carriers O 0 1.602996763105935e-10
who O 0 8.633712633709933e-10
had O 0 6.323894012894016e-07
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9999995231628418

Six O 0 1.574288262418122e-06
non O 0 1.0307094271411188e-05
- O 0 1.2954759540662053e-06
Ashkenazi O 0 1.0026698191722971e-06
individuals O 0 2.4750490545955017e-10
shared O 0 1.1706884350815017e-09
the O 0 1.2556277129149862e-09
common O 0 3.735072695576491e-09
Ashkenazi O 0 1.2589564448717283e-06
haplotype O 0 1.2537309146409825e-07
, O 0 3.279507498898937e-10
four O 0 5.172139383446961e-10
had O 0 4.064355962896116e-09
a O 0 5.765130595136725e-10
closely O 0 1.1519138420901243e-10
related O 0 8.981888566239604e-10
pattern O 0 6.138811126099597e-10
, O 0 2.430325905800057e-11
and O 0 5.5047865571422605e-11
the O 0 8.784208915812997e-09
rest O 0 1.2718669673006389e-08
( O 0 6.9677728864459e-11
n O 0 1.4243085599829897e-09
= O 0 1.0937985628345359e-08
6 O 0 2.2378390251986957e-09
) O 0 6.734938301500293e-11
displayed O 0 3.3496307949576476e-09
a O 0 3.880277432699586e-09
distinct O 0 1.7236182259239285e-08
BRCA1 O 0 4.7297658056777436e-07
allelic O 0 1.1865349733852781e-06
pattern O 0 2.2773279795273993e-07
. O 0 4.931281409881194e-07

We O 0 5.6598974396138146e-08
conclude O 0 1.2571074137213145e-07
that O 0 1.1627995233354227e-09
the O 0 6.680188846530655e-09
185delAG O 0 4.665688265959034e-06
BRCA1 O 0 9.754952543516993e-07
mutation O 0 3.7229674898497933e-09
occurs O 0 7.312575545093125e-11
in O 0 1.067587754310928e-10
some O 0 1.725257714468853e-10
non O 0 4.3886547018701094e-07
- O 0 3.123720091480209e-07
Ashkenazi O 0 5.887237080060004e-07
populations O 0 2.263786269551815e-09
at O 0 5.364486632686294e-10
rates O 0 1.1563082713550443e-09
comparable O 0 4.068293479875251e-10
with O 0 1.5688192064877704e-11
that O 0 5.64707058892111e-10
of O 0 3.419485139488643e-08
Ashkenazim O 0 2.7036665414925665e-05
. O 0 6.818484621362586e-07

The O 0 3.6588207308341225e-07
majority O 0 4.100563444353611e-09
of O 0 1.0927059257426208e-08
Jewish O 0 1.2159762263763696e-07
185delAG O 0 1.881265490055739e-07
mutation O 0 1.877682676010295e-09
carriers O 0 9.078698209874503e-11
have O 0 1.8130275059036194e-10
a O 0 9.962107805350229e-10
common O 0 2.8869013846133385e-09
allelic O 0 3.5640468354358745e-08
pattern O 0 7.837684390388233e-10
, O 0 3.3600316973192434e-11
supporting O 0 1.1990358705915583e-09
the O 0 4.889157967369329e-09
founder O 0 2.2718241510233383e-08
effect O 0 7.384724831638323e-09
notion O 0 6.50441744909358e-09
, O 0 4.699664962748429e-11
but O 0 1.0950242448903857e-11
dating O 0 9.858448501987027e-10
the O 0 1.463880544561036e-10
mutations O 0 5.6641441537053083e-11
origin O 0 8.756247810159934e-11
to O 0 2.913651542257867e-10
an O 0 3.720592584022242e-11
earlier O 0 2.6361435256916366e-10
date O 0 1.3201406190432863e-08
than O 0 3.625696964881797e-10
currently O 0 2.7635033150730237e-10
estimated O 0 4.898041416900867e-10
. O 0 2.748902083737903e-08

However O 0 3.682192684095753e-08
, O 0 2.6125276941790787e-10
the O 0 1.2231692048114695e-10
different O 0 1.743294571199261e-11
allelic O 0 9.245646026556642e-09
pattern O 0 1.1069003491570584e-09
at O 0 2.2656100995277484e-08
the O 0 4.323566216157815e-08
BRCA1 O 0 5.3944528843885564e-08
locus O 0 1.8784573896368784e-08
even O 0 7.705862059559365e-10
in O 0 4.1737882594539144e-10
some O 0 8.910983062548894e-11
Jewish O 0 6.764439675066569e-09
mutation O 0 5.420872639660956e-10
carriers O 0 9.166393338810863e-11
, O 0 4.6162518252401696e-11
might O 0 1.145031847116229e-09
suggest O 0 4.252516117020377e-09
that O 0 1.2129493243140388e-10
the O 0 2.0669013167662342e-09
mutation O 0 6.900181537261574e-10
arose O 0 8.368878923192824e-10
independently O 0 2.8198163803949683e-09
. O 0 4.102785222670491e-09
. O 0 7.534674040243772e-08

Crystal O 0 8.283454917545896e-07
structure O 0 3.3327799542348657e-07
of O 0 1.9236019852542086e-06
the O 0 4.0368104237131774e-06
hemochromatosis B-Disease 1 1.0
protein O 0 2.431698078453337e-07
HFE O 0 6.632355052715866e-06
and O 0 9.112532395327833e-10
characterization O 0 2.3544963312360778e-08
of O 0 2.6960522703234346e-08
its O 0 3.2339777522594204e-09
interaction O 0 2.14174478152529e-09
with O 0 7.251628464377546e-11
transferrin O 0 2.5561672600815655e-07
receptor O 0 5.934848701372175e-08
. O 0 1.6276449343877175e-07

HFE O 0 0.2775934338569641
is O 0 2.26459746954788e-07
an O 0 5.512251544104174e-09
MHC O 0 2.8725375500471273e-07
- O 0 1.5338198409153847e-06
related O 0 2.250410062742958e-07
protein O 0 4.853146329253377e-09
that O 0 1.441904755317136e-11
is O 0 8.107655714330309e-13
mutated O 0 1.2186446296524878e-10
in O 0 5.193946939208161e-10
the O 0 6.919588457776626e-08
iron B-Disease 1 1.0
- I-Disease 1 1.0
overload I-Disease 1 1.0
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 0.00045703916111961007

HFE O 0 0.00011029961751773953
binds O 0 9.969415515342916e-08
to O 0 3.7936040087060974e-08
transferrin O 0 2.7685109671438113e-07
receptor O 0 1.8756827202537352e-08
( O 0 4.5597936537689066e-10
TfR O 0 1.3474698334903223e-06
) O 0 3.9453670885869485e-10
and O 0 8.777149146377283e-11
reduces O 0 2.2359831763907323e-09
its O 0 4.879810999725009e-10
affinity O 0 4.499638439625642e-09
for O 0 3.83409082260755e-09
iron O 0 1.0399387662118897e-07
- O 0 6.619386994088927e-08
loaded O 0 2.6158911481388714e-08
transferrin O 0 1.6416956327702792e-07
, O 0 3.2766329649547288e-09
implicating O 0 3.1191802918328904e-07
HFE O 0 0.00021062642917968333
in O 0 5.980512014502892e-07
iron O 0 0.038155559450387955
metabolism O 1 0.9791703224182129
. O 0 1.8370673160461592e-06

The O 0 3.6019455365021713e-06
2 O 0 3.3194651223311666e-06
. O 0 9.705538559501292e-07

6 O 0 7.749179530947004e-06
A O 0 1.1920652696062461e-06
crystal O 0 7.763834020124705e-08
structure O 0 4.99442307955178e-07
of O 0 2.101590325764846e-06
HFE O 1 0.999796450138092
reveals O 0 5.020745774686475e-08
the O 0 7.891294839801333e-10
locations O 0 1.6249593670636386e-08
of O 0 9.561087210840924e-08
hemochromatosis B-Disease 1 1.0
mutations O 0 1.3004380150505312e-07
and O 0 2.2401023258566966e-09
a O 0 1.642525546685647e-07
patch O 0 0.0026096568908542395
of O 0 1.1930843584195827e-06
histidines O 0 6.29427086096257e-06
that O 0 8.880509522191105e-11
could O 0 2.7490879017655345e-10
be O 0 3.640415191519253e-10
involved O 0 3.983674501384371e-10
in O 0 5.872150765640072e-09
pH O 0 9.260965612156724e-07
- O 0 7.351028585844688e-08
dependent O 0 3.0474559764570586e-08
interactions O 0 9.539334655528364e-09
. O 0 6.112190220619595e-08

We O 0 1.40677025228797e-06
also O 0 2.0221481378257522e-08
demonstrate O 0 1.2143166827627283e-07
that O 0 1.392546300493791e-09
soluble O 0 9.285236046707723e-08
TfR O 0 1.1328323807902052e-06
and O 0 1.4594595532102517e-09
HFE O 0 1.7820840412241523e-06
bind O 0 1.601302379583558e-08
tightly O 0 2.7400764324170268e-08
at O 0 4.821253796194469e-08
the O 0 1.0361388191881815e-08
basic O 0 3.2057542398433725e-07
pH O 0 2.914069625603588e-07
of O 0 4.359468785963827e-09
the O 0 7.99202926060616e-09
cell O 0 3.366823975170519e-08
surface O 0 2.662283948851041e-09
, O 0 7.85707887640541e-11
but O 0 8.373202131650714e-11
not O 0 1.5748408133120506e-09
at O 0 1.542456118386326e-08
the O 0 5.087579069140702e-08
acidic O 0 9.180225788441021e-07
pH O 0 3.0191761197784217e-06
of O 0 8.57446096347303e-08
intracellular O 0 1.2499482409111806e-06
vesicles O 0 3.251729503972456e-05
. O 0 1.988901658478426e-06

TfR O 0 0.0004621099797077477
HFE O 0 0.00018569364328868687
stoichiometry O 0 1.7330945638605044e-06
( O 0 1.6373691291704517e-09
2 O 0 6.665095142466271e-09
1 O 0 1.6881120501466285e-08
) O 0 4.93258878186964e-10
differs O 0 3.515414848109799e-09
from O 0 1.194908061386002e-09
TfR O 0 1.742411939176236e-07
transferrin O 0 1.0523875104695435e-08
stoichiometry O 0 2.9447164706652984e-09
( O 0 2.3900792803233095e-11
2 O 0 3.531750725205285e-10
2 O 0 1.8010786195787887e-09
) O 0 2.1438235908721737e-10
, O 0 1.3464002135421538e-10
implying O 0 6.398008345342987e-09
a O 0 2.608614158017275e-10
different O 0 1.4139294769732746e-11
mode O 0 1.8455747152756885e-08
of O 0 5.743476250152924e-10
binding O 0 1.370141444745343e-09
for O 0 7.21037007878067e-09
HFE O 0 4.3930245738010854e-05
and O 0 3.985806884543308e-08
transferrin O 0 1.198207428387832e-06
to O 0 6.550984466002774e-08
TfR O 0 2.105733301505097e-06
, O 0 5.854008944261579e-10
consistent O 0 6.358882753687567e-09
with O 0 2.563980278091904e-11
our O 0 1.4515316948404688e-08
demonstration O 0 2.0515139809162974e-08
that O 0 6.073497815783924e-10
HFE O 0 5.548632088903105e-06
, O 0 6.687353337753166e-09
transferrin O 0 1.5687653842633154e-07
, O 0 2.065340565238216e-09
and O 0 7.445706828868026e-10
TfR O 0 5.267169171929709e-07
form O 0 5.373579914369486e-10
a O 0 1.6493898469249757e-09
ternary O 0 1.049957454313244e-08
complex O 0 1.352166805190791e-07
. O 0 4.3621167833407526e-07

Identification O 0 4.49553272119374e-06
of O 0 1.290009095100686e-07
three O 0 5.010561965335114e-10
novel O 0 1.179303321663383e-09
mutations O 0 2.61627747244475e-10
and O 0 5.2477373141401884e-11
a O 0 2.654387820655302e-10
high O 0 3.110097956948721e-09
frequency O 0 1.9370223469650227e-07
of O 0 2.0911985032512348e-08
the O 0 4.397167430170157e-08
Arg778Leu O 0 9.549347623760696e-07
mutation O 0 1.0769963809664773e-09
in O 0 2.9494479081293434e-10
Korean O 0 1.5756805282762798e-07
patients O 0 2.6576769673880563e-09
with O 0 8.053181732581294e-11
Wilson B-Disease 0 4.258890839992091e-07
disease I-Disease 0 7.690085368494692e-08
. O 0 9.573660975092935e-08

Four O 0 2.0000499034722452e-08
mutations O 0 4.3659742487989206e-10
- O 0 3.841183815467275e-09
- O 0 1.682971451089088e-08
R778L O 0 2.8242916982890165e-07
, O 0 1.7136120300520474e-10
A874V O 0 5.1722530258757615e-08
, O 0 6.518283135470426e-11
L1083F O 0 2.8096122761667175e-08
, O 0 1.5426392802053712e-11
and O 0 2.7704351399787663e-12
2304delC O 0 3.598908948632129e-10
- O 0 4.715730583804145e-10
- O 0 4.497493044652856e-09
in O 0 2.768115514584224e-09
the O 0 1.4205923548615829e-08
copper O 0 1.2748251343452921e-08
- O 0 2.4194086734041775e-09
transporting O 0 1.9302053289038668e-09
enzyme O 0 7.144941305270436e-10
, O 0 2.0875262629616032e-10
P O 0 5.266224434308242e-08
- O 0 5.114832646313516e-08
type O 0 2.0237250453192246e-07
ATPase O 0 1.5218649423331954e-05
( O 0 7.524786904689051e-10
ATP7B O 0 9.112112593356869e-07
) O 0 4.798723571286523e-11
, O 0 8.086686702213353e-12
were O 0 2.8778434496556926e-11
identified O 0 3.1985250559252165e-10
in O 0 1.886354406011037e-10
Korean O 0 3.9527495232505316e-07
Patients O 0 1.2202903576508106e-08
with O 0 5.2695826868731643e-11
Wilson B-Disease 0 3.445457252837514e-07
disease I-Disease 0 2.376852279439845e-07
. O 0 1.2240414548614353e-07

Arg778Leu O 0 2.1995358110871166e-05
, O 0 8.077187807487007e-09
the O 0 6.062066848500081e-09
most O 0 3.075797949669834e-10
frequently O 0 3.7763248084132783e-10
reported O 0 3.1335625760853247e-10
mutation O 0 8.398894357775077e-10
of O 0 7.227757281569325e-10
this O 0 8.207867718823536e-11
enzyme O 0 1.371890101520279e-10
, O 0 1.9497140013591263e-11
was O 0 2.503574569878708e-10
found O 0 1.321738551940399e-11
in O 0 4.225644487099167e-11
six O 0 3.3773431273864674e-10
of O 0 1.4459980435255204e-10
eight O 0 2.6669125241518543e-10
unrelated O 0 2.8842470078949134e-10
patients O 0 2.129844217657606e-10
studied O 0 2.5478223975028413e-09
, O 0 1.945094502131539e-10
an O 0 1.1287808882043393e-10
allele O 0 7.347367159127316e-09
frequency O 0 1.2381795500004955e-07
of O 0 2.7206930042211752e-08
37 O 0 1.061578473127156e-06
. O 0 1.34809317842155e-06

5 O 0 1.3042500768278842e-06
% O 0 1.3785986574532672e-08
, O 0 1.8004252255732212e-10
which O 0 1.33166307841881e-11
is O 0 2.96964774819386e-12
considerably O 0 1.1751913331359276e-10
higher O 0 3.052478825260607e-10
than O 0 1.3985286886897264e-11
those O 0 3.202259291068543e-11
in O 0 1.8872037266248753e-10
other O 0 8.091956549272084e-10
Asian O 0 8.377622862099088e-08
populations O 0 5.973207706233552e-09
. O 0 5.717065221233497e-08

The O 0 1.8885276631408487e-07
novel O 0 8.752215840956978e-09
single O 0 2.3153450268154074e-09
nucleotide O 0 1.0677868544917146e-07
deletion O 0 1.1387211884539283e-07
, O 0 5.472942099515876e-10
2304delC O 0 2.927491671300686e-08
, O 0 9.058426925223628e-11
was O 0 1.0853853371628475e-09
found O 0 2.0581196469304786e-10
in O 0 3.633817691195418e-10
one O 0 1.3966640066698233e-09
patient O 0 2.7501029009613376e-08
. O 0 1.431368872317762e-07

Since O 0 5.326248952997048e-08
a O 0 1.8155855707746582e-09
mutation O 0 1.1418710421651213e-10
at O 0 8.17627687776934e-10
cDNA O 0 1.811764072101596e-08
nucleotide O 0 2.167784032280906e-07
2302 O 0 2.8569413188961335e-05
( O 0 6.549479847350881e-10
2302insC O 0 3.0044528642747537e-08
) O 0 9.369460068908708e-11
had O 0 3.8856076689519625e-10
been O 0 2.809716348473046e-10
previously O 0 6.928616014256761e-10
described O 0 2.9414140567673996e-10
, O 0 5.249226400771967e-12
this O 0 6.595769503486837e-12
region O 0 2.4248913987889864e-10
of O 0 9.371144971126455e-10
the O 0 4.190765956479936e-09
ATP7B O 0 1.050115656653361e-06
gene O 0 3.284617244858623e-09
may O 0 1.3843104440525167e-09
be O 0 9.476401885422092e-10
susceptible O 0 6.976065058950098e-09
to O 0 7.946428404181916e-09
gene O 0 5.512107748018025e-08
rearrangements O 0 8.13837323221378e-06
causing O 0 2.468960929036257e-06
Wilson B-Disease 0 2.529966877773404e-05
disease I-Disease 0 1.0361862905483576e-06
. O 0 2.4966251999103406e-07

Disruption O 0 1.638204776099883e-05
of O 0 1.804566807095398e-07
splicing O 0 2.4171082912971542e-08
regulated O 0 3.372415235958215e-08
by O 0 9.254939592473477e-10
a O 0 2.7499809096553918e-09
CUG O 0 1.510617693156746e-07
- O 0 9.865747108150913e-10
binding O 0 9.70695968049995e-10
protein O 0 5.701859873141757e-09
in O 0 2.6874014125155554e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 6.107882654760033e-05

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.1274456710452796e-06
DM B-Disease 1 1.0
) O 0 9.742781692523295e-09
is O 0 3.725373343144156e-10
caused O 0 5.357758126045553e-10
by O 0 8.85716569531958e-11
a O 0 9.733118755406167e-10
CTG O 0 2.945863997183551e-08
expansion O 0 1.1555344459068806e-09
in O 0 2.782156449665507e-10
the O 0 7.124922318801907e-10
3 O 0 2.7527096158053155e-09
untranslated O 0 3.604463643114286e-07
region O 0 2.6554527465805222e-09
of O 0 3.6197078667754568e-09
the O 0 6.307619315748525e-08
DM B-Disease 1 1.0
gene O 0 1.2238750741744298e-06
. O 0 1.3457554359774804e-06

One O 0 1.0361526747715288e-08
model O 0 3.386131552929328e-08
of O 0 8.471511137031484e-08
DM B-Disease 1 1.0
pathogenesis O 1 0.9999943971633911
suggests O 0 1.5542742914931296e-07
that O 0 7.196952755972319e-11
RNAs O 0 7.826674308653025e-10
from O 0 2.8591842227143616e-09
the O 0 4.088442917549173e-09
expanded O 0 8.398546746946067e-09
allele O 0 3.042923690799171e-09
create O 0 4.008642376374105e-11
a O 0 1.7484702574677158e-10
gain O 0 1.8580703642356866e-09
- O 0 1.8273909052624049e-09
of O 0 1.2072719490774375e-09
- O 0 1.0647291937004866e-09
function O 0 3.241188706315512e-10
mutation O 0 1.346574796112776e-10
by O 0 1.1210862099764185e-11
the O 0 2.728074155466942e-10
inappropriate O 0 1.2667240589792073e-09
binding O 0 8.773087256663814e-10
of O 0 1.2431999873996347e-09
proteins O 0 1.203888932987951e-10
to O 0 3.1972275937874883e-09
the O 0 1.3632679873865072e-08
CUG O 0 1.922650699270889e-05
repeats O 0 3.0541482942680886e-07
. O 0 2.254884918784228e-07

Data O 0 5.138300025464559e-07
presented O 0 1.6376104028381633e-08
here O 0 1.3945299137674283e-08
indicate O 0 2.367673168635065e-08
that O 0 2.492810680099211e-10
the O 0 8.870424395013288e-10
conserved O 0 2.7750244324664664e-09
heterogeneous O 0 1.4944353310397673e-08
nuclear O 0 1.7581139388767042e-07
ribonucleoprotein O 0 1.8081897223964916e-07
, O 0 1.2957919182099431e-09
CUG O 0 1.4383613233803771e-07
- O 0 1.613251421339612e-09
binding O 0 1.0925949034401583e-09
protein O 0 7.471000484926549e-10
( O 0 4.161607863872874e-11
CUG O 0 2.4123096409311984e-07
- O 0 2.5743828402369218e-08
BP O 0 2.6872475800132634e-08
) O 0 4.851271467876117e-11
, O 0 4.064677067150413e-11
may O 0 8.906060333657706e-10
mediate O 0 3.3145568067993736e-08
the O 0 3.0060047784274957e-09
trans O 0 2.0729506999828118e-08
- O 0 3.356232269879911e-08
dominant O 0 6.863013712887778e-09
effect O 0 1.0968236097141926e-08
of O 0 1.4142383930604296e-09
the O 0 1.2275263028271866e-09
RNA O 0 1.8537136270424526e-08
. O 0 9.19166893709189e-08

CUG O 0 0.000288825249299407
- O 0 1.4298083442554343e-05
BP O 0 4.5489571220969083e-07
was O 0 1.7735791502104803e-08
found O 0 1.4088584465721254e-10
to O 0 5.4412765959632736e-11
bind O 0 8.587705546680979e-11
to O 0 7.849173533358567e-10
the O 0 1.8179245886429385e-09
human O 0 5.952099702000169e-09
cardiac O 1 0.9999847412109375
troponin O 0 0.0006868465570732951
T O 0 2.1526309410546673e-06
( O 0 4.812355514083322e-10
cTNT O 0 7.784029065760478e-08
) O 0 6.218733167306922e-11
pre O 0 5.347268583477671e-08
- O 0 3.7338332425918e-09
messenger O 0 1.8306841598203505e-09
RNA O 0 1.2009286898262417e-09
and O 0 1.61404459242398e-10
regulate O 0 1.144097372396402e-09
its O 0 3.776944312861019e-10
alternative O 0 2.000820664704861e-08
splicing O 0 1.8905188881035428e-07
. O 0 3.922209828033374e-07

Splicing O 0 7.604407414874004e-07
of O 0 2.1963575136396685e-07
cTNT O 0 4.759602688864106e-06
was O 0 9.181209037478766e-08
disrupted O 0 1.9581663934786775e-07
in O 0 1.6199871311073366e-07
DM B-Disease 1 1.0
striated O 0 9.058065188582987e-05
muscle O 0 7.389180041172949e-07
and O 0 1.5097824102028312e-09
in O 0 1.0121072868685133e-09
normal O 0 1.4548911408951426e-08
cells O 0 3.876194032415015e-09
expressing O 0 1.3209081606291306e-09
transcripts O 0 8.761084302477684e-09
that O 0 5.399789504423325e-10
contain O 0 1.3346197924590797e-08
CUG O 0 3.0813964713161113e-06
repeats O 0 9.78358514203137e-08
. O 0 2.1858343757230614e-07

Altered O 0 5.130601039127214e-06
expression O 0 7.847771144042781e-07
of O 0 3.7220459603304334e-08
genes O 0 1.885513523092186e-09
regulated O 0 2.7173429728577503e-08
posttranscriptionally O 0 4.026680358037993e-07
by O 0 4.910615913900074e-09
CUG O 0 4.834001447306946e-05
- O 0 2.9865923352190293e-06
BP O 0 1.6528368007584504e-07
therefore O 0 1.7132402163611005e-09
may O 0 1.0043861298214551e-09
contribute O 0 3.006222604184927e-09
to O 0 9.571250814133236e-08
DM B-Disease 1 1.0
pathogenesis O 0 0.04789090156555176
. O 0 8.95821656854423e-08
. O 0 2.2341431815675605e-07

Identification O 0 3.7198467452981276e-06
of O 0 1.2580667885231378e-07
a O 0 9.780166898565312e-09
novel O 0 2.4607137660836997e-08
nonsense O 0 1.307451498178125e-07
mutation O 0 3.0911615489515043e-09
and O 0 1.8439016979954204e-10
a O 0 7.097145093837298e-10
missense O 0 2.7386644063653875e-09
substitution O 0 6.6408327725753225e-09
in O 0 1.0322667165496568e-08
the O 0 3.860539266042906e-08
vasopressin O 0 1.809390141715994e-06
- O 0 8.39904643612499e-08
neurophysin O 0 2.569850323652645e-07
II O 0 1.2597009799719672e-06
gene O 0 3.5484915006378515e-09
in O 0 2.0278287937713912e-09
two O 0 1.1424206025623107e-09
Spanish O 0 1.1916453956928308e-07
kindreds O 0 5.224415531301929e-07
with O 0 1.682347927633998e-09
familial B-Disease 1 0.9933059811592102
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
. O 0 5.1806116971420124e-05

Familial B-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 9.597300021368937e-08
FNDI B-Disease 1 1.0
) O 0 5.75747449715891e-09
is O 0 8.077815638607433e-10
an O 0 1.610957589548434e-09
autosomal B-Disease 1 0.9999957084655762
dominant I-Disease 1 0.9999610185623169
disease I-Disease 1 0.9999942779541016
caused O 0 1.5742470438340206e-08
by O 0 1.221690942854181e-10
deficiency O 0 1.779909553079051e-08
in O 0 1.6182569950728976e-08
the O 0 3.3104885233115056e-07
antidiuretic O 0 6.3953539211070165e-06
hormone O 0 1.1738936223082419e-07
arginine O 0 9.213100327087886e-08
vasopressin O 0 8.866238232485557e-08
( O 0 5.598037311482784e-11
AVP O 0 7.987551953192451e-08
) O 0 3.7499864324885834e-12
encoded O 0 1.460455020807494e-11
by O 0 3.2685649326014143e-11
the O 0 3.740541210106585e-09
AVP O 0 1.7325926819466986e-05
- O 0 2.8173619170956954e-07
neurophysin O 0 5.859080374648329e-06
II O 1 0.803644597530365
( O 0 1.2828916595708506e-08
AVP O 0 3.417059269850142e-05
- O 0 9.16680775731038e-08
NPII O 0 1.2765303836204112e-06
) O 0 2.971186074951504e-10
gene O 0 2.0233161812655e-09
on O 0 6.452472689488786e-08
chromosome O 0 3.243926300910971e-07
20p13 O 0 5.2085306379012764e-05
. O 0 9.153980613518797e-07

In O 0 1.3687211364299401e-08
this O 0 5.422040594282862e-10
study O 0 3.4365077450360104e-10
, O 0 1.934766409583677e-11
we O 0 9.238673714939694e-11
analyzed O 0 1.223258494498225e-09
two O 0 1.15013561174937e-10
families O 0 6.40804076468271e-11
with O 0 1.250545778042067e-10
FNDI B-Disease 1 1.0
using O 0 1.2250594316753904e-08
direct O 0 7.449617367427663e-09
automated O 0 2.7291915216665075e-07
fluorescent O 0 5.3479315198501354e-08
, O 0 7.620692410448271e-10
solid O 0 3.4777538626684645e-09
phase O 0 3.653821911697719e-09
, O 0 9.767928133008752e-11
single O 0 4.744502013487306e-10
- O 0 1.12230458260143e-09
stranded O 0 2.1992148102611964e-09
DNA O 0 1.3174503155077844e-10
sequencing O 0 2.480291083628572e-09
of O 0 5.01618702131168e-09
PCR O 0 2.138759100489551e-06
- O 0 5.460265583678847e-06
amplified O 0 2.8079624826204963e-05
AVP O 0 0.00018352118786424398
- O 0 1.050206719810376e-06
NPII O 0 7.705934876867104e-06
DNA O 0 1.807222531624575e-07
. O 0 1.7766762994142482e-07

In O 0 2.4629862593883445e-08
one O 0 9.330551886677085e-10
of O 0 6.483394376921581e-10
the O 0 3.821749861021573e-10
families O 0 1.8975980509150503e-11
, O 0 1.4967150782640992e-11
affected O 0 1.2534273098607773e-11
individuals O 0 2.2734797985174415e-12
presented O 0 1.3352173811043144e-09
a O 0 1.7066652535646654e-09
novel O 0 7.129793200277845e-09
nonsense O 0 1.77234831255646e-08
mutation O 0 2.6796442842424995e-10
in O 0 1.3997729364501055e-10
exon O 0 2.3016382133533853e-09
3 O 0 2.2741248884017295e-09
of O 0 7.521084310901927e-10
the O 0 4.672165987429366e-10
gene O 0 1.1584423698085544e-10
, O 0 1.566206019043559e-11
consisting O 0 4.933213993557617e-12
in O 0 4.1436760273017015e-11
a O 0 5.492351018432373e-10
G O 0 3.0866676326013476e-08
to O 0 3.3482209005342156e-08
T O 0 1.0077989998080739e-07
transition O 0 3.6130121117139424e-08
at O 0 1.8416118408026705e-08
nucleotide O 0 1.9675516327311016e-08
2101 O 0 5.477552349475445e-07
, O 0 2.4383225993851454e-10
which O 0 8.958930060483372e-13
produces O 0 2.461721419159263e-13
a O 0 5.135752066676158e-12
stop O 0 1.5001139219705806e-10
signal O 0 2.5452044916107752e-09
in O 0 2.2884272254941607e-09
codon O 0 2.1263886651468056e-07
82 O 0 5.22554216786375e-07
( O 0 7.157288539616502e-09
Glu O 0 1.482828247389989e-05
) O 0 3.4030025464204527e-09
of O 0 2.865070669599845e-08
NPII O 0 4.71706734970212e-05
. O 0 4.874197543358605e-07

The O 0 7.0931724849288e-07
premature O 0 1.9876426904374966e-06
termination O 0 6.32663272881473e-08
eliminates O 0 4.371786488377438e-08
part O 0 3.273984194862578e-09
of O 0 2.1272155592555464e-08
the O 0 3.330558229208691e-08
C O 0 1.5290353871932894e-07
- O 0 2.5873374553953e-09
terminal O 0 6.062876423129637e-09
domain O 0 7.555610359588627e-09
of O 0 2.00433003527678e-09
NPII O 0 1.0904365126407356e-06
, O 0 1.936170113125968e-10
including O 0 1.5659261387579448e-10
a O 0 3.256686864627767e-10
cysteine O 0 3.6020267324410327e-10
residue O 0 2.0825808633162524e-08
in O 0 2.7420619108653455e-09
position O 0 5.610043558590405e-07
85 O 0 3.48206413036678e-07
, O 0 2.5960414373749074e-10
which O 0 9.453825743077626e-12
could O 0 1.883470115982e-11
be O 0 1.247215004884783e-11
involved O 0 6.916316044186521e-12
in O 0 1.3622450389938479e-10
the O 0 6.082241821303569e-09
correct O 0 2.8347454872346134e-07
folding O 0 2.1891911217153392e-07
of O 0 1.1723536808005974e-08
the O 0 3.658516689597491e-08
prohormone O 0 0.00019190151942893863
. O 0 8.013238925741462e-07

In O 0 9.56259693651873e-09
the O 0 7.667644297271181e-09
second O 0 1.6785570267074945e-08
family O 0 7.153873049503545e-10
, O 0 6.132886559706563e-11
a O 0 4.3251017350920407e-11
G279A O 0 1.28640464946983e-09
substitution O 0 1.4863329456105134e-09
at O 0 1.070144861614608e-09
position O 0 1.5744864301225903e-09
- O 0 1.2301492047228635e-09
1 O 0 8.873205281645369e-09
of O 0 1.7913249772405493e-09
the O 0 1.2112275626918745e-09
signal O 0 8.378865601343932e-09
peptide O 0 8.376017102129651e-10
was O 0 2.758622885679074e-09
observed O 0 6.26851515139748e-10
in O 0 5.748473919098274e-10
all O 0 5.448673734420595e-10
affected O 0 6.877766134394392e-10
individuals O 0 1.803786842113908e-10
. O 0 4.367311134956253e-08

This O 0 2.587354686056642e-07
missense O 0 7.0001251515350305e-06
mutation O 0 1.8715093119681114e-07
, O 0 2.2006414468478397e-09
which O 0 5.621622611862165e-10
replaces O 0 6.935344458725012e-07
Ala O 0 0.00043387047480791807
with O 0 6.544163877464371e-09
Thr O 1 0.9999634027481079
, O 0 2.225363449070983e-09
is O 0 3.055401417983994e-11
frequent O 0 1.581673264583472e-10
among O 0 8.425379838250535e-11
FNDI B-Disease 1 1.0
patients O 0 1.091349872694991e-06
and O 0 3.2077382416950684e-10
is O 0 1.7980023025998548e-10
thought O 0 1.2479610678184372e-09
to O 0 1.9593155986541433e-09
reduce O 0 8.36237390444694e-09
the O 0 7.583794037202551e-09
efficiency O 0 4.981275125715001e-08
of O 0 6.537551833218913e-09
cleavage O 0 1.0454707100038263e-09
by O 0 1.477429512064532e-09
signal O 0 5.942233656242024e-07
peptidases O 0 2.422181523797917e-06
. O 0 3.0230598468961034e-08
. O 0 3.291348775746883e-07

Genetic O 0 1.3022342955082422e-06
heterogeneity O 0 3.902181902049051e-07
of O 0 1.6380798228965432e-07
Saethre B-Disease 1 0.9999961853027344
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 1.4517580471107294e-09
due O 0 1.702560439298395e-07
to O 0 8.587178257357664e-08
TWIST O 0 3.1440358725376427e-06
and O 0 1.0693908336634195e-07
FGFR O 0 0.00045850450987927616
mutations O 0 2.484888455001055e-07
. O 0 7.104301857907558e-07

Thirty O 0 1.0360486157878768e-05
- O 0 3.0197807063814253e-06
two O 0 1.3681253907549262e-09
unrelated O 0 4.498676986486316e-09
patients O 0 5.072894326829669e-10
with O 0 5.495622403331457e-13
features O 0 1.3134817677951105e-09
of O 0 2.9237584797670024e-08
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 3.0101816594907405e-09
a O 0 1.0153464735651596e-08
common O 0 4.859994078287855e-06
autosomal B-Disease 1 0.9999932050704956
dominant I-Disease 1 0.7373878359794617
condition I-Disease 1 1.0
of O 1 0.9999226331710815
craniosynostosis B-Disease 1 1.0
and O 0 1.664935734879691e-05
limb B-Disease 1 1.0
anomalies I-Disease 1 0.999974250793457
, O 0 1.7002806940169535e-09
were O 0 1.265014648588192e-09
screened O 0 6.643619432367132e-09
for O 0 1.5123539753858495e-08
mutations O 0 8.265306772337055e-10
in O 0 1.1754010209585886e-08
TWIST O 0 7.679420832573669e-07
, O 0 6.078901826356287e-09
FGFR2 O 0 1.8061351738651865e-06
, O 0 2.736956661308909e-09
and O 0 3.910054502398452e-09
FGFR3 O 0 4.5115786633687094e-05
. O 0 7.699595130361558e-07

Nine O 0 1.4080545440720016e-07
novel O 0 9.91120607807261e-09
and O 0 1.1025155233213013e-09
three O 0 9.144603962951692e-10
recurrent O 0 4.8594841928206733e-08
TWIST O 0 2.72218869667995e-07
mutations O 0 8.20862666728317e-09
were O 0 1.7403692931239334e-09
found O 0 2.3330895548845376e-10
in O 0 3.307751850201157e-10
12 O 0 2.431595547136567e-08
families O 0 6.576844624461842e-10
. O 0 4.2236202091316954e-08

Seven O 0 5.018314297444704e-08
families O 0 8.068588158716139e-11
were O 0 1.681840083866959e-10
found O 0 8.296354575554332e-11
to O 0 6.760811910311304e-10
have O 0 6.567693611181369e-10
the O 0 1.527807391710212e-08
FGFR3 O 0 4.2502440919633955e-05
P250R O 0 4.060479113832116e-06
mutation O 0 5.974484018622661e-09
, O 0 1.0224251306700793e-10
and O 0 8.783814647861377e-11
one O 0 1.319587911163822e-10
individual O 0 3.85749349129938e-11
was O 0 2.0202273187663877e-09
found O 0 1.8289555980821603e-10
to O 0 2.178927038798406e-09
have O 0 8.099723114440849e-10
an O 0 6.425643905849654e-10
FGFR2 O 0 8.455978672827769e-07
VV269 O 0 8.236576718445576e-07
- O 0 9.856595539758928e-08
270 O 0 9.946775492153392e-08
deletion O 0 1.0374291150583304e-06
. O 0 5.782486596217495e-07

To O 0 4.745593074062526e-08
date O 0 9.236941878043581e-08
, O 0 5.975209771413859e-10
our O 0 2.8937854890109804e-10
detection O 0 1.914358893628787e-09
rate O 0 4.799879382844097e-10
for O 0 2.6937452268782636e-11
TWIST O 0 4.1816331730615275e-08
or O 0 1.8408602642239202e-08
FGFR O 0 4.895346592093119e-06
mutations O 0 2.9756170860650855e-09
is O 0 2.13726571163253e-11
68 O 0 8.064976464439155e-10
% O 0 3.628545380829351e-11
in O 0 5.008887402069284e-11
our O 0 2.23040741431646e-09
Saethre B-Disease 0 0.00021184474462643266
- I-Disease 1 0.9891992211341858
Chotzen I-Disease 1 0.9999997615814209
syndrome I-Disease 1 0.9999991655349731
patients O 0 5.88105315557641e-08
, O 0 1.5023322863516597e-11
including O 0 1.7927756501556757e-11
our O 0 3.326157349547998e-09
five O 0 2.7766750010371766e-10
patients O 0 8.048329364074291e-11
elsewhere O 0 7.704348270465289e-10
reported O 0 1.1506232633351487e-09
with O 0 1.465244370280061e-09
TWIST O 0 6.384995504049584e-05
mutations O 0 3.714582589964266e-06
. O 0 2.2334581899485784e-06

More O 0 1.489679846145009e-08
than O 0 3.2913949343793547e-10
35 O 0 3.0052020871806917e-09
different O 0 1.547272171498193e-10
TWIST O 0 7.157250792033665e-08
mutations O 0 4.633704975276487e-09
are O 0 3.7856329182517356e-11
now O 0 3.8577949862395045e-11
known O 0 1.3292478229232074e-10
in O 0 1.3779348495557286e-10
the O 0 7.391823819702381e-10
literature O 0 2.279602462351704e-08
. O 0 5.13808444679853e-08

The O 0 1.1696622550516622e-06
most O 0 2.6461395297161516e-09
common O 0 5.094585309173283e-10
phenotypic O 0 6.1417075869485416e-09
features O 0 1.2235874535804214e-09
, O 0 2.524075393139924e-11
present O 0 1.932406144822263e-11
in O 0 1.373848083907614e-11
more O 0 2.517045382885441e-12
than O 0 2.578121743868067e-12
a O 0 7.40692090994699e-11
third O 0 2.5496404987279675e-09
of O 0 5.28460275539544e-10
our O 0 1.673719163264309e-09
patients O 0 3.275419102610755e-10
with O 0 1.0050673834860469e-11
TWIST O 0 1.697732017191811e-07
mutations O 0 8.052656141899206e-08
, O 0 3.4372369395185842e-09
are O 0 7.274906232979106e-10
coronal B-Disease 0 6.267342769206152e-07
synostosis I-Disease 0 1.1485907634778414e-05
, O 0 2.3271187643558733e-08
brachycephaly B-Disease 0 1.4425623703573365e-05
, O 0 4.581689339033801e-08
low B-Disease 0 0.00037318142130970955
frontal I-Disease 1 0.9999998807907104
hairline I-Disease 1 1.0
, O 0 7.276838732650504e-05
facial B-Disease 1 1.0
asymmetry I-Disease 1 1.0
, O 0 9.14521990580397e-07
ptosis B-Disease 1 0.9999985694885254
, O 0 5.099947486542078e-08
hypertelorism B-Disease 0 0.00015212873404379934
, O 0 1.3309516155857182e-08
broad B-Disease 0 2.5661424842837732e-06
great I-Disease 1 0.5207335948944092
toes I-Disease 0 0.08159281313419342
, O 0 3.50786812930437e-08
and O 0 1.1877895111922498e-08
clinodactyly B-Disease 0 7.173121412051842e-05
. O 0 9.168711585516576e-07

Significant O 0 2.332666099391645e-06
intra O 0 8.971003262558952e-05
- O 0 2.99373868983821e-06
and O 0 1.6853549666961953e-08
interfamilial O 0 7.285977517312858e-06
phenotypic O 0 5.638132165586285e-07
variability O 0 4.177304546715277e-08
is O 0 6.987403711189444e-11
present O 0 3.8819687048219365e-11
for O 0 2.6415189480211154e-10
either O 0 4.1186232202505835e-09
TWIST O 0 4.43000715222297e-07
mutations O 0 6.040427535936033e-08
or O 0 2.4307190926720068e-08
FGFR O 0 1.3193599443184212e-05
mutations O 0 1.0524018989599426e-07
. O 0 3.041371030576556e-07

The O 0 2.818780728830461e-07
overlap O 0 7.1153651859390266e-09
in O 0 7.152808900734442e-10
clinical O 0 5.75679370840021e-09
features O 0 1.488264095295122e-10
and O 0 2.2661513290889168e-11
the O 0 2.47885684201421e-10
presence O 0 1.6744144959446317e-10
, O 0 7.117282024154958e-12
in O 0 2.295471972224572e-11
the O 0 9.590681027127346e-11
same O 0 5.312989284633751e-11
genes O 0 1.6007815906160516e-10
, O 0 6.18308668154377e-11
of O 0 1.628839840783769e-10
mutations O 0 2.0677994039264291e-10
for O 0 9.423280211695584e-11
more O 0 8.147857388784985e-12
than O 0 2.1179211162625222e-11
one O 0 8.638369186630968e-11
craniosynostotic B-Disease 0 2.665837151027972e-08
condition I-Disease 0 7.393818890477633e-08
- O 0 1.1430925539457348e-08
such O 0 1.057883114441438e-09
as O 0 1.76864278778055e-09
Saethre B-Disease 0 4.542740441593196e-07
- I-Disease 0 2.4340222282148716e-08
Chotzen I-Disease 0 1.7315547893304029e-06
, I-Disease 0 7.288725734078128e-10
Crouzon I-Disease 0 8.847216122376267e-06
, I-Disease 0 2.329178183657632e-09
and I-Disease 0 3.6123282143307733e-09
Pfeiffer I-Disease 0 8.654601697344333e-05
syndromes I-Disease 1 0.7544131278991699
- O 1 0.7543231844902039
support O 1 0.9995896220207214
the O 0 0.00024626668891869485
hypothesis O 0 1.6532986535366945e-07
that O 0 4.9038904881282264e-11
TWIST O 0 1.229035717642546e-08
and O 0 8.147741925590424e-10
FGFRs O 0 2.2505365393499233e-07
are O 0 4.8222856263713254e-11
components O 0 2.144401545223218e-09
of O 0 5.103476752310598e-09
the O 0 3.3303788615768326e-09
same O 0 4.517238250123512e-10
molecular O 0 2.91654839168487e-10
pathway O 0 9.749240303946749e-11
involved O 0 1.1726583246107758e-11
in O 0 1.3186268743581309e-10
the O 0 8.68281357924161e-09
modulation O 0 0.0001303033932344988
of O 0 1.7268320107177715e-06
craniofacial O 1 1.0
and O 0 2.0047914404131006e-06
limb O 0 0.0004963395185768604
development O 0 3.413353795167495e-07
in O 0 4.267442399452648e-09
humans O 0 1.6969080585127472e-09
. O 0 4.361180028222833e-10
. O 0 6.575016975318704e-09

Mutation O 0 2.3274472127354784e-08
analysis O 0 2.8127311590964155e-09
of O 0 8.071073587245792e-09
UBE3A O 1 0.9072719216346741
in O 0 0.0012021558359265327
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 5.974321538815275e-05
. O 0 1.0834131813908243e-07

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.5429746724748838e-07
AS B-Disease 1 1.0
) O 0 1.5400154484979112e-09
is O 0 9.936199779625454e-11
caused O 0 2.852548197651572e-10
by O 0 5.336897937469054e-11
chromosome O 0 1.0280539974871772e-08
15q11 O 0 1.141649818237056e-06
- O 0 3.37281193196759e-07
q13 O 0 2.7772928206104552e-06
deletions O 0 9.83359242923143e-08
of O 0 1.9572350407059957e-09
maternal O 0 4.840843814690743e-08
origin O 0 4.898164984723508e-09
, O 0 1.1288520118668544e-10
by O 0 2.0812208900711227e-10
paternal O 1 0.9995294809341431
uniparental B-Disease 1 1.0
disomy I-Disease 1 1.0
( O 0 8.383825189639538e-08
UPD B-Disease 1 1.0
) O 0 1.1823122481047221e-09
15 O 0 1.0569195296739053e-08
, O 0 1.3345471949754995e-10
by O 0 2.328563730724653e-10
imprinting O 0 2.8131005819886923e-05
defects O 0 1.1244519555475563e-05
, O 0 4.6540307718778706e-10
and O 0 4.355857341487024e-11
by O 0 4.3743241667781874e-11
mutations O 0 1.8572793303306412e-10
in O 0 2.6926849638897465e-09
the O 0 8.107458882022911e-08
UBE3A O 0 3.11514304485172e-05
gene O 0 1.9874482859449927e-07
. O 0 1.0771620964078465e-06

UBE3A O 0 0.0009590997360646725
encodes O 0 7.409869908769906e-07
a O 0 4.239301887309921e-08
ubiquitin O 0 1.5211485404620362e-08
- O 0 1.3721087377405183e-08
protein O 0 1.6517344436639547e-10
ligase O 0 3.979120144492754e-09
and O 0 1.584899322892852e-09
shows O 0 3.852874641552262e-08
brain O 0 5.393438300416165e-07
- O 0 8.389520189666655e-08
specific O 0 1.4770054690416146e-07
imprinting O 0 0.00013325003965292126
. O 0 2.9346056180656888e-06

Here O 0 3.135177450985793e-07
we O 0 2.4666016784635758e-08
describe O 0 3.329135722651699e-08
UBE3A O 0 2.0225943444529548e-05
coding O 0 1.036357025441248e-05
- O 0 5.533751391340047e-06
region O 0 1.3848635660451691e-07
mutations O 0 1.0567688235596506e-07
detected O 0 2.4057108305441943e-08
by O 0 1.0970400976528794e-10
SSCP O 0 4.1326012478748453e-07
analysis O 0 1.9840493692413474e-09
in O 0 5.764911326089361e-10
13 O 0 2.355259809405652e-08
AS B-Disease 1 0.9999998807907104
individuals O 0 6.790066425788055e-11
or O 0 3.326041664308832e-10
families O 0 1.8753909536428637e-10
. O 0 8.359215541986487e-09

Two O 0 7.408485203086457e-08
identical O 0 2.219696781935454e-08
de O 0 4.428773934250785e-07
novo O 0 3.118763913789735e-07
5 O 0 3.509582029437297e-07
- O 0 5.764629804616561e-07
bp O 0 1.5114780183012044e-07
duplications O 0 1.8921224409496062e-07
in O 0 7.576535843156762e-09
exon O 0 1.1584062775682469e-07
16 O 0 5.664822211315368e-08
were O 0 1.4374749390810848e-08
found O 0 1.592026066532526e-08
. O 0 1.23111377092755e-07

Among O 0 5.570703720536585e-08
the O 0 6.557070442170243e-09
other O 0 2.6549448750579074e-10
11 O 0 1.5638136341422637e-09
unique O 0 8.924730954262827e-10
mutations O 0 2.275118538008769e-09
, O 0 1.409070776725585e-10
8 O 0 1.0518756532462703e-08
were O 0 1.1485101758523797e-08
small O 0 2.727674974778438e-09
deletions O 0 2.0982268722491426e-07
or O 0 9.912491272245916e-09
insertions O 0 5.997824104042593e-08
predicted O 0 1.179324193856246e-08
to O 0 2.839857460301687e-09
cause O 0 7.982888128310606e-09
frameshifts O 0 5.8848460326998975e-08
, O 0 8.735628886924474e-11
1 O 0 3.5081337834697024e-09
was O 0 3.1230924513181435e-09
a O 0 3.096151668380287e-10
mutation O 0 8.796053468929088e-11
to O 0 1.6180330686399458e-10
a O 0 1.5227756555713512e-10
stop O 0 3.991074415399254e-10
codon O 0 1.37462274896194e-09
, O 0 3.4069868454222885e-11
1 O 0 1.5710844847305339e-09
was O 0 8.114989569207864e-09
a O 0 1.185527787050944e-09
missense O 0 2.3454511222098517e-08
mutation O 0 4.620614446615434e-10
, O 0 2.2625666964981583e-11
and O 0 1.6566239699478125e-11
1 O 0 3.5871099424156228e-09
was O 0 1.0682101425629753e-08
predicted O 0 1.0882693857183767e-08
to O 0 2.6356319349218893e-09
cause O 0 1.5930885499670921e-09
insertion O 0 7.267282331469005e-09
of O 0 1.0795100813254521e-08
an O 0 1.6439594130446267e-09
isoleucine O 0 1.6316809023919632e-06
in O 0 1.0325621246920491e-08
the O 0 3.606251297583185e-08
hect O 0 6.922545026100124e-07
domain O 0 1.560879248074798e-08
of O 0 4.6711616796812905e-09
the O 0 5.701414451664277e-09
UBE3A O 0 1.9359081306902226e-06
protein O 0 2.744159788292677e-09
, O 0 2.911594923493688e-11
which O 0 3.254876836805698e-12
functions O 0 1.1260994220441134e-10
in O 0 4.761645522322056e-10
E2 O 0 5.4089799306211717e-08
binding O 0 7.458674566862555e-09
and O 0 1.5538740294473996e-09
ubiquitin O 0 2.2504544006096694e-08
transfer O 0 2.7248691480963316e-07
. O 0 5.773807743025827e-07

Eight O 0 4.4611766725211055e-07
of O 0 1.6757516263510297e-08
the O 0 1.870355204047769e-09
cases O 0 3.4568920642685796e-11
were O 0 1.2549948580353742e-10
familial O 0 6.5482841371533596e-09
, O 0 8.216408109440465e-10
and O 0 7.392091383451316e-10
five O 0 6.21809892464853e-09
were O 0 1.0467241295941676e-08
sporadic O 0 9.687432793725748e-07
. O 0 5.093471827422036e-06

In O 0 7.404565280921815e-07
two O 0 1.2484902001119735e-08
familial O 0 4.2519911147564926e-08
cases O 0 7.45086381481741e-10
and O 0 8.876412105340847e-11
one O 0 9.908852210971375e-11
sporadic O 0 4.297566746913617e-09
case O 0 3.1313536208443793e-09
, O 0 1.790672499168977e-09
mosaicism O 0 1.1528552022355143e-05
for O 0 8.416670738142784e-08
UBE3A O 0 2.132271220034454e-05
mutations O 0 6.538710906056622e-09
was O 0 2.5574087292312697e-09
detected O 0 2.9519803268485134e-10
in O 0 3.4535176801631096e-11
the O 0 2.1093472801769764e-10
mother O 0 3.187033692508834e-10
of O 0 2.4253909991500677e-10
three O 0 7.207008601017861e-11
AS B-Disease 1 0.9999996423721313
sons O 0 1.0060528410349434e-08
, O 0 1.774720301273014e-11
in O 0 2.9100733975329085e-11
the O 0 1.8858112293962392e-10
maternal O 0 1.8017242382484255e-06
grandfather O 0 0.00015880222781561315
of O 0 0.34296223521232605
two O 0 3.55589622813568e-06
AS B-Disease 1 1.0
first O 0 3.850549546768889e-06
cousins O 0 9.028408243239028e-08
, O 0 1.0855359666717135e-10
and O 0 2.5596412142614433e-11
in O 0 1.4662284719690888e-09
the O 0 1.499832791296285e-07
mother O 0 2.0713855519716162e-08
of O 0 1.2928579451454425e-07
an O 0 2.0517683552156996e-08
AS B-Disease 1 1.0
daughter O 0 0.07204694300889969
. O 0 3.945951539208181e-05

The O 0 1.3893361483496847e-07
frequencies O 0 1.2469908661216778e-08
with O 0 1.7508520674947015e-11
which O 0 1.575920990926072e-11
we O 0 1.8245618904622063e-10
detected O 0 5.700248051354606e-10
mutations O 0 1.457720055775269e-10
were O 0 7.995576978281349e-10
5 O 0 2.666649345783867e-09
( O 0 6.607168284711307e-11
14 O 0 8.203504542336759e-10
% O 0 3.472269000104333e-11
) O 0 1.043039699749615e-11
of O 0 3.977848953007346e-11
35 O 0 2.8240509930554936e-10
in O 0 2.3860800488217926e-11
sporadic O 0 1.7090365789229622e-09
cases O 0 3.929399167157399e-11
and O 0 4.723650637306065e-11
8 O 0 9.425788149997061e-09
( O 0 1.0599043170911315e-10
80 O 0 1.3757426309268794e-09
% O 0 3.739032000682485e-11
) O 0 2.0302145381512204e-11
of O 0 7.712813027138665e-11
10 O 0 3.300630324609699e-10
in O 0 2.006206867299909e-10
familial O 0 1.2540366967073169e-08
cases O 0 1.1599485816304878e-09
. O 0 1.899087997969673e-09
. O 0 4.192358815657826e-08

The O 0 1.5500554582104087e-05
hemochromatosis B-Disease 1 1.0
845 O 0 2.829370941981324e-07
G O 0 9.710573678489709e-09
- O 0 2.1630512936354762e-09
- O 0 3.067328169237271e-09
> O 0 1.6939047497999127e-08
A O 0 2.4720023805713254e-09
and O 0 5.713532511691932e-12
187 O 0 1.7152863851510602e-10
C O 0 1.1310061331926136e-08
- O 0 1.2373245539265554e-08
- O 0 1.302251320112191e-07
> O 0 2.391037241977756e-06
G O 0 1.2679535075221793e-06
mutations O 0 1.916515302013977e-08
: O 0 1.4922690860785792e-10
prevalence O 0 1.6407463832024405e-08
in O 0 1.9029994247077298e-10
non O 0 2.6677705022848386e-07
- O 0 2.0204505801757477e-07
Caucasian O 0 2.3368535551071545e-07
populations O 0 4.500910932847546e-08
. O 0 1.0533297256642982e-07

Hemochromatosis B-Disease 0 0.0016361658927053213
, O 0 2.9606782803170972e-08
the O 0 5.254072220850503e-06
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 1 1.0
iron I-Disease 1 1.0
metabolism I-Disease 1 1.0
, O 0 9.423329316859963e-08
leads O 0 1.0416797380230491e-07
, O 0 1.4244851964662075e-09
if O 0 1.9968060982478164e-08
untreated O 0 3.0429304388235323e-05
, O 0 1.7248670269864874e-09
to O 0 2.1910971099714516e-06
progressive O 1 1.0
iron B-Disease 1 1.0
overload I-Disease 1 0.999992847442627
and O 0 7.746586305756864e-08
premature B-Disease 0 1.3156397471902892e-05
death I-Disease 0 8.936558515415527e-07
. O 0 4.1341149881191086e-07

The O 0 4.464151061256416e-05
hemochromatosis B-Disease 1 1.0
gene O 0 5.62147397431545e-06
, O 0 1.6752753850823865e-08
HFE O 0 0.001245063845999539
, O 0 1.672797722562791e-08
recently O 0 1.2031922125288474e-08
has O 0 4.453390781145039e-11
been O 0 1.9755735242155126e-11
identified O 0 2.352132932870177e-10
, O 0 4.3625589252194175e-11
and O 0 8.822887559434278e-11
characterization O 0 1.1415869138886592e-08
of O 0 1.4759599764602171e-08
this O 0 6.840950028674797e-10
gene O 0 2.556940437159483e-09
has O 0 1.1672185440403382e-10
shown O 0 1.4453142849202294e-10
that O 0 8.764865569443892e-12
it O 0 3.0268849492837147e-12
contains O 0 3.696343144760084e-12
two O 0 1.6458143441838713e-12
mutations O 0 1.1000379426806539e-11
that O 0 2.407174936810974e-12
result O 0 1.4173991841337497e-11
in O 0 1.0003840811290132e-10
amino O 0 5.808250061467568e-11
acid O 0 5.2087369140085826e-11
substitutions O 0 1.0005290346226658e-10
- O 0 3.21198553865365e-11
cDNA O 0 6.657061568660083e-10
nucleotides O 0 1.195762378003451e-10
845 O 0 7.507010568730266e-10
G O 0 3.652433078205064e-10
- O 0 1.1604199823267436e-09
- O 0 3.3713656311107343e-09
> O 0 2.004380661446703e-08
A O 0 2.9191948414108992e-08
( O 0 2.0463911815093994e-11
C282Y O 0 6.8314087720011685e-09
) O 0 4.109694789339313e-12
and O 0 2.7887258474690313e-12
187 O 0 1.8969294190984698e-10
C O 0 1.8789162226084954e-08
- O 0 3.033716922118401e-08
- O 0 3.382788236194756e-07
> O 0 1.0715403959693504e-06
G O 0 6.102824841036636e-07
( O 0 8.865722600504e-10
H63D O 0 2.530416622903431e-06
) O 0 2.6323414559215053e-09
. O 0 4.103773321162407e-08

Although O 0 5.901885378989391e-05
hemochromatosis B-Disease 1 1.0
is O 0 2.183657477061729e-09
common O 0 9.219204566424111e-11
in O 0 5.557408006007236e-11
Caucasians O 0 4.067894110448833e-08
, O 0 1.2580410324591895e-10
affecting O 0 1.7058970902539272e-09
> O 0 2.3324199460716954e-08
= O 0 2.1309434217187118e-08
1 O 0 7.87112597322448e-09
/ O 0 4.342343018493011e-08
300 O 0 2.685770716936986e-09
individuals O 0 3.0809754053562344e-11
of O 0 2.3006979654738302e-10
northern O 0 2.687615463514703e-09
European O 0 6.297687704659438e-09
origin O 0 7.855392780697912e-09
, O 0 1.8832699288928723e-10
it O 0 2.0594184343969424e-11
has O 0 2.223735084960765e-12
not O 0 1.2257773789048354e-11
been O 0 2.617384260716893e-11
recognized O 0 1.5778826856216455e-10
in O 0 1.398113291806169e-10
other O 0 1.9305945730963003e-10
populations O 0 9.286661994956091e-10
. O 0 2.6436939748464283e-08

The O 0 3.045707330784353e-07
present O 0 3.1149363088900373e-09
study O 0 1.2706661278727438e-09
used O 0 9.250915589120723e-10
PCR O 0 2.3433761597857483e-08
and O 0 3.457777397741779e-10
restriction O 0 1.0366784763959913e-08
- O 0 1.8109744259753313e-10
enzyme O 0 1.4050605297299956e-11
digestion O 0 2.8704444376970173e-10
to O 0 3.3062677595729895e-11
analyze O 0 9.983292664772492e-11
the O 0 4.9049101585874055e-11
frequency O 0 6.403318764114374e-09
of O 0 5.112291145970005e-10
the O 0 4.913236484327399e-10
845 O 0 9.79461067807108e-10
G O 0 5.533834501747492e-10
- O 0 7.658870204707569e-10
- O 0 1.3693522982194395e-09
> O 0 7.314814531866887e-09
A O 0 1.5017894705593449e-09
and O 0 5.576911762256165e-12
187 O 0 3.546295548884082e-11
C O 0 7.138362123626507e-10
- O 0 5.806325420465441e-10
- O 0 8.087532421541255e-09
> O 0 2.223952293434195e-07
G O 0 1.617831912881229e-07
mutations O 0 5.272101422093556e-09
in O 0 9.882358265045355e-10
HLA O 0 1.7258460616176308e-07
- O 0 1.200013883817519e-07
typed O 0 1.2971692342489405e-07
samples O 0 1.503739355257494e-08
from O 0 1.6812147507483388e-10
non O 0 3.684483118604476e-08
- O 0 2.044389191269147e-08
Caucasian O 0 1.4628296796104223e-08
populations O 0 1.267371874114076e-09
, O 0 4.1841884124149686e-11
comprising O 0 1.2346593192269495e-10
Australian O 0 1.439082542020742e-08
Aboriginal O 0 2.4652045738093875e-08
, O 0 2.7931134835568194e-11
Chinese O 0 4.2824757628956434e-10
, O 0 3.1788606469351777e-11
and O 0 1.0849025844361648e-10
Pacific O 0 1.0810764905500037e-07
Islanders O 0 3.309448175059515e-06
. O 0 2.823718148192711e-07

Results O 0 1.7465461610299826e-07
showed O 0 1.1309759351263438e-08
that O 0 8.768866188724189e-11
the O 0 2.644947316721158e-10
845 O 0 4.8384873885254365e-09
G O 0 1.9730570954834548e-08
- O 0 1.755867806707556e-08
- O 0 2.7183848061440585e-08
> O 0 1.0540813377701852e-07
A O 0 7.996969308976531e-09
mutation O 0 3.8870531793300245e-10
was O 0 8.813485358194484e-11
present O 0 1.372397161192307e-11
in O 0 2.83927464872491e-11
these O 0 1.7012197206511814e-11
populations O 0 2.6802665989422714e-11
( O 0 5.005609208380557e-12
allele O 0 5.948192494109605e-10
frequency O 0 1.2990459818951194e-09
0 O 0 2.3284218997332573e-10
. O 0 5.8024703097903085e-11
32 O 0 3.902304035463544e-10
% O 0 2.37137098152429e-11
) O 0 1.522983995860816e-11
, O 0 1.0975313539940412e-11
and O 0 8.735958137440214e-12
, O 0 6.545551860942522e-12
furthermore O 0 1.1153728635138194e-10
, O 0 9.20953417693493e-12
it O 0 7.627024879719446e-12
was O 0 6.015186682084561e-10
always O 0 7.321399597692846e-10
seen O 0 1.004160199435944e-09
in O 0 1.5942548670100365e-10
conjunction O 0 7.441494087601086e-09
with O 0 4.734521663607438e-10
HLA O 0 3.7921536204521544e-06
haplotypes O 0 7.916146671504976e-08
common O 0 4.4580333868893263e-10
in O 0 6.793175050257005e-11
Caucasians O 0 2.2966260004864125e-09
, O 0 2.3057838624551685e-11
suggesting O 0 5.137579250913404e-10
that O 0 1.5650803569799976e-11
845 O 0 3.6778111667246094e-09
G O 0 2.931291298580163e-08
- O 0 1.810942222846279e-07
- O 0 4.655003351672349e-07
> O 0 2.7555011001823004e-06
A O 0 1.0603040578871514e-07
may O 0 3.9579113320087345e-09
have O 0 8.95212376450516e-11
been O 0 5.454431351026301e-11
introduced O 0 5.784769885330832e-10
into O 0 3.734684436706992e-11
these O 0 1.1224854379321414e-11
populations O 0 4.002713438477912e-11
by O 0 4.073416257077689e-11
Caucasian O 0 6.847548661426117e-08
admixture O 0 4.2631248220459383e-07
. O 0 7.258584560076997e-07

187 O 0 7.870769280771128e-08
C O 0 7.323375683654376e-08
- O 0 7.234808752087929e-09
- O 0 1.4492383293429612e-08
> O 0 6.142880693005282e-08
G O 0 5.283116522036835e-08
was O 0 3.1091549335116042e-09
present O 0 7.856418987595148e-11
at O 0 1.2608858401819134e-09
an O 0 4.2014058898587336e-11
allele O 0 9.06889008334133e-10
frequency O 0 6.234142979621993e-09
of O 0 2.826644251996413e-09
2 O 0 1.7661936624335794e-07
. O 0 6.662148166469706e-07

68 O 0 1.1689151051541558e-06
% O 0 2.531358012092255e-09
in O 0 9.562100000692908e-10
the O 0 1.8350121422372467e-09
two O 0 1.3347686844689122e-10
populations O 0 2.289788358922351e-10
analyzed O 0 1.1679903266781366e-08
( O 0 2.210607696895295e-09
Australian O 0 1.484869471823913e-06
Aboriginal O 0 4.1972634789999574e-07
and O 0 4.405020237463475e-10
Chinese O 0 1.5235238848276822e-08
) O 0 2.8479558711325126e-09
. O 0 5.236407218944805e-08

In O 0 4.22036663394465e-08
the O 0 4.32086224577688e-08
Australian O 0 1.888250267256808e-07
Aboriginal O 0 2.972799073575061e-08
samples O 0 6.351061343501385e-10
, O 0 6.282081625730296e-12
187 O 0 9.627428715353048e-11
C O 0 6.701629029493006e-09
- O 0 4.41656489158504e-09
- O 0 2.4870713488667207e-08
> O 0 1.514063256990994e-07
G O 0 5.98328995238262e-08
was O 0 2.3857595898846284e-09
found O 0 6.532957508298409e-11
to O 0 1.7625566284262817e-10
be O 0 1.5130968700205472e-10
associated O 0 4.840518208482081e-09
with O 0 3.7614658610074514e-10
HLA O 0 0.0005773728480562568
haplotypes O 0 2.7179394237464294e-06
common O 0 5.372209788134796e-09
in O 0 3.171546358871069e-10
Caucasians O 0 1.4645801016399673e-08
, O 0 6.317484035900378e-11
suggesting O 0 1.0068585964972954e-09
that O 0 1.502223519189716e-11
it O 0 1.4956220290018862e-11
was O 0 6.73530176076298e-10
introduced O 0 9.560258140695055e-10
by O 0 5.93751228739059e-11
recent O 0 1.876465427486096e-09
admixture O 0 3.746233545598443e-08
. O 0 7.602493923286602e-08

In O 0 4.866329561536986e-08
the O 0 1.3172783752679607e-08
Chinese O 0 8.234564141673673e-09
samples O 0 8.41516967220457e-10
analyzed O 0 3.570261863927726e-10
, O 0 3.607422346951772e-11
187 O 0 2.852107439110796e-10
C O 0 6.958444043192458e-09
- O 0 2.6876769698702674e-09
- O 0 8.81547812525696e-09
> O 0 3.9213862379483544e-08
G O 0 1.5662353192169576e-08
was O 0 4.442483048094914e-10
present O 0 6.687499859436841e-11
in O 0 1.1254595172482951e-10
association O 0 2.0529093702759127e-10
with O 0 8.124657197017271e-12
a O 0 1.5588969004554087e-09
wide O 0 1.9449730714882207e-09
variety O 0 2.7013269399134288e-09
of O 0 4.323794655647362e-09
HLA O 0 8.526291708221834e-07
haplotypes O 0 1.273552072689199e-07
, O 0 6.039616029518413e-10
showing O 0 1.2879735056259278e-09
this O 0 8.636063392186699e-11
mutation O 0 1.3048090385936462e-10
to O 0 2.1739486599781088e-10
be O 0 3.5607136683601937e-10
widespread O 0 8.317301014582057e-11
and O 0 1.2942937520354914e-11
likely O 0 1.182197228999371e-09
to O 0 2.16613527115328e-09
predate O 0 9.89407880069848e-08
the O 0 3.276664273244023e-09
more O 0 3.521477554002672e-11
genetically O 0 2.0673932010772944e-10
restricted O 0 8.267735385203423e-10
845 O 0 5.6922542235327e-09
G O 0 2.9039231463912074e-08
- O 0 1.0807176664684448e-07
- O 0 1.419930555357496e-07
> O 0 1.0177932381338906e-06
A O 0 2.004522627885308e-07
mutation O 0 1.0890858703760387e-07
. O 0 4.8182933198859246e-08

Genotype O 0 2.4564411432947963e-05
- O 0 3.1471379315917147e-06
phenotype O 0 7.730675122274988e-08
correlations O 0 1.2512799685282516e-07
in O 0 3.1907964626043395e-07
attenuated B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
. O 0 0.0001943643146660179

Germ O 0 0.00043692978215403855
- O 0 1.3385655620368198e-05
line O 0 2.557913205691875e-07
mutations O 0 2.2937598487260402e-08
of O 0 2.4714331914310605e-08
the O 0 4.1427888675116264e-08
tumor B-Disease 0 5.541380119211681e-07
suppressor O 0 1.920549948408734e-06
APC O 0 4.600481062766448e-08
are O 0 1.4347562027339222e-10
implicated O 0 5.044010098487206e-09
in O 0 9.139381518252776e-08
attenuated B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 7.955696332828666e-07
AAPC B-Disease 1 1.0
) O 0 1.066835175755898e-09
, O 0 3.305428847300007e-11
a O 0 5.045737092035374e-11
variant O 0 5.928806956490007e-08
of O 0 4.611701115209144e-06
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 1.397126254687464e-07
FAP B-Disease 0 3.6265557810111204e-06
) O 0 7.155104952971669e-09
. O 0 7.636385390696887e-08

AAPC B-Disease 1 1.0
is O 0 1.8209760810350417e-08
recognized O 0 3.2068467881174456e-09
by O 0 7.972562887648138e-11
the O 0 1.0062921607101316e-09
occurrence O 0 1.244280056766911e-08
of O 0 3.305060447544861e-09
< O 0 1.3698385146199143e-06
100 O 0 2.418081805899419e-07
colonic B-Disease 0 1.6185909998966963e-06
adenomas I-Disease 0 3.9354659975288087e-07
and O 0 1.279674283205523e-10
a O 0 7.58223761554433e-11
later O 0 6.765519811047227e-10
onset O 0 0.015050523914396763
of O 0 0.00020780241175089031
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 1.6862278240381556e-10
age O 0 3.963604999768222e-10
> O 0 4.471064407596259e-09
40 O 0 2.1157389173964702e-09
years O 0 5.594272267650524e-10
) O 0 1.4276948512303989e-09
. O 0 6.501592508811882e-08

The O 0 1.5767297156799032e-07
aim O 0 2.7234611366111494e-07
of O 0 1.5155122712329216e-09
this O 0 1.2554018935517774e-10
study O 0 2.698354317764995e-10
was O 0 1.3311870494803202e-09
to O 0 2.4015882615913142e-09
assess O 0 1.660888813148631e-07
genotype O 0 6.368443905557797e-07
- O 0 3.98541533286334e-06
phenotype O 0 3.8057220308473916e-07
correlations O 0 1.277074375138909e-07
in O 0 1.5791358976002812e-07
AAPC B-Disease 1 1.0
families O 0 3.8835075599763513e-08
. O 0 1.4114263535702776e-07

By O 0 1.6463475027705954e-09
protein O 0 5.744221209802447e-10
- O 0 4.369192119213494e-09
truncation O 0 8.321120503751445e-08
test O 0 4.332448355626184e-08
( O 0 2.1508859138208436e-09
PTT O 0 6.096693141444121e-07
) O 0 2.7988037235027186e-11
assay O 0 1.4115705271322554e-09
, O 0 5.910416600585222e-11
the O 0 2.438741153465429e-10
entire O 0 6.97294888496458e-10
coding O 0 4.412761001049148e-08
region O 0 3.933084524732067e-09
of O 0 6.901501592437853e-09
the O 0 1.1397158772297189e-08
APC B-Disease 0 3.265828141252314e-08
gene O 0 1.1528947796435318e-09
was O 0 1.6459644758270997e-09
screened O 0 3.2242710723551227e-09
in O 0 4.3510933744883573e-10
affected O 0 2.0879402373719103e-10
individuals O 0 1.2136266817897035e-11
from O 0 6.622286052859749e-10
11 O 0 1.9262530770447484e-07
AAPC B-Disease 1 1.0
kindreds O 0 8.345787705366092e-07
, O 0 3.13828185660725e-10
and O 0 3.573843998516679e-11
their O 0 2.3276890137591266e-10
phenotypic O 0 4.2429256552622974e-08
differences O 0 9.582316273792912e-09
were O 0 5.235907707401566e-08
examined O 0 5.741345603382797e-07
. O 0 8.718245680938708e-07

Five O 0 7.335383855888722e-08
novel O 0 1.607293675931487e-08
germ O 0 1.0069244126498234e-05
- O 0 1.4382861763806432e-06
line O 0 1.558706657078801e-07
APC B-Disease 0 1.528030963982019e-07
mutations O 0 2.574233937124859e-09
were O 0 1.444113606474673e-09
identified O 0 3.834602857466507e-09
in O 0 1.0336478339922905e-08
seven O 0 1.2644923685911635e-07
kindreds O 0 6.596337698283605e-06
. O 0 1.0154160463571316e-06

Mutations O 0 3.179714838097425e-07
were O 0 9.92933291144027e-09
located O 0 1.3396765918827214e-09
in O 0 7.237110355440279e-10
three O 0 3.761263175916518e-11
different O 0 8.019043762352851e-12
regions O 0 4.384330745677012e-11
of O 0 1.2543805993914248e-09
the O 0 1.1183328041397544e-08
APC B-Disease 0 3.363556899671494e-08
gene O 0 8.988932376219338e-10
( O 0 1.9461397771092237e-11
1 O 0 1.1867744564852956e-09
) O 0 3.955884578243918e-11
at O 0 8.210752633353025e-10
the O 0 3.0295507769118046e-10
5 O 0 5.599171681858195e-10
end O 0 2.3426378614743726e-09
spanning O 0 3.1834010427722603e-10
exons O 0 5.544875114615877e-10
4 O 0 2.3200209808837968e-10
and O 0 3.8403592805824616e-11
5 O 0 8.553674990530169e-10
, O 0 1.3268465492988213e-10
( O 0 6.30883453117681e-12
2 O 0 2.2011106826091975e-10
) O 0 1.959608864066098e-11
within O 0 6.685612480294978e-11
exon O 0 9.792967547994635e-10
9 O 0 1.3939043252975125e-09
, O 0 1.0208175277304221e-10
and O 0 4.1291116359420954e-11
( O 0 5.133646112376322e-12
3 O 0 2.2081411699126363e-10
) O 0 2.7306341215949104e-11
at O 0 8.201189172218903e-10
the O 0 4.936673847488748e-10
3 O 0 1.390136783463447e-09
distal O 0 8.014896302199759e-09
end O 0 7.934649204344169e-08
of O 0 8.235506498976974e-09
the O 0 1.2110549896249267e-08
gene O 0 2.336881799180901e-08
. O 0 1.7806642915729753e-07

Variability O 0 1.4189291732691345e-06
in O 0 9.327709271644835e-09
the O 0 1.2281546446502034e-08
number O 0 2.139002219792019e-08
of O 0 5.618883278657449e-07
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 0 1.0547063311605598e-06
most O 0 2.1756203782974382e-10
apparent O 0 2.2474880290168642e-10
in O 0 3.1507314118828234e-11
individuals O 0 3.2001144355947586e-12
with O 0 1.2162609244401046e-12
mutations O 0 7.869947055150206e-11
in O 0 5.569571470687151e-10
region O 0 5.498181465668495e-09
1 O 0 9.746983096192707e-07
, O 0 1.224019441359303e-09
and O 0 7.779676458596896e-09
upper O 1 0.9999905824661255
- O 1 0.9999815225601196
gastrointestinal O 0 0.2623738646507263
manifestations O 0 1.8930550140794367e-06
were O 0 1.021988937921492e-09
more O 0 1.6611581901693206e-11
severe O 0 2.828945966371066e-10
in O 0 1.5783642448585766e-10
them O 0 6.897392657023715e-10
. O 0 6.386014206327673e-08

In O 0 1.1627401264036052e-08
individuals O 0 5.816698164795575e-11
with O 0 2.3804558584722413e-12
mutations O 0 7.530281953549434e-11
in O 0 4.8919604478392387e-11
either O 0 4.712233381276576e-10
region O 0 3.362225775571659e-10
2 O 0 3.006646931424939e-09
or O 0 5.199468078309621e-10
region O 0 1.712132102760222e-10
3 O 0 1.5061583091835473e-09
, O 0 7.486673780920938e-11
the O 0 2.2925240872329056e-10
average O 0 6.726225132425157e-10
number O 0 3.727726183289093e-10
of O 0 7.848260374920812e-10
adenomas B-Disease 0 9.924694950314006e-07
tended O 0 5.996268725994014e-08
to O 0 4.275002574161135e-09
be O 0 5.370424660533502e-10
lower O 0 8.106493254445013e-10
than O 0 1.096087890589681e-11
those O 0 9.896437835887895e-12
in O 0 2.2529892881872904e-11
individuals O 0 4.664761632522385e-12
with O 0 2.214161579777718e-12
mutations O 0 9.291582780956986e-11
in O 0 3.1221483731691535e-11
region O 0 1.253628867381451e-10
1 O 0 3.1974349834484883e-09
, O 0 8.30734439571934e-11
although O 0 1.0894022489660316e-10
age O 0 3.683341409654872e-10
at O 0 1.2542561433903643e-09
diagnosis O 0 1.1782138642502105e-07
was O 0 6.47589626368017e-09
similar O 0 1.4352002919437723e-09
. O 0 9.914347742778773e-08

In O 0 2.1187258880672744e-06
all O 0 8.828082513900881e-07
AAPC B-Disease 1 1.0
kindreds O 0 3.4218385280837538e-06
, O 0 1.3587062586140064e-09
a O 0 1.3649193997267162e-09
predominance O 0 2.688319682420115e-07
of O 0 2.7486353815220355e-07
right O 1 0.9731895923614502
- O 1 1.0
sided O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 1 0.999976634979248
rectal B-Disease 1 1.0
polyp I-Disease 0 0.006937037687748671
sparing O 0 5.069282451586332e-07
was O 0 6.605047531138553e-08
observed O 0 2.574456381410073e-08
. O 0 1.196816015180957e-07

No O 0 0.00011755814193747938
desmoid B-Disease 1 0.7389828562736511
tumors I-Disease 1 1.0
were O 0 1.6064822716543858e-07
found O 0 2.4663087128118377e-09
in O 0 1.6091732391032565e-09
these O 0 6.529613738592843e-09
kindreds O 0 3.305807922515669e-06
. O 0 7.637978569619008e-07

Our O 0 2.0174807104922365e-06
data O 0 5.2904777447793094e-08
suggest O 0 2.267234400221696e-09
that O 0 3.258176714537875e-11
, O 0 9.565141734224625e-11
in O 0 3.92276833238725e-09
AAPC B-Disease 1 1.0
families O 0 6.318824352646857e-10
, O 0 2.8870083407239733e-11
the O 0 6.348018638524522e-11
location O 0 5.7382232299119096e-09
of O 0 4.199871561638702e-09
the O 0 7.785692446304893e-08
APC B-Disease 0 3.014089543285081e-06
mutation O 0 1.852427189419359e-08
may O 0 1.0847836406924216e-08
partially O 0 2.880786098558019e-08
predict O 0 2.5577502338336444e-09
specific O 0 2.506289398240824e-09
phenotypic O 0 4.4828593104284664e-07
expression O 0 3.387139884125645e-07
. O 0 7.698478725615132e-07

This O 0 4.12020240148081e-09
should O 0 1.4475939336122678e-09
help O 0 1.3531407105915605e-09
in O 0 3.298314121824575e-10
the O 0 1.893445844558528e-09
design O 0 6.274358099744859e-08
of O 0 1.3480769389673242e-08
tailored O 0 1.4627592292981717e-07
clinical O 0 4.3371863966967794e-07
- O 0 1.098804887078586e-07
management O 0 1.1428199719887289e-08
protocols O 0 6.922188049429678e-07
in O 0 7.330817619610741e-10
this O 0 7.620354347537273e-11
subset O 0 6.946425656906285e-10
of O 0 1.8280871261211473e-10
FAP B-Disease 0 3.2020992080106225e-08
patients O 0 1.2787818581827537e-09
. O 0 6.671145302838966e-10
. O 0 2.7692152571034967e-08

Wilms B-Disease 1 0.9967173933982849
' I-Disease 0 2.6974854336003773e-05
tumor I-Disease 0 4.245652235113084e-06
1 O 0 1.1444630132473321e-07
and O 0 2.5519659718753473e-09
Dax O 0 0.0004807983641512692
- O 0 6.083288894842553e-08
1 O 0 1.0569401354132424e-07
modulate O 0 9.920304364641197e-07
the O 0 5.0688758079786567e-08
orphan O 0 4.3888721990015256e-08
nuclear O 0 1.4953734250866546e-08
receptor O 0 5.583487006077803e-09
SF O 0 8.489431024827354e-07
- O 0 3.830642469893064e-08
1 O 0 1.0154452390054303e-08
in O 0 5.209414566387238e-10
sex O 0 2.167390572571648e-10
- O 0 9.703880754496907e-11
specific O 0 9.32344895732129e-11
gene O 0 1.6374598343915636e-09
expression O 0 3.462704256662619e-08
. O 0 1.2603027244040277e-07

Products O 0 6.471008759945107e-07
of O 0 1.9428568975854432e-08
steroidogenic O 0 6.473613893831498e-07
factor O 0 1.6770977495639272e-08
1 O 0 1.8278486280109973e-08
( O 0 1.1776281338971017e-10
SF O 0 5.079963329990278e-07
- O 0 3.2606372712962184e-08
1 O 0 1.4088760380559506e-08
) O 0 8.45882808242493e-10
and O 0 3.413735738533319e-09
Wilms B-Disease 0 0.06678584218025208
tumor I-Disease 0 1.909239472297486e-05
1 O 0 1.2251253167505638e-07
( O 0 9.098951037067593e-10
WT1 O 0 5.828634357385454e-07
) O 0 1.576011821047274e-10
genes O 0 4.747251203252034e-11
are O 0 3.800824672356429e-12
essential O 0 3.7866403346242805e-09
for O 0 5.593077112564515e-10
mammalian O 0 3.177671601406473e-07
gonadogenesis O 0 3.648002575573628e-07
prior O 0 1.1942211131099612e-07
to O 0 1.9627201197636168e-08
sexual O 0 2.8007183239253663e-09
differentiation O 0 3.3688536404952174e-08
. O 0 6.68789184032903e-08

In O 0 3.0033127984552266e-08
males O 0 2.290236267299406e-08
, O 0 5.845774420087935e-10
SF O 0 4.240331236360362e-06
- O 0 2.873814253234741e-07
1 O 0 7.841669003028073e-08
participates O 0 1.7811653263422045e-09
in O 0 3.0525371119694e-10
sexual O 0 4.4911279556414385e-11
development O 0 2.4398845790973844e-11
by O 0 1.1149830191070631e-11
regulating O 0 2.683374411560635e-09
expression O 0 8.637423221102836e-09
of O 0 2.1014172624234106e-09
the O 0 5.8101838895652236e-09
polypeptide O 0 1.3093382733586623e-07
hormone O 0 1.7497822568657284e-07
Mullerian O 0 1.346503722743364e-06
inhibiting O 0 2.51385102956192e-07
substance O 0 1.456172924463317e-07
( O 0 1.4429186734332689e-09
MIS O 0 1.2575318578456063e-05
) O 0 1.0103082814794107e-08
. O 0 1.08107442997607e-07

Here O 0 1.7676462960025674e-07
, O 0 1.4212393484314134e-09
we O 0 8.555796626730228e-10
show O 0 1.9645358673159308e-09
that O 0 3.346601884501865e-10
WT1 O 0 2.681590785869048e-06
- O 0 1.2678652865361073e-06
KTS O 0 1.1187551535840612e-05
isoforms O 0 1.116521630706302e-07
associate O 0 3.516369417866372e-07
and O 0 1.07197539733761e-09
synergize O 0 1.952817854089517e-07
with O 0 7.05398628397802e-10
SF O 0 1.3881067388865631e-05
- O 0 3.2687233897377155e-07
1 O 0 1.5140200559926598e-07
to O 0 3.540529291967687e-08
promote O 0 7.221017881420266e-07
MIS O 0 0.00018525154155213386
expression O 0 6.172655275804573e-07
. O 0 2.5040026230271906e-07

In O 0 8.672936502307493e-08
contrast O 0 5.145204085010846e-08
, O 0 7.9845019484992e-09
WT1 O 0 2.707314706640318e-05
missense O 0 9.208916935676825e-07
mutations O 0 1.5303971423463736e-08
, O 0 2.607037086210795e-10
associated O 0 2.025540180028429e-09
with O 0 9.511726822841737e-11
male B-Disease 0 4.9993502670986345e-08
pseudohermaphroditism I-Disease 1 1.0
in O 0 2.5798814817790117e-07
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 8.184207089811935e-09
fail O 0 3.590397454900085e-07
to O 0 1.7459125700725053e-08
synergize O 0 9.099841236093198e-07
with O 0 7.76517872225213e-09
SF O 1 0.999930739402771
- O 0 0.000452256528660655
1 O 0 0.00011149605415994301
. O 0 3.662235030787997e-06

Additionally O 0 1.727578364807414e-07
, O 0 1.0504597192095844e-09
the O 0 1.441917252265057e-09
X O 0 3.268651767029951e-07
- O 0 1.0692500751474654e-07
linked O 0 5.3324292537126894e-08
, O 0 1.2880514710378321e-10
candidate O 0 4.0400074952096077e-10
dosage O 0 2.675934638318722e-07
- O 0 2.6069454150956517e-08
sensitive O 0 7.97588981527042e-08
sex O 0 2.8419162578785517e-09
- O 0 1.3386727282238553e-09
reversal O 0 1.5663899066709064e-09
gene O 0 9.138518830553721e-10
, O 0 4.6420359223198204e-10
Dax O 0 2.128719825122971e-05
- O 0 3.136274528969807e-08
1 O 0 3.5354950966848264e-08
, O 0 1.112362868482819e-09
antagonizes O 0 1.611013722424559e-08
synergy O 0 1.5658551122399444e-09
between O 0 3.168402484821087e-10
SF O 0 2.831351139320759e-06
- O 0 2.0248737087058544e-07
1 O 0 8.751652558203205e-08
and O 0 4.886342441778879e-09
WT1 O 0 8.651820280647371e-06
, O 0 3.6509845147136843e-10
most O 0 1.470029827033148e-11
likely O 0 6.53872997413707e-11
through O 0 1.2538864044286946e-11
a O 0 4.160195105074038e-11
direct O 0 3.741117138300609e-10
interaction O 0 2.2048164682875182e-10
with O 0 6.092743670693679e-11
SF O 0 1.8165921574109234e-05
- O 0 2.312779088242678e-06
1 O 0 1.9239266748627415e-06
. O 0 1.1218021427339409e-06

We O 0 2.7403987701291044e-07
propose O 0 3.1073784612090094e-07
that O 0 3.239713164404634e-09
WT1 O 0 1.2388743925839663e-05
and O 0 7.111365363243749e-08
Dax O 0 0.0064103687182068825
- O 0 1.0777863934663401e-07
1 O 0 2.008284027965601e-08
functionally O 0 7.879688013190389e-09
oppose O 0 2.765355278100401e-09
each O 0 1.2040398192358914e-11
other O 0 4.2985053017030594e-11
in O 0 1.1646662523290274e-09
testis O 0 2.72852275884361e-07
development O 0 1.8660115674862254e-09
by O 0 2.2348435602115302e-10
modulating O 0 1.1096450691638893e-07
SF O 0 1.091279318643501e-05
- O 0 2.661270457338105e-07
1 O 0 2.3551616834538436e-07
- O 0 1.3412872590379266e-07
mediated O 0 9.488238106314384e-08
transactivation O 0 1.7514244063931983e-06
. O 0 1.5496809169235348e-08
. O 0 6.066660773740296e-08

A O 0 1.1840866136481054e-06
mouse O 0 7.431738424656942e-08
model O 0 1.2049813591374914e-08
for O 0 1.688592590198823e-07
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 1.0
- O 1 0.9972922205924988
centre O 0 1.1567803085199557e-05
mutations O 0 1.5878585202244722e-07
. O 0 4.945453113691656e-08

Imprinting O 0 6.565321655216394e-06
in O 0 1.1922479359327554e-07
the O 0 8.56785646874414e-08
15q11 O 0 2.244561756015173e-06
- O 0 1.0097325997548978e-07
q13 O 0 3.735545135441498e-07
region O 0 7.304423732534815e-10
involves O 0 2.4187660208063733e-10
an O 0 8.758436337297226e-11
imprinting O 0 1.1161632755829487e-06
centre O 0 6.220022896741284e-07
( O 0 1.532343835153327e-10
IC O 0 2.3315214647823268e-08
) O 0 7.949239877458325e-11
, O 0 1.0210993509063293e-11
mapping O 0 8.003354923236117e-11
in O 0 2.5352596758065893e-11
part O 0 9.904355113832253e-11
to O 0 2.6825552890130666e-09
the O 0 1.1088380214019367e-09
promoter O 0 8.189485534160212e-09
and O 0 1.1920626707961901e-09
first O 0 2.831259138247333e-08
exon O 0 2.0597462935256772e-07
of O 0 3.508744228497562e-08
SNRPN O 0 3.9425136492354795e-05
. O 0 4.94154960506421e-07

Deletion O 0 9.188439435092732e-06
of O 0 2.136097947413873e-07
this O 0 1.3501972873086743e-08
IC O 0 1.1736377700799494e-06
abolishes O 0 1.7077038592105964e-06
local O 0 3.3496576179459225e-08
paternally O 0 1.339822830459525e-08
derived O 0 5.714813622326176e-10
gene O 0 1.6989344653328686e-10
expression O 0 2.1045008791187314e-10
and O 0 5.441969357783405e-12
results O 0 9.841197301518889e-11
in O 0 1.2872005683561838e-08
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.0715413054640521e-06
PWS B-Disease 1 1.0
) O 0 2.162462386934294e-08
. O 0 5.944501069166108e-08

We O 0 2.81865453644059e-07
have O 0 1.1917761222335344e-09
created O 0 1.359165113790084e-09
two O 0 5.161042704315832e-10
deletion O 0 4.214590987317024e-08
mutations O 0 1.3680007349137213e-08
in O 0 8.224110281673802e-09
mice O 0 2.652361672517145e-07
to O 0 6.325619494873536e-08
understand O 0 9.585882025930914e-07
PWS B-Disease 1 1.0
and O 0 7.508134558520396e-08
the O 0 6.983602673926725e-08
mechanism O 0 2.6927614271698985e-07
of O 0 6.7171384010578095e-09
this O 0 4.9632249421449615e-09
IC O 0 2.5658537197159603e-06
. O 0 1.0751393801911036e-06

Mice O 0 0.0023540761321783066
harbouring O 0 0.00011914371134480461
an O 0 3.7542591257988533e-08
intragenic O 0 1.7713464330881834e-05
deletion O 0 3.1538108942186227e-06
in O 0 8.986162924884411e-08
Snrpn O 0 2.423410114715807e-05
are O 0 8.10139177964686e-10
phenotypically O 0 3.0230950187615235e-07
normal O 0 1.8726412065461773e-07
, O 0 8.024589881472366e-10
suggesting O 0 1.6410593772775428e-08
that O 0 2.651786845664361e-10
mutations O 0 2.0520138921398257e-09
of O 0 3.483290766936875e-09
SNRPN O 0 8.911019335755554e-07
are O 0 3.458659400545905e-11
not O 0 2.2570764701690393e-10
sufficient O 0 2.738263482626735e-08
to O 0 4.922584295741217e-08
induce O 0 1.3039967598160729e-05
PWS B-Disease 1 1.0
. O 0 2.248746568511706e-05

Mice O 0 5.9212663472862914e-05
with O 0 3.0612379298133874e-09
a O 0 8.44326120130745e-09
larger O 0 7.678444546854735e-09
deletion O 0 9.002220480169854e-08
involving O 0 1.416041395252421e-09
both O 0 9.152980040560976e-10
Snrpn O 0 2.2934322885248548e-07
and O 0 6.295834964475944e-10
the O 0 7.840080584742282e-09
putative O 0 5.1937945499958e-07
PWS O 1 1.0
- O 0 7.615983008690819e-07
IC O 0 4.5953862581882277e-07
lack O 0 2.799793890062574e-07
expression O 0 6.545137321012362e-09
of O 0 8.015672015027064e-10
the O 0 8.937779960582759e-10
imprinted O 0 9.124120126102753e-09
genes O 0 5.002733782788482e-09
Zfp127 O 0 7.932679295663547e-07
( O 0 9.402961742566163e-10
mouse O 0 4.3783874303926495e-08
homologue O 0 6.2575304582424e-07
of O 0 2.3261469195290374e-08
ZNF127 O 0 1.0178040611208417e-05
) O 0 6.1579532584232766e-09
, O 0 1.5235674055702475e-08
Ndn O 0 9.733915248943958e-06
and O 0 2.2957337364459818e-08
Ipw O 0 0.0001051831422955729
, O 0 9.128733324814675e-09
and O 0 7.387144229653586e-10
manifest O 0 2.6066173219874145e-08
several O 0 9.621338170617832e-10
phenotypes O 0 3.2610103062324924e-08
common O 0 6.0076108532314265e-09
to O 0 2.425400964511937e-07
PWS B-Disease 1 1.0
infants O 0 0.0007492822478525341
. O 0 8.149363566190004e-07

These O 0 2.2022382140107766e-08
data O 0 5.281159065617658e-09
demonstrate O 0 1.974072683097461e-09
that O 0 1.2342207117432835e-11
both O 0 2.1466705149575382e-11
the O 0 5.435449867974285e-10
position O 0 1.1479472483699737e-08
of O 0 2.310717395204165e-09
the O 0 1.0283103257791026e-09
IC O 0 9.343877671597056e-09
and O 0 9.322684291213079e-11
its O 0 4.8682158998447633e-11
role O 0 3.9751660296794e-10
in O 0 2.887637906567875e-10
the O 0 1.122953396937021e-09
coordinate O 0 7.551590464061064e-09
expression O 0 9.90676838341642e-08
of O 0 4.097045369633179e-09
genes O 0 6.250653883377311e-10
is O 0 2.746586638679993e-11
conserved O 0 1.3579076751923935e-10
between O 0 1.3607337479015769e-10
mouse O 0 8.144159835410392e-08
and O 0 1.81206272209522e-10
human O 0 5.143216963432451e-10
, O 0 2.7918566763984742e-11
and O 0 1.6093435611930218e-11
indicate O 0 2.2989443682064348e-09
that O 0 8.778672927478581e-11
the O 0 2.344962224398728e-09
mouse O 0 7.141664326582031e-08
is O 0 4.690253047057169e-11
a O 0 3.262367806455835e-11
suitable O 0 7.806919555264358e-10
model O 0 3.3263269916261606e-10
system O 0 2.0812525314273245e-10
in O 0 6.742058994424482e-11
which O 0 2.6795558827341637e-11
to O 0 8.058088085682868e-10
investigate O 0 1.2580608776957547e-09
the O 0 6.63687826918391e-10
molecular O 0 1.995548615241205e-09
mechanisms O 0 5.080364573473162e-08
of O 0 4.1824210761376435e-09
imprinting O 0 1.7357324466615864e-08
in O 0 2.7033511540430766e-10
this O 0 9.049463955967951e-11
region O 0 3.4269057036517836e-10
of O 0 2.643141816527361e-10
the O 0 5.092457566746589e-10
genome O 0 8.260433309592585e-11
. O 0 5.636772160144687e-10
. O 0 2.409825938798349e-08

Mutations O 0 3.133977770630736e-06
of O 0 2.98025923939349e-07
the O 0 1.9562624231639347e-07
ATM O 0 4.859599812334636e-06
gene O 0 2.9381535426864502e-08
detected O 0 1.3326356906873116e-08
in O 0 6.5806746718521936e-09
Japanese O 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 0.9999988079071045
: O 0 8.254558148124147e-11
possible O 0 2.065048271271408e-10
preponderance O 0 1.6406836778060097e-08
of O 0 1.9534720507863312e-09
the O 0 5.68304381332041e-09
two O 0 2.233881524205117e-09
founder O 0 1.5998469393707637e-07
mutations O 0 1.3399787057721824e-08
4612del165 O 0 1.0951345075227437e-06
and O 0 5.983561646161206e-09
7883del5 O 0 2.277441853948403e-05
. O 0 5.228223471931415e-07

The O 0 2.743267089044821e-07
ATM O 0 4.0133134461939335e-05
( O 0 6.398499152737713e-08
A O 1 1.0
- O 1 1.0
T O 1 1.0
, O 0 4.283123633541663e-09
mutated O 0 1.0830195629196737e-09
) O 0 4.260850353099421e-11
gene O 0 2.626607542577375e-10
on O 0 7.134037360856382e-09
human O 0 5.513976386595232e-09
chromosome O 0 3.670496795393774e-08
11q22 O 0 1.2647998119064141e-05
. O 0 1.0325246648790198e-06

3 O 0 2.5961167011701036e-06
has O 0 2.6123547769429933e-09
recently O 0 8.665635986560005e-10
been O 0 1.0110224463177886e-10
identified O 0 6.635153537715155e-11
as O 0 6.575059940949757e-11
the O 0 4.810618917105991e-11
gene O 0 2.2948589209481618e-11
responsible O 0 3.851546165334341e-11
for O 0 2.7306341215949104e-11
the O 0 2.8057961509730944e-10
human O 0 6.888692727358148e-09
recessive B-Disease 1 0.9996743202209473
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.00039398911758325994
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 2.849956892703176e-08
. O 0 1.3880925564535573e-07

In O 0 2.7355490317404474e-08
order O 0 6.398936047702364e-09
to O 0 1.2818172079320789e-09
define O 0 2.9282609670389093e-09
the O 0 3.354712063696752e-10
types O 0 2.3607726884478097e-09
of O 0 1.0509887404808183e-09
disease O 0 1.8309226135215795e-08
- O 0 1.1058078897008272e-08
causing O 0 1.7720735989712466e-09
ATM O 0 7.452278083519559e-08
mutations O 0 2.4274271481772303e-10
in O 0 1.7900636528622726e-10
Japanese O 0 9.296774805989116e-05
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 6.872041069527768e-08
as O 0 8.4430594460283e-11
well O 0 2.518910253990203e-11
as O 0 1.651613915076844e-11
to O 0 1.0923005555607546e-10
look O 0 2.8334118384876206e-10
for O 0 1.9315447852275014e-10
possible O 0 3.954062854916174e-09
mutational O 0 2.6290919663551904e-07
hotspots O 0 1.312881749981898e-07
, O 0 2.2575542824032624e-10
reverse O 0 9.780889431709738e-10
- O 0 7.398975321315504e-10
transcribed O 0 1.4369917478163075e-09
RNA O 0 2.993701397890902e-10
derived O 0 3.7063718760776965e-10
from O 0 1.6327706547913934e-11
ten O 0 1.9198792555741306e-10
patients O 0 2.7769489832629723e-11
belonging O 0 6.811364666736708e-11
to O 0 1.3918446950533792e-10
eight O 0 6.83493400766011e-11
unrelated O 0 4.152270194346386e-10
Japanese O 0 2.1327350623323582e-05
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
families O 0 1.3232432927168247e-09
was O 0 2.7981235106722124e-09
analyzed O 0 1.948834871257077e-09
for O 0 5.021947857564157e-10
mutations O 0 1.1236518382418126e-09
by O 0 3.9528919026921017e-10
the O 0 6.974628430356233e-09
restriction O 0 2.7270782965160834e-08
endonuclease O 0 2.5944203230210405e-08
fingerprinting O 0 2.2899566687328843e-08
method O 0 7.639415144922168e-08
. O 0 1.4440267648296867e-07

As O 0 2.2088222806360136e-07
has O 0 3.663722658586721e-10
been O 0 5.570610292493505e-11
reported O 0 1.6679747860681715e-11
by O 0 4.494544927208244e-12
others O 0 1.4829511230107784e-10
, O 0 4.213764753790983e-11
mutations O 0 2.07536987595347e-10
that O 0 5.1536035855503926e-11
lead O 0 5.926226176455884e-09
to O 0 3.388618807775856e-08
exon O 0 8.130176354370633e-08
skipping O 0 1.0244215076227192e-07
or O 0 1.1340215877453375e-08
premature O 0 1.5397408503758925e-07
protein O 0 1.9206898294044095e-09
truncation O 0 4.5230969192289194e-08
were O 0 4.8477430958371315e-09
also O 0 1.0351723922497058e-09
predominant O 0 8.242531102098383e-09
in O 0 3.826084338243163e-09
our O 0 1.1835317081931862e-07
mutants O 0 9.232571187567373e-07
. O 0 2.977191968511761e-07

Six O 0 6.705441535359569e-08
different O 0 4.153996868705434e-10
mutations O 0 5.566428429304437e-10
were O 0 1.7351249603780872e-10
identified O 0 3.2512750824942316e-10
on O 0 2.792216013958182e-09
12 O 0 7.841590488055772e-09
of O 0 3.611997367869435e-09
the O 0 5.92905280427658e-09
16 O 0 3.299412298929383e-08
alleles O 0 7.542176660990663e-09
examined O 0 3.283695662048558e-07
. O 0 9.907284947985318e-07

Four O 0 2.985032381275232e-07
were O 0 3.2113838699388e-08
deletions O 0 7.32348723886389e-08
involving O 0 2.3589046271865755e-09
a O 0 9.99736560203246e-09
loss O 0 3.449099139629652e-08
of O 0 4.573682943487256e-08
a O 0 1.2641374169675146e-08
single O 0 1.341318700553984e-08
exon O 0 1.0351338630698592e-07
exon O 0 1.5859350810387696e-07
7 O 0 7.006557325439644e-07
, O 0 6.0181730709985e-09
exon O 0 1.2108013436318288e-07
16 O 0 7.889286024465036e-08
, O 0 8.34584934494842e-09
exon O 0 4.0294153791364806e-07
33 O 0 2.8962742248950235e-07
or O 0 2.1590251364500546e-08
exon O 0 1.0712379889810109e-06
35 O 0 1.0878875400521792e-06
. O 0 6.929506639608007e-07

The O 0 2.2341750138821226e-07
others O 0 8.522688332845973e-09
were O 0 4.282935783805897e-09
minute O 0 4.240814277522986e-08
deletions O 0 3.84831331246005e-08
, O 0 9.121783328680522e-10
4649delA O 0 4.6562195876731494e-08
in O 0 2.8575051214119185e-09
exon O 0 9.806452538896338e-08
33 O 0 7.881044439272955e-08
and O 0 1.87427628972614e-09
7883del5 O 0 1.066847858055553e-06
in O 0 2.7396948709679236e-08
exon O 0 2.1041914806119166e-06
55 O 0 1.772245468600886e-06
. O 0 1.0734796660472057e-06

The O 0 4.651280960388249e-06
mutations O 0 4.102185471310804e-07
4612del165 O 0 8.467115435450978e-07
and O 0 9.214392582279629e-10
7883del5 O 0 1.940620535378912e-07
were O 0 1.7856656153725226e-09
found O 0 2.01485036988025e-10
in O 0 5.603495792372293e-11
more O 0 4.827915411204087e-12
than O 0 5.794007201104234e-12
two O 0 4.182502868349536e-12
unrelated O 0 1.9972183629146656e-11
families O 0 7.077276590293502e-13
; O 0 2.196951821853421e-12
44 O 0 8.994535671824622e-11
% O 0 1.3491578514102098e-11
( O 0 1.892930256985892e-12
7 O 0 3.429651840303194e-10
of O 0 4.389479058009016e-10
16 O 0 3.1212346041087358e-09
) O 0 2.5651850088515005e-10
of O 0 1.2509375757474572e-09
the O 0 5.600528374394287e-10
mutant O 0 3.318470831459308e-09
alleles O 0 3.8009659308890775e-10
had O 0 9.533581701859362e-10
one O 0 1.1209926736865938e-10
of O 0 1.970223428848783e-10
the O 0 8.270558682355045e-10
two O 0 5.832187510712572e-10
mutations O 0 6.063454627280862e-09
. O 0 1.0165715025323152e-07

The O 0 1.084963628272817e-06
4612del165 O 0 1.4482485539701884e-06
mutations O 0 3.989219621303164e-09
in O 0 2.7177909922571075e-10
three O 0 1.2312533805014514e-11
different O 0 2.5821228835654075e-12
families O 0 1.2950215986379243e-12
were O 0 2.269425619649823e-11
all O 0 1.313212386055973e-11
ascribed O 0 3.819878635624718e-09
to O 0 5.830977478638033e-09
the O 0 4.719953761167517e-09
same O 0 4.048834600922646e-09
T O 0 9.11997943831011e-09
- O 0 4.9380224353967606e-09
- O 0 6.246128059217426e-09
> O 0 2.3359239875730964e-08
A O 0 2.1535131455863166e-09
substitution O 0 3.756692734668832e-09
at O 0 2.4738984194527802e-09
the O 0 4.931328123625178e-10
splice O 0 5.637753375253851e-09
donor O 0 2.817042599190245e-09
site O 0 8.408387763836345e-09
in O 0 1.936913740507862e-09
intron O 0 2.555282890170929e-06
33 O 0 1.8716427803155966e-06
. O 0 5.840909693688445e-07

Microsatellite O 0 2.2579355572815984e-05
genotyping O 0 2.4437317733827513e-06
around O 0 1.2106715630011422e-08
the O 0 2.9408617763238e-08
ATM O 0 4.4079511098971125e-06
locus O 0 2.82640968407577e-07
also O 0 6.2616591911535124e-09
indicated O 0 3.201902298854975e-09
that O 0 3.8767669630068724e-11
a O 0 1.8974613547051433e-10
common O 0 5.044892836814086e-10
haplotype O 0 2.19084270725034e-08
was O 0 5.379571454966481e-09
shared O 0 4.933586317257266e-10
by O 0 2.1545173631287717e-11
the O 0 2.7493082810359226e-10
mutant O 0 2.337473548053026e-09
alleles O 0 2.392657738603532e-10
in O 0 3.7053682344634353e-10
both O 0 3.670985071480004e-09
mutations O 0 5.980163564345276e-08
. O 0 4.051463804444211e-07

This O 0 6.649694483940038e-08
suggests O 0 3.059430042640088e-08
that O 0 7.555443770623782e-11
these O 0 8.013650160121344e-11
two O 0 4.784523333078994e-10
founder O 0 1.076272440059256e-07
mutations O 0 1.213397116117676e-08
may O 0 1.1324891246999869e-08
be O 0 3.806830406460904e-09
predominant O 0 3.849906704544992e-08
among O 0 4.0240882848152637e-10
Japanese O 0 2.413170250292751e-07
ATM O 0 2.093973989758524e-06
mutant O 0 3.0104246206974494e-07
alleles O 0 5.770197120114062e-08
. O 0 3.292635994966986e-07

W474C O 0 1.1035343959520105e-05
amino O 0 5.244623224598399e-08
acid O 0 3.252517144503031e-09
substitution O 0 2.0108357201564786e-09
affects O 0 6.541486102795702e-11
early O 0 8.380235949623227e-10
processing O 0 2.595730519416861e-09
of O 0 2.12092277074305e-09
the O 0 5.490339849423265e-10
alpha O 0 4.314459067789045e-10
- O 0 3.884257152031445e-11
subunit O 0 1.9695546582543244e-10
of O 0 1.1510924158297797e-10
beta O 0 4.0048560023819846e-09
- O 0 1.0903637104320296e-08
hexosaminidase O 0 9.023054303725075e-08
A O 0 4.259464780886901e-09
and O 0 4.826960706139083e-11
is O 0 6.469121245633591e-12
associated O 0 3.9503145199404344e-10
with O 0 1.318561509977556e-10
subacute O 0 0.00011238435399718583
G B-Disease 0 2.05428441404365e-05
( I-Disease 0 3.150860905520858e-09
M2 I-Disease 0 2.2938552319828887e-06
) I-Disease 0 1.8459797246350718e-08
gangliosidosis I-Disease 0 1.4653433936473448e-05
. O 0 6.417370173039671e-07

Mutations O 0 1.2812562033559516e-07
in O 0 1.2343355670907386e-08
the O 0 1.2178952957242473e-08
HEXA O 0 1.048892499966314e-06
gene O 0 3.678428450726301e-09
, O 0 1.2048122222108049e-10
encoding O 0 5.200747610345502e-10
the O 0 1.5354927329624957e-09
alpha O 0 4.5974676843307805e-10
- O 0 3.723318528492392e-11
subunit O 0 1.134113497558431e-10
of O 0 1.6940322755676362e-10
beta O 0 6.020549836449618e-09
- O 0 1.1387683684915828e-08
hexosaminidase O 0 2.6890737103713036e-07
A O 0 4.5989285268888125e-08
( O 0 1.1909757902106577e-10
Hex O 0 2.2327922621911966e-08
A O 0 1.1824910828295288e-08
) O 0 1.2807584159890695e-10
, O 0 8.858314776150067e-11
that O 0 6.579702060971471e-11
abolish O 0 4.0072578144645377e-07
Hex O 0 2.543565926771407e-07
A O 0 5.412010839478398e-09
enzyme O 0 3.640081847056109e-10
activity O 0 4.722736424156437e-09
cause O 0 6.912042863405077e-06
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 9.592313610085057e-10
TSD B-Disease 0 2.7980584036413347e-06
) O 0 7.767614329523553e-11
, O 0 4.005814430163568e-11
the O 0 7.392429446362314e-10
fatal O 0 1.0728107469049064e-07
infantile B-Disease 0 9.913485882862005e-06
form I-Disease 0 1.5878471870678368e-08
of I-Disease 0 5.293375124892918e-07
G I-Disease 0 5.552192874347384e-07
( I-Disease 0 3.4018263206370136e-10
M2 I-Disease 0 1.9690126862315083e-07
) I-Disease 0 1.4512652191100983e-09
gangliosidosis I-Disease 0 3.110242516868311e-07
, I-Disease 0 5.151974957762206e-10
Type I-Disease 0 2.0415599877310342e-08
1 I-Disease 0 3.0610357271143585e-07
. O 0 6.450651426348486e-07

Less O 0 1.1518797009557602e-06
severe O 0 5.467810751724755e-06
, O 0 7.855513572962991e-09
subacute O 0 2.649694579304196e-06
( O 0 6.253035589320888e-11
juvenile O 0 9.717877702541955e-08
- O 0 1.2753022815559234e-07
onset O 1 0.9999971389770508
) O 0 1.3848703295238352e-09
and O 0 1.0422893659267629e-08
chronic O 1 1.0
( O 0 1.0286924090330274e-10
adult O 0 4.509306279487646e-07
- O 0 4.943915499211471e-08
onset O 0 0.004301684908568859
) O 0 2.1730034438505186e-10
variants O 0 6.6150431798917e-09
are O 0 4.6961341065854256e-11
characterized O 0 6.415941389281699e-11
by O 0 1.0348949995575563e-11
a O 0 3.551428318093741e-10
broad O 0 2.4058197656273705e-09
spectrum O 0 1.1726557502811374e-08
of O 0 2.088721001713978e-10
clinical O 0 3.200595566354991e-09
manifestations O 0 2.8842208621426835e-09
and O 0 3.8189645890085444e-11
are O 0 8.681575423830079e-12
associated O 0 1.5973899980536999e-10
with O 0 2.0435401634766315e-11
residual O 0 2.0606298676284496e-06
levels O 0 1.8492362869437784e-05
of O 0 3.3918720987458073e-07
Hex O 0 9.93128423942835e-07
A O 0 1.7200474644596397e-07
enzyme O 0 1.0300010622188438e-08
activity O 0 6.073642566661874e-08
. O 0 1.1875862071519805e-07

We O 0 1.8923961064842842e-08
identified O 0 3.788974023422043e-09
a O 0 9.625045205297056e-10
1422 O 0 7.66013272368582e-07
G O 0 1.0507651637681192e-07
- O 0 1.2705679353075539e-07
- O 0 1.1344676664748476e-07
> O 0 3.243845867473283e-07
C O 0 4.2220739260301343e-07
( O 0 1.472622891685038e-11
amino O 0 1.977478181203196e-10
acid O 0 1.9117343819097243e-10
W474C O 0 9.326761585271015e-10
) O 0 1.44141656618392e-13
substitution O 0 7.464985574134886e-11
in O 0 4.863761129958455e-11
the O 0 3.5432348721720075e-10
first O 0 9.307231652044834e-10
position O 0 4.404426157122998e-09
of O 0 8.742501167446903e-10
exon O 0 2.4735506087836256e-08
13 O 0 2.243785424127509e-08
of O 0 2.6944020348196318e-08
HEXA O 0 0.00033782655373215675
of O 0 2.360488622343837e-07
a O 0 5.4004029692578115e-08
non O 0 4.376043307274813e-06
- O 0 1.7479742098203133e-07
Jewish O 0 3.388826428363245e-07
proband O 0 2.795373075059615e-05
who O 0 4.19688506170246e-09
manifested O 0 1.9204891898993992e-08
a O 0 5.276789227792733e-09
subacute O 0 3.351642874349636e-07
variant O 0 7.69621146901045e-06
of O 0 3.218846541130915e-05
G B-Disease 0 2.7580867026699707e-05
( I-Disease 0 2.4115902608201623e-09
M2 I-Disease 0 1.1464635463198647e-06
) I-Disease 0 8.915990612479163e-09
gangliosidosis I-Disease 0 3.398766921236529e-06
. O 0 2.6246976858601556e-07

On O 0 3.533679318934446e-06
the O 0 1.9756883773425216e-07
second O 0 8.047671258282207e-07
maternally O 0 7.554945113952272e-06
inherited O 0 7.403036306641297e-06
allele O 0 1.7187439027566143e-07
, O 0 1.1963419144223053e-10
we O 0 7.052637640558856e-11
identified O 0 2.7259727808370826e-10
the O 0 5.437305605759946e-10
common O 0 7.520345945977169e-08
infantile O 1 0.9999994039535522
disease O 0 8.850549056660384e-05
- O 0 1.8491623166028148e-07
causing O 0 2.7110536393593065e-07
4 O 0 2.9040256777079776e-06
- O 0 4.6328909775184e-06
bp O 0 1.894310628358653e-07
insertion O 0 1.965799789616085e-08
, O 0 9.520644272953405e-10
+ O 0 3.982691154647e-08
TATC O 0 9.125512860919116e-07
1278 O 0 8.852464361552848e-07
, O 0 1.134252580747841e-09
in O 0 1.4678513959864858e-09
exon O 0 1.8839621418464958e-07
11 O 0 2.2812102429270453e-07
. O 0 5.326350560608262e-07

Pulse O 0 4.421153789735399e-06
- O 0 4.649368747777771e-07
chase O 0 6.214425951611702e-08
analysis O 0 5.653377765924006e-09
using O 0 1.0905655045689855e-08
proband O 0 1.1285042091913056e-06
fibroblasts O 0 3.989521701441845e-06
revealed O 0 1.9621811730985428e-08
that O 0 1.2670327287356287e-10
the O 0 3.7889144599567715e-10
W474C O 0 1.3524577013868111e-08
- O 0 7.115701361470883e-10
containing O 0 3.336926290842257e-10
alpha O 0 7.278070368599288e-10
- O 0 1.2597194121166666e-10
subunit O 0 1.6856884776927927e-09
precursor O 0 3.009643876339396e-07
was O 0 6.347737269152276e-08
normally O 0 4.817381604738102e-09
synthesized O 0 3.987175389852382e-08
, O 0 1.4602218045833837e-10
but O 0 4.016502408443756e-11
not O 0 1.720732445420481e-10
phosphorylated O 0 3.97957578002206e-09
or O 0 8.5207824129796e-10
secreted O 0 1.0209367795610547e-09
, O 0 9.110424914471338e-11
and O 0 1.3441857349416608e-10
the O 0 4.765690952979185e-09
mature O 0 1.207595001773143e-08
lysosomal O 0 1.0243980597124391e-07
alpha O 0 4.760113192503468e-09
- O 0 6.413130582139104e-10
subunit O 0 1.9910093573827226e-09
was O 0 1.70220566531043e-08
not O 0 1.0812533979276395e-08
detected O 0 1.75144677427852e-07
. O 0 9.320402938328698e-08

When O 0 1.1327833959740019e-07
the O 0 8.82904060972578e-09
W474C O 0 3.329021325271242e-08
- O 0 1.275466510186618e-09
containing O 0 1.0905498032398597e-10
alpha O 0 1.588233433658104e-10
- O 0 2.1346176562464514e-11
subunit O 0 1.8642604127094842e-10
was O 0 3.5219649419104826e-09
transiently O 0 1.2793583081815996e-08
co O 0 2.1345138989659063e-09
- O 0 1.0692231988684853e-08
expressed O 0 8.680524077320229e-10
with O 0 7.969731645462996e-12
the O 0 2.892069361770666e-10
beta O 0 1.746730121654494e-10
- O 0 1.83017958427234e-11
subunit O 0 6.952679404426121e-11
to O 0 9.836993025702512e-11
produce O 0 3.4707808849177013e-10
Hex O 0 6.163619303833912e-08
A O 0 1.416310198010251e-07
( O 0 2.252586450701699e-10
alphabeta O 0 7.892266040698814e-08
) O 0 8.181000321627607e-11
in O 0 3.7948161279999226e-10
COS O 0 5.8162406446626846e-08
- O 0 1.1735730609530037e-08
7 O 0 6.297735222204892e-09
cells O 0 5.222460242038096e-09
, O 0 2.390983244726641e-10
the O 0 2.4305776835653603e-10
mature O 0 3.2159838680989594e-10
alpha O 0 5.426147864362463e-10
- O 0 1.0191464339115441e-10
subunit O 0 4.441737533333878e-10
was O 0 2.6010436027235073e-09
present O 0 2.0202842176963998e-10
, O 0 2.5441825729499712e-11
but O 0 6.145107426386298e-12
its O 0 6.940552299550262e-12
level O 0 3.6124295221817704e-10
was O 0 1.5780511619656323e-10
much O 0 4.525610095007515e-11
lower O 0 2.5988206031613004e-10
than O 0 5.4761113178758425e-12
that O 0 6.0610856611464925e-12
from O 0 2.3118919972864305e-11
normal O 0 1.4430011630039985e-09
alpha O 0 1.3687361244407725e-09
- O 0 1.315259123835233e-09
subunit O 0 5.091178145733011e-09
transfections O 0 1.0194101918159504e-07
, O 0 8.31000684931027e-11
although O 0 4.5085338240546946e-11
higher O 0 6.39563790816311e-10
than O 0 9.371100249955244e-12
in O 0 4.201582137763893e-11
those O 0 6.467520269337612e-11
cells O 0 5.096071897803256e-10
transfected O 0 1.0703250730159652e-08
with O 0 2.6195018376640178e-11
an O 0 2.388285125221046e-10
alpha O 0 2.4787254471192455e-09
- O 0 9.010801549358405e-10
subunit O 0 2.6401805186537786e-09
associated O 0 2.2583446224189174e-08
with O 0 5.8248303957952885e-09
infantile O 1 0.9838345050811768
TSD B-Disease 0 0.004645186476409435
. O 0 1.4883414678479312e-06

Furthermore O 0 3.570538353869779e-07
, O 0 7.775430299616914e-10
the O 0 3.115083191396195e-10
precursor O 0 4.7222794563595016e-08
level O 0 1.3934855758179765e-07
of O 0 6.853438261344991e-09
the O 0 4.548876830767767e-09
W474C O 0 2.4077031923752656e-08
alpha O 0 1.3640085727573137e-09
- O 0 1.192917292724971e-10
subunit O 0 3.2045155418103377e-10
was O 0 2.8848095023903397e-09
found O 0 1.397273546865918e-10
to O 0 9.911479970092785e-11
accumulate O 0 2.398689025184808e-10
in O 0 8.151017361068824e-11
comparison O 0 6.82299328147451e-10
to O 0 2.7072690755858275e-09
the O 0 3.0339293299874726e-09
normal O 0 2.1047759091175067e-08
alpha O 0 2.7236213284709265e-08
- O 0 4.164041556009579e-09
subunit O 0 6.059708290706567e-09
precursor O 0 1.7040240152255137e-07
levels O 0 1.5597727553995355e-07
. O 0 5.1010953683316984e-08

We O 0 6.171498423412913e-09
conclude O 0 9.17581299830772e-09
that O 0 2.6393684460224165e-10
the O 0 1.1143079792219623e-09
1422 O 0 3.3680432807159377e-06
G O 0 3.0503642278745247e-07
- O 0 2.2604828586736403e-07
- O 0 1.5134078523715289e-07
> O 0 4.806159950021538e-07
C O 0 6.577652698069869e-07
mutation O 0 6.141528396952367e-10
is O 0 5.978760455466192e-12
the O 0 5.6025663275338644e-11
cause O 0 4.041844192670396e-09
of O 0 1.664868776174444e-08
Hex B-Disease 0 1.713348501652945e-05
A I-Disease 0 2.3237505956785753e-05
enzyme I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 1.2683548789027554e-07
the O 0 3.179054033353168e-07
proband O 0 1.3585093256551772e-05
. O 0 2.046822515922031e-07

The O 0 1.923107078027897e-07
resulting O 0 1.2606749422161556e-08
W474C O 0 4.233007757648011e-07
substitution O 0 1.7951931852167036e-07
clearly O 0 1.4835354278375235e-08
interferes O 0 5.175082140596032e-09
with O 0 3.706596141128671e-11
alpha O 0 3.4236145030064336e-09
- O 0 3.088790612171266e-10
subunit O 0 1.1091298990351106e-09
processing O 0 2.3221160549979913e-09
, O 0 8.21059192857021e-11
but O 0 2.717613460656576e-11
because O 0 6.8860017514438265e-12
the O 0 2.1180947620824675e-11
base O 0 2.3206626897920302e-10
substitution O 0 6.410073027929286e-10
falls O 0 6.056215529071096e-10
at O 0 2.4782753627050624e-10
the O 0 3.361764200349171e-10
first O 0 3.541601234502423e-09
position O 0 3.243907187311379e-08
of O 0 8.622970781857475e-09
exon O 0 1.0335871536426566e-07
13 O 0 6.045891609574028e-08
, O 0 5.631560218155585e-10
aberrant O 0 3.844547791231889e-09
splicing O 0 1.5072769699031596e-08
may O 0 4.508710294004459e-09
also O 0 2.819524613784097e-10
contribute O 0 1.5128582830925552e-09
to O 0 1.726250253852868e-08
Hex B-Disease 0 1.1199977052456234e-05
A I-Disease 0 1.3562515960074961e-05
deficiency I-Disease 0 3.331649850224494e-06
in O 0 8.5904341418086e-09
this O 0 4.570113620872007e-09
proband O 0 8.069236514529621e-07
. O 0 5.189375151815057e-09
. O 0 5.257102131395186e-08

Two O 0 5.439853012489948e-08
frequent O 0 1.011930184091625e-08
missense O 0 4.1382961057934153e-07
mutations O 0 3.930417449282686e-07
in O 0 2.879841531466809e-06
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 8.995752432383597e-05

Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 1.0024976404565678e-08
an O 0 2.3641945290364674e-07
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 2.3162424440670293e-06
by O 0 3.3427025036836255e-11
early O 0 5.69790472582099e-07
childhood O 1 0.9999988079071045
deafness B-Disease 1 1.0
and O 1 0.9881551265716553
goiter B-Disease 1 1.0
. O 0 0.31837981939315796

A O 0 2.233529556860958e-07
century O 0 3.0261578132240174e-08
after O 0 1.4192266251100705e-09
its O 0 1.754428893829818e-11
recognition O 0 1.7174076050174847e-10
as O 0 4.2501707708808567e-10
a O 0 3.479784460580504e-09
syndrome O 0 9.811036250084726e-08
by O 0 1.8335626073007205e-10
Vaughan O 0 2.858240577552351e-07
Pendred O 0 4.901550596514426e-07
, O 0 3.070218246303824e-10
the O 0 1.4785176416509671e-09
disease O 0 2.0672413114652954e-08
gene O 0 2.6075557268967486e-09
( O 0 8.319780420151801e-10
PDS O 0 1.1540783816599287e-05
) O 0 9.434092396176652e-10
was O 0 2.3070983345974128e-08
mapped O 0 8.518771466015096e-09
to O 0 1.5195508851206796e-08
chromosome O 0 1.8155795089569438e-08
7q22 O 0 5.834846433572238e-06
- O 0 1.2407959957272396e-06
q31 O 0 1.1825251931441016e-05
. O 0 3.670052706183924e-07

1 O 0 3.3490098871880036e-07
and O 0 5.896190646836885e-09
, O 0 1.5145846798958473e-09
recently O 0 5.11348385856536e-09
, O 0 3.0986210819428095e-10
found O 0 1.4641514389790444e-10
to O 0 2.001376842031277e-09
encode O 0 2.223896444775164e-08
a O 0 4.4868023962862935e-08
putative O 0 2.9729606012551812e-06
sulfate O 0 1.6085687093436718e-06
transporter O 0 2.5827296212810325e-06
. O 0 9.411489259036898e-07

We O 0 6.901873206288656e-08
performed O 0 1.1916562847602563e-08
mutation O 0 1.0482640311337832e-09
analysis O 0 1.5346377502112318e-09
of O 0 1.906990121369745e-09
the O 0 9.617563634378712e-09
PDS B-Disease 0 7.282839646904904e-07
gene O 0 8.375825588657904e-10
in O 0 2.2695738344236105e-10
patients O 0 6.664328533467767e-10
from O 0 1.3382941976836094e-10
14 O 0 4.229502970076737e-09
Pendred B-Disease 0 3.1280240619935284e-08
families O 0 1.0781996823139295e-11
originating O 0 3.8652878120437606e-10
from O 0 1.234438107289293e-10
seven O 0 1.3028916834301185e-10
countries O 0 2.2557799378430943e-11
and O 0 8.900825215762964e-11
identified O 0 3.534812442751445e-09
all O 0 4.085449312185574e-09
mutations O 0 2.5593230645881704e-08
. O 0 1.3053086433956196e-07

The O 0 3.122604766758741e-06
mutations O 0 5.4311648511884414e-08
include O 0 3.357581546126198e-09
three O 0 5.627812660335962e-10
single O 0 4.106300188766454e-09
base O 0 9.874339923499065e-08
deletions O 0 2.2317240677693917e-07
, O 0 6.415507236567919e-09
one O 0 1.873429189558351e-09
splice O 0 1.0169807040938394e-07
site O 0 3.304992546304675e-08
mutation O 0 2.3737853904748363e-09
and O 0 5.002960823397018e-10
10 O 0 7.300461390968849e-08
missense O 0 5.088223588245455e-06
mutations O 0 1.026122390612727e-06
. O 0 3.2981024560285732e-06

One O 0 4.5266529014043044e-07
missense O 0 3.407705207791878e-06
mutation O 0 4.651816709611012e-08
( O 0 2.6729471414022044e-10
L236P O 0 5.478034026396017e-08
) O 0 9.764183211968813e-11
was O 0 1.0987871723600051e-09
found O 0 5.434617686428389e-11
in O 0 7.662460943524962e-11
a O 0 3.6143871229299407e-10
homozygous O 0 1.6093637533742822e-09
state O 0 5.095972602231491e-11
in O 0 3.712923857257522e-10
two O 0 1.2910422730882942e-10
consanguineous O 0 1.491889101146171e-08
families O 0 2.1525992793813842e-11
and O 0 1.1428356525011729e-11
in O 0 1.303821356435364e-10
a O 0 4.3066070154473834e-10
heterozygous O 0 5.861226504144668e-10
state O 0 3.944454832205402e-11
in O 0 4.2889991558325846e-10
five O 0 4.6066758740970215e-10
additional O 0 2.685104805166816e-09
non O 0 2.357084980530999e-07
- O 0 2.338657196787608e-07
consanguineous O 0 1.446012788619555e-06
families O 0 5.98260285755714e-09
. O 0 7.568696247517437e-08

Another O 0 5.936387879046379e-07
missense O 0 1.4544365512847435e-05
mutation O 0 1.4680698257052427e-07
( O 0 2.732359893897751e-10
T416P O 0 7.265428081382197e-08
) O 0 9.319910815319687e-11
was O 0 1.5770320604957533e-09
found O 0 8.932884293377796e-11
in O 0 3.851031646351366e-11
a O 0 1.348934713929495e-10
homozygous O 0 3.927482783439018e-10
state O 0 1.4297889261438712e-11
in O 0 1.65258542961233e-10
one O 0 8.715458910124596e-11
family O 0 1.5839336786616087e-11
and O 0 9.368097443618328e-12
in O 0 8.046411453799251e-11
a O 0 2.470323390291185e-10
heterozygous O 0 2.6907737149528543e-10
state O 0 1.9755960756207003e-11
in O 0 4.121339935991841e-10
four O 0 1.2130632054407897e-09
families O 0 4.4567921575477953e-10
. O 0 1.7743607472198164e-08

Pendred B-Disease 0 3.556951560312882e-05
patients O 0 1.9625842639925395e-07
in O 0 8.660249184444524e-10
three O 0 2.1225121660251034e-10
non O 0 6.045787159791871e-08
- O 0 2.850288538525092e-08
consanguineous O 0 2.145030890687849e-07
families O 0 2.618613936800074e-10
were O 0 1.8960034930959324e-10
shown O 0 3.318089414339198e-10
to O 0 1.4111396495763984e-09
be O 0 1.1948989575572e-09
compound O 0 2.839717794245189e-08
heterozygotes O 0 1.3386126340719784e-07
for O 0 4.6633452654987195e-09
L236P O 0 3.6400163594407786e-07
and O 0 3.2695097740287338e-09
T416P O 0 4.061749223183142e-06
. O 0 2.2675344268918707e-07

In O 0 2.6158412325116842e-08
total O 0 4.287561861104905e-09
, O 0 1.7956924835971222e-10
one O 0 1.0979444436953756e-10
or O 0 2.0474856532448626e-10
both O 0 1.545862188256919e-10
of O 0 5.56804213847073e-10
these O 0 3.9216796476893023e-11
mutations O 0 3.4810619664593645e-11
were O 0 4.131916336858055e-11
found O 0 1.5277145867798048e-11
in O 0 1.1674947120177137e-10
nine O 0 1.0308810471926222e-09
of O 0 4.662124575283144e-10
the O 0 1.0592944299503415e-09
14 O 0 7.36601490913813e-09
families O 0 4.53657056365131e-10
analyzed O 0 3.671077664080258e-08
. O 0 2.2225506768336345e-07

The O 0 1.1124042487153929e-07
identification O 0 2.869761033252871e-07
of O 0 7.564885606825555e-08
two O 0 6.892858728235751e-09
frequent O 0 1.0707721820324423e-08
PDS B-Disease 0 1.1260081009822898e-06
mutations O 0 1.4294549988136396e-09
will O 0 8.067684298396216e-10
facilitate O 0 3.055895803072417e-08
the O 0 7.132880952553933e-09
molecular O 0 2.7700869154045904e-08
diagnosis O 0 0.00015824777074158192
of O 0 2.5815672870521666e-06
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 7.16331214789534e-06

Insertional O 0 0.0001397751475451514
mutation O 0 9.061808015076167e-08
by O 0 4.46894771188866e-10
transposable O 0 1.3394631537266832e-07
element O 0 2.5044702312015943e-08
, O 0 1.5281299559077866e-09
L1 O 0 1.9034303022635868e-07
, O 0 4.4949868827082184e-10
in O 0 1.3266699960823303e-09
the O 0 2.4190021008507756e-07
DMD B-Disease 1 1.0
gene O 0 1.0103028813546189e-07
results O 0 1.809432781385567e-08
in O 0 2.5749425702770168e-08
X B-Disease 1 0.9999101161956787
- I-Disease 0 0.004991454537957907
linked I-Disease 0 3.112770355073735e-05
dilated I-Disease 0 0.002301648259162903
cardiomyopathy I-Disease 1 1.0
. O 0 8.894868369679898e-05

X B-Disease 1 0.9880213141441345
- I-Disease 1 0.9999480247497559
linked I-Disease 1 0.9999328851699829
dilated I-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
( O 0 7.128816292834017e-08
XLDCM B-Disease 0 0.00016694939404260367
) O 0 1.550273659445267e-10
is O 0 2.660306523682987e-11
a O 0 2.427538170479693e-10
clinical O 0 3.9742754864846574e-08
phenotype O 0 1.8787625322147505e-07
of O 0 2.985083824569301e-07
dystrophinopathy B-Disease 0 1.6723655789974146e-05
which O 0 1.1794090148953273e-09
is O 0 5.0795728734343015e-11
characterized O 0 7.074180130572927e-11
by O 0 3.88327182909709e-11
preferential O 0 5.555858137995529e-07
myocardial B-Disease 0 0.0001526936248410493
involvement I-Disease 0 1.2229931733998e-08
without O 0 9.212248741619078e-10
any O 0 4.049535429206941e-10
overt O 0 3.0405105100328456e-09
clinical O 0 3.150772442950256e-08
signs O 0 8.238275484018232e-08
of O 0 1.5857823427722906e-06
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 1 0.9876032471656799

To O 0 3.457523689576192e-08
date O 0 9.233612985326545e-08
, O 0 4.767161665419906e-10
several O 0 1.375657313756884e-11
mutations O 0 1.395225601719119e-10
in O 0 8.486980562771862e-10
the O 0 4.776645710080629e-07
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
gene O 0 0.015741713345050812
, O 0 4.057704643400939e-07
DMD O 1 1.0
, O 0 1.4741727838440966e-09
have O 0 2.5725626490169518e-11
been O 0 2.990264286184541e-11
identified O 0 4.7130580688170554e-11
in O 0 4.284009605393102e-11
patients O 0 3.5045072399597643e-10
with O 0 1.3134603647768639e-11
XLDCM B-Disease 0 4.517713932727929e-06
, O 0 9.812937129538568e-10
but O 0 3.3603925198022466e-10
a O 0 2.9377361654425727e-10
pathogenic O 0 7.804090706997613e-10
correlation O 0 7.524786904689051e-10
of O 0 7.842768101617992e-10
these O 0 4.1919787086008853e-10
cardiospecific O 0 1.678725851661511e-07
mutations O 0 2.4858843872266334e-09
in O 0 8.701847242775784e-09
DMD O 1 1.0
with O 0 6.214518233349509e-09
the O 0 5.993455829411687e-07
XLDCM B-Disease 0 0.0005063581047579646
phenotype O 0 3.874977210216457e-07
has O 0 3.402884085623725e-10
remained O 0 5.6065374565150705e-09
to O 0 1.4840326745257926e-09
be O 0 1.9807824269690855e-09
elucidated O 0 2.862350584109663e-06
. O 0 6.420418685593177e-07

We O 0 1.0321706156446453e-07
report O 0 3.940308079819488e-09
here O 0 2.2271584576571968e-10
the O 0 2.2040638758547004e-10
identification O 0 7.988066208497457e-09
of O 0 1.5804377806460934e-09
a O 0 6.657975837320862e-10
unique O 0 5.737322839038939e-10
de O 0 1.5427627886310802e-07
novo O 0 6.373845451435045e-08
L1 O 0 1.1153679935205218e-07
insertion O 0 8.56561399587008e-09
in O 0 3.813487303716556e-09
the O 0 1.2925836401223023e-08
muscle O 0 8.954882169120992e-09
exon O 0 1.7045644895574696e-08
1 O 0 1.3511195717796909e-08
in O 0 1.597111420892361e-08
DMD O 1 1.0
in O 0 2.1919795756275562e-08
three O 0 8.796997574833654e-10
XLDCM B-Disease 0 4.0511278598387435e-07
patients O 0 4.06543909647894e-10
from O 0 4.3967079976781065e-11
two O 0 2.2260106952165515e-11
unrelated O 0 1.6009900072333494e-09
Japanese O 0 3.074056849072804e-07
families O 0 1.806163218986967e-09
. O 0 2.5250953328281867e-08

The O 0 1.6033141037041787e-07
insertion O 0 4.247565499326811e-08
was O 0 2.079397631860047e-08
a O 0 7.553632719314862e-10
5 O 0 7.458983430908006e-10
- O 0 9.11437536554871e-10
truncated O 0 3.311774632308584e-09
form O 0 4.0285808022844094e-10
of O 0 3.936264925119559e-10
human O 0 1.0479535988983102e-10
L1 O 0 2.6573274691799043e-09
inversely O 0 6.393515716851539e-10
integrated O 0 4.246315743472451e-09
in O 0 6.556029052973145e-10
the O 0 1.5343333270578796e-09
5 O 0 2.4966326783726345e-09
- O 0 6.544613295744739e-09
untranslated O 0 4.36652840107854e-07
region O 0 1.7514116823491577e-09
in O 0 1.3471406212772763e-09
the O 0 4.184727231404395e-09
muscle O 0 3.63622532084662e-09
exon O 0 7.706645099858633e-09
1 O 0 3.1543605505390815e-09
, O 0 4.288408170238789e-11
which O 0 4.5825361734419534e-12
affected O 0 1.7869039581341895e-11
the O 0 6.01844268866003e-11
transcription O 0 1.248613434867707e-09
or O 0 4.2893508189756346e-10
the O 0 1.6206718189692992e-09
stability O 0 3.628562353696907e-06
of O 0 4.871155923069637e-09
the O 0 2.5464719222156873e-09
muscle O 0 3.828113381842968e-09
form O 0 3.543836335495598e-10
of O 0 1.054406117972917e-09
dystrophin O 0 1.669409499527319e-08
transcripts O 0 4.734957759211511e-09
but O 0 3.14573540827201e-11
not O 0 4.32418614804142e-11
that O 0 6.853559386676977e-12
of O 0 2.2044632785878093e-10
the O 0 1.1830392665501677e-08
brain O 0 2.7067906557931565e-05
or O 0 5.703636318798999e-08
Purkinje O 0 7.342168828472495e-06
cell O 0 7.322271500243005e-08
form O 0 4.0508563170504885e-10
, O 0 1.0816710721561762e-10
probably O 0 8.541957363661368e-09
due O 0 4.7292378013708e-08
to O 0 1.8308387694787598e-08
its O 0 8.268744577932807e-10
unique O 0 1.4543576343228892e-09
site O 0 4.52230120018271e-09
of O 0 4.792314323154301e-10
integration O 0 1.8259147083199423e-08
. O 0 2.0631257768854994e-07

We O 0 2.0291147961870593e-07
speculate O 0 5.1528353139929095e-08
that O 0 7.184691036554725e-11
this O 0 3.1387652893455353e-11
insertion O 0 4.293061017790478e-09
of O 0 2.699616974410901e-09
an O 0 1.5717042944896065e-10
L1 O 0 3.39681811567516e-08
sequence O 0 6.842985622590447e-10
in O 0 1.8701349802086042e-08
DMD O 1 1.0
is O 0 7.244181365884117e-10
responsible O 0 9.392953775888557e-11
for O 0 1.2613375621750578e-10
some O 0 2.1055757831733857e-11
of O 0 1.2366627166748856e-10
the O 0 5.895982313486314e-11
population O 0 7.790767813861676e-13
of O 0 5.8550972230342335e-12
Japanese O 0 7.399077350811467e-09
patients O 0 3.154906336177987e-10
with O 0 2.4076629578928532e-11
XLDCM B-Disease 0 1.7562615539645776e-06
. O 0 3.0242709669892065e-08
. O 0 2.9508021270885365e-07

Severe O 0 1.8700369764701463e-05
early O 1 0.9509865045547485
- O 0 0.09178801625967026
onset O 1 0.9999994039535522
obesity B-Disease 1 1.0
, O 0 1.6865342455929522e-09
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 2.8605910529222456e-07
red O 1 0.9998917579650879
hair O 1 0.9999998807907104
pigmentation O 1 0.9999998807907104
caused O 0 1.3595953532785643e-05
by O 0 1.5567731992405243e-08
POMC O 0 1.5769488527439535e-05
mutations O 0 5.853654450049817e-09
in O 0 3.1453366577949282e-09
humans O 0 1.7458859247199143e-08
. O 0 3.245899904413818e-08

Sequential O 0 2.0155083291228948e-07
cleavage O 0 4.996843117055505e-08
of O 0 5.8873606434417525e-08
the O 0 3.752467669926318e-09
precursor O 0 6.632022486741107e-09
protein O 0 2.19785092903102e-10
pre O 0 1.600959507186417e-07
- O 0 5.841633665681911e-08
pro O 0 5.753184950663126e-07
- O 0 3.0301379183583776e-07
opiomelanocortin O 0 8.584178203818738e-07
( O 0 4.475498860401217e-10
POMC O 0 2.118746124324389e-06
) O 0 1.2594575382607331e-10
generates O 0 1.346913969246799e-10
the O 0 1.3916701124827568e-09
melanocortin O 0 1.3706344361708034e-06
peptides O 0 5.963693183730356e-08
adrenocorticotrophin O 0 1.0909441243711626e-06
( O 0 4.6552739441096946e-10
ACTH O 0 7.171092306634819e-07
) O 0 1.795510962132596e-10
, O 0 3.3969441148862245e-10
melanocyte O 0 1.7946400703294785e-06
- O 0 1.2068429668943281e-06
stimulating O 0 4.0087047636916395e-06
hormones O 0 6.100990049162647e-06
( O 0 4.122071295409313e-10
MSH O 0 3.857529009110294e-06
) O 0 1.1245561426509454e-10
alpha O 0 3.5459204461574245e-09
, O 0 3.904699480417051e-11
beta O 0 1.4024513772525893e-09
and O 0 3.2065804872472015e-11
gamma O 0 9.81438308400584e-09
as O 0 3.964512329535097e-10
well O 0 3.770674883440961e-10
as O 0 3.0337893308640673e-10
the O 0 1.3123266362491393e-10
opioid O 0 1.4312474538868969e-09
- O 0 2.1733474742102743e-10
receptor O 0 8.507720916650641e-11
ligand O 0 4.435483536013862e-09
beta O 0 6.277086868067272e-07
- O 0 4.993889888282865e-07
endorphin O 0 9.939297888195142e-05
. O 0 3.5538650422495266e-07

While O 0 9.37735791239902e-08
a O 0 2.7870550312059095e-09
few O 0 4.6440018497406754e-10
cases O 0 7.09018677103046e-11
of O 0 1.2752937594839864e-09
isolated O 0 5.138486471878423e-07
ACTH B-Disease 1 0.9999997615814209
deficiency I-Disease 0 0.00012413429794833064
have O 0 1.4715805463083598e-08
been O 0 1.2841034013888475e-08
reported O 0 4.303308376307768e-09
( O 0 2.2301001323388192e-10
OMIM O 0 3.066852514166385e-06
201400 O 0 3.607871690292086e-07
) O 0 8.639676196686707e-10
, O 0 3.069550447154512e-10
an O 0 1.5108021500509494e-09
inherited O 1 0.9907023906707764
POMC O 1 1.0
defect O 1 1.0
has O 0 5.395602187263648e-09
not O 0 6.13822603856562e-10
been O 0 1.0904208785911251e-10
described O 0 1.5382443929734535e-10
so O 0 2.279704341967559e-10
far O 0 3.871996945292722e-09
. O 0 3.997775621655819e-08

Recent O 0 3.4229282164233155e-07
studies O 0 1.8392073641848583e-08
in O 0 4.71098382526236e-10
animal O 0 1.4317354246617953e-10
models O 0 8.336072804260297e-11
elucidated O 0 5.1715303150956515e-09
a O 0 1.0453031773494104e-09
central O 0 1.338525290606185e-08
role O 0 1.0842272857303215e-08
of O 0 1.847244135433357e-08
alpha O 0 1.323942484532381e-07
- O 0 8.958644315271158e-08
MSH O 0 8.993689334602095e-06
in O 0 3.973924744826718e-09
the O 0 5.628813859459569e-09
regulation O 0 5.292092453146324e-08
of O 0 3.484877109105611e-10
food O 0 2.4640128826192154e-10
intake O 0 5.219586568516732e-11
by O 0 1.5454265200453426e-13
activation O 0 4.873755843348704e-10
of O 0 1.2272501903609623e-09
the O 0 7.885657460349194e-09
brain O 0 1.963907259039388e-08
melanocortin O 0 3.3235522778340965e-08
- O 0 2.3480191124747307e-09
4 O 0 4.488940330560354e-09
- O 0 7.3723547266979494e-09
receptor O 0 2.880268024085808e-09
( O 0 1.065854349224793e-10
MC4 O 0 2.32762613450177e-06
- O 0 2.7584349027165445e-08
R O 0 5.662183610866123e-09
; O 0 1.1035395514058521e-10
refs O 0 1.6208518971438934e-08
3 O 0 1.121506443269027e-09
- O 0 1.6467212038406842e-09
5 O 0 1.2208017929893344e-09
) O 0 2.099304063918339e-11
and O 0 2.1891391477346644e-11
the O 0 4.2139275402419685e-10
linkage O 0 2.4591651381911106e-08
of O 0 3.478297871950531e-09
human O 0 1.7867771262558563e-08
obesity B-Disease 1 1.0
to O 0 1.5444454604107705e-09
chromosome O 0 3.3170832747231316e-10
2 O 0 1.446189279441512e-09
in O 0 9.571496928373335e-10
close O 0 6.309445854668638e-09
proximity O 0 1.4674490067534407e-08
to O 0 2.5420229476935674e-08
the O 0 4.3843709107704854e-08
POMC O 0 5.28299324287218e-06
locus O 0 4.6333632042205863e-08
, O 0 3.203317611166767e-10
led O 0 2.5077417920016387e-10
to O 0 1.9022954045322393e-10
the O 0 1.8415573233010463e-10
proposal O 0 4.683756715806453e-10
of O 0 3.067186227223573e-10
an O 0 1.9504181603124948e-10
association O 0 5.737891828339059e-10
of O 0 6.3750347223390236e-09
POMC O 0 0.0003539502795320004
with O 0 3.8276173341955655e-09
human O 0 7.672269362046791e-07
obesity B-Disease 1 1.0
. O 0 3.4952660143972025e-07

The O 0 3.17894439660904e-08
dual O 0 1.6949186942838423e-07
role O 0 2.451193381602934e-07
of O 0 7.733402753729024e-07
alpha O 0 3.6754889151779935e-05
- O 0 1.4771359929000027e-05
MSH O 0 0.001910654129460454
in O 0 1.1829489388048842e-08
regulating O 0 1.39690641276502e-07
food O 0 2.0591309990436457e-08
intake O 0 1.1999973459353441e-08
and O 0 1.4597650865866285e-10
influencing O 0 8.830727892927825e-06
hair O 0 0.22460439801216125
pigmentation O 0 0.07193902134895325
predicts O 0 2.9784862576320847e-08
that O 0 1.0814914935819431e-10
the O 0 1.7523964224164246e-10
phenotype O 0 1.9324006839127605e-09
associated O 0 8.316797250884633e-10
with O 0 1.978039260164266e-11
a O 0 3.4308704766061737e-09
defect O 0 5.762058918890034e-08
in O 0 3.246065638506934e-09
POMC O 0 3.0072505978750996e-06
function O 0 4.588315505316132e-09
would O 0 1.2969020302122658e-09
include O 0 4.837416689440488e-09
obesity B-Disease 1 1.0
, O 0 3.1510036246906736e-10
alteration O 0 2.302614916516177e-07
in O 0 1.0596611588198357e-07
pigmentation O 1 0.9998773336410522
and O 0 4.367754627310205e-06
ACTH B-Disease 1 1.0
deficiency I-Disease 0 0.00027563050389289856
. O 0 1.3881973472962272e-06

The O 0 2.3200372822884674e-07
observation O 0 1.7904141031976906e-06
of O 0 1.7104585525729021e-09
these O 0 2.479708105518341e-10
symptoms O 0 2.470354054651125e-08
in O 0 6.075745462297277e-10
two O 0 8.585204214206499e-10
probands O 0 2.967811383314256e-07
prompted O 0 1.0450166065822941e-08
us O 0 2.8147921771193296e-09
to O 0 4.691447674787241e-09
search O 0 7.41177563767792e-09
for O 0 1.702906371470192e-09
mutations O 0 6.963113974300938e-10
within O 0 1.4053005426006848e-09
their O 0 3.0648092064211596e-08
POMC O 0 2.1964253392070532e-05
genes O 0 1.5455489688065427e-07
. O 0 9.019739763971302e-07

Patient O 0 7.198443654488074e-06
1 O 0 1.6484683840189973e-07
was O 0 5.578380424253737e-08
found O 0 8.003709917048241e-10
to O 0 1.700005025639939e-09
be O 0 6.148455633514516e-10
a O 0 2.036750768041884e-10
compound O 0 1.457545528715798e-09
heterozygote O 0 9.447423288122536e-09
for O 0 1.5982859480345724e-10
two O 0 3.704426695949614e-11
mutations O 0 1.3929547793001262e-10
in O 0 4.261835884200593e-10
exon O 0 1.3967393464042743e-08
3 O 0 2.4904652562440788e-08
( O 0 7.024046899672953e-10
G7013T O 0 2.9513594768104667e-07
, O 0 4.882846349474335e-10
C7133delta O 0 8.516111904555146e-08
) O 0 5.593245311352746e-11
which O 0 8.839475158783916e-12
interfere O 0 6.153746401338367e-10
with O 0 1.257306325025409e-11
appropriate O 0 1.7299219834399082e-08
synthesis O 0 1.3809295751343598e-07
of O 0 2.640735985437459e-08
ACTH O 0 1.6973610854620347e-06
and O 0 1.2358644774224103e-08
alpha O 0 7.896082024672069e-06
- O 0 1.1095230547653046e-05
MSH O 0 0.0010002886410802603
. O 0 1.1785774631789536e-06

Patient O 0 1.686927498667501e-05
2 O 0 1.2368860780043178e-07
was O 0 4.2947011280602965e-08
homozygous O 0 9.344376827868928e-09
for O 0 6.639891969584255e-10
a O 0 5.676043524083241e-10
mutation O 0 1.6347533049465568e-10
in O 0 8.984321064886558e-10
exon O 0 3.714202279070378e-08
2 O 0 5.8940571534549235e-08
( O 0 1.5343449843996382e-09
C3804A O 0 2.940761874015152e-07
) O 0 3.354903854724256e-10
which O 0 2.364845264057891e-10
abolishes O 0 9.233663718077878e-07
POMC O 0 2.541921094234567e-05
translation O 0 5.516089913726319e-06
. O 0 2.0771121853613295e-06

These O 0 1.4869630859948302e-08
findings O 0 5.609276154672216e-09
represent O 0 3.5287880950640726e-10
the O 0 3.3912150865234025e-10
first O 0 1.527325710348748e-09
examples O 0 2.406040033875456e-09
of O 0 6.581964417939901e-10
a O 0 1.1226413576537198e-08
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
within O 0 2.6824851673268313e-08
the O 0 1.010117500754859e-08
POMC O 0 5.068537802799256e-07
gene O 0 1.096287616242364e-09
and O 0 1.0565637947879125e-10
define O 0 9.837922476663152e-09
a O 0 5.069491937348403e-09
new O 0 1.165291649840583e-07
monogenic B-Disease 1 1.0
endocrine I-Disease 1 0.9999998807907104
disorder I-Disease 0 0.29182127118110657
resulting O 0 4.927040997415588e-10
in O 0 1.4934706249469798e-10
early O 0 3.270218712714268e-06
- O 0 3.733462108357344e-06
onset O 1 0.7670272588729858
obesity B-Disease 1 1.0
, O 0 2.5575745965511487e-09
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 1.2549528491945239e-06
red O 1 0.7078849673271179
hair O 0 0.1517440527677536
pigmentation O 0 0.09904388338327408
. O 0 4.430810065514379e-07
. O 0 6.638263130298583e-07

A O 0 1.5775133306306088e-06
European O 0 2.735127111463953e-07
multicenter O 0 4.64336108052521e-06
study O 0 7.621470388130547e-08
of O 0 6.742916980329028e-07
phenylalanine B-Disease 1 1.0
hydroxylase I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 2.0644870701858054e-08
classification O 0 1.5699409772196304e-08
of O 0 7.454905137649348e-09
105 O 0 9.699545699959344e-08
mutations O 0 7.859585204883501e-10
and O 0 3.1692967694674223e-10
a O 0 2.401612242408646e-08
general O 0 2.2565325252799084e-07
system O 0 1.1664385901610785e-08
for O 0 1.0540642803036349e-09
genotype O 0 1.2599579157779317e-09
- O 0 5.110704748290118e-09
based O 0 2.338481408514781e-09
prediction O 0 1.281842827438595e-07
of O 0 5.683336468109701e-09
metabolic O 0 1.5338416687882273e-06
phenotype O 0 4.3210022226958245e-07
. O 0 1.1683651734983869e-07

Phenylketonuria B-Disease 0 0.0399496927857399
( O 0 1.6416166204180627e-08
PKU B-Disease 0 2.76524260698352e-05
) O 0 6.242959926794356e-09
and O 0 7.299567172935895e-09
mild B-Disease 0 0.019338121637701988
hyperphenylalaninemia I-Disease 1 1.0
( O 0 5.58851880327893e-08
MHP B-Disease 1 1.0
) O 0 2.3243138524975393e-09
are O 0 1.9336321432916748e-09
allelic B-Disease 0 9.886426596494857e-06
disorders I-Disease 0 2.673619383131154e-05
caused O 0 3.900527456579539e-09
by O 0 4.0958226393827957e-11
mutations O 0 1.2050282993669725e-10
in O 0 1.6818947623509217e-10
the O 0 1.280492711863701e-09
gene O 0 5.327371321861563e-10
encoding O 0 5.619473952833687e-08
phenylalanine O 0 2.6743937269202434e-06
hydroxylase O 0 1.9792480088653974e-05
( O 0 1.1273835198721827e-08
PAH O 0 5.0007194658974186e-05
) O 0 1.850241382328477e-08
. O 0 2.9030104542471236e-07

Previous O 0 2.0786737877642736e-06
studies O 0 3.635284073766343e-08
have O 0 7.643795041367696e-10
suggested O 0 1.3727100567351158e-09
that O 0 3.19478575538934e-11
the O 0 2.4509633211877713e-10
highly O 0 3.4951701533003643e-09
variable O 0 4.2975855762961146e-07
metabolic O 0 0.00015575019642710686
phenotypes O 0 0.0001437921164324507
of O 0 8.661892934469506e-06
PAH B-Disease 1 1.0
deficiency I-Disease 0 0.2615834176540375
correlate O 0 1.3911254427512176e-05
with O 0 3.054963215731732e-08
PAH O 1 0.9999905824661255
genotypes O 0 0.00011950350017286837
. O 0 2.129557515218039e-06

We O 0 7.903916525719978e-07
identified O 0 7.271972179978548e-08
both O 0 1.4679578663745474e-09
causative O 0 5.4711318142608434e-08
mutations O 0 3.754903588060188e-08
in O 0 2.4972519607757704e-09
686 O 0 4.305888623434839e-08
patients O 0 1.2023136264360801e-08
from O 0 1.4298668915557755e-09
seven O 0 6.614261138793154e-09
European O 0 2.8605493085365197e-08
centers O 0 1.2965249140961532e-07
. O 0 1.498409005762369e-07

On O 0 7.103956818355073e-07
the O 0 4.301494715974741e-09
basis O 0 2.306780322314239e-09
of O 0 1.0492663404804148e-09
the O 0 1.247408953908291e-09
phenotypic O 0 1.35719968596959e-08
characteristics O 0 2.726839021249816e-08
of O 0 1.5075530157560024e-08
297 O 0 1.0156330887411968e-08
functionally O 0 2.2814250044689288e-08
hemizygous O 0 6.599783830552042e-08
patients O 0 1.326614484931099e-09
, O 0 1.2767553507486706e-11
105 O 0 6.634375271374893e-09
of O 0 4.768591743697925e-09
the O 0 1.3788695518712757e-08
mutations O 0 4.3630934976057745e-10
were O 0 5.632677102518358e-10
assigned O 0 6.856445633474095e-09
to O 0 2.4060918590862457e-08
one O 0 1.6837764515997833e-09
of O 0 1.067010146904579e-09
four O 0 3.7157010801536217e-10
arbitrary O 0 4.4177443925264015e-09
phenotype O 0 4.384920426758754e-09
categories O 0 9.545285450940355e-09
. O 0 7.653532918538986e-08

We O 0 6.881215313114808e-07
proposed O 0 7.940326440802892e-08
and O 0 6.546959863129587e-09
tested O 0 3.554644223413561e-08
a O 0 7.208744157161107e-10
simple O 0 3.377330082265928e-10
model O 0 3.0834104713939325e-10
for O 0 5.218471835211069e-11
correlation O 0 5.4315090619594386e-11
between O 0 4.3257619708469974e-11
genotype O 0 4.707438883144732e-09
and O 0 1.247844383378549e-09
phenotypic O 0 9.978985104908134e-08
outcome O 0 5.498587256624887e-07
. O 0 2.0961399513907963e-06

The O 0 1.1933398980090715e-07
observed O 0 1.0552315465872653e-08
phenotype O 0 7.752880115674543e-09
matched O 0 1.0212605872084168e-08
the O 0 1.3086579597754167e-09
predicted O 0 4.145284560053142e-09
phenotype O 0 1.7995610557264285e-09
in O 0 1.470350230459161e-10
79 O 0 1.0187625854030102e-08
% O 0 6.098708343893477e-11
of O 0 4.8668697544274053e-11
the O 0 2.8356976489174457e-11
cases O 0 5.397910417259677e-12
, O 0 1.7422199750580236e-12
and O 0 3.530481029051513e-12
in O 0 8.945347934607994e-11
only O 0 1.8105150711988927e-10
5 O 0 7.421447900668454e-10
of O 0 1.333468196973442e-10
184 O 0 3.680167004471713e-10
patients O 0 8.426236375314033e-10
was O 0 6.1680505147876374e-09
the O 0 4.524673524741729e-09
observed O 0 1.5214997262091856e-08
phenotype O 0 7.153849068686213e-09
more O 0 2.6206212547230656e-11
than O 0 6.029400936857776e-12
one O 0 4.060939952366116e-12
category O 0 6.916332784268064e-11
away O 0 2.2809396038603325e-10
from O 0 6.330402174681282e-11
that O 0 1.6696076812761085e-11
expected O 0 1.233050217486209e-09
. O 0 9.339925099993707e-08

Among O 0 7.226647369407146e-08
the O 0 9.365002995309624e-09
seven O 0 2.5295709971118185e-10
contributing O 0 1.947355054987554e-10
centers O 0 3.6822031534988753e-10
, O 0 1.2798468881913827e-11
the O 0 4.447449006295123e-11
proportion O 0 7.254312428539578e-11
of O 0 1.7182792688696935e-10
patients O 0 1.8225446152264624e-10
for O 0 4.4188375181164474e-10
whom O 0 1.8407610991033607e-09
the O 0 4.821821608658183e-09
observed O 0 2.561841849768598e-09
phenotype O 0 1.4804590886541291e-09
did O 0 1.0899369184969032e-09
not O 0 3.4762404066412955e-10
match O 0 2.0392396660184886e-09
the O 0 8.296770492854932e-10
predicted O 0 9.164037861886243e-10
phenotype O 0 9.193010797048373e-10
was O 0 7.857292039226138e-10
4 O 0 6.342164016182039e-10
% O 0 7.24966475740274e-11
- O 0 1.726226273035536e-09
23 O 0 2.31730679089992e-09
% O 0 3.2523603255008027e-10
( O 0 9.534704276115136e-11
P O 0 1.6209321884730343e-08
< O 0 1.3201835180609578e-08
. O 0 1.929872928130294e-10
0001 O 0 2.096203843393596e-06
) O 0 3.04492542291257e-10
, O 0 6.697047777448617e-11
suggesting O 0 1.821961692627383e-09
that O 0 1.6870699282023338e-11
differences O 0 5.958317866872065e-11
in O 0 9.82757833445369e-11
methods O 0 1.9834476283620006e-09
used O 0 6.896734849881625e-10
for O 0 4.240446049852409e-10
mutation O 0 1.0852362342106403e-09
detection O 0 6.919773198887924e-08
or O 0 4.912714235416615e-09
phenotype O 0 3.965590167354094e-08
classification O 0 1.0855282228661167e-09
may O 0 2.9619293129279356e-10
account O 0 8.687311287003396e-11
for O 0 4.668644984495707e-11
a O 0 7.157117953848768e-11
considerable O 0 2.0276615109171559e-10
proportion O 0 1.6712685402264782e-10
of O 0 1.0379640480451258e-09
genotype O 0 3.062583289192844e-07
- O 0 4.0838967834133655e-06
phenotype O 0 1.4618083241657587e-06
inconsistencies O 0 5.695715685760661e-07
. O 0 8.105570827865449e-07

Our O 0 1.7344437992505846e-06
data O 0 1.5811808395937987e-07
indicate O 0 5.3308326641854364e-08
that O 0 3.239285228939792e-10
the O 0 1.0743502976140462e-08
PAH O 0 8.114765660138801e-05
- O 0 1.8383361748419702e-06
mutation O 0 1.5909058959096e-08
genotype O 0 8.120238703668292e-09
is O 0 4.431884720323964e-11
the O 0 2.492149542288047e-10
main O 0 2.523240283380801e-09
determinant O 0 9.083595386982779e-08
of O 0 8.919736416146407e-08
metabolic O 1 0.9187374711036682
phenotype O 0 8.92182697498356e-07
in O 0 5.289465754287903e-09
most O 0 1.0179890264083724e-09
patients O 0 9.549511403861288e-09
with O 0 1.7119794470943361e-09
PAH B-Disease 1 1.0
deficiency I-Disease 1 0.9999971389770508
. O 0 1.6403291738242842e-05

In O 0 6.279470454728653e-08
the O 0 8.37309865886482e-09
present O 0 2.808510923824059e-10
study O 0 3.336557141686569e-10
, O 0 4.537347234045974e-11
the O 0 3.039169749197157e-10
classification O 0 1.5803985897733241e-09
of O 0 4.203029035920736e-09
105 O 0 4.509994369072956e-07
PAH O 0 3.642535375547595e-05
mutations O 0 1.8157734871238063e-08
may O 0 2.559770839738462e-09
allow O 0 2.6989783741271367e-09
the O 0 1.3713885582689045e-09
prediction O 0 1.6834079019645287e-08
of O 0 7.540389423965621e-10
the O 0 7.056435435970343e-10
biochemical O 0 3.6445733542223024e-08
phenotype O 0 1.0206686162916867e-08
in O 0 1.0628239399679273e-09
> O 0 3.982652785339269e-08
10 O 0 4.317062263226035e-09
, O 0 9.745001333660852e-11
000 O 0 2.2233619390021886e-08
genotypes O 0 3.787921087905488e-08
, O 0 2.6686475251835873e-10
which O 0 1.711115971136934e-11
may O 0 6.975685307164525e-11
be O 0 1.4749446455852855e-11
useful O 0 2.3118666703236812e-10
for O 0 4.9269352486724927e-11
the O 0 6.131837260170414e-10
management O 0 8.067396528588233e-09
of O 0 8.14841349949802e-09
hyperphenylalaninemia B-Disease 1 1.0
in O 0 4.984706336585987e-08
newborns O 0 3.7102523720022873e-07
. O 0 8.174414034556321e-08

Somatic O 0 2.1786139768664725e-05
instability O 0 4.0846134652383626e-06
of O 0 2.0350137219793396e-07
the O 0 2.0145841972407652e-07
CTG O 0 8.229421837313566e-06
repeat O 0 1.6157348170509067e-07
in O 0 1.5886802984255155e-08
mice O 0 1.0001637740231217e-08
transgenic O 0 2.650574648654924e-09
for O 0 1.7197916424294135e-09
the O 0 4.4711435975841596e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 0 5.619864396066987e-07
is O 0 3.1241692566297274e-10
age O 0 4.661324104482389e-10
dependent O 0 3.584297025849281e-10
but O 0 1.928959249275497e-11
not O 0 3.878327520245861e-11
correlated O 0 6.886941572581406e-10
to O 0 1.4074517107331985e-09
the O 0 4.4720791514407665e-09
relative O 0 2.4335611215065e-07
intertissue O 0 4.81122299333947e-07
transcription O 0 1.4950974502880854e-07
levels O 0 2.0809019929401984e-07
and O 0 5.341822539861596e-09
proliferative O 0 0.00023166586470324546
capacities O 0 0.00033805661951191723
. O 0 1.1357184121152386e-05

A O 0 2.3694412448094226e-05
( O 0 1.4089566846564594e-08
CTG O 0 1.6991619986583828e-06
) O 0 7.198315832290803e-10
nexpansion O 0 7.387404821201926e-08
in O 0 4.044572177175354e-10
the O 0 5.762668675579619e-10
3 O 0 4.378819085104624e-09
- O 0 2.4457868619265355e-08
untranslated O 0 1.424344077349815e-06
region O 0 7.902821508309898e-09
( O 0 4.5776202273195565e-11
UTR O 0 2.416652478132164e-07
) O 0 2.492030748424412e-10
of O 0 1.3261944875608833e-09
the O 0 2.0400227285222172e-08
DM O 1 1.0
protein O 0 4.885934856702079e-08
kinase O 0 1.1755550133329962e-07
gene O 0 2.5752568078019067e-08
( O 0 1.6142386038975332e-10
DMPK O 0 4.86463136439852e-07
) O 0 6.169915273135373e-11
is O 0 6.915722335076868e-12
responsible O 0 8.80055056606821e-11
for O 0 3.8537303903574127e-10
causing O 0 2.4339121864613844e-06
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 8.384087095691939e-07
DM B-Disease 1 1.0
) O 0 2.5056120733779608e-08
. O 0 1.8706705873228202e-07

Major O 0 7.753093086648732e-05
instability O 0 0.00018935090338345617
, O 0 9.671849099390784e-09
with O 0 1.9769766379518217e-10
very O 0 8.466898848702442e-10
large O 0 1.2310404085003057e-10
expansions O 0 5.0640220905506794e-09
between O 0 2.5805252379385024e-10
generations O 0 1.4187179209201872e-09
and O 0 8.798754780325879e-11
high O 0 1.2615040123620247e-09
levels O 0 2.692561729134013e-09
of O 0 9.46137501678379e-10
somatic O 0 3.4168260754086077e-07
mosaicism O 0 2.163190174542251e-06
, O 0 3.584036956105763e-10
is O 0 1.5182419557668858e-11
observed O 0 1.490727263853131e-10
in O 0 2.359645812077815e-10
patients O 0 2.7723900952736358e-09
. O 0 2.1030823305068225e-08

There O 0 3.4685214700402867e-08
is O 0 1.820897599369431e-10
a O 0 1.3971802881318496e-10
good O 0 2.2636641172635308e-10
correlation O 0 4.039589149296141e-11
between O 0 1.1875452878007398e-11
repeat O 0 5.9995604040352646e-09
size O 0 3.551558824810286e-09
( O 0 1.2353000566900363e-10
at O 0 1.2555294581773069e-09
least O 0 1.5098364225529792e-10
in O 0 1.276166672337098e-10
leucocytes O 0 2.3468114562774645e-08
) O 0 5.401548652805843e-11
, O 0 9.060598625543204e-12
clinical O 0 3.741145448987737e-10
severity O 0 2.445533775485842e-09
and O 0 2.7625268392283964e-11
age O 0 4.434527411945055e-09
of O 0 8.86197426552826e-09
onset O 0 7.990879566932563e-06
. O 0 2.3305950946905796e-07

The O 0 1.3669831560036982e-06
trinucleotide O 0 0.00021364558779168874
repeat O 0 1.5387587382065249e-06
instability O 0 5.872701649423107e-07
mechanisms O 0 9.062661661118909e-07
involved O 0 7.408948565768014e-09
in O 0 6.698999044374432e-08
DM B-Disease 1 1.0
and O 0 1.9729411349089787e-07
other O 0 2.4406840992696743e-08
human O 0 6.71565558718612e-08
genetic B-Disease 1 1.0
diseases I-Disease 1 1.0
are O 0 1.7255004716720812e-11
unknown O 0 6.060367319093984e-09
. O 0 2.5827683103329946e-08

We O 0 2.526131765989703e-07
studied O 0 3.0448825327766826e-07
somatic O 0 3.0502001209242735e-06
instability O 0 3.30435682371899e-07
by O 0 1.4081928956244383e-09
measuring O 0 9.900851694055746e-09
the O 0 9.829257408000558e-09
CTG O 0 2.8607956892301445e-07
repeat O 0 9.364610420448116e-09
length O 0 8.183719812926427e-10
at O 0 1.6911341216285791e-09
several O 0 2.191829877318252e-11
ages O 0 1.8334508911088676e-10
in O 0 4.3426175849736737e-11
various O 0 6.786574080486218e-10
tissues O 0 2.9962521352899785e-08
of O 0 1.6226326948753922e-09
transgenic O 0 6.216509973455686e-09
mice O 0 2.4929591724287548e-09
carrying O 0 8.1768386506198e-10
a O 0 3.6477776355070546e-09
( O 0 1.7868921897701284e-09
CTG O 0 1.231205828844395e-06
) O 0 1.940171134862112e-09
55expansion O 0 1.5326530444781383e-07
surrounded O 0 1.884844724742152e-09
by O 0 6.079800551894721e-11
45 O 0 2.3617454658619863e-09
kb O 0 1.7028852994371846e-07
of O 0 1.3331771242519608e-08
the O 0 5.3938457256208494e-08
human O 0 8.940975959603747e-08
DM B-Disease 1 1.0
region O 0 1.051735694090894e-07
, O 0 9.346688978340012e-10
using O 0 6.799456109263247e-09
small O 0 5.9681060093907945e-09
- O 0 1.5206764203412604e-07
pool O 0 3.896462601460371e-07
PCR O 0 1.818827513488941e-06
. O 0 3.7499870586543693e-07

These O 0 7.923669187448468e-08
mice O 0 7.146951475078822e-08
have O 0 2.17369150457003e-10
been O 0 1.3196685411109854e-10
shown O 0 1.982754516127727e-10
to O 0 6.894024795478515e-10
reproduce O 0 1.4785071833500751e-08
the O 0 1.4981389462320749e-09
intergenerational O 0 6.7305405693218745e-09
and O 0 9.45246436678815e-10
somatic O 0 3.8541352864740475e-07
instability O 0 1.2342748334503995e-07
of O 0 4.480753990065978e-09
the O 0 6.056438461854441e-09
55 O 0 5.00943961867506e-08
CTG O 0 6.501294365079957e-07
repeat O 0 4.8318316459017296e-08
suggesting O 0 1.5116732754449913e-08
that O 0 1.763036591717615e-11
surrounding O 0 1.1816842643286307e-11
sequences O 0 4.736886230483073e-11
and O 0 1.0130222355408947e-10
the O 0 7.77557795927919e-10
chromatin O 0 1.273837590964888e-09
environment O 0 6.1980167664899e-09
are O 0 1.4557660632519287e-11
involved O 0 6.005783370621742e-11
in O 0 3.2605096400573075e-10
instability O 0 5.127726510067987e-08
mechanisms O 0 1.1418241001592833e-06
. O 0 2.7052374207414687e-07

As O 0 2.169026380727246e-08
observed O 0 2.628583573027754e-09
in O 0 2.753091643548089e-10
some O 0 1.0109819231773898e-10
of O 0 7.826509995645381e-10
the O 0 4.853970114737649e-09
tissues O 0 6.339521263498682e-08
of O 0 4.558719979286252e-08
DM B-Disease 1 1.0
patients O 0 4.789660010828811e-07
, O 0 6.334472529845314e-11
there O 0 1.9897089184595096e-11
is O 0 5.673634739106204e-12
a O 0 3.2011053530123235e-11
tendency O 0 1.1069251071305075e-10
for O 0 4.4946244642796174e-11
repeat O 0 1.6403824965038893e-09
length O 0 1.2385846792639654e-09
and O 0 1.2814945771211228e-09
somatic O 0 2.2206162952898012e-07
mosaicism O 0 1.6211075148930831e-07
to O 0 5.662353363966588e-10
increase O 0 3.30474189680352e-11
with O 0 3.782433567744992e-12
the O 0 6.682365216725827e-10
age O 0 2.292551481986038e-09
of O 0 1.51895307443084e-09
the O 0 1.4616471588624336e-08
mouse O 0 7.176127496677509e-07
. O 0 3.950123073082068e-07

Furthermore O 0 1.0467421134308097e-06
, O 0 3.2682940798167692e-09
we O 0 1.4117750302133913e-09
observed O 0 7.893432574235248e-10
no O 0 8.801327999741204e-10
correlation O 0 4.3687228834521363e-10
between O 0 1.8328843998105526e-10
the O 0 9.446883275643359e-09
somatic O 0 8.51533332024701e-06
mutation O 0 6.769901972347725e-08
rate O 0 2.8240495453246695e-07
and O 0 8.506074955505483e-09
tissue O 0 2.3528582460130565e-07
proliferation O 0 1.4466291759163141e-05
capacity O 0 2.2328289617234987e-07
. O 0 3.1055239446686755e-07

The O 0 1.4880930621075095e-06
somatic O 0 1.329923361481633e-05
mutation O 0 9.549605550773776e-08
rates O 0 1.2332441201579059e-07
in O 0 9.479801388323494e-10
different O 0 1.0722349674807674e-09
tissues O 0 2.5449047313941264e-08
were O 0 1.851779729555858e-09
also O 0 1.1688561230016603e-10
not O 0 3.6494789829033536e-11
correlated O 0 5.834679961402855e-10
to O 0 1.2081081690595852e-09
the O 0 2.3353348144183883e-09
relative O 0 1.0632649605213373e-07
inter O 0 2.9269445533941507e-08
- O 0 2.8638694971050427e-07
tissue O 0 2.203048943272279e-08
difference O 0 3.465786546641425e-10
in O 0 1.401800203693071e-11
transcriptional O 0 1.0731469185509823e-10
levels O 0 8.377104010470759e-10
of O 0 1.582826092416667e-10
the O 0 8.325383715757084e-10
three O 0 2.6907737149528543e-10
genes O 0 3.197299092150274e-10
( O 0 1.466015225881634e-10
DMAHP O 0 7.044264407340961e-07
, O 0 1.0628867785911211e-09
DMPK O 0 7.247351732075913e-07
and O 0 5.208232178866012e-10
59 O 0 1.1050719450622637e-08
) O 0 1.8616345964783676e-10
surrounding O 0 1.5894705551744437e-09
the O 0 5.997615737385331e-09
repeat O 0 2.6136417474731388e-08
. O 0 6.8356320603868426e-09
. O 0 5.969531002847361e-08

A O 0 6.51727305012173e-07
novel O 0 1.345221249948736e-07
missense O 0 2.3318252715398557e-06
mutation O 0 1.0883046464016388e-08
in O 0 6.590041845555561e-10
patients O 0 3.3742282301574278e-09
from O 0 6.174379896251025e-10
a O 0 3.778985124824885e-09
retinoblastoma B-Disease 0 2.591409156593727e-06
pedigree O 0 4.1416561202822777e-07
showing O 0 3.113868629611716e-08
only O 0 1.1357355056418328e-09
mild O 0 2.8508853056052885e-09
expression O 0 1.5699073152575238e-09
of O 0 1.2829962647842308e-09
the O 0 4.6383830110130475e-09
tumor B-Disease 0 1.963658746717556e-07
phenotype O 0 6.709189648290703e-08
. O 0 1.845645698494991e-07

We O 0 1.8008395841206948e-07
have O 0 9.609124607123931e-10
used O 0 4.703272216133314e-10
single O 0 3.838845352710507e-10
strand O 0 1.4009648996449187e-09
conformation O 0 6.641120431361003e-10
polymorphism O 0 1.3322284386774186e-09
analysis O 0 7.670064583464864e-11
to O 0 1.9564540265637476e-10
study O 0 2.8324825818160093e-10
the O 0 7.147735181511905e-10
27 O 0 3.1434790770390464e-08
exons O 0 1.5292037858216645e-08
of O 0 4.362987748862679e-09
the O 0 1.0709907627415305e-08
RB1 O 0 1.51143183302338e-06
gene O 0 1.7544976582684058e-09
in O 0 2.679164112784349e-10
individuals O 0 1.1991283833945321e-11
from O 0 9.461623151629794e-11
a O 0 9.357731256542934e-10
family O 0 9.140662671214272e-10
showing O 0 1.9800694417426712e-08
mild O 0 2.1562966523447358e-08
expression O 0 1.0039366671321659e-08
of O 0 9.808113432541177e-09
the O 0 2.282887479054807e-08
retinoblastoma B-Disease 0 4.444578735274263e-06
phenotype O 0 4.217783668991615e-07
. O 0 2.6496417149246554e-07

In O 0 4.3880351796588e-08
this O 0 9.008503276675128e-09
family O 0 3.279158944380356e-09
affected O 0 4.316508261936747e-10
individuals O 0 1.3963536923955466e-11
developed O 0 1.2388210457459081e-09
unilateral B-Disease 0 0.000128573490655981
tumors I-Disease 1 1.0
and O 0 9.125233901841057e-09
, O 0 1.7459607370984287e-10
as O 0 2.2723936621282803e-10
a O 0 1.1518436204838167e-10
result O 0 2.0619782270525633e-10
of O 0 7.817007041666102e-10
linkage O 0 2.0138649858836288e-08
analysis O 0 1.4235678413854203e-08
, O 0 2.063836435084454e-09
unaffected O 0 7.924621314714386e-08
mutation O 0 9.295487157778837e-10
carriers O 0 1.7957539621971108e-10
were O 0 5.705360073271493e-10
also O 0 4.5679152127497957e-10
identified O 0 1.2123415604747834e-09
within O 0 1.6609729147631924e-09
the O 0 1.4021392047425252e-08
pedigree O 0 1.3020739970670547e-06
. O 0 3.000722017532098e-07

A O 0 4.4822263589594513e-07
single O 0 1.8385339473070417e-08
band O 0 3.075754406722808e-08
shift O 0 2.1852669007671466e-08
using O 0 9.623765784283478e-09
SSCP O 0 7.999342983566748e-07
was O 0 1.1836192470582318e-08
identified O 0 1.6012068337900587e-09
in O 0 8.546108265505836e-10
exon O 0 6.495552984375763e-09
21 O 0 5.047686268966345e-09
which O 0 1.8685135036444755e-11
resulted O 0 8.04484603933453e-11
in O 0 7.406383839558828e-11
a O 0 5.848964090837683e-10
missense O 0 1.1134693167491605e-08
mutation O 0 4.284485821681727e-10
converting O 0 1.4816229354508437e-09
a O 0 3.2329048327284227e-09
cys O 0 8.768525390223658e-07
- O 0 4.5472222609532764e-07
- O 0 4.673578928304778e-07
> O 0 3.4913546187453903e-07
arg O 0 1.874320787464967e-07
at O 0 4.893486504897737e-09
nucleotide O 0 1.3203395710092991e-08
position O 0 5.724998075606891e-08
28 O 0 1.1195432847443954e-07
in O 0 1.8253157207936965e-08
the O 0 3.172197295953083e-07
exon O 0 6.4596792981319595e-06
. O 0 1.3706173831451451e-06

The O 0 4.5692850108025596e-06
mutation O 0 1.5986481116669893e-07
destroyed O 0 7.649780968677078e-07
an O 0 1.0436621344922514e-08
NdeI O 0 3.0869912279740674e-06
restriction O 0 3.973946434143727e-07
enzyme O 0 1.112446135209666e-08
site O 0 1.173848858115889e-07
. O 0 5.338667463661295e-08

Analysis O 0 3.8819820247226744e-08
of O 0 7.906063359541804e-09
all O 0 1.1800773691561517e-09
family O 0 2.1343825318265175e-10
members O 0 1.1350245743280141e-10
demonstrated O 0 1.1192711202312466e-09
that O 0 3.827584083015978e-11
the O 0 1.5132159969510894e-09
missense O 0 2.455055891914526e-07
mutation O 0 2.3329940646021896e-08
co O 0 1.876716915205634e-08
- O 0 3.1409922485181596e-07
segregated O 0 5.991878282429752e-08
with O 0 1.4009428339623042e-10
patients O 0 1.4776613710409947e-08
with O 0 6.188560774944563e-11
tumors B-Disease 1 1.0
or O 0 1.037400991776849e-07
who O 0 1.493713597255919e-09
, O 0 9.716975141182971e-11
as O 0 1.3409139354436661e-09
a O 0 1.908598390443217e-09
result O 0 4.056193159129862e-09
of O 0 7.4424879592527304e-09
linkage O 0 1.2228206003328523e-08
analysis O 0 2.6698963040416857e-09
had O 0 2.258274678368366e-09
been O 0 2.5775540035688493e-10
predicted O 0 8.512936466864574e-10
to O 0 9.047069204903835e-10
carry O 0 6.409147434993656e-09
the O 0 1.4555933347537575e-08
predisposing O 0 5.554885319725145e-06
mutation O 0 1.558565401182932e-07
. O 0 2.209214216009059e-07

These O 0 1.5828216959334895e-08
observations O 0 1.5553544230328953e-08
point O 0 2.6306701261802345e-09
to O 0 2.1592043430995744e-10
another O 0 2.2669349730719546e-10
region O 0 8.145146779270362e-10
of O 0 3.933437131564688e-09
the O 0 8.415270258410601e-09
RB1 O 0 9.031367653733469e-07
gene O 0 1.6546931602690051e-09
where O 0 3.939141512976363e-10
mutations O 0 4.845152612453774e-10
only O 0 1.4949155802135294e-10
modify O 0 4.912751538910243e-09
the O 0 1.416781691965241e-09
function O 0 1.3757059935670668e-09
of O 0 1.2495425805170157e-09
the O 0 1.1617929951412975e-09
gene O 0 7.994616635365048e-10
and O 0 2.866007431379103e-10
raise O 0 6.685057840627451e-09
important O 0 2.5412170145955315e-09
questions O 0 1.5558819788097367e-09
for O 0 4.820522314652465e-10
genetic O 0 4.668275543906475e-09
counseling O 0 1.8946342272840866e-09
in O 0 2.672165787254155e-11
families O 0 7.317134745332687e-12
with O 0 1.6394479090270364e-12
these O 0 8.52698883724301e-11
distinctive O 0 2.8485152014923187e-09
phenotypes O 0 6.753780468216064e-08
. O 0 1.4086449340311447e-08
. O 0 7.70479644529587e-08

Maternal B-Disease 0 0.00011246110807405785
disomy I-Disease 0 0.0004589991003740579
and O 0 1.732605778670404e-05
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 1 1.0
with O 0 1.5351676596608854e-09
gamete O 0 3.175160543378297e-07
complementation O 0 2.8990928058192367e-07
in O 0 6.57505105916556e-10
a O 0 7.02318925238643e-10
case O 0 6.428206300590489e-10
of O 0 1.2703316176754242e-09
familial O 0 2.2027926149803534e-08
translocation O 0 2.093057993590719e-08
( O 0 2.1274881162325343e-11
3 O 0 2.48637610500424e-10
; O 0 3.158216396736968e-11
15 O 0 2.8900524196018296e-09
) O 0 8.951953067715124e-11
( O 0 3.935099121554764e-11
p25 O 0 7.666506718351229e-08
; O 0 1.0895248592213136e-10
q11 O 0 3.644468904440146e-08
. O 0 8.102639392770783e-11
2 O 0 2.9237290366523894e-09
) O 0 1.881482747378982e-09
. O 0 4.359545968668499e-08

Maternal B-Disease 1 1.0
uniparental I-Disease 1 1.0
disomy I-Disease 1 1.0
( I-Disease 0 2.1208122689131415e-06
UPD I-Disease 1 1.0
) I-Disease 0 4.942092957094246e-09
for I-Disease 0 1.844250863136665e-09
chromosome I-Disease 0 9.05218300317756e-09
15 I-Disease 0 1.2709114649567255e-08
is O 0 5.2906311276412765e-11
responsible O 0 1.5573654865708164e-10
for O 0 1.3736942139352948e-10
an O 0 1.907981411752857e-11
estimated O 0 1.4636592285399708e-11
30 O 0 2.898861983791079e-10
% O 0 1.0860220708841517e-11
of O 0 6.325969262310771e-12
cases O 0 5.164612227465115e-12
of O 0 5.036973060867922e-09
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 9.158364377981343e-07
PWS B-Disease 1 1.0
) O 0 1.9129982931076484e-08
. O 0 7.005294833106746e-08

We O 0 1.198360166654311e-07
report O 0 5.50737588866923e-09
on O 0 2.015943412203569e-09
an O 0 3.2798371657483116e-11
unusual O 0 2.8155316966760324e-10
case O 0 7.104946631031339e-10
of O 0 2.165945200971464e-09
maternal B-Disease 0 1.1289636859146412e-05
disomy I-Disease 0 1.032938962453045e-05
15 I-Disease 0 1.7082464864870417e-07
in O 0 5.006803149854022e-08
PWS B-Disease 1 1.0
that O 0 3.2930105309247892e-09
is O 0 3.093541395271515e-11
most O 0 7.91220648027613e-12
consistent O 0 1.643469665912889e-10
with O 0 2.8578043252160124e-13
adjacent O 0 5.758435395186723e-11
- O 0 4.917127260917198e-10
1 O 0 2.8169404586719793e-09
segregation O 0 2.4664744913138748e-08
of O 0 4.919050167195849e-10
a O 0 1.7096952742434723e-09
paternal O 0 3.597558361434494e-06
t O 0 3.7964415611213553e-08
( O 0 1.0548677382982152e-11
3 O 0 1.6196294305714787e-10
; O 0 2.2181952455402332e-11
15 O 0 1.1477453432107154e-09
) O 0 2.4724904415518445e-11
( O 0 1.4812852333623283e-11
p25 O 0 3.61676306681602e-08
; O 0 3.2037070912815935e-11
q11 O 0 1.0530440519573858e-08
. O 0 1.6081315099003568e-11
2 O 0 5.338730499349076e-11
) O 0 4.7095331107138705e-12
with O 0 1.7231611103285527e-12
simultaneous O 0 1.2151108563784874e-08
maternal O 0 1.117390297622478e-06
meiotic O 0 7.630955224158242e-06
nondisjunction O 0 1.6162509837158723e-06
for O 0 7.546292479787553e-09
chromosome O 0 2.51305465326368e-08
15 O 0 2.423063278911286e-07
. O 0 2.970867285512213e-07

The O 0 1.5969217201927677e-06
patient O 0 0.00015509042714256793
( O 0 4.916367868368354e-10
J O 0 1.2483597799928248e-07
. O 0 2.907849794286932e-10
B O 0 1.6329972041262408e-08
. O 0 3.8350945683052196e-12
) O 0 4.1046575860459455e-12
, O 0 3.4150525289600164e-12
a O 0 2.5281421053846564e-11
17 O 0 7.731740248040353e-11
- O 0 9.247171084414418e-11
year O 0 3.5172975643149584e-10
- O 0 7.851259198332627e-09
old O 0 2.0950711387968113e-08
white O 0 1.5258698748965571e-09
male O 0 8.714797772313432e-10
with O 0 2.0132551875606808e-11
PWS B-Disease 1 1.0
, O 0 5.553066895203074e-10
was O 0 1.6789852841370134e-09
found O 0 9.237809822648657e-11
to O 0 1.1881265971069865e-09
have O 0 5.185968321441692e-10
47 O 0 1.4194737829598125e-08
chromosomes O 0 1.9951529317552286e-09
with O 0 4.3329068111219726e-10
a O 0 3.172977613985495e-08
supernumerary O 0 0.00011869896843563765
, O 0 1.195738619230724e-08
paternal O 0 1.5440651623066515e-05
der O 1 0.5972775816917419
( O 0 1.1306777736308504e-09
15 O 0 6.646788452968622e-09
) O 0 4.993081989534964e-11
consisting O 0 1.9665628847587158e-10
of O 0 8.132975959362909e-10
the O 0 3.6432787897666685e-09
short O 0 1.9374502002733607e-08
arm O 0 2.62488732971633e-08
and O 0 1.167326013629122e-09
the O 0 1.507610569717599e-08
proximal O 0 2.0966176634829026e-06
long O 0 1.2214364630835917e-07
arm O 0 2.2330887361476925e-07
of O 0 1.8022822345642453e-08
chromosome O 0 5.120491142207584e-09
15 O 0 1.1118777010210579e-08
, O 0 2.8207455815554283e-10
and O 0 8.405849349912842e-10
distal O 0 6.176200031404733e-07
chromosome O 0 2.636953468027059e-05
arm O 0 0.0001100811714422889
3p O 1 0.9806348085403442
. O 0 5.2634909479820635e-06

The O 0 3.737926817848347e-05
t O 0 1.5090108718140982e-07
( O 0 1.8794509351605093e-11
3 O 0 1.4869133702077875e-10
; O 0 1.1664124527355213e-11
15 O 0 3.5400934961238306e-10
) O 0 1.9957180005802932e-11
was O 0 2.400964149718021e-10
present O 0 2.4209018470444654e-11
in O 0 4.045943441388644e-11
the O 0 7.265182205840048e-11
balanced O 0 1.8372385557352544e-10
state O 0 1.1356433154974255e-11
in O 0 5.249188930744886e-11
the O 0 2.1923536597245885e-10
patients O 0 2.4741711457387794e-10
father O 0 4.870066572237874e-10
and O 0 5.502175937088793e-10
a O 0 1.7773517768659985e-08
sister O 0 1.1345038046783884e-06
. O 0 1.689858549980272e-06

Fluorescent O 0 2.5564943371136906e-06
in O 0 2.7246398914826386e-08
situ O 0 3.331566063025093e-07
hybridization O 0 1.2972979357428471e-09
analysis O 0 3.123722391862316e-10
demonstrated O 0 7.168569626792021e-10
that O 0 2.8947112068467007e-11
the O 0 1.9321757527279715e-09
PWS B-Disease 1 1.0
critical O 0 2.0003977851956734e-07
region O 0 9.388033683777053e-10
resided O 0 3.765072875694386e-08
on O 0 5.816473702680014e-08
the O 0 1.1196875648877835e-09
derivative O 0 2.127165776855122e-09
chromosome O 0 2.061621540150327e-09
3 O 0 9.559547597959295e-10
and O 0 3.0454059413154155e-11
that O 0 7.99476023577439e-12
there O 0 2.3631175141702876e-11
was O 0 1.942585425851462e-09
no O 0 1.0640652803317607e-09
deletion O 0 5.563225435878394e-09
of O 0 2.9787630140276633e-09
the O 0 2.0662007216287748e-08
PWS B-Disease 1 1.0
region O 0 9.794354660641602e-09
on O 0 3.4493822909098526e-08
the O 0 2.9427791314873275e-09
normal O 0 2.2920804809700712e-08
pair O 0 6.137222285929056e-09
of O 0 3.1124061106169165e-09
15s O 0 1.2912229294670396e-06
present O 0 5.6153668381853095e-09
in O 0 9.381275134501266e-08
J O 0 0.00018251290020998567
. O 0 2.8088998078601435e-06

B O 0 0.0023092699702829123
. O 0 4.510012786340667e-06

Methylation O 0 3.3903458529493946e-07
analysis O 0 3.498413292390978e-08
at O 0 3.942617965435602e-08
exon O 0 2.610527971569354e-08
alpha O 0 5.125868440813974e-08
of O 0 4.656927732327176e-09
the O 0 3.92679577743138e-09
small O 0 4.921312246608522e-10
nuclear O 0 4.7465434249716054e-08
ribonucleoprotein O 0 2.4376632268285903e-07
- O 0 1.155354709680978e-07
associated O 0 8.894660652458697e-08
polypeptide O 0 9.416267943151979e-08
N O 0 5.87355373227183e-08
( O 0 7.9075329617595e-11
SNRPN O 0 9.39140818445594e-08
) O 0 6.286615672479456e-11
gene O 0 7.412380154114828e-10
showed O 0 3.974993667554827e-09
a O 0 8.590232969396538e-10
pattern O 0 1.3012606547846417e-09
characteristic O 0 2.454946024244009e-09
of O 0 1.3665084619418622e-09
only O 0 2.5732313502224713e-10
the O 0 3.400587311741532e-10
maternal O 0 3.7791025420119695e-08
chromosome O 0 1.2153751782761901e-08
15 O 0 1.2291744155845663e-07
in O 0 7.878609409317505e-08
J O 0 0.00016875022265594453
. O 0 3.3334615636704257e-06

B O 0 0.0012346749426797032
. O 0 2.8442361781344516e-06

Maternal B-Disease 0 0.0007555431220680475
disomy I-Disease 0 0.00027326689451001585
was O 0 8.717198056729103e-07
confirmed O 0 1.3105144525127344e-08
by O 0 1.0189131482984948e-10
polymerase O 0 2.8934832307925262e-09
chain O 0 9.050037941271682e-10
reaction O 0 8.671616896771539e-11
analysis O 0 1.2787519654278157e-10
of O 0 2.1221356616418774e-10
microsatellite O 0 9.440398685001128e-09
repeats O 0 5.32110799866814e-09
at O 0 1.7399818474927997e-08
the O 0 3.17671222660465e-09
gamma O 0 2.3421787176403086e-08
- O 0 1.8100541510079893e-08
aminobutyric O 0 1.7882317138173676e-07
acid O 0 1.70434990565127e-08
receptor O 0 6.8837402444899e-09
beta3 O 0 1.1602439542457432e-07
subunit O 0 2.325543491110693e-08
( O 0 8.027682407707459e-10
GABRB3 O 0 2.858727839338826e-06
) O 0 4.9715151995144424e-09
locus O 0 1.118708155445347e-06
. O 0 3.463286191163206e-07

A O 0 5.0915023166453466e-05
niece O 0 0.0010981420055031776
( O 0 1.458731269110558e-08
B O 0 4.401010755827883e-07
. O 0 9.026312336457565e-11
B O 0 5.594338770009699e-09
. O 0 5.80647465872608e-12
) O 0 5.7272801952390484e-12
with O 0 2.245407635867447e-12
45 O 0 1.0366127956018545e-09
chromosomes O 0 2.6988844492592534e-10
and O 0 8.165457893172245e-11
the O 0 5.944494896326091e-10
derivative O 0 1.254638948289255e-09
3 O 0 3.727399222608341e-10
but O 0 1.8722414243943497e-11
without O 0 2.5523930191617694e-10
the O 0 6.916190953276669e-10
der O 0 1.8087121134158224e-06
( O 0 1.4496764899618597e-10
15 O 0 1.9196386702446944e-09
) O 0 1.551477418759717e-10
demonstrated O 0 3.679509141818471e-09
a O 0 1.0611771461555008e-09
phenotype O 0 7.2872698986259365e-09
consistent O 0 4.958351951245277e-09
with O 0 5.37679406206748e-12
that O 0 9.97276306674566e-12
reported O 0 4.281240639780748e-11
for O 0 3.043152882464817e-11
haploinsufficiency O 0 5.0411273377903854e-08
of O 0 5.606665798296717e-09
distal O 0 2.3129466626414796e-06
3 O 0 7.514924800489098e-05
p O 0 4.13680900237523e-05
. O 0 4.966324240740505e-07

Uniparental B-Disease 1 1.0
disomy I-Disease 1 1.0
associated O 0 8.613191084805294e-07
with O 0 5.117559709333364e-10
unbalanced O 0 1.7179718270199373e-06
segregation O 0 9.861859325610567e-06
of O 0 2.1616999390516867e-07
non O 0 8.839785550662782e-06
- O 0 5.108699951961171e-07
Robertsonian O 0 1.5988631503205397e-06
translocations O 0 2.1172402853153471e-07
has O 0 2.7845986627639263e-10
been O 0 8.573957516189168e-11
reported O 0 7.454200451340043e-11
previously O 0 6.77105815860557e-10
but O 0 4.90296449273675e-11
has O 0 6.32090343608005e-12
not O 0 1.2589716595623468e-11
, O 0 6.182233978219154e-12
to O 0 5.162500427147165e-10
our O 0 2.9787117217239256e-09
knowledge O 0 8.877623081104957e-09
, O 0 6.599534807527618e-11
been O 0 5.93397969650411e-11
observed O 0 6.97688296025234e-11
in O 0 1.9424584163374448e-10
a O 0 2.14359596739655e-09
case O 0 6.522157480759461e-09
of O 0 5.4623313872070867e-08
PWS B-Disease 1 1.0
. O 0 8.220566087402403e-06

Furthermore O 0 3.984807335655205e-06
, O 0 1.5399162833773516e-08
our O 0 2.3757163347681853e-08
findings O 0 6.3987650733565715e-09
are O 0 7.42863895397683e-11
best O 0 3.758649391727431e-09
interpreted O 0 8.54722070897651e-09
as O 0 2.0066748263047884e-09
true O 0 9.68030189341107e-09
gamete O 0 2.5475813458797347e-07
complementation O 0 3.320112682558829e-07
resulting O 0 7.0408310293146315e-09
in O 0 8.082844615842077e-09
maternal B-Disease 1 0.9996978044509888
UPD I-Disease 1 1.0
15 I-Disease 0 0.00015085682389326394
and O 0 7.470403943443671e-06
PWS B-Disease 1 1.0

Schwartz B-Disease 1 0.9999983310699463
- I-Disease 1 1.0
Jampel I-Disease 1 1.0
syndrome I-Disease 1 1.0
type I-Disease 0 6.239462777557492e-07
2 I-Disease 0 1.6138160674472601e-07
and O 0 3.773309664723001e-09
Stuve B-Disease 1 1.0
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
: O 0 3.5299680956057955e-09
a O 0 8.83134398943497e-10
case O 0 1.4935447323338735e-10
for O 0 7.331414642042233e-11
" O 0 2.99211611043404e-09
lumping O 0 9.201821526971798e-09
" O 0 1.0768083313905663e-07
. O 0 1.690903417284062e-07

Recent O 0 2.3772210866468413e-08
studies O 0 2.825657929861336e-09
demonstrated O 0 9.277530743645457e-09
the O 0 2.0398387423625763e-09
existence O 0 6.1465237344293655e-09
of O 0 1.5130313668620943e-09
a O 0 1.0014536977465127e-09
genetically O 0 1.6394566815236544e-09
distinct O 0 1.7454412915007822e-10
, O 0 2.099067794580911e-11
usually O 0 6.938461090399972e-12
lethal O 0 2.6370173406009556e-11
form O 0 3.637940426334807e-12
of O 0 1.2022459416893838e-10
the O 0 2.5485027421723316e-09
Schwartz B-Disease 0 0.0695122703909874
- I-Disease 1 0.9999997615814209
Jampel I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.4494671018994154e-09
SJS B-Disease 0 0.002515912288799882
) O 0 9.002628864607232e-09
of O 0 2.1356761692459258e-07
myotonia B-Disease 1 1.0
and O 0 5.069995950179873e-06
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 1.0555077523122236e-07
which O 0 2.8853819333818365e-09
we O 0 1.0832887475942243e-08
called O 0 4.466105707479073e-08
SJS B-Disease 0 6.922275497345254e-05
type I-Disease 0 2.152627166651655e-05
2 I-Disease 0 1.8395658116787672e-05
. O 0 2.4102778297674377e-06

This O 0 1.2444407104794664e-07
disorder O 0 0.00010802380711538717
is O 0 1.4719832297505064e-10
reminiscent O 0 7.176412797349485e-09
of O 0 8.247873495292879e-10
another O 0 1.5280184062493873e-10
rare O 0 5.561058835645838e-10
condition O 0 1.5496934224756842e-07
, O 0 3.851768348717144e-10
the O 0 2.3516237845910837e-08
Stuve B-Disease 1 1.0
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.5579025784973055e-06
SWS B-Disease 1 1.0
) O 0 5.077114284546269e-10
, O 0 8.033223392045485e-11
which O 0 3.8592670725812184e-11
comprises O 0 6.900836846401859e-11
campomelia B-Disease 0 2.7629845078536164e-08
at O 0 3.0273572537709015e-09
birth O 0 2.7906611421713023e-07
with O 0 6.060170587574021e-09
skeletal B-Disease 1 0.9999998807907104
dysplasia I-Disease 1 1.0
, O 0 3.6749941756397675e-08
contractures B-Disease 0 4.658520992961712e-06
, O 0 4.709815870640455e-10
and O 0 6.348478687190351e-11
early B-Disease 0 5.210086442275497e-07
death I-Disease 0 3.8896750993444584e-06
. O 0 5.452826599139371e-07

To O 0 1.6567742022743914e-07
test O 0 8.832679476711291e-09
for O 0 3.2835822949550675e-10
possible O 0 2.22988849607475e-09
nosologic O 0 3.3609219940444746e-07
identity O 0 3.857122177208794e-09
between O 0 1.2756069811548088e-10
these O 0 1.0123408777928944e-09
disorders O 0 3.41762707023463e-08
, O 0 3.4380447707510475e-12
we O 0 8.770450511674799e-12
reviewed O 0 4.6473513926059695e-10
the O 0 4.4128406484489346e-10
literature O 0 5.261701074843472e-10
and O 0 4.773209605346551e-11
obtained O 0 1.5845124101687702e-09
a O 0 1.3241564789101545e-10
follow O 0 2.4218035910017477e-10
- O 0 5.294641391984101e-10
up O 0 1.472623550879959e-10
of O 0 1.0987677434570742e-10
the O 0 1.1468562904903834e-10
only O 0 2.885180636069684e-11
two O 0 3.739743324043809e-12
surviving O 0 2.2067530025537963e-09
patients O 0 5.195235353028238e-10
, O 0 1.0967780503245983e-11
one O 0 5.0511102245298645e-11
with O 0 3.841824774974967e-11
SJS B-Disease 0 0.00023620898718945682
type I-Disease 1 0.9975320100784302
2 I-Disease 0 8.688069101481233e-06
at O 0 5.21014591470248e-08
age O 0 9.689108404487001e-10
10 O 0 2.042204599872477e-10
years O 0 3.690005592749124e-11
and O 0 1.6237549499420467e-11
another O 0 1.646384278908286e-10
with O 0 1.4570668283031551e-10
SWS B-Disease 0 5.737512037740089e-05
at O 0 6.427534948727498e-09
age O 0 4.108203999209081e-09
7 O 0 3.0361654523858306e-08
years O 0 1.6919157630468362e-08
. O 0 1.3427116130060313e-07

Patients O 0 2.1628641206916654e-06
reported O 0 6.889148695954361e-10
as O 0 4.3729583842910813e-10
having O 0 1.279208738935722e-09
either O 0 3.959559080612962e-08
neonatal O 1 1.0
SJS B-Disease 1 1.0
or O 1 0.9999958276748657
SWS B-Disease 1 0.9999938011169434
presented O 0 9.514367960150594e-09
a O 0 1.9017222518957766e-10
combination O 0 3.3994715376017837e-10
of O 0 1.3061510206746618e-10
a O 0 1.9770973747057496e-10
severe O 0 1.1325813620288727e-09
, O 0 8.579290750043711e-11
prenatal O 0 2.965646217489848e-06
- O 0 6.836461921011505e-07
onset O 1 0.992668628692627
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 0 7.209840363620046e-11
with O 0 1.8510902533019902e-10
congenital B-Disease 1 1.0
joint I-Disease 1 1.0
contractures I-Disease 1 1.0
, O 1 1.0
respiratory O 1 1.0
and O 1 1.0
feeding O 1 1.0
difficulties O 1 0.9999992847442627
, O 0 2.8859558298677257e-08
tendency O 0 8.919497673787191e-08
to O 0 5.750376885771402e-08
hyperthermia B-Disease 0 3.336763256811537e-05
, O 0 9.789152127792633e-11
and O 0 1.7305334248929327e-11
frequent O 0 2.057349429707145e-11
death O 0 2.9102359411226075e-10
in O 0 1.8930873535438764e-10
infancy O 0 4.373596240725419e-08
) O 0 6.31938806838761e-11
with O 0 8.891200276028854e-12
a O 0 8.547999530428285e-10
distinct O 0 3.92264842830059e-09
campomelic B-Disease 0 0.00027971743838861585
- I-Disease 0 0.00021591193217318505
metaphyseal I-Disease 0 0.018240097910165787
skeletal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 0 0.17003734409809113

The O 0 7.119996894289216e-07
similarity O 0 7.752291963925018e-08
of O 0 6.92753800990431e-08
the O 0 3.7252352313998927e-08
clinical O 0 2.2883483552504913e-07
and O 0 2.6238999861760703e-09
radiographic O 0 4.55483423138503e-05
findings O 0 7.936023962429317e-07
is O 0 8.373205462319788e-10
so O 0 3.399782955160191e-10
extensive O 0 6.217043768685926e-09
that O 0 4.919059604091558e-10
these O 0 9.224767616444751e-10
disorders O 0 4.9895287901335905e-08
appear O 0 4.985226453868563e-09
to O 0 2.1605690569970193e-09
be O 0 1.2209461219825357e-09
a O 0 1.077021027917624e-09
single O 0 3.314883922911349e-09
entity O 0 4.39943264041176e-08
. O 0 7.512044248869643e-07

The O 0 5.489653744916723e-07
follow O 0 7.698010051626625e-08
- O 0 5.19569667289943e-08
up O 0 3.752832711256815e-09
observation O 0 8.201835726140416e-07
of O 0 2.6706603595272327e-09
an O 0 9.166042924668716e-11
identical O 0 6.914014916148403e-10
and O 0 1.2974309127056216e-10
unique O 0 7.160237736059116e-09
pattern O 0 8.238055215770146e-08
of O 0 6.579560363206838e-08
progressive O 1 0.9999969005584717
bone B-Disease 1 1.0
dysplasia I-Disease 1 0.9992635846138
in O 0 1.2091823009541258e-07
the O 0 8.783592875261093e-08
two O 0 4.812089615668924e-10
patients O 0 8.183204669443e-10
( O 0 5.8403633491910245e-12
one O 0 3.7956540688277585e-11
with O 0 1.6736473318346157e-11
SJS B-Disease 0 2.098335926348227e-06
type I-Disease 0 6.231850875337841e-07
2 I-Disease 0 9.333621164842043e-08
, O 0 3.255786473754796e-10
one O 0 2.612931537804286e-10
with O 0 1.1803738542148778e-10
SWS B-Disease 0 0.00013950724678579718
) O 0 3.8165196003525637e-10
surviving O 0 1.4673349824079196e-07
beyond O 0 6.357696946679425e-08
infancy O 0 2.3224457379455998e-07
adds O 0 9.9109982443224e-09
to O 0 1.7727023182700918e-09
the O 0 1.4143598514593236e-09
evidence O 0 2.031591561646451e-09
in O 0 2.861889059069256e-10
favor O 0 2.3802245507908992e-08
of O 0 4.439757894658669e-09
identity O 0 3.569311957107857e-08
. O 0 2.1611126044263074e-07

The O 0 1.8028861177299405e-06
hypothesis O 0 1.9323649667057907e-06
that O 0 7.326026896237181e-09
SWS B-Disease 0 0.21137557923793793
and O 0 2.684553024323577e-08
SJS B-Disease 0 0.0003340361581649631
type I-Disease 0 4.491136860451661e-05
2 I-Disease 0 6.995580861257622e-07
are O 0 1.246876046856471e-09
the O 0 6.983307265784333e-09
same O 0 2.1454541254684045e-08
disorder O 0 5.017965349907172e-07
should O 0 1.037908647916197e-09
be O 0 1.5498743954900362e-10
testable O 0 1.1225336216114101e-09
by O 0 2.443573121624354e-11
molecular O 0 3.5090488847977497e-10
methods O 0 1.0366153269103506e-08
. O 0 3.360964617726836e-09
. O 0 1.0344351863977863e-07

A O 0 2.02482851818786e-06
mouse O 0 2.3600271958912344e-07
model O 0 2.6420256205028636e-08
of O 0 1.2927340087287575e-08
severe O 0 0.004536127205938101
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 0 7.322376040974632e-05
defects O 0 0.000190282822586596
in O 0 1.972222634094578e-07
hemostasis O 0 0.14086169004440308
and O 0 1.0709870679193045e-07
thrombosis B-Disease 0 7.055512105580419e-05
. O 0 7.966355610733444e-07

von B-Disease 1 0.782016396522522
Willebrand I-Disease 0 0.010076531209051609
factor I-Disease 0 1.7672127796686254e-05
( I-Disease 0 6.94535913225991e-08
vWf I-Disease 0 0.00048789175343699753
) I-Disease 0 1.0915747452600044e-06
deficiency I-Disease 1 0.9999595880508423
causes O 1 0.5744756460189819
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 1 0.9999970197677612
humans O 0 3.4275608413736336e-06
. O 0 1.1657918008722845e-07

We O 0 5.458622922560608e-07
generated O 0 4.215859217282514e-09
a O 0 3.741233101095531e-09
mouse O 0 1.1199166038977637e-08
model O 0 5.855485873951238e-09
for O 0 1.4898694500331544e-09
this O 0 4.57646170959336e-10
disease O 0 3.798146797073798e-10
by O 0 9.297836806032578e-12
using O 0 2.66973193552289e-10
gene O 0 6.692913445682791e-10
targeting O 0 3.171422946479652e-08
. O 0 1.5598352831602824e-07

vWf B-Disease 0 0.00020753889111801982
- I-Disease 0 0.0003077530418522656
deficient I-Disease 0 4.466432801564224e-05
mice O 0 1.4581211871700361e-05
appeared O 0 1.9192154354641389e-07
normal O 0 5.490450050160689e-08
at O 0 3.521045011112278e-09
birth O 0 4.213029480837349e-09
; O 0 1.531981486113665e-10
they O 0 3.37467692679283e-10
were O 0 8.821579577933392e-10
viable O 0 1.4780073342990363e-07
and O 0 1.2990567732629188e-08
fertile O 0 1.2896257430838887e-06
. O 0 7.548756002506707e-07

Neither O 0 2.215915810666047e-05
vWf O 0 0.00019993871683254838
nor O 0 7.079464558046311e-05
vWf O 0 0.0003298129595350474
propolypeptide O 0 0.00048713735304772854
( O 0 7.859397754828024e-08
von B-Disease 0 0.0018783985869958997
Willebrand I-Disease 0 0.0013155161868780851
antigen O 0 2.569468051660806e-06
II O 1 0.9999010562896729
) O 0 2.1549523054886777e-08
were O 0 2.2586547743230767e-08
detectable O 0 3.2066807875708037e-07
in O 0 1.1082882389601423e-09
plasma O 0 2.213794303429495e-08
, O 0 5.364814148478558e-10
platelets O 0 2.5280010973460776e-08
, O 0 7.365885124066551e-10
or O 0 9.669999245787153e-10
endothelial O 0 9.366861064563636e-09
cells O 0 1.1582026893108832e-08
of O 0 4.032311373691755e-09
the O 0 1.1289392531921294e-08
homozygous O 0 4.4813290855927335e-07
mutant O 0 8.55904943364294e-07
mice O 0 8.538130487067974e-07
. O 0 3.429616981520667e-07

The O 0 2.9036741580057424e-06
mutant O 0 1.649010846449528e-05
mice O 0 1.4016269233252387e-05
exhibited O 0 2.3731111014058115e-06
defects O 0 2.170675179513637e-05
in O 0 5.1862212302467015e-08
hemostasis O 0 6.4704936448833905e-06
with O 0 1.450362330235322e-10
a O 0 3.83074283405449e-09
highly O 0 5.345962961200712e-08
prolonged O 0 0.00022329750936478376
bleeding O 0 3.147399183944799e-06
time O 0 6.569666766154114e-08
and O 0 3.5831915212725107e-09
spontaneous O 0 6.774500604933564e-08
bleeding O 0 8.793701056220016e-08
events O 0 1.5219045468306547e-10
in O 0 1.2965255258290398e-10
approximately O 0 2.2550829259504468e-11
10 O 0 2.2910422170507871e-10
% O 0 2.5396459935045357e-10
of O 0 1.6528319823905235e-09
neonates O 0 5.886552116862731e-07
. O 0 5.039762527303537e-07

As O 0 2.9143658153429897e-08
in O 0 1.0408187645083444e-09
the O 0 7.613660257810295e-10
human O 0 2.646466101818845e-10
disease O 0 8.593625255848281e-10
, O 0 1.34387492453647e-11
the O 0 1.0246726800389183e-09
factor O 0 2.108725816185597e-08
VIII O 0 4.2089814087376e-05
level O 0 1.1818419807241298e-05
in O 0 9.665911626655088e-09
these O 0 4.789118435155615e-09
mice O 0 1.1140370759221696e-07
was O 0 3.0280213891842322e-09
reduced O 0 1.928563753139656e-09
strongly O 0 4.2625186713607377e-10
as O 0 1.3443011981362218e-10
a O 0 1.8362820985995398e-10
result O 0 1.5086244753437228e-10
of O 0 3.429586614700497e-10
the O 0 1.4563451555815732e-09
lack O 0 4.723187174704435e-09
of O 0 3.835668449525542e-10
protection O 0 4.982602774816769e-09
provided O 0 2.5230575406709477e-09
by O 0 4.687563670557893e-10
vWf O 0 5.576089279202279e-06
. O 0 9.994239462685073e-07

Defective O 0 0.0027339840307831764
thrombosis B-Disease 0 0.0008137631230056286
in O 0 1.1462827842478873e-07
mutant O 0 1.3183223472879035e-06
mice O 0 1.7108858685332962e-07
was O 0 3.83790998981226e-09
also O 0 5.076434411721564e-11
evident O 0 2.714744540277536e-10
in O 0 1.8768080145559196e-10
an O 0 3.695668077119407e-11
in O 0 6.819242392985814e-11
vivo O 0 3.792331071394983e-08
model O 0 5.178205242373224e-08
of O 0 6.633442239944998e-08
vascular B-Disease 1 0.9999817609786987
injury I-Disease 1 0.9999829530715942
. O 0 2.518309656807105e-06

In O 0 4.453677959759261e-08
this O 0 4.3674230898460564e-10
model O 0 5.643423062196007e-09
, O 0 6.143531794400303e-10
the O 0 4.389707264351728e-09
exteriorized O 0 1.0064426305689267e-06
mesentery O 0 3.1707020298199495e-06
was O 0 1.5002576958522695e-07
superfused O 0 8.322944040628499e-07
with O 0 1.4653589452962024e-09
ferric O 0 1.818481359805446e-05
chloride O 0 5.318109742802335e-06
and O 0 2.4213905547298964e-08
the O 0 4.096801831110497e-07
accumulation O 0 9.319688615505584e-06
of O 0 4.904225647806015e-07
fluorescently O 0 3.0686749141750624e-06
labeled O 0 6.91751651515915e-08
platelets O 0 2.5733223552037998e-08
was O 0 1.2097506107977551e-08
observed O 0 2.3035839902263433e-09
by O 0 1.027434026745766e-09
intravital O 0 2.661590315256035e-06
microscopy O 0 7.469997854059329e-06
. O 0 7.258834102685796e-07

We O 0 3.034139979263273e-07
conclude O 0 5.923284902564774e-07
that O 0 1.0328471411469309e-09
these O 0 2.5424909400051376e-10
mice O 0 1.601406296458663e-08
very O 0 4.4503617457891664e-10
closely O 0 1.479090983025344e-08
mimic O 0 0.09058785438537598
severe O 1 0.9679503440856934
human O 0 0.45041829347610474
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 7.992456403371762e-07
will O 0 3.5794155195389976e-08
be O 0 2.3664978865411967e-09
very O 0 3.8982327782433046e-11
useful O 0 4.694193922460954e-10
for O 0 1.9265988110417354e-11
investigating O 0 1.675407208800994e-11
the O 0 2.2952979794599315e-10
role O 0 5.49671330674073e-09
of O 0 4.8132942076506424e-09
vWf O 0 9.804563205761951e-08
in O 0 2.387534836501004e-09
normal O 0 2.0036893033648084e-07
physiology O 0 1.8039129656699515e-07
and O 0 3.035456330735542e-10
in O 0 6.071390057371673e-10
disease O 0 5.927715540643419e-10
models O 0 1.985294817430372e-09
. O 0 1.3812035959404056e-09
. O 0 1.0007709505543971e-07

Oral O 0 6.104662315919995e-05
contraceptives O 0 1.5388204701594077e-05
and O 0 2.4275753629510177e-10
the O 0 1.177550057462895e-09
risk O 0 6.972449995146235e-08
of O 0 2.3676698219787795e-06
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9883458614349365

Hereditary B-Disease 1 1.0
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 1.0
Clinical O 0 0.0002780402428470552
Study O 0 3.643384616225376e-08
Group O 0 1.5610243098151955e-09
. O 0 1.535209293024309e-08

BACKGROUND O 0 1.9931736460421234e-05
Women O 0 2.8814897135021056e-08
with O 0 2.183601216509956e-11
mutations O 0 7.183622446893523e-11
in O 0 2.0743608220019638e-10
either O 0 2.972162516101662e-09
the O 0 4.68915999363162e-08
BRCA1 O 0 1.1121347398557191e-07
or O 0 2.7624363241329775e-08
the O 0 5.243542844368676e-08
BRCA2 O 0 8.403966234027394e-08
gene O 0 1.0351803858554831e-09
have O 0 8.232466791602278e-11
a O 0 8.916253152468911e-11
high O 0 3.1378868947662397e-10
lifetime O 0 4.3839674113144156e-09
risk O 0 8.986968680346763e-08
of O 0 8.654740213387413e-07
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0005413703038357198

Oral O 0 4.2889732867479324e-05
contraceptives O 1 0.9950783252716064
protect O 0 2.4600562028354034e-05
against O 1 0.9999939203262329
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 1 0.8113082647323608
general O 0 5.045358648203546e-06
, O 0 1.2671639293415637e-09
but O 0 2.377771868289358e-10
it O 0 3.1766422825540985e-11
is O 0 3.703873579369299e-12
not O 0 1.5378301063129207e-11
known O 0 1.4126040615014546e-10
whether O 0 2.654377551092324e-10
they O 0 7.704480387005219e-10
also O 0 1.952190631371309e-09
protect O 0 6.320816314797639e-09
against O 0 4.381576435008583e-09
hereditary B-Disease 0 1.742893800837919e-05
forms I-Disease 0 2.7001387934433296e-06
of I-Disease 0 0.411878764629364
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.2637399777304381e-05

METHODS O 0 4.620610525307711e-07
We O 0 1.9546646523593836e-09
enrolled O 0 1.7599878221474796e-09
207 O 0 5.158663718418666e-09
women O 0 1.5152666898998746e-09
with O 0 7.855438077797317e-09
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 4.722745750029844e-09
161 O 0 1.5072216807965333e-09
of O 0 1.5703235378694558e-09
their O 0 7.242844102250956e-09
sisters O 0 5.599690311441918e-08
as O 0 2.132150989098136e-08
controls O 0 1.6093022736640705e-07
in O 0 3.698817252484332e-09
a O 0 5.337229325164117e-09
case O 0 4.1268717332343385e-09
- O 0 2.8269424134919063e-08
control O 0 9.120382316041287e-08
study O 0 2.3684680883206966e-08
. O 0 4.863814595523763e-08

All O 0 1.481727593954929e-07
the O 0 2.0043730231122936e-08
patients O 0 3.5986087443262704e-09
carried O 0 5.945560710429731e-10
a O 0 1.2945733374181145e-10
pathogenic O 0 9.916760745909414e-10
mutation O 0 3.919931879092786e-10
in O 0 6.713651856671277e-10
either O 0 2.633071005675447e-08
BRCA1 O 0 1.623980416809445e-08
( O 0 3.0240879245191365e-11
179 O 0 2.029662882208072e-09
women O 0 2.115665281854362e-10
) O 0 4.712114032301429e-11
or O 0 1.546001549002085e-09
BRCA2 O 0 1.1335322369632195e-07
( O 0 6.938345037399429e-11
28 O 0 1.401612514939643e-08
women O 0 3.4194052034308697e-09
) O 0 1.20733878450352e-09
. O 0 4.631419159295547e-08

The O 0 1.226789549946261e-06
control O 0 4.856677264797327e-07
women O 0 1.2859509013196657e-09
were O 0 6.781019495916141e-11
enrolled O 0 4.4447800995328635e-10
regardless O 0 9.890956942371076e-10
of O 0 3.9318751032801913e-10
whether O 0 2.410724397883257e-10
or O 0 5.80313741505023e-10
not O 0 1.1166655378147539e-09
they O 0 8.142381768827534e-10
had O 0 2.7641635647057683e-09
either O 0 9.389040656060388e-09
mutation O 0 6.745695912968586e-08
. O 0 1.585402742421138e-07

Lifetime O 0 1.1532844155226485e-06
histories O 0 3.581410510378191e-07
of O 0 6.069102909123103e-08
oral O 0 1.5297368918254506e-06
- O 0 1.4649691593149328e-07
contraceptive O 0 1.8485646080534934e-07
use O 0 6.922433737344136e-10
were O 0 5.925090279523815e-11
obtained O 0 6.92594648299405e-10
by O 0 4.0920745958406e-11
interview O 0 5.421019633189417e-09
or O 0 1.0545584544496833e-10
by O 0 3.172717080376919e-12
written O 0 3.088282407581744e-11
questionnaire O 0 1.4888359642362126e-12
and O 0 7.042696504103163e-13
were O 0 1.1055003266979835e-11
compared O 0 1.6419116066757056e-11
between O 0 2.540815648155448e-12
patients O 0 5.5395233539146105e-11
and O 0 9.222242761119936e-12
control O 0 1.2719276298867044e-08
women O 0 5.487356125044585e-10
, O 0 2.4564987197162047e-11
after O 0 1.7523396622642906e-10
adjustment O 0 4.3398067361977155e-09
for O 0 8.298982334675742e-11
year O 0 1.7434416410555542e-10
of O 0 1.4900676525986256e-10
birth O 0 5.436986860729576e-09
and O 0 1.7078505276657552e-09
parity O 0 1.6889708831513417e-06
. O 0 1.408080123610489e-07

RESULTS O 0 6.168418167362688e-07
The O 0 2.7372923483426348e-08
adjusted O 0 5.068798358820459e-08
odds O 0 6.1265581052794e-08
ratio O 0 1.223983190357103e-07
for O 0 8.545725904696155e-06
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 8.494420171700767e-07
with O 0 1.2261451576289772e-10
any O 0 1.265922255910823e-09
past O 0 5.48451062343247e-10
use O 0 5.334959585212573e-09
of O 0 2.77639067292057e-09
oral O 0 1.4199048337104614e-07
contraceptives O 0 1.1866560498674517e-06
was O 0 2.2258314302803228e-08
0 O 0 9.219041885444312e-08
. O 0 1.6848125028445793e-07

5 O 0 1.7450794587148266e-07
( O 0 9.444102166966672e-10
95 O 0 1.702209715404024e-07
percent O 0 2.0171750492181673e-08
confidence O 0 1.582906428154729e-08
interval O 0 3.8912020272618975e-09
, O 0 5.685781359621167e-11
0 O 0 1.3337481119535255e-10
. O 0 1.4392394394324715e-11
3 O 0 2.099120877119276e-10
to O 0 4.582488555282538e-10
0 O 0 3.471158360746074e-10
. O 0 1.3837184176246353e-10
8 O 0 8.734039269597815e-09
) O 0 3.812120397128638e-09
. O 0 8.638102144686854e-08

The O 0 6.060369628357876e-07
risk O 0 7.525625989046603e-08
decreased O 0 3.269790438409359e-09
with O 0 1.4559486428977753e-12
increasing O 0 8.102531146025882e-11
duration O 0 8.99825014499811e-09
of O 0 5.014921811152817e-10
use O 0 1.2659229220446377e-08
( O 0 2.536228171923227e-10
P O 0 2.3731121956416246e-08
for O 0 2.614332084149851e-10
trend O 0 2.265202914131237e-09
, O 0 2.7058825666226305e-11
< O 0 2.6709454647999564e-09
0 O 0 3.9156047848543096e-10
. O 0 1.9022654978995135e-11
001 O 0 1.108825364859456e-09
) O 0 1.2848749841865015e-12
; O 0 4.1058692903939153e-13
use O 0 4.38281737291657e-11
for O 0 2.2122840018234946e-11
six O 0 4.8179828182615125e-11
or O 0 1.1872690330871905e-11
more O 0 1.3137353618158931e-12
years O 0 1.3592440541165818e-11
was O 0 1.0123616528412427e-10
associated O 0 1.4281380245062536e-10
with O 0 2.7647972886818417e-12
a O 0 3.6788899704376377e-10
60 O 0 1.1935369359505899e-09
percent O 0 5.3301432711982955e-11
reduction O 0 4.940667874819837e-10
in O 0 2.6911237682725186e-09
risk O 0 1.325807374996657e-07
. O 0 3.10233275513383e-07

Oral O 0 0.00023836483887862414
- O 0 2.049277100013569e-06
contraceptive O 0 3.688980768856709e-06
use O 0 5.3022564117100046e-08
protected O 0 0.003563792211934924
against O 1 0.9999322891235352
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 1.67995040101232e-08
for O 0 4.0321093686124243e-10
carriers O 0 1.8250562172639206e-10
of O 0 6.908741911892946e-10
the O 0 3.167565765238578e-08
BRCA1 O 0 1.4204087506186625e-07
mutation O 0 8.797836348328758e-10
( O 0 2.358650254274952e-11
odds O 0 3.772064882667792e-09
ratio O 0 6.867436064261767e-10
, O 0 9.198930679688022e-12
0 O 0 3.480239013642361e-11
. O 0 2.2923468678825998e-12
5 O 0 1.399649493527555e-11
; O 0 3.1919764140880824e-12
95 O 0 7.466844031966957e-09
percent O 0 8.352485370011209e-10
confidence O 0 2.9191766781622164e-09
interval O 0 5.047992024387327e-10
, O 0 2.6900330921120208e-11
0 O 0 1.1076242006913262e-10
. O 0 1.3693457825980637e-11
3 O 0 2.467977766595908e-10
to O 0 3.6174077622241896e-10
0 O 0 2.349621885944231e-10
. O 0 3.214663951700558e-11
9 O 0 8.640763105027816e-10
) O 0 2.5138944745317637e-11
and O 0 1.1545285560909946e-11
for O 0 3.2768922991754934e-11
carriers O 0 3.302878248678809e-10
of O 0 9.670368950054353e-10
the O 0 3.5974714762687654e-08
BRCA2 O 0 4.563706625049235e-06
mutation O 0 7.1147137070681765e-09
( O 0 2.6356094390278528e-11
odds O 0 3.746074561661317e-09
ratio O 0 2.1774719527467568e-10
, O 0 7.1702309888121984e-12
0 O 0 3.759541636338959e-11
. O 0 4.1573931797156405e-12
4 O 0 4.4226046436168787e-11
; O 0 1.1907683172829309e-11
95 O 0 1.9627201197636168e-08
percent O 0 3.676829063437026e-09
confidence O 0 3.7061760327361526e-09
interval O 0 4.731714464689674e-10
, O 0 3.9097225457140894e-11
0 O 0 1.2928165482595233e-10
. O 0 1.373567752593896e-11
2 O 0 2.4744731264014774e-10
to O 0 3.3741559546385247e-10
1 O 0 5.267434821654149e-10
. O 0 1.746916777900509e-10
1 O 0 4.433428291150676e-09
) O 0 4.209816495404084e-09
. O 0 6.461857537942706e-08

CONCLUSIONS O 0 0.00011123438889626414
Oral O 0 0.0002492342027835548
- O 0 2.321673946426017e-06
contraceptive O 0 1.0081602113132249e-06
use O 0 2.117523267841648e-09
may O 0 1.3133107101825914e-10
reduce O 0 5.588310925119799e-10
the O 0 4.760546401527677e-10
risk O 0 6.601332103173263e-08
of O 0 8.367241548512538e-07
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 1.5833326472147746e-07
women O 0 1.0922365234478093e-09
with O 0 4.812423896882745e-12
pathogenic O 0 1.8234173893016958e-10
mutations O 0 3.5739206039053784e-10
in O 0 2.3792521286480905e-09
the O 0 1.2613945443717967e-07
BRCA1 O 0 1.1308744660709635e-06
or O 0 9.72357725004258e-07
BRCA2 O 0 2.223773844889365e-05
gene O 0 8.54480458656326e-06

A O 0 4.713020018698444e-07
Japanese O 0 4.388095476315357e-06
family O 0 1.4522462343791176e-08
with O 0 2.105521534900845e-09
adrenoleukodystrophy B-Disease 1 1.0
with O 0 1.482632128180228e-09
a O 0 6.9239689537425875e-09
codon O 0 9.396604383482554e-08
291 O 0 1.4327421915538707e-08
deletion O 0 7.31802742848231e-08
: O 0 1.1905197938588685e-09
a O 0 1.5274714826318814e-09
clinical O 0 3.5915064700020594e-08
, O 0 2.646274310791341e-10
biochemical O 0 5.482852571958574e-08
, O 0 1.9870827205892283e-09
pathological O 0 4.004457707651454e-07
, O 0 1.913807556874758e-09
and O 0 7.346900865456973e-10
genetic O 0 5.91270321592674e-08
report O 0 8.887673885737968e-08
. O 0 3.6267110203880293e-07

We O 0 3.950453830725564e-08
report O 0 1.6260934820877537e-09
a O 0 6.010369979492225e-10
Japanese O 0 2.1752413204012555e-07
family O 0 2.4507917917304667e-09
with O 0 6.324772261478984e-09
adrenoleukodystrophy B-Disease 1 1.0
( O 0 3.2923000503615185e-07
ALD B-Disease 1 1.0
) O 0 1.8377291355342606e-10
with O 0 1.027768148365027e-11
a O 0 4.780345563837329e-10
three O 0 9.342852880234176e-11
base O 0 1.179342135060324e-08
pair O 0 1.8010176461302763e-08
deletion O 0 4.0831377390304624e-08
( O 0 2.1587019671809315e-10
delGAG O 0 2.952512723197742e-08
291 O 0 7.587406813946984e-10
) O 0 2.3538639787323845e-11
in O 0 5.352518428480835e-10
the O 0 7.613333963263358e-08
ALD B-Disease 1 1.0
gene O 0 7.590032282678294e-07
. O 0 9.923162451741518e-07

A O 0 1.3562754475060501e-06
variety O 0 3.554420402451797e-08
of O 0 7.480029928785825e-09
phenotypes O 0 4.7141259784666545e-08
were O 0 2.368286011744658e-09
observed O 0 1.5226573335525018e-09
within O 0 3.6900141275886256e-10
this O 0 7.457304773694773e-10
family O 0 1.0593979915540785e-08
. O 0 1.3825517442001e-07

While O 0 8.939255025097737e-08
the O 0 5.0820414543295556e-08
proband O 0 1.3160763955966104e-05
( O 0 5.136276404194007e-10
patient O 0 3.9074471658295806e-08
1 O 0 1.3073962357168512e-08
) O 0 3.9286893183110294e-10
was O 0 5.952962567334907e-09
classified O 0 6.928804197059435e-09
as O 0 1.1571156255385517e-09
having O 0 1.1076416450706006e-09
a O 0 2.5176721818453984e-10
rare O 0 3.029464179515884e-10
intermediate O 0 5.928257884590948e-10
type O 0 2.6746211911898854e-09
of O 0 1.2645008373723954e-09
adult O 0 2.3708392404842016e-07
cerebral O 0 5.811982717318642e-08
and O 0 1.1894529805545062e-09
cerebello O 0 0.00021209899568930268
- O 0 7.089259452186525e-05
brain O 0 0.0001068894998752512
stem O 0 2.3005290117339428e-08
forms O 0 6.914328137819226e-11
, O 0 1.0786481083324695e-11
his O 0 2.3902810286635656e-10
younger O 0 3.2397442506493235e-09
brother O 0 1.618883693765838e-08
( O 0 4.425954741593685e-11
patient O 0 1.7289283338328687e-09
2 O 0 6.868785540348199e-10
) O 0 7.648238986579514e-11
and O 0 3.8029168702991e-10
nephew O 0 0.0007484332891181111
( O 0 9.410496826234294e-10
patient O 0 3.1862535365689837e-07
3 O 0 1.93716207519401e-08
) O 0 3.9423961317730516e-10
had O 0 8.169017462478223e-09
a O 0 2.3014418815137105e-08
childhood O 0 4.506590630626306e-05
ALD B-Disease 1 1.0
type O 0 0.0004714095557574183
. O 0 8.198276191251352e-06

Another O 0 2.5260837901441846e-06
nephew O 0 0.00034764676820486784
( O 0 5.336760811047725e-09
patient O 0 9.297708629674162e-07
4 O 0 6.456079404415505e-08
) O 0 6.170553512596655e-10
of O 0 2.341177030018571e-09
patient O 0 1.7167911892101984e-07
1 O 0 1.9591489319736866e-07
was O 0 1.556083617515469e-07
classified O 0 2.268498633384297e-08
as O 0 6.9299934679634134e-09
having O 0 4.9434132343151305e-09
an O 0 3.746522814207509e-10
adolescent O 0 2.251643671513648e-08
form O 0 9.016096202962842e-10
. O 0 3.124202052617875e-08

The O 0 1.4396526637483475e-07
tau O 0 3.324642960933488e-08
level O 0 1.5299564282145184e-08
in O 0 2.172275248568667e-09
the O 0 3.0642019055449055e-07
cerebrospinal O 0 0.0005424700793810189
fluid O 0 5.452668119687587e-06
( O 0 4.592719538010215e-09
CSF O 0 2.894694034694112e-06
) O 0 9.732667449746657e-11
in O 0 3.444940444019551e-10
patient O 0 7.627607345739307e-08
1 O 0 2.1281651996218898e-08
was O 0 1.4685775262535117e-08
as O 0 9.68807367662805e-10
high O 0 8.777321647279734e-10
as O 0 7.864334877760726e-11
that O 0 4.298855542372859e-12
of O 0 1.649831833649973e-11
patients O 0 3.6576339179639206e-10
with O 0 3.520324587391599e-10
Alzheimers B-Disease 1 1.0
disease I-Disease 0 7.575702329631895e-05
( O 0 5.284932907967388e-11
AD B-Disease 0 3.1845948456066253e-07
) O 0 3.085747879438827e-09
. O 0 1.0495393354403859e-07

His O 0 1.4540648408001289e-05
brain O 0 1.1330862434988376e-05
magnetic O 0 3.8696370552315784e-07
resonance O 0 2.88243569457336e-07
image O 0 1.934295852379364e-07
( O 0 1.4390076907844218e-09
MRI O 0 4.0416500269202515e-05
) O 0 4.473111214764458e-09
showed O 0 4.836791944740071e-08
abnormalities B-Disease 0 1.5629950667062076e-07
in I-Disease 0 1.977087160653923e-09
the I-Disease 0 1.897210033519059e-08
bilateral I-Disease 0 1.6872523701749742e-05
cerebellar I-Disease 1 0.9977551102638245
hemispheres I-Disease 0 0.00012334751954767853
and O 0 4.111012330554331e-08
brain O 0 1.0432826456963085e-05
stem O 0 2.4900188577703375e-08
, O 0 7.50060517168416e-12
but O 0 1.47900615365959e-12
not O 0 1.3671614187971137e-11
in O 0 7.247010630484496e-11
the O 0 4.3168646435276514e-09
cerebral O 0 1.6897072896426835e-07
white O 0 5.013948811694036e-09
matter O 0 1.5363480487806669e-09
, O 0 1.3061603881814321e-11
where O 0 4.791075522425636e-12
marked O 0 2.0260558855622612e-11
reductions O 0 1.6359146259858903e-09
of O 0 7.941333701744213e-10
the O 0 3.7110425843422945e-09
cerebral O 0 3.0601420064613194e-08
blood O 0 2.797706954993373e-09
flow O 0 4.141925913359046e-09
and O 0 3.11633135963163e-10
oxygen O 0 5.288002924430657e-09
metabolism O 0 9.733252426258332e-09
were O 0 4.047452595301593e-09
clearly O 0 3.871044373937593e-09
demonstrated O 0 1.7909184135689316e-09
by O 0 2.864319059714404e-10
positron O 0 4.407646514437147e-08
emission O 0 1.6718144024707726e-07
tomography O 0 6.354324341373285e-06
( O 0 1.1524952547858902e-08
PET O 0 3.6394753806234803e-06
) O 0 5.318987472691106e-09
. O 0 9.9559812838379e-08

In O 0 2.1369592317910246e-08
patients O 0 3.94960109062481e-09
2 O 0 7.428528903119513e-10
and O 0 6.728801543731677e-11
3 O 0 2.6055122503976236e-09
, O 0 1.2398132520630156e-10
the O 0 5.879297604316491e-10
autopsy O 0 2.8323448475475743e-08
findings O 0 1.921002201754618e-08
showed O 0 4.65202987243174e-08
massive O 0 6.524324902557055e-08
demyelination B-Disease 1 1.0
of I-Disease 0 8.854676138980722e-07
the I-Disease 0 1.2069568811057252e-06
cerebral I-Disease 0 8.774255547905341e-05
white I-Disease 0 3.813138249597614e-09
matter I-Disease 0 6.581462042021258e-10
with O 0 2.649261452575269e-12
sparing O 0 1.2319389064430197e-08
of O 0 4.0004909607205263e-08
the O 0 3.607648295655963e-07
U O 0 5.5775035434635356e-05
- O 0 3.5285609101265436e-06
fibers O 0 3.174236695713262e-08
, O 0 2.36368202788384e-10
compatible O 0 1.4016285909690396e-08
with O 0 2.37347953790934e-11
the O 0 6.1739475754052364e-09
findings O 0 2.26953300597188e-08
of O 0 6.795180240715126e-08
childhood O 1 0.9627248048782349
ALD B-Disease 1 1.0
. O 0 5.276808587950654e-05

Oleic O 0 0.0006593320867978036
and O 0 7.765239047330397e-07
erucic O 1 0.8690824508666992
acids O 0 2.0665358533733524e-05
( O 0 2.552301925362599e-09
Lorenzos O 0 1.1662583574434393e-06
Oil O 0 3.626675493251241e-08
) O 0 4.031430397843927e-11
were O 0 5.039091366398907e-11
administered O 0 1.4381811019870128e-10
to O 0 2.5720436891418785e-10
patients O 0 2.892631967288395e-10
1 O 0 6.727828849584228e-10
and O 0 2.2043961100948195e-10
4 O 0 1.1453119341808815e-08
, O 0 1.7294848886351133e-10
but O 0 5.2943056189080906e-11
sufficient O 0 4.601338865484195e-09
effectiveness O 0 8.1267312879163e-09
was O 0 5.657056156849194e-09
not O 0 2.744693583522917e-09
obtained O 0 1.7351770509321796e-07
. O 0 4.401144906296395e-07

The O 0 8.217776894525741e-07
findings O 0 3.472691645356463e-08
in O 0 1.386969206151889e-09
this O 0 8.236727411237155e-10
family O 0 5.935024138814526e-10
suggest O 0 1.1686671630428691e-09
that O 0 6.247238837353564e-12
delGAG291 O 0 1.1636048791174858e-09
is O 0 8.724135996951432e-12
part O 0 6.180704559266559e-11
of O 0 1.0043248455104958e-09
the O 0 3.794897285303023e-09
cause O 0 4.640294370972242e-09
of O 0 6.65028832003145e-09
Japanese O 0 1.9798406356130727e-05
ALD B-Disease 1 1.0
with O 0 1.6958370263608913e-09
phenotypic O 0 1.3248406105503818e-07
variations O 0 6.315432301562396e-07
. O 0 5.742572284361813e-07

Moreover O 0 3.903700758201012e-07
, O 0 6.785434991662953e-10
although O 0 2.2756468931461882e-10
the O 0 2.7419505554959756e-10
scale O 0 4.56972149009971e-09
of O 0 2.6210138504012548e-09
the O 0 2.216391736808987e-09
study O 0 1.1604995853176092e-09
is O 0 1.2428905127315204e-11
limited O 0 7.946121538537909e-10
, O 0 5.160095614686888e-11
there O 0 9.782470666852561e-11
is O 0 1.1295863550087049e-10
a O 0 9.58472412548872e-10
possibility O 0 1.2376314195705618e-08
that O 0 1.6642170974634496e-09
PET O 0 2.2920664832781767e-06
can O 0 3.496011657944109e-08
detect O 0 8.8987820845432e-07
an O 0 1.0274032291590629e-08
insidious B-Disease 0 9.266758752346504e-06
lesion I-Disease 1 0.9999814033508301
which O 0 2.617701611029588e-09
is O 0 6.428141352543548e-11
undetectable O 0 2.2317265813143194e-09
by O 0 7.509494762136804e-12
computed O 0 4.242462381398582e-09
tomogram O 0 1.1472269534351653e-06
( O 0 5.575885864139707e-10
CT O 0 0.0002915323420893401
) O 0 1.215717637670366e-09
or O 0 2.6939999120401126e-09
MRI O 0 1.8047268213194911e-06
analysis O 0 1.6840238092896698e-09
, O 0 1.4985861510052878e-11
and O 0 3.988079831651614e-12
that O 0 2.3727406758128344e-12
the O 0 5.79654102494942e-11
higher O 0 3.544615267969675e-09
level O 0 5.894031929187804e-09
of O 0 4.3778317082576734e-10
tau O 0 3.1520330789902573e-09
reflects O 0 5.607593833723001e-10
the O 0 1.3670890808281655e-10
process O 0 4.570355482957922e-10
of O 0 1.4161171124627003e-09
neuronal B-Disease 0 2.954196816062904e-06
degeneration I-Disease 1 0.5970376133918762
in O 0 5.694134870282141e-07
ALD B-Disease 1 1.0
. O 0 2.8118265618104488e-06

Lorenzos O 0 2.8830874725827016e-05
Oil O 0 1.2227872048242716e-07
should O 0 3.692316730141698e-10
be O 0 2.6969997415915437e-11
given O 0 1.3534956141980636e-11
in O 0 4.4696784468056805e-11
the O 0 1.7357439097143157e-10
early O 0 3.506769319372438e-09
stage O 0 2.454398462248264e-09
. O 0 5.558855598053469e-09
. O 0 5.930198199166625e-08

Nonsense O 0 1.0321887202735525e-05
mutation O 0 5.8082147091909064e-08
in O 0 1.5361964145199636e-08
exon O 0 2.748467693436396e-07
4 O 0 3.836744895124866e-07
of O 0 3.113411395361254e-08
human O 0 2.642089658166924e-09
complement O 0 1.9223657332645416e-08
C9 O 0 4.009266831417335e-06
gene O 0 2.1946652495330454e-08
is O 0 4.30141894325331e-10
the O 0 1.211694300451427e-09
major O 0 5.788879153811877e-09
cause O 0 5.973674888082314e-09
of O 0 6.2317062621275454e-09
Japanese O 0 5.300418706610799e-06
complement B-Disease 0 4.7726865886943415e-05
C9 I-Disease 1 0.9998037219047546
deficiency I-Disease 0 7.662364805582911e-05
. O 0 2.015634663621313e-06

Deficiency B-Disease 0 0.008795181289315224
of I-Disease 0 1.925132437463617e-06
the I-Disease 0 1.0609742275846656e-06
ninth I-Disease 0 2.1222424493316794e-06
component I-Disease 0 9.664200462111694e-08
of I-Disease 0 6.722278733661824e-09
human I-Disease 0 1.3373712137720872e-09
complement I-Disease 0 1.4316364627120493e-07
( O 0 3.3980929181609554e-09
C9 O 0 0.0001007945102173835
) O 0 1.6151171511324947e-09
is O 0 1.5621076654426247e-10
the O 0 8.515128602226696e-10
most O 0 2.9141852819769554e-10
common O 0 1.018129314189764e-08
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 2.2027368817845172e-09
Japan O 0 2.3639548984988323e-08
but O 0 4.469030701059751e-11
is O 0 6.283483715979754e-12
rare O 0 7.876930357975098e-11
in O 0 4.722335369966579e-11
other O 0 6.176838901472692e-11
countries O 0 4.0578160276361075e-10
. O 0 3.3810589883387365e-08

We O 0 1.003439251689997e-07
studied O 0 6.481681680270412e-08
the O 0 1.9265160577930374e-09
molecular O 0 1.8418463421099318e-09
basis O 0 2.0058683602997007e-08
of O 0 3.928730407665171e-08
C9 B-Disease 1 0.9999995231628418
deficiency I-Disease 0 1.4089832802710589e-05
in O 0 3.4864292786096485e-08
four O 0 8.768106241063833e-09
Japanese O 0 1.116616886065458e-06
C9 B-Disease 0 3.328792445245199e-05
- I-Disease 0 4.245370632816048e-07
deficient I-Disease 0 2.1072588651804836e-07
patients O 0 3.7470911706805055e-08
who O 0 1.18100063062343e-09
had O 0 2.110017405243525e-08
suffered O 0 1.207957848237129e-05
from O 0 6.651838339166716e-05
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 5.842174232384423e-06

Direct O 0 3.178077534471413e-08
sequencing O 0 5.2384947935024684e-08
of O 0 5.722705864741329e-08
amplified O 0 3.4733082543425553e-07
C9 O 0 1.5310066601159633e-06
cDNA O 0 9.48963148061921e-08
and O 0 2.929283260399984e-09
DNA O 0 8.822660824137074e-09
revealed O 0 6.805269237020184e-09
a O 0 1.4881454957205165e-09
nonsense O 0 2.8367552751262792e-09
substitution O 0 4.8769939198223256e-09
( O 0 1.4998106923069798e-10
CGA O 0 1.3117953301389207e-07
- O 0 3.453628139027387e-08
- O 0 4.7961869142909563e-08
> O 0 9.434658920781658e-08
TGA O 0 2.5782753709790995e-06
) O 0 2.805227751478956e-11
at O 0 3.1313579507141753e-10
codon O 0 1.5644461281993927e-09
95 O 0 5.305228256702321e-09
in O 0 4.1828973618152077e-10
exon O 0 1.170059515942512e-08
4 O 0 1.516637837539747e-08
in O 0 8.305323540014342e-09
the O 0 3.9440170240823136e-08
four O 0 1.661937076846698e-08
C9 B-Disease 0 4.4478627387434244e-05
- I-Disease 0 3.43064471053367e-06
deficient I-Disease 0 1.1650442957034102e-06
individuals O 0 2.8125113349375397e-09
. O 0 6.763165316669983e-08

An O 0 1.4339812537400576e-07
allele O 0 8.449386967868122e-08
- O 0 2.0476477402553428e-08
specific O 0 1.640771429833876e-08
polymerase O 0 1.3921732033850276e-07
chain O 0 2.0789057586512172e-08
reaction O 0 1.7652087569430819e-09
system O 0 9.226597819100846e-10
designed O 0 1.1179531966831746e-08
to O 0 4.846115952972241e-09
detect O 0 1.7336668767242713e-09
exclusively O 0 5.397741142942891e-10
only O 0 9.525324973225224e-11
one O 0 2.714681084092785e-11
of O 0 3.632658757135587e-11
the O 0 1.2171044727615765e-10
normal O 0 1.8569400461743157e-09
and O 0 1.0415075052394585e-10
mutant O 0 6.946509589766947e-09
alleles O 0 1.4345489240952247e-09
indicated O 0 2.106951946245772e-09
that O 0 2.4016500593804224e-11
all O 0 6.910491623379755e-11
the O 0 2.1288207308067797e-10
four O 0 5.41768574446877e-11
patients O 0 1.3857910478864977e-11
were O 0 2.3104769833470762e-11
homozygous O 0 8.253303040994808e-10
for O 0 3.8550315717422734e-10
the O 0 1.7530693563472255e-09
mutation O 0 4.366340622397047e-10
in O 0 4.069752868041121e-10
exon O 0 1.1956245771216345e-08
4 O 0 5.395355273662972e-09
and O 0 9.173249659877314e-11
that O 0 2.2639178726135967e-11
the O 0 2.0483136020654769e-10
parents O 0 1.7602386215287424e-10
of O 0 2.759489858839004e-10
patient O 0 2.9486617592056064e-09
2 O 0 1.359326606831246e-08
were O 0 5.371546407673122e-08
heterozygous O 0 3.5554990063246805e-07
. O 0 9.000165732686582e-07

The O 0 3.75633305793599e-07
common O 0 1.727953247154801e-08
mutation O 0 2.833343337727001e-09
at O 0 2.25250174068492e-09
codon O 0 1.863942244995087e-08
95 O 0 1.1645106212654355e-07
in O 0 6.388643392085669e-09
exon O 0 9.552337587592774e-08
4 O 0 2.30427499303687e-08
might O 0 2.959846812089495e-09
be O 0 2.4735904990969004e-10
responsible O 0 1.4796734670863287e-10
for O 0 3.701405570932792e-10
most O 0 1.661581316980687e-09
Japanese O 0 4.501092462305678e-06
C9 B-Disease 1 0.9161093235015869
deficiency I-Disease 0 1.5517209703830304e-06
. O 0 1.5238523332072873e-08
. O 0 8.30022841569189e-08

BRCA1 O 0 1.0409820561108063e-06
required O 0 2.74883387163527e-08
for O 0 2.2825596968090167e-09
transcription O 0 4.928098746859177e-07
- O 0 3.2581992854829878e-06
coupled O 0 1.6921534324865206e-06
repair O 0 2.254978971905075e-05
of O 0 7.530221068918763e-08
oxidative O 0 6.355890604936576e-07
DNA O 0 2.538683077091264e-07
damage O 0 2.5057324819499627e-06
. O 0 2.4791866053419653e-06

The O 0 1.585635072842706e-05
breast B-Disease 1 1.0
and I-Disease 1 0.9997417330741882
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 0 4.1453422454651445e-05
gene O 0 2.101318727909529e-07
BRCA1 O 0 1.1800626964486582e-07
encodes O 0 7.402578106052715e-09
a O 0 4.005301335041622e-08
zinc O 0 3.3295059438387398e-06
finger O 0 1.110553426997285e-07
protein O 0 4.0210368368320815e-09
of O 0 1.2303156271542548e-09
unknown O 0 1.2004643501484225e-08
function O 0 8.18327094975757e-09
. O 0 6.508849992314936e-08

Association O 0 4.365504082670668e-07
of O 0 2.969534840246979e-08
the O 0 2.575463220466645e-08
BRCA1 O 0 2.306129287532599e-09
protein O 0 4.0939949347285065e-11
with O 0 3.3402852966241126e-12
the O 0 6.813135611238863e-10
DNA O 0 2.1340011979731344e-09
repair O 0 3.590259822772168e-08
protein O 0 5.97863314411029e-09
Rad51 O 0 4.5227000811109974e-08
and O 0 1.7256757134376244e-10
changes O 0 8.757956027061198e-10
in O 0 4.2107703435156907e-10
the O 0 2.435691925928296e-10
phosphorylation O 0 7.429946102810447e-10
and O 0 4.703200051636713e-10
cellular O 0 1.1235710140056199e-08
localization O 0 4.631056924608856e-07
of O 0 8.527061723384577e-09
the O 0 4.075378701173804e-09
protein O 0 4.74209782552748e-09
after O 0 2.400292187232367e-09
exposure O 0 5.1970051373473325e-08
to O 0 2.6753101955989678e-09
DNA O 0 4.3109260161600105e-08
- O 0 3.286665730684035e-07
damaging O 0 8.263013739906455e-08
agents O 0 5.001913550017889e-09
are O 0 5.5698983619789644e-11
consistent O 0 1.198167121074789e-09
with O 0 2.0520538393520305e-12
a O 0 1.1324425425174311e-10
role O 0 1.0925552684781792e-09
for O 0 2.0202697292859284e-09
BRCA1 O 0 1.8993171480019555e-08
in O 0 7.752968933516513e-09
DNA O 0 7.626632481105844e-08
repair O 0 2.1364501662901603e-05
. O 0 4.796672328666318e-06

Here O 0 3.5885386751033366e-07
, O 0 1.551626160889441e-09
it O 0 3.002162754506266e-11
is O 0 6.052075507412269e-12
shown O 0 2.36471897618884e-10
that O 0 1.1640460123585328e-10
mouse O 0 1.7513089645149194e-08
embryonic O 0 1.088296812667977e-07
stem O 0 2.8506255134175262e-08
cells O 0 2.7056081819409883e-08
deficient B-Disease 0 1.4601431530536502e-07
in I-Disease 0 6.454513812315099e-09
BRCA1 I-Disease 0 8.885703728367389e-09
are O 0 6.864604024103826e-11
defective O 0 4.0645105059411435e-09
in O 0 1.1795326937402706e-09
the O 0 4.588998514520881e-09
ability O 0 1.1744659689227888e-09
to O 0 1.401151972224568e-09
carry O 0 1.2634665536026546e-09
out O 0 1.0019499119273689e-10
transcription O 0 3.023480843467041e-08
- O 0 6.465938326982723e-07
coupled O 0 1.943792995007243e-06
repair O 0 1.446825081075076e-05
of O 0 7.558583803302099e-08
oxidative O 0 1.3942485566076357e-07
DNA O 0 2.2949018685380906e-08
damage O 0 6.823038489756073e-08
, O 0 8.133969053858436e-10
and O 0 5.857929141761531e-10
are O 0 1.7094180515542234e-09
hypersensitive O 0 3.677627319120802e-05
to O 0 2.4702379960217513e-05
ionizing O 1 0.9995594620704651
radiation O 0 0.028470436111092567
and O 0 1.2782045644144091e-08
hydrogen O 0 2.503467122494385e-08
peroxide O 0 1.7973754893318983e-06
. O 0 4.4587611114366155e-07

These O 0 5.673624414725964e-08
results O 0 2.8267429286188417e-08
suggest O 0 2.8689967734862876e-08
that O 0 1.6765884236491502e-09
BRCA1 O 0 1.6527508250874234e-08
participates O 0 7.999101381273022e-10
, O 0 1.2915965519333383e-10
directly O 0 3.286639849164885e-10
or O 0 5.650378498422981e-10
indirectly O 0 1.5532192199074757e-09
, O 0 4.2929909627176244e-11
in O 0 3.066250309213814e-10
transcription O 0 4.471284000828746e-07
- O 0 1.4395953940038453e-06
coupled O 0 1.7893695485327044e-06
repair O 0 1.2708088434010278e-05
of O 0 4.741982806422129e-08
oxidative O 0 1.1685133216587928e-07
DNA O 0 1.510252545244839e-08
damage O 0 2.3083044808913655e-08
. O 0 1.4150431937309804e-08
. O 0 1.2525335080226796e-07

Truncation O 0 6.6258562583243474e-06
mutations O 0 5.383844836615026e-08
in O 0 8.677449869765042e-09
the O 0 1.0838095754195365e-08
transactivation O 0 1.8571661257738015e-06
region O 0 3.020172556489342e-08
of O 0 3.175726348558783e-08
PAX6 O 0 5.393804531195201e-05
result O 0 2.9013321523052582e-08
in O 0 1.4601007514158937e-08
dominant O 0 2.729345283114526e-07
- O 0 2.680726538528688e-07
negative O 0 1.1346231509890004e-08
mutants O 0 1.733589130026303e-07
. O 0 9.32728525526727e-08

PAX6 O 0 0.0006000163848511875
is O 0 4.000803954795629e-08
a O 0 3.582760976783561e-09
transcription O 0 4.197367431402199e-08
factor O 0 1.7057386614283132e-08
with O 0 4.829741814815769e-11
two O 0 1.1954683076798034e-10
DNA O 0 2.066806725764536e-09
- O 0 6.2913603215974945e-09
binding O 0 9.797718192317006e-09
domains O 0 1.908705016262502e-08
( O 0 1.0172995085211411e-10
paired O 0 3.492484745848401e-09
box O 0 1.0227205748947199e-08
and O 0 6.348687686674737e-10
homeobox O 0 9.478000606577552e-08
) O 0 1.0734765160114179e-10
and O 0 1.6135737190836608e-10
a O 0 1.1130929511438126e-09
proline O 0 4.646301121624674e-08
- O 0 9.145166401935967e-09
serine O 0 4.0795800515525116e-08
- O 0 1.0848606279978412e-07
threonine O 0 2.6396060093247797e-07
( O 0 1.8401634382936294e-10
PST O 0 7.723607268417254e-06
) O 0 5.567365679581826e-09
- O 0 9.305357906441714e-08
rich O 0 3.670608705874656e-08
transactivation O 0 1.1865997294080444e-05
domain O 0 1.473933821216633e-06
. O 0 2.0560803193347965e-07

PAX6 O 0 0.1634802222251892
regulates O 0 1.5983559933374636e-05
eye O 0 0.0013656631344929338
development O 0 2.214424057456199e-07
in O 0 9.205508355591974e-09
animals O 0 5.7508673378947606e-09
ranging O 0 9.735717787506815e-10
from O 0 5.301877270547095e-10
jellyfish O 0 2.962388556682072e-09
to O 0 4.538831976930169e-09
Drosophila O 0 5.5318874814247465e-08
to O 0 1.3645608198942227e-08
humans O 0 2.8339281143985318e-08
. O 0 6.682243025579737e-08

Heterozygous O 0 5.959213353889936e-07
mutations O 0 1.6006611147645344e-08
in O 0 3.0391420491326926e-09
the O 0 1.1048485681897091e-08
human O 0 5.422322590931117e-09
PAX6 O 0 8.642939064884558e-06
gene O 0 3.810428239603425e-08
result O 0 4.449031365538758e-09
in O 0 2.428025780432108e-09
various O 0 3.330798303835536e-09
phenotypes O 0 3.405913417964257e-08
, O 0 1.3084401617735608e-10
including O 0 3.5993480418383683e-10
aniridia B-Disease 1 1.0
, O 0 3.5146989318946e-08
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 4.893526579508034e-07
autosomal B-Disease 0 0.04125634580850601
dominant I-Disease 0 3.197211481165141e-05
keratitis I-Disease 1 0.9999979734420776
, O 0 2.1816353168446767e-08
and O 0 3.1461180327596594e-08
familial B-Disease 1 0.9999455213546753
foveal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 1 1.0

It O 0 1.6461065399653307e-08
is O 0 3.2082217438222926e-10
believed O 0 2.837117873966122e-09
that O 0 8.262433792705082e-11
the O 0 1.3306259427636746e-09
mutated O 0 7.013424152546577e-08
allele O 0 4.3641472302624607e-07
of O 0 1.251402892421538e-07
PAX6 O 0 0.0002523911534808576
produces O 0 4.0623868713396405e-09
an O 0 3.258395775418421e-10
inactive O 0 2.394714648801255e-08
protein O 0 2.443309776722913e-09
and O 0 1.0513034887082995e-09
aniridia B-Disease 1 1.0
is O 0 1.1125856902438613e-09
caused O 0 3.685013683085714e-10
due O 0 4.669611364249704e-09
to O 0 1.745979183453983e-08
genetic O 0 3.747305399315337e-08
haploinsufficiency O 0 1.423944695488899e-06
. O 0 2.933428504547919e-07

However O 0 2.435404553580156e-07
, O 0 2.1073536249360814e-09
several O 0 4.76972628060679e-10
truncation O 0 7.736427676263702e-08
mutations O 0 1.2299754548195097e-09
have O 0 6.095684373930155e-11
been O 0 2.908408756885361e-11
found O 0 4.358930317388543e-12
to O 0 2.6619206838773835e-11
occur O 0 2.8865240059294806e-11
in O 0 1.1833448110287748e-10
the O 0 1.208891875492668e-09
C O 0 1.100465585324173e-08
- O 0 1.0693878005341162e-09
terminal O 0 2.259403553139805e-09
half O 0 7.86279430453618e-10
of O 0 4.444635770539662e-10
PAX6 O 0 3.071258447562286e-07
in O 0 5.414702575201602e-10
patients O 0 2.086468331441438e-09
with O 0 3.205969170694267e-11
Aniridia B-Disease 1 1.0
resulting O 0 6.566081012238101e-09
in O 0 1.1860344928393829e-09
mutant O 0 4.489436822296966e-09
proteins O 0 1.4445812601682206e-10
that O 0 2.996819112310867e-11
retain O 0 7.836671755967473e-09
the O 0 4.355363181218763e-09
DNA O 0 7.76399389224025e-09
- O 0 9.032796732810766e-09
binding O 0 3.4800102799437127e-09
domains O 0 1.306092012320903e-09
but O 0 1.203002697458544e-10
have O 0 1.3933507125862832e-10
lost O 0 3.7175886813400894e-09
most O 0 2.073269056435123e-10
of O 0 1.5672954045697907e-09
the O 0 1.4030621997562776e-08
transactivation O 0 1.9371054804651067e-05
domain O 0 3.1559022772853496e-06
. O 0 6.515682002827816e-07

It O 0 9.833232006428716e-09
is O 0 8.276661300765653e-11
not O 0 1.1354272383412578e-10
clear O 0 4.681862675326443e-10
whether O 0 9.97583127215762e-11
such O 0 2.769492413179364e-10
mutants O 0 2.278279396250582e-07
really O 0 1.0958826734963623e-08
behave O 0 8.488923453064956e-10
as O 0 1.0528387051067511e-09
loss O 0 8.819712182805972e-10
- O 0 6.1855813804356785e-09
of O 0 6.949398390077022e-09
- O 0 7.652624312015632e-09
function O 0 1.969792329248321e-09
mutants O 0 1.4368335854442194e-08
as O 0 4.953311649735781e-10
predicted O 0 1.706216057328902e-09
by O 0 3.8538700009027593e-10
haploinsufficiency O 0 5.3513876991928555e-06
. O 0 7.436402711391565e-07

Contrary O 0 1.7290300320382812e-06
to O 0 1.1242740960426545e-08
this O 0 1.3256373776471264e-10
theory O 0 1.4234151635150738e-09
, O 0 5.855122636733157e-11
our O 0 5.318050999569834e-10
data O 0 7.928292689030059e-09
showed O 0 1.8176576910278186e-09
that O 0 6.689821613337088e-11
these O 0 2.179320890416392e-10
mutants O 0 1.2787166880912082e-08
are O 0 2.372105012415915e-10
dominant O 0 5.003812475479208e-09
- O 0 1.820746753367075e-08
negative O 0 3.048971741748119e-09
in O 0 1.4873339226895155e-09
transient O 0 3.188088726346905e-08
transfection O 0 6.164629695604162e-08
assays O 0 8.815848495657974e-09
when O 0 1.8243123678374218e-09
they O 0 8.978308096985188e-10
are O 0 1.1738225669244429e-10
coexpressed O 0 6.75890916568278e-08
with O 0 2.5655225166509865e-10
wild O 0 2.1093016755457938e-07
- O 0 3.455335502167145e-07
type O 0 1.9920148588425945e-06
PAX6 O 0 0.0023429272696375847
. O 0 4.696186806540936e-06

We O 0 9.58924886163004e-08
found O 0 2.692458922481933e-09
that O 0 8.397448708619137e-11
the O 0 1.3960673728163897e-09
dominant O 0 4.129259778551386e-08
- O 0 1.1095816176975859e-07
negative O 0 2.8005366914385377e-09
effects O 0 2.9761917375026314e-08
result O 0 1.3716946467567936e-09
from O 0 1.1835531443793457e-09
the O 0 1.7757413317553983e-09
enhanced O 0 1.6305136796290753e-08
DNA O 0 2.4378494778432014e-09
binding O 0 1.1698290114381393e-09
ability O 0 6.156355869535446e-09
of O 0 4.2407632960816954e-09
these O 0 3.3613043459723713e-09
mutants O 0 2.912405534516438e-07
. O 0 2.7754398956858495e-07

Kinetic O 0 4.409762084378599e-07
studies O 0 9.755076035844468e-08
of O 0 4.5585348829035865e-09
binding O 0 5.851265694190033e-09
and O 0 1.427918117080651e-09
dissociation O 0 2.1054463061886963e-08
revealed O 0 3.6963136995638024e-09
that O 0 1.1814792200137703e-11
various O 0 8.987093014223291e-11
truncation O 0 4.4629892670400295e-08
mutants O 0 1.960605233719548e-09
have O 0 1.73020001104085e-11
3 O 0 1.554519568625068e-10
- O 0 1.3391656672467889e-09
5 O 0 9.66792068624045e-09
- O 0 7.277494518120875e-08
fold O 0 1.9386405369914428e-08
higher O 0 2.028727230651839e-08
affinity O 0 2.485391226159095e-09
to O 0 2.128886622543291e-09
various O 0 1.1241234609826734e-09
DNA O 0 8.780837723598722e-10
- O 0 3.478229926301424e-10
binding O 0 2.0634575992328763e-10
sites O 0 4.5403364401508384e-10
when O 0 5.823381360459123e-11
compared O 0 5.328821758854296e-11
with O 0 4.96891026588453e-12
the O 0 8.943015772366891e-10
wild O 0 3.0677451690053203e-08
- O 0 6.462757085046178e-08
type O 0 2.472027915700892e-07
PAX6 O 0 0.0004933077143505216
. O 0 2.9336599709495204e-06

These O 0 1.1253812104428107e-08
results O 0 1.7627324044866555e-09
provide O 0 1.9794643701942505e-09
a O 0 1.8354906483608602e-10
new O 0 4.806218756314706e-10
insight O 0 3.8574161642657145e-09
into O 0 1.345866196267309e-10
the O 0 1.8104184817957503e-10
role O 0 1.2791282477664367e-09
of O 0 1.5155932064914168e-09
mutant O 0 1.3578967639205075e-07
PAX6 O 0 1.695656646916177e-05
in O 0 5.984351503229846e-08
causing O 0 2.2341879457599134e-07
aniridia B-Disease 1 1.0
. O 0 1.127474291706676e-07
. O 0 3.250866598136781e-07

Reversal O 0 1.980788738364936e-06
of O 0 1.1405948896481277e-07
severe O 0 9.585145744495094e-05
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 0 0.0051168352365493774
excellent O 0 1.890965563688951e-06
neuropsychologic O 0 1.68468872630001e-07
outcome O 0 1.3833398426754684e-08
in O 0 5.094218380463644e-09
very B-Disease 0 9.128506839317652e-09
- I-Disease 0 1.906309705645981e-07
long I-Disease 0 1.9698896380759834e-07
- I-Disease 0 3.9618711866751255e-07
chain I-Disease 0 1.261814475128631e-07
acyl I-Disease 0 1.7352908798784483e-06
- I-Disease 0 2.1064249722257955e-07
coenzyme I-Disease 0 2.200610651925672e-06
A I-Disease 0 1.0041492259915685e-06
dehydrogenase I-Disease 0 5.411589881987311e-05
deficiency I-Disease 0 0.00042758864583447576
. O 0 1.4853127368041896e-06

Very B-Disease 0 1.8133133039555105e-07
- I-Disease 0 2.163999965887342e-07
long I-Disease 0 3.0416721585879714e-08
- I-Disease 0 6.038262512220172e-08
chain I-Disease 0 1.986378883600537e-08
acyl I-Disease 0 2.086613335450238e-07
- I-Disease 0 2.7049065209894252e-08
coenzyme I-Disease 0 9.507115095175322e-08
A I-Disease 0 2.421649014650029e-08
dehydrogenase I-Disease 0 4.9341839059025006e-08
( I-Disease 0 4.29706464855073e-10
VLCAD I-Disease 0 9.088843398785684e-06
) I-Disease 0 4.156622157580614e-09
deficiency I-Disease 0 2.2008153166552802e-07
is O 0 7.190918971389237e-10
a O 0 1.3136627785570454e-08
disorder O 1 0.9999966621398926
of O 0 9.91892306956288e-07
fatty O 0 8.5193296399666e-06
acid O 0 1.3224147323853686e-06
beta O 0 3.0059320010877855e-07
oxidation O 0 9.630673503124854e-08
that O 0 8.95794105559844e-09
reportedly O 0 1.4563625860830598e-08
has O 0 3.951367358312474e-11
high O 0 5.398996805183742e-10
rates O 0 6.801038399117942e-09
of O 0 2.1102244951443083e-10
morbidity O 0 3.8312532524287235e-07
and O 0 2.162296341978731e-09
mortality O 0 2.313295226485934e-06
. O 0 9.353349383900422e-08

We O 0 1.2261697435178576e-08
describe O 0 5.387745805052191e-09
the O 0 2.655198005907522e-10
outcome O 0 2.220339245795344e-09
of O 0 2.6322661828004357e-09
a O 0 5.272349778984164e-10
5 O 0 2.4309576573955383e-10
- O 0 8.844387028306144e-11
year O 0 6.621019704722286e-11
- O 0 4.01263744453928e-10
old O 0 2.1402091210376284e-09
girl O 0 7.070477536785802e-09
with O 0 1.9435071607620813e-10
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 9.953375901261552e-09
was O 0 1.100746960247534e-08
first O 0 6.875028102371061e-09
seen O 0 4.292299404795585e-09
at O 0 9.731503380905338e-10
5 O 0 5.275440972951628e-09
months O 0 6.13427031392888e-10
of O 0 1.5188798829779415e-10
age O 0 2.2628784956957304e-10
with O 0 1.2484144794322471e-11
severe O 0 4.584993718026453e-08
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 1 0.9038794636726379
hepatomegaly B-Disease 1 1.0
, O 0 0.00013793871039524674
encephalopathy B-Disease 0 3.5254506656201556e-05
, O 0 2.081237626683219e-09
and O 0 6.753713588381061e-09
hypotonia B-Disease 1 0.9999892711639404
. O 0 0.00014146947069093585

Biochemical O 0 3.563344307622174e-06
studies O 0 3.653155545180198e-06
indicated O 1 0.9726410508155823
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 0 3.490286871965509e-06
by O 0 2.3448953889726454e-09
a O 0 8.545069540843997e-09
stable O 0 5.932641329309263e-07
yet O 0 3.0595700195590325e-08
inactive O 0 2.752160810359783e-07
enzyme O 0 8.821604069453315e-08
. O 0 4.6108738160910434e-07

Molecular O 0 2.8114436645410024e-07
genetic O 0 2.4132893017281276e-08
analysis O 0 5.86617243669707e-09
of O 0 7.73322295088974e-09
her O 0 1.527279991364594e-08
VLCAD O 0 0.0001161711843451485
gene O 0 2.938126613116765e-07
revealed O 0 2.579330384833156e-07
a O 0 4.6986503576817995e-08
T1372C O 0 1.982264620892238e-06
( O 0 1.8578401039803794e-09
F458L O 0 8.15997111658362e-07
) O 0 2.673407495379365e-09
missense O 0 5.44368731425493e-07
mutation O 0 2.5607880260736238e-08
and O 0 3.105592893959397e-09
a O 0 5.9292819543088626e-08
1668 O 0 0.0022641238756477833
ACAG O 0 0.005491708870977163
1669 O 0 0.0002350524446228519
splice O 0 1.5001896827016026e-05
site O 0 1.2489734899645555e-06
mutation O 0 1.5135003650357248e-07
. O 0 1.350331757521417e-07

After O 0 1.0218962387398278e-07
initial O 0 1.884098210780394e-08
treatment O 0 1.51400257664136e-07
with O 0 3.2444605335690824e-10
intravenous O 0 2.3621069544788043e-08
glucose O 0 2.898489093183798e-08
and O 0 4.776827267072292e-10
carnitine O 0 1.2065824250839796e-07
, O 0 5.805550484794253e-10
the O 0 1.3066308923725956e-08
patient O 0 8.281789831698916e-08
has O 0 5.292911942067491e-11
thrived O 0 3.6576758288831e-10
on O 0 6.849972256084413e-10
a O 0 8.264550155345773e-10
low O 0 4.512394724542901e-08
- O 0 4.188665769788713e-08
fat O 0 1.3606798177079327e-07
diet O 0 8.047926769449987e-08
supplemented O 0 4.445350310078311e-09
with O 0 3.538613152498371e-11
medium O 0 3.3220985073967313e-07
- O 0 2.583537650480139e-07
chain O 0 5.4730417531345665e-08
triglyceride O 0 2.511917216452275e-07
oil O 0 8.730795286737703e-08
and O 0 2.5211188692253472e-09
carnitine O 0 2.5012531068568933e-07
and O 0 8.426622177815091e-10
avoidance O 0 3.094195335506811e-07
of O 0 4.072358095186246e-08
fasting O 0 5.2805023642577e-07
. O 0 2.6978680622846696e-08

Her O 0 7.576800271635875e-05
ventricular O 1 1.0
hypertrophy O 1 0.9999998807907104
resolved O 0 5.490962848853087e-07
significantly O 0 1.553039474799789e-08
over O 0 6.825098125551321e-11
1 O 0 1.984208131133869e-09
year O 0 6.629426452242626e-10
, O 0 1.2079438838075163e-10
and O 0 8.349583524580595e-11
cognitively O 0 7.583999206417502e-08
, O 0 1.4811080140120225e-10
she O 0 1.866149457185884e-10
is O 0 1.633206764273254e-11
in O 0 4.8413998504637235e-11
the O 0 3.579835594624825e-10
superior O 0 4.34885549793762e-09
range O 0 4.97741670102414e-09
for O 0 1.7548591468852237e-09
age O 0 5.117994561487649e-08
. O 0 2.83513486465381e-07

Clinical O 0 1.7131915228674188e-05
recognition O 0 4.2762552766362205e-05
of O 1 0.9999926090240479
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 2.283092115362706e-08
important O 0 2.3524659997775643e-09
because O 0 3.515256835617819e-11
it O 0 1.0022514068674937e-11
is O 0 3.327859255525256e-12
one O 0 1.0169206622612226e-11
of O 0 1.5029406885691543e-10
the O 0 3.105296686456427e-09
few O 0 9.45831235554806e-09
directly O 0 6.3809468819897575e-09
treatable O 0 2.425587979359989e-07
causes O 0 1.9495860481555383e-09
of O 0 2.357209094583368e-09
cardiomyopathy B-Disease 1 1.0
in O 0 1.4199470115272561e-06
children O 0 5.078056641849571e-09
. O 0 1.3273434573690679e-09
. O 0 1.4183830110425788e-08

Cloning O 0 2.3947936824697535e-06
of O 0 7.48676765027767e-09
a O 0 4.717161106171375e-10
novel O 0 3.091668476784548e-09
member O 0 5.062795960242283e-09
of O 0 9.211603924086376e-09
the O 0 2.7053088658135493e-08
low O 0 1.0917688797462688e-07
- O 0 2.15390327795717e-09
density O 0 1.44906267540712e-10
lipoprotein O 0 6.544663033736242e-09
receptor O 0 2.5303174311375187e-07
family O 0 1.596009724380565e-07
. O 0 1.0569859796305536e-06

A O 0 4.1007461959452485e-07
gene O 0 1.0912417636177452e-08
encoding O 0 3.1222004537312387e-08
a O 0 1.461527254775774e-08
novel O 0 1.5542928721856697e-08
transmembrane O 0 8.33897484397994e-09
protein O 0 1.863113219258139e-09
was O 0 1.3690990563475225e-09
identified O 0 1.4498202638435487e-10
by O 0 6.9587781717506125e-12
DNA O 0 4.2705648045648914e-11
sequence O 0 7.787162407957293e-12
analysis O 0 4.92653105810259e-11
within O 0 2.1452747564487673e-11
the O 0 3.9877950941402673e-10
insulin B-Disease 0 0.00019342181622050703
- I-Disease 0 0.37288153171539307
dependent I-Disease 1 0.9999938011169434
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 0 5.4452895525969325e-09
IDDM B-Disease 0 2.501625658624107e-06
) O 0 4.5271489335085846e-10
locus O 0 4.108903439714595e-08
IDDM4 O 0 1.895374452942633e-06
on O 0 9.931249422834298e-08
chromosome O 0 1.8864810158447654e-07
11q13 O 0 1.9412385881878436e-05
. O 0 6.095984304010926e-07

Based O 0 5.742321107504722e-08
on O 0 5.4619146538925634e-08
its O 0 3.1953499846082423e-09
chromosomal O 0 3.00764128269293e-07
position O 0 2.9436534987326013e-06
, O 0 9.133012679463093e-10
this O 0 1.2832133966522719e-10
gene O 0 1.0302868974632062e-10
is O 0 1.9334235601409233e-11
a O 0 6.106227329327751e-11
candidate O 0 2.9705515824929307e-10
for O 0 1.6610481046175352e-10
conferring O 0 3.5720226776447817e-08
susceptibility O 0 9.8466148301668e-07
to O 0 5.828678695252165e-07
diabetes B-Disease 1 0.9776291847229004
. O 0 3.7471058931259904e-06

The O 0 1.273784505428921e-06
gene O 0 8.287082664537593e-08
, O 0 6.577650424333115e-09
termed O 0 1.0350016310667343e-07
low O 0 1.167994128081773e-07
- O 0 3.8855954009875404e-09
density O 0 5.893699417391929e-11
lipoprotein O 0 1.0244675108239676e-09
receptor O 0 9.2540569651689e-10
related O 0 2.6938971053880323e-09
protein O 0 4.2305658976005134e-10
5 O 0 2.2525359355540786e-09
( O 0 2.2917971340130627e-11
LRP5 O 0 9.660293187607749e-08
) O 0 3.6542154718821607e-11
, O 0 3.138777085465172e-11
encodes O 0 5.155481597185485e-11
a O 0 1.4464283937254407e-10
protein O 0 6.548305231390827e-10
of O 0 2.568123491641927e-09
1615 O 0 3.952251063310541e-06
amino O 0 7.808654345353716e-08
acids O 0 7.703412130410925e-09
that O 0 9.433782921508538e-11
contains O 0 3.47369320807811e-11
conserved O 0 6.033360616664041e-11
modules O 0 5.916081513568372e-10
which O 0 4.639278544660286e-12
are O 0 3.523847880160247e-12
characteristic O 0 1.2683971650773174e-09
of O 0 2.8722695333271986e-09
the O 0 1.182342224126387e-08
low O 0 5.124265385347826e-07
- O 0 1.516510650390046e-08
density O 0 6.794396711917727e-10
lipoprotein O 0 2.1206366440651436e-08
( O 0 3.0488422897434475e-10
LDL O 0 1.750710225678631e-07
) O 0 2.0960213564791275e-09
receptor O 0 2.998845616275503e-07
family O 0 1.5635154682058783e-07
. O 0 4.7367851152557705e-07

These O 0 1.8484882957636728e-08
modules O 0 7.475323471339834e-09
include O 0 2.0582424653525777e-09
a O 0 3.300845818898779e-09
putative O 0 7.89187453165141e-08
signal O 0 8.974549814411148e-08
peptide O 0 6.560285203960348e-09
for O 0 1.3999098547046174e-09
protein O 0 4.5502976386835314e-10
export O 0 3.448441532327706e-08
, O 0 1.6449569484322524e-09
four O 0 8.98519536551845e-10
epidermal O 0 2.4492228689609874e-08
growth O 0 1.983508246539145e-09
factor O 0 1.2233331014854798e-09
( O 0 8.161129411154988e-11
EGF O 0 8.059079448230477e-08
) O 0 9.107348902803736e-11
repeats O 0 7.474193486345371e-10
with O 0 4.3547609962502065e-11
associated O 0 3.3629859785833105e-08
spacer O 0 5.29572275809187e-07
domains O 0 3.409033055845612e-08
, O 0 3.5538338938323477e-10
three O 0 5.288280230386633e-11
LDL O 0 2.5712258988619396e-09
- O 0 7.487609643419546e-09
receptor O 0 4.522853203070554e-09
( O 0 2.8487964764956075e-10
LDLR O 0 2.976571977342246e-06
) O 0 3.133251991194186e-10
repeats O 0 5.496441080055092e-09
, O 0 2.332448956199329e-10
a O 0 9.738466699715786e-10
single O 0 1.2823460515676288e-08
transmembrane O 0 1.3863457937191015e-08
spanning O 0 6.3923732973591996e-09
domain O 0 2.0985986282084923e-08
, O 0 4.4651307651299987e-10
and O 0 3.8149622350047707e-10
a O 0 5.4328408438664155e-09
cytoplasmic O 0 2.636896283547685e-07
domain O 0 1.0383962489868281e-06
. O 0 2.4206613602473226e-07

The O 0 6.532306429107848e-07
encoded O 0 2.458977732544554e-08
protein O 0 9.509595777501545e-09
has O 0 1.9356459490804667e-10
a O 0 1.421786299804495e-10
unique O 0 7.279208902311041e-10
organization O 0 2.1765469426782147e-09
of O 0 2.973829849040044e-09
EGF O 0 5.2720060921274126e-06
and O 0 1.0059991062405516e-08
LDLR O 0 4.349819937488064e-05
repeats O 0 3.949111260226346e-09
; O 0 7.520908201774645e-11
therefore O 0 1.5242292983330685e-09
, O 0 2.294124890056537e-10
LRP5 O 0 8.057731974986382e-07
likely O 0 6.268111363283424e-09
represents O 0 3.9604444723728705e-11
a O 0 2.8083006406443012e-11
new O 0 5.786014029007802e-11
category O 0 1.0384433313248564e-09
of O 0 1.4881370580255293e-09
the O 0 1.767443258415824e-08
LDLR O 0 7.840131729608402e-05
family O 0 1.1211011496925494e-07
. O 0 2.3636535217974597e-07

Both O 0 2.0501161657193734e-07
human O 0 4.623545990511957e-08
and O 0 1.3046735247712604e-08
mouse O 0 1.567959202475322e-06
LRP5 O 0 2.466925434418954e-05
cDNAs O 0 1.0576131899142638e-06
have O 0 1.3273534493762895e-09
been O 0 1.7939953966816802e-09
isolated O 0 3.8835130666825535e-09
and O 0 2.9777333376834747e-10
the O 0 5.614456899394327e-09
encoded O 0 2.6147124465580873e-09
mature O 0 2.599059856223107e-09
proteins O 0 2.0727659172381507e-11
are O 0 2.8410340486423324e-12
95 O 0 1.6835451921437539e-09
% O 0 6.035617144961591e-11
identical O 0 2.481581606872396e-10
, O 0 4.4175375163435504e-11
indicating O 0 1.8382489974655414e-09
a O 0 3.3604949378762683e-10
high O 0 1.4915783053126574e-09
degree O 0 4.836432410115776e-08
of O 0 5.0372319648772645e-09
evolutionary O 0 1.1242870634475821e-08
conservation O 0 2.7352764497834414e-09
. O 0 6.549229492058828e-10
. O 0 2.1566176400256154e-08

The O 0 5.021099696023157e-06
APC B-Disease 0 1.4165724451231654e-06
variants O 0 2.636750480178307e-07
I1307K O 0 3.838970314973267e-06
and O 0 8.205852108922329e-10
E1317Q O 0 1.1232543783989968e-07
are O 0 4.407623224733648e-11
associated O 0 2.8381908379060405e-08
with O 0 1.6285079027511529e-06
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 2.020794909185497e-08
but O 0 1.837156989037414e-11
not O 0 2.8874930224631612e-11
always O 0 3.951209151531465e-11
with O 0 2.7649293445064504e-12
a O 0 1.57454638216592e-09
family O 0 3.047872842998345e-09
history O 0 4.75384602793838e-08
. O 0 1.9868909362230625e-07

Classical O 1 0.7728055715560913
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 1.3397466602782515e-07
FAP B-Disease 0 3.930615548597416e-06
) O 0 3.958784688951056e-10
is O 0 8.545207597077109e-11
a O 0 1.3702223800038382e-09
high O 0 0.0037695837672799826
- O 1 1.0
penetrance O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 0.999975323677063
disease I-Disease 1 0.9998890161514282
that O 0 1.0938851213726508e-10
predisposes O 0 3.4251754765790565e-09
to O 0 2.397321785529982e-10
hundreds O 0 9.415573182236514e-11
or O 0 1.3330461734462062e-10
thousands O 0 1.4642945744824942e-09
of O 0 9.778193543752423e-08
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999992847442627
carcinoma I-Disease 1 1.0
and O 0 3.137147785992056e-08
that O 0 1.2445944275185639e-10
results O 0 2.464473625174435e-10
from O 0 2.453058589590995e-10
truncating O 0 2.1859756671460673e-08
mutations O 0 1.2125381809724445e-09
in O 0 3.7063030422501697e-09
the O 0 5.159906990570562e-08
APC B-Disease 0 8.680314635967079e-07
gene O 0 9.95413955706681e-08
. O 0 6.605412750104733e-07

A O 0 3.347352617311117e-07
variant O 0 9.657474464574989e-08
of O 0 2.0731800276507784e-08
FAP B-Disease 0 2.7484887255013746e-07
is O 0 5.515785606036161e-09
attenuated B-Disease 1 0.9999996423721313
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
, O 0 4.821076871053265e-09
which O 0 3.517161561994442e-11
results O 0 9.630366643031962e-11
from O 0 9.11763928246323e-11
germ O 0 1.1221622031598599e-07
- O 0 1.5418354593066397e-08
line O 0 3.541216209157483e-09
mutations O 0 1.3596906933699415e-10
in O 0 8.993437938809024e-11
the O 0 2.2467337712495095e-10
5 O 0 3.693542138805128e-10
and O 0 2.8966941692520898e-11
3 O 0 1.3546489485705138e-09
regions O 0 3.5303093781635653e-10
of O 0 4.073746229238395e-09
the O 0 2.1895644408687076e-08
APC B-Disease 0 3.9009989905025577e-07
gene O 0 1.2814236072244967e-07
. O 0 9.345910143565561e-07

Attenuated B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 0 3.1627132557332516e-05
have O 0 2.641246943380082e-10
" O 0 1.8545827096261291e-09
multiple O 0 2.017436528944927e-08
" O 1 0.9999998807907104
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 8.584733812710965e-09
typically O 0 3.135182669034009e-10
fewer O 0 1.0922208450170334e-11
than O 0 1.3825615999274454e-12
100 O 0 1.698487461787579e-10
) O 0 3.244403357083314e-11
without O 0 2.2974058211389092e-09
the O 0 5.0532733553154685e-09
florid O 0 6.239093863769085e-07
phenotype O 0 4.301882938761992e-08
of O 0 9.403736456192746e-09
classical O 0 6.868450554975425e-07
FAP B-Disease 0 5.488944680109853e-06
. O 0 4.803222850569e-07

Another O 0 3.392642327071371e-07
group O 0 2.986038527552637e-09
of O 0 1.8904324772250902e-09
patients O 0 8.33794189247783e-09
with O 0 6.697826321344635e-11
multiple O 0 2.1671826289093588e-07
adenomas B-Disease 1 0.9999977350234985
has O 0 8.213078928065443e-08
no O 0 8.845121080014451e-09
mutations O 0 3.729603570423734e-10
in O 0 1.2134334648195022e-09
the O 0 2.4785709484831386e-08
APC B-Disease 0 2.321258385507008e-08
gene O 0 2.7287210269122397e-09
, O 0 1.705951629960012e-10
and O 0 8.554421754292107e-11
their O 0 8.512530680349073e-10
phenotype O 0 2.9598243855843975e-09
probably O 0 1.0897331925718845e-09
results O 0 2.0235776942989503e-10
from O 0 1.975570679269012e-10
variation O 0 3.046815022500482e-09
at O 0 1.4317232732707907e-08
a O 0 2.469222160073059e-09
locus O 0 8.874761370236683e-09
, O 0 4.181358037591565e-10
or O 0 2.2970629565133294e-10
loci O 0 5.998276320084983e-10
, O 0 3.100677006817598e-11
elsewhere O 0 4.873374481739745e-10
in O 0 7.411093405629288e-10
the O 0 1.0516911785884986e-08
genome O 0 8.79113137841614e-09
. O 0 1.3355153782868e-07

Recently O 0 1.0866576758417068e-06
, O 0 1.0928429272638596e-09
however O 0 3.3768920992827134e-10
, O 0 9.550721324913525e-11
a O 0 3.937443704415955e-10
missense O 0 5.773290823185562e-08
variant O 0 1.1887900654983241e-06
of O 0 1.7098554963013157e-05
APC B-Disease 0 6.228502024896443e-05
( O 0 4.744368897746654e-09
I1307K O 0 5.846928615937941e-06
) O 0 1.16116372073094e-09
was O 0 2.9182261940263743e-08
described O 0 4.5737764686748505e-09
that O 0 5.876425041018152e-11
confers O 0 7.258956102873526e-09
an O 0 1.2400111319699203e-11
increased O 0 1.4977524775972029e-10
risk O 0 1.4930305880511696e-08
of O 0 4.6879884507688985e-07
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 1.1986504944161425e-07
including O 0 8.615732571826129e-10
multiple O 0 2.7586122275380376e-09
adenomas B-Disease 0 1.568336074342369e-06
, O 0 3.846689633490996e-09
in O 0 3.306632123667441e-08
Ashkenazim O 0 0.000172438973095268
. O 0 1.0846698614841443e-06

We O 0 1.8633402021350776e-07
have O 0 1.5472227943291728e-09
studied O 0 2.3902515522422618e-08
a O 0 5.305551997736302e-09
set O 0 5.146457926485937e-09
of O 0 4.960827859612493e-10
164 O 0 1.7937421548097632e-09
patients O 0 5.064096919582539e-10
with O 0 2.8180823993806392e-11
multiple O 0 3.621814903453924e-05
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.7619926333427429
/ I-Disease 1 1.0
or I-Disease 0 0.035300362855196
carcinoma I-Disease 1 1.0
and O 0 2.140393995375689e-08
analyzed O 0 9.835727787788073e-09
codons O 0 5.343687270453756e-09
1263 O 0 4.3207012367929565e-07
- O 0 9.407059309296528e-08
1377 O 0 2.511158072593389e-06
( O 0 1.908627478286462e-09
exon O 0 1.6492845134052914e-07
15G O 0 1.3003131016375846e-06
) O 0 4.746357196161455e-10
of O 0 3.513638491270399e-09
the O 0 2.446398106314973e-08
APC B-Disease 0 9.030974723600593e-08
gene O 0 6.237901750694164e-09
for O 0 6.9437273708672365e-09
germ O 0 5.57422254132689e-06
- O 0 4.202830723443185e-07
line O 0 4.8411116893021244e-08
variants O 0 1.6127452795444697e-07
. O 0 1.507763585095745e-07

Three O 0 1.966812490650227e-08
patients O 0 4.403031717004069e-09
with O 0 2.3006749283460692e-11
the O 0 4.067263859042214e-09
I1307K O 0 6.676165753560781e-07
allele O 0 8.739171164506843e-09
were O 0 1.946746985836967e-09
detected O 0 5.127371416335791e-09
, O 0 1.0227703406417987e-10
each O 0 7.613917829552008e-11
of O 0 2.815694122304535e-09
Ashkenazi O 0 1.0880503396037966e-06
descent O 0 1.0435824151500128e-06
. O 0 1.1865666920130025e-06

Four O 0 5.962009907989341e-08
patients O 0 9.93448523445295e-09
had O 0 1.5605063907742078e-09
a O 0 7.65768726207483e-10
germ O 0 2.2939732389204437e-06
- O 0 8.370018349523889e-07
line O 0 8.410201530750783e-07
E1317Q O 0 3.906026904587634e-06
missense O 0 2.4407361820522055e-07
variant O 0 5.412198333942797e-07
of O 0 6.38318908841029e-08
APC O 0 6.390863660499235e-08
that O 0 1.3931114595244765e-10
was O 0 1.6441978889503162e-09
not O 0 1.6044802986225903e-10
present O 0 1.0407349287921974e-10
in O 0 2.8761273918043173e-10
controls O 0 1.2743388566605063e-08
; O 0 9.68378294219363e-11
one O 0 2.2568268087663768e-10
of O 0 8.379401339464465e-11
these O 0 8.608315449354365e-12
individuals O 0 9.279995175082156e-12
had O 0 8.658597727695394e-10
an O 0 1.4211493093441163e-10
unusually O 0 7.490205122806515e-10
large O 0 2.4840346446453054e-10
number O 0 1.2231838875109702e-09
of O 0 6.651861284012739e-09
metaplastic B-Disease 0 1.391510340909008e-05
polyps I-Disease 0 4.138558779231971e-06
of I-Disease 0 3.419504679413876e-08
the I-Disease 0 6.238284555593054e-08
colorectum I-Disease 0 5.239252004685113e-06
. O 0 3.5123542829751386e-07

There O 0 2.595475336875097e-07
is O 0 9.758063246323445e-10
increasing O 0 4.045297152810434e-10
evidence O 0 1.936629079324348e-09
that O 0 6.637988769764291e-11
there O 0 4.33395402898995e-11
exist O 0 5.209494502445011e-10
germ O 0 5.612928433151865e-08
- O 0 7.793874878814222e-09
line O 0 2.7469666541435345e-09
variants O 0 9.589721017277952e-09
of O 0 6.386621009824012e-09
the O 0 7.201464313766337e-09
APC B-Disease 0 1.1910700870032542e-08
gene O 0 9.44622824405883e-10
that O 0 6.431992438660217e-11
predispose O 0 3.0238442860763826e-08
to O 0 3.250067770466103e-09
the O 0 8.83415729457937e-10
development O 0 2.3737491972042335e-09
of O 0 3.2074156663952635e-09
multiple O 0 0.007809035945683718
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 1.0
carcinoma I-Disease 1 1.0
, O 0 7.051299544258427e-09
but O 0 1.4394077596513455e-10
without O 0 1.0326580701658372e-09
the O 0 2.710493163249339e-09
florid O 0 5.182661766411911e-07
phenotype O 0 8.483217328603132e-08
of O 0 8.158552944337316e-09
classical O 0 3.2567655239290616e-07
FAP B-Disease 0 1.160267117938929e-07
, O 0 6.717836703584723e-11
and O 0 5.484285334894645e-12
possibly O 0 2.0714231718788056e-10
with O 0 2.1137432082429797e-12
importance O 0 1.2451613429220743e-07
for O 0 0.011603063903748989
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 0 7.944664730530349e-07
in O 0 6.541015507011139e-10
the O 0 8.218837277418345e-10
general O 0 2.0815353884984233e-09
population O 0 1.3896554913739312e-11
. O 0 2.648470887045562e-10
. O 0 2.433715984295759e-08

Genomic O 0 7.314581296213873e-08
structure O 0 2.49546161512626e-09
of O 0 1.7436952992611054e-09
the O 0 5.95221338883789e-09
human O 0 2.8508520699688233e-07
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 0 2.711801130317326e-07
CLD B-Disease 1 0.9669181704521179
) O 0 1.0862536647948673e-08
gene O 0 9.9048982349359e-08
. O 0 8.756250053920667e-07

Congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 0 3.444435492383491e-07
CLD B-Disease 1 0.9999995231628418
) O 0 5.195475605290767e-09
is O 0 7.783249600379349e-10
caused O 0 1.129858429038677e-09
by O 0 1.3247528074522563e-10
mutations O 0 1.1850552761316635e-09
in O 0 1.9028334463655483e-09
a O 0 2.587016822985788e-09
gene O 0 7.755479036752888e-10
which O 0 4.3831041574016183e-10
encodes O 0 4.334578473930151e-09
an O 0 2.631713735823382e-09
intestinal O 0 5.780518108622346e-07
anion O 0 9.744086071350466e-08
transporter O 0 4.2109030573556083e-07
. O 0 1.3670336329596466e-07

We O 0 1.8290992898073455e-07
report O 0 1.6160054627789577e-08
here O 0 1.5411614207039293e-09
the O 0 9.274377377188614e-10
complete O 0 2.382885222473874e-09
genomic O 0 2.116494712822714e-08
organization O 0 2.2639632391019404e-09
of O 0 1.0445297959904565e-09
the O 0 8.705664633623655e-09
human O 0 1.5007593390237162e-08
CLD B-Disease 0 5.096680615679361e-05
gene O 0 2.3736689058750926e-08
which O 0 4.874983194902427e-10
spans O 0 4.348023607825269e-10
approximately O 0 1.8774910445773507e-11
39kb O 0 4.079105764276392e-08
, O 0 2.794100784075937e-10
and O 0 3.6581293549886595e-10
comprises O 0 1.6961314575070219e-09
21 O 0 8.059785727709823e-08
exons O 0 1.519993588772195e-07
. O 0 1.465170242909153e-07

All O 0 2.3506400737005606e-07
exon O 0 9.221800496561627e-07
/ O 0 1.3698123666472384e-06
intron O 0 3.0514175364260154e-07
boundaries O 0 1.3811009003106278e-09
conform O 0 6.37695833916041e-08
to O 0 2.6419348486683703e-08
the O 0 6.290054699320535e-08
GT O 0 2.100055462506134e-05
/ O 0 1.2558994967548642e-05
AG O 0 7.032363100734074e-06
rule O 0 2.8943404686287977e-06
. O 0 6.010731112837675e-07

An O 0 2.23883063199537e-08
analysis O 0 4.075355608534892e-09
of O 0 3.4272600313300927e-09
the O 0 6.401231100738869e-09
putative O 0 5.2376854853264376e-08
promoter O 0 3.971842943428783e-08
region O 0 3.946468041249318e-09
sequence O 0 7.320379857844728e-10
shows O 0 2.3795982073693267e-08
a O 0 3.548554161625361e-08
putative O 0 2.435230953778955e-06
TATA O 0 2.217362407463952e-06
box O 0 3.1708242431705003e-07
and O 0 2.7408644243109848e-09
predicts O 0 1.8742985830044745e-08
multiple O 0 1.0365396319045317e-09
transcription O 0 6.51621618885656e-08
factor O 0 2.5493742228377414e-08
binding O 0 4.069244496918145e-08
sites O 0 1.8768535881008575e-07
. O 0 1.7014194497733115e-07

The O 0 4.338088217537006e-07
genomic O 0 8.02946686917494e-08
structure O 0 4.582543233766501e-09
was O 0 1.490677448146016e-08
determined O 0 1.4584522478600093e-09
using O 0 1.5090713123555588e-09
DNA O 0 4.165940481470898e-09
from O 0 8.348583491191164e-10
several O 0 1.238043279006007e-10
sources O 0 6.618081083153982e-10
including O 0 2.4209018470444654e-11
multiple O 0 8.816511409825978e-11
large O 0 1.3327595693723993e-09
- O 0 1.2082197997642652e-07
insert O 0 9.886369980449672e-07
libaries O 0 1.6523291890280234e-07
and O 0 3.9210459878979975e-10
genomic O 0 7.899370935149364e-09
DNA O 0 5.321646234790478e-09
from O 0 3.1962521518380527e-09
Finnish O 0 8.557110959372949e-06
CLD B-Disease 1 0.8357241749763489
patients O 0 1.933122348418692e-06
and O 0 1.4562458794387112e-08
controls O 0 9.131832484854385e-06
. O 0 1.7174131698993733e-06

Exon O 0 1.1693165333781508e-06
- O 0 1.00064880825812e-07
specific O 0 4.269282261049057e-09
primers O 0 3.794682612578981e-08
developed O 0 2.670049070729874e-09
in O 0 2.6138435860190157e-10
this O 0 1.2742622235162315e-10
study O 0 7.906251348055449e-11
will O 0 3.6554422683243715e-11
facilitate O 0 1.4564562889063382e-09
mutation O 0 1.355299483751793e-10
screening O 0 3.1180494297622374e-10
studies O 0 2.53380227910327e-09
of O 0 2.9027075187926243e-10
patients O 0 5.114114687287952e-10
with O 0 8.202291276737661e-12
the O 0 7.96433319294465e-09
disease O 0 1.5034009592795883e-08
. O 0 3.61314995700468e-08

Genomic O 0 6.007234532035e-08
sequencing O 0 2.9057238393193074e-08
of O 0 4.341067594282322e-08
a O 0 1.1950584166697809e-07
BAC O 0 0.010361181572079659
clone O 0 0.0001336237182840705
H O 1 1.0
_ O 0 1.7733560397914516e-08
RG364P16 O 0 9.399256839515147e-08
revealed O 0 2.4102659867963894e-09
the O 0 3.210854082613679e-10
presence O 0 4.88760754091544e-10
of O 0 1.057899212675295e-09
another O 0 4.033147704696205e-10
, O 0 2.9075099966524576e-11
highly O 0 1.9920644300785995e-10
homologous O 0 3.472012677363523e-10
gene O 0 1.5588285107170918e-09
3 O 0 1.810268379642821e-08
of O 0 2.1039451070237192e-08
the O 0 4.7653482937448643e-08
CLD B-Disease 0 3.7096597225172445e-05
gene O 0 2.7045144790349696e-08
, O 0 8.374883009309997e-10
with O 0 3.4298855422498775e-11
a O 0 8.497006431795739e-10
similar O 0 1.1779313635607025e-10
genomic O 0 2.9140307944430788e-09
structure O 0 1.3158563128001788e-09
, O 0 1.0289356866532984e-10
recently O 0 6.795870810538673e-11
identified O 0 5.4718538727849264e-11
as O 0 9.49805720185104e-11
the O 0 2.1554948048674305e-08
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 0 1.3976087132050452e-07
( O 0 3.988860075576639e-10
PDS B-Disease 0 2.2616170269884606e-07
) O 0 9.222440866540893e-11
. O 0 8.155967012868359e-10
. O 0 2.653712272149278e-08

The O 0 3.12450242745399e-06
APCI1307K O 0 0.36446613073349
allele O 0 6.265081538003869e-06
and O 0 4.646245610473443e-09
cancer B-Disease 0 3.878593020090193e-07
risk O 0 1.6205149222514592e-08
in O 0 1.245780256731166e-09
a O 0 2.9750097940706155e-09
community O 0 1.7825545206573423e-10
- O 0 5.64932212121505e-10
based O 0 7.615152258777513e-11
study O 0 3.3947419875168805e-10
of O 0 2.852559022326062e-10
Ashkenazi O 0 1.6561169502438133e-07
Jews O 0 9.915502374724383e-08
. O 0 6.26438492190573e-08

Mutations O 0 3.0071073524595704e-06
in O 0 1.8389448541711317e-07
APC O 0 3.5972180967291933e-07
are O 0 4.719923896168154e-10
classically O 0 5.522988431039266e-07
associated O 0 2.911316698828159e-07
with O 0 3.3161066426146135e-07
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 2.954980260483353e-08
FAP B-Disease 0 2.9708161264352384e-07
) O 0 4.769760281186919e-11
, O 0 1.8415949321060054e-11
a O 0 5.564984584260912e-10
highly O 0 1.2611202691914514e-05
penetrant O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 4.283046564523829e-06
by O 0 8.063776868461048e-10
multiple O 0 2.7357264897887035e-08
intestinal O 1 0.9307529330253601
polyps B-Disease 0 4.779593609782751e-07
and O 0 3.5082707572353655e-11
, O 0 1.2630653467571307e-11
without O 0 3.3549296674095785e-10
surgical O 0 6.609287765968475e-07
intervention O 0 9.329206659458578e-05
, O 0 1.6656198642550635e-10
the O 0 8.076490587427543e-10
development O 0 3.119587432820481e-08
of O 0 0.0025117620825767517
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 1.1831677859674983e-08
CRC B-Disease 0 1.5569327160847024e-06
) O 0 2.8083944059176247e-09
. O 0 6.111828554367094e-08

APC B-Disease 0 1.8102937247022055e-05
is O 0 1.6190041307595493e-08
a O 0 2.7567621074808812e-08
tumour O 1 1.0
- O 0 3.0323232635964814e-07
suppressor O 0 3.560908226063475e-07
gene O 0 9.236216236274686e-09
, O 0 2.2775052677115326e-10
and O 0 3.6558345239967593e-10
somatic O 0 2.4612754714326e-06
loss O 0 3.0716626042703865e-07
occurs O 0 3.5583546775797004e-08
in O 0 2.4769127549006953e-07
tumours B-Disease 1 1.0
. O 0 8.715970579942223e-06

The O 0 3.3075612009270117e-06
germline O 0 2.546505584177794e-06
T O 0 4.007823051210835e-08
- O 0 3.806372994574758e-09
to O 0 1.541858196674184e-09
- O 0 2.959141376379648e-09
A O 0 2.456388870086812e-09
transversion O 0 8.030841769368635e-09
responsible O 0 3.6201688868864323e-10
for O 0 2.888298766823283e-10
the O 0 1.7867225921008867e-08
APC O 0 1.1135350632685004e-06
I1307K O 0 4.5901610974397045e-06
allele O 0 4.004949616387421e-08
converts O 0 5.103359956848408e-09
the O 0 6.1546856500172e-10
wild O 0 6.878001501675612e-10
- O 0 1.9677261209327668e-10
type O 0 4.281283383367196e-10
sequence O 0 3.422548355835886e-10
to O 0 4.505718464997699e-09
a O 0 7.978872673675141e-08
homopolymer O 0 0.0016032038256525993
tract O 0 2.598373066575732e-05
( O 0 3.0863069877540283e-09
A8 O 0 2.818114239744318e-07
) O 0 1.2946869965002605e-10
that O 0 2.9203375828679157e-11
is O 0 1.8019565006799354e-11
genetically O 0 7.412436220377572e-10
unstable O 0 2.4112372543072524e-08
and O 0 4.416353949210361e-09
prone O 0 1.253539778645063e-07
to O 0 5.440517014676516e-08
somatic O 0 8.690207323525101e-06
mutation O 0 1.343285447319431e-07
. O 0 2.490713200131722e-07

The O 0 1.5056068605190376e-06
I1307K O 0 3.2986370115395403e-06
allele O 0 4.887361271244117e-08
was O 0 6.4930136822738405e-09
found O 0 4.051528834647655e-10
in O 0 8.399631545863429e-10
6 O 0 6.313156291071209e-07
. O 0 4.762049741202645e-07

1 O 0 3.1560766728944145e-06
% O 0 9.052842386836346e-08
of O 0 7.537045831895739e-08
unselected O 0 0.0008051908225752413
Ashkenazi O 0 4.9563386710360646e-05
Jews O 0 5.023093194722605e-07
and O 0 1.03377539861782e-09
higher O 0 1.7372094873735477e-08
proportions O 0 3.4706901796965894e-09
of O 0 5.94377258522627e-09
Ashkenazim O 0 2.82619862446154e-06
with O 0 5.31018617966339e-10
family O 0 5.2751589763033735e-09
or O 0 1.9652028893091256e-09
personal O 0 4.419348087481012e-08
histories O 0 1.318597213639805e-07
of O 0 3.2797365179249027e-07
CRC B-Disease 0 0.000619921600446105
( O 0 1.6538601599336289e-09
ref O 0 4.437177949512261e-07
. O 0 1.7372883132082961e-09
2 O 0 2.2438323199480692e-08
) O 0 4.548755594413478e-09
. O 0 5.607428477105714e-08

To O 0 2.262332543523371e-08
evaluate O 0 1.9770201475921567e-08
the O 0 2.713167246426451e-09
role O 0 1.3677580845694592e-08
of O 0 2.3568100360193966e-08
I1307K O 0 1.903990892060392e-06
in O 0 1.7920255279690878e-09
cancer B-Disease 0 1.1073253425308849e-08
, O 0 8.937094120309297e-11
we O 0 6.882331926583163e-10
genotyped O 0 2.0698321634426975e-07
5 O 0 7.787875233589148e-08
, O 0 1.0791971760681918e-08
081 O 0 1.58971542987274e-05
Ashkenazi O 0 1.431356849934673e-06
volunteers O 0 5.031694172430434e-08
in O 0 2.8859541423287283e-09
a O 0 8.314041011203699e-09
community O 0 7.479916241948104e-09
survey O 0 3.569121531654673e-08
. O 0 7.587964034883043e-08

Risk O 0 4.350701601651963e-06
of O 0 2.5746478726773603e-08
developing O 0 5.7256047512055375e-06
colorectal B-Disease 1 1.0
, I-Disease 0 2.021240652538836e-05
breast I-Disease 1 0.9999998807907104
and I-Disease 0 1.0223271118547927e-07
other I-Disease 0 4.30153797026378e-08
cancers I-Disease 0 0.0003471883828751743
were O 0 3.455763319948346e-08
compared O 0 9.750737106628549e-09
between O 0 1.47117840132438e-09
genotyped O 0 1.05463595900801e-06
I1307K O 0 1.4182768381942878e-07
carriers O 0 1.1757501638953727e-09
and O 0 1.5499423966502945e-10
non O 0 2.0415212631519353e-08
- O 0 1.887474621042884e-09
carriers O 0 1.7136055074917778e-10
and O 0 2.9775501508844116e-11
their O 0 1.219279260888939e-10
first O 0 1.0039838960196334e-09
- O 0 1.5952473786384758e-09
degree O 0 2.0179523829710888e-08
relatives O 0 3.302509909985929e-08
. O 0 9.425072988733518e-08

Sperm O 0 6.537840846476684e-08
DNA O 0 3.0799678363280236e-09
analysis O 0 1.410044747629513e-09
in O 0 2.3958737216389636e-09
a O 0 8.311587151865751e-08
Friedreich B-Disease 0 0.0007893825531937182
ataxia I-Disease 1 0.9084296822547913
premutation O 0 0.007924682460725307
carrier O 0 8.978279311122606e-07
suggests O 0 2.1650794224115089e-07
both O 0 4.656466323638142e-09
meiotic O 0 1.4866988067296916e-06
and O 0 4.822612531540926e-09
mitotic O 0 7.988603556441376e-08
expansion O 0 1.3092645190226904e-07
in O 0 9.357663977027642e-09
the O 0 3.6270630943135984e-08
FRDA B-Disease 0 5.657351266563637e-06
gene O 0 4.8456197276891544e-08
. O 0 1.6194063334751263e-07

Friedreich B-Disease 1 0.9999998807907104
ataxia I-Disease 1 1.0
is O 0 3.491487916562619e-07
usually O 0 4.214398074964265e-08
caused O 0 6.730755397477139e-10
by O 0 7.92386555675817e-12
an O 0 1.2074550560792208e-11
expansion O 0 9.706254688879312e-10
of O 0 1.698702067898239e-09
a O 0 3.572934170747999e-09
GAA O 0 5.831036276049417e-08
trinucleotide O 0 4.572086425014277e-07
repeat O 0 1.5263044161883954e-08
in O 0 9.047350424395972e-09
intron O 0 1.6267588875962247e-07
1 O 0 5.149229309608927e-08
of O 0 2.2424632817319434e-08
the O 0 5.135536795819462e-08
FRDA B-Disease 0 1.596295078343246e-05
gene O 0 2.5032960593307507e-07
. O 0 7.296799253708741e-07

Occasionally O 0 9.081236385100055e-07
, O 0 4.3927053106074254e-09
a O 0 5.09974018569892e-09
fully O 0 6.385307926848327e-08
expanded O 0 2.7501659616291363e-08
allele O 0 6.647310613061563e-08
has O 0 4.1589259813790136e-11
been O 0 8.38944400061159e-11
found O 0 3.401571732619679e-11
to O 0 1.0100702912962944e-10
arise O 0 3.1977809289429615e-10
from O 0 2.127132359142081e-10
a O 0 7.114059341617462e-10
premutation O 0 2.365795204184451e-08
of O 0 5.208530828859637e-10
100 O 0 9.926568012019743e-09
or O 0 6.793126616777556e-10
less O 0 6.379718087146102e-09
triplet O 0 4.454209374671336e-07
repeats O 0 2.7539198299564305e-07
. O 0 6.98972542068077e-07

We O 0 3.0308603982120985e-07
have O 0 1.3966801049036803e-09
examined O 0 5.1784789789621755e-09
the O 0 1.1064043015096559e-09
sperm O 0 2.8578754918129334e-09
DNA O 0 3.77014419683519e-09
of O 0 7.594983308933934e-09
a O 0 2.7302268890139203e-08
premutation O 0 1.4646858517153305e-06
carrier O 0 2.278659678722761e-07
. O 0 6.559461667166033e-07

This O 0 8.127742034957919e-08
mans O 0 1.3263389746498433e-06
leucocyte O 0 5.341091764421435e-07
DNA O 0 5.24566381443492e-08
showed O 0 8.642992987972775e-09
one O 0 1.1822236245517814e-10
normal O 0 5.6527955649698924e-09
allele O 0 4.960773569706589e-09
and O 0 4.88962148548211e-10
one O 0 9.957719093733886e-10
allele O 0 4.184439905685622e-09
of O 0 5.729974272838945e-10
approximately O 0 8.142159863000487e-11
100 O 0 2.5173099160724632e-08
repeats O 0 3.150633887116783e-08
. O 0 1.2266485782674863e-07

His O 0 1.124334062296839e-06
sperm O 0 6.164207775327668e-07
showed O 0 2.851381530888375e-08
an O 0 1.0617515200372907e-10
expanded O 0 1.2056680098737615e-09
allele O 0 4.5527652758892145e-09
in O 0 9.994634009302672e-10
a O 0 1.1486328332921403e-08
tight O 0 6.039160638238172e-08
range O 0 8.386300542895242e-09
centering O 0 9.684526514064373e-10
on O 0 1.5239560724467083e-09
a O 0 4.681621756930099e-10
size O 0 4.293697064561286e-10
of O 0 2.8535276919150476e-10
approximately O 0 8.771058185308434e-11
320 O 0 1.510903757662163e-08
trinucleotide O 0 7.907868166512344e-06
repeats O 0 7.775850576763332e-07
. O 0 1.169503889286716e-06

His O 0 5.431088993645972e-06
affected O 0 7.047859753583907e-07
son O 0 1.1153631021443289e-05
has O 0 3.31563643207744e-09
repeat O 0 3.4366733903112845e-09
sizes O 0 1.1382994102859811e-08
of O 0 9.589556704270308e-09
1040 O 0 1.8751521224658063e-07
and O 0 1.131366378359644e-08
540 O 0 8.830314186525356e-07
. O 0 3.5094817008030077e-07

These O 0 6.361189974768422e-08
data O 0 3.80337041860912e-08
suggest O 0 1.5116468077280842e-09
that O 0 4.2380239942407805e-12
expansion O 0 9.500249198435284e-11
occurs O 0 5.250137130596855e-12
in O 0 4.276529217556169e-12
two O 0 1.7502535878954895e-12
stages O 0 2.2665317539471985e-11
, O 0 1.594947611482933e-11
the O 0 2.2441042080156848e-10
first O 0 1.070177502171532e-09
during O 0 3.0568270137365516e-09
meiosis O 0 1.3617444949431956e-09
followed O 0 4.0368958176273395e-10
by O 0 6.183936002157608e-11
a O 0 1.1100739216729494e-09
second O 0 4.379579365831887e-09
mitotic O 0 2.116895103654315e-07
expansion O 0 1.4732438557985006e-06
. O 0 9.472558417655819e-07

We O 0 1.4262644754126086e-07
also O 0 3.813814597464216e-09
show O 0 1.862956677811667e-09
that O 0 2.1849343515012443e-11
in O 0 8.733379991410217e-11
all O 0 1.7603628277296224e-10
informative O 0 1.6757986109894318e-09
carrier O 0 8.992755984316148e-10
father O 0 2.9606768148227047e-09
to O 0 1.067491162132228e-08
affected O 0 1.3877367033288124e-09
child O 0 2.844850355288031e-09
transmissions O 0 7.232893750597214e-08
, O 0 7.778733907004565e-11
with O 0 1.0708421128990953e-11
the O 0 1.485482625795953e-09
notable O 0 1.8610389895812318e-09
exception O 0 4.449642432291512e-09
of O 0 6.650614503556085e-10
the O 0 1.3463545833758417e-09
premutation O 0 9.913554066542929e-08
carrier O 0 5.61115909292198e-09
, O 0 2.964325451770833e-10
the O 0 1.3630671036324316e-09
expansion O 0 3.5353938443449806e-08
size O 0 2.9717317495681073e-09
decreases O 0 2.9921047861591887e-09
. O 0 2.061546711118467e-09
. O 0 8.264542117331075e-08

The O 0 1.7645871821514447e-06
R496H O 0 1.2430116839823313e-05
mutation O 0 1.343603202030863e-07
of O 0 2.2381987818675952e-08
arylsulfatase O 0 5.838475772179663e-06
A O 0 4.776969149133947e-07
does O 0 1.321332199211156e-08
not O 0 2.3516419034308456e-08
cause O 0 1.4330832982523134e-06
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
. O 0 1.3753488019574434e-05

Deficiency B-Disease 0 0.0007317010313272476
of I-Disease 0 4.982861355529167e-06
arylsulfatase I-Disease 1 0.9978057742118835
A I-Disease 0 0.0010973545722663403
( O 0 4.654284069260939e-08
ARSA O 0 4.093469033250585e-05
) O 0 6.787687079068405e-10
enzyme O 0 2.728236969673503e-09
activity O 0 4.9299604398811425e-08
causes O 0 1.0639987522154115e-06
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 8.392625261421927e-08
MLD B-Disease 1 1.0
) O 0 3.662559322492598e-08
. O 0 1.6319533813202725e-07

A O 0 5.230008923717833e-07
number O 0 2.3429114648365612e-08
of O 0 4.615087689785469e-08
ARSA O 0 0.00012791802873834968
gene O 0 2.268107692771082e-07
mutations O 0 5.6925937741425514e-08
responsible O 0 3.014365645981343e-08
for O 0 2.244423740194179e-07
MLD B-Disease 1 1.0
have O 0 7.085520081773211e-08
been O 0 8.400084183790568e-09
identified O 0 1.2039360619553463e-08
. O 0 5.919880052829285e-08

Recently O 0 5.395182256506814e-07
, O 0 1.4503326317694132e-09
the O 0 1.6893447751797908e-09
R496H O 0 4.342467434526043e-07
mutation O 0 1.5793236940453426e-08
of O 0 1.5721465018714298e-08
ARSA O 0 5.063544085714966e-05
was O 0 8.995319689120151e-08
proposed O 0 2.659751086042661e-09
to O 0 7.372575328012942e-10
be O 0 3.3463468107619576e-10
a O 0 3.433225370663706e-10
cause O 0 2.3745052590840032e-09
of O 0 1.1000165223151726e-08
MLD B-Disease 1 1.0
( O 0 7.794692891138766e-09
Draghia O 0 8.148400070240314e-07
et O 0 1.77874298401548e-07
al O 0 1.733103118795043e-07
. O 0 8.332150525092175e-10
, O 0 1.7845240563030274e-10
1997 O 0 5.619384957356033e-09
) O 0 2.880790050951987e-09
. O 0 5.4177974107005866e-08

We O 0 5.156817337592656e-07
have O 0 5.265689662081741e-09
investigated O 0 2.0607064499245098e-08
the O 0 1.5699351152420604e-08
R496H O 0 1.5273316193997744e-06
mutation O 0 6.852915568344997e-09
and O 0 1.2123942128017262e-10
found O 0 1.5750924176050063e-10
this O 0 5.38397000593438e-11
mutation O 0 4.922203755697296e-10
at O 0 4.4507861285403294e-10
a O 0 1.7177287370273575e-10
relatively O 0 5.277529108171919e-11
high O 0 4.479894927245098e-11
frequency O 0 1.690291656641918e-10
in O 0 3.303072051985545e-11
an O 0 9.800286970840233e-11
African O 0 2.469118465242559e-09
American O 0 4.542822229502974e-10
population O 0 2.472564470876182e-12
( O 0 6.513715348349658e-13
f O 0 7.182447969711347e-10
= O 0 2.325369230504748e-09
0 O 0 3.686714822315196e-10
. O 0 8.632736192559776e-11
09 O 0 3.346196919551403e-08
, O 0 2.3201139620621092e-10
n O 0 4.425613209235735e-09
= O 0 4.291057464911319e-08
61 O 0 1.162773433094344e-08
subjects O 0 3.564427686342242e-08
) O 0 5.98200955437278e-09
. O 0 7.135986379580572e-08

The O 0 3.708902659127489e-05
ARSA O 0 6.814488006057218e-05
enzyme O 0 9.801287781385781e-09
activity O 0 5.5415578792405995e-09
in O 0 2.2350481188038174e-10
subjects O 0 7.504394439195039e-09
with O 0 7.618824841848504e-12
and O 0 2.906478877018337e-11
without O 0 1.3671341836385409e-09
the O 0 1.7404987451286047e-09
R496H O 0 1.374495468553505e-07
mutation O 0 1.4645793466883106e-09
was O 0 1.0707942310617113e-09
determined O 0 6.288634057938225e-10
and O 0 2.1105867054060923e-10
found O 0 5.297298155682029e-10
to O 0 2.0040089587780585e-09
be O 0 2.75953837558518e-09
normal O 0 7.41350376642913e-08
. O 0 2.832697134635964e-07

It O 0 1.1681774658711674e-08
is O 0 8.00789018429171e-11
therefore O 0 2.353371386654146e-10
concluded O 0 2.5193738206752414e-09
that O 0 7.143316493873897e-11
the O 0 1.7712254996027355e-09
R496H O 0 1.3591965171144693e-06
mutation O 0 2.6594177526817475e-08
of O 0 1.3845092183828456e-08
ARSA O 0 6.725943967467174e-05
does O 0 4.8937667251891526e-09
not O 0 6.379653472166069e-10
negatively O 0 5.299440886119555e-10
influence O 0 8.666533268808507e-09
the O 0 6.512436812045053e-09
activity O 0 1.4516812640863463e-08
of O 0 3.901628797819967e-09
ARSA O 0 4.194288976577809e-06
and O 0 6.574574773487996e-10
is O 0 4.116106067098002e-11
not O 0 1.7970835930469775e-10
a O 0 6.26452334451244e-10
cause O 0 1.3367291273880255e-08
of O 0 2.3714997610113642e-07
MLD B-Disease 1 1.0

Down O 0 2.2866975086799357e-06
- O 0 3.091632265750377e-07
regulation O 0 7.792821179464227e-07
of O 0 7.489855136100232e-08
transmembrane O 0 1.464005521256695e-07
carbonic O 0 1.9824157789116725e-05
anhydrases O 0 1.8985378119396046e-05
in O 0 9.58432792685926e-07
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 1.0
lines O 0 4.7175440442970284e-08
by O 0 3.3379465858018875e-09
wild O 0 1.4864022546134947e-07
- O 0 3.966574411151669e-07
type O 0 1.0391419891675469e-05
von B-Disease 1 1.0
Hippel I-Disease 1 0.9999992847442627
- I-Disease 0 0.062234267592430115
Lindau I-Disease 0 0.01032669935375452
transgenes O 0 0.0006556351436302066
. O 0 7.292414011317305e-06

To O 0 1.7679780057733296e-06
discover O 0 2.545585005009343e-07
genes O 0 3.872395737403167e-09
involved O 0 4.777076068052111e-09
in O 0 1.300673257986773e-08
von B-Disease 1 1.0
Hippel I-Disease 1 1.0
- I-Disease 1 1.0
Lindau I-Disease 1 0.9999992847442627
( O 0 4.624833849220522e-08
VHL B-Disease 0 2.4230264898505993e-05
) O 0 4.157740374211016e-09
- O 0 3.247119906291118e-08
mediated O 0 5.7845998213679195e-08
carcinogenesis O 0 2.106124156853184e-05
, O 0 1.0759738655607975e-09
we O 0 7.806219559647332e-10
used O 0 3.5739990522642984e-08
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 1.0
lines O 0 3.5736519521378796e-07
stably O 0 1.2791920198651496e-06
transfected O 0 9.187655081177581e-08
with O 0 1.6796923574258216e-10
wild O 0 2.5319678798041423e-08
- O 0 6.110616368459887e-08
type O 0 1.0556150300544687e-06
VHL O 0 0.0006676592747680843
- O 0 4.6805125748505816e-05
expressing O 0 9.664095159678254e-07
transgenes O 0 3.800229387707077e-05
. O 0 1.6188548670470482e-06

Large O 0 4.7414403070433764e-08
- O 0 2.2717459913224047e-08
scale O 0 3.1906072450738066e-08
RNA O 0 6.480185987811637e-08
differential O 0 2.582606555279199e-07
display O 0 1.1033365332480116e-08
technology O 0 7.334543994375053e-08
applied O 0 2.9697991976718185e-07
to O 0 1.0478947487513324e-08
these O 0 3.309367224701987e-10
cell O 0 3.6127210112368857e-09
lines O 0 2.5980126383551294e-10
identified O 0 2.4578181712087144e-09
several O 0 3.8179029382412466e-10
differentially O 0 1.993313532011598e-07
expressed O 0 1.9759485159198675e-09
genes O 0 6.318089385004555e-10
, O 0 3.698942541152661e-10
including O 0 2.454345615632292e-10
an O 0 6.130549956573361e-10
alpha O 0 3.0875920487005715e-08
carbonic O 0 8.391630217374768e-07
anhydrase O 0 3.1788586056791246e-06
gene O 0 1.0070207423495958e-07
, O 0 1.1220205209383494e-08
termed O 0 9.559159934724448e-07
CA12 O 0 0.00028633218607865274
. O 0 1.6382842886741855e-06

The O 0 9.746536306920461e-07
deduced O 0 1.1700990398821887e-07
protein O 0 7.64792229546174e-10
sequence O 0 4.282998677940242e-10
was O 0 2.8903612836472803e-09
classified O 0 4.063286151989587e-09
as O 0 9.654114174750816e-10
a O 0 1.8548375058102806e-09
one O 0 1.2632063173256824e-09
- O 0 1.4407817161554703e-07
pass O 0 3.783744375596143e-07
transmembrane O 0 3.856977741634182e-07
CA O 0 1.0365310117776971e-05
possessing O 0 1.152254299086053e-06
an O 0 2.375172591939645e-08
apparently O 0 1.4411980941986258e-07
intact O 0 1.02756828823658e-07
catalytic O 0 1.785898184891721e-08
domain O 0 8.250415106658693e-08
in O 0 2.1238466985096238e-08
the O 0 8.375274518357401e-08
extracellular O 0 7.357143658737186e-07
CA O 0 6.315580321825109e-06
module O 0 1.8840174789147568e-06
. O 0 6.605122848668543e-07

Reintroduced O 0 1.6019817849155515e-05
wild O 0 1.8033160813502036e-06
- O 0 5.98978715515841e-07
type O 0 8.775854212217382e-07
VHL B-Disease 0 0.00033889521728269756
strongly O 0 1.2747770483656495e-07
inhibited O 0 1.055852081321973e-07
the O 0 1.3366372897394285e-08
overexpression O 0 3.656563407616886e-08
of O 0 2.5826685234875413e-09
the O 0 2.4402593279404527e-09
CA12 O 0 1.7051148404334526e-07
gene O 0 8.368033488359572e-10
in O 0 4.279960830189111e-10
the O 0 7.200282592378926e-09
parental O 0 0.0004056934267282486
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 1.0
lines O 0 3.497670832075528e-06
. O 0 3.9275651033676695e-06

Similar O 0 8.226169256886351e-08
results O 0 6.797614471309998e-09
were O 0 2.7571813721039007e-09
obtained O 0 1.237900448813889e-08
with O 0 2.548579125516426e-10
CA9 O 0 2.2969019482843578e-05
, O 0 5.573804084946232e-09
encoding O 0 5.3014069578694034e-08
another O 0 4.900840622212854e-08
transmembrane O 0 2.1404515848644223e-07
CA O 0 3.6685378290712833e-06
with O 0 2.7352344833531106e-09
an O 0 1.2446312425140604e-08
intact O 0 5.891482715014718e-07
catalytic O 0 3.196150544226839e-07
domain O 0 1.3262579159345478e-06
. O 0 2.9584299454654683e-07

Although O 0 3.2364297908316075e-07
both O 0 8.069134693755586e-09
domains O 0 2.6967466482119562e-08
of O 0 2.3508389901394366e-08
the O 0 2.8071159619003083e-08
VHL B-Disease 0 2.4994840259751072e-06
protein O 0 2.3234096868662846e-09
contribute O 0 2.787565289708027e-09
to O 0 8.781344540409464e-09
regulation O 0 1.5111305629034177e-06
of O 0 2.0164294767255342e-07
CA12 O 0 5.950281774858013e-05
expression O 0 3.661337757421279e-07
, O 0 2.005316579456462e-09
the O 0 4.858128566098685e-09
elongin O 0 1.0230663605170776e-07
binding O 0 6.4335576865914845e-09
domain O 0 1.7525117357308773e-08
alone O 0 2.204775695346939e-09
could O 0 9.653856603009103e-10
effectively O 0 1.4798161807050292e-08
regulate O 0 3.030475852483505e-07
CA9 O 0 0.0016565195983275771
expression O 0 2.4979590307339095e-05
. O 0 4.353781150712166e-06

We O 0 2.544260269132792e-06
mapped O 0 4.673169769375818e-06
CA12 O 0 7.35660141799599e-05
and O 0 1.476875866046612e-07
CA9 O 0 9.614787995815277e-05
loci O 0 2.7117724243908015e-07
to O 0 9.111932541827628e-08
chromosome O 0 2.4065277770546345e-08
bands O 0 7.537591955042444e-07
15q22 O 0 4.187877948425012e-06
and O 0 3.822088956439984e-08
17q21 O 0 1.4994916455179919e-05
. O 0 7.336236649280181e-07

2 O 0 4.669992392791755e-07
respectively O 0 1.8112979205398005e-07
, O 0 1.707238128645372e-09
regions O 0 2.8061295509473894e-09
prone O 0 2.6597524183102905e-08
to O 0 5.689432036604103e-09
amplification O 0 2.8364112836243294e-07
in O 0 1.032720007287935e-07
some O 0 1.9485609570324414e-08
human O 0 2.6643425243833008e-08
cancers B-Disease 0 8.342732371602324e-07
. O 0 1.6620646192677668e-07

Additional O 0 3.019709424734174e-07
experiments O 0 2.608333282694275e-08
are O 0 1.0291359431313651e-10
needed O 0 3.2895766111096236e-09
to O 0 4.940884923421152e-10
define O 0 5.153215631992225e-09
the O 0 2.581599822804037e-09
role O 0 4.18213552677571e-08
of O 0 9.745647133740931e-08
CA O 0 1.2362792176645598e-06
IX O 0 4.7839144826866686e-05
and O 0 8.995491640462205e-08
CA O 0 3.5794751056528185e-06
XII O 0 2.8135648335592123e-06
enzymes O 0 1.4073766596567339e-09
in O 0 3.8589473838612776e-09
the O 0 1.0410913020564294e-08
regulation O 0 1.5810843478902825e-07
of O 0 6.426591259156567e-09
pH O 0 5.6746305432398e-08
in O 0 4.311261125877763e-09
the O 0 8.052115418877293e-09
extracellular O 0 1.0637331016027929e-08
microenvironment O 0 2.7576570005294343e-07
and O 0 1.4045761775882681e-10
its O 0 7.690147824090943e-11
potential O 0 2.828676459731838e-10
impact O 0 4.3995056486778594e-09
on O 0 1.0577145559409473e-07
cancer B-Disease 0 1.601776631332541e-07
cell O 0 9.372082132586002e-08
growth O 0 3.3590115577908364e-08
. O 0 1.6130621816046187e-07

A O 0 5.749345177719078e-07
gene O 0 2.9140101887037417e-08
encoding O 0 2.627467665661243e-07
a O 0 1.812113481491906e-07
transmembrane O 0 3.294513462037685e-08
protein O 0 3.976798446103658e-09
is O 0 3.980429527650209e-11
mutated O 0 3.749331956015567e-10
in O 0 2.613893546055124e-10
patients O 0 4.941206999120595e-09
with O 0 5.659287483084086e-10
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.9996786117553711
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 0 5.945265456830384e-06
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 1.011088990310327e-08
. O 0 8.108912652460276e-08

Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 2.593105250525696e-07
WFS B-Disease 0 0.0014669456286355853
; O 0 7.987883243743e-09
OMIM O 0 8.554964551876765e-06
222300 O 0 9.012286739107367e-08
) O 0 8.1902581938742e-11
is O 0 5.7090252664204755e-11
an O 0 3.1513958109741225e-09
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 1.0
defined O 0 1.8015535729887233e-08
by O 0 5.026688440490368e-11
young O 0 1.5685274190602172e-09
- O 0 4.209594095527791e-08
onset O 1 1.0
non O 1 1.0
- O 0 0.0001215213633258827
immune O 0 0.0001645741576794535
insulin B-Disease 1 1.0
- I-Disease 1 0.9999980926513672
dependent I-Disease 1 0.9999991655349731
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 6.048064278729726e-06
progressive O 1 1.0
optic B-Disease 1 0.9999408721923828
atrophy I-Disease 0 0.07248389720916748
. O 0 7.953928616188932e-06

Linkage O 0 5.346929356164765e-06
to O 0 7.949903846338202e-08
markers O 0 5.729641117113715e-08
on O 0 2.1281799433836568e-07
chromosome O 0 4.1228861391573446e-07
4p O 0 3.6584442568710074e-05
was O 0 1.048147026949664e-07
confirmed O 0 8.897642622684998e-09
in O 0 1.4539138781799466e-09
five O 0 2.564540579896857e-09
families O 0 4.977974144004804e-10
. O 0 2.9441899584981002e-08

On O 0 4.4256196929381986e-07
the O 0 1.0561618246640592e-08
basis O 0 3.9833441434211636e-08
of O 0 1.569530994061097e-08
meiotic O 0 7.388497760985047e-05
recombinants O 0 0.0011414210312068462
and O 0 1.6217548193253606e-08
disease O 0 4.200707053314545e-07
- O 0 2.8542654462171413e-08
associated O 0 4.4728576398256337e-08
haplotypes O 0 2.743638560787076e-07
, O 0 1.2555773087896682e-09
the O 0 1.0129826755189697e-08
WFS B-Disease 0 8.370820978598204e-06
gene O 0 3.3329972115581086e-09
was O 0 4.1842720399642985e-09
localized O 0 2.6481806969513855e-08
to O 0 2.3003842386515316e-08
a O 0 1.919738963351847e-07
BAC O 0 0.005199864972382784
/ O 0 2.914127253461629e-05
P1 O 0 4.970729605702218e-06
contig O 0 1.0281215509166941e-05
of O 0 2.1912020642389507e-08
less O 0 8.822442332245828e-09
than O 0 1.13264841949956e-09
250 O 0 4.897130878589451e-08
kb O 0 4.448628260433907e-06
. O 0 6.198634423526528e-07

Mutations O 0 9.589139438048733e-08
in O 0 3.550204352720243e-09
a O 0 1.0550257334429602e-09
novel O 0 1.4373864321015617e-09
gene O 0 1.7264140117490001e-09
( O 0 2.824578904103703e-10
WFS1 O 0 6.231191491679056e-07
) O 0 5.698367333550891e-10
encoding O 0 3.222256239610033e-08
a O 0 3.457253328065235e-08
putative O 0 2.0156277003025025e-07
transmembrane O 0 3.431171569090452e-09
protein O 0 5.698475580295792e-10
were O 0 1.9763585212828616e-10
found O 0 6.512454464591144e-11
in O 0 6.216812481474321e-11
all O 0 2.098804602335136e-10
affected O 0 8.986732885629678e-11
individuals O 0 3.3031145093426195e-12
in O 0 7.35156879816401e-10
six O 0 2.434886070545872e-08
WFS B-Disease 0 4.6322806156240404e-05
families O 0 2.4974411427791665e-10
, O 0 4.961828517502376e-11
and O 0 3.558810884873864e-11
these O 0 1.0310299142224366e-10
mutations O 0 1.7821262521255932e-10
were O 0 5.750491194334018e-10
associated O 0 5.797265778539895e-09
with O 0 4.3161380025580343e-10
the O 0 9.582264937080254e-08
disease O 0 4.980876155968872e-08
phenotype O 0 2.0115386689667503e-08
. O 0 4.6350159266239643e-08

WFS1 O 0 5.645877536153421e-05
appears O 0 4.140956022524733e-08
to O 0 1.4443835016919593e-09
function O 0 6.86801282512306e-10
in O 0 1.1169040137204433e-09
survival O 0 0.01866689883172512
of O 0 2.9399364720461563e-08
islet O 0 1.2116595371480798e-07
beta O 0 1.9927566086153092e-07
- O 0 6.540547303757194e-08
cells O 0 6.711811106896448e-09
and O 0 5.576225592385242e-10
neurons O 0 1.2759659995253969e-08
. O 0 1.8089359343775868e-08
. O 0 1.3613561122838291e-07

Stable O 0 5.96471090830164e-06
interaction O 0 3.3093183748889032e-09
between O 0 9.988397609017596e-11
the O 0 1.0718934628783927e-09
products O 0 2.0678871948121014e-09
of O 0 1.236123203796069e-09
the O 0 7.617557251649032e-09
BRCA1 O 0 1.8427574133283997e-08
and O 0 6.838174471113234e-09
BRCA2 O 0 1.813952721363421e-08
tumor B-Disease 0 1.9162301967412532e-08
suppressor O 0 3.1569925340591e-08
genes O 0 8.343234991770032e-10
in O 0 2.388245379236764e-09
mitotic O 0 2.4921575914049754e-07
and O 0 2.7272966107716456e-08
meiotic O 0 9.288915862271097e-06
cells O 0 1.7280774500250118e-06
. O 0 1.1751048987207469e-06

BRCA1 O 0 4.647209061658941e-05
and O 0 1.9360602721008036e-07
BRCA2 O 0 1.090251316782087e-06
account O 0 2.5564919070575343e-09
for O 0 2.3282130390267497e-10
most O 0 1.986887564198181e-11
cases O 0 7.426509927854763e-12
of O 0 1.172057451093167e-10
familial O 0 2.8792797035492868e-09
, O 0 8.227647729786014e-11
early O 0 3.819363669776976e-08
onset O 0 0.44851869344711304
breast B-Disease 0 0.23291172087192535
and I-Disease 0 8.051662916841451e-06
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 4.355607075012813e-07
encode O 0 2.55703813678565e-09
products O 0 5.984931217284384e-09
that O 0 4.094853622849115e-11
each O 0 2.4194800676835548e-11
interact O 0 1.7708834398888484e-10
with O 0 1.891354989291827e-10
hRAD51 O 0 1.8319568653168972e-06
. O 0 7.530363745900104e-07

Results O 0 9.997102523584545e-08
presented O 0 1.4557627103783943e-08
here O 0 7.706292493026012e-09
show O 0 1.3121877806554494e-08
that O 0 3.6564762329049927e-10
BRCA1 O 0 1.4293167538426133e-08
and O 0 4.598899927543698e-09
BRCA2 O 0 6.743997715830119e-08
coexist O 0 1.0289093133053484e-08
in O 0 1.1995024973288082e-09
a O 0 1.3320531344618303e-09
biochemical O 0 1.2207698851796067e-08
complex O 0 6.728782420140078e-09
and O 0 1.7742549651700301e-09
colocalize O 0 9.384206691720465e-07
in O 0 1.71879239729833e-08
subnuclear O 0 1.2886027889180696e-06
foci O 0 2.560121856731712e-07
in O 0 1.2641632185506069e-09
somatic O 0 1.3028780720958366e-08
cells O 0 1.203648403169666e-09
and O 0 1.1843565017599644e-10
on O 0 1.8607593688102497e-08
the O 0 1.867026089286128e-09
axial O 0 2.8111759586835205e-09
elements O 0 5.3660960119827905e-09
of O 0 7.255758660562606e-09
developing O 0 5.1486498620079146e-08
synaptonemal O 0 1.9170054201822495e-06
complexes O 0 1.5624601701347274e-07
. O 0 3.1814803946872416e-07

Like O 0 2.5039887532329885e-06
BRCA1 O 0 2.1490145627467427e-06
and O 0 6.842952871011221e-08
RAD51 O 0 4.498998896451667e-05
, O 0 1.713745376719089e-07
BRCA2 O 0 7.938339763313706e-07
relocates O 0 8.72208971713917e-08
to O 0 3.2765658630751204e-08
PCNA O 0 1.9118098748549528e-07
+ O 0 3.191737762975322e-09
replication O 0 1.3055782843718333e-10
sites O 0 4.192122482482574e-10
following O 0 3.989560071193665e-10
exposure O 0 1.1597014015762852e-08
of O 0 6.450276424097012e-10
S O 0 2.2273008326578747e-08
phase O 0 1.2717165986941836e-08
cells O 0 5.8994896079411774e-08
to O 0 2.494195143754041e-07
hydroxyurea O 0 3.215110336896032e-05
or O 0 2.092336188752597e-07
UV O 0 0.0003532615664880723
irradiation O 0 4.17528826801572e-06
. O 0 3.997642750164232e-07

Thus O 0 4.521505729826458e-07
, O 0 7.66986740785569e-09
BRCA1 O 0 1.3687315281174506e-08
and O 0 8.268445372827671e-10
BRCA2 O 0 2.315293379240302e-08
participate O 0 1.6754758691561733e-09
, O 0 6.688061215953667e-11
together O 0 1.2420208091168394e-11
, O 0 2.8266576579394354e-11
in O 0 1.442021085873435e-10
a O 0 8.807456985948647e-10
pathway O 0 5.519984913604503e-09
( O 0 1.2386502934447208e-10
s O 0 2.5276525317252663e-09
) O 0 1.787756227777937e-11
associated O 0 6.378120254169062e-10
with O 0 1.683745851077667e-11
the O 0 4.75056882720537e-10
activation O 0 3.773352741376357e-09
of O 0 3.4088409872623515e-10
double O 0 3.498683287528337e-10
- O 0 1.0579053189019305e-09
strand O 0 9.660580113646233e-10
break O 0 2.7989788264903837e-08
repair O 0 3.252804958719935e-07
and O 0 1.03383310801064e-08
/ O 0 1.4533679859596305e-06
or O 0 1.2027746798537464e-08
homologous O 0 1.3045217350793337e-08
recombination O 0 1.3333297133044653e-08
. O 0 7.645405730727362e-08

Dysfunction O 1 0.9999769926071167
of O 0 4.834066658077063e-06
this O 0 2.69063105129419e-09
pathway O 0 5.490342847025431e-09
may O 0 2.53242898873296e-10
be O 0 7.499192933302368e-11
a O 0 1.1316653170112545e-10
general O 0 6.6848887536608e-10
phenomenon O 0 9.87549930719922e-10
in O 0 3.746199184195831e-11
the O 0 1.817587330643633e-10
majority O 0 5.7803085234953144e-12
of O 0 2.3753410696714106e-11
cases O 0 1.1644385108922073e-11
of O 0 1.9360224534636927e-10
hereditary B-Disease 1 0.9999901056289673
breast I-Disease 1 1.0
and I-Disease 1 0.9107673168182373
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 6.395141826942563e-05
. O 0 1.148707042375463e-06

A O 0 2.223125079581223e-07
novel O 0 1.699519636133573e-08
Arg362Ser O 0 8.411950034314941e-07
mutation O 0 2.632602580376897e-09
in O 0 3.3903804763646406e-10
the O 0 6.000038244025063e-10
sterol O 0 9.41806099774567e-09
27 O 0 2.670061292064929e-07
- O 0 1.002413796413748e-07
hydroxylase O 0 1.6085165270851576e-06
gene O 0 2.3477381816405796e-08
( O 0 1.9719377519766823e-10
CYP27 O 0 2.889195229727193e-07
) O 0 7.087266190586305e-11
: O 0 2.796957283834889e-11
its O 0 3.085479788333956e-11
effects O 0 4.355471094896757e-09
on O 0 1.73964327387921e-08
pre O 0 1.481186302498827e-07
- O 0 4.42390835075912e-09
mRNA O 0 2.5230959543875997e-09
splicing O 0 2.6742858594275276e-08
and O 0 1.4334823328354673e-09
enzyme O 0 1.3629735118314557e-09
activity O 0 2.393061748762193e-08
. O 0 4.9184361472498495e-08

A O 0 1.4422595029373042e-07
novel O 0 1.2661596215934878e-08
C O 0 3.091134033184062e-07
to O 0 9.929290722965334e-10
A O 0 2.7596753771064186e-09
mutation O 0 4.0521469513166153e-10
in O 0 3.0122937477727874e-10
the O 0 1.5623886628901573e-09
sterol O 0 1.094512303012607e-08
27 O 0 1.0919812609699875e-07
- O 0 7.054746475887441e-08
hydroxylase O 0 6.20704611264955e-07
gene O 0 2.4149564126219047e-08
( O 0 2.9144575641737447e-10
CYP27 O 0 6.259309088818554e-07
) O 0 2.4228294370765013e-10
was O 0 2.1454364951267735e-09
identified O 0 6.067129576514674e-10
by O 0 4.8808325436855426e-11
sequencing O 0 1.480716882440447e-08
amplified O 0 4.1655698623799253e-07
CYP27 O 0 3.7027691632829374e-06
gene O 0 5.949012393813291e-09
products O 0 3.605884701940454e-09
from O 0 3.4250891012277407e-10
a O 0 7.946818758597374e-10
patient O 0 5.92013682521042e-09
with O 0 8.360885872527035e-10
cerebrotendinous B-Disease 1 1.0
xanthomatosis I-Disease 1 1.0
( O 0 6.975242428097772e-08
CTX B-Disease 0 0.00011021876707673073
) O 0 2.364009077382434e-08
. O 0 1.6565988403272058e-07

The O 0 5.236447009338008e-07
mutation O 0 2.5959748128911997e-08
changed O 0 8.217872959903616e-08
the O 0 1.2773758939488289e-08
adrenodoxin O 0 1.7954447173451626e-07
cofactor O 0 2.2593356518996188e-08
binding O 0 5.3445132763840775e-09
residue O 0 1.655584114246267e-08
362Arg O 0 3.189889241639321e-08
to O 0 5.703850280980305e-09
362Ser O 0 1.4961342742481065e-07
( O 0 1.019539563884564e-09
CGT O 0 2.4192488012886315e-07
362Arg O 0 3.41867718134381e-07
to O 0 5.3733497651364814e-08
AGT O 0 2.4502223823219538e-05
362Ser O 0 1.255583299553109e-07
) O 0 8.292937864196048e-11
, O 0 7.410167097987586e-12
and O 0 2.4336739221086923e-12
was O 0 2.367760987276313e-10
responsible O 0 2.0204228567965998e-10
for O 0 4.946808740413644e-09
deficiency O 0 7.165559509303421e-05
in O 0 5.36569871201209e-07
the O 0 4.826378585676139e-07
sterol O 0 1.337212864882531e-07
27 O 0 4.0917066712609085e-07
- O 0 2.077324268157099e-08
hydroxylase O 0 3.6102843381513594e-08
activity O 0 2.4871127379810787e-09
, O 0 8.800278214482482e-12
as O 0 1.2026327850245266e-11
confirmed O 0 5.3311292880220407e-11
by O 0 1.0557191405802246e-11
expression O 0 1.0803643535339802e-09
of O 0 6.878368985496763e-10
mutant O 0 1.687840756048331e-09
cDNA O 0 1.5939585651381094e-08
into O 0 3.723024111224049e-09
COS O 0 4.889878368885547e-07
- O 0 1.2622827227914968e-07
1 O 0 6.444686562190327e-08
cells O 0 8.85709425801906e-08
. O 0 2.0017125734739238e-07

Quantitative O 0 1.021942580337054e-06
analysis O 0 1.3010776456212625e-08
showed O 0 3.0300550957207406e-09
that O 0 3.1006652106979615e-11
the O 0 3.9854455846644044e-10
expression O 0 1.7269179419798775e-09
of O 0 7.987452921298654e-10
CYP27 O 0 1.3083814920378245e-08
gene O 0 2.3445887592510317e-11
mRNA O 0 1.5603418557219584e-10
in O 0 7.756396636082741e-10
the O 0 2.6592337221131856e-09
patient O 0 9.663661870717988e-09
represented O 0 4.210459092490737e-09
52 O 0 2.664282305886445e-07
. O 0 3.31751095927757e-07

5 O 0 1.2988564890292764e-07
% O 0 2.19299867154632e-09
of O 0 1.3587736491516011e-09
the O 0 1.616429989859114e-09
normal O 0 4.360677152703829e-08
level O 0 4.389914636249159e-07
. O 0 2.4403846055065515e-07

As O 0 3.9080578773109664e-08
the O 0 1.5095203975690197e-09
mutation O 0 5.2753953982964674e-11
occurred O 0 7.525242234907026e-11
at O 0 2.027228246381796e-10
the O 0 5.981044826075532e-11
penultimate O 0 1.4630047173724847e-09
nucleotide O 0 1.2478539312965609e-09
of O 0 1.2130262350140697e-09
exon O 0 5.026032479094056e-09
6 O 0 9.157385072455781e-09
( O 0 2.6283803258864147e-11
- O 0 1.044743069833487e-09
2 O 0 6.279455622149044e-09
position O 0 1.0943123385231956e-07
of O 0 6.18948758912552e-09
exon O 0 7.395511403274213e-08
6 O 0 1.0715469755950835e-07
- O 0 2.0719139115499274e-07
intron O 0 1.1211496939722565e-06
6 O 0 7.381798639016779e-08
splice O 0 3.684061411490802e-08
site O 0 7.931498124946756e-09
) O 0 1.3153161892986986e-10
of O 0 8.391431993715059e-10
the O 0 3.1531572908249927e-09
gene O 0 6.659808260423006e-09
, O 0 9.416044610688346e-10
we O 0 2.489338513100847e-09
hypothesized O 0 4.791137264703593e-09
that O 0 1.4309191331829396e-10
the O 0 1.6243545397642833e-09
mutation O 0 2.1743438161081485e-09
may O 0 9.414230506266108e-10
partially O 0 2.3932109627367026e-09
affect O 0 5.519361079286966e-10
the O 0 3.291740213740013e-10
normal O 0 1.9138869655765944e-10
splicing O 0 1.276015820783627e-10
efficiency O 0 2.2158337387168103e-09
in O 0 1.639738123060397e-09
exon O 0 2.8845470012583974e-08
6 O 0 1.7293084297875794e-08
and O 0 4.5606374232676217e-10
cause O 0 2.4578028501309745e-10
alternative O 0 6.213661807308313e-10
splicing O 0 2.488341532824734e-09
elsewhere O 0 2.797333475967889e-09
, O 0 2.938861307089091e-11
which O 0 1.371127495396196e-12
resulted O 0 1.4166883811894682e-11
in O 0 1.2033625831908701e-11
decreased O 0 7.33939409247597e-10
transcript O 0 3.164200679250939e-09
in O 0 5.153930615620084e-10
the O 0 1.0307989128932604e-08
patient O 0 4.913579232379561e-08
. O 0 8.211042512584754e-08

Transfection O 0 3.902560274582356e-05
of O 0 2.1389801929672103e-07
constructed O 0 9.079732166128451e-08
minigenes O 0 4.124679264805309e-07
, O 0 8.137315821166169e-11
with O 0 1.992886975235586e-12
or O 0 4.4403970084205824e-11
without O 0 6.375249772538893e-10
the O 0 1.3483590910468024e-09
mutation O 0 8.783919702715082e-10
, O 0 5.860362889409387e-11
into O 0 6.950826025864387e-10
COS O 0 2.081396246467193e-07
- O 0 6.892572201877556e-08
1 O 0 1.6199308561226644e-08
cells O 0 4.906196782172856e-09
confirmed O 0 1.964629570139209e-09
that O 0 1.8364492218592154e-11
the O 0 5.392513102719931e-10
mutant O 0 2.3281309324829635e-08
minigene O 0 2.7316679052091786e-07
was O 0 7.553074610200383e-09
responsible O 0 7.360688725199793e-10
for O 0 1.9286071351043432e-10
a O 0 1.5588574875380345e-10
mRNA O 0 9.697964653554436e-10
species O 0 4.5650823399245866e-11
alternatively O 0 1.3968978751499606e-10
spliced O 0 3.6163469996353115e-09
at O 0 1.4553406479933528e-08
an O 0 1.763240220498119e-09
activated O 0 1.5769659285069793e-06
cryptic O 0 2.1348066070459026e-07
5 O 0 1.7161781329377845e-08
splice O 0 1.5857006019359687e-07
site O 0 9.222734576042058e-08
88 O 0 1.66725584449523e-07
bp O 0 6.148751729995183e-09
upstream O 0 4.867002356689909e-10
from O 0 1.7251425288300481e-10
the O 0 1.143682815119007e-09
3 O 0 3.7233365279831787e-09
end O 0 2.3589688424863198e-08
of O 0 5.960961502182727e-09
exon O 0 1.3411873567292787e-07
6 O 0 3.12781565980913e-07
. O 0 4.693150685852743e-07

Our O 0 5.585992539636209e-07
data O 0 2.045964997421379e-08
suggest O 0 4.315111379327163e-09
that O 0 2.3253494615960157e-11
the O 0 2.911812457817575e-10
C O 0 3.39031913654253e-08
to O 0 5.949713499653342e-10
A O 0 1.8867294393487555e-09
mutation O 0 1.6714468697998086e-10
at O 0 4.435954936710118e-10
the O 0 2.331577153569242e-10
penultimate O 0 2.652390307389396e-09
nucleotide O 0 1.2889074252342425e-09
of O 0 8.331578760234493e-10
exon O 0 4.176370804742646e-09
6 O 0 1.8430595716267817e-08
of O 0 7.169011606578124e-09
the O 0 6.332534052688743e-09
CYP27 O 0 4.6779402396168734e-07
gene O 0 1.1745734385115725e-09
not O 0 2.607290772171922e-10
only O 0 1.2173088925759856e-10
causes O 0 4.224921246187563e-10
the O 0 2.195107873248503e-09
deficiency B-Disease 0 7.87755780606858e-08
in I-Disease 0 2.1267529959345666e-08
the I-Disease 0 2.2575441960270837e-07
sterol I-Disease 0 3.699842920923402e-07
27 I-Disease 0 1.3465140682455967e-06
- I-Disease 0 8.429073261595477e-08
hydroxylase I-Disease 0 3.132583117348986e-07
activity I-Disease 0 2.941634491548939e-09
, O 0 1.5041873996368693e-11
but O 0 8.088290454066893e-12
also O 0 8.600573031536385e-11
partially O 0 2.968655543611476e-09
leads O 0 5.973588984575784e-11
to O 0 2.594797640642632e-11
alternative O 0 5.699671845604826e-10
pre O 0 7.872507090667114e-09
- O 0 3.069591525406423e-10
mRNA O 0 6.055383972025652e-10
splicing O 0 1.485370049181256e-08
of O 0 1.0217535262313504e-08
the O 0 1.188177112254607e-08
gene O 0 2.826424960744589e-08
. O 0 4.2460874283278827e-07

To O 0 3.0986896604190406e-07
our O 0 1.7771720095538512e-08
knowledge O 0 7.356369291500187e-09
, O 0 1.6154296650361388e-11
this O 0 2.7162853129952813e-12
is O 0 2.108886633031548e-12
the O 0 3.285014968379407e-11
first O 0 2.3144741678748915e-10
report O 0 7.886776648424743e-11
regarding O 0 1.7046603018044948e-10
effects O 0 2.7377189404376168e-09
on O 0 2.192848125304181e-09
pre O 0 4.220912064312188e-09
- O 0 4.0641809362362835e-11
mRNA O 0 2.0897002878106363e-11
splicing O 0 5.901812927255889e-10
of O 0 2.7976415628572227e-10
a O 0 1.2034044594155802e-10
mutation O 0 1.095125101713279e-10
at O 0 4.347244508817738e-10
the O 0 2.1493837265573745e-10
- O 0 1.1626752893789671e-09
2 O 0 4.504713491115808e-09
position O 0 5.3007401135118926e-08
of O 0 5.271357128577847e-09
a O 0 1.0381031145811903e-08
5 O 0 9.176446980063702e-08
splice O 0 1.3967974155093543e-06
site O 0 7.535550707871153e-07
. O 0 3.2772851454865304e-07

ATM O 0 2.618911639729049e-05
germline O 0 1.8935113985207863e-05
mutations O 0 2.7674147418110806e-08
in O 0 5.966330096640604e-09
classical O 1 0.9999967813491821
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 1.0
in O 0 2.403170284992484e-08
the O 0 8.249687155625907e-09
Dutch O 0 8.549912990929442e-07
population O 0 2.3176990882056714e-10
. O 0 7.662117162965387e-09

Germline O 0 9.502103057457134e-05
mutations O 0 1.0818582296678869e-07
in O 0 1.746025724003175e-08
the O 0 1.712450625745987e-08
ATM O 0 1.2159809159584256e-07
gene O 0 3.187593244913245e-10
are O 0 1.264580996342135e-12
responsible O 0 2.2504884240881484e-12
for O 0 4.6346020771137475e-11
the O 0 1.3314855777935009e-06
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 5.75551098336291e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 4.512325801897532e-08
. O 0 2.397942182597035e-07

In O 0 4.0415681468175535e-08
our O 0 1.467213905925746e-08
study O 0 4.094676264720931e-10
, O 0 1.7628013632142725e-11
we O 0 1.8568674375885053e-11
have O 0 2.359337551716134e-12
determined O 0 8.877359958248121e-11
the O 0 1.1755573181559953e-09
ATM O 0 1.4357809732246096e-06
mutation O 0 3.643090940030902e-09
spectrum O 0 3.3986224945437016e-10
in O 0 3.554049068932308e-11
19 O 0 9.153817703833056e-10
classical O 0 1.172686779682408e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 4.837235110244364e-07
, O 0 3.12487674625217e-11
including O 0 8.618173015506603e-12
some O 0 3.7219389896481214e-12
immigrant O 0 4.560721938995371e-11
populations O 0 2.655799365147704e-11
, O 0 4.155085997492591e-12
as O 0 2.634272661117265e-11
well O 0 4.759962909939297e-11
as O 0 2.3390600567552156e-10
12 O 0 1.3548607791236122e-09
of O 0 4.977432910280299e-10
Dutch O 0 8.20027423742431e-08
ethnic O 0 2.2793218701355755e-10
origin O 0 8.873120016517078e-09
. O 0 9.76691723053591e-08

Both O 0 1.1574120328816662e-08
the O 0 1.4978132067966499e-09
protein O 0 1.776119668006615e-10
truncation O 0 4.326882319105607e-08
test O 0 2.399744047920649e-08
( O 0 2.4175865753761627e-09
PTT O 0 1.697412812973198e-06
) O 0 1.1882302086707597e-10
and O 0 9.258147720681009e-11
the O 0 4.6311496304518585e-10
restriction O 0 2.5000744585668144e-08
endonuclease O 0 3.1517825505034125e-07
fingerprinting O 0 3.6093032917960954e-07
( O 0 8.735167589257742e-10
REF O 0 7.904679932835279e-08
) O 0 2.051542269398965e-11
method O 0 5.791394031007258e-10
were O 0 7.759781012195432e-11
used O 0 3.3921399023029153e-10
and O 0 3.655491187526394e-11
compared O 0 2.28425278692157e-10
for O 0 1.9302631715234497e-10
their O 0 1.7002896313123017e-10
detection O 0 3.6373075662510246e-09
efficiency O 0 1.5843402145776508e-09
, O 0 4.5642725710060006e-11
identifying O 0 6.348445102943856e-10
76 O 0 5.551259008029774e-09
% O 0 7.518298483777386e-11
and O 0 1.5477348569437055e-11
60 O 0 5.513416390101611e-10
% O 0 9.50246062392246e-11
of O 0 3.4889541256077905e-10
the O 0 8.385608318839388e-10
mutations O 0 7.25230986375891e-10
, O 0 1.5634319394663976e-09
respectively O 0 1.3917019714426715e-07
. O 0 5.036552579440468e-07

Most O 0 4.317220714256109e-08
patients O 0 6.589504497611642e-09
were O 0 7.51705475643405e-10
found O 0 3.085257882506909e-10
to O 0 1.6681991343858726e-09
be O 0 2.5166075889870854e-09
compound O 0 3.919132609553344e-07
heterozygote O 0 5.931752639298793e-06
. O 0 2.735466466674552e-07

Seventeen O 0 2.951949454654823e-06
mutations O 0 2.271650600960129e-08
were O 0 1.971062646433097e-09
distinct O 0 2.1605472966257366e-10
, O 0 1.2537579308080637e-10
of O 0 1.6360542087756613e-10
which O 0 7.335762206017726e-12
10 O 0 1.1239300462539958e-10
were O 0 1.9940638029680713e-10
not O 0 1.3237229090634628e-09
reported O 0 1.0719466425612723e-09
previously O 0 4.573176681788027e-08
. O 0 2.635437965636811e-07

Mutations O 0 1.68239091635769e-06
are O 0 7.710644567282543e-09
small O 0 3.774648593690699e-09
deletions O 0 9.000174259199412e-07
or O 0 2.275332917633932e-07
point O 0 1.2535629139165394e-06
mutations O 0 4.8456936241336734e-08
frequently O 0 7.632013243608071e-09
affecting O 0 6.075053349263726e-09
splice O 0 3.57024589447974e-07
sites O 0 1.512946141701832e-07
. O 0 2.0200458550334588e-07

Moreover O 0 6.814557877987681e-07
, O 0 5.268723679563436e-09
a O 0 1.1876423400281055e-08
16 O 0 1.8157463443913002e-07
. O 0 3.40232361395465e-07

7 O 0 1.8824692915586638e-06
- O 0 4.337906034379557e-07
kb O 0 2.806139264066587e-06
genomic O 0 2.124394171687527e-07
deletion O 0 1.202088242280297e-07
of O 0 1.0027195074258088e-08
the O 0 4.908705886208509e-09
3 O 0 8.119247496551907e-09
end O 0 2.295492862458559e-08
of O 0 2.5251372104406755e-09
the O 0 9.112984256098855e-10
gene O 0 2.432757606474212e-10
, O 0 1.815503997137924e-11
most O 0 3.9841723670219764e-12
likely O 0 7.485959074848836e-11
a O 0 7.791206568796838e-11
result O 0 1.8730496320618073e-10
of O 0 3.3897534779114835e-10
recombination O 0 7.207214686166807e-11
between O 0 5.869032343452929e-11
two O 0 8.657156935765187e-11
LINE O 0 1.0831250341070131e-09
elements O 0 2.918791319750369e-10
, O 0 9.59992363380735e-11
was O 0 3.769152101540385e-09
identified O 0 8.537869078395488e-09
. O 0 7.08765526269417e-08

The O 0 3.118195763818221e-07
most O 0 7.076653152360279e-10
frequently O 0 4.087037375199998e-10
found O 0 3.041934412695291e-11
mutation O 0 5.836791466817814e-11
, O 0 2.703879438056833e-12
identified O 0 3.57766316572139e-11
in O 0 3.142293369950977e-11
three O 0 1.1564438642808206e-11
unrelated O 0 3.3316860381660263e-10
Turkish O 0 2.3786186886809446e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
individuals O 0 3.264627457255642e-11
, O 0 7.740899934938206e-12
was O 0 3.1131408562146134e-10
previously O 0 2.0093585129110636e-10
described O 0 2.933277926109312e-11
to O 0 2.845656002503638e-11
be O 0 1.8904161222521587e-11
a O 0 7.862865220031878e-11
Turkish O 0 4.3197577070941406e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
founder O 0 8.284439900307916e-06
mutation O 0 2.8882749347758363e-07
. O 0 9.53093604039168e-08

The O 0 3.7781731521135953e-07
presence O 0 4.3839527563704905e-08
of O 0 4.902813088847324e-08
a O 0 4.582091150950873e-08
founder O 0 9.707232493383344e-07
mutation O 0 2.2702041135858053e-08
among O 0 4.2133952576906e-11
relatively O 0 1.4608625420464705e-10
small O 0 1.0268883833541853e-11
ethnic O 0 2.0277831063592044e-12
population O 0 5.177915388121512e-13
groups O 0 3.335495941947375e-13
in O 0 1.1286813497712878e-11
Western O 0 3.641500212481219e-09
Europe O 0 4.158287492117552e-09
could O 0 5.816792825186212e-09
indicate O 0 4.766554706492343e-09
a O 0 6.59453047724412e-10
high O 0 2.221423711645798e-09
carrier O 0 7.499882936912172e-10
frequency O 0 8.076140645130181e-09
in O 0 2.9978841631361774e-10
such O 0 1.8287367176128555e-09
communities O 0 4.054290680954864e-09
. O 0 1.297999716598497e-07

In O 0 5.0212438651442426e-08
patients O 0 1.760307632991953e-08
of O 0 1.6880951081432727e-09
Dutch O 0 3.687204639390984e-07
ethnic O 0 2.2226984142115214e-10
origin O 0 2.0489789864797103e-09
, O 0 1.1317516368514191e-10
however O 0 3.6398248304259084e-10
, O 0 1.1575875674685321e-10
no O 0 7.035537707977824e-10
significant O 0 1.0437053443723698e-09
founder O 0 1.6791783963299167e-08
effect O 0 1.0101753211699815e-08
could O 0 3.348640476019682e-09
be O 0 2.949083643954964e-09
identified O 0 4.629158212310358e-08
. O 0 2.2852493941627472e-07

The O 0 3.284318950136367e-07
observed O 0 3.9788339734059264e-08
genetic O 0 4.043470891446077e-09
heterogeneity O 0 3.4581022489987845e-09
including O 0 9.627170588499823e-11
the O 0 8.657210504026125e-10
relative O 0 1.998517689116852e-07
high O 0 2.2322242898553668e-07
percentage O 0 7.474114482874938e-08
of O 0 2.1355413437618154e-08
splice O 0 4.946980993736361e-07
- O 0 3.603522031880857e-07
site O 0 5.010700832031034e-08
mutations O 0 5.710076855791613e-09
had O 0 2.056464998290153e-09
no O 0 1.2412169070330492e-09
reflection O 0 3.9788545791452634e-09
on O 0 2.3638692780991732e-08
the O 0 2.420023825777662e-08
phenotype O 0 2.7745454644900747e-07
. O 0 3.43205783792655e-07

All O 0 1.2066740495697559e-08
patients O 0 1.0395133642759902e-09
manifested O 0 3.940809623070862e-10
classical O 0 8.689461594713066e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
and O 0 2.144578559182264e-08
increased O 0 8.667858963917752e-08
cellular O 0 2.732034509733694e-08
radioresistant O 0 5.554025861442824e-08
DNA O 0 4.991934421383348e-09
synthesis O 0 3.005175415182748e-07
. O 0 3.454514967415889e-07

Determination O 0 1.7844530475485954e-06
of O 0 2.6323385782234254e-07
the O 0 1.863035947735625e-08
genomic O 0 3.0407090179096485e-08
structure O 0 8.366585646513158e-09
of O 0 9.05387498306709e-09
the O 0 5.0551243191421236e-09
COL4A4 O 0 6.02766476731631e-07
gene O 0 2.592811076951307e-09
and O 0 2.6269231234721246e-10
of O 0 1.3131935538979178e-09
novel O 0 4.397217878704396e-08
mutations O 0 9.142630119640671e-07
causing O 0 9.161352068076667e-07
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.000453960063168779

Autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 5.525307145148872e-08
a O 0 3.6103873668480446e-08
progressive O 1 0.9541533589363098
hematuric B-Disease 1 1.0
glomerulonephritis I-Disease 1 1.0
characterized O 0 0.0056494916789233685
by O 0 5.975636696575748e-08
glomerular B-Disease 1 0.9999977350234985
basement I-Disease 1 1.0
membrane I-Disease 1 1.0
abnormalities I-Disease 1 0.8763945698738098
and O 0 4.22136076094759e-10
associated O 0 1.5050908075409097e-08
with O 0 6.552550169125482e-11
mutations O 0 6.279213260462768e-10
in O 0 4.574445822136397e-10
either O 0 2.8929203477190413e-09
the O 0 9.780390719527077e-09
COL4A3 O 0 1.0562181387285818e-06
or O 0 5.319809481818538e-09
the O 0 9.53893408706108e-09
COL4A4 O 0 5.038532435719389e-07
gene O 0 1.7735680701846945e-09
, O 0 1.8405706125879107e-10
which O 0 3.1003224293391085e-11
encode O 0 1.4118127777962286e-09
the O 0 7.166400362024206e-09
alpha3 O 0 1.3110866348142736e-06
and O 0 8.417388563941586e-09
alpha4 O 0 1.822057311073877e-05
type O 0 2.2139429347589612e-05
IV O 1 1.0
collagen O 0 7.895675662439317e-05
chains O 0 2.3361480998573825e-06
, O 0 4.6909200968059395e-09
respectively O 0 2.7592557572120313e-08
. O 0 1.0108541914632951e-07

To O 0 4.178587431624692e-08
date O 0 8.452352773247185e-08
, O 0 1.7714373024002583e-10
mutation O 0 1.6365839239362856e-11
screening O 0 2.1838314490096877e-10
in O 0 1.2194009135768624e-09
the O 0 2.020848732797731e-08
two O 0 6.41293518288677e-10
genes O 0 1.0737760680612496e-09
has O 0 1.0099392849793887e-10
been O 0 1.7768041205012963e-10
hampered O 0 2.6683739662303196e-09
by O 0 1.1848806658054656e-10
the O 0 9.887942908903824e-09
lack O 0 2.3196207621367648e-08
of O 0 6.203016433836694e-10
genomic O 0 1.046995157238939e-09
structure O 0 8.377231131007079e-10
information O 0 8.02413513412148e-09
. O 0 3.621001098963461e-08

We O 0 7.399447810030324e-08
report O 0 2.7663367152541696e-09
here O 0 3.4736952203573424e-10
the O 0 2.6109536754859164e-10
complete O 0 1.9651316129909446e-09
characterization O 0 4.726602220728182e-09
of O 0 1.7205199487335676e-09
the O 0 2.046362190810669e-09
48 O 0 2.695553646958615e-08
exons O 0 1.0870723876621469e-08
of O 0 4.380431573025589e-09
the O 0 2.2827002510439343e-08
COL4A4 O 0 1.01355562946992e-05
gene O 0 3.4752424937778414e-08
, O 0 1.5245142925834898e-09
a O 0 5.293278038109861e-10
comprehensive O 0 3.986420527013479e-09
gene O 0 8.158005382341571e-10
screen O 0 8.019682695703523e-09
, O 0 6.037209066001026e-10
and O 0 3.0075630874648596e-10
the O 0 9.165873060545948e-10
subsequent O 0 1.2156992079681572e-09
detection O 0 1.8706415971792012e-08
of O 0 2.9668201229071656e-10
10 O 0 3.135673110055137e-10
novel O 0 6.218072168273636e-10
mutations O 0 4.371206729913979e-10
in O 0 2.5399851666385587e-10
eight O 0 8.713235688517784e-10
patients O 0 2.898045581289921e-09
diagnosed O 0 8.537644902162356e-08
with O 0 1.4833458017449175e-08
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 5.831284215673804e-05

Furthermore O 0 5.350859737518476e-07
, O 0 2.415604383187997e-09
we O 0 1.3407680521382304e-09
identified O 0 1.720021236550906e-09
a O 0 2.4414323895882717e-09
glycine O 0 5.254054613601511e-08
to O 0 5.924172441496012e-08
alanine O 0 1.6176667827494384e-07
substitution O 0 7.15591227162804e-07
in O 0 2.672343839549285e-07
the O 0 4.955140298079641e-07
collagenous O 0 1.3479427707352443e-06
domain O 0 5.636172861755995e-09
that O 0 1.0510157848198087e-11
is O 0 2.1295330950021896e-12
apparently O 0 1.713252595347825e-10
silent O 0 3.5821938748625826e-09
in O 0 5.345794917843705e-10
the O 0 2.124530329439267e-09
heterozygous O 0 1.0487141155479662e-09
carriers O 0 9.422938818115512e-11
, O 0 3.4831609818652964e-11
in O 0 3.588599695181216e-10
11 O 0 3.502432477375805e-08
. O 0 1.2613850230991375e-07

5 O 0 3.2089232604448625e-07
% O 0 5.431338490069493e-09
of O 0 4.224995908685969e-09
all O 0 5.209603859412937e-10
control O 0 4.570811285020682e-09
individuals O 0 3.7368289018679945e-11
, O 0 5.135411540457824e-11
and O 0 4.9225484799464425e-11
in O 0 7.046509487018682e-10
one O 0 8.079633628810257e-10
control O 0 3.6630394273373668e-09
individual O 0 2.1267022864979168e-10
homozygous O 0 4.0558680858282514e-09
for O 0 7.052937123219749e-10
this O 0 1.0032489283773316e-09
glycine O 0 6.097913995972704e-08
substitution O 0 5.043185637987335e-07
. O 0 7.787442655171617e-07

There O 0 8.651176841567576e-08
has O 0 4.521246710353921e-10
been O 0 3.5656683161633396e-10
no O 0 3.9841760446357455e-10
previous O 0 7.774703658647297e-10
finding O 0 6.690032083866981e-09
of O 0 1.8289355585565659e-09
a O 0 8.845049137562455e-10
glycine O 0 1.1278135758630015e-08
substitution O 0 8.471317158864622e-08
that O 0 6.659131579489497e-10
is O 0 4.29213123376293e-11
not O 0 1.1200949889822454e-10
associated O 0 5.948952996881474e-10
with O 0 2.207622279426502e-11
any O 0 8.413099661375156e-10
obvious O 0 5.918308065844258e-09
phenotype O 0 5.729627439166052e-09
in O 0 1.715110498068384e-09
homozygous O 0 4.3693358264818016e-08
individuals O 0 6.208188962908423e-10
. O 0 5.807605418794992e-08

Founder O 0 0.0001101415473385714
BRCA1 O 0 3.0621733912994387e-06
and O 0 2.1755768742082182e-08
BRCA2 O 0 7.825382652981716e-08
mutations O 0 1.340405009209178e-09
in O 0 8.910138182827154e-10
French O 0 8.542381806364574e-07
Canadian O 0 0.00033471640199422836
breast B-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 4.0082130681184935e-07
. O 0 8.124113151097845e-07

We O 0 3.8936985191639906e-08
have O 0 3.0782101867465883e-10
identified O 0 3.749017485343842e-10
four O 0 4.149441554246458e-11
mutations O 0 2.618672639842501e-11
in O 0 6.351337511478761e-11
each O 0 3.16124765253889e-11
of O 0 1.0426408625363592e-09
the O 0 4.131387640882167e-07
breast B-Disease 1 0.9998277425765991
cancer I-Disease 0 7.0107748797454406e-06
- O 0 3.7537441244239744e-07
susceptibility O 0 1.0718412823962353e-07
genes O 0 1.1842629099589885e-08
, O 0 6.576396316404498e-09
BRCA1 O 0 2.1498287594567955e-08
and O 0 7.890305298019484e-09
BRCA2 O 0 6.734999402624453e-08
, O 0 2.066919968513048e-10
in O 0 3.6289901639285915e-10
French O 0 8.807952411871156e-08
Canadian O 0 1.7035155508438038e-07
breast B-Disease 0 4.963852688888437e-07
cancer I-Disease 0 6.927155027369736e-08
and O 0 5.18165336416132e-07
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 8.239060633741246e-08
from O 0 1.461477161512903e-08
Quebec O 0 1.5769207948324038e-06
. O 0 5.037426831222547e-07

To O 0 6.990839551690442e-07
identify O 0 6.83915516219713e-07
founder O 0 1.4429326711251633e-06
effects O 0 2.6475690901861526e-05
, O 0 5.315275330985969e-09
we O 0 6.277455444347879e-09
examined O 0 5.94774185458391e-09
independently O 0 1.2203298815904873e-08
ascertained O 0 9.800016869121464e-07
French O 0 9.319387004325108e-07
Canadian O 0 7.189156008280406e-07
cancer B-Disease 0 1.8998861150976154e-08
families O 0 1.7427092754984663e-11
for O 0 1.691622709965035e-11
the O 0 2.9783737975908053e-11
distribution O 0 8.178722282758955e-11
of O 0 1.7452715661558926e-10
these O 0 3.535936543563878e-10
eight O 0 3.807280712919692e-09
mutations O 0 1.2725172027217013e-08
. O 0 1.7940412533334893e-07

Mutations O 0 3.803135086855036e-07
were O 0 1.1190198101473925e-08
found O 0 6.033364363666749e-10
in O 0 3.2049432552305746e-10
41 O 0 3.084507937956005e-08
of O 0 9.372883802427623e-09
97 O 0 1.919897840707563e-06
families O 0 1.4456383645722326e-08
. O 0 2.3865942466727574e-07

Six O 0 4.795528525392001e-07
of O 0 1.9402088824449493e-08
eight O 0 3.6190519470125082e-09
mutations O 0 4.5976872309339e-10
were O 0 1.6980283845668964e-09
observed O 0 2.2473862770766573e-09
at O 0 1.0692700946890454e-08
least O 0 2.7206863428830275e-09
twice O 0 2.5799717917607268e-08
. O 0 1.4544907855906786e-07

The O 0 5.860600595042342e-06
BRCA1 O 0 2.0779780243174173e-06
C4446T O 0 3.1541630960418843e-06
mutation O 0 3.145296290085753e-08
was O 0 1.4566904127377711e-08
the O 0 2.9513627097799144e-09
most O 0 1.4126659564350774e-10
common O 0 2.730338732881421e-10
mutation O 0 4.687062959973787e-10
found O 0 4.585301582871182e-11
, O 0 1.158744454554661e-11
followed O 0 1.969798907319742e-10
by O 0 1.5518031304395663e-10
the O 0 4.862080515977141e-08
BRCA2 O 0 2.3096218626506015e-07
8765delAG O 0 2.1118216864124406e-07
mutation O 0 1.8290586822899968e-08
. O 0 7.126451606609407e-08

Together O 0 3.4576228102878304e-08
, O 0 9.755048990811588e-10
these O 0 6.714877265334707e-11
mutations O 0 1.8657865530347095e-10
were O 0 1.7890226799988085e-10
found O 0 4.075110388024328e-11
in O 0 1.1050497322750985e-10
28 O 0 3.3047090397531065e-08
of O 0 3.6878982090371437e-09
41 O 0 6.736872393275917e-09
families O 0 1.7826896209216514e-11
identified O 0 7.015183434155858e-10
to O 0 3.280497651303449e-09
have O 0 1.5107762818544757e-09
a O 0 1.852610864716553e-08
mutation O 0 4.456524749230084e-08
. O 0 1.6344033326731733e-07

The O 0 6.796366278649657e-07
odds O 0 6.925126285750594e-07
of O 0 3.7561984633782686e-09
detection O 0 6.702807553438106e-08
of O 0 2.8133591012391435e-09
any O 0 1.49297019191863e-09
of O 0 7.727958717396177e-09
the O 0 3.6514826717848337e-08
four O 0 1.0275757134081687e-08
BRCA1 O 0 1.4291096306351392e-08
mutations O 0 3.0234275083529383e-09
was O 0 3.876077769859876e-08
18 O 0 2.4356160110983183e-07
. O 0 6.028843131389294e-07

7x O 0 0.0003496141580399126
greater O 0 7.588512289657956e-07
if O 0 1.0955983675842162e-08
one O 0 2.994672287925937e-10
or O 0 2.7098287155857825e-11
more O 0 9.780893543004376e-13
cases O 0 1.874431686255118e-11
of O 0 1.5735775349412506e-08
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 2.2166109658883215e-07
also O 0 4.099403871915541e-10
present O 0 3.97179164557393e-11
in O 0 7.357446318856375e-10
the O 0 2.4594889680429333e-08
family O 0 2.529578324583781e-08
. O 0 1.9507032789078949e-07

The O 0 1.089374109142227e-06
odds O 0 9.756263352755923e-07
of O 0 7.942731805599124e-09
detection O 0 1.5730171298855566e-07
of O 0 6.760944248895839e-09
any O 0 3.758047206758874e-09
of O 0 1.1064638982816177e-08
the O 0 2.2227895968285338e-08
four O 0 1.9209435819789178e-08
BRCA2 O 0 9.401660605590223e-08
mutations O 0 4.046595947215792e-09
was O 0 3.520690583513897e-08
5 O 0 2.3380863467536983e-07
. O 0 3.5903735806641635e-07

3x O 0 0.0001781222817953676
greater O 0 4.994308611117049e-08
if O 0 8.657508043796724e-10
there O 0 1.0376429576686164e-10
were O 0 2.5846777496063567e-10
at O 0 5.879252640283994e-10
least O 0 2.8562052029057483e-11
five O 0 6.608298543792079e-12
cases O 0 5.922883711262372e-12
of O 0 2.3542065519244204e-10
breast B-Disease 0 8.642804800729209e-07
cancer I-Disease 0 1.1325284532404112e-07
in O 0 4.142156839748168e-08
the O 0 2.1658570403815247e-06
family O 0 1.5589027668738709e-07
. O 0 1.0477966725375154e-06

Interestingly O 0 1.202923129994815e-07
, O 0 2.839178891989036e-10
the O 0 1.5191957414284474e-10
presence O 0 2.2965460089174883e-10
of O 0 2.8061135637358348e-09
a O 0 2.2233966490148305e-07
breast B-Disease 1 0.9999723434448242
cancer I-Disease 0 1.225532378157368e-05
case O 0 4.335257042242802e-09
< O 0 1.4634191813911457e-07
36 O 0 1.2555827488824889e-08
years O 0 6.581989953069467e-10
of O 0 5.473891895313443e-10
age O 0 2.233259577266722e-09
was O 0 5.30451993441261e-09
strongly O 0 1.9719414989793904e-10
predictive O 0 3.000711679135293e-09
of O 0 5.357697063779199e-10
the O 0 8.027070119709379e-10
presence O 0 1.4032113249129452e-09
of O 0 4.661573349551418e-10
any O 0 8.301249687647783e-10
of O 0 6.447718470248276e-10
the O 0 1.6784152956361709e-09
eight O 0 2.0650650078835042e-09
mutations O 0 1.8121328881903764e-09
screened O 0 1.2152237616191996e-07
. O 0 7.741342074041313e-07

Carriers O 0 8.450692945416449e-08
of O 0 9.528659639101988e-09
the O 0 2.6197144453732335e-09
same O 0 8.450281585581365e-10
mutation O 0 5.241377887266196e-10
, O 0 1.1331119202651063e-11
from O 0 9.08340503508187e-12
different O 0 5.355361987202656e-12
families O 0 1.1000253659354531e-11
, O 0 1.3185658294390112e-11
shared O 0 9.476253115536792e-11
similar O 0 7.680546476596106e-11
haplotypes O 0 4.8210213599020335e-09
, O 0 1.244129244071246e-10
indicating O 0 5.1125961242348694e-09
that O 0 9.642368847817551e-11
the O 0 2.8794649997720967e-10
mutant O 0 3.236513945736874e-09
alleles O 0 1.803456550764082e-10
were O 0 8.472807178083741e-11
likely O 0 1.348327560712903e-10
to O 0 1.1204796118713389e-10
be O 0 5.2967297214934206e-11
identical O 0 3.8343939134932725e-11
by O 0 5.113339439366538e-12
descent O 0 1.379847458515826e-09
for O 0 2.1699345098546985e-10
a O 0 2.6574273337409693e-10
mutation O 0 1.2488081402306506e-10
in O 0 2.308944979656502e-10
the O 0 3.842890894389939e-09
founder O 0 7.922399447579664e-08
population O 0 1.2834704132824726e-10
. O 0 8.89236684287198e-09

The O 0 5.6600701014986043e-08
identification O 0 7.848986172120931e-08
of O 0 3.3161565937689375e-08
common O 0 2.1189653409692255e-07
BRCA1 O 0 7.055324431348708e-07
and O 0 8.212138880026032e-08
BRCA2 O 0 3.761828963888547e-07
mutations O 0 1.3532079901068528e-09
will O 0 5.967510929849595e-10
facilitate O 0 5.932752067394631e-09
carrier O 0 1.32692246079813e-10
detection O 0 7.460651652024808e-09
in O 0 1.0045566600780376e-09
French O 0 3.5218835137129645e-07
Canadian O 0 9.088080901165085e-07
breast B-Disease 0 8.470413376926444e-06
cancer I-Disease 0 4.823305062018335e-07
and O 0 7.37005109385791e-07
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 7.454139563378703e-07
. O 0 8.075879804891883e-07

Are O 0 1.1482018180686282e-07
Dp71 O 0 2.574042991909664e-05
and O 0 4.7858971896630464e-08
Dp140 O 0 3.908634607796557e-05
brain O 0 1.554704249429051e-05
dystrophin O 0 9.418905619895668e-07
isoforms O 0 1.8647214972133952e-07
related O 0 2.1580454756531253e-08
to O 0 6.218443537875373e-09
cognitive B-Disease 0 1.264264710698626e-06
impairment I-Disease 0 2.8579575882758945e-05
in O 0 2.3807435354683548e-05
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
? O 1 0.9999929666519165

Molecular O 0 8.473908792439033e-07
study O 0 2.3498124335219472e-08
and O 0 5.219389920263495e-10
neuropsychological O 0 2.494163808819394e-08
analysis O 0 3.4416913763379853e-09
were O 0 1.3669828602402845e-09
performed O 0 1.211111988475011e-09
concurrently O 0 7.079744568372348e-10
on O 0 2.758806960656557e-09
49 O 0 9.973819548037e-10
patients O 0 2.411106037047972e-10
with O 0 5.514289580510479e-10
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 2.464415956637822e-06
DMD B-Disease 1 1.0
) O 0 4.0134642831368694e-10
in O 0 1.4752915555860113e-10
order O 0 5.81015846545796e-10
to O 0 9.019123781150995e-10
find O 0 1.135419203102117e-09
a O 0 1.2264773918690963e-10
molecular O 0 5.357451704490757e-10
explanation O 0 1.4063542552733566e-09
for O 0 1.782367448077693e-10
the O 0 1.1964725876723037e-09
cognitive B-Disease 0 3.0616780577474856e-07
impairment I-Disease 0 1.0262441207942175e-07
observed O 0 1.6354746446012314e-09
in O 0 1.0097549463239375e-09
most O 0 9.700393377443106e-09
DMD B-Disease 1 1.0
patients O 0 1.4379635615568986e-07
. O 0 3.218589128550775e-08

Complete O 0 2.4670208631505375e-07
analysis O 0 3.1096725194856845e-08
of O 0 9.683958523964975e-09
the O 0 5.460078611463359e-09
dystrophin O 0 4.4420552569590654e-08
gene O 0 1.1308766367790213e-08
was O 0 7.567753534942767e-09
performed O 0 7.358867737394803e-09
to O 0 9.051665195158876e-09
define O 0 5.650987233707383e-08
the O 0 2.0817827461883098e-08
localization O 0 9.966798643290531e-06
of O 0 8.282500374434676e-08
deletions O 0 2.366502229733669e-07
and O 0 4.190973346140936e-09
duplications O 0 3.261458303427389e-08
in O 0 1.680782846236184e-09
relation O 0 4.752764848348079e-09
to O 0 9.683773782853677e-09
the O 0 1.601589438848805e-08
different O 0 4.371828410398848e-08
DMD B-Disease 1 1.0
promoters O 0 1.069786594598554e-05
. O 0 1.4529632608173415e-06

Qualitative O 0 5.233521278569242e-07
analysis O 0 1.3682826427441341e-08
of O 0 1.2622773937209786e-08
the O 0 2.5103094714040708e-08
Dp71 O 0 2.113305527018383e-06
transcript O 0 9.480532270345066e-08
and O 0 4.78120265601234e-10
testing O 0 7.750525221617011e-10
for O 0 1.1026642793288133e-10
the O 0 2.3739971100056323e-10
specific O 0 6.030856369854121e-10
first O 0 7.55009299524545e-09
exon O 0 1.9961817088187672e-08
of O 0 3.3864786530557467e-09
Dp140 O 0 4.4087781247981184e-07
were O 0 4.242624473960177e-09
also O 0 7.631368870164579e-10
carried O 0 1.1937144606122274e-09
out O 0 1.2150617179074175e-09
. O 0 6.10724910643512e-08

Neuropsychological O 0 1.4280230971053243e-05
analysis O 0 1.1587124504330859e-07
assessed O 0 6.07022627718834e-07
verbal O 0 3.810933719705645e-07
and O 0 3.892643718472755e-08
visuospatial O 0 4.136023562750779e-05
intelligence O 0 1.2853405451096478e-06
, O 0 7.362868981175552e-09
verbal O 0 9.345770735080805e-08
memory O 0 9.717535249365028e-06
, O 0 3.5046829882645625e-09
and O 0 1.1263082688728332e-09
reading O 0 8.715834383110632e-07
skills O 0 2.9322607588255778e-05
. O 0 2.7362434593669605e-06

Comparison O 0 2.2774568151362473e-06
of O 0 9.625990315953459e-08
molecular O 0 2.0633717667806195e-07
and O 0 8.025635267472353e-09
psychometric O 0 1.1288764653727412e-05
findings O 0 4.4985162617194874e-07
demonstrated O 0 1.7673630736680934e-07
that O 0 1.658326587161696e-09
deletions O 0 5.987605788959627e-08
and O 0 2.158760503689905e-09
duplications O 0 1.1549003531285962e-08
that O 0 1.603513571923898e-10
were O 0 1.482419326181983e-10
localized O 0 1.9958839025946418e-09
in O 0 8.576448440322793e-10
the O 0 4.916632878604332e-09
distal O 0 2.6436588029810082e-08
part O 0 1.635434720981266e-08
of O 0 1.1913397912621804e-07
the O 0 4.850881296647458e-08
gene O 0 1.1665030719143488e-08
seemed O 0 2.2958344558787758e-08
to O 0 2.216311356662004e-09
be O 0 4.1486286628256153e-10
preferentially O 0 1.0349592294289778e-09
associated O 0 6.126847917897749e-09
with O 0 7.899577658676549e-10
cognitive B-Disease 0 9.872468945104629e-05
impairment I-Disease 0 0.0001306537596974522
. O 0 6.926943001417385e-07

Two O 0 1.2641547186831303e-07
altered O 0 4.659284797980945e-07
Dp71 O 0 6.76916670272476e-06
transcripts O 0 4.222186760216573e-07
and O 0 3.454377894840377e-09
two O 0 8.955697849977184e-10
deleted O 0 3.520260705158762e-08
Dp140 O 0 3.074411125680854e-08
DNA O 0 2.713160529577152e-10
sequences O 0 3.536467646503283e-11
were O 0 1.7512136185615645e-10
found O 0 8.83356304770544e-11
in O 0 7.826237574670714e-11
four O 0 2.548268263069531e-10
patients O 0 2.0430929170700551e-10
with O 0 3.588461125469955e-11
severe O 0 6.862126156192971e-07
cerebral B-Disease 1 0.971581757068634
dysfunction I-Disease 1 0.9911748170852661
. O 0 1.5796353181940503e-05

These O 0 6.507348615514275e-08
findings O 0 2.643285768044734e-08
suggest O 0 4.65437066665686e-09
that O 0 3.4748461053002444e-11
some O 0 5.468199677782781e-12
sequences O 0 2.2537027799529596e-11
located O 0 8.025474035333602e-11
in O 0 3.044478280589402e-10
the O 0 4.499294714577218e-09
distal O 0 1.971812046974719e-08
part O 0 8.058829159551806e-09
of O 0 9.189895067152065e-09
the O 0 1.3482150951205085e-09
gene O 0 2.4471563664363316e-10
and O 0 5.691434129539985e-11
, O 0 1.7768439497523048e-11
in O 0 2.1436265956742417e-11
particular O 0 1.2178569264165162e-10
, O 0 5.224267893289003e-11
some O 0 1.8257907685725883e-10
DMD B-Disease 1 1.0
isoforms O 0 6.605224456279757e-08
expressed O 0 2.12875672644941e-09
in O 0 2.382194441707952e-09
the O 0 3.517663316188191e-08
brain O 0 2.5906285827659303e-07
may O 0 5.010561965335114e-10
be O 0 1.1094510032894078e-10
related O 0 3.812692661586681e-10
to O 0 1.8725541117703415e-09
the O 0 3.3994735915143792e-09
cognitive B-Disease 0 1.6525734736205777e-06
impairment I-Disease 0 2.741470552791725e-07
associated O 0 2.9315481597791404e-08
with O 0 6.121696483063488e-09
DMD B-Disease 1 1.0
. O 0 5.170817871658073e-07
. O 0 2.3890444822427526e-07

I1307K O 0 0.00011955068475799635
APC O 0 2.294885916853673e-06
and O 0 6.2240674836289145e-09
hMLH1 O 0 2.437446937619825e-07
mutations O 0 3.48077344725084e-09
in O 0 1.0385462489992392e-09
a O 0 2.417568145673954e-09
non O 0 7.696468173890025e-08
- O 0 1.7757930237394248e-08
Jewish O 0 1.4042294438354475e-08
family O 0 1.508054792154212e-10
with O 0 1.463221037389939e-11
hereditary B-Disease 1 0.9999997615814209
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.999997615814209

We O 0 2.740335958151263e-07
describe O 0 1.2453158149128285e-07
a O 0 6.127747642636905e-09
French O 0 7.407114566149176e-08
Canadian O 0 3.0201212553038204e-07
hereditary B-Disease 1 0.9999997615814209
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 2.803072050028277e-07
HNPCC B-Disease 1 0.999945878982544
) O 0 1.417668427095009e-09
kindred O 0 4.3440159913643583e-08
which O 0 6.587185658046835e-11
carries O 0 1.498635382457536e-10
a O 0 5.849341150332421e-11
novel O 0 6.280411191106339e-10
truncating O 0 7.778062638408301e-08
mutation O 0 5.68082247909274e-09
in O 0 4.777158224555933e-09
hMLH1 O 0 2.4164921796909766e-06
. O 0 5.863032015440695e-07

Interestingly O 0 6.209064622453297e-07
, O 0 5.81632653151587e-09
the O 0 9.91585746845658e-09
I1307K O 0 1.7932850369106745e-06
APC O 0 3.204262952749559e-07
polymorphism O 0 1.6585099160693062e-07
, O 0 1.2736207921637543e-10
associated O 0 1.0499309199829554e-09
with O 0 8.15664289582907e-12
an O 0 8.802561110576868e-12
increased O 0 1.0959233520679845e-10
risk O 0 1.3922789143805403e-08
of O 0 3.1550908374811115e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 6.4873444394208946e-09
is O 0 1.9378724319674134e-11
also O 0 8.320136246631193e-12
present O 0 5.032451885766953e-12
in O 0 8.921527405725271e-11
this O 0 4.353749860630529e-10
family O 0 7.319769235181184e-09
. O 0 8.941658791172813e-08

The O 0 4.288327090762323e-06
I1307K O 0 1.605677061888855e-05
polymorphism O 0 3.897915121342521e-06
has O 0 1.4558729777292e-09
previously O 0 7.978409044540058e-10
only O 0 3.0724599947573594e-11
been O 0 2.2099898300265153e-11
identified O 0 2.8591157219537422e-11
in O 0 2.3733348619714434e-11
individuals O 0 9.108214182873553e-12
of O 0 4.5327130937522497e-10
self O 0 1.1997289561804791e-07
- O 0 1.6943077696396358e-07
reported O 0 6.992276979644885e-09
Ashkenazi O 0 1.717189093142224e-07
Jewish O 0 3.6663756475263654e-08
origins O 0 1.1513202480273321e-07
. O 0 7.094309495414564e-08

In O 0 7.43937977887299e-09
addition O 0 1.3507426288583702e-09
, O 0 3.286506483624052e-11
in O 0 3.069666049126951e-11
this O 0 7.0883209024597e-11
family O 0 1.577178526668277e-10
, O 0 2.0223185973056168e-11
there O 0 1.018432647242884e-11
appears O 0 4.037694484315679e-11
to O 0 9.747418150407583e-11
be O 0 4.876070658355047e-10
no O 0 1.9835761921882522e-09
relationship O 0 1.8521356670575528e-10
between O 0 2.56180632263181e-10
the O 0 2.9422853042859742e-09
I1307K O 0 1.5786730145350703e-08
polymorphism O 0 1.030444618521642e-09
and O 0 2.5856478416685924e-11
the O 0 3.2921798620577647e-10
presence O 0 1.4073014975579667e-09
or O 0 1.834186247329228e-09
absence O 0 3.119063762824226e-08
of O 0 1.3515029095856335e-09
cancer B-Disease 0 3.5568941125774245e-09
. O 0 1.174703445627756e-09
. O 0 3.019654215563605e-08

Identification O 0 7.906366477072879e-07
of O 0 3.7356876703142916e-08
a O 0 1.6479591025131413e-09
novel O 0 1.9623560554293817e-09
mutation O 0 1.0309891829152207e-09
of O 0 1.5253345253540829e-09
the O 0 7.9391870855261e-09
CPO O 0 3.1493249252889655e-07
gene O 0 1.3956361621936253e-09
in O 0 4.429362654434499e-09
a O 0 1.943157101891302e-08
Japanese O 0 9.022664016811177e-06
hereditary B-Disease 1 0.8801552057266235
coproporphyria I-Disease 0 0.00012352266639936715
family O 0 9.862218774969733e-08
. O 0 1.896827086511621e-07

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 0.9999997615814209
( O 0 7.108138788680662e-08
HCP B-Disease 0 0.003456481732428074
) O 0 1.0005453354722249e-08
is O 0 3.065263598500678e-09
an O 0 1.3201783666261235e-08
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
characterized O 0 6.240412186997446e-09
by O 0 8.529395939538276e-11
a O 0 3.1801070665693487e-09
deficiency B-Disease 0 9.21181779744984e-08
of I-Disease 0 1.2805257654235902e-07
coproporphyrinogen I-Disease 0 1.8128374676962267e-06
oxidase I-Disease 0 2.0914578513497872e-08
( O 0 1.9764866132643277e-10
CPO O 0 3.5938612086283683e-07
) O 0 2.0852577997665378e-10
caused O 0 5.074065057009136e-10
by O 0 1.5752959700576774e-11
a O 0 2.833060730456083e-10
mutation O 0 8.399098083700096e-11
in O 0 2.6402297015337695e-10
the O 0 1.485239842224928e-08
CPO O 0 3.461183951003477e-06
gene O 0 7.462049467221732e-08
. O 0 7.115517064448795e-07

Only O 0 1.1912238306877043e-07
11 O 0 2.981447266847681e-08
mutations O 0 9.429456326870422e-09
of O 0 9.897925146162834e-09
the O 0 6.76055700310485e-09
gene O 0 2.7978031003073056e-09
have O 0 1.0774772185584425e-09
been O 0 6.885654268984354e-10
reported O 0 1.7655882311728988e-10
in O 0 1.349377942716501e-09
HCP B-Disease 0 0.17610102891921997
patients O 0 3.6455057852435857e-06
. O 0 8.042032391131215e-07

We O 0 1.8818612090854003e-07
report O 0 8.898508596644206e-09
another O 0 3.032545325964975e-10
mutation O 0 1.5896214899946415e-10
in O 0 3.9045303101836737e-10
a O 0 4.495571914731045e-09
Japanese O 0 2.516180302336579e-06
family O 0 3.215613375573412e-08
. O 0 1.4031404305114847e-07

Polymerase O 0 7.489454105780169e-07
chain O 0 4.646097551130879e-08
reaction O 0 1.0733951505415007e-09
- O 0 2.9930291578494916e-09
single O 0 1.3039911372914048e-09
strand O 0 1.0328727872987997e-09
conformational O 0 3.444546592401565e-10
polymorphism O 0 3.0874594547647405e-10
and O 0 4.950085480404098e-12
direct O 0 3.1511883380463956e-11
sequence O 0 4.373537556418006e-12
analyses O 0 1.1260370413879173e-10
demonstrated O 0 5.588491891472813e-10
a O 0 1.0233485170374479e-09
C O 0 2.0005993306426717e-08
to O 0 3.7387701268265516e-10
T O 0 6.444644262693089e-10
substitution O 0 3.005670712319386e-10
in O 0 1.2574195851211556e-10
exon O 0 1.08951703214899e-09
1 O 0 2.0931487654252123e-09
of O 0 1.215856859637654e-09
the O 0 4.795160268855625e-09
CPO O 0 2.12590194337281e-07
gene O 0 6.417034126293686e-10
at O 0 1.3724509306811683e-09
nucleotide O 0 6.301628552307648e-09
position O 0 5.5691206313213115e-08
85 O 0 4.059252489696519e-08
, O 0 9.43275665910015e-11
which O 0 1.7577281644087783e-11
lies O 0 4.091184682697424e-11
in O 0 7.547652086659085e-11
the O 0 2.606526328108316e-09
putative O 0 1.0096864144770734e-07
presequence O 0 1.0867286448501545e-07
for O 0 1.4773900991471578e-09
targeting O 0 2.5560593641671403e-08
to O 0 3.8994063089603515e-08
mitochondria O 0 1.2274541631995817e-06
. O 0 8.052822408899374e-07

This O 0 1.2592546561052131e-08
mutation O 0 2.125620568449449e-09
changes O 0 1.6175897288306373e-09
the O 0 1.7237554716942327e-09
codon O 0 6.874805169587717e-09
for O 0 3.4774338963927676e-10
glutamine O 0 1.3242134500046632e-08
to O 0 2.2681210243291616e-09
a O 0 1.392843951286693e-09
termination O 0 2.014714262088546e-08
codon O 0 3.050037733487443e-08
at O 0 1.91027478280148e-08
amino O 0 5.159962679357477e-09
acid O 0 1.1004718913909528e-08
position O 0 7.327273721102756e-08
29 O 0 7.3183622362194e-07
. O 0 9.335238360108633e-07

MaeI O 0 3.104786082985811e-05
restriction O 0 3.42873363479157e-07
analysis O 0 1.1170707026053606e-08
showed O 0 4.677714660061838e-09
two O 0 4.9693582582222007e-11
other O 0 5.682114067456778e-12
carriers O 0 6.401724983451373e-11
in O 0 3.5123431940675687e-10
the O 0 2.3476443899994592e-08
family O 0 3.573665097178491e-08
. O 0 2.672088896815694e-07

The O 0 5.288356987875886e-06
C O 0 0.0004576196370180696
- O 0 9.132302693615202e-06
T O 0 1.4205036222847411e-06
mutation O 0 1.3861096714862242e-09
is O 0 1.1218475801100247e-11
located O 0 9.51487933581463e-12
within O 0 5.318920998087506e-11
a O 0 3.4344108112982497e-10
recently O 0 4.5717243879472846e-10
proposed O 0 1.3781241425814272e-10
putative O 0 1.1830701973636337e-09
alternative O 0 2.6910418338133013e-09
translation O 0 6.6817560373522156e-09
initiation O 0 3.941051929245987e-09
codon O 0 4.113945806238917e-08
( O 0 1.31062313779573e-10
TIC O 0 4.62155158587052e-09
- O 0 3.4112883628978352e-09
1 O 0 6.204096347772747e-09
) O 0 1.3718561009401498e-10
, O 0 2.3550899078128573e-11
supporting O 0 3.0862110089735495e-10
that O 0 7.007022739813351e-11
TIC O 0 1.0869852573591743e-08
- O 0 1.8144959312849096e-08
1 O 0 8.192363054604357e-08
is O 0 7.44685757503305e-10
the O 0 2.3891657541241784e-09
real O 0 2.066996884764194e-08
TIC O 0 4.0490920127922436e-07
rather O 0 3.6267222558450385e-09
than O 0 3.619436972357448e-10
TIC O 0 1.7278708241974527e-08
- O 0 1.337305466364569e-08
2 O 0 7.85696663285762e-09
. O 0 5.596654695239067e-09
. O 0 6.093484472557975e-08

Human B-Disease 0 4.301521627780858e-08
complement I-Disease 0 1.7036843757978204e-07
factor I-Disease 0 5.868111657036934e-06
H I-Disease 1 1.0
deficiency I-Disease 0 5.119341585668735e-05
associated O 0 2.0227209915901767e-06
with O 0 3.5431511946626415e-07
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 1.0

This O 0 6.694576892840587e-09
study O 0 1.937042970467928e-09
reports O 0 1.5287414389941745e-10
on O 0 5.71209968214248e-10
six O 0 7.77769584847654e-11
cases O 0 8.825104709508924e-12
of O 0 1.4023919525651962e-10
deficiency B-Disease 0 4.365143357887291e-09
in I-Disease 0 4.190653601909844e-09
the I-Disease 0 1.1251151121882685e-08
human I-Disease 0 1.964028939482887e-10
complement I-Disease 0 1.868696308804374e-10
regulatory I-Disease 0 1.7402498331264837e-09
protein I-Disease 0 1.919382430770611e-09
Factor I-Disease 0 2.4377484919568815e-08
H I-Disease 1 0.8318754434585571
( O 0 2.1778748249268176e-10
FH O 0 3.296742647762585e-07
) O 0 2.067388100990275e-11
in O 0 4.173069875768043e-11
the O 0 4.414581200595791e-11
context O 0 3.5185923619174275e-10
of O 0 4.946030390806655e-11
an O 0 5.0059168615890215e-11
acute B-Disease 0 9.261000855076418e-07
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.0003579414915293455

Five O 0 2.294539171998622e-07
of O 0 7.1951897773203655e-09
the O 0 2.3994224385148755e-09
cases O 0 9.59036947079106e-11
were O 0 1.1586168829902377e-10
observed O 0 8.676281915143136e-11
in O 0 2.759904110805067e-11
children O 0 1.8741922944154332e-11
presenting O 0 3.0402133588403046e-10
with O 0 6.169259547661454e-10
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 5.290664830681635e-07
HUS B-Disease 1 1.0
) O 0 7.801791213069009e-08
. O 0 5.491821752912074e-07

Two O 0 1.3235519347176705e-08
of O 0 2.856436864817624e-09
the O 0 1.5309014056441583e-09
children O 0 2.8715668731749133e-10
exhibited O 0 1.19579794954916e-08
a O 0 1.5718384815954778e-07
homozygous O 0 0.00460153678432107
deficiency O 0 3.875509264616994e-07
characterized O 0 5.577172612625247e-10
by O 0 5.500399441471515e-11
the O 0 8.820339125747978e-09
absence O 0 6.380449946163935e-08
of O 0 1.825906759123086e-09
the O 0 4.640469120076318e-10
150 O 0 3.5971725598216153e-10
- O 0 5.201710173707852e-10
kD O 0 9.723774496706028e-08
form O 0 6.4854105419343e-10
of O 0 2.5195949771017467e-09
Factor O 0 8.562057018934865e-08
H O 1 1.0
and O 0 1.283279454922237e-10
the O 0 5.93167404083772e-10
presence O 0 2.056965986430015e-10
, O 0 5.554014279735009e-12
upon O 0 1.380942166173682e-10
immunoblotting O 0 1.846050068365912e-08
, O 0 2.602951708341461e-11
of O 0 1.1282686590563529e-10
the O 0 4.302198319816597e-10
42 O 0 1.556024420423796e-09
- O 0 8.531564343883247e-10
kD O 0 8.611272050984553e-08
Factor O 0 1.508602842648088e-08
H O 0 0.00012136944133089855
- O 0 5.4449160735714486e-09
like O 0 9.321546312612838e-11
protein O 0 1.0924547377832994e-10
1 O 0 8.25283064109783e-10
( O 0 1.8147632702136818e-11
FHL O 0 1.0057998878210128e-07
- O 0 6.804437902019345e-09
1 O 0 6.504541349983128e-09
) O 0 1.261765830706807e-10
and O 0 9.965980124482243e-11
other O 0 1.6602373642538026e-10
FH O 0 6.76246145303594e-07
- O 0 1.262282189884445e-08
related O 0 4.493754701684338e-09
protein O 0 4.478128701190798e-10
( O 0 2.363622318701797e-11
FHR O 0 1.56418650476553e-07
) O 0 1.9461558753430808e-10
bands O 0 1.3637171036862128e-07
. O 0 1.7057523393759766e-07

Southern O 0 5.04354966324172e-06
blot O 0 4.811002781934803e-06
and O 0 1.6808244795996075e-09
PCR O 0 1.7879260738595804e-08
analysis O 0 5.717245010750105e-10
of O 0 1.0251628018709269e-10
DNA O 0 7.461160578259296e-10
of O 0 2.838090595869147e-10
one O 0 1.997558507493835e-10
patient O 0 1.0758163249136032e-08
with O 0 8.44148528855726e-10
homozygous O 0 0.000326996436342597
deficiency O 0 3.8389994188037235e-06
ruled O 0 2.4508070239903645e-08
out O 0 9.235295306275759e-10
the O 0 1.4861173402991312e-09
presence O 0 4.387168961450527e-10
of O 0 5.340352604576992e-10
a O 0 3.0023988850658156e-10
large O 0 1.7276122199483268e-10
deletion O 0 1.6463513219378e-08
of O 0 1.3103445439810457e-08
the O 0 4.8630170113028726e-08
FH O 0 1.1251664545852691e-05
gene O 0 1.6157773785607787e-08
as O 0 6.135115526717527e-09
the O 0 4.1904297809480795e-09
underlying O 0 5.9115532025089124e-08
defect O 0 3.945386239934123e-08
for O 0 2.1254298321338183e-09
the O 0 3.2414459383289795e-07
deficiency O 0 0.0008852299069985747
. O 0 6.211343134054914e-06

The O 0 3.602766014410008e-07
other O 0 1.0148289986133818e-09
four O 0 8.156584435647929e-11
children O 0 3.3050888414987156e-11
presented O 0 1.3143638399881752e-09
with O 0 1.3414536148559364e-09
heterozygous O 0 2.0859357391600497e-05
deficiency O 0 5.160325144970557e-07
and O 0 8.508050375333198e-10
exhibited O 0 1.166767233939936e-07
a O 0 1.8028909920531078e-08
normal O 0 7.198912754802222e-08
immunoblotting O 0 1.0503364222813616e-07
pattern O 0 9.040238557744829e-10
of O 0 5.540604086640144e-10
proteins O 0 3.894138136950609e-11
of O 0 1.2616989675251489e-09
the O 0 3.135532722353673e-08
FH O 0 0.0003181587380822748
family O 0 2.1514536285849317e-07
. O 0 5.360288355404919e-07

Factor B-Disease 1 0.9970375299453735
H I-Disease 1 1.0
deficiency I-Disease 0 0.15755987167358398
is O 0 7.524126321989399e-10
the O 0 1.2122167714068155e-09
only O 0 4.916867357707133e-09
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 0 2.6802356387634063e-06
with O 0 1.434070995287584e-08
HUS B-Disease 1 1.0
. O 0 0.00010200917313341051

These O 0 3.4803836257424337e-08
observations O 0 4.395574393356583e-08
suggest O 0 2.468073301287177e-09
a O 0 3.01415586934084e-10
role O 0 1.3899406070549958e-09
for O 0 2.795477405115321e-09
FH O 0 0.0002552299411036074
and O 0 9.481056650884057e-08
/ O 0 2.99609837384196e-05
or O 0 5.6157983152616e-08
FH O 0 4.387007720652036e-06
receptors O 0 7.874249696726565e-09
in O 0 2.588966596661635e-09
the O 0 9.603467354679651e-09
pathogenesis O 0 1.920084741868777e-06
of O 0 8.271729967646024e-09
idiopathic O 0 0.00011331364657962695
HUS B-Disease 1 0.9999656677246094
. O 0 1.6040007722040173e-07
. O 0 1.914331164698524e-07

Further O 0 3.262404391080054e-07
evidence O 0 4.406579279248035e-08
for O 0 1.4354905042424093e-09
a O 0 1.1448090253551868e-09
major O 0 2.3729433973329606e-09
ancient O 0 1.5704928557624953e-07
mutation O 0 3.2268096674670232e-06
underlying O 0 0.000313332537189126
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 0 1.9731838563075144e-07
linkage O 0 4.0301912918039307e-08
disequilibrium O 0 2.0453953197829833e-08
studies O 0 2.849438907048807e-09
in O 0 1.5180197376896132e-10
the O 0 4.068720638183976e-10
Japanese O 0 2.0042659087948778e-08
population O 0 2.003651411452978e-11
. O 0 1.144682348908077e-09

The O 0 4.116491254535504e-05
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.0745227996267204e-07
DM B-Disease 1 1.0
) O 0 1.3064358483916294e-09
mutation O 0 1.9552983676618396e-09
is O 0 4.473490675116487e-11
an O 0 1.0074612671884253e-10
unstable O 0 2.991084713244163e-08
( O 0 4.729548974680142e-10
CTG O 0 1.3692439893020492e-07
) O 0 8.119580008347782e-11
n O 0 7.467281792905567e-10
repeat O 0 1.1096801255661148e-09
, O 0 2.3091332665425846e-11
present O 0 2.3884342420510407e-11
at O 0 3.160242345590092e-10
a O 0 4.123492172714016e-11
copy O 0 1.922658032782465e-09
number O 0 5.6421797789418804e-11
of O 0 2.7962266183068074e-11
5 O 0 7.461398165986566e-11
- O 0 1.2569119078875701e-09
37 O 0 3.04698355435562e-09
repeats O 0 8.324509970236704e-10
on O 0 3.0194282629736335e-09
normal O 0 4.944582521204666e-09
chromosomes O 0 6.048181400153396e-10
but O 0 3.019265393255921e-10
amplified O 0 2.4121250774555847e-08
to O 0 4.816426368847715e-09
50 O 0 1.1376894093473311e-08
- O 0 3.6147747017878373e-09
3000 O 0 5.43919664863779e-09
copies O 0 1.2838340168741524e-08
on O 0 2.4228046413554694e-07
DM B-Disease 1 0.9999996423721313
chromosomes O 0 9.071637236957031e-07
. O 0 6.26988367002923e-07

Previous O 0 9.392480251335655e-07
findings O 0 2.0879065587564583e-08
in O 0 6.909334770988096e-10
Caucasian O 0 1.0156428587038135e-08
populations O 0 7.169541071938568e-10
of O 0 1.3439838131290571e-09
a O 0 4.4787224595665975e-08
DM B-Disease 1 1.0
founder O 0 6.881878562126076e-06
chromosome O 0 8.113260463460392e-08
raise O 0 1.783096870155987e-08
a O 0 2.333135240562001e-09
question O 0 4.767427785878908e-09
about O 0 3.566047110381554e-11
the O 0 1.4163081818452383e-10
molecular O 0 1.8063828211012378e-10
events O 0 9.684410912091934e-11
involved O 0 9.375752257900771e-11
in O 0 3.2084970791323997e-10
the O 0 3.384670543837842e-09
expansion O 0 8.514211202736988e-08
mutation O 0 2.0492223029577872e-08
. O 0 3.571443585315137e-08

To O 0 4.090169340997818e-07
investigate O 0 2.3206384369700572e-08
whether O 0 5.076013387395051e-09
a O 0 1.3042057211976044e-08
founder O 0 1.1405644073647636e-07
chromosome O 0 9.246316601263516e-09
for O 0 4.328085445592933e-09
the O 0 1.1855311754516151e-07
DM B-Disease 1 1.0
mutation O 0 5.85841286593336e-09
exists O 0 1.1402148669681367e-10
in O 0 2.601140310087846e-11
the O 0 1.7818643782696597e-10
Japanese O 0 1.490239753820788e-08
population O 0 7.36414922097861e-12
, O 0 1.5519384388706925e-11
we O 0 2.0960883029275124e-10
genotyped O 0 1.1523633602905647e-08
families O 0 2.021713178812501e-11
using O 0 9.75519248713752e-11
polymorphic O 0 4.435963263382803e-10
markers O 0 2.045378755255456e-09
near O 0 1.0085835810969002e-07
the O 0 8.462176737111804e-08
( O 0 8.149839691995453e-10
CTG O 0 2.5280260729232396e-07
) O 0 2.81281026248692e-10
n O 0 5.644876122090636e-09
repeat O 0 1.0979119835496931e-08
region O 0 2.438351742739542e-09
and O 0 2.419644040685398e-09
constructed O 0 2.0139079026648687e-07
haplotypes O 0 2.4536470846214797e-06
. O 0 3.701663899846608e-07

Six O 0 7.680615965455218e-08
different O 0 4.0027767211903154e-10
haplotypes O 0 4.543745646401476e-08
were O 0 8.496345849096087e-09
found O 0 1.9501362746865425e-09
and O 0 3.780859625379662e-09
DM B-Disease 1 1.0
alleles O 0 5.887798337766981e-08
were O 0 2.3998493858812253e-08
always O 0 3.388754521438386e-08
haplotype O 0 3.163804365158285e-07
A O 0 5.327021312950819e-07
. O 0 5.611841515928973e-07

To O 0 5.8925735402226564e-08
find O 0 1.9916663873686957e-09
an O 0 1.0011165507695097e-11
origin O 0 9.805634776371974e-11
of O 0 4.741045889211648e-10
the O 0 4.164073530432688e-09
( O 0 5.737125774452068e-10
CTG O 0 3.292390999831696e-07
) O 0 3.9250414030078673e-10
n O 0 5.081118192862277e-09
repeat O 0 4.861057778526856e-09
mutation O 0 3.4056177322661085e-10
and O 0 4.6871052178376615e-11
to O 0 2.1593000720798727e-09
investigate O 0 2.1177253284321296e-09
the O 0 1.0478942158442806e-09
mechanism O 0 6.029860344369808e-08
of O 0 8.138065776819303e-10
the O 0 1.924888026749727e-10
expansion O 0 4.692770061431872e-10
mutation O 0 4.623786076241032e-11
in O 0 1.0799368344027727e-11
the O 0 3.505187112784469e-11
Japanese O 0 1.1702508961874969e-09
population O 0 6.111301243706679e-13
we O 0 3.1708899828758463e-12
have O 0 1.0816926781370695e-12
studied O 0 1.7123052975520636e-10
90 O 0 3.593512598598636e-09
Japanese O 0 2.6740799512481317e-06
DM B-Disease 1 1.0
families O 0 1.769716040378455e-09
comprising O 0 2.9093699671634e-10
190 O 0 1.528975501763341e-09
affected O 0 7.211163888243277e-10
and O 0 3.4660310732625987e-10
130 O 0 2.762641670983612e-08
unaffected O 0 1.1086148532513107e-07
members O 0 1.612067990208743e-08
. O 0 2.043134657014889e-07

The O 0 8.864240612638241e-07
results O 0 1.8466206341827274e-08
suggest O 0 8.293294051497924e-09
that O 0 7.420226932897123e-11
a O 0 6.298621069156241e-10
few O 0 9.400324962882678e-10
common O 0 5.942885628051897e-10
ancestral O 0 2.1826842555583426e-08
mutations O 0 7.236216070793944e-09
in O 0 1.1854147663470371e-09
both O 0 1.9434451825617316e-09
Caucasian O 0 4.098454553513875e-08
and O 0 1.5931735930507784e-09
Japanese O 0 3.7605269653795403e-07
populations O 0 1.0094963753815023e-10
have O 0 2.8696040769299325e-12
originated O 0 6.822101043801876e-12
by O 0 7.79369624392956e-13
expansion O 0 4.2805811673041205e-10
of O 0 1.2422891881858078e-10
an O 0 1.7436703123041575e-11
ancestral O 0 5.050178053522814e-10
n O 0 6.994087531353443e-10
= O 0 2.6853761436740342e-09
5 O 0 7.381693589714189e-10
repeat O 0 4.75323602699973e-09
to O 0 3.0551599028427745e-09
n O 0 9.753657437272523e-09
= O 0 4.996852709382438e-08
19 O 0 2.648241270719609e-08
- O 0 5.201884434313797e-08
37 O 0 5.119244050888483e-08
copies O 0 5.728487622036482e-07
. O 0 4.769281076733023e-07

These O 0 9.414288903997203e-09
data O 0 5.441012085327657e-09
support O 0 3.9454953193462927e-10
multistep O 0 2.4248475227750532e-08
models O 0 1.1913500230775753e-07
of O 0 2.9187393124630034e-07
triplet O 0 3.0975249956100015e-06
repeat O 0 2.521885562600801e-07
expansion O 0 8.248117211451245e-08
that O 0 8.093032494160823e-11
have O 0 5.353789026690814e-12
been O 0 9.432715893098464e-12
proposed O 0 1.1966608259861289e-11
for O 0 1.5850890044966093e-10
both O 0 7.952372094166549e-09
DM B-Disease 1 1.0
and O 0 2.1269504202336975e-07
Friedreichs B-Disease 0 8.349046402145177e-05
ataxia I-Disease 0 4.569034354062751e-05
. O 0 2.4479950866407307e-07
. O 0 7.158792527661717e-07

The O 0 2.574687307799195e-08
molecular O 0 7.095727561079457e-09
basis O 0 4.824896748800711e-08
of O 0 7.484334219043376e-07
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 1.6566866989364826e-08
the O 0 3.1658788923749626e-09
western O 0 2.658888886841737e-09
Cape O 0 2.4677262899786e-08
, O 0 5.177357501051638e-11
South O 0 3.0199578393563797e-09
Africa O 0 1.8309433968966005e-08
. O 0 1.2789946879365743e-08

Deficiency B-Disease 0 0.0001728920469759032
of I-Disease 0 1.0488685120435548e-06
the I-Disease 0 3.639423198364966e-07
sixth I-Disease 0 8.733865684007469e-07
component I-Disease 0 1.1265875343724474e-07
of I-Disease 0 6.922159734301658e-09
human I-Disease 0 1.6455405926762978e-09
complement I-Disease 0 3.6919792023581977e-07
( O 0 1.1486591233733634e-08
C6 O 1 0.6696043014526367
) O 0 1.014801909171581e-09
has O 0 6.870799762470625e-11
been O 0 2.8466928467252295e-11
reported O 0 2.241416600934354e-11
in O 0 7.389659197054588e-12
a O 0 2.898385177696472e-11
number O 0 1.3759118844269835e-11
of O 0 2.088774682731942e-12
families O 0 5.971805623790349e-13
from O 0 4.2724283312589595e-12
the O 0 3.534902925927952e-11
western O 0 5.089884069775508e-10
Cape O 0 2.045028679731331e-08
, O 0 1.244962466451227e-10
South O 0 4.312683987706123e-09
Africa O 0 2.0095484387638862e-08
. O 0 1.5518519802526498e-08

Meningococcal B-Disease 1 0.9997376799583435
disease I-Disease 0 5.826058622915298e-05
is O 0 4.3592171539152957e-10
endemic O 0 1.3831828737931318e-10
in O 0 3.43939113300884e-11
the O 0 1.1145226963549248e-09
Cape O 0 5.244453049613185e-08
and O 0 9.156345126548615e-11
almost O 0 4.734808725648243e-11
all O 0 6.378844067539413e-12
pedigrees O 0 4.3306100372397793e-10
of O 0 3.632812939358132e-10
total O 0 5.02383045386523e-07
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 1.1451132486683946e-08
C6Q0 O 0 6.09939615969779e-06
) O 0 3.5139180454279995e-10
have O 0 1.2416993822039757e-10
been O 0 4.5643683277418745e-11
ascertained O 0 1.617115330532215e-08
because O 0 4.127917174745477e-10
of O 0 2.2007127231660206e-09
recurrent O 0 3.5205475796828978e-06
disease O 0 2.6723794235294918e-06
. O 0 1.4473840792561532e-07

We O 0 7.106281429969385e-08
have O 0 1.261944548858196e-09
sequenced O 0 9.401261991115462e-09
the O 0 9.155953328843225e-09
expressed O 0 5.421557425222545e-09
exons O 0 3.4672183346629026e-08
of O 0 9.421510682727785e-09
the O 0 1.0643053549586057e-08
C6 O 0 6.054246455278189e-07
gene O 0 2.154273204268975e-09
from O 0 2.2458510051670544e-10
selected O 0 9.742887607799844e-10
cases O 0 2.485289404829949e-11
and O 0 2.3422376885240404e-11
have O 0 1.4842159445915826e-10
found O 0 1.4779698298550414e-10
three O 0 9.477735263274667e-11
molecular O 0 3.890409772111525e-08
defects O 0 1.1325558261887636e-05
leading O 0 1.3721013658596348e-07
to O 0 5.551636945710925e-07
total O 0 6.751836281182477e-06
deficiency O 0 0.003106157062575221
879delG O 0 7.777496762173541e-07
, O 0 4.0587605498743073e-10
which O 0 3.89222230834374e-11
is O 0 1.2605166910262255e-11
the O 0 1.524327469804021e-10
common O 0 6.900260918207834e-10
defect O 0 1.7568225985087338e-08
in O 0 8.01058219757067e-10
the O 0 1.3212893001934845e-08
Cape O 0 3.2066776611827663e-07
and O 0 8.685227537164053e-10
hitherto O 0 5.280325865442137e-08
unreported O 0 7.947671853969496e-09
, O 0 1.9220548763687617e-11
and O 0 8.398197068326674e-12
1195delC O 0 6.9242593880858294e-09
and O 0 4.433203804055097e-11
1936delG O 0 1.8450856842378016e-08
, O 0 2.3935693704846273e-11
which O 0 2.1227446883598233e-12
have O 0 1.3307786947067135e-12
been O 0 1.1096240246089017e-11
previously O 0 4.4903483709113345e-11
reported O 0 3.328495812304766e-11
in O 0 1.7021391240934491e-10
African O 0 5.032308081354131e-08
- O 0 9.059095162911035e-08
Americans O 0 2.0660154476104253e-08
. O 0 6.011980246967141e-08

We O 0 3.2907399827308836e-07
also O 0 6.53844933751202e-09
show O 0 3.5219918093076785e-09
that O 0 3.1853426146755126e-11
the O 0 6.331311031004816e-10
879delG O 0 4.044452239782004e-08
and O 0 2.2670312294081896e-09
1195delC O 0 9.004484127217438e-07
defects O 0 1.1606987726509033e-07
are O 0 4.8434405791608626e-11
associated O 0 1.2956979933420598e-09
with O 0 1.9617527047266492e-10
characteristic O 0 3.473219112493098e-05
C6 O 1 1.0
/ O 1 0.9542087912559509
C7 O 0 5.262552076601423e-05
region O 0 1.3788195474262466e-08
DNA O 0 3.701310546944114e-08
marker O 0 9.982792192886336e-08
haplotypes O 0 8.313600829978895e-08
, O 0 5.10015585319934e-10
although O 0 3.699154038638852e-10
small O 0 1.2482008482361806e-10
variations O 0 1.2150709327585218e-09
were O 0 8.837161225017098e-09
observed O 0 7.797045498136868e-08
. O 0 4.1304852516077517e-07

The O 0 5.627571226796135e-07
1936delG O 0 1.1572982430152479e-06
defect O 0 2.329371682208148e-06
was O 0 2.925030173628329e-08
observed O 0 1.9312655918923838e-09
only O 0 1.5222789695457095e-10
once O 0 7.111993632902269e-11
in O 0 4.0706042703231304e-11
the O 0 6.700731081110689e-10
Cape O 0 3.356180755531568e-08
, O 0 6.994817919325769e-11
but O 0 2.5296998870660836e-11
its O 0 4.0680740026610707e-11
associated O 0 1.068708899154558e-09
haplotype O 0 1.5788026885843465e-08
could O 0 1.1480365547100746e-09
be O 0 2.734060977616082e-09
deduced O 0 3.363855967108975e-07
. O 0 1.7476725133747095e-07

The O 0 4.3695024487533374e-07
data O 0 6.851507095007037e-08
from O 0 1.156153839332319e-09
the O 0 4.277188381252017e-09
haplotypes O 0 7.521077094452266e-08
indicate O 0 1.4463580555457156e-08
that O 0 5.397470317913822e-11
these O 0 6.937590779632075e-11
three O 0 2.482991243168975e-11
molecular O 0 2.6155255739013228e-09
defects O 0 4.6334753811549945e-09
account O 0 1.5977678902157066e-10
for O 0 4.984045398614967e-10
the O 0 1.6973620731164374e-08
defects O 0 1.983155243578949e-06
in O 0 1.8680815117022576e-08
all O 0 7.972601245853639e-09
the O 0 1.4779319990054773e-08
38 O 0 5.854885642975205e-08
unrelated O 0 1.0517673842969089e-08
C6Q0 O 0 5.654005690303165e-07
individuals O 0 1.974518638869771e-11
we O 0 2.987176339619424e-10
have O 0 4.408144335665831e-11
studied O 0 2.583747438222872e-09
from O 0 1.8324518569201587e-09
the O 0 3.953310567794688e-08
Cape O 0 1.5867564115978894e-06
. O 0 2.176228974803962e-07

We O 0 7.81291547014007e-08
have O 0 2.8671559570980776e-10
also O 0 7.526146372782705e-11
observed O 0 1.280235639722349e-10
the O 0 4.0035250115089127e-10
879delG O 0 2.095370810195618e-08
defect O 0 8.689208463863451e-09
in O 0 7.340443808345753e-10
two O 0 3.872322018594332e-09
Dutch O 1 0.9999998807907104
C6 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
kindreds O 0 4.286388957552845e-06
, O 0 2.381498331871512e-10
but O 0 5.4300793028705385e-11
the O 0 3.347789545582458e-10
879delG O 0 2.757435346723014e-08
defect O 0 5.164298144677559e-08
in O 0 1.5784072937563565e-09
the O 0 6.233063487570689e-08
Cape O 0 6.848599127806665e-07
probably O 0 5.8584350703938526e-09
did O 0 8.446623400715225e-10
not O 0 1.1307720038100655e-10
come O 0 2.857012959545102e-10
from O 0 3.445544960456459e-10
The O 0 5.054391571945871e-09
Netherlands O 0 1.6537070735012094e-07
. O 0 1.6430513838372462e-08
. O 0 3.2485823453498597e-07

Complement B-Disease 1 0.9999998807907104
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 4.544785525695261e-08
seven O 0 4.3665755455890576e-09
further O 0 2.5070259201953604e-09
molecular O 0 9.660956834522949e-08
defects O 0 1.0647803492247476e-06
and O 0 3.3073686012130565e-09
their O 0 3.3419942724322027e-07
associated O 0 4.6453347749775276e-05
marker O 0 6.1319760789046995e-06
haplotypes O 0 1.8430300769978203e-06
. O 0 8.589632329858432e-07

Seven O 0 9.72833760215508e-08
further O 0 3.3357698825398074e-09
molecular O 0 9.969943981502638e-09
bases O 0 1.226558481448592e-07
of O 0 5.968500317976577e-06
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 3.9790766237501884e-08
described O 0 1.9312766141865723e-07
. O 0 2.2612503869368084e-07

All O 0 2.2083672490680328e-07
these O 0 3.068445497689254e-09
new O 0 2.262984288847747e-08
molecular O 0 1.237970650436182e-07
defects O 0 7.352767283919093e-08
involve O 0 1.883766476140636e-09
single O 0 5.236993505519649e-09
- O 0 8.809158735800793e-09
nucleotide O 0 1.0140830397631362e-07
events O 0 1.685406303408854e-08
, O 0 1.9349086777253888e-09
deletions O 0 4.0816271251742364e-08
and O 0 1.2500122048564322e-09
substitutions O 0 5.850108308891322e-08
, O 0 6.498882543226614e-10
some O 0 2.7193361451516296e-10
of O 0 1.1825128654052719e-09
which O 0 6.563883464538733e-11
alter O 0 2.2389331277850033e-08
splice O 0 9.513699694707611e-08
sites O 0 1.6878994202329523e-08
, O 0 3.861669595206507e-10
and O 0 4.61504806592572e-10
others O 0 9.16129838657298e-09
codons O 0 6.47610818305111e-07
. O 0 8.499881687384914e-07

They O 0 4.3057898579945686e-08
are O 0 6.71069103064248e-11
distributed O 0 2.7128915780494367e-10
along O 0 8.722846334130452e-10
the O 0 1.8769137355434395e-08
C7 O 0 4.989642093278235e-06
gene O 0 7.830395887253871e-09
, O 0 1.9967470732407122e-10
but O 0 1.3453725980494546e-11
predominantly O 0 5.834484805011808e-12
towards O 0 1.7083220948954647e-10
the O 0 2.3403187721093843e-10
3 O 0 4.556162114255358e-09
end O 0 1.1892193185758515e-07
. O 0 1.615278790723096e-07

All O 0 1.4259897795909637e-07
were O 0 1.970559893038626e-08
found O 0 1.0118680338067065e-09
in O 0 8.5189294507515e-10
compound O 0 1.5425258936829778e-07
heterozygous O 0 3.0774327086646736e-08
individuals O 0 1.592082160550845e-10
. O 0 2.6508084616239103e-08

The O 0 1.6419240637333132e-05
C6 O 1 0.9794711470603943
/ O 0 0.00498355133458972
C7 O 0 0.000515879481099546
marker O 0 2.092401018671808e-06
haplotypes O 0 4.946896297042258e-07
associated O 0 1.0931439931027853e-07
with O 0 2.307308344384751e-09
most O 0 2.47215524495914e-07
C7 B-Disease 1 0.9999990463256836
defects I-Disease 0 3.6020610423292965e-05
are O 0 3.48856321608082e-09
tabulated O 0 3.6417798554566616e-08
. O 0 1.692322371127375e-08
. O 0 1.5432425470862654e-07

A O 0 1.1552834848771454e-06
genome O 0 1.826517248559867e-08
- O 0 4.2466421490416906e-08
wide O 0 2.4217401417558904e-09
search O 0 1.411042838128651e-09
for O 0 6.944991803869982e-11
chromosomal O 0 2.329396942002404e-08
loci O 0 7.201769136599978e-08
linked O 0 4.186150306395575e-07
to O 0 3.6994119767541633e-08
mental O 1 0.8768236041069031
health O 0 1.5456160795679352e-08
wellness O 0 2.3421428352321527e-08
in O 0 5.003456537977513e-10
relatives O 0 2.317191771794569e-09
at O 0 9.208967810536706e-09
high O 0 4.135454645393111e-08
risk O 0 9.357774644058736e-08
for O 0 1.0078085921350066e-07
bipolar B-Disease 1 1.0
affective I-Disease 1 0.9997383952140808
disorder I-Disease 1 0.6024003028869629
among O 0 2.201807486335028e-10
the O 0 1.2246592628883946e-09
Old O 0 4.252526863979256e-08
Order O 0 7.790713141275774e-08
Amish O 0 3.4630129448487423e-06
. O 0 1.1270259392404114e-07

Bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
( O 0 2.9210104557364502e-08
BPAD B-Disease 1 1.0
; O 0 5.01706927025225e-06
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 0 5.831422456026303e-09
is O 0 1.0222340335319657e-10
characterized O 0 6.249863820917412e-11
by O 0 2.0102853409698085e-11
episodes O 0 8.80946071646349e-09
of O 0 5.834348559830005e-09
mania B-Disease 0 3.041440166384746e-08
and O 0 7.19577564201046e-10
/ O 0 3.615595005612704e-06
or O 0 3.606443499393208e-08
hypomania B-Disease 0 1.8974001250171568e-06
interspersed O 0 1.1382771392121072e-09
with O 0 6.484340408369205e-12
periods O 0 3.7289176191279694e-08
of O 0 1.1899551566330047e-08
depression B-Disease 0 8.579218615523132e-07
. O 0 5.2961617313940224e-08

Compelling O 0 1.6159302731466596e-06
evidence O 0 1.309430643914311e-07
supports O 0 6.922463491321196e-09
a O 0 3.18871790083719e-10
significant O 0 7.353994635472816e-10
genetic O 0 9.636783593336418e-10
component O 0 3.305407059173149e-09
in O 0 6.074992731086581e-10
the O 0 3.4834766182711974e-09
susceptibility O 0 5.427943960967241e-08
to O 0 2.6408969233671087e-08
develop O 0 1.5197819038803573e-06
BPAD B-Disease 1 1.0
. O 0 1.677120235399343e-05

To O 0 2.6945512487941414e-08
date O 0 8.431227627170301e-08
, O 0 1.3791739972290884e-09
however O 0 1.2974711305346887e-09
, O 0 2.0076691698012183e-10
linkage O 0 7.4193855503779105e-09
studies O 0 1.3582321933824915e-09
have O 0 1.806486071842528e-10
attempted O 0 5.241000522460126e-09
only O 0 3.24264171069899e-10
to O 0 3.972659090578645e-09
identify O 0 5.218898024850205e-08
chromosomal O 0 1.4872517795083695e-06
loci O 0 2.75156764928397e-07
that O 0 3.2944051930883234e-09
cause O 0 5.756705778736659e-09
or O 0 1.1292503043769386e-10
increase O 0 2.445597890865514e-10
the O 0 6.424578091746014e-10
risk O 0 1.712619601690335e-09
of O 0 3.629552436379413e-09
developing O 0 3.5807750009553274e-07
BPAD B-Disease 1 1.0
. O 0 1.200640599563485e-05

To O 0 7.853913785993427e-08
determine O 0 1.3271010068649503e-08
whether O 0 2.5270645576114248e-09
there O 0 7.673316426703991e-10
could O 0 9.65933200092195e-09
be O 0 6.156814169600011e-09
protective O 0 6.983628964007949e-08
alleles O 0 2.1282047235615664e-09
that O 0 6.661186185974444e-11
prevent O 0 1.667215393519328e-10
or O 0 8.634103154658845e-11
reduce O 0 8.50375159178185e-10
the O 0 2.7530022705946067e-10
risk O 0 1.20533927283617e-09
of O 0 1.467800325727353e-10
developing O 0 4.982460222180407e-09
BPAD B-Disease 1 1.0
, O 0 9.33279009629473e-11
similar O 0 1.3198188202057093e-11
to O 0 1.8686711900084418e-10
what O 0 2.16565810423619e-11
is O 0 1.2101957890670034e-12
observed O 0 2.669852880443635e-11
in O 0 4.523090235686311e-11
other O 0 2.0467096906173765e-09
genetic B-Disease 1 1.0
disorders I-Disease 1 1.0
, O 0 4.802843886486663e-11
we O 0 4.2257732035810847e-11
used O 0 2.862381665025282e-09
mental O 0 2.4850046997926256e-07
health O 0 1.765340096326895e-09
wellness O 0 3.770692913462881e-08
( O 0 1.0649277293328652e-10
absence O 0 2.222522610395572e-08
of O 0 2.1155612817125302e-09
any O 0 7.438656357550144e-09
psychiatric B-Disease 0 0.0011316819582134485
disorder I-Disease 0 1.0176132292372131e-07
) O 0 1.1361827277622805e-11
as O 0 7.830254500351685e-11
the O 0 2.4106966423076415e-10
phenotype O 0 5.50371859198151e-10
in O 0 2.837733104055218e-10
our O 0 3.135435466816716e-09
genome O 0 1.1848970693506544e-09
- O 0 2.8204580004853597e-08
wide O 0 1.8029149728704397e-08
linkage O 0 6.075201213207038e-07
scan O 0 0.0002666885848157108
of O 0 6.926283191432958e-08
several O 0 1.9532706563296642e-09
large O 0 2.1718651321833704e-09
multigeneration O 0 1.6653664260957157e-06
Old O 0 3.9518863559351303e-07
Order O 0 1.0270920824950736e-07
Amish O 0 1.209074412145128e-06
pedigrees O 0 1.332781067731048e-07
exhibiting O 0 3.900373357623721e-08
an O 0 5.644626432932398e-10
extremely O 0 3.384967639519232e-09
high O 0 6.196175661443704e-08
incidence O 0 1.7418400375390775e-06
of O 0 5.092490482638823e-06
BPAD B-Disease 1 1.0
. O 0 3.118028325843625e-05

We O 0 3.4202554388684803e-07
have O 0 3.2904863278560015e-09
found O 0 5.763591826024594e-10
strong O 0 4.799916020203909e-10
evidence O 0 1.281587502788284e-09
for O 0 2.182773684022976e-10
a O 0 6.120700613010399e-10
locus O 0 7.3549388801552595e-09
on O 0 1.2337166843678915e-08
chromosome O 0 6.909459671078366e-08
4p O 0 9.691251761978492e-06
at O 0 5.7531632791096854e-08
D4S2949 O 0 2.657620825630147e-07
( O 0 7.478510172242991e-11
maximum O 0 1.0921890947201973e-08
GENEHUNTER O 0 6.750277492528767e-08
- O 0 9.520430666043467e-09
PLUS O 0 1.194936150028525e-08
nonparametric O 0 8.300260390115e-08
linkage O 0 3.167364592826516e-09
score O 0 5.28526777898719e-10
= O 0 9.027177894083138e-10
4 O 0 2.3029676776697983e-10
. O 0 4.280056864480741e-11
05 O 0 9.393486521958039e-08
, O 0 2.180992331179965e-10
P O 0 5.3533688593176976e-09
= O 0 1.7098582549834873e-09
5 O 0 2.0940622846854495e-10
. O 0 2.601045941130753e-11
22 O 0 4.263055186637388e-10
x O 0 4.1608738676757184e-09
10 O 0 9.211404972120363e-10
( O 0 1.3616182834019774e-11
- O 0 1.0506441272539746e-09
4 O 0 1.275924033095066e-09
) O 0 4.758383617686768e-11
; O 0 6.80165437860758e-11
SIBPAL O 0 1.3208439497702784e-07
Pempirical O 0 2.8025047171809092e-08
value O 0 1.609844896277579e-10
< O 0 1.7098354954114825e-09
3 O 0 7.204372654001645e-10
x O 0 1.121763748557214e-08
10 O 0 2.6255970730915124e-09
( O 0 3.8831906440384145e-11
- O 0 2.363209850031467e-09
5 O 0 3.348110455547726e-09
) O 0 1.5530110530903585e-10
) O 0 8.605414297813141e-11
and O 0 8.223741132518114e-11
suggestive O 0 6.486008174988456e-09
evidence O 0 3.8952616132625906e-10
for O 0 3.341918408672484e-11
a O 0 1.8929717515714373e-10
locus O 0 9.685638957535048e-09
on O 0 2.531687748330569e-08
chromosome O 0 1.7319993617093132e-07
4q O 0 4.46724106950569e-06
at O 0 2.499960061186357e-08
D4S397 O 0 1.7031061361194588e-07
( O 0 3.9063682844009406e-11
maximum O 0 5.238821820796602e-09
GENEHUNTER O 0 4.109538309648997e-08
- O 0 5.237303035698915e-09
PLUS O 0 5.411061376747739e-09
nonparametric O 0 1.640108138190044e-08
linkage O 0 1.3039513913071232e-09
score O 0 3.134549009242704e-10
= O 0 4.252652119340894e-10
3 O 0 8.589884359366806e-11
. O 0 2.281756554534109e-11
29 O 0 2.1103303549097063e-09
, O 0 5.3145099432327925e-11
P O 0 2.2832260526683967e-09
= O 0 1.1428585855455253e-09
2 O 0 1.0110263320983748e-10
. O 0 2.8593230214091214e-11
57 O 0 8.034682918989233e-10
x O 0 4.8383301809451496e-09
10 O 0 1.6225647492262851e-09
( O 0 1.4691272504085973e-11
- O 0 1.6441664696387193e-09
3 O 0 8.238597026810623e-10
) O 0 3.971874912300777e-11
; O 0 6.37067620878895e-11
SIBPAL O 0 2.2464003279765166e-07
Pempirical O 0 2.9973211468359295e-08
value O 0 3.5750591376171315e-10
< O 0 9.655310995171362e-10
1 O 0 7.592140249812473e-10
x O 0 1.8882749586168757e-08
10 O 0 3.420011829291525e-09
( O 0 6.070252633882944e-11
- O 0 5.268100622402017e-09
3 O 0 2.059565851197931e-09
) O 0 9.810854212366493e-11
) O 0 1.7680745756365468e-11
that O 0 2.6320562483000964e-12
are O 0 6.605287497518653e-12
linked O 0 3.885357813260271e-09
to O 0 1.5586183010896093e-08
mental O 0 4.1731149394763634e-05
health O 0 1.4394976233234047e-07
wellness O 0 1.6602410823907121e-06
. O 0 1.3020797950957785e-07

These O 0 1.9094611047876242e-07
findings O 0 4.419061383487133e-08
are O 0 2.8001292950996515e-10
consistent O 0 1.3073090165960366e-08
with O 0 4.44455722226067e-11
the O 0 3.5483764815325003e-09
hypothesis O 0 4.616194981821309e-09
that O 0 4.517113679630702e-12
certain O 0 4.501487724239972e-11
alleles O 0 4.2864148341870134e-10
could O 0 1.5095088512495636e-09
prevent O 0 5.601855868064831e-09
or O 0 2.3257820114253036e-09
modify O 0 2.0413368417848687e-07
the O 0 9.7658698905434e-09
clinical O 0 4.6942787435000355e-08
manifestations O 0 6.575395161689812e-08
of O 0 1.1358269880190619e-08
BPAD B-Disease 1 1.0
and O 0 1.3495323747392263e-09
perhaps O 0 9.730074523872645e-10
other O 0 1.1616439754558172e-10
related O 0 1.2896014922603172e-08
affective B-Disease 0 2.9677964903385146e-06
disorders I-Disease 1 0.5199295878410339
. O 0 7.140423576856847e-07

Segregation O 0 2.684735954971984e-05
distortion O 0 4.116228228667751e-05
in O 0 3.4576933103380725e-06
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.00037406847695820034

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 3.402431275389972e-06
DM B-Disease 1 1.0
) O 0 2.00698959673673e-08
is O 0 2.025706491437518e-09
an O 0 3.3680362943044884e-09
autosomal B-Disease 1 0.9999700784683228
dominant I-Disease 0 0.05347355455160141
disease I-Disease 0 0.0021930597722530365
which O 0 1.2418952151371787e-11
, O 0 8.577237227760937e-13
in O 0 1.0654472096249812e-11
the O 0 2.2937442223369686e-10
typical O 0 1.086004508543681e-09
pedigree O 0 1.144507821848606e-09
, O 0 2.2477526784303592e-11
shows O 0 1.4434795025941582e-10
a O 0 4.702679912149677e-10
three O 0 1.1366861618622437e-10
generation O 0 2.0143106738146344e-08
anticipation O 0 2.1453789145198243e-07
cascade O 0 2.723700163187459e-07
. O 0 9.835353012022097e-07

This O 0 5.657153412386151e-09
results O 0 2.191476777824164e-09
in O 0 1.737851640370991e-09
infertility B-Disease 0 9.884240171231795e-06
and O 0 1.0792243188006978e-07
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.8003779578279477e-09
CDM B-Disease 0 1.9965359143725436e-08
) O 0 5.758179523474016e-12
with O 0 3.946401799098664e-12
the O 0 6.249631923083143e-09
disappearance O 0 2.3669851145768916e-07
of O 0 2.6064133962222513e-08
DM B-Disease 1 1.0
in O 0 4.3962952389620114e-08
that O 0 3.2393672189101608e-09
pedigree O 0 1.4186812791194825e-07
. O 0 7.048505068496524e-08

The O 0 6.301787180973406e-08
concept O 0 9.286564051080859e-08
of O 0 1.0834685149063716e-08
segregation O 0 1.3927441955274844e-07
distortion O 0 2.1196807153955888e-07
, O 0 1.1281395956297402e-10
where O 0 3.658455483002143e-11
there O 0 5.6390894558056015e-12
is O 0 9.949104257458985e-13
preferential O 0 1.0433988117952708e-09
transmission O 0 5.115707857328289e-09
of O 0 9.356107000257907e-10
the O 0 8.038561483125761e-10
larger O 0 7.518671102380026e-11
allele O 0 1.1527321319704242e-09
at O 0 2.31946906126268e-09
the O 0 2.7495994814330516e-08
DM B-Disease 1 1.0
locus O 0 1.7402680896339007e-07
, O 0 2.794591225097065e-10
has O 0 9.796115307825204e-12
been O 0 1.576726769980663e-11
put O 0 1.007242275696818e-10
forward O 0 2.032041201971424e-09
to O 0 4.666237174433263e-09
explain O 0 1.383865022575037e-08
partially O 0 1.7790645401305483e-08
the O 0 6.078458292257949e-10
maintenance O 0 1.0237144465463643e-07
of O 0 4.5649063196151474e-08
DM B-Disease 1 1.0
in O 0 2.1421094231754978e-08
the O 0 9.579738780018943e-09
population O 0 1.4417982086012415e-10
. O 0 4.110916052013636e-09

In O 0 3.598651687752863e-08
a O 0 8.543439733443847e-09
survey O 0 2.0519277388331147e-09
of O 0 1.9631984926604673e-09
DM B-Disease 1 1.0
in O 0 1.3742353921486483e-08
Northern O 0 5.943049785628318e-08
Ireland O 0 3.481910582081582e-08
, O 0 8.770895121301692e-10
59 O 0 1.680924732738731e-08
pedigrees O 0 7.349360231501123e-08
were O 0 1.552598050125198e-08
ascertained O 0 1.2722692872557673e-06
. O 0 3.9162966913863784e-07

Sibships O 0 4.174074092588853e-06
where O 0 2.5673203563059133e-09
the O 0 2.424262457445536e-10
status O 0 2.177381608348128e-09
of O 0 9.046309812354991e-10
all O 0 7.360306114589932e-11
the O 0 2.6249000195655015e-10
members O 0 4.8838776772752723e-11
had O 0 1.599249621619947e-10
been O 0 3.394688349867003e-11
identified O 0 3.357641942258738e-11
were O 0 7.744920677010825e-11
examined O 0 9.540730427914923e-10
to O 0 1.3025890366336057e-09
determine O 0 3.5103964179938885e-09
the O 0 2.839922297326325e-09
transmission O 0 6.979261968353967e-08
of O 0 4.304523404385918e-09
the O 0 8.730145140134482e-08
DM B-Disease 1 1.0
expansion O 0 5.287380986374046e-07
from O 0 2.4923791919206906e-09
affected O 0 6.303969568577372e-10
parents O 0 1.6053743057131697e-10
to O 0 1.159789264626454e-09
their O 0 3.0765152647660443e-09
offspring O 0 2.40191781131216e-07
. O 0 2.5707839768074336e-07

Where O 0 1.1476642924890257e-07
the O 0 2.264841114651972e-08
transmitting O 0 1.1258350696152775e-06
parent O 0 5.779799305827282e-09
was O 0 3.9069998791774196e-08
male O 0 2.0944758816199283e-08
, O 0 2.2295991719545327e-09
58 O 0 1.2559257811517455e-07
. O 0 2.611529623663955e-07

3 O 0 3.164205679695442e-07
% O 0 6.380143080519929e-09
of O 0 2.8483739811235864e-09
the O 0 8.15282508170867e-10
offspring O 0 2.7360016474631266e-09
were O 0 8.910104321024903e-10
affected O 0 2.1568580255149072e-10
, O 0 1.0996079047309593e-11
and O 0 1.533541869880306e-11
in O 0 1.7454046541409696e-10
the O 0 1.937490168302247e-09
case O 0 2.788372310824627e-10
of O 0 1.8747187136014531e-10
a O 0 4.6563039535207906e-10
female O 0 1.683362338411598e-09
transmitting O 0 4.327914382429299e-08
parent O 0 3.1611904205419705e-09
, O 0 3.3850451330863507e-09
68 O 0 1.084307768906001e-06
. O 0 1.6213593880820554e-06

7 O 0 9.091184551834885e-07
% O 0 1.4133115122660911e-08
were O 0 8.147776675571095e-09
affected O 0 8.7868059495122e-09
. O 0 1.7644261163241026e-07

Studies O 0 4.4944002297597763e-07
on O 0 1.2706236418580374e-07
meiotic O 0 1.0491546618141001e-06
drive O 0 3.168025273225794e-07
in O 0 3.2866118715446646e-08
DM B-Disease 1 1.0
have O 0 5.967855543076439e-09
shown O 0 3.262506376167096e-10
increased O 0 1.318760101121086e-10
transmission O 0 1.1191794158094126e-09
of O 0 9.847881538016523e-11
the O 0 2.699517553939046e-10
larger O 0 1.8965135017978696e-10
allele O 0 4.661709240849632e-09
at O 0 5.4492375056724995e-09
the O 0 1.6597070384705148e-08
DM B-Disease 1 0.9999997615814209
locus O 0 1.9660362227114092e-08
in O 0 5.123558910469228e-09
non O 0 5.740897449868498e-06
- O 0 1.2478050848585553e-05
DM O 1 1.0
heterozygotes O 0 1.0016233318310697e-05
for O 0 2.976833179957339e-08
CTGn O 0 1.648579927859828e-05
. O 0 2.2438672431235318e-07

This O 0 6.854382661458658e-08
study O 0 9.078257257044697e-09
provides O 0 2.230355344856605e-10
further O 0 3.256182476429892e-11
evidence O 0 2.5630769728834935e-10
that O 0 6.59365895216979e-11
the O 0 1.8331588691467005e-08
DM B-Disease 1 1.0
expansion O 0 1.7498819033789914e-06
tends O 0 4.3500520519046404e-08
to O 0 1.9301977793872993e-09
be O 0 1.0188534460553456e-09
transmitted O 0 1.991712927917888e-08
preferentially O 0 1.2037569163680928e-08
. O 0 1.1586516279749048e-07

Diagnosis O 1 1.0
of O 0 0.0004277784319128841
hemochromatosis B-Disease 1 1.0
. O 0 0.050155866891145706

If O 0 2.0392290025483817e-06
untreated O 0 0.00032497415668331087
, O 0 1.2712558117300432e-08
hemochromatosis B-Disease 1 1.0
can O 0 1.7430417642572138e-07
cause O 0 6.056359893591434e-07
serious O 0 1.773126712123485e-07
illness O 0 4.896565997114521e-07
and O 0 6.635166027724182e-11
early B-Disease 0 6.486406078920481e-08
death I-Disease 0 1.4915819690486387e-08
, O 0 4.664995473246947e-11
but O 0 2.5258477601153295e-11
the O 0 5.503130728889971e-10
disease O 0 7.271812041409476e-10
is O 0 3.829275872085924e-12
still O 0 1.1024682035343236e-11
substantially O 0 7.538419888319936e-10
under O 0 1.316377193916196e-07
- O 1 0.5916407704353333
diagnosed O 0 5.408158540376462e-05
. O 0 1.392153421875264e-06

The O 0 2.9201889901742106e-06
cornerstone O 0 1.284365680476185e-05
of O 0 2.7689351256299233e-08
screening O 0 2.6931536112329013e-08
and O 0 1.0657409399428275e-09
case O 0 4.970905909118528e-10
detection O 0 2.449750802213657e-08
is O 0 7.27790050447652e-11
the O 0 5.756285448299536e-10
measurement O 0 5.42224292132687e-08
of O 0 1.1705908242731766e-08
serum O 0 8.973847798188217e-08
transferrin O 0 1.3918294428094669e-07
saturation O 0 3.188274888543674e-07
and O 0 1.6521827239657227e-09
the O 0 4.3434528862462685e-08
serum O 0 3.119254756711598e-07
ferritin O 0 8.771971238275e-07
level O 0 5.42765860700456e-07
. O 0 3.425961949687917e-07

Once O 0 1.4871071698507876e-06
the O 0 1.7768128302009245e-08
diagnosis O 0 1.3383090845309198e-05
is O 0 1.1089093532312688e-10
suspected O 0 3.007289306466987e-09
, O 0 2.35688413230406e-10
physicians O 0 1.6823038961888415e-08
must O 0 1.4901514688858697e-08
use O 0 6.253885089790856e-07
serum O 0 7.893190741015133e-06
ferritin O 0 1.7600390492589213e-05
levels O 0 1.3016472621529829e-05
and O 0 7.343054875263988e-08
hepatic O 0 5.3406107326736674e-05
iron O 0 0.0002607108617667109
stores O 0 2.169946810681722e-06
on O 0 3.163792428040324e-07
liver O 0 3.520026439218782e-07
biopsy O 0 6.200236271070025e-07
specimens O 0 5.545596870604186e-09
to O 0 6.233604743499654e-10
assess O 0 1.4850669138866124e-08
patients O 0 1.3837877510525232e-09
for O 0 4.6482642734879676e-10
the O 0 1.8425561076895747e-09
presence O 0 7.515839506311295e-09
of O 0 4.463355551820314e-08
iron B-Disease 0 0.0037366573233157396
overload I-Disease 0 0.00011585370521061122
. O 0 9.239846576747368e-07

Liver O 1 1.0
biopsy O 1 1.0
is O 0 1.1985973991102128e-08
also O 0 1.5798219676899095e-10
used O 0 1.7040849287219828e-10
to O 0 3.513904445195948e-10
establish O 0 7.692531944769598e-09
the O 0 4.723907487402812e-09
presence O 0 6.595993085056762e-09
or O 0 5.1655391075655643e-08
absence O 0 1.3207939446147066e-05
of O 0 2.6864327651310305e-08
cirrhosis B-Disease 0 4.086203261977062e-06
, O 0 1.7582689471051793e-10
which O 0 5.098235202061208e-12
can O 0 1.7401418847540207e-11
affect O 0 4.453333535270332e-10
prognosis O 0 1.0945143458229722e-06
and O 0 6.196906099376065e-09
management O 0 5.562782234846964e-07
. O 0 5.263890443529817e-07

A O 0 2.0781098442057555e-07
DNA O 0 6.071300351351283e-09
- O 0 4.1731058608718286e-09
based O 0 4.1566600161857536e-10
test O 0 7.351119712950549e-10
for O 0 5.91551696516035e-10
the O 0 1.159515594650884e-08
HFE O 0 7.579799421364442e-05
gene O 0 6.418019182774515e-08
is O 0 1.1665153565321162e-10
commercially O 0 4.344627324570638e-09
available O 0 6.8218777293793664e-09
, O 0 1.613065063466035e-11
but O 0 7.523601533443447e-12
its O 0 1.0715694824525723e-11
place O 0 1.0306838715834488e-10
in O 0 8.31029203784972e-11
the O 0 8.550673502583095e-10
diagnosis O 0 7.351873136940412e-06
of O 0 1.7843454713784013e-08
hemochromatosis B-Disease 1 1.0
is O 0 2.5974442596776726e-09
still O 0 3.702288198237369e-10
being O 0 7.011437541670773e-10
evaluated O 0 3.312591090320893e-08
. O 0 1.375202174358492e-07

Currently O 0 4.588983415487746e-07
, O 0 1.8778762989057896e-09
the O 0 2.084749706199318e-09
most O 0 5.428526031470149e-11
useful O 0 8.377950555527036e-10
role O 0 1.7798909568433885e-10
for O 0 7.090011217014691e-11
this O 0 2.4494527933738297e-11
test O 0 3.828308781095302e-10
is O 0 2.8491031148908386e-12
in O 0 7.410252099437908e-12
the O 0 5.502708011473345e-11
detection O 0 3.8937873370059606e-08
of O 0 2.8812683350309953e-09
hemochromatosis B-Disease 1 1.0
in O 0 7.694516312994892e-08
the O 0 8.392049011263225e-08
family O 0 2.738793358769698e-10
members O 0 3.5150958532792487e-11
of O 0 6.542222319438906e-11
patients O 0 4.623609828335873e-11
with O 0 1.256174309537117e-12
a O 0 4.0095007869389576e-10
proven O 0 8.81520900719579e-09
case O 0 9.181410631775577e-10
of O 0 6.719804268584539e-09
the O 0 2.3952085825840186e-07
disease O 0 3.736970768386527e-07
. O 0 1.478300646340358e-07

It O 0 1.8867449824711002e-08
is O 0 2.7306823469075425e-10
crucial O 0 3.645505231020252e-08
to O 0 1.5035077183256362e-07
diagnose O 1 1.0
hemochromatosis B-Disease 1 1.0
before O 1 1.0
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 0 2.4101108664353887e-08
because O 0 1.0802304606372104e-09
phlebotomy O 0 6.550724720000289e-06
therapy O 0 2.2921385607332923e-06
can O 0 1.9129864359257454e-09
avert O 0 7.545791049778927e-07
serious O 0 4.595947757479735e-06
chronic O 1 0.9999998807907104
disease O 0 4.2360306906630285e-06
and O 0 2.0627256847038922e-10
can O 0 2.9825988900888944e-10
even O 0 1.269873234344132e-10
lead O 0 6.703415600384233e-10
to O 0 1.5585877033430506e-09
normal O 0 8.572266452233634e-09
life O 0 1.1884914163928784e-09
expectancy O 0 5.686979775987311e-09
. O 0 6.448505063261223e-10
. O 0 5.1488367347474195e-08

Prevalence O 0 0.00020521458645816892
of O 0 1.9286923702566128e-07
the O 0 1.579911668159184e-07
I1307K O 0 7.557597655249992e-06
APC B-Disease 0 1.986856972280293e-07
gene O 0 1.8696133530227144e-09
variant O 0 1.2314854913597628e-08
in O 0 1.9255939065487837e-09
Israeli O 0 1.3972380941140727e-07
Jews O 0 6.371861704934645e-09
of O 0 7.209689095732941e-11
differing O 0 5.813999889164867e-12
ethnic O 0 1.625343739805607e-12
origin O 0 4.632869782250637e-11
and O 0 3.074459090091075e-11
risk O 0 3.3959157708096654e-09
for O 0 2.1871480271329347e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.15079034864902496

BACKGROUND O 0 3.1521445635007694e-05
& O 0 4.144701051700395e-06
AIMS O 0 1.699414724498638e-06
Israeli O 0 3.6188197327646776e-07
Jews O 0 2.4889031280395102e-08
of O 0 2.394347831113919e-09
European O 0 3.387822467004753e-09
birth O 0 5.019501259084791e-08
, O 0 9.6089969314761e-10
i O 0 4.5088652811386964e-09
. O 0 5.168746541883706e-10
e O 0 3.5198026715477226e-09
. O 0 2.4694846167960804e-10
, O 0 2.1392611293524766e-10
Ashkenazim O 0 1.285905426584577e-07
, O 0 7.538961815933831e-11
have O 0 4.0574269638549154e-11
the O 0 1.524543380426735e-09
highest O 0 0.0003481665044091642
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 0 0.4445701241493225
of O 0 8.31602342543647e-09
any O 0 3.728901187827205e-09
Israeli O 0 1.2840762337873457e-06
ethnic O 0 2.0342671991357975e-09
group O 0 4.997831926090157e-09
. O 0 7.44666550644979e-08

The O 0 6.629294148297049e-06
I1307K O 0 2.959471930807922e-05
APC B-Disease 0 5.343363795873302e-07
gene O 0 4.341479176162011e-09
variant O 0 3.42443939871373e-08
was O 0 3.9651819605524e-08
found O 0 1.1443200831351419e-09
in O 0 1.1916897468822185e-09
6 O 0 3.8501201515828143e-07
. O 0 3.300127389138652e-07

1 O 0 2.654558386439021e-07
% O 0 1.9766837056067743e-09
of O 0 6.420131093420878e-10
American O 0 1.0987222243130645e-09
Jews O 0 2.0090760166624477e-09
, O 0 1.1627495841159963e-11
28 O 0 1.8117621292113029e-10
% O 0 5.254467694282283e-11
of O 0 2.6728247393137394e-10
their O 0 7.523157563582572e-08
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 0 1.094039475901809e-06
, O 0 8.100707604707935e-11
but O 0 2.383382900761344e-11
not O 0 1.583985859143766e-10
in O 0 3.7897529558961196e-10
non O 0 1.0001831896033764e-07
- O 0 4.9013731739933064e-08
Jews O 0 6.910646277447086e-08
. O 0 1.0046188236856324e-07

We O 0 2.550610531670827e-07
assessed O 0 6.470922926382627e-07
the O 0 5.564045935102513e-08
I1307K O 0 2.3669474558118964e-06
prevalence O 0 5.072280018225683e-08
in O 0 1.0232366343121413e-10
Israeli O 0 2.4742206505834474e-08
Jews O 0 4.736421033157967e-09
of O 0 1.6175240313831551e-10
differing O 0 1.4068948263334935e-11
ethnic O 0 5.998304283827416e-12
origin O 0 7.903552118326829e-11
and O 0 3.798884123940027e-11
risk O 0 4.617727533684501e-09
for O 0 1.1868909410850392e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.06327875703573227

METHODS O 0 1.3357145007830695e-06
DNA O 0 9.477151508008319e-08
samples O 0 1.794981940861362e-08
from O 0 7.144069225084593e-10
500 O 0 4.805176700983793e-09
unrelated O 0 1.0216419932262966e-09
Jews O 0 7.242733968126913e-09
of O 0 2.744379612451553e-09
European O 0 5.543968395471666e-09
or O 0 1.018076289938108e-09
non O 0 2.778330809860563e-08
- O 0 4.357058269732761e-09
European O 0 6.280435060901368e-10
origin O 0 2.4539617560215277e-10
, O 0 6.951919942488338e-12
with O 0 2.2684064099765672e-13
or O 0 1.0822669149757047e-11
without O 0 7.179526417822046e-11
a O 0 4.881381757138037e-11
personal O 0 4.56659127179293e-10
and O 0 3.916260371550351e-11
/ O 0 4.216919080590742e-07
or O 0 9.527805211462237e-09
family O 0 6.983743028321499e-10
history O 0 1.607887933907648e-09
of O 0 3.411163018718355e-10
neoplasia B-Disease 0 4.018416532858282e-08
, O 0 1.0240215619905513e-10
were O 0 2.938537468910596e-10
examined O 0 3.670964199287141e-09
for O 0 1.976853347684937e-09
the O 0 1.9865635803029136e-09
I1307K O 0 3.670342962891482e-08
variant O 0 3.6319831586695273e-09
by O 0 1.541413524597246e-10
the O 0 2.4762401018563196e-09
allele O 0 4.70155248066817e-09
- O 0 2.958119971196993e-09
specific O 0 2.9480209384757927e-09
oligonucleotide O 0 1.514667019364424e-06
( O 0 1.1150421030947655e-08
ASO O 0 7.059779363771668e-06
) O 0 4.631643957253573e-10
method O 0 6.246965256195836e-08
. O 0 4.611656123643115e-08

RESULTS O 0 3.7721466128459724e-07
In O 0 2.874335658376026e-09
persons O 0 5.00359031985198e-10
at O 0 3.188553865385302e-10
average O 0 1.3422668532214743e-10
risk O 0 2.799739606818008e-10
for O 0 2.4136991072509772e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 3.424688088671246e-07
I1307K O 0 6.088930604164489e-07
was O 0 2.8915358996073337e-09
found O 0 1.6068782415779026e-10
in O 0 4.6193543434824846e-10
5 O 0 1.130344529087779e-07
. O 0 2.929067761670012e-07

0 O 0 3.8538155422429554e-07
% O 0 1.7572304722435206e-09
of O 0 1.4131221748314715e-09
120 O 0 1.3847918367559942e-08
European O 0 2.268914123249033e-08
and O 0 5.8538445202316325e-09
1 O 0 1.3195486872064066e-06
. O 0 9.664188382885186e-07

6 O 0 5.086890837446845e-07
% O 0 6.255070239546967e-09
of O 0 2.1338180111740712e-09
188 O 0 7.2712613707892615e-09
non O 0 2.9211980745458277e-07
- O 0 2.2447513003953645e-07
European O 0 1.1222736162608271e-07
Jews O 0 1.6532419522263808e-07
( O 0 1.703392704666129e-10
P O 0 1.1279706946254464e-08
= O 0 4.524250751813952e-09
0 O 0 6.257692142241922e-10
. O 0 1.5816672971347145e-10
08 O 0 9.04997605744029e-08
) O 0 3.3187745884788455e-09
. O 0 6.284586362426126e-08

It O 0 4.707708445295111e-09
occurred O 0 3.6107232759263752e-09
in O 0 1.2321427211858804e-09
15 O 0 5.7184504242968615e-08
. O 0 1.007737466807157e-07

4 O 0 1.303790924112036e-07
% O 0 2.0950821078002946e-09
of O 0 1.5115227958162336e-09
52 O 0 4.090829897052117e-09
Ashkenazi O 0 3.7586868728567424e-08
Israelis O 0 1.5644475581666484e-07
with O 0 1.1227434537630643e-09
familial O 1 0.9997790455818176
cancer B-Disease 1 1.0
( O 0 7.591242634497064e-10
P O 0 8.718297550558418e-08
= O 0 1.0150560392219177e-08
0 O 0 7.776260191327822e-10
. O 0 8.487428815318054e-11
02 O 0 6.764222604260794e-08
) O 0 2.5384338728229316e-11
and O 0 1.7717405667583286e-11
was O 0 5.261941993239816e-10
not O 0 2.5330906816556364e-10
detected O 0 1.502494240135377e-09
in O 0 2.669996723714263e-10
51 O 0 7.391432355063898e-09
non O 0 2.8286422093515284e-07
- O 0 1.3899828843477735e-07
European O 0 1.3326407533043039e-08
Jews O 0 4.6660080244009805e-08
at O 0 7.153958314631836e-09
increased O 0 2.2380610698036207e-09
cancer B-Disease 0 7.890124997800285e-09
risk O 0 5.14298381659728e-09
. O 0 4.290247446192552e-08

Colorectal B-Disease 1 0.9997175335884094
neoplasia I-Disease 0 0.00011522295244503766
occurred O 0 1.945424855875899e-06
personally O 0 3.7073935033049565e-08
or O 0 1.2051316888861408e-10
in O 0 5.821992193899561e-11
the O 0 6.633735921690587e-11
families O 0 3.582987639222379e-12
of O 0 3.9972358756301674e-11
13 O 0 1.8236340215693758e-09
of O 0 3.1998630412033435e-09
20 O 0 8.70269687425207e-08
Ashkenazi O 0 3.233227516830084e-07
I1307K O 0 1.4122329616839124e-07
carriers O 0 3.6480260479088145e-10
, O 0 2.9022022632330113e-11
8 O 0 1.4671237558161465e-09
of O 0 8.824221353620487e-10
whom O 0 2.0738515349449926e-09
also O 0 2.8771276472383533e-09
had O 0 5.2139998985012426e-09
a O 0 1.577453279111296e-09
personal O 0 3.73677053744359e-08
or O 0 3.5486269478468557e-09
family O 0 6.581010181250235e-10
history O 0 7.2657853067426e-09
of O 0 8.87044659947378e-09
noncolonic O 0 9.469087672187015e-06
neoplasia B-Disease 0 0.0002455187786836177
. O 0 1.0382524123997428e-05

CONCLUSIONS O 0 3.214325261069462e-05
The O 0 2.0998713807784952e-06
I1307K O 0 1.9186029021511786e-05
APC O 0 6.905335112605826e-07
variant O 0 3.0477821155727725e-07
may O 0 4.1193402466888074e-08
represent O 0 2.267307896985926e-09
a O 0 1.4253955793464002e-09
susceptibility O 0 3.918700031135813e-09
gene O 0 3.7205323266675805e-09
for O 0 4.180564516786944e-08
colorectal B-Disease 1 1.0
, I-Disease 0 2.5299553385593754e-07
or I-Disease 0 3.140566207093798e-08
other I-Disease 0 2.6734685576457196e-09
, I-Disease 0 5.675100944735334e-10
cancers I-Disease 0 6.013998898879436e-08
in O 0 3.2311662234718597e-09
Ashkenazi O 0 1.5755168760733795e-06
Jews O 0 1.0316864518244984e-07
, O 0 3.3635086382766133e-10
and O 0 1.218344869435839e-10
partially O 0 8.363777226350066e-09
explains O 0 7.444727612160307e-10
the O 0 1.7947542063634359e-10
higher O 0 1.1543607847386284e-08
incidence O 0 2.4399750486736593e-07
of O 0 6.89125670305657e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 3.3757046935534163e-07
European O 0 1.2388693448883714e-07
Israelis O 0 7.454800652340055e-07
. O 0 1.3907505547194887e-07

Systematic O 0 2.581387548161729e-07
analysis O 0 2.045730873589946e-08
of O 0 1.595689269606737e-08
coproporphyrinogen O 0 9.224544896824227e-07
oxidase O 0 3.6302196804172127e-07
gene O 0 3.5269857789899106e-07
defects O 0 1.995338243432343e-05
in O 0 1.1658056564556318e-06
hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 0.9999436140060425
and O 0 5.7900855665593554e-08
mutation O 0 4.782329554586795e-08
update O 0 9.808987670112401e-06
. O 0 7.112857360880298e-07

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 1.0
( O 0 1.1749632022883816e-07
HC B-Disease 1 0.9847365021705627
) O 0 2.88456334374132e-08
is O 0 2.1612902578738158e-09
an O 0 1.0055190013957827e-09
acute O 0 0.00021724303951486945
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 1 0.9895384311676025
autosomal O 1 1.0
dominant O 1 0.9964333772659302
inheritance O 0 1.705783006400452e-06
caused O 0 9.81749437301005e-08
by O 0 6.898467908023065e-11
deficient B-Disease 0 2.283983890905006e-09
activity I-Disease 0 1.7999729484685645e-09
of I-Disease 0 5.0063233558717e-09
coproporphyrinogen I-Disease 0 4.394400718865654e-07
III I-Disease 0 2.4123697585309856e-05
oxidase I-Disease 0 3.0093167424638523e-07
( O 0 3.630736378212873e-09
CPO O 0 3.890776952175656e-06
) O 0 6.7970575834408464e-09
. O 0 1.2411020122726768e-07

Clinical O 0 3.848384221782908e-05
manifestations O 0 1.8312986867385916e-05
of O 0 3.7110518746885646e-07
the O 0 2.404028123237367e-07
disease O 0 1.6209855857596267e-07
are O 0 1.428246236556685e-11
characterized O 0 1.4441726460534543e-11
by O 0 6.636289174438703e-12
acute O 0 1.1167576197124163e-08
attacks O 0 1.7611705871445338e-08
of O 0 2.485364802851109e-07
neurological B-Disease 1 1.0
dysfunction I-Disease 1 0.9999914169311523
often O 0 1.2260692905385895e-08
precipitated O 0 3.1816116408123207e-09
by O 0 6.57987466595733e-12
drugs O 0 7.515879030250971e-10
, O 0 2.2820089567998636e-11
fasting O 0 9.493213326550176e-09
, O 0 5.306419748052349e-10
cyclical O 0 7.230651704048796e-07
hormonal O 0 6.1406594795698766e-06
changes O 0 5.192289336264366e-07
, O 0 1.669282134741934e-08
or O 0 4.1355651347885214e-08
infectious B-Disease 0 2.0490679162321612e-06
diseases I-Disease 0 7.596709110657685e-07
. O 0 1.0937864658444596e-07

Skin O 1 1.0
photosensitivity O 1 0.9999992847442627
may O 0 6.429906534322072e-06
also O 0 4.280746868090546e-09
be O 0 9.69530122851836e-10
present O 0 2.640794916075606e-09
. O 0 1.128263775740379e-07

The O 0 1.1208161367903813e-06
seven O 0 1.3915859575774903e-08
exons O 0 3.288142025326124e-08
, O 0 8.548455832091406e-10
the O 0 4.93553686808923e-09
exon O 0 8.475712576228034e-08
/ O 0 3.4421731243128306e-07
intron O 0 2.3130515103275684e-07
boundaries O 0 8.994780476001552e-10
and O 0 8.559513514638795e-11
part O 0 5.683398751621382e-10
of O 0 1.4247705237835362e-09
3 O 0 3.4886629141084313e-09
noncoding O 0 1.4328427333509808e-09
sequence O 0 7.448278105393058e-10
of O 0 3.759825339955114e-09
the O 0 1.3326128645019253e-08
CPO O 0 4.383911118566175e-07
gene O 0 1.4387524505110605e-09
were O 0 3.135178339164213e-09
systematically O 0 5.4866897691852046e-09
analyzed O 0 1.2884820987935086e-09
by O 0 7.121508938112697e-11
an O 0 2.351325523175518e-10
exon O 0 4.634916006551748e-09
- O 0 4.252102669966007e-09
by O 0 1.693900797405945e-09
- O 0 7.74605410924778e-08
exon O 0 2.917965673532308e-07
denaturing O 0 2.895544184866594e-06
gradient O 0 9.511975918030657e-08
gel O 0 6.697529215671238e-07
electrophoresis O 0 2.298765977570838e-08
( O 0 8.093356540506136e-11
DGGE O 0 1.3735834158978832e-07
) O 0 4.680521248356939e-11
strategy O 0 2.190390091527661e-09
followed O 0 1.8292452275137094e-10
by O 0 3.4895363508480326e-12
direct O 0 3.0492421088101906e-11
sequencing O 0 1.5627872607115734e-10
in O 0 7.272866753282869e-10
seven O 0 2.277037447484531e-09
unrelated O 0 1.7242792083038694e-08
heterozygous O 0 9.742394269096621e-08
HC B-Disease 0 3.5795228541246615e-06
patients O 0 9.07239225966805e-08
from O 0 4.657185304068889e-09
France O 0 2.79442868844626e-08
, O 0 5.469477648567533e-10
Holland O 0 2.231114848427751e-08
, O 0 2.3139046234632588e-10
and O 0 1.9023861652645024e-10
Czech O 0 1.849204664949866e-07
Republic O 0 2.2186188743944513e-06
. O 0 4.495087068789871e-06

Seven O 0 1.4581296170490532e-07
novel O 0 8.960623354425934e-09
mutations O 0 4.3384829062631525e-09
and O 0 3.938134540693028e-10
two O 0 2.353972849977737e-10
new O 0 6.771371907632329e-09
polymorphisms O 0 4.7435747774215997e-07
were O 0 2.5813704951360705e-07
detected O 0 4.776185846822045e-07
. O 0 1.1891540907527087e-06

Among O 0 5.035246530837867e-08
these O 0 6.382391837256307e-10
mutations O 0 1.6840623340286243e-09
two O 0 3.5006858523090045e-10
are O 0 1.4401574377487236e-10
missense O 0 1.7573562161032896e-07
( O 0 1.1276388711678464e-09
G197W O 0 1.1263194892308093e-06
, O 0 5.96520055573535e-10
W427R O 0 1.1028635782395213e-07
) O 0 9.272638906709929e-11
, O 0 5.71569354346213e-11
two O 0 5.261347607588007e-11
are O 0 9.225149810720978e-11
nonsense O 0 4.200546754873358e-08
( O 0 5.087544829862622e-10
Q306X O 0 6.954996365493571e-07
, O 0 7.01946611947335e-10
Q385X O 0 1.2072304400589928e-07
) O 0 1.2964217199762373e-10
, O 0 5.371486935801251e-11
two O 0 2.8112751709885586e-11
are O 0 3.131481879359299e-11
small O 0 3.82974735257946e-10
deletions O 0 1.5153170807025163e-07
( O 0 5.354784948785607e-10
662de14bp O 0 7.025447246178373e-08
; O 0 1.794223658535543e-10
1168del3bp O 0 8.930750539093424e-08
removing O 0 2.4277072796508037e-08
a O 0 1.473618893577111e-09
glycine O 0 8.289181785414712e-09
at O 0 2.8821601105732952e-08
position O 0 1.0252517945730233e-08
390 O 0 1.5661330010630081e-09
) O 0 1.821209329178064e-11
, O 0 1.0889342379194478e-11
and O 0 6.71989634076775e-12
one O 0 6.552021945827047e-12
is O 0 1.5031599012380048e-12
a O 0 1.516227768338929e-11
splicing O 0 2.9371212129092328e-09
mutation O 0 3.0340452372712434e-09
( O 0 4.341342563218831e-11
IVS1 O 0 1.3461568926231848e-07
- O 0 1.4873772435919363e-08
15c O 0 9.305053367825167e-07
- O 0 4.382665252933293e-08
- O 0 2.626444839393116e-08
> O 0 3.783790347711147e-08
g O 0 1.2863980103361428e-08
) O 0 3.1169539171926886e-11
which O 0 1.0949678663774165e-11
creates O 0 3.9848884608728596e-11
a O 0 1.5082504689623022e-10
new O 0 4.994036850725081e-10
acceptor O 0 1.4566841066709912e-09
splice O 0 2.176444979795633e-07
site O 0 2.809393322422693e-07
. O 0 1.7807253982482507e-07

The O 0 3.547357323441247e-07
pathological O 0 1.8185642147727776e-07
significance O 0 6.054892764950637e-08
of O 0 1.7881410130371478e-08
the O 0 7.914844779577379e-09
point O 0 3.730290387693458e-08
mutations O 0 2.3194293152783985e-09
G197W O 0 6.80633576166656e-08
, O 0 1.934760129884694e-10
W427R O 0 8.243745241998113e-08
, O 0 1.2350362399438097e-10
and O 0 1.1970471835986984e-10
the O 0 1.476126065824701e-08
in O 0 1.3433694157072296e-08
- O 0 9.826130309420478e-08
frame O 0 2.0060029726209905e-07
deletion O 0 3.3629088846964805e-08
390delGly O 0 3.177748508775835e-09
were O 0 1.2521615688765309e-10
assessed O 0 2.4881885440919405e-10
by O 0 1.113064328206459e-11
their O 0 8.442978954859015e-11
respective O 0 9.678173817917468e-10
expression O 0 3.705327822345339e-09
in O 0 2.645330898776166e-10
a O 0 2.921932695798546e-10
prokaryotic O 0 1.1291513557498689e-10
system O 0 1.7993197209964507e-10
using O 0 2.8840710375455103e-10
site O 0 7.96891830301405e-10
- O 0 1.633693597069552e-10
directed O 0 1.7588157319448072e-10
mutagenesis O 0 1.1995047088930733e-07
. O 0 2.14123559771906e-07

These O 0 1.1682554479364171e-08
mutations O 0 8.501561676865776e-10
resulted O 0 3.960129169033877e-10
in O 0 1.355640738553987e-10
the O 0 1.2405565463780022e-09
absence O 0 1.3122804176646241e-08
or O 0 3.237549672796547e-10
a O 0 2.330509951686821e-10
dramatic O 0 1.315171305193985e-09
decrease O 0 1.7037974586742166e-08
of O 0 1.3448466518184432e-07
CPO O 0 2.8642223696806468e-05
activity O 0 9.790778676688205e-07
. O 0 1.0522970796955633e-06

The O 0 1.0016357236963813e-06
two O 0 4.329175240513905e-09
polymorphisms O 0 2.2416164924266013e-08
were O 0 1.7068214619442301e-09
localized O 0 5.920871348763512e-09
in O 0 6.873437929932891e-10
noncoding O 0 4.98393326608948e-09
part O 0 5.3856084036851826e-09
of O 0 5.7502753669780304e-09
the O 0 5.786612855551709e-10
gene O 0 4.369020770167431e-11
1 O 0 6.883539849233955e-10
) O 0 6.170997740584383e-11
a O 0 7.93735077664337e-10
C O 0 3.174442397835264e-08
/ O 0 6.532067331477265e-09
G O 0 2.8287747699806687e-09
polymorphism O 0 2.9417634994644004e-09
in O 0 9.3014818070003e-10
the O 0 8.127305051175426e-09
promotor O 0 2.6119530502910493e-06
region O 0 2.0046254434191724e-08
, O 0 1.7898323934062432e-09
142 O 0 1.4118861635381563e-08
bp O 0 9.956945490330327e-09
upstream O 0 1.2611840460863277e-09
from O 0 8.624495562159495e-10
the O 0 5.981778405939053e-10
transcriptional O 0 5.480860765239015e-10
initiation O 0 9.859500993414372e-10
site O 0 2.1752273315911452e-09
( O 0 2.8116129216493313e-11
- O 0 2.5832544991999384e-09
142C O 0 9.301916037429692e-08
/ O 0 9.446648796540558e-09
G O 0 3.2171698638450152e-09
) O 0 9.06682194601327e-12
, O 0 4.82406779453437e-12
and O 0 2.6684971506790722e-12
2 O 0 4.2352404916456976e-10
) O 0 1.2274929683808722e-10
a O 0 2.6160593691315626e-09
6 O 0 2.4500078410483184e-08
bp O 0 1.5780830864287054e-08
deletion O 0 2.181780089927088e-09
polymorphism O 0 1.0069604039486535e-09
in O 0 1.9344095769646685e-10
the O 0 6.63844812454073e-10
3 O 0 1.1766027041559823e-09
noncoding O 0 1.876307997861204e-09
part O 0 7.402165547176764e-10
of O 0 3.2143727679567746e-09
the O 0 5.2416604390259636e-09
CPO O 0 5.251720267551718e-07
gene O 0 5.0664565875990775e-09
, O 0 2.5710935602774043e-09
574 O 0 3.717491026122843e-08
bp O 0 1.2330179544051134e-08
downstream O 0 1.2510164015822056e-09
of O 0 9.522950206175551e-10
the O 0 8.969339715392266e-10
last O 0 3.812641591327548e-10
base O 0 1.0690024421222688e-09
of O 0 7.1932064471536e-11
the O 0 6.561216847611462e-11
normal O 0 1.5139320908019727e-09
termination O 0 1.7045385547476144e-08
codon O 0 3.0373357162716275e-08
( O 0 7.01621372112271e-10
+ O 0 7.610851326944612e-08
574 O 0 1.2176450070455758e-07
delATTCTT O 0 3.709304223775689e-07
) O 0 2.856099134973533e-09
. O 0 6.242832029101919e-08

Five O 0 2.0390461941133253e-06
intragenic O 0 7.508802355005173e-06
dimorphisms O 0 1.7814196553445072e-06
are O 0 5.892241694560596e-10
now O 0 4.2877881800684747e-10
well O 0 2.9499203080263214e-10
characterized O 0 1.523336318198787e-10
and O 0 8.46072795157582e-11
the O 0 1.0126596228232643e-09
high O 0 1.857361597856766e-09
degree O 0 1.480166211820233e-08
of O 0 4.1927963323473705e-09
allelic O 0 1.8660696099459528e-08
heterogeneity O 0 4.297074696069103e-09
in O 0 1.2601621968144627e-09
HC B-Disease 0 4.251949121680809e-06
is O 0 9.077075202590379e-10
demonstrated O 0 2.2693802392836915e-09
with O 0 8.520416143464882e-12
seven O 0 4.85029134911219e-11
new O 0 4.8770640304063306e-11
different O 0 8.249958008410552e-12
mutations O 0 9.116525589991653e-11
making O 0 4.5478312088453876e-11
a O 0 1.169629948449824e-10
total O 0 1.2206195776354178e-10
of O 0 6.085650317011471e-10
nineteen O 0 2.470599724802014e-07
CPO O 0 0.00010474603914190084
gene B-Disease 0 3.0779426651861286e-06
defects I-Disease 0 1.1418999747547787e-05
reported O 0 1.5121145224838983e-08
so O 0 1.0730308863671212e-09
far O 0 5.738285957512801e-10
. O 0 1.2618915912199213e-09
. O 0 4.0097496878388483e-08

Coincidence O 0 1.4070224096940365e-06
of O 0 7.780733568552023e-08
two O 0 8.784254990068519e-10
novel O 0 3.6414862236711087e-09
arylsulfatase O 0 5.123737878420798e-07
A O 0 3.621484623295146e-08
alleles O 0 1.1400636878988735e-08
and O 0 3.012973204263858e-09
mutation O 0 6.197014812414636e-08
459 O 0 8.183102551129195e-08
+ O 0 7.042901302156679e-07
1G O 0 4.458128842088627e-06
> O 0 1.432308351922984e-07
A O 0 1.5944875642048828e-08
within O 0 1.0825529361824238e-09
a O 0 2.2020312240300655e-09
family O 0 1.6096490806916108e-09
with O 0 1.7011436703739946e-09
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
: O 0 6.550779363401205e-10
molecular O 0 3.149525362733385e-10
basis O 0 1.6260655044675332e-09
of O 0 2.087136907746867e-09
phenotypic O 0 2.154309726165593e-07
heterogeneity O 0 4.3906279643124435e-06
. O 0 5.374505690269871e-06

In O 0 3.3705120472404815e-08
a O 0 1.6625522292201822e-08
family O 0 3.780994961566364e-10
with O 0 2.0470198452970934e-11
three O 0 2.7909208277776543e-10
siblings O 0 1.0646403758585166e-08
, O 0 8.475248280959136e-11
one O 0 1.4257776383141962e-11
developed O 0 4.395886085695189e-11
classical O 0 2.1372960645749117e-07
late O 1 1.0
infantile O 1 1.0
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 9.359271579967299e-09
MLD B-Disease 1 1.0
) O 0 3.9863803924511387e-10
, O 0 5.4745371430575673e-11
fatal O 0 1.1186308546129453e-09
at O 0 1.4075645093925004e-09
age O 0 1.3603607129653028e-09
5 O 0 2.818439925889038e-09
years O 0 6.351703607521131e-10
, O 0 6.031589117050373e-11
with O 0 1.3468900474100653e-11
deficient O 0 1.5031477573757002e-07
arylsulfatase O 0 6.159275017125765e-06
A O 0 2.6023608370451257e-06
( O 0 4.371325967866824e-09
ARSA O 0 6.345258952933364e-06
) O 0 1.6655785084473962e-10
activity O 0 1.0066627531557515e-09
and O 0 5.30641676432797e-11
increased O 0 3.6632001876313325e-09
galactosylsulfatide O 0 1.040968300003442e-06
( O 0 2.2637904883993087e-09
GS O 0 0.0009187782416120172
) O 0 9.059869299221646e-09
excretion O 0 1.615908900021168e-07
. O 0 9.04666279666344e-08

The O 0 4.340496388977044e-07
two O 0 9.13123576751218e-10
other O 0 8.257345501805347e-11
siblings O 0 2.5927122671021152e-09
, O 0 8.842733489888843e-11
apparently O 0 5.451815887624889e-09
healthy O 0 6.858146051058611e-09
at O 0 5.637323496898716e-09
12 O 0 4.4714159486147764e-08
( O 0 1.66147595681565e-10
1 O 0 1.2602542120987437e-08
/ O 0 4.638102168996738e-08
2 O 0 6.3434857366928554e-09
) O 0 4.2445463810381057e-11
and O 0 3.072038456952697e-11
15 O 0 3.8874684027412343e-10
years O 0 1.617607298110002e-10
, O 0 2.374462085286133e-11
respectively O 0 3.676182414036333e-10
, O 0 1.864568915932452e-11
and O 0 8.007641424945255e-12
their O 0 1.1001622529649424e-10
father O 0 4.31903046660409e-09
, O 0 2.819583733160158e-10
apparently O 0 5.650445444871366e-09
healthy O 0 2.5758648547480334e-09
as O 0 9.058150063356862e-11
well O 0 2.2981803959876146e-10
, O 0 1.9404514106646786e-10
presented O 0 6.016855991219927e-08
ARSA O 0 0.0002355446486035362
and O 0 3.6148868787222455e-08
GS O 1 0.9997885823249817
values O 0 3.277358162634414e-09
within O 0 1.3989027991545555e-10
the O 0 1.2447938513293622e-10
range O 0 2.2391197784799033e-09
of O 0 2.2166410929003177e-09
MLD B-Disease 1 1.0
patients O 0 1.5836362763366196e-06
. O 0 4.7197221419992275e-07

Mutation O 0 5.877417219579684e-09
screening O 0 2.8981230748570397e-09
and O 0 2.229313261770116e-10
sequence O 0 6.216670234149291e-11
analysis O 0 1.1221804596672769e-09
disclosed O 0 1.2500390056402466e-08
the O 0 2.5386397428661667e-09
involvement O 0 1.1763609641946005e-08
of O 0 3.115286917321214e-09
three O 0 3.6587363694273733e-10
different O 0 6.744969027749903e-10
ARSA O 0 7.556458513136022e-06
mutations O 0 6.092064186447033e-09
being O 0 2.003370580538899e-09
the O 0 6.77193690012956e-10
molecular O 0 3.799612624533211e-09
basis O 0 2.903557572153659e-08
of O 0 2.189915271344489e-08
intrafamilial O 0 6.199382823979249e-06
phenotypic O 0 5.511672952707158e-06
heterogeneity O 0 6.278605269471882e-06
. O 0 5.450453045341419e-06

The O 0 1.9319452349009225e-07
late O 0 1.7767637473298237e-05
infantile O 0 4.4091320887673646e-05
patient O 0 1.6537985914055753e-07
inherited O 0 2.489055006549279e-08
from O 0 7.707732230244346e-09
his O 0 1.3542199894800433e-07
mother O 0 4.200610703719576e-08
the O 0 1.5709176182099327e-08
frequent O 0 9.085944219222597e-10
0 O 0 4.602023206956574e-09
- O 0 1.0193301314131986e-08
type O 0 1.4036542950179864e-07
mutation O 0 6.495369575532095e-08
459 O 0 3.4917668756406783e-08
+ O 0 1.1907740571359682e-07
1G O 0 5.74591410895664e-07
> O 0 1.9006002105470543e-08
A O 0 4.439503431541425e-09
, O 0 2.0549336537944995e-11
and O 0 8.922935307298374e-12
from O 0 1.371204816358329e-10
his O 0 6.705029864662038e-09
father O 0 1.8689904734969787e-08
a O 0 7.783397815153137e-10
novel O 0 3.9577732757756223e-10
, O 0 2.184613601130536e-11
single O 0 5.113988121863144e-10
basepair O 0 3.871341647254667e-08
microdeletion O 0 5.211069620258968e-08
of O 0 2.4395052644621273e-09
guanine O 0 8.947080409882346e-09
at O 0 2.9650959465499227e-09
nucleotide O 0 1.4841033957324612e-09
7 O 0 9.460766392521691e-09
in O 0 1.6335168773196074e-09
exon O 0 2.728930503792526e-08
1 O 0 2.6114145512678988e-08
( O 0 8.432184395168463e-10
7delG O 0 1.955792470198503e-07
) O 0 5.056493890265301e-09
. O 0 7.732045759212269e-08

The O 0 5.8505821698418e-07
two O 0 1.1137858635379416e-08
clinically O 0 1.0213277164439205e-05
unaffected O 0 9.743843776277572e-08
siblings O 0 1.146809314178654e-08
carried O 0 1.956697692762077e-09
the O 0 2.594483516915602e-09
maternal O 0 2.6139963665627874e-05
mutation O 0 1.0450270337969414e-07
459 O 0 5.4221395373588166e-08
+ O 0 2.3021539163892157e-07
1G O 0 9.938579523804947e-07
> O 0 3.458915287524178e-08
A O 0 4.742287451620086e-09
and O 0 6.658086582067568e-11
, O 0 2.6818058190825056e-11
on O 0 1.2683004646518725e-09
their O 0 7.633508825044544e-10
paternal O 0 7.057598736537329e-07
allele O 0 2.4687382804700064e-08
, O 0 2.6399524233333693e-10
a O 0 2.902037776753019e-10
novel O 0 1.0884079193473895e-09
cytosine O 0 7.467827245477565e-09
to O 0 4.191482716464634e-10
thymidine O 0 4.462955516260081e-08
transition O 0 2.4192484460172636e-08
at O 0 1.9463655576146266e-08
nucleotide O 0 3.2881668943218756e-08
2435 O 0 1.7242550711671356e-06
in O 0 5.783581613627575e-09
exon O 0 4.37791136675969e-08
8 O 0 1.478089828310658e-08
, O 0 1.5064362257621866e-10
resulting O 0 4.434091635530102e-11
in O 0 3.257623337749038e-11
substitution O 0 3.4041194307832257e-09
of O 0 3.4086866662619286e-09
alanine O 0 5.774094802291074e-08
464 O 0 4.562555844245253e-08
by O 0 8.088041347775743e-09
valine O 0 2.676738949958235e-05
( O 0 2.848200342242535e-09
A464V O 0 1.8780598338707932e-06
) O 0 3.442512275242393e-09
. O 0 6.038366251459593e-08

The O 0 8.999007263810199e-07
fathers O 0 2.9241249421829707e-07
genotype O 0 2.3115955372077224e-08
thus O 0 8.910142845763858e-09
was O 0 3.676494486626325e-08
7delG O 0 2.6819845970749157e-06
/ O 0 1.4098717656452209e-05
A464V O 0 7.879842451075092e-05
. O 0 8.750365054766007e-07

Mutation O 0 2.2129092940303963e-06
A464V O 0 1.3631727142637828e-06
was O 0 7.801654433592375e-09
not O 0 5.035222239158088e-10
found O 0 4.568226699697142e-11
in O 0 7.614644331743747e-11
18 O 0 3.5687792721006417e-09
unrelated O 0 1.5700315714184399e-07
MLD B-Disease 1 1.0
patients O 0 3.8890229347998684e-07
and O 0 1.9948220852938903e-09
50 O 0 1.7026432885813847e-07
controls O 0 2.0818440589209786e-06
. O 0 1.5741170500405133e-06

A464V O 0 4.528682620730251e-05
, O 0 9.601837547279501e-09
although O 0 4.369366646272965e-09
clearly O 0 4.611937853837844e-08
modifying O 0 1.2863722986367065e-05
ARSA O 1 0.9995357990264893
and O 0 1.8520138382882578e-06
GS O 1 1.0
levels O 0 5.035375579609536e-06
, O 0 6.306181687953938e-10
apparently O 0 1.0653269377769448e-08
bears O 0 2.7386290568642835e-08
little O 0 9.271972079005764e-10
significance O 0 1.476652022880387e-09
for O 0 1.902523971697434e-10
clinical O 0 5.090110111183321e-09
manifestation O 0 6.189206658291369e-08
of O 0 4.581199775088862e-08
MLD B-Disease 1 1.0
, O 0 1.5019249843817306e-08
mimicking O 0 4.0013460989030136e-07
the O 0 7.469254370562339e-08
frequent O 0 2.3985137431736803e-07
ARSA O 0 0.0009445123723708093
pseudodeficiency O 0 9.171316196443513e-05
allele O 0 2.9708378406212432e-06
. O 0 5.517913450603373e-07

Our O 0 2.3427914186413545e-07
results O 0 1.1511221309490338e-08
demonstrate O 0 4.332380232341393e-09
that O 0 2.458790809845013e-11
in O 0 1.4391517491607608e-11
certain O 0 9.489076191471213e-11
genetic O 0 1.1210978811959649e-09
conditions O 0 7.797223844363543e-08
MLD B-Disease 1 1.0
- O 0 4.3811760406242684e-05
like O 0 7.16670967904065e-07
ARSA O 1 0.9998028874397278
and O 0 4.783998974744463e-07
GS O 1 1.0
values O 0 3.441194351694321e-08
need O 0 3.864161879363337e-09
not O 0 1.6256056223351578e-10
be O 0 9.399835770862452e-11
paralleled O 0 1.2313580155520754e-09
by O 0 9.442766013556536e-11
clinical O 0 1.1890594464603055e-07
disease O 0 8.34152125150922e-09
, O 0 5.2384867277321945e-11
a O 0 2.853897673738004e-10
finding O 0 1.2915749580955094e-09
with O 0 3.012751853548323e-11
serious O 0 2.9318265593047954e-09
diagnostic O 0 3.2257294151349925e-06
and O 0 2.2144531541812285e-08
prognostic O 0 0.00027844507712870836
implications O 0 1.6403386098318151e-06
. O 0 1.0629936468831147e-06

Moreover O 0 1.8844864371203585e-06
, O 0 9.912263898570473e-09
further O 0 3.5642777618249966e-08
ARSA O 0 3.185317837051116e-05
alleles O 0 2.387795738911791e-08
functionally O 0 2.6913614448176304e-08
similar O 0 1.6863701546299126e-09
to O 0 5.601332286886418e-09
A464V O 0 1.317590374583233e-07
might O 0 1.7188503953491363e-09
exist O 0 3.8738862118137263e-10
which O 0 1.522173879997535e-11
, O 0 7.64030332056631e-12
together O 0 6.638491839572325e-12
with O 0 7.360848909565565e-12
0 O 0 7.91777399200555e-09
- O 0 2.265471898965643e-08
type O 0 6.390096274344614e-08
mutations O 0 4.5300037498918755e-08
, O 0 3.157609174131437e-10
may O 0 7.390699163778436e-09
cause O 0 8.883741742238271e-08
pathological O 0 2.775564462353941e-05
ARSA O 1 0.9972858428955078
and O 0 2.7831845272885403e-07
GS O 1 1.0
levels O 0 1.0557851055637002e-06
, O 0 5.030227970270751e-11
but O 0 8.416879172801206e-12
not O 0 2.411500513166409e-11
clinical O 0 5.914682077445832e-10
outbreak O 0 4.348023607825269e-10
of O 0 2.1482239598302755e-10
the O 0 1.3397967180139858e-09
disease O 0 1.5223465821279092e-09
. O 0 6.964548382448754e-10
. O 0 2.8086049042030936e-08

Human O 0 0.00017026124987751245
MLH1 O 1 1.0
deficiency O 1 0.9999456405639648
predisposes O 0 0.0003833608643617481
to O 0 2.7663543278322322e-06
hematological B-Disease 1 1.0
malignancy I-Disease 1 1.0
and O 0 9.419052560133423e-08
neurofibromatosis B-Disease 1 0.9079198241233826
type I-Disease 0 0.0013463282957673073
1 I-Disease 1 0.7166382074356079
. O 0 1.5214034647215158e-05

Heterozygous O 0 2.077488488794188e-06
germ O 0 5.792112460767385e-06
- O 0 3.977533253873844e-07
line O 0 1.4610395560055167e-08
mutations O 0 6.263806140438533e-10
in O 0 4.900742034408268e-10
the O 0 1.3607707183282969e-09
DNA O 0 3.3989417946855838e-09
mismatch O 0 3.9261312423377603e-08
repair O 0 3.99506262738214e-07
genes O 0 1.0271936190520137e-08
lead O 0 1.534706512984485e-07
to O 0 1.8500492160455906e-06
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.18896768987178802

The O 0 4.885263820142427e-07
disease O 0 3.779917960855528e-07
susceptibility O 0 2.570369339593981e-08
of O 0 2.070657867392356e-09
individuals O 0 8.299932269251187e-11
who O 0 6.120202566961552e-09
constitutionally O 0 1.4133879631117452e-05
lack O 0 6.610204764001537e-06
both O 0 1.755181422424812e-08
wild O 0 6.667665530812883e-08
- O 0 1.9336921397439255e-08
type O 0 7.003182034281963e-09
alleles O 0 8.485248614853447e-10
is O 0 4.422528662728631e-11
unknown O 0 2.6048779133702737e-08
. O 0 9.025119140915194e-08

We O 0 6.650493133975033e-08
have O 0 3.817713645215548e-10
identified O 0 3.917241253592607e-10
three O 0 1.2670611955478694e-11
offspring O 0 4.043245183105171e-10
in O 0 2.708259172479188e-10
a O 0 6.796552209920037e-09
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 1 0.8911829590797424
who O 0 1.8373876642385767e-08
developed O 0 2.1506906477952725e-07
hematological B-Disease 1 1.0
malignancy I-Disease 1 0.9592380523681641
at O 0 6.296921384318921e-08
a O 0 5.38986022480259e-10
very O 0 1.3616208854871914e-11
early O 0 3.403937354207187e-09
age O 0 3.6826106053489127e-10
, O 0 2.2405617292053925e-11
and O 0 1.9866715911254218e-11
at O 0 5.062599783833832e-10
least O 0 4.759890398498001e-11
two O 0 1.4317511586037224e-11
of O 0 3.470547460526774e-11
them O 0 6.048581774331652e-11
displayed O 0 5.26463779237929e-08
signs O 0 1.6616635889477038e-07
of O 0 3.439127382875995e-08
neurofibromatosis B-Disease 0 0.0002996994589921087
type I-Disease 0 2.2529684429173358e-06
1 I-Disease 0 2.757128186203772e-06
( O 0 7.822574588089992e-09
NF1 B-Disease 0 2.0401008441695012e-05
) O 0 3.226339728712446e-08
. O 0 2.3438283847099228e-07

DNA O 0 1.691744699883202e-08
sequence O 0 8.268650208975714e-10
analysis O 0 9.660395816624145e-10
and O 0 1.5764146932273349e-10
allele O 0 7.59326990174003e-10
- O 0 4.5318143682138157e-10
specific O 0 2.4068055881620865e-10
amplification O 0 5.527475810396254e-09
in O 0 7.572804605615602e-10
two O 0 2.9587166050504266e-10
siblings O 0 9.183061422390892e-09
revealed O 0 8.024747977231073e-09
a O 0 1.200107213605861e-08
homozygous O 0 2.078213810818852e-06
MLH1 O 0 0.00022144487593322992
mutation O 0 1.0048162835119001e-07
( O 0 2.6535171282482395e-10
C676T O 0 2.9656925448762195e-07
- O 0 4.010308600754797e-07
- O 0 8.007960445866047e-07
> O 0 1.4948365105738048e-06
Arg226Stop O 0 3.649697646324057e-06
) O 0 2.493529827063412e-09
. O 0 3.3495684448325846e-08

Thus O 0 5.587760938396968e-07
, O 0 3.1722620086327424e-09
a O 0 5.810671499517639e-09
homozygous O 0 8.998958378469979e-08
germ O 0 2.311303251190111e-05
- O 0 5.292080004437594e-06
line O 0 2.2102854018157814e-06
MLH1 O 0 0.00011669746891129762
mutation O 0 1.0681836748460682e-08
and O 0 3.839724094234498e-10
consequent O 0 3.156161028528004e-06
mismatch O 0 0.10982869565486908
repair O 1 1.0
deficiency O 1 0.9830425977706909
results O 0 2.6757660975818e-07
in O 0 2.4920810304251972e-08
a O 0 2.1210331269116978e-08
mutator O 0 3.102690970990807e-05
phenotype O 0 7.27986844140105e-08
characterized O 0 2.0111107223996783e-10
by O 0 2.018734485131901e-11
leukemia B-Disease 0 0.00011467403237475082
and O 0 6.757607451390868e-08
/ O 1 1.0
or O 1 0.9999988079071045
lymphoma B-Disease 1 1.0
associated O 1 1.0
with O 0 1.0196746558222003e-07
neurofibromatosis B-Disease 1 1.0
type I-Disease 0 0.0006371335475705564
1 I-Disease 0 7.71410996094346e-05
. O 0 9.570465664410222e-08
. O 0 1.938029328130142e-07

Missense O 0 1.9846120267175138e-05
mutations O 0 8.43405842942957e-08
in O 0 1.62599818054332e-08
the O 0 2.4568725720541806e-08
most O 0 3.3062000359684873e-10
ancient O 0 1.102153923682181e-09
residues O 0 4.457908264754451e-09
of O 0 2.16826823162819e-09
the O 0 1.751185330078897e-08
PAX6 O 0 5.423705079010688e-05
paired O 0 2.7123155632580165e-07
domain O 0 9.06447041870706e-08
underlie O 0 3.778335724291537e-07
a O 0 2.1450479170681547e-09
spectrum O 0 2.194405901434493e-08
of O 0 3.2747211609063243e-09
human O 0 5.081431595499453e-07
congenital B-Disease 1 1.0
eye I-Disease 1 1.0
malformations I-Disease 1 1.0
. O 0 0.2316434383392334

Mutations O 0 3.7976295175212726e-07
of O 0 4.748019222233779e-08
the O 0 9.057640859566618e-09
human O 0 3.6195075825418144e-09
PAX6 O 0 2.0644201867980883e-05
gene O 0 1.6494763031005277e-06
underlie O 1 0.9999998807907104
aniridia B-Disease 1 1.0
( O 0 2.843181164280395e-06
congenital B-Disease 1 1.0
absence I-Disease 1 1.0
of I-Disease 0 0.0007069736602716148
the I-Disease 0 2.73712566922768e-06
iris I-Disease 0 3.8050429793656804e-06
) O 0 5.439193540013321e-10
, O 0 1.7067033897255612e-10
a O 0 2.7755011622332404e-09
rare O 0 5.648303726957238e-07
dominant O 1 0.9999680519104004
malformation B-Disease 1 1.0
of I-Disease 1 1.0
the I-Disease 1 1.0
eye I-Disease 1 1.0
. O 0 0.00019594523473642766

The O 0 1.1267836725892266e-06
spectrum O 0 1.4144219449008233e-06
of O 0 1.2132228732752992e-07
PAX6 O 0 0.0021001086570322514
mutations O 0 6.659492441940529e-07
in O 0 1.2760126821831363e-07
aniridia B-Disease 1 1.0
patients O 0 2.899048467952525e-07
is O 0 2.4669316936454244e-11
highly O 0 2.164973478269161e-10
biased O 0 8.584041255588204e-10
, O 0 1.6856675777443542e-11
with O 0 4.591775744355875e-12
92 O 0 4.230101779967299e-08
% O 0 2.004868077110089e-10
of O 0 2.2322534098950797e-10
all O 0 6.357760845565608e-11
reported O 0 1.5302496769731277e-10
mutations O 0 4.5532580483786944e-10
leading O 0 2.431014500814399e-09
to O 0 5.140522230107081e-09
premature O 0 4.5553477434623346e-07
truncation O 0 8.723285986889096e-07
of O 0 8.126765038696249e-08
the O 0 1.861739207242863e-08
protein O 0 1.304662822221303e-09
( O 0 7.118738931666257e-11
nonsense O 0 4.660553276636392e-09
, O 0 5.484361229046719e-11
splicing O 0 2.5730952923908035e-09
, O 0 3.6834113537054236e-10
insertions O 0 7.687823710966768e-09
and O 0 9.178954818445106e-11
deletions O 0 1.6834328375736618e-09
) O 0 1.6300696903392975e-11
and O 0 1.685236845905269e-11
just O 0 2.579998714669074e-10
2 O 0 2.8695534837197556e-09
% O 0 3.401612325149017e-10
leading O 0 4.666315112089592e-10
to O 0 2.1272945904815543e-10
substitution O 0 1.404189298170877e-08
of O 0 1.0290996499406901e-08
one O 0 3.4186015129833436e-10
amino O 0 2.9230085019094076e-10
acid O 0 2.9153859881780875e-10
by O 0 1.7286793524418087e-11
another O 0 7.129354329116211e-10
( O 0 3.134525139447675e-10
missense O 0 1.616422196093481e-07
) O 0 3.746074561661317e-09
. O 0 8.415226204760984e-08

The O 0 2.4692829470041033e-07
extraordinary O 0 2.7601348762118505e-08
conservation O 0 2.2977049596306642e-08
of O 0 2.99781710566549e-09
the O 0 1.9717845134437084e-09
PAX6 O 0 5.346616376300517e-07
protein O 0 3.8324894369168305e-09
at O 0 7.313000871533859e-09
the O 0 3.839967455121496e-09
amino O 0 2.3635312373926354e-08
acid O 0 5.441108541504036e-08
level O 0 1.2419047834555386e-07
amongst O 0 1.9747512070011908e-08
vertebrates O 0 5.5390239594999e-07
predicts O 0 2.5007087955941643e-08
that O 0 4.871265057992957e-10
pathological O 0 9.040467716658895e-07
missense O 0 1.8725783093032078e-06
mutations O 0 3.397083503386966e-08
should O 0 4.489436822296966e-09
in O 0 6.753503867251709e-10
fact O 0 5.931493074484706e-10
be O 0 6.805109808993848e-10
common O 0 3.2426725193879236e-10
even O 0 6.035467264853267e-11
though O 0 1.7376907204824654e-11
they O 0 3.36767974618013e-11
are O 0 9.008902131235619e-12
hardly O 0 2.3179209662771427e-09
ever O 0 6.373426786332459e-10
seen O 0 6.0659179901279e-09
in O 0 1.676499650216101e-08
aniridia B-Disease 1 1.0
patients O 0 2.124540969816735e-06
. O 0 3.3100212704084697e-07

This O 0 6.950143216499782e-08
indicates O 0 5.865862462428595e-08
that O 0 5.22291272730957e-11
there O 0 3.3821757894347826e-11
is O 0 7.088872024108017e-12
a O 0 3.57554159891027e-11
heavy O 0 6.8236603034677046e-09
ascertainment O 0 6.582654350495432e-07
bias O 0 2.423012190888585e-08
in O 0 9.153189317601118e-10
the O 0 1.3431536993735449e-09
selection O 0 1.054140663647729e-09
of O 0 2.5419139015880887e-10
patients O 0 2.5725785390839917e-10
for O 0 1.311743630383333e-10
PAX6 O 0 6.624691764045565e-07
mutation O 0 1.1795395771230233e-09
analysis O 0 4.428997169014792e-10
and O 0 8.393540723572457e-11
that O 0 1.2801650017824073e-10
the O 0 5.70270852762178e-09
missing O 0 5.318188982528227e-07
PAX6 O 0 0.0003962747287005186
missense O 0 2.2654283384326845e-05
mutations O 0 3.5490489835865446e-07
frequently O 0 2.132773246898978e-08
may O 0 3.1303397207693706e-08
underlie O 0 1.0650098829501076e-06
phenotypes O 0 1.494078247787911e-07
distinct O 0 5.841497507930171e-09
from O 0 6.190408630146749e-09
textbook O 0 3.939867747249082e-05
aniridia B-Disease 1 1.0
. O 0 1.4551902722814702e-06

Here O 0 4.2364570163044846e-07
we O 0 1.0750040857487875e-08
present O 0 1.79139669764794e-09
four O 0 8.976784870995402e-10
novel O 0 1.9321362287882948e-08
PAX6 O 0 4.380307291285135e-05
missense O 0 2.699680408113636e-06
mutations O 0 3.8786588163475244e-08
, O 0 7.091556786242847e-10
two O 0 1.187500653365703e-10
in O 0 6.10423878111277e-10
association O 0 1.0067241484890133e-09
with O 0 7.539091573249834e-11
atypical O 0 2.8183289941807743e-06
phenotypes O 0 0.02248712070286274
ectopia B-Disease 0 0.0033475011587142944
pupillae I-Disease 0 1.706851071503479e-05
( O 0 3.8119053052954044e-11
displaced B-Disease 0 3.8404637803246544e-10
pupils I-Disease 0 2.197269477477448e-09
) O 0 9.647800336409773e-10
and O 0 1.6301210337132943e-07
congenital B-Disease 1 1.0
nystagmus I-Disease 1 1.0
( O 0 6.570111676929002e-10
searching B-Disease 0 5.524085011643365e-08
gaze I-Disease 0 1.1243582065390001e-07
) O 0 1.036978142243683e-10
, O 0 5.336511094133911e-11
and O 0 6.983886385869553e-11
two O 0 1.547865585704855e-10
in O 0 1.0313726539479262e-09
association O 0 6.532835938877213e-10
with O 0 3.238548318407197e-11
more O 0 1.130789795134035e-09
recognizable O 0 1.4329357327369507e-06
aniridia B-Disease 1 1.0
phenotypes O 0 4.256131433066912e-06
. O 0 4.3866629084732267e-07

Strikingly O 0 2.499896436347626e-05
, O 0 4.357617555683646e-08
all O 0 2.218358163830203e-09
four O 0 4.843203615934044e-10
mutations O 0 1.4440026951945129e-10
are O 0 2.386644354368528e-11
located O 0 1.306634522801886e-10
within O 0 1.9117099014920313e-09
the O 0 4.443911194584871e-08
PAX6 O 0 3.9047150494297966e-05
paired O 0 2.1596889610009384e-07
domain O 0 7.259208700816089e-08
and O 0 1.0686558304939808e-09
affect O 0 9.727480154708701e-09
amino O 0 1.657080805905764e-09
acids O 0 6.989033241033837e-10
which O 0 7.999489091969902e-12
are O 0 2.261650502294321e-12
highly O 0 1.0235235575750679e-10
conserved O 0 3.189569719452834e-10
in O 0 9.844318693552623e-10
all O 0 1.0581656662012051e-09
known O 0 2.074167948507011e-09
paired O 0 6.0725162676078526e-09
domain O 0 1.1361498408746229e-08
proteins O 0 9.512403087441612e-10
. O 0 2.7397783597393754e-08

Our O 0 8.505330697516911e-07
results O 0 8.644546767300199e-08
support O 0 2.490707728952657e-08
the O 0 2.375755592254336e-09
hypothesis O 0 1.5449049817206628e-09
that O 0 5.88665271042399e-12
the O 0 5.51468593013027e-11
under O 0 4.322852353855211e-10
- O 0 2.30362351416602e-09
representation O 0 2.16783813122845e-09
of O 0 1.169028962522134e-08
missense O 0 1.208474941449822e-06
mutations O 0 9.016964241936876e-08
is O 0 2.8486280001516207e-10
caused O 0 3.552153016173065e-10
by O 0 1.7476899094592824e-10
ascertainment O 0 7.457762694684789e-05
bias O 0 2.1972165598072024e-07
and O 0 1.0462904986852095e-09
suggest O 0 4.620352545003925e-09
that O 0 9.045558573006485e-12
a O 0 5.941975383949583e-11
substantial O 0 1.3250263108943727e-09
burden O 0 2.113860801955525e-07
of O 0 3.1353059171124187e-07
PAX6 B-Disease 1 0.9998769760131836
- I-Disease 0 0.00014094490325078368
related I-Disease 0 1.252231754733657e-06
disease I-Disease 0 1.1740088666556403e-05
remains O 0 3.974455431432489e-09
to O 0 3.4025987583063966e-10
be O 0 7.766284837451565e-10
uncovered O 0 2.381341701607198e-08
. O 0 1.1777933295320508e-08
. O 0 1.9231730163937755e-07

The O 0 4.199129080006969e-07
chromosomal O 0 1.5963658483997278e-07
order O 0 1.1055636406354097e-07
of O 0 2.6459289870217617e-08
genes O 0 7.641189014861993e-09
controlling O 0 9.639108355941062e-08
the O 0 2.4543867311876966e-06
major O 0 1.655125197430607e-05
histocompatibility O 0 0.00030921175493858755
complex O 0 2.407166721241083e-05
, O 0 3.2455456100421998e-09
properdin O 0 2.9690261271753116e-07
factor O 0 5.2941825146035626e-08
B O 0 8.532164201824344e-07
, O 0 4.341955267550546e-11
and O 0 2.0317612869913404e-10
deficiency B-Disease 0 1.8776780052576214e-05
of I-Disease 1 0.9574208855628967
the I-Disease 1 0.9999929666519165
second I-Disease 0 0.005134109407663345
component I-Disease 0 1.0343400163037586e-06
of I-Disease 0 1.0513746673268543e-07
complement I-Disease 0 2.394907824054826e-06
. O 0 1.6120899317684234e-06

The O 0 1.673066520879729e-07
relationship O 0 1.0340239775530335e-09
of O 0 4.677795040208821e-09
the O 0 7.764300313795047e-10
genes O 0 1.4254657176859808e-10
coding O 0 7.587106942708033e-09
for O 0 3.494774747370144e-10
HLA O 0 6.24878779831306e-08
to O 0 7.030215964931585e-09
those O 0 6.983836842167079e-10
coding O 0 1.8635583742820927e-08
for O 0 1.5085993565477906e-09
properdin O 0 1.2513348224274523e-07
Factor O 0 2.131081622280817e-08
B O 0 7.898530896000011e-08
allotypes O 0 1.1989450321436834e-08
and O 0 9.920117678696716e-12
for O 0 3.500645884280118e-10
deficiency B-Disease 0 9.181978555261594e-08
of I-Disease 0 2.3229529233503854e-07
the I-Disease 0 5.236516926743207e-07
second I-Disease 0 7.313227001759515e-08
component I-Disease 0 5.248045553685188e-08
of I-Disease 0 1.9341420909313456e-08
complement I-Disease 0 1.092138063540915e-06
( O 0 5.0714650257077665e-09
C2 O 0 4.452936536836205e-06
) O 0 1.1674568256569984e-10
was O 0 8.099908521685961e-10
studied O 0 3.2642821778949838e-09
in O 0 3.488308530918971e-10
families O 0 6.179290412688943e-11
of O 0 3.126368885997266e-10
patients O 0 2.895051309792507e-09
with O 0 1.0672299710634547e-09
connective O 1 0.9999532699584961
tissue O 1 1.0
disorders O 1 1.0
. O 0 2.2359217837220058e-06

Patients O 0 7.090075087035075e-07
were O 0 4.525865016091757e-09
selected O 0 6.581339917488549e-09
because O 0 6.161213206290483e-11
they O 0 2.182773684022976e-10
were O 0 1.2211068822765014e-09
heterozygous O 0 1.5481091963920335e-08
or O 0 1.0682855489108078e-08
homozygous O 0 1.2844967386627104e-05
for O 0 4.646597517421469e-05
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 1.586364533068263e-06

12 O 0 4.279867482637201e-07
families O 0 6.661481921632628e-10
with O 0 4.9617053521355814e-11
15 O 0 1.4665368475164087e-08
matings O 0 3.718051857504179e-07
informative O 0 7.217463007691549e-06
for O 0 3.291922985226847e-05
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 8.597748291094831e-08
found O 0 1.2862409803915398e-08
. O 0 3.9226954129389924e-08

Of O 0 3.201747404091293e-06
57 O 0 1.0141144457520568e-06
informative O 0 3.392755445474904e-07
meioses O 0 1.750885076035047e-06
, O 0 8.963593201016806e-10
two O 0 1.8455896533264848e-11
crossovers O 0 1.9871879142208115e-10
were O 0 4.079117044142322e-10
noted O 0 8.760278613628714e-10
between O 0 8.72765637538464e-10
the O 0 0.00026225182227790356
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 2.532507314967347e-09
and O 0 1.3045128866018274e-10
the O 0 1.8500392329201532e-09
HLA O 0 5.1046285420852655e-08
- O 0 1.4068491793750582e-07
B O 0 6.253998776628578e-07
gene O 0 5.590026774804358e-10
, O 0 3.0988503429973946e-11
with O 0 2.099214899131674e-12
a O 0 1.2548920236277183e-10
recombinant O 0 3.405572213122099e-10
fraction O 0 1.4533233505531484e-09
of O 0 1.2034148788586663e-08
0 O 0 2.833367034327239e-07
. O 0 4.877024935012741e-07

035 O 0 0.006228602025657892
. O 0 3.2748517696745694e-05

A O 0 3.537452073487657e-07
lod O 0 8.107294888759498e-06
score O 0 2.606697648843692e-07
of O 0 2.02557224326938e-08
13 O 0 1.0902368785536964e-08
was O 0 1.1682615985719735e-09
calculated O 0 1.0839951158914118e-09
for O 0 5.962914051416135e-10
linkage O 0 2.894854105761624e-06
between O 0 6.4467778429389e-05
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 2.5656217150782368e-09
HLA O 0 2.7584303552430356e-07
- O 0 2.3974800456016965e-07
B O 0 1.2426884268279537e-06
at O 0 2.407008814486744e-09
a O 0 5.508294861900076e-11
maximum O 0 4.2775125108640566e-10
likelihood O 0 1.2599908616461875e-10
value O 0 5.706633499080738e-10
of O 0 9.404126366518994e-10
the O 0 9.335054951264965e-10
recombinant O 0 1.2774824531547324e-09
fraction O 0 3.284065908104594e-09
of O 0 2.662644327244834e-09
0 O 0 5.997308960559167e-08
. O 0 1.3694319989099313e-07

04 O 0 0.00709800748154521
. O 0 2.8152959202998318e-05

18 O 0 1.9908134163415525e-07
families O 0 6.820261022610907e-10
with O 0 3.930006320373991e-11
21 O 0 2.108601293571155e-08
informative O 0 1.226642254437138e-08
matings O 0 1.8126280920682802e-08
for O 0 6.370209248984793e-09
both O 0 4.1344985213243035e-09
properdin O 0 9.383795713802101e-07
Factor O 0 2.931828930741176e-07
B O 0 8.818574315228034e-07
allotype O 0 1.8044273986106418e-07
and O 0 1.2444313357562464e-09
HLA O 0 1.0806213595060399e-06
- O 0 3.5174396089132642e-06
B O 0 1.6716145182726905e-05
were O 0 1.1975783031914489e-08
found O 0 6.207232949861918e-09
. O 0 4.6456634095193294e-08

Of O 0 6.8102967816230375e-06
72 O 0 6.207630121934926e-06
informative O 0 9.389685828864458e-07
meioses O 0 3.13428245135583e-06
, O 0 1.564326890246548e-09
three O 0 2.844290081238654e-10
recombinants O 0 8.795898764901722e-08
were O 0 3.623817912412619e-09
found O 0 1.1101098928989472e-09
, O 0 2.0372636910792608e-10
giving O 0 5.488057785996148e-10
a O 0 2.422011480263109e-10
recombinant O 0 1.0404337391634044e-09
fraction O 0 4.130833453075411e-09
of O 0 2.106836305415527e-08
0 O 0 4.6543419784939033e-07
. O 0 3.093558120781381e-07

042 O 0 0.0012011450016871095
. O 0 1.9358238205313683e-05

A O 0 8.703261755726999e-08
lod O 0 3.2366813229600666e-06
score O 0 1.2758204093188397e-07
of O 0 2.2671491350934048e-08
16 O 0 2.0463280847593524e-08
between O 0 3.499530942807638e-10
HLA O 0 8.468148848805868e-07
- O 0 2.723066018006648e-06
B O 0 6.375258635671344e-06
and O 0 2.7889360265653806e-10
Factor O 0 2.3981243657544837e-08
B O 0 2.612937066714949e-07
allotypes O 0 3.42880497328224e-08
was O 0 1.5956793664173574e-09
calculated O 0 2.974164248215061e-09
at O 0 1.482700073829335e-09
a O 0 8.746032370554602e-11
maximum O 0 7.168761140263769e-10
likelihood O 0 1.3615256144738908e-10
value O 0 6.046474432253035e-10
of O 0 4.474610959537273e-10
the O 0 3.891170441416847e-10
recombinant O 0 4.877364068178736e-10
fraction O 0 8.754248437270462e-10
of O 0 1.8140071667005486e-09
0 O 0 7.657708778197048e-08
. O 0 1.686378112708553e-07

04 O 0 0.006661862134933472
. O 0 3.0053130103624426e-05

A O 0 3.52591200680763e-08
crossover O 0 2.9865965256448135e-09
was O 0 1.9859272004651984e-09
shown O 0 3.0639818460187485e-10
to O 0 3.3947936128875256e-10
have O 0 2.8652793679362354e-11
occurred O 0 3.7197977337255494e-11
between O 0 1.472829887563809e-12
genes O 0 1.0985722748158011e-11
for O 0 2.4912835683288392e-11
Factor O 0 9.350149543507769e-10
B O 0 9.74729807978747e-09
and O 0 1.375560255978403e-11
HLA O 0 9.608469575539402e-09
- O 0 4.764875782825584e-08
D O 0 5.6043809593120386e-08
, O 0 2.1440894892865714e-10
in O 0 1.1958468937312006e-10
which O 0 9.8900974215832e-12
HLA O 0 4.834889377747231e-09
- O 0 4.461338320993491e-08
D O 0 1.4850419916001556e-07
segregared O 0 5.496684138961427e-07
with O 0 1.8869662776754836e-10
HLA O 0 4.463934715204232e-07
- O 0 7.168999900386552e-07
A O 0 1.524235017313913e-06
and O 0 7.932678514066538e-09
B O 0 3.497516081552021e-05
. O 0 4.9821682779338516e-08

These O 0 6.504119465233771e-09
studies O 0 2.8406048624418645e-09
suggest O 0 2.289859413195927e-09
that O 0 1.780636922632528e-11
the O 0 7.694417325510017e-11
genes O 0 6.507103189612451e-11
for O 0 1.926078047054247e-10
Factor O 0 3.0753969326724473e-07
B O 1 0.9999874830245972
and O 0 1.2351112673059106e-05
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 3.489706024151218e-10
located O 0 2.652013157689037e-11
outside O 0 3.381190882834062e-10
those O 0 3.0312658633180334e-11
for O 0 1.0558465213250656e-10
HLA O 0 1.5938338648879835e-08
, O 0 5.347260481625149e-11
that O 0 8.110582518094933e-12
the O 0 6.113778927563374e-11
order O 0 3.6194783281651155e-10
of O 0 2.994649528353932e-10
genese O 0 3.20579651713615e-08
is O 0 1.774676239296724e-11
HLA O 0 1.3243315333255623e-09
- O 0 5.685125703536187e-09
A O 0 2.9208992557983038e-08
, O 0 6.668813418153618e-11
- O 0 3.696882799886225e-10
B O 0 1.1453949788631235e-08
, O 0 1.320891746675601e-11
- O 0 6.325263646189683e-10
D O 0 7.187618500381632e-09
, O 0 9.263888961497102e-11
Factor O 0 5.038368655618797e-08
B O 0 1.0475616363692097e-05
allotype O 0 6.156577728688717e-05
, O 0 3.320366204206948e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 3.071477516769505e-10
that O 0 1.1120775307571495e-11
the O 0 6.900467697246171e-11
genes O 0 2.154584288760475e-10
coding O 0 5.454397751236684e-07
for O 0 1.7997492705035256e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 6.909690597467488e-10
Factor O 0 2.5395999969646255e-08
B O 0 7.370431376330089e-08
allotypes O 0 2.5863606811782347e-09
are O 0 7.91565868841354e-13
approximately O 0 1.0428044061941422e-12
3 O 0 1.1211673950350942e-11
- O 0 1.2911531566128787e-10
- O 0 1.8595949224931019e-09
5 O 0 4.419632215757474e-09
centimorgans O 0 7.359628284575592e-08
from O 0 7.907522414640766e-10
the O 0 1.0917886594796755e-09
HLA O 0 3.547992477592743e-08
- O 0 5.798850111204956e-08
A O 0 7.412852909283174e-08
and O 0 5.936835467679202e-10
HLA O 0 1.3451995073410217e-07
- O 0 7.641951071946096e-08
B O 0 1.3936755749455187e-07
loci O 0 9.805863898648681e-10
, O 0 5.2125998829810616e-12
and O 0 9.663293385961391e-13
that O 0 1.0558616697978196e-12
the O 0 1.0979486070317179e-10
apparent O 0 1.4719004681751358e-08
lack O 0 1.6830184677019133e-06
of O 0 1.586758031635327e-07
recombinants O 0 4.261401613803173e-07
between O 0 3.885963495431355e-10
the O 0 7.716940864099797e-09
Factor O 0 6.614995129439194e-08
B O 0 6.209353159647435e-06
gene O 0 7.886666253398289e-07
and O 0 6.568540356965968e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 1.2505964264164504e-07
suggests O 0 5.2775344094868615e-09
that O 0 7.600826218423506e-12
these O 0 7.117146282042963e-12
two O 0 2.9094405704088722e-11
genes O 0 3.3544625410719675e-10
lie O 0 2.6519602069896564e-09
in O 0 4.902041550458591e-10
close O 0 8.686622976483704e-09
proximity O 0 6.10294037528547e-08
to O 0 5.632189115090114e-08
one O 0 9.89624560077118e-09
another O 0 1.7124147433378312e-08
. O 0 1.8830586157037033e-07

Distribution O 0 4.665002251158512e-08
of O 0 3.737562082051227e-08
emerin O 0 7.819726306479424e-07
and O 0 1.6606942487840115e-09
lamins O 0 2.2522485778608825e-06
in O 0 3.492559486062419e-08
the O 0 2.2999483917374164e-07
heart O 0 1.1122408238861681e-07
and O 0 4.1434805586604284e-10
implications O 0 3.3540674682086546e-09
for O 0 3.934232939428739e-09
Emery B-Disease 1 0.9803956151008606
- I-Disease 1 1.0
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.00028678763192147017

Emerin O 0 0.001871477346867323
is O 0 7.626486819845013e-08
a O 0 1.0493348412410342e-08
nuclear O 0 9.12593378643578e-08
membrane O 0 3.8707657523673333e-08
protein O 0 2.7453324058512862e-09
which O 0 3.576769089241871e-11
is O 0 1.577502885263815e-11
missing O 0 1.7086780879083108e-09
or O 0 1.4121298574920615e-10
defective O 0 1.6418608694834802e-08
in O 0 1.9984026877750694e-08
Emery B-Disease 1 1.0
- I-Disease 1 1.0
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 5.473866693250784e-08
EDMD B-Disease 1 1.0
) O 0 7.79571873721352e-09
. O 0 5.856069762444349e-08

It O 0 3.1510170028781204e-09
is O 0 4.329525973845172e-11
one O 0 2.028522835817448e-11
member O 0 3.400490167226877e-10
of O 0 3.1618117013465508e-09
a O 0 3.4857713160363346e-08
family O 0 1.1391029453022838e-08
of O 0 6.040301059329067e-08
lamina O 0 0.00032129010651260614
- O 0 3.598364628487616e-06
associated O 0 2.0957391200226994e-07
proteins O 0 2.406984334069051e-10
which O 0 1.5714126180843557e-11
includes O 0 5.277488515642581e-11
LAP1 O 0 1.4976345141803904e-07
, O 0 6.749885650414456e-10
LAP2 O 0 1.1618244570854586e-06
and O 0 1.1091918494798847e-08
lamin O 0 7.64504584367387e-05
B O 0 2.357562152610626e-06
receptor O 0 3.978234275336945e-08
( O 0 1.7461149193209735e-09
LBR O 0 2.824630428222008e-06
) O 0 6.415519226976585e-09
. O 0 1.5132549435747933e-07

A O 0 6.1853993429394905e-06
panel O 0 1.863745495711555e-07
of O 0 2.885421857001802e-08
16 O 0 1.5967458466548123e-08
monoclonal O 0 6.232264038175117e-09
antibodies O 0 3.1313476256400463e-09
( O 0 4.343630455316827e-10
mAbs O 0 5.834440344187897e-07
) O 0 1.3851001456899326e-09
has O 0 2.3322088704702537e-10
been O 0 2.5306953754800077e-10
mapped O 0 1.8505050825012859e-09
to O 0 2.0412982415507486e-09
six O 0 1.7636160587475302e-10
specific O 0 7.531617690625936e-11
sites O 0 3.583797980599712e-10
throughout O 0 4.902939165774001e-10
the O 0 1.3185017522232556e-09
emerin O 0 1.2418166939198727e-08
molecule O 0 8.104354687343829e-11
using O 0 3.1027507230163565e-09
phage O 0 3.98685564562129e-08
- O 0 7.278241120900475e-09
displayed O 0 6.39044728245608e-09
peptide O 0 1.3506190610357294e-09
libraries O 0 2.554561673306921e-09
and O 0 1.2838180518670583e-10
has O 0 1.1342751390919226e-11
been O 0 1.3966360186412619e-11
used O 0 4.1693803964903964e-10
to O 0 4.028114286569462e-09
localize O 0 3.535590167302871e-07
emerin O 0 1.0059416126750875e-06
in O 0 5.328491869960317e-09
human O 0 1.174742081389013e-08
and O 0 1.8951448410575722e-08
rabbit O 0 3.3048590921680443e-06
heart O 0 7.550321697635809e-06
. O 0 4.084784450242296e-06

Several O 0 1.988750852888188e-07
mAbs O 0 3.998945430794265e-06
against O 0 8.015446972819973e-09
different O 0 1.5951681087145175e-09
emerin O 0 9.403028684573655e-07
epitopes O 0 5.241763574304059e-07
did O 0 8.460094846896027e-08
not O 0 7.87947751490492e-09
recognize O 0 7.675165392129202e-09
intercalated O 0 3.6545907278195955e-07
discs O 0 2.570683818703401e-06
in O 0 1.8341310692449042e-08
the O 0 4.284122212538932e-08
heart O 0 3.2070141742224223e-07
, O 0 4.3846676289760467e-10
though O 0 2.9623359321107046e-10
they O 0 2.572985990934029e-10
recognized O 0 3.275202109520592e-09
cardiomyocyte O 0 9.270353729107228e-08
nuclei O 0 2.343237781587959e-08
strongly O 0 4.279067411516735e-08
, O 0 7.427168879914348e-10
both O 0 1.6836384508778224e-09
at O 0 2.006354833383739e-07
the O 0 1.3250186725599633e-07
rim O 0 1.7478491542988195e-07
and O 0 5.708049033437135e-10
in O 0 1.5356449445391718e-09
intranuclear O 0 2.969847230360756e-07
spots O 0 5.157928839594206e-08
or O 0 6.378805039730651e-09
channels O 0 7.898259468674951e-08
. O 0 9.384353205632578e-08

A O 0 6.4921023295028135e-06
polyclonal O 0 2.7435560696176253e-05
rabbit O 0 4.366246685094666e-06
antiserum O 0 5.632856300508138e-06
against O 0 5.144419290559199e-08
emerin O 0 3.1275940273189917e-06
did O 0 3.3111578545685916e-07
recognize O 0 2.219439210193741e-07
both O 0 2.3298456497400366e-08
nuclear O 0 5.631125077343313e-07
membrane O 0 2.4402800136158476e-07
and O 0 1.4000647308165526e-09
intercalated O 0 1.0500720293293853e-07
discs O 0 8.266039941418057e-08
but O 0 3.19331339149187e-10
, O 0 3.848711627174595e-11
after O 0 1.0969983255115778e-10
affinity O 0 2.379223484894055e-10
purification O 0 2.080221550571082e-09
against O 0 3.0505059589458483e-10
a O 0 2.2843268943084638e-10
pure O 0 7.850404770692876e-09
- O 0 1.1044376968527558e-08
emerin O 0 2.763715087894525e-07
band O 0 9.34931776441772e-08
on O 0 1.857068454569344e-08
a O 0 3.0938747119790833e-09
western O 0 3.0886049273703975e-08
blot O 0 8.319682933688455e-07
, O 0 1.0189272758864831e-09
it O 0 1.8985402139293228e-10
stained O 0 5.395718361000945e-08
only O 0 2.2704755853197867e-09
the O 0 1.4351401178558376e-09
nuclear O 0 8.853395172536693e-08
membrane O 0 6.33709134945093e-07
. O 0 6.271546340030909e-07

These O 0 1.3955038014046295e-08
results O 0 3.4657883229982644e-09
would O 0 5.463002827887919e-10
not O 0 6.891221621119215e-11
be O 0 6.029668431217772e-11
expected O 0 6.444644262693089e-10
if O 0 1.3203539372952378e-09
immunostaining O 0 1.4143314785997063e-07
at O 0 1.466257248949887e-08
intercalated O 0 1.795431074924636e-07
discs O 0 2.8853924050054047e-07
were O 0 3.074298149385868e-09
due O 0 1.6868181518248093e-08
to O 0 4.82737005924605e-09
a O 0 3.195701758773595e-10
product O 0 4.88341422855143e-10
of O 0 8.006793561499137e-10
the O 0 4.05563627126071e-09
emerin O 0 3.5529910746845417e-07
gene O 0 7.314856276252613e-09
and O 0 8.637615622753003e-10
, O 0 1.4590358088373279e-10
therefore O 0 1.5145760201562553e-09
, O 0 3.894308833740645e-11
cast O 0 4.709151402160217e-10
some O 0 1.552063477738841e-10
doubt O 0 2.8986921751794625e-09
upon O 0 1.61214719351932e-09
the O 0 2.458591774612273e-09
hypothesis O 0 9.650419130480259e-09
that O 0 6.504236732540747e-11
cardiac B-Disease 0 2.2023064957465976e-05
defects I-Disease 0 3.068481873924611e-06
in O 0 1.2285275374779303e-07
EDMD B-Disease 1 1.0
are O 0 1.3144164645595424e-09
caused O 0 2.9913613253107485e-10
by O 0 3.513165452995182e-11
absence O 0 2.7395230972615536e-07
of O 0 5.359961008366554e-08
emerin O 0 5.932612111791968e-06
from O 0 4.248618878932575e-08
intercalated O 0 4.205860022921115e-05
discs O 0 0.00015168129175435752
. O 0 9.867549124464858e-07

Although O 0 2.172693456259367e-07
emerin O 0 1.8818159333022777e-06
was O 0 1.333235655209819e-08
abundant O 0 9.526206490306777e-09
in O 0 1.7888734937798745e-09
the O 0 3.5246483065520806e-08
membranes O 0 5.779575644737633e-07
of O 0 8.72667893503376e-09
cardiomyocyte O 0 1.3847494706453745e-08
nuclei O 0 5.743071018748935e-10
, O 0 5.0664326900484724e-11
it O 0 2.021917529237971e-11
was O 0 5.8676050684880465e-09
absent O 0 1.2435143048605823e-07
from O 0 2.2541777333628943e-09
many O 0 1.6748488707030162e-10
non O 0 2.0318291049647996e-08
- O 0 5.910298916944612e-09
myocyte O 0 1.378431022658333e-07
cells O 0 3.614250898564819e-09
in O 0 8.810868146191808e-10
the O 0 7.023903236813567e-09
heart O 0 1.5362425642706512e-07
. O 0 4.918539389109355e-07

This O 0 4.094615757566089e-09
distribution O 0 2.3381960811974523e-09
of O 0 3.160786743450217e-09
emerin O 0 3.026585204679577e-07
was O 0 6.9963324023092355e-09
similar O 0 1.7533627327814827e-10
to O 0 1.0648590897943677e-09
that O 0 5.904399885681144e-11
of O 0 1.0761482815979662e-09
lamin O 0 1.407403601660917e-06
A O 0 3.146028149103586e-08
, O 0 2.851884284282846e-10
a O 0 2.907977469934764e-10
candidate O 0 5.280934578522078e-10
gene O 0 7.066726093185594e-10
for O 0 1.3285514910421625e-09
an O 0 1.6386501044962642e-09
autosomal O 0 1.3627355599510338e-07
form O 0 6.292094667514903e-08
of O 0 1.2371364391583484e-05
EDMD B-Disease 1 1.0
. O 0 4.726767201645998e-06

In O 0 1.422332047695818e-07
contrast O 0 1.3160445178073132e-07
, O 0 2.9298041326342172e-08
lamin O 0 0.0005467009614221752
B1 O 0 0.002628699643537402
was O 0 2.273554855491966e-06
absent O 0 1.2336585314187687e-05
from O 0 4.212268223113824e-08
cardiomyocyte O 0 2.444665767598053e-07
nuclei O 0 8.865389311552008e-09
, O 0 1.9621539948389e-09
showing O 0 1.2324305487254605e-07
that O 0 2.0291645697056993e-08
lamin O 0 0.0017216687556356192
B1 O 0 4.3095631554024294e-05
is O 0 3.311634022562515e-10
not O 0 1.2261779092082037e-10
essential O 0 1.0699046093520792e-08
for O 0 9.041307702517543e-10
localization O 0 4.175379672233248e-06
of O 0 9.456007887820306e-08
emerin O 0 3.743787601706572e-06
to O 0 5.4883457778487355e-08
the O 0 3.318763575066441e-08
nuclear O 0 1.5468392575712642e-06
lamina O 0 0.0013910739216953516
. O 0 4.859451564698247e-06

Lamin O 1 0.9999996423721313
B1 O 1 0.6837321519851685
is O 0 2.1243165448936452e-08
also O 0 2.42368103364754e-09
almost O 0 1.2899501466989705e-09
completely O 0 6.177388911510207e-08
absent O 0 1.0031490091932938e-06
from O 0 6.027917009987505e-08
skeletal O 0 8.538328074791934e-06
muscle O 0 7.046018026812817e-07
nuclei O 0 1.138742163675488e-06
. O 0 1.6463285419376916e-06

In O 0 1.462600494051003e-06
EDMD B-Disease 1 1.0
, O 0 4.895288174822099e-09
the O 0 6.09247929883594e-10
additional O 0 2.67074184989724e-09
absence O 0 1.6577841677190008e-07
of O 0 1.674469558565761e-07
lamin O 1 0.9999873638153076
B1 O 1 0.9999948740005493
from O 0 8.328995022566232e-07
heart O 1 0.9999998807907104
and O 0 8.413655450567603e-06
skeletal O 1 1.0
muscle O 0 2.029118695645593e-05
nuclei O 0 8.979343846249321e-08
which O 0 6.003727293091288e-09
already O 0 3.474041498918723e-09
lack O 0 1.4108853463312698e-07
emerin O 0 1.3862764944860828e-06
may O 0 7.205613439253966e-09
offer O 0 2.5711277551465628e-09
an O 0 1.9629568803747333e-11
alternative O 0 3.625187039446587e-09
explanation O 0 2.3775610813459025e-08
of O 0 1.6038691486031098e-09
why O 0 7.704808346886693e-09
these O 0 8.596690581619271e-10
tissues O 0 6.106119343485261e-08
are O 0 1.3784710872766226e-10
particularly O 0 2.5660462643628534e-10
affected O 0 1.6798909485693514e-10
. O 0 1.8776507015871857e-09
. O 0 9.291329661209602e-08

Genetic O 0 2.780446948236204e-07
mapping O 0 7.52572688611508e-08
of O 0 3.1787926957349555e-08
the O 0 1.3627719397391047e-07
copper B-Disease 0 1.4311616723716725e-05
toxicosis I-Disease 0 0.000559302163310349
locus O 0 5.098897304378625e-07
in O 0 3.026082850965395e-08
Bedlington O 0 7.443828053510515e-06
terriers O 0 1.1191093562956667e-06
to O 0 5.021090743184686e-08
dog O 0 3.3318926284664485e-08
chromosome O 0 7.305162585957703e-10
10 O 0 9.61407398136771e-10
, O 0 1.7475824606871804e-11
in O 0 6.354984594114654e-11
a O 0 5.635073518917011e-10
region O 0 9.64776369904996e-10
syntenic O 0 9.60184109999318e-08
to O 0 3.0452229626831695e-09
human O 0 1.4549957905174438e-09
chromosome O 0 3.1072875383841847e-09
region O 0 1.3441178836615109e-08
2p13 O 0 1.2748229892167728e-05
- O 0 3.0984231216280023e-06
p16 O 0 7.6288961281534284e-06
. O 0 7.132447308322298e-07

Abnormal O 1 1.0
hepatic B-Disease 1 1.0
copper I-Disease 0 0.0012966468930244446
accumulation I-Disease 0 2.3241673261509277e-05
is O 0 4.421956967259888e-10
recognized O 0 2.660673348309217e-10
as O 0 3.3227887108466803e-10
an O 0 5.464931285281693e-10
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 0 1.3635806794809469e-07
man O 0 2.852910085948679e-08
, O 0 6.75248634784964e-10
mouse O 0 6.016362164018574e-08
, O 0 5.129503932721491e-09
rat O 0 1.944390078278957e-06
and O 0 1.4738283482529368e-07
dog O 0 0.00023451562447007746
. O 0 2.4036364266066812e-05

The O 0 9.305727530772856e-07
major O 0 2.959115761314024e-07
cause O 0 1.266605977434665e-06
of O 0 6.805037173762685e-07
hepatic B-Disease 1 0.9999997615814209
copper I-Disease 1 0.9999512434005737
accumulation I-Disease 1 0.9999855756759644
in O 0 2.502625466149766e-05
man O 0 7.552414444944588e-07
is O 0 1.1097182062158595e-09
a O 0 2.424892509012011e-09
dysfunctional O 0 8.152129638006045e-09
ATP7B O 0 2.25029270950472e-06
gene O 0 2.49382594574854e-08
, O 0 2.2624220274991558e-09
causing O 0 1.926410497787856e-08
Wilson B-Disease 0 2.661922735569533e-06
disease I-Disease 0 1.936856079964855e-07
( O 0 3.5679201260130355e-10
WD B-Disease 0 3.952960014430573e-06
) O 0 2.5712029838587114e-08
. O 0 2.8380782168824226e-07

Mutations O 0 8.898493319975387e-07
in O 0 3.9822808162170986e-08
the O 0 7.24867916801486e-08
ATP7B O 0 5.065028290118789e-06
genes O 0 1.1285667511629072e-08
have O 0 9.44547218217906e-10
also O 0 3.290622774265728e-10
been O 0 1.5686495158373504e-10
demonstrated O 0 1.2663038395643866e-09
in O 0 5.336638686515016e-09
mouse O 0 1.9732676719286246e-06
and O 0 2.2457983561707806e-07
rat O 0 4.3725445721065626e-05
. O 0 1.3070068689557957e-06

The O 0 4.653122232411988e-06
ATP7B O 0 0.00014490133617073298
gene O 0 2.5354529498144984e-07
has O 0 9.658535082834874e-10
been O 0 1.2819681427522767e-10
excluded O 0 1.2913631275424109e-09
in O 0 3.104916046492434e-10
the O 0 1.6464699603702115e-09
much O 0 1.0693653740290188e-09
rarer O 0 6.226374011930602e-07
human O 0 2.081650336549501e-07
copper B-Disease 0 0.0004365575732663274
overload I-Disease 0 0.22291573882102966
disease O 0 6.132097041700035e-05
non B-Disease 0 3.503352672851179e-06
- I-Disease 0 3.5460988101476687e-07
Indian I-Disease 0 2.760835116077942e-08
childhood I-Disease 0 1.0083678034789045e-06
cirrhosis I-Disease 0 4.265151801519096e-06
, O 0 6.253348949769588e-10
indicating O 0 1.2165765284066765e-08
genetic O 0 1.1472732097672633e-08
heterogeneity O 0 5.309573793965683e-07
. O 0 5.157860414328752e-07

By O 0 1.7774932636882568e-09
investigating O 0 1.5987197121702934e-09
the O 0 4.512599183215116e-09
common O 0 2.8432197041183827e-07
autosomal O 1 0.999992847442627
recessive O 1 0.999987006187439
copper B-Disease 1 0.9999834299087524
toxicosis I-Disease 1 0.9999998807907104
( O 0 2.2974935287578546e-09
CT B-Disease 0 0.00013088894775137305
) O 0 6.698775423252812e-10
in O 0 1.8075564156561086e-08
Bedlington O 0 0.00015348817396443337
terriers O 0 1.1549328519322444e-05
, O 0 1.8346131280821965e-09
we O 0 1.636776048030697e-09
have O 0 7.499164483837362e-11
identified O 0 1.9067672440975514e-10
a O 0 5.84397669145531e-11
new O 0 3.208656118580677e-10
locus O 0 1.848268649240481e-09
involved O 0 3.557529826281325e-10
in O 0 5.284101156632914e-09
progressive O 1 0.9999998807907104
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 7.49079731576785e-07

We O 0 1.0934130756368177e-07
examined O 0 8.181401511819786e-08
whether O 0 1.119299497531756e-08
the O 0 3.348335653186041e-08
WD B-Disease 0 4.345603156252764e-05
gene O 0 1.5125090158107923e-06
ATP7B O 0 0.00048490057815797627
was O 0 2.0540360878840147e-07
also O 0 6.135124075434817e-10
causative O 0 2.316687952585994e-09
for O 0 4.457319235928736e-10
CT B-Disease 0 7.461418135790154e-06
by O 0 6.020776655013549e-10
investigating O 0 2.4561124245536803e-09
the O 0 7.160593451516206e-09
chromosomal O 0 3.046596361855336e-07
co O 0 3.173967684233503e-07
- O 0 1.061030843629851e-06
localization O 1 0.9897270798683167
of O 0 4.5351839617069345e-06
ATP7B O 0 4.01520446757786e-05
and O 0 1.1514751374619436e-09
C04107 O 0 1.3464175196986616e-07
, O 0 5.699147057058873e-11
using O 0 1.4937155679017877e-10
fluorescence O 0 9.42016242788668e-09
in O 0 8.49675085845547e-09
situ O 0 1.2225988257341669e-06
hybridization O 0 2.7726398954541764e-08
( O 0 7.356815157066876e-10
FISH O 0 1.530936373228542e-07
) O 0 2.180615021885046e-09
. O 0 9.390100785822142e-08

C04107 O 0 0.0001546385756228119
is O 0 1.6878189512681274e-08
an O 0 1.0755183410537938e-09
anonymous O 0 1.368324298312018e-08
microsatellite O 0 2.1481405099166295e-07
marker O 0 2.6120775942217733e-07
closely O 0 3.0652184790369574e-08
linked O 0 3.7811255992892256e-07
to O 0 9.172664476864156e-07
CT B-Disease 1 1.0
. O 0 3.4219439839944243e-05

However O 0 1.3489664070220897e-06
, O 0 7.050832095956139e-08
BAC O 0 1.2713384421658702e-05
clones O 0 4.1293864683211723e-07
containing O 0 7.437127180764946e-08
ATP7B O 0 5.450276603369275e-06
and O 0 4.59714577516479e-09
C04107 O 0 9.846107786870562e-07
mapped O 0 4.869736969226324e-08
to O 0 3.7062974911350466e-08
the O 0 4.3878177535816576e-08
canine O 0 2.448756504236371e-07
chromosome O 0 2.1883952427970144e-08
regions O 0 3.938474879561227e-09
CFA22q11 O 0 1.1502341976665775e-06
and O 0 1.2924843417749798e-09
CFA10q26 O 0 8.459979881081381e-07
, O 0 2.419162925537677e-10
respectively O 0 1.6575297800969224e-09
, O 0 1.2293321915990418e-10
demonstrating O 0 3.161956474428962e-09
that O 0 1.214750522393615e-10
WD B-Disease 0 2.709518298615876e-07
cannot O 0 1.4025056671584935e-08
be O 0 1.550289119300885e-09
homologous O 0 3.4876581622711456e-09
to O 0 1.0542039774463774e-07
CT B-Disease 0 0.010736250318586826
. O 0 4.074769549333723e-06

The O 0 9.538839549350087e-06
copper O 0 2.0812565253436333e-06
transport O 0 9.552537960644258e-08
genes O 0 5.465353680733642e-08
CTR1 O 0 7.898507647041697e-06
and O 0 5.14327869183262e-09
CTR2 O 0 1.5114524103410076e-05
were O 0 2.8669621343624385e-08
also O 0 2.2997206361452527e-09
excluded O 0 2.951858091293502e-09
as O 0 4.621099336521439e-10
candidate O 0 9.366678543898388e-10
genes O 0 3.7175229561370315e-10
for O 0 1.8586268080156287e-09
CT B-Disease 0 0.00016581869567744434
since O 0 1.1755000883795219e-07
they O 0 9.332657313620984e-09
both O 0 3.0119964300467927e-09
mapped O 0 7.523372858031507e-08
to O 0 3.652046842717027e-08
canine O 0 4.2896826357718965e-07
chromosome O 0 1.2005152427718713e-07
region O 0 1.2292635176436306e-07
CFA11q22 O 0 8.84920809767209e-05
. O 0 2.958101276817615e-06

2 O 0 1.440369828742405e-06
- O 0 3.855944214592455e-06
22 O 0 2.039662604147452e-06
. O 0 9.326144549959281e-07

5 O 0 2.0656747437897138e-05
. O 0 5.040347787144128e-06

A O 0 2.621555950099719e-07
transcribed O 0 7.259718159957629e-09
sequence O 0 7.947683067222044e-10
identified O 0 1.3331383774684014e-09
from O 0 3.1419655766029564e-10
the O 0 1.2876345545365098e-09
C04107 O 0 4.011233656342483e-08
- O 0 5.20035348117176e-09
containing O 0 3.7174449629695516e-10
BAC O 0 3.587488492939883e-07
was O 0 1.6931835933320372e-09
found O 0 3.390805691783072e-11
to O 0 4.144229404090538e-11
be O 0 4.901599265361156e-11
homologous O 0 6.273607328077802e-11
to O 0 9.311813542467462e-10
a O 0 2.2752573158868472e-09
gene O 0 9.969982173174685e-09
expressed O 0 2.0857997551360086e-09
from O 0 2.4881945392962734e-09
human O 0 3.330137499091279e-09
chromosome O 0 3.233792789103518e-09
2p13 O 0 1.302885976883772e-07
- O 0 1.4609755183414563e-08
p16 O 0 3.5702520051472675e-08
, O 0 1.697729457017516e-10
a O 0 3.8709316307894426e-10
region O 0 6.579040090493038e-10
devoid O 0 3.4519953118206104e-08
of O 0 6.30049568073332e-10
any O 0 3.05710512460422e-10
positional O 0 2.2033479751826235e-07
candidate O 0 1.0339537936943088e-07
genes O 0 7.041383298656001e-08
. O 0 8.684289127813827e-07

Molecular O 0 5.226378974043655e-08
analysis O 0 6.059592827512006e-09
of O 0 1.0851209708562237e-08
the O 0 2.1858838294974703e-08
APC B-Disease 0 4.714296863994605e-08
gene O 0 1.6821619652773734e-09
in O 0 1.2430957374576224e-09
205 O 0 3.3401947874267535e-09
families O 0 2.6056404256458165e-10
: O 0 2.8641386484729026e-10
extended O 0 4.124355967860538e-08
genotype O 0 1.6360814925064915e-07
- O 0 2.6231614924654423e-07
phenotype O 0 1.4839994122439748e-08
correlations O 0 1.529147586332158e-09
in O 0 4.776044004728419e-10
FAP B-Disease 0 1.7098983562391368e-08
and O 0 2.646061147970613e-11
evidence O 0 1.9053093824883405e-10
for O 0 6.69712410528156e-11
the O 0 2.844067759077973e-10
role O 0 4.203822623338738e-09
of O 0 1.9184170696462388e-08
APC B-Disease 0 5.970681371536557e-08
amino O 0 4.587213275897284e-09
acid O 0 5.219771281872454e-09
changes O 0 1.356154211151761e-08
in O 0 2.840735760401003e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 1 0.9789696931838989
. O 0 2.6704331048676977e-06

BACKGROUND O 0 2.138058334821835e-05
/ O 0 5.3528374337474816e-06
AIMS O 0 1.5850081354074064e-06
The O 0 1.3450308422591206e-08
development O 0 5.5851621993951994e-08
of O 0 1.5381028788397089e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 2.9802079026808315e-08
a O 0 1.1372333075243546e-09
variable O 0 3.6638569955727007e-09
range O 0 1.98267979811817e-09
of O 0 5.176284401109399e-10
extracolonic O 0 5.2874714384643084e-08
manifestations O 0 8.070892221212489e-08
in O 0 7.337510510296852e-07
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 1.140313887759703e-08
FAP B-Disease 0 2.7885459985554917e-07
) O 0 6.494641630050424e-11
is O 0 1.6770503388774394e-11
the O 0 7.714696242944186e-11
result O 0 1.6077182640739096e-10
of O 0 1.2810497107551555e-09
the O 0 5.528319135805759e-09
dominant O 0 2.7142297298610174e-08
inheritance O 0 6.706624162688968e-07
of O 0 2.6825042368727736e-05
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 4.765154937302896e-09
APC B-Disease 0 7.431199833263236e-08
) O 0 5.224768950817804e-10
gene O 0 5.6084417110469076e-09
mutations O 0 4.160296640520755e-08
. O 0 5.173087060938997e-07

In O 0 3.216607069589372e-08
this O 0 7.502429788530662e-10
study O 0 2.4840346446453054e-10
, O 0 3.78262829045517e-12
direct O 0 7.722513600816328e-11
mutation O 0 9.71050947984331e-11
analysis O 0 2.358075679165239e-10
of O 0 1.1146565892516946e-09
the O 0 8.406943585725912e-09
APC B-Disease 0 2.2741520666613724e-08
gene O 0 1.433613561196978e-09
was O 0 7.288409875627622e-09
performed O 0 8.313248756053326e-09
to O 0 5.814274839366362e-09
determine O 0 5.534153579844769e-09
genotype O 0 1.0744182077360165e-07
- O 0 2.09096185699309e-07
phenotype O 0 1.966868801162036e-08
correlations O 0 2.553563138718573e-09
for O 0 2.6849509282556028e-09
nine O 0 1.380342395940204e-09
extracolonic O 0 6.223144310979478e-08
manifestations O 0 6.182656164810396e-09
and O 0 1.7402422558543407e-10
to O 0 5.421392224036481e-09
investigate O 0 3.901866829636447e-09
the O 0 1.7587126199813952e-09
incidence O 0 6.970016102059162e-07
of O 0 3.203192733280957e-08
APC B-Disease 0 2.004008479161712e-07
mutations O 0 3.8354071030255454e-09
in O 0 3.166689666045386e-08
non O 1 1.0
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.7073612727690488e-05

METHODS O 0 4.380235623102635e-06
The O 0 3.2274883210448024e-07
APC B-Disease 0 4.1046703813663044e-07
gene O 0 2.1081708823089684e-08
was O 0 3.9583053279557134e-08
analysed O 0 1.4824094840548696e-08
in O 0 1.4026172445724683e-09
190 O 0 7.475579266724708e-09
unrelated O 0 7.720033501357193e-09
FAP B-Disease 0 3.5859827107742603e-08
and O 0 1.2219472655949914e-10
15 O 0 1.7757352921421443e-08
non O 0 0.0031748490873724222
- O 1 0.9999575614929199
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 2.531874372380116e-07
using O 0 2.032242818472696e-09
denaturing O 0 1.7249361405902164e-07
gradient O 0 3.1208653439307454e-09
gel O 0 1.1572951486016336e-08
electrophoresis O 0 7.493934917057743e-10
, O 0 7.110922267683506e-11
the O 0 2.0708029735416744e-10
protein O 0 2.7897326809744882e-11
truncation O 0 5.713475914603805e-09
test O 0 1.866987009435661e-09
, O 0 3.588002464582907e-11
and O 0 2.0416583354498918e-11
direct O 0 7.881698071976473e-10
sequencing O 0 4.612087067812354e-08
. O 0 2.2643277475253853e-07

RESULTS O 0 4.3650061343214475e-06
Chain O 0 1.126990483157897e-07
terminating O 0 6.209592129380326e-08
signals O 0 2.624857486921428e-08
were O 0 1.7044108346908615e-09
only O 0 1.8228366038819388e-10
identified O 0 2.973635504499583e-10
in O 0 7.640059418445588e-11
patients O 0 2.532100362717671e-10
belonging O 0 3.100477374839983e-10
to O 0 2.0178436699325175e-09
the O 0 8.661013239930071e-09
FAP B-Disease 0 2.970685670788953e-07
group O 0 4.565615663310041e-10
( O 0 1.891606489501374e-11
105 O 0 1.9692373953716924e-08
patients O 0 1.6999702978637288e-08
) O 0 1.615508504748675e-09
. O 0 2.390519000528002e-07

Amino O 0 4.6083238203209476e-07
acid O 0 2.2407744992847256e-08
changes O 0 8.588938449349826e-10
were O 0 2.556217459925847e-10
identified O 0 2.0357023011730035e-10
in O 0 1.4151578520138486e-10
four O 0 1.0995580834727292e-10
patients O 0 5.2066906341963204e-11
, O 0 1.709751264178383e-12
three O 0 5.256379533025157e-12
of O 0 3.0007385465324887e-10
whom O 0 4.672810138828254e-09
belonged O 0 1.794511604202853e-06
to O 0 3.488373522486654e-06
the O 0 1.810864432627568e-06
non O 0 0.03024759329855442
- O 0 2.4036987724684877e-06
FAP O 0 2.0448492250579875e-06
group O 0 9.2861709433123e-09
of O 0 6.212541734385013e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.999997615814209
. O 0 2.030395535257412e-06

Genotype O 0 0.0001347032084595412
- O 0 1.886948120954912e-05
phenotype O 0 3.4592986253301206e-07
correlations O 0 7.139495661334649e-09
identified O 0 3.4121605541059807e-09
significant O 0 2.1733610466867503e-09
differences O 0 6.564202958969645e-09
in O 0 1.227836055051057e-08
the O 0 3.8183145534276264e-08
nature O 0 2.9610720542194713e-09
of O 0 1.184083719962814e-09
certain O 0 3.7023606402897258e-09
extracolonic O 0 2.1335611677386623e-07
manifestations O 0 2.0261129662912936e-08
in O 0 1.8190414730057114e-09
FAP B-Disease 0 1.4691650562781433e-07
patients O 0 1.7647104888496301e-09
belonging O 0 4.6264173048093937e-10
to O 0 2.3216599753794753e-09
three O 0 9.727476601995022e-10
mutation O 0 5.317648543723408e-09
subgroups O 0 4.3371443325668224e-08
. O 0 1.173281418687111e-07

CONCLUSIONS O 0 7.484537036361871e-06
Extended O 0 1.5080813682288863e-06
genotype O 0 8.083786156021233e-07
- O 0 5.786994279333157e-07
phenotype O 0 4.6662393060614704e-08
correlations O 0 5.143572678889541e-09
made O 0 6.805914165575189e-10
in O 0 1.7559564913227632e-10
this O 0 4.0757473784847065e-11
study O 0 3.770730602759009e-11
may O 0 4.078671775320508e-11
have O 0 1.8727450146194258e-11
the O 0 6.597911106354104e-11
potential O 0 3.35593254574551e-11
to O 0 2.470073590110644e-10
determine O 0 1.3538997700734967e-09
the O 0 4.286146992882323e-09
most O 0 6.485125769728484e-10
appropriate O 0 4.348293458633634e-08
surveillance O 0 1.6088800975921913e-06
and O 0 5.57333690309747e-09
prophylactic O 0 5.968501136521809e-05
treatment O 0 1.3079204563837266e-07
regimens O 0 2.2435669322362628e-08
for O 0 2.460270043247448e-10
those O 0 5.280489240311326e-11
patients O 0 2.0174460713118236e-10
with O 0 2.3825863157411753e-12
mutations O 0 2.042609831276465e-10
associated O 0 6.310995614988713e-10
with O 0 3.304464341047364e-11
life O 0 8.788834549022795e-09
threatening O 0 5.54688739384801e-09
conditions O 0 5.365085442576856e-08
. O 0 1.2179945940715697e-07

This O 0 5.046688045240444e-08
study O 0 5.0462807266171694e-09
also O 0 1.0384428039689197e-10
provided O 0 8.544702445600905e-11
evidence O 0 8.372307708226501e-11
for O 0 8.417846975028453e-11
the O 0 1.2447066710663535e-09
pathological O 0 5.996131591246012e-08
nature O 0 3.2244618086707533e-09
of O 0 1.4534924375197988e-09
amino O 0 1.18918985769767e-09
acid O 0 1.4979960605288056e-09
changes O 0 1.474923738697953e-09
in O 0 6.195936652630962e-09
APC O 0 2.1079684131564136e-07
associated O 0 2.990092085042306e-08
with O 0 1.5530229879878732e-10
both O 0 7.601935747558741e-10
FAP B-Disease 0 1.9030304443390378e-08
and O 0 6.109165950896056e-10
non O 0 0.004732509143650532
- O 1 0.9999011754989624
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 5.888309260626556e-06
. O 0 2.9149314073606547e-09
. O 0 1.5427296773395938e-08

Inherited B-Disease 1 1.0
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 0 4.803190677193925e-06
cancer B-Disease 1 0.9992266893386841
risk O 0 2.1223913790890947e-05
of O 0 4.189599712844938e-05
the O 0 0.16028346121311188
APC O 0 8.474482456222177e-05
I1307K O 0 7.943434320623055e-05
polymorphism O 0 1.616377289792581e-06
. O 0 4.026695705761085e-07

Germ O 0 9.618951298762113e-05
- O 0 1.3323074199433904e-06
line O 0 5.5185772396271204e-08
and O 0 7.048781558438577e-10
somatic O 0 5.374743849984043e-08
truncating O 0 1.8825090819518664e-07
mutations O 0 1.6741253716645588e-08
of O 0 1.0844527054132413e-08
the O 0 4.970360834022358e-08
APC B-Disease 0 4.800414998840097e-08
gene O 0 6.287988796316313e-09
are O 0 5.242697942442476e-10
thought O 0 1.5584667778512085e-08
to O 0 2.5174490048129883e-08
initiate O 0 2.984900902447407e-06
colorectal B-Disease 1 1.0
tumor I-Disease 0 2.393893555563409e-05
formation O 0 1.7939112240128452e-07
in O 0 4.792529466612905e-07
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 2.2723454549122835e-06
sporadic O 1 0.9999997615814209
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 0 2.1497120542335324e-05
respectively O 0 3.308922168798745e-05
. O 0 2.5880406155920355e-06

Recently O 0 3.187496417922375e-07
, O 0 9.480053408950084e-10
an O 0 1.9099520576215667e-10
isoleucine O 0 1.470866948238836e-07
- O 0 1.8921795685855614e-08
- O 0 3.24875522039747e-08
> O 0 4.4712880509223396e-08
lysine O 0 7.5542700983533e-09
polymorphism O 0 9.801152112132172e-10
at O 0 1.014333617099794e-09
codon O 0 1.6669943647684704e-08
1307 O 0 1.4911472590029007e-07
( O 0 1.2469325572084244e-10
I1307K O 0 7.106525146127751e-08
) O 0 1.6494079713158527e-10
of O 0 9.118826249654433e-10
the O 0 1.4609699228174122e-08
APC B-Disease 0 1.2381924818782863e-07
gene O 0 4.688343935299599e-09
has O 0 3.457947123086669e-11
been O 0 1.8430463752383552e-11
identified O 0 1.1884516808169376e-11
in O 0 1.0378461978710618e-11
6 O 0 5.15325282446355e-10
% O 0 2.88175455720463e-11
- O 0 2.8789157169306634e-10
7 O 0 1.5934439323572747e-09
% O 0 1.4957340921384343e-10
of O 0 3.069468568206446e-10
the O 0 5.923657675488414e-10
Ashkenazi O 0 2.8407905361405028e-08
Jewish O 0 6.337971036884937e-09
population O 0 7.162907766922189e-11
. O 0 3.4297451545484137e-09

To O 0 2.5321278940282355e-07
assess O 0 1.1148484873046982e-06
the O 0 2.723169423290983e-08
risk O 0 2.5298149353147892e-08
of O 0 1.9891228664192795e-09
this O 0 4.781275930731965e-10
common O 0 1.4708614326508496e-09
APC B-Disease 0 2.2261160026459947e-08
allelic O 0 2.1339777944717753e-08
variant O 0 8.820023111866249e-08
in O 0 9.833348713073065e-08
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 0 1.937398508289334e-08
we O 0 5.435504046857886e-09
have O 0 3.018890970540866e-10
analyzed O 0 1.2795454695790909e-09
a O 0 7.180653294192041e-10
large O 0 4.251095031548857e-10
cohort O 0 2.265124692257814e-07
of O 0 1.1119904996803598e-07
unselected O 0 0.00021777789515908808
Ashkenazi O 0 1.0336701961932704e-05
Jewish O 0 4.918736635772802e-07
subjects O 0 6.07696847509942e-07
with O 0 2.0737209727172967e-09
adenomatous B-Disease 0 0.000132967354147695
polyps I-Disease 0 3.818031018454349e-06
and O 0 3.7985384282457346e-10
. O 0 4.828088595587587e-09
or O 0 0.049563124775886536
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 4.8865967272604394e-08
for O 0 5.2314753418158944e-08
the O 0 1.4507949117614771e-06
APC O 0 3.1916715670377016e-06
I1307K O 0 4.51216374131036e-06
polymorphism O 0 6.588828114217904e-07
. O 0 3.4665907833186793e-07

The O 0 7.277672011696268e-06
APC O 0 5.072095063951565e-06
I1307K O 0 3.7160705232963664e-06
allele O 0 4.936066844152265e-08
was O 0 4.012685295151641e-09
identified O 0 1.1726416504487247e-09
in O 0 8.407821661116088e-10
48 O 0 2.4958483280101973e-08
( O 0 4.2065698147020214e-11
10 O 0 2.095924406253502e-10
. O 0 3.533440207093008e-11
1 O 0 1.1999166105169934e-09
% O 0 8.658461447819121e-11
) O 0 4.876933232256242e-11
of O 0 3.048894747781361e-10
476 O 0 2.6792330132252573e-08
patients O 0 2.4030555323406588e-08
. O 0 4.14128003001224e-08

Compared O 0 1.6276395342629257e-08
with O 0 3.942070628260019e-11
the O 0 5.337165709384806e-10
frequency O 0 1.2978233598914812e-08
in O 0 3.065150910863679e-10
two O 0 1.721962676615174e-11
separate O 0 6.00032913980475e-12
population O 0 8.385627804120832e-13
control O 0 7.06972813624418e-11
groups O 0 1.3837994985999025e-11
, O 0 1.0606018840952913e-10
the O 0 1.1352984330414984e-08
APC O 0 1.1640603361229296e-06
I1307K O 0 6.394634056050563e-06
allele O 0 9.177531978821207e-08
is O 0 4.3589572923385944e-11
associated O 0 1.8224750875095452e-10
with O 0 2.0044148632547554e-12
an O 0 4.1060826613814605e-12
estimated O 0 3.4958513948218917e-12
relative O 0 3.499724399169679e-10
risk O 0 7.636231647012437e-10
of O 0 1.4882249876890796e-09
1 O 0 8.457446938336943e-07
. O 0 1.58247064518946e-06

5 O 0 1.04336550066364e-06
- O 0 7.843416938158043e-07
1 O 0 1.1388942766643595e-06
. O 0 6.864429451525211e-07

7 O 0 8.760133596297237e-07
for O 0 2.6508749328968406e-07
colorectal B-Disease 1 1.0
neoplasia I-Disease 1 0.9999873638153076
( O 0 3.039259866000066e-08
both O 0 1.6534887237185103e-08
P O 0 6.185242114042921e-07
= O 0 8.164986553538256e-08
. O 0 1.7702088683790862e-09
01 O 0 4.837364144805179e-07
) O 0 2.3662996007089987e-09
. O 0 3.989974928231277e-08

Furthermore O 0 4.036222946979251e-07
, O 0 1.2929404213934959e-09
compared O 0 1.171099439645218e-09
with O 0 1.617230932504654e-10
noncarriers O 0 6.885345101181883e-06
, O 0 3.6911654177629316e-08
APC O 0 1.2636801329790615e-06
I1307K O 0 1.97328836293309e-06
carriers O 0 1.1446939396364542e-08
had O 0 2.703615553656391e-09
increased O 0 5.76793557360844e-10
numbers O 0 1.3239350726834687e-09
of O 0 1.2547060057599424e-09
adenomas B-Disease 0 7.787630602251738e-05
and O 0 1.9575275018723914e-06
colorectal B-Disease 1 1.0
cancers I-Disease 1 1.0
per O 0 4.269585929250752e-07
patient O 0 2.596307240310125e-06
( O 0 3.516351931853734e-10
P O 0 1.9495242042921745e-07
= O 0 2.7524643897436363e-08
. O 0 4.1766867742154545e-10
03 O 0 1.2863543474850303e-07
) O 0 5.861625768099898e-11
, O 0 9.952563946591386e-12
as O 0 2.3395051521046817e-11
well O 0 4.2267727512479425e-11
as O 0 1.1483162337677655e-10
a O 0 3.8286079862004385e-10
younger O 0 4.828788480182311e-09
age O 0 8.622148328640833e-09
at O 0 4.973604106339735e-08
diagnosis O 0 1.2022516784782056e-05
. O 0 3.4995719033759087e-07

We O 0 1.0282269613526296e-07
conclude O 0 1.7029078946961818e-07
that O 0 4.606695469533406e-09
the O 0 3.227435385610988e-08
APC O 0 1.2461217693271465e-06
I1307K O 0 3.502731487969868e-06
variant O 0 1.510963443251967e-06
leads O 0 1.049210762715802e-08
to O 0 1.0619086054930449e-08
increased O 0 6.342762617350672e-07
adenoma B-Disease 1 1.0
formation O 0 5.324116045812843e-07
and O 0 9.204695894382553e-10
directly O 0 3.432072959164145e-10
contributes O 0 9.153709040754521e-11
to O 0 6.387552292652643e-11
3 O 0 3.627287636920329e-10
% O 0 2.319431452457721e-11
- O 0 5.083849452525158e-10
4 O 0 1.007909644634708e-09
% O 0 1.5582807266767418e-10
of O 0 1.2249110059592283e-10
all O 0 1.117423445440302e-10
Ashkenazi O 0 1.8524607412473415e-06
Jewish O 0 8.982029248727486e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 7.849157555028796e-06

The O 0 1.3994038283726695e-07
estimated O 0 1.855056774857644e-09
relative O 0 3.2736362953755815e-08
risk O 0 1.4071465770371105e-08
for O 0 1.1318558312822802e-09
carriers O 0 3.0749665036466922e-09
may O 0 5.608698394610201e-09
justify O 0 1.2694869155893684e-08
specific O 0 9.769958453365035e-11
clinical O 0 1.6104652333925884e-10
screening O 0 1.2740264399013768e-10
for O 0 1.3024444023290727e-10
the O 0 1.761209095230143e-10
360 O 0 2.283530919910959e-09
, O 0 2.263170900684841e-11
000 O 0 7.067992302545179e-10
Americans O 0 1.477439975916539e-10
expected O 0 1.1311732800445284e-10
to O 0 2.2747094485797703e-10
harbor O 0 1.0299538999447577e-08
this O 0 6.769302340892125e-10
allele O 0 8.231925363588743e-09
, O 0 1.0985309190081338e-10
and O 0 2.1766860883176697e-11
genetic O 0 5.05394337491083e-11
testing O 0 3.4573337248655633e-11
in O 0 6.820097438187123e-12
the O 0 1.0680562684273198e-10
setting O 0 9.297083658488248e-10
of O 0 8.61812704533449e-11
long O 0 1.615944357491461e-11
- O 0 1.9645383930733118e-10
term O 0 3.5951099874864667e-09
- O 0 9.335517914266234e-10
outcome O 0 2.3128104986724907e-10
studies O 0 1.4081680266286867e-10
may O 0 2.944780530533819e-11
impact O 0 6.639470223612776e-11
significantly O 0 4.580349877159051e-09
on O 0 0.00012565511860884726
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 0 5.07372249103355e-07
in O 0 4.1914249848673535e-11
this O 0 5.078177808814921e-11
population O 0 3.202784565337069e-11
. O 0 8.82116335532146e-09

Localization O 0 1.754627919581253e-05
of O 0 1.2321719111696439e-07
human O 0 2.0563051705835278e-08
BRCA1 O 0 2.13796216286255e-08
and O 0 4.758694549522602e-10
its O 0 1.3057382952652574e-09
loss O 0 7.50752970901658e-09
in O 0 1.0691778573601596e-09
high O 0 9.417917112841678e-09
- O 0 3.759746292075761e-09
grade O 0 3.8643850786002076e-08
, O 0 1.593176590652945e-09
non B-Disease 0 0.0008115588570944965
- I-Disease 0 0.3634245991706848
inherited I-Disease 1 1.0
breast I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 0.29423069953918457

Although O 0 4.371111117507098e-08
the O 0 3.771467582680543e-09
link O 0 6.421432718894948e-09
between O 0 2.296589723949083e-10
the O 0 8.2102555865049e-09
BRCA1 O 0 2.351507255582419e-08
tumour B-Disease 1 1.0
- O 0 6.3497203051099405e-09
suppressor O 0 5.767369515297105e-08
gene O 0 6.979312239252522e-09
and O 0 2.8596531809199632e-09
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 1.631046302463801e-07
established O 0 1.2213660305349094e-08
, O 0 5.282947343476785e-11
the O 0 2.1394692961695938e-10
role O 0 7.872337781655858e-10
, O 0 4.04569606982097e-11
if O 0 4.797295893865794e-11
any O 0 3.229334855081589e-10
, O 0 1.7656422157674712e-10
of O 0 8.601578338485183e-10
BRCA1 O 0 2.0605886774660576e-08
in O 0 1.3072416038539814e-08
non B-Disease 1 0.9999713897705078
- I-Disease 0 0.35133597254753113
familial I-Disease 0 0.00011562777945073321
cancers I-Disease 1 0.9999994039535522
is O 0 1.8178657468226334e-09
unclear O 0 8.695263886693283e-08
. O 0 1.1310594061342272e-07

BRCA1 O 0 5.076828074379591e-06
mutations O 0 1.6775617339703786e-08
are O 0 2.472350379978394e-10
rare O 0 2.6944417808039134e-09
in O 0 1.1815999290121226e-09
sporadic B-Disease 0 5.869555366189161e-07
cancers I-Disease 0 4.40488729509525e-05
, O 0 7.272616953102329e-10
but O 0 1.3998057157849075e-09
loss O 0 1.2716782293864526e-07
of O 0 5.188180693949107e-07
BRCA1 O 0 2.2085730577714457e-08
resulting O 0 5.275196945930816e-10
from O 0 1.4515495749822804e-10
reduced O 0 2.108664354238954e-09
expression O 0 6.6463061720867245e-09
or O 0 3.5195810710320075e-09
incorrect O 0 6.123999440887928e-08
subcellular O 0 1.2498170463004499e-06
localization O 0 8.224761586461682e-06
is O 0 7.838850679675602e-10
postulated O 0 8.957239394646876e-09
to O 0 9.662421973644086e-10
be O 0 7.710445476538652e-11
important O 0 9.812463341862809e-11
in O 0 4.901872796558848e-10
non B-Disease 0 2.2348782295011915e-05
- I-Disease 0 7.746412302367389e-05
familial I-Disease 1 0.9999935626983643
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 1 1.0

Epigenetic O 0 0.0005754302255809307
loss O 0 2.358100209676195e-05
, O 0 5.4070583566101504e-09
however O 0 1.6693959548064186e-09
, O 0 1.1917801467919986e-10
has O 0 3.932216097873864e-12
not O 0 6.9732210457307264e-12
received O 0 2.079577135494226e-11
general O 0 5.841260808381321e-10
acceptance O 0 1.142301275791624e-08
due O 0 2.3853056418943197e-08
to O 0 1.8204168839019985e-08
controversy O 0 1.2078086308875413e-09
regarding O 0 2.8201392332505293e-09
the O 0 1.1167314850624166e-09
subcellular O 0 3.765849214687478e-07
localization O 0 1.3636494259117171e-05
of O 0 8.209037360984439e-08
BRCA1 O 0 6.105313588022909e-09
proteins O 0 2.2113529063449988e-10
, O 0 1.0634459285396858e-10
reports O 0 3.33725103107696e-10
of O 0 9.309251286504505e-11
which O 0 1.563048822317281e-11
have O 0 3.159469560976014e-11
ranged O 0 4.5417678506964876e-09
from O 0 1.2718365249853036e-10
exclusively O 0 1.1590374215941779e-09
nuclear O 0 1.096869706174175e-08
, O 0 3.663722658586721e-10
to O 0 2.3409403304697207e-09
conditionally O 0 1.1616739570285972e-08
nuclear O 0 1.0340738043623787e-08
, O 0 2.1453208653987588e-10
to O 0 4.182716395462194e-09
the O 0 1.1525589371785827e-08
ER O 0 3.675622110677068e-06
/ O 0 7.535259101132397e-06
golgi O 0 7.797953912813682e-06
, O 0 1.2121804005005288e-08
to O 0 1.6410748315820456e-08
cytoplasmic O 0 3.7620868198473545e-08
invaginations O 0 8.122091230688966e-07
into O 0 7.686489666980378e-09
the O 0 1.7395372253758978e-08
nucleus O 0 1.2612358091246278e-07
. O 0 2.344588523328639e-07

In O 0 2.0556816693328983e-08
an O 0 6.48909759259908e-10
attempt O 0 5.983218809291202e-09
to O 0 4.965592381722672e-09
resolve O 0 1.1403029631651407e-08
this O 0 2.9561667003186187e-10
issue O 0 4.84608841944123e-09
, O 0 1.1342130706859521e-10
we O 0 4.883135007460737e-10
have O 0 2.3359839063097354e-10
comprehensively O 0 5.1024187541770516e-08
characterized O 0 1.2605450905311955e-08
19 O 0 2.1916581260938983e-07
anti O 0 3.0526912269124296e-06
- O 0 1.709199523247662e-06
BRCA1 O 0 1.1016462764246171e-07
antibodies O 0 2.6925167873059763e-08
. O 0 2.0714969650725834e-07

These O 0 7.847055627507871e-08
reagents O 0 9.007601988741953e-07
detect O 0 1.0687750062743362e-07
a O 0 3.1520388521499854e-09
220 O 0 4.469623338110296e-09
- O 0 1.4136619874705048e-08
kD O 0 3.1016818979878735e-07
protein O 0 2.8076125868636836e-09
localized O 0 2.165516654883959e-08
in O 0 1.1055689697059279e-09
discrete O 0 6.312647737871657e-09
nuclear O 0 6.134450813988224e-08
foci O 0 8.350819484803651e-07
in O 0 3.1758840890461215e-08
all O 0 1.1231318097770782e-08
epithelial O 0 1.6893270071705047e-07
cell O 0 8.117176264477166e-08
lines O 0 5.923397883300652e-10
, O 0 4.8373013927793806e-11
including O 0 1.8749037045129313e-11
those O 0 4.3513567749009496e-11
derived O 0 4.301716316490456e-09
from O 0 7.988904648925654e-09
breast B-Disease 0 4.184592398814857e-06
malignancies I-Disease 0 1.2221417819091585e-05
. O 0 7.794367320457241e-07

Immunohistochemical O 0 0.00040436373092234135
staining O 0 2.6458983484189957e-05
of O 0 3.043134881863807e-07
human O 0 1.408919558798516e-07
breast O 0 7.507556347263744e-06
specimens O 0 5.857689302501967e-07
also O 0 4.7521055535071355e-08
revealed O 0 1.287666435700885e-07
BRCA1 O 0 8.576881782573764e-08
nuclear O 0 1.843207684260051e-07
foci O 0 3.9409146666002925e-06
in O 0 4.915186764264945e-07
benign O 1 1.0
breast O 1 1.0
, O 0 4.2860676785494434e-07
invasive B-Disease 1 0.9999971389770508
lobular I-Disease 1 1.0
cancers I-Disease 1 0.9999998807907104
and O 0 2.0412583126017125e-06
low B-Disease 1 1.0
- I-Disease 1 0.9999983310699463
grade I-Disease 1 1.0
ductal I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 0.0019153016619384289

Conversely O 0 1.3080417602395755e-06
, O 0 1.7878100777579675e-08
BRCA1 O 0 1.0174734654810891e-07
expression O 0 1.035097874080293e-08
was O 0 4.142392207029388e-09
reduced O 0 1.0864747990169121e-09
or O 0 1.5214518533923638e-10
undetectable O 0 9.99629712339356e-09
in O 0 3.1792974503064286e-11
the O 0 2.4500007578254213e-10
majority O 0 1.7394549342575338e-11
of O 0 2.213821626018131e-10
high O 0 4.735806857780744e-09
- O 0 1.722106723889283e-08
grade O 0 9.994506626753719e-07
, O 0 4.669595909945201e-08
ductal B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 0 3.979180984714503e-09
suggesting O 0 5.198984798227002e-09
that O 0 2.1825768622973918e-11
absence O 0 6.515769257475768e-08
of O 0 3.610215415505991e-08
BRCA1 O 0 1.7792951112483024e-08
may O 0 1.401643801024477e-09
contribute O 0 1.3305371249217046e-09
to O 0 3.765171729952499e-09
the O 0 5.427392757439975e-09
pathogenesis O 0 1.2543984666990582e-05
of O 0 5.925016921537463e-09
a O 0 8.673986529039723e-10
significant O 0 1.3409369170602758e-09
percentage O 0 9.85484316373686e-09
of O 0 3.5912102180901684e-09
sporadic B-Disease 0 2.1699839635402896e-05
breast I-Disease 1 0.9992223978042603
cancers I-Disease 0 0.14155453443527222
. O 0 2.414174787190859e-06
. O 0 7.905318852863275e-06

